data_2lwy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lwy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.041 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 99.1 m-85 -126.12 154.03 43.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.837 1.655 . . . . 0.0 111.415 172.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -70.64 162.14 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.495 0.664 . . . . 0.0 112.327 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.47 150.26 5.05 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.439 1.096 . . . . 0.0 112.639 173.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.18 -6.22 22.76 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 117.877 -1.513 . . . . 0.0 116.788 -173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.5 m -63.1 120.38 11.34 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.81 2.305 . . . . 0.0 110.147 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.0 mmt -76.02 146.44 39.48 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.915 1.286 . . . . 0.0 112.224 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 mm -131.64 134.1 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 127.685 2.394 . . . . 0.0 109.918 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 tp -78.91 127.01 31.46 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -120.63 173.89 6.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.667 1.587 . . . . 0.0 111.792 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.87 -24.85 67.66 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.939 -1.1 . . . . 0.0 113.429 175.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 p -107.31 -19.31 13.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.539 1.135 . . . . 0.0 113.518 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.89 -115.34 0.61 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.439 1.019 . . . . 0.0 113.363 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -122.8 153.32 39.7 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.048 1.739 . . . . 0.0 111.799 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.1 p -136.53 152.29 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.929 1.691 . . . . 0.0 110.268 168.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.26 146.09 37.1 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.773 -1.204 . . . . 0.0 110.819 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.2 tt -62.65 -29.49 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 121.044 -1.035 . . . . 0.0 112.664 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -65.39 -11.12 39.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.689 1.196 . . . . 0.0 113.729 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -120.13 -3.65 10.07 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.914 1.685 . . . . 0.0 113.371 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.1 mm -61.43 137.89 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 120.018 1.281 . . . . 0.0 108.806 166.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -124.16 159.05 30.91 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.021 1.328 . . . . 0.0 112.027 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.62 131.71 47.06 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.792 -1.193 . . . . 0.0 110.579 165.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.88 -4.44 82.68 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.601 1.095 . . . . 0.0 115.046 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.92 155.55 37.32 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.148 1.474 . . . . 0.0 111.542 163.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -109.48 150.76 27.64 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.362 1.465 . . . . 0.0 112.393 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.23 157.78 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.567 1.947 . . . . 0.0 110.072 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -73.97 137.9 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.795 -0.566 . . . . 0.0 110.712 165.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.41 118.24 16.19 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -98.05 111.88 24.03 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -54.47 114.76 7.25 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.873 1.269 . . . . 0.0 112.365 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.89 -4.52 14.96 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.711 2.274 . . . . 0.0 114.09 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -77.19 -46.87 21.87 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.682 1.193 . . . . 0.0 112.234 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 t -141.22 6.37 1.93 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.143 0.977 . . . . 0.0 112.84 -168.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 54.68 33.0 18.42 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.573 1.549 . . . . 0.0 114.037 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -71.05 125.85 27.98 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 167.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -96.66 120.13 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 124.227 1.011 . . . . 0.0 109.029 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.6 154.73 50.59 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.2 133.62 36.04 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.078 0.951 . . . . 0.0 108.998 162.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -138.92 152.54 47.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.078 0.951 . . . . 0.0 110.878 171.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 t -89.09 160.16 17.19 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.0 t -96.12 133.73 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.463 1.905 . . . . 0.0 111.575 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 mt -90.8 -43.0 10.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.932 0.893 . . . . 0.0 113.355 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -148.94 156.12 41.82 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.796 2.038 . . . . 0.0 111.138 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.4 p -132.34 103.49 6.24 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.08 1.752 . . . . 0.0 110.416 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -91.06 150.73 21.3 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.6 1.56 . . . . 0.0 112.727 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.8 t -143.02 129.57 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.342 1.057 . . . . 0.0 110.453 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -122.89 175.54 6.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.307 1.843 . . . . 0.0 110.931 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -128.2 137.44 52.04 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.679 1.192 . . . . 0.0 111.323 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.9 t -148.35 149.34 31.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.691 1.196 . . . . 0.0 111.88 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.2 p -91.21 -14.74 30.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.895 1.278 . . . . 0.0 113.863 170.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -100.32 111.34 23.6 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.384 -0.822 . . . . 0.0 111.399 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -120.5 157.83 28.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 122.939 1.352 . . . . 0.0 112.922 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 tp -126.39 133.31 51.33 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.535 1.934 . . . . 0.0 109.259 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -110.4 124.86 52.51 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.215 1.006 . . . . 0.0 108.773 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.8 mt -118.24 138.76 52.13 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.977 0.911 . . . . 0.0 109.779 171.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.6 m -106.54 122.34 46.11 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.99 117.97 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.075 1.35 . . . . 0.0 108.515 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.65 28.24 51.22 Favored Glycine 0 CA--C 1.544 1.888 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.7 -9.3 78.08 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.35 1.452 . . . . 0.0 115.737 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -92.79 122.93 35.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.002 1.401 . . . . 0.0 110.068 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.0 t -78.98 125.81 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.566 0.746 . . . . 0.0 110.617 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mt -121.77 103.77 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.979 1.711 . . . . 0.0 109.352 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -80.58 122.55 27.19 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.11 1.764 . . . . 0.0 111.035 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 t -146.16 178.22 8.39 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.629 1.172 . . . . 0.0 112.702 -167.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.8 p -82.23 152.75 26.25 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.048 0.927 . . . . 0.0 112.472 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -65.69 -19.38 65.88 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.44 9.38 31.71 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.976 1.311 . . . . 0.0 113.616 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.1 t60 -65.56 129.84 94.46 Favored Pre-proline 0 CA--C 1.552 1.053 0 O-C-N 120.465 -1.397 . . . . 0.0 113.042 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.7 119.92 4.97 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.98 3.12 . . . . 0.0 114.732 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -112.2 150.04 31.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.963 2.105 . . . . 0.0 111.223 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -93.86 130.8 39.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.275 0.943 . . . . 0.0 113.382 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.14 134.32 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 127.499 2.319 . . . . 0.0 111.339 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -58.06 130.26 45.75 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.733 1.213 . . . . 0.0 111.677 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 60.88 16.41 6.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.779 1.632 . . . . 0.0 114.555 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.9 t -133.8 -58.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.255 1.022 . . . . 0.0 111.231 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.93 -152.12 17.16 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.925 0.774 . . . . 0.0 113.714 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -86.75 139.16 30.99 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -170.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.12 149.01 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.249 1.82 . . . . 0.0 111.666 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.93 134.03 51.19 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.482 1.113 . . . . 0.0 112.632 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.95 -36.61 72.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.343 1.457 . . . . 0.0 112.856 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.72 -8.28 81.47 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.508 -1.162 . . . . 0.0 114.559 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -103.02 -12.88 17.12 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.025 1.412 . . . . 0.0 113.731 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.2 mt -56.97 163.08 2.13 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.27 1.428 . . . . 0.0 113.543 170.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.97 164.53 18.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.614 1.565 . . . . 0.0 110.727 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.5 t -67.92 143.73 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 122.39 1.09 . . . . 0.0 110.347 167.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.59 3.69 89.0 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.716 -1.047 . . . . 0.0 114.315 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -84.95 160.56 20.06 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.641 1.72 . . . . 0.0 111.471 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -104.84 103.71 13.36 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.399 1.08 . . . . 0.0 112.458 -160.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.8 mt -93.56 175.84 6.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.07 0.948 . . . . 0.0 110.453 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -122.19 158.85 28.5 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.76 -178.0 3.53 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.398 1.479 . . . . 0.0 113.871 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.1 p -61.25 -17.66 54.48 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -90.33 -25.57 20.41 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.243 1.383 . . . . 0.0 111.603 170.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.73 19.31 18.04 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.796 1.665 . . . . 0.0 112.369 -176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -88.4 155.61 19.59 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.007 1.723 . . . . 0.0 110.793 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -80.73 128.11 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -169.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.6 mt -107.48 162.72 13.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.094 2.158 . . . . 0.0 112.231 169.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.83 139.71 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.365 1.066 . . . . 0.0 111.195 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.5 t -73.73 124.95 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.427 0.691 . . . . 0.0 109.44 171.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -94.83 -33.63 12.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.425 1.89 . . . . 0.0 112.912 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -156.73 149.01 23.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.929 1.291 . . . . 0.0 111.292 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -124.73 127.43 47.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.836 2.054 . . . . 0.0 110.3 166.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -140.37 154.06 46.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.667 1.987 . . . . 0.0 111.505 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 tp -140.43 148.67 41.56 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.554 1.542 . . . . 0.0 110.083 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -155.28 164.86 38.2 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.718 0.807 . . . . 0.0 113.102 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mm -96.11 124.62 48.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 123.751 0.82 . . . . 0.0 109.188 161.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.95 150.65 45.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.744 1.218 . . . . 0.0 112.638 172.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -78.4 -13.02 60.03 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.685 1.594 . . . . 0.0 113.075 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -146.87 153.32 45.91 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.55 2.34 . . . . 0.0 110.132 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.48 114.76 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.916 2.411 . . . . 0.0 111.131 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.5 t -85.55 142.8 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.382 1.473 . . . . 0.0 109.989 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -79.71 139.39 37.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.119 0.962 . . . . 0.0 111.613 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.1 m -141.46 141.43 30.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.005 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -120.18 146.61 45.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.241 1.417 . . . . 0.0 110.77 -165.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -153.9 159.57 41.81 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.868 1.267 . . . . 0.0 111.397 173.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -150.72 163.14 39.29 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.434 -1.416 . . . . 0.0 113.568 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -120.26 138.85 53.43 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.72 149.42 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 127.557 2.343 . . . . 0.0 111.898 -168.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.89 -33.86 76.18 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 -168.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -143.81 -53.25 0.35 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.895 1.225 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -66.24 165.95 12.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.684 0.754 . . . . 0.0 110.297 167.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -133.51 27.64 4.04 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.429 1.492 . . . . 0.0 112.25 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.5 p -128.66 164.69 22.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.239 1.816 . . . . 0.0 111.881 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -159.03 -176.59 5.95 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.455 1.902 . . . . 0.0 109.922 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -127.24 138.37 53.09 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.395 1.078 . . . . 0.0 112.95 -171.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.47 143.6 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.194 0.997 . . . . 0.0 113.612 -171.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.35 168.83 20.07 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.615 1.579 . . . . 0.0 114.657 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.36 -22.8 61.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.175 1.39 . . . . 0.0 113.279 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -91.27 -0.9 57.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.762 1.625 . . . . 0.0 114.786 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 62.67 44.25 6.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.9 t -71.64 137.9 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.094 1.358 . . . . 0.0 111.406 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 57.2 tp -80.69 125.63 30.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.704 1.601 . . . . 0.0 113.247 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.49 160.07 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.894 1.678 . . . . 0.0 111.696 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -102.31 156.9 17.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.019 1.328 . . . . 0.0 113.06 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.088 1.755 . . . . 0.0 113.651 171.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.086 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 91.6 m-85 -121.26 156.02 33.39 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.332 1.453 . . . . 0.0 111.511 169.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.95 160.78 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.34 0.591 . . . . 0.0 112.054 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.59 152.5 2.71 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.905 0.86 . . . . 0.0 112.95 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.18 -9.16 20.69 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-O 117.349 -1.806 . . . . 0.0 116.696 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -62.91 123.55 18.79 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 120.878 2.339 . . . . 0.0 110.811 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -80.57 141.91 34.61 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.426 1.49 . . . . 0.0 112.294 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.81 134.85 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.87 2.068 . . . . 0.0 110.036 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.06 126.84 31.62 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.297 1.039 . . . . 0.0 113.032 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.8 p -121.9 172.75 7.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.025 1.33 . . . . 0.0 111.487 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.8 -20.32 65.69 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 120.844 -1.16 . . . . 0.0 113.268 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 p -109.41 -13.07 14.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.913 2.085 . . . . 0.0 113.759 -170.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.24 -112.75 0.64 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 126.087 1.803 . . . . 0.0 112.443 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -133.33 141.67 48.06 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.222 1.009 . . . . 0.0 112.583 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -133.06 144.29 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.446 1.899 . . . . 0.0 109.111 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.59 147.8 47.25 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.274 -0.891 . . . . 0.0 111.027 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -62.9 -27.6 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 120.315 -1.491 . . . . 0.0 113.043 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.58 -16.35 63.83 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.206 1.003 . . . . 0.0 113.457 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -110.61 -10.41 14.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.293 1.837 . . . . 0.0 113.146 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.4 mm -65.12 137.47 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 119.407 1.003 . . . . 0.0 108.921 162.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -127.65 166.06 18.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.915 2.086 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.53 133.67 46.18 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.89 -0.506 . . . . 0.0 110.511 160.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.29 6.73 89.09 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.972 1.272 . . . . 0.0 115.674 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -85.38 155.44 21.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.295 1.048 . . . . 0.0 110.333 165.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.59 135.25 52.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.311 1.044 . . . . 0.0 112.539 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.8 157.13 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.016 1.726 . . . . 0.0 110.652 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.3 mm -76.1 142.38 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.75 0.31 . . . . 0.0 111.275 168.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.63 126.73 22.66 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.904 0.881 . . . . 0.0 109.144 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.435 ' HG1' ' CE1' ' A' ' 125' ' ' HIS . 95.0 m -88.41 107.95 19.12 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 165.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -52.94 116.35 9.03 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.529 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.11 -11.22 28.72 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.673 2.249 . . . . 0.0 114.272 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -78.23 -49.1 14.38 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.748 1.219 . . . . 0.0 111.766 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 t -121.67 -7.88 9.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.525 1.13 . . . . 0.0 112.677 -167.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.276 12.9 m-85 53.5 43.02 31.83 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.703 1.601 . . . . 0.0 112.12 -173.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -81.44 131.37 35.28 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.927 0.891 . . . . 0.0 108.755 165.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.17 123.38 47.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 123.232 0.613 . . . . 0.0 110.621 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.2 159.22 42.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.311 1.045 . . . . 0.0 112.502 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -92.14 126.06 37.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.64 1.176 . . . . 0.0 108.87 164.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -137.84 152.83 49.48 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.189 0.996 . . . . 0.0 111.153 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -83.56 156.08 22.96 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.311 1.045 . . . . 0.0 113.058 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.8 t -87.58 134.55 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.706 1.602 . . . . 0.0 111.071 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.6 mt -84.21 -49.03 9.18 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.426 1.09 . . . . 0.0 112.508 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -151.28 159.77 44.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.694 1.998 . . . . 0.0 110.38 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.5 p -120.17 122.96 42.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.919 2.088 . . . . 0.0 109.571 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -101.46 147.02 26.85 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.89 0.876 . . . . 0.0 112.998 173.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.03 135.09 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.06 1.344 . . . . 0.0 110.077 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -126.86 170.93 11.71 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.028 2.131 . . . . 0.0 109.246 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -131.56 136.59 47.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.426 0.69 . . . . 0.0 111.714 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 t -154.57 146.93 23.91 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.598 0.759 . . . . 0.0 111.348 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.7 p -84.24 -18.32 36.89 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.716 0.806 . . . . 0.0 111.884 162.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -99.47 110.03 22.54 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 120.857 -1.152 . . . . 0.0 110.766 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.1 mt -121.5 172.53 8.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.767 1.627 . . . . 0.0 111.383 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.7 tp -141.32 130.48 23.43 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.893 1.277 . . . . 0.0 111.321 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -112.19 106.9 15.61 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.019 -1.05 . . . . 0.0 109.971 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.8 142.25 29.8 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.458 -0.776 . . . . 0.0 110.376 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.6 m -115.45 120.83 40.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.951 0.901 . . . . 0.0 109.471 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.02 117.37 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 126.32 1.848 . . . . 0.0 108.634 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.57 30.09 41.51 Favored Glycine 0 CA--C 1.543 1.789 0 N-CA-C 115.717 1.047 . . . . 0.0 115.717 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.08 6.4 84.8 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -102.37 129.38 48.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.881 1.341 . . . . 0.0 110.149 165.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -86.71 129.02 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.895 0.878 . . . . 0.0 110.287 164.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mt -121.7 101.51 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.07 1.348 . . . . 0.0 109.201 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.87 117.16 15.32 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.819 1.648 . . . . 0.0 110.732 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 t -142.72 -179.97 6.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.886 1.274 . . . . 0.0 112.464 -165.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.0 p -87.72 156.98 19.18 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 122.135 0.969 . . . . 0.0 112.353 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -59.45 -31.38 69.26 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.534 1.134 . . . . 0.0 113.082 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -101.05 8.96 42.67 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.5 t60 -64.08 128.12 92.68 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.474 1.034 . . . . 0.0 112.871 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.12 119.07 2.74 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.181 2.587 . . . . 0.0 114.947 -175.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -108.74 150.3 27.79 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.98 2.112 . . . . 0.0 111.472 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -98.19 130.04 44.94 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.517 1.053 . . . . 0.0 113.556 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.97 137.1 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.762 2.425 . . . . 0.0 111.392 -173.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -57.59 121.93 11.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.767 2.027 . . . . 0.0 112.671 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 53.03 30.04 8.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.616 1.967 . . . . 0.0 114.262 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.5 t -136.29 -50.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.469 1.508 . . . . 0.0 112.009 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.71 -153.58 17.53 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.046 0.831 . . . . 0.0 113.783 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -87.57 141.24 28.77 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.415 -1.05 . . . . 0.0 113.667 -173.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.95 145.28 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.284 1.433 . . . . 0.0 111.808 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.25 137.12 57.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.949 1.3 . . . . 0.0 112.098 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.18 -35.77 69.99 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.346 1.058 . . . . 0.0 113.64 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.04 -16.82 67.04 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 121.299 -0.876 . . . . 0.0 114.02 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -103.29 -2.04 27.8 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.467 1.907 . . . . 0.0 113.512 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.28 151.82 39.52 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.676 -0.64 . . . . 0.0 110.836 162.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.21 157.87 39.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.894 1.678 . . . . 0.0 109.623 170.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.53 136.8 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.07 4.78 88.17 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-O 118.856 -0.969 . . . . 0.0 115.441 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -83.29 150.17 26.32 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.546 1.673 . . . . 0.0 110.098 170.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -108.6 113.54 26.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.561 1.544 . . . . 0.0 112.631 -165.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.6 165.49 11.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.645 1.578 . . . . 0.0 112.627 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.71 142.42 36.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.667 1.587 . . . . 0.0 110.892 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -96.11 -178.13 4.23 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.986 0.915 . . . . 0.0 113.203 166.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.7 p -62.57 -1.77 0.91 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.628 1.971 . . . . 0.0 116.257 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.7 mtm-85 -117.8 -27.49 6.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.101 2.161 . . . . 0.0 111.565 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 104.43 17.32 15.67 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.813 2.149 . . . . 0.0 113.449 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -69.28 159.3 33.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.891 0.876 . . . . 0.0 111.14 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.3 t -75.87 131.41 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.747 0.784 . . . . 0.0 110.786 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.6 mt -117.5 158.47 24.49 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.931 2.092 . . . . 0.0 109.699 161.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.4 142.26 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.408 0.683 . . . . 0.0 111.277 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.48 129.4 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.429 1.091 . . . . 0.0 110.352 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -102.45 -33.91 9.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.351 2.26 . . . . 0.0 112.966 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -159.52 152.19 21.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.795 1.638 . . . . 0.0 111.797 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -124.92 124.06 41.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.053 2.141 . . . . 0.0 109.816 159.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -118.59 140.17 50.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.891 2.076 . . . . 0.0 109.868 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 tp -121.31 125.59 47.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.884 1.274 . . . . 0.0 110.637 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.66 159.34 39.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.582 0.706 . . . . 0.0 112.268 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.7 mm -111.36 114.07 46.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 166.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.36 150.7 42.8 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 122.103 0.954 . . . . 0.0 111.723 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.04 -22.09 60.69 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.944 1.298 . . . . 0.0 112.819 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -134.74 151.88 76.56 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 126.292 1.837 . . . . 0.0 111.131 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.91 111.28 3.0 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.683 2.256 . . . . 0.0 110.899 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.16 141.5 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 126.245 1.818 . . . . 0.0 109.674 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -75.28 134.27 41.12 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.297 1.046 . . . . 0.0 110.247 172.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.44 130.49 67.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.226 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -112.36 148.18 34.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.012 1.725 . . . . 0.0 110.959 -166.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -153.35 169.02 24.13 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.327 1.451 . . . . 0.0 109.867 171.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -148.73 171.74 15.73 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 120.398 -1.439 . . . . 0.0 111.674 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -128.52 139.55 52.26 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.817 0.847 . . . . 0.0 112.682 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.413 ' H ' ' ND2' ' A' ' 135' ' ' ASN . 89.9 t -98.47 145.43 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.982 1.713 . . . . 0.0 111.62 -169.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.13 -40.62 86.04 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -166.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -133.6 -36.9 0.95 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.035 0.934 . . . . 0.0 112.57 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.76 160.45 29.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.933 0.873 . . . . 0.0 110.533 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -114.95 11.52 16.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.202 1.401 . . . . 0.0 112.832 -171.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 p -145.5 166.51 25.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.191 1.797 . . . . 0.0 112.381 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -156.42 -179.01 7.76 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.768 1.627 . . . . 0.0 110.774 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.435 ' CE1' ' HG1' ' A' ' 29' ' ' THR . 25.0 m170 -122.79 138.54 54.61 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.161 1.384 . . . . 0.0 112.413 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -123.3 141.46 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.323 1.449 . . . . 0.0 111.962 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.96 -176.22 53.21 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 168.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.53 -34.66 72.54 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.995 1.718 . . . . 0.0 112.41 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -82.73 -4.54 58.03 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.362 1.065 . . . . 0.0 113.471 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 59.14 47.17 12.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.202 1.801 . . . . 0.0 114.093 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 t -72.96 137.15 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.916 1.286 . . . . 0.0 111.316 -170.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 52.7 tp -81.43 125.98 31.09 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.167 1.387 . . . . 0.0 113.104 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.1 m -138.33 156.72 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.956 1.702 . . . . 0.0 111.301 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -105.81 146.66 29.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.851 1.26 . . . . 0.0 112.129 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 118' ' ' VAL . 18.3 m-20 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.177 0.991 . . . . 0.0 111.835 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.025 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.431 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 96.9 m-85 -128.02 153.23 47.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.408 1.483 . . . . 0.0 112.168 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 m -69.07 154.72 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.15 139.69 28.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.816 0.847 . . . . 0.0 111.55 171.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.72 -6.09 81.7 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.113 -1.382 . . . . 0.0 116.156 -170.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.9 m -64.3 123.43 19.12 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 121.163 2.482 . . . . 0.0 110.336 172.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.5 mmt -83.16 142.12 31.44 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.337 1.055 . . . . 0.0 112.08 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.19 135.03 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.369 2.267 . . . . 0.0 109.642 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.69 133.41 42.07 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 p -137.23 165.84 25.19 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.281 1.432 . . . . 0.0 111.195 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.56 -19.33 63.57 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.44 1.096 . . . . 0.0 113.372 170.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.4 p -86.57 -32.73 20.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.955 1.302 . . . . 0.0 111.64 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.71 -98.79 0.19 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.211 1.862 . . . . 0.0 110.612 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.4 mt -130.48 149.29 52.22 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.153 0.981 . . . . 0.0 111.867 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.5 141.25 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.859 1.663 . . . . 0.0 108.884 169.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.18 148.79 49.39 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.122 -0.986 . . . . 0.0 110.75 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.1 tt -61.48 -28.17 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 120.752 -1.217 . . . . 0.0 112.847 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.98 -6.64 46.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.905 1.282 . . . . 0.0 113.96 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -117.59 -7.96 11.0 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.121 1.769 . . . . 0.0 114.322 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.1 mm -66.81 139.41 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.928 0.785 . . . . 0.0 109.545 161.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -120.42 162.73 19.02 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.614 1.966 . . . . 0.0 110.32 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.5 135.54 54.37 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.093 0.473 . . . . 0.0 110.139 155.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.04 11.6 83.52 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.728 -1.04 . . . . 0.0 115.192 -176.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -96.86 158.0 15.64 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.846 1.323 . . . . 0.0 110.947 162.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -112.55 137.95 50.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.997 1.719 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -135.07 161.25 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.199 1.799 . . . . 0.0 111.163 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -76.52 143.11 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.661 0.664 . . . . 0.0 111.425 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.84 132.06 23.3 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.49 172.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.9 m -79.69 112.98 17.5 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 162.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -52.9 123.49 32.76 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 124.585 1.154 . . . . 0.0 112.392 171.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.0 -2.46 11.78 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 123.076 2.517 . . . . 0.0 114.778 -174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -90.78 -48.86 6.78 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.687 1.195 . . . . 0.0 112.004 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 t -127.67 1.56 6.13 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -166.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 61.02 27.41 17.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.339 1.456 . . . . 0.0 114.365 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.85 120.13 15.13 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.422 1.489 . . . . 0.0 109.157 170.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.5 t -100.56 120.48 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.454 0.701 . . . . 0.0 109.163 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.24 164.94 33.37 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.833 0.853 . . . . 0.0 112.089 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.56 137.82 48.34 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.692 0.397 . . . . 0.0 110.416 159.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -135.71 153.04 51.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.687 1.195 . . . . 0.0 111.117 161.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 t -78.12 154.46 31.24 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.2 t -91.93 135.0 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 127.039 2.136 . . . . 0.0 110.393 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.1 mt -87.56 -49.48 7.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.579 1.151 . . . . 0.0 112.33 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -146.57 156.66 43.4 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.179 1.392 . . . . 0.0 111.132 -175.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.5 p -124.86 119.51 29.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.238 1.815 . . . . 0.0 109.071 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -106.72 149.45 27.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.522 1.129 . . . . 0.0 113.316 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.6 t -139.03 142.32 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.2 1.4 . . . . 0.0 111.379 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -139.96 178.22 7.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.419 2.287 . . . . 0.0 111.988 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -129.65 141.09 50.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.05 1.74 . . . . 0.0 111.992 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 t -155.2 153.1 30.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.64 1.176 . . . . 0.0 111.639 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 p -90.0 -18.41 26.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.435 1.094 . . . . 0.0 113.296 164.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -95.0 106.98 19.0 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.391 -0.818 . . . . 0.0 111.725 -177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.7 mt -118.72 168.51 10.66 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.854 1.262 . . . . 0.0 112.571 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 tp -139.04 133.95 32.35 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.715 1.606 . . . . 0.0 110.967 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -106.06 138.1 42.83 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.469 1.508 . . . . 0.0 109.889 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.2 mt -127.21 130.53 49.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.309 1.043 . . . . 0.0 109.961 167.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.9 m -96.73 124.1 40.61 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 167.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.57 117.53 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.362 1.465 . . . . 0.0 109.289 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.53 29.36 31.56 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.09 7.75 79.86 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 116.856 1.502 . . . . 0.0 116.856 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -112.04 140.33 46.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.844 1.822 . . . . 0.0 108.519 163.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -108.49 134.4 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 124.612 1.165 . . . . 0.0 111.837 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 57.9 mt -129.17 136.45 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.858 1.663 . . . . 0.0 109.278 -171.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -120.44 107.21 12.62 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.249 1.42 . . . . 0.0 109.905 -162.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -138.73 175.65 9.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.223 1.409 . . . . 0.0 113.241 -157.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 p -82.87 152.16 25.7 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.922 0.868 . . . . 0.0 111.472 166.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -56.87 -31.02 64.41 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.652 1.181 . . . . 0.0 112.702 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -95.4 1.64 54.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.022 1.329 . . . . 0.0 114.109 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.431 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.0 t60 -65.69 126.64 92.03 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 118.509 -0.758 . . . . 0.0 112.602 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.28 117.37 2.8 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.732 2.288 . . . . 0.0 114.508 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -100.98 143.21 31.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.004 2.121 . . . . 0.0 111.046 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -89.15 127.48 35.73 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.537 1.062 . . . . 0.0 112.432 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.41 136.53 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.472 1.909 . . . . 0.0 110.395 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.2 tptt -50.85 130.75 25.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.772 1.629 . . . . 0.0 110.658 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t70 58.7 10.09 1.34 Allowed 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.5 t -131.55 -47.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.406 -1.433 . . . . 0.0 111.567 -167.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.63 -162.59 14.83 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.791 0.71 . . . . 0.0 113.3 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -76.72 147.5 37.34 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -172.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.91 145.8 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.102 2.161 . . . . 0.0 111.014 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.15 136.72 58.11 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.771 0.828 . . . . 0.0 112.839 172.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.88 -39.47 62.69 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.455 1.502 . . . . 0.0 113.41 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.34 -17.42 74.26 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 121.217 -0.927 . . . . 0.0 114.199 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -104.7 5.32 33.38 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.167 2.187 . . . . 0.0 113.806 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.04 160.89 30.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.632 0.651 . . . . 0.0 110.544 165.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -125.01 150.31 46.85 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.54 1.136 . . . . 0.0 111.58 172.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.72 134.85 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.26 4.35 81.14 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.791 -1.005 . . . . 0.0 114.956 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -92.33 159.53 15.55 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.247 1.524 . . . . 0.0 112.396 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -108.88 109.01 20.0 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.915 1.286 . . . . 0.0 112.47 -157.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 mt -103.14 -177.69 3.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.702 1.601 . . . . 0.0 111.725 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.1 mt -134.53 156.75 48.08 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.445 1.098 . . . . 0.0 113.274 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.96 -175.7 2.79 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.485 1.514 . . . . 0.0 114.413 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -64.62 -6.51 7.84 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -103.44 -16.02 15.71 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.104 1.762 . . . . 0.0 112.605 167.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.04 19.54 50.33 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.442 1.496 . . . . 0.0 112.238 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -84.2 145.94 28.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.46 1.104 . . . . 0.0 110.278 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.9 t -76.0 115.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.087 0.47 . . . . 0.0 110.985 -174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.6 mt -93.37 157.64 16.13 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.973 1.709 . . . . 0.0 111.388 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 t -123.04 138.78 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.294 1.037 . . . . 0.0 110.841 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.16 126.01 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.664 0.786 . . . . 0.0 109.414 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -106.35 -25.25 12.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.759 2.024 . . . . 0.0 113.089 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -163.07 150.81 13.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.933 1.293 . . . . 0.0 111.857 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -120.59 128.37 52.98 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.739 2.016 . . . . 0.0 109.466 161.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -130.85 123.78 29.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.985 1.314 . . . . 0.0 110.964 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.3 tp -102.26 129.32 48.64 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.033 1.333 . . . . 0.0 109.795 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -126.88 149.59 49.69 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.105 0.955 . . . . 0.0 112.961 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.2 mm -111.68 105.6 19.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 171.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.65 154.55 32.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.25 1.02 . . . . 0.0 111.369 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.43 -21.31 28.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.912 0.885 . . . . 0.0 112.054 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -136.95 140.39 31.44 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.43 1.492 . . . . 0.0 110.321 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.12 117.63 4.43 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.019 3.146 . . . . 0.0 111.886 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.04 137.04 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.557 1.543 . . . . 0.0 110.001 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -74.98 135.52 41.33 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.98 0.895 . . . . 0.0 110.566 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -132.6 133.84 59.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 125.096 1.358 . . . . 0.0 110.946 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -117.2 153.94 32.0 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.713 1.605 . . . . 0.0 111.273 -166.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -152.49 155.71 38.0 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.332 2.253 . . . . 0.0 109.348 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -150.46 161.04 43.28 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.57 -1.331 . . . . 0.0 112.614 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.4 148.39 43.84 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.26 144.85 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 125.806 1.643 . . . . 0.0 112.819 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.74 -29.22 63.15 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -164.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -138.63 -41.08 0.5 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.792 -1.192 . . . . 0.0 113.144 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -75.88 165.36 25.11 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.706 -0.621 . . . . 0.0 110.134 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -124.99 32.05 5.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.376 1.471 . . . . 0.0 110.747 -170.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -156.85 164.02 38.54 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.588 1.555 . . . . 0.0 111.268 -162.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -161.97 174.3 13.26 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.189 1.796 . . . . 0.0 110.447 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -121.07 136.34 55.0 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.767 1.227 . . . . 0.0 112.975 -173.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.9 m -127.27 144.91 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.712 1.605 . . . . 0.0 113.91 -173.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.72 172.94 30.13 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 126.038 1.78 . . . . 0.0 115.063 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.63 -20.03 63.62 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.48 -1.6 . . . . 0.0 113.236 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -85.08 -2.18 57.7 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 169.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 57.33 51.52 9.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.664 1.585 . . . . 0.0 112.694 163.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.02 140.1 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.845 2.058 . . . . 0.0 111.697 -168.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 46.0 tp -79.07 127.37 31.91 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.134 1.373 . . . . 0.0 114.33 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.48 154.71 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.858 1.663 . . . . 0.0 111.377 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -103.04 141.63 35.48 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.086 0.954 . . . . 0.0 113.272 -169.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.27 0 CA-C-O 116.322 -1.799 . . . . 0.0 111.242 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.982 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.415 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.4 m-85 -122.35 154.14 38.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.088 1.355 . . . . 0.0 111.491 172.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 m -69.3 154.69 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.0 0.429 . . . . 0.0 111.998 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.21 140.58 20.91 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.034 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.53 -9.46 71.47 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.544 2.021 . . . . 0.0 114.662 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 59.0 m -67.4 126.46 29.35 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.367 1.583 . . . . 0.0 111.5 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.4 mmt -78.1 143.6 37.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.858 1.663 . . . . 0.0 112.487 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.0 mm -129.61 139.0 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.608 1.963 . . . . 0.0 110.431 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.92 129.77 34.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.262 1.425 . . . . 0.0 113.066 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.8 p -134.66 173.03 12.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.777 1.231 . . . . 0.0 113.71 -167.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.07 -13.12 32.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.55 1.54 . . . . 0.0 113.794 171.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.7 p -124.33 1.89 8.43 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.7 -117.89 2.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.396 1.951 . . . . 0.0 110.758 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.51 142.54 46.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.496 1.118 . . . . 0.0 112.634 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.97 148.91 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 127.269 2.227 . . . . 0.0 108.94 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.87 147.33 51.86 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.313 -0.867 . . . . 0.0 112.027 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.5 tt -62.48 -33.31 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 120.936 -1.103 . . . . 0.0 112.514 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.8 pm0 -68.71 -16.5 63.84 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -104.78 -14.74 15.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.039 1.336 . . . . 0.0 112.571 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.2 mm -58.66 133.96 23.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 O-C-N 121.126 -0.984 . . . . 0.0 109.432 164.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -119.81 161.67 20.4 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.386 1.874 . . . . 0.0 112.357 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.38 133.74 53.18 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.84 -0.538 . . . . 0.0 110.556 167.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.13 -6.54 81.22 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.869 1.223 . . . . 0.0 114.785 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.96 150.72 40.61 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.099 1.45 . . . . 0.0 109.628 168.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.87 120.6 42.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.87 0.868 . . . . 0.0 111.2 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.5 m -106.06 151.46 8.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 125.195 1.398 . . . . 0.0 110.083 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.6 mm -81.67 137.08 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.52 116.23 13.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 m -93.07 111.41 23.04 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -52.95 115.01 6.62 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.897 1.279 . . . . 0.0 112.24 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -74.61 -1.61 11.32 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.054 2.503 . . . . 0.0 115.285 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -85.67 -46.75 10.45 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.785 -1.197 . . . . 0.0 112.317 170.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -126.31 -7.4 6.43 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.166 0.986 . . . . 0.0 113.127 -163.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.279 95.5 m-85 58.13 30.41 19.31 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.344 2.257 . . . . 0.0 115.017 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.92 130.05 39.12 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.57 0.748 . . . . 0.0 109.238 170.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -92.37 128.34 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.766 0.826 . . . . 0.0 109.501 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.37 149.36 39.29 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -69.3 136.11 51.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.389 0.676 . . . . 0.0 110.235 156.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 149.01 44.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.886 1.274 . . . . 0.0 110.026 159.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -78.06 153.58 32.16 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.898 0.856 . . . . 0.0 113.176 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.0 t -85.88 120.62 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.7 1.6 . . . . 0.0 109.757 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.71 -52.05 23.49 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.32 0.648 . . . . 0.0 111.12 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -146.24 156.58 43.48 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.266 1.426 . . . . 0.0 111.9 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 p -117.73 118.47 32.15 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.266 1.827 . . . . 0.0 111.148 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -104.52 151.93 23.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.693 1.597 . . . . 0.0 113.316 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.4 140.98 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.0 1.72 . . . . 0.0 109.016 173.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -140.76 176.54 8.71 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.081 1.752 . . . . 0.0 109.889 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -131.61 134.32 45.89 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.576 1.15 . . . . 0.0 111.271 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -144.21 152.03 40.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.211 1.004 . . . . 0.0 110.926 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.7 p -96.76 -15.03 21.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.219 1.407 . . . . 0.0 113.658 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -109.17 106.05 15.77 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.824 0.85 . . . . 0.0 110.682 -170.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.3 mt -116.78 163.94 15.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 122.369 1.081 . . . . 0.0 113.817 -172.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -137.26 129.14 28.97 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.694 1.597 . . . . 0.0 111.853 -176.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -110.51 103.83 12.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.616 1.566 . . . . 0.0 111.188 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.21 141.29 28.59 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.057 0.943 . . . . 0.0 110.058 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.0 m -114.18 125.26 53.73 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 167.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.06 119.46 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.953 1.301 . . . . 0.0 109.891 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.05 24.55 35.64 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.158 0.885 . . . . 0.0 115.149 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.89 -0.36 69.62 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.042 1.306 . . . . 0.0 116.285 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -108.74 125.54 52.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.592 1.696 . . . . 0.0 110.292 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -91.7 134.74 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.143 0.977 . . . . 0.0 112.64 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 mt -133.9 132.21 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.642 1.977 . . . . 0.0 108.828 -170.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -120.99 105.92 11.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.154 0.982 . . . . 0.0 109.538 -159.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 t -140.05 175.75 9.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.916 0.887 . . . . 0.0 113.328 -156.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.0 p -80.54 152.39 28.67 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.897 0.879 . . . . 0.0 112.182 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -61.18 -29.37 69.76 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.974 -1.079 . . . . 0.0 112.656 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -94.19 2.4 55.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.397 1.079 . . . . 0.0 113.456 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.415 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.1 t60 -64.52 128.73 93.72 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 120.97 -1.081 . . . . 0.0 112.826 -172.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -79.93 112.39 2.86 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.561 2.841 . . . . 0.0 114.45 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -102.64 145.59 29.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.18 1.792 . . . . 0.0 111.956 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -93.3 132.04 37.88 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -116.65 135.63 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 127.303 2.241 . . . . 0.0 111.395 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -55.39 129.38 38.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.154 0.982 . . . . 0.0 110.982 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 64.66 9.01 4.83 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.47 1.908 . . . . 0.0 115.588 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.4 t -132.06 -44.66 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 120.882 -1.136 . . . . 0.0 112.344 -172.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.23 -147.75 17.83 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.213 -0.771 . . . . 0.0 112.377 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.28 53.4 p90 -91.26 143.12 26.98 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -144.63 147.98 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.829 2.052 . . . . 0.0 111.922 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -59.37 135.04 57.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.911 0.885 . . . . 0.0 112.63 171.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.58 -37.15 72.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.738 1.215 . . . . 0.0 113.014 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.36 -18.32 71.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.997 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -97.06 -1.94 44.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.629 1.572 . . . . 0.0 113.943 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.9 mt -70.51 156.59 39.19 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.651 0.78 . . . . 0.0 112.46 171.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -118.26 156.91 28.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.789 1.636 . . . . 0.0 111.433 170.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.36 132.33 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.883 0.873 . . . . 0.0 110.065 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.76 60.87 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.98 1.276 . . . . 0.0 115.655 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -86.97 159.03 19.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.489 1.645 . . . . 0.0 113.047 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -101.89 102.92 13.56 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.448 1.499 . . . . 0.0 112.361 -159.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.7 mt -95.81 166.84 11.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.528 1.131 . . . . 0.0 111.67 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.62 153.44 22.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.92 1.288 . . . . 0.0 110.306 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -109.89 -174.35 2.47 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 172.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.9 p -57.59 -12.75 3.03 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -103.7 -26.6 12.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.171 1.389 . . . . 0.0 111.342 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.83 22.2 24.04 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.335 1.922 . . . . 0.0 111.819 -167.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -76.75 159.58 30.03 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.764 0.826 . . . . 0.0 109.898 167.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.26 130.73 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.528 0.68 . . . . 0.0 112.328 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.4 158.65 20.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.036 2.934 . . . . 0.0 111.227 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.13 139.24 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.212 1.005 . . . . 0.0 111.266 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.2 t -73.71 125.75 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.539 0.736 . . . . 0.0 110.23 172.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -100.96 -26.71 13.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.621 2.369 . . . . 0.0 113.515 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -161.77 152.4 17.63 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.203 1.401 . . . . 0.0 111.565 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -127.17 132.8 50.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.737 1.615 . . . . 0.0 111.067 156.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -132.12 154.83 49.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 128.524 2.73 . . . . 0.0 110.023 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 tt -142.6 137.18 29.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.509 1.524 . . . . 0.0 110.436 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -135.1 149.89 50.13 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.1 mm -106.58 105.67 19.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.954 1.302 . . . . 0.0 108.6 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.62 148.35 49.47 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.754 1.222 . . . . 0.0 113.221 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.19 -14.61 60.15 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.748 1.219 . . . . 0.0 113.354 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -151.25 153.52 32.72 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 126.708 2.003 . . . . 0.0 110.69 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.18 122.92 11.31 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.328 2.686 . . . . 0.0 112.861 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.97 142.04 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.8 1.64 . . . . 0.0 109.837 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -79.81 140.62 36.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.797 0.839 . . . . 0.0 111.269 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.2 m -143.75 150.59 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.307 1.043 . . . . 0.0 111.162 -173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -128.1 147.15 50.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.712 1.205 . . . . 0.0 111.265 -165.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -155.94 166.79 32.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.257 1.823 . . . . 0.0 109.129 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -150.54 172.33 15.66 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.329 -1.482 . . . . 0.0 111.655 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -122.02 132.7 54.65 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.47 138.23 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.948 1.699 . . . . 0.0 111.486 -172.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.38 -33.33 65.63 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -148.28 -37.08 0.19 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.025 -1.047 . . . . 0.0 113.689 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -73.71 166.65 22.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.987 0.915 . . . . 0.0 110.424 172.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -133.77 28.58 3.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.448 1.499 . . . . 0.0 112.791 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.7 p -136.34 161.24 36.34 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.075 1.75 . . . . 0.0 111.511 175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -157.6 -179.28 8.02 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.287 1.835 . . . . 0.0 109.814 167.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -132.95 139.33 47.25 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.26 1.024 . . . . 0.0 112.841 -168.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.78 141.4 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -170.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.36 172.55 31.59 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.39 1.472 . . . . 0.0 115.709 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.33 -19.23 65.31 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.927 -1.337 . . . . 0.0 113.808 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -93.77 1.51 56.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.402 1.481 . . . . 0.0 114.154 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 57.74 46.17 17.64 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.861 1.664 . . . . 0.0 114.217 166.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.26 138.09 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.397 1.079 . . . . 0.0 111.632 -171.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.66 124.96 28.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.799 1.639 . . . . 0.0 112.498 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.97 151.82 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.311 1.444 . . . . 0.0 110.845 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -81.69 146.76 29.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.976 0.51 . . . . 0.0 110.569 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 C--O 1.251 1.18 0 C-N-CA 124.788 1.235 . . . . 0.0 113.592 178.254 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.966 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -119.45 151.22 38.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.842 1.257 . . . . 0.0 110.915 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.82 158.73 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.272 0.558 . . . . 0.0 111.918 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.21 150.6 4.45 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.089 0.947 . . . . 0.0 111.63 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.47 -18.97 15.96 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 117.272 -1.849 . . . . 0.0 116.357 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.9 m -63.6 121.41 13.83 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.202 2.501 . . . . 0.0 110.718 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -77.76 143.77 37.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.476 1.111 . . . . 0.0 112.387 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.2 mm -126.81 136.46 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 127.548 2.339 . . . . 0.0 109.828 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -78.5 129.09 34.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.518 1.127 . . . . 0.0 113.441 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -127.52 173.59 9.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.57 1.548 . . . . 0.0 111.751 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.53 -15.1 63.14 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.851 -1.156 . . . . 0.0 113.371 172.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 p -109.03 -8.74 15.14 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.898 1.679 . . . . 0.0 114.21 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.38 -113.98 0.97 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.408 1.48 . . . . 0.0 111.412 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.8 mt -120.66 153.97 36.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.625 1.17 . . . . 0.0 111.584 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -137.63 144.99 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.667 1.987 . . . . 0.0 108.029 166.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.75 148.32 46.46 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.756 -1.215 . . . . 0.0 111.316 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 tt -63.32 -27.4 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 120.42 -1.425 . . . . 0.0 113.056 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -70.46 -7.15 41.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.964 1.306 . . . . 0.0 114.351 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -118.17 -15.37 9.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.644 1.578 . . . . 0.0 113.084 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.02 135.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.918 1.235 . . . . 0.0 110.295 169.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -120.75 159.06 26.18 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.644 1.578 . . . . 0.0 112.375 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 137.89 55.5 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.421 -0.8 . . . . 0.0 110.533 167.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.61 -6.67 72.4 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.376 0.989 . . . . 0.0 115.133 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -67.95 177.65 2.08 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.812 1.306 . . . . 0.0 110.99 167.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -120.14 153.45 36.17 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.9 -1.125 . . . . 0.0 112.584 168.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 m -141.45 160.83 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.754 1.622 . . . . 0.0 110.609 175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.2 mm -77.99 135.87 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 122.041 -0.412 . . . . 0.0 111.2 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.2 120.82 21.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.754 1.222 . . . . 0.0 107.71 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.2 m -96.65 103.18 15.07 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -47.84 118.91 6.55 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.027 1.331 . . . . 0.0 112.479 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.46 -10.37 28.47 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.27 1.98 . . . . 0.0 114.107 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -77.54 -34.96 53.71 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.791 1.636 . . . . 0.0 113.315 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.7 t -144.91 -3.91 0.76 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.142 1.377 . . . . 0.0 112.702 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 54.73 40.23 31.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.598 1.559 . . . . 0.0 113.565 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -77.87 124.22 27.73 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.505 1.122 . . . . 0.0 109.494 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -85.92 123.85 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.083 0.553 . . . . 0.0 110.779 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.35 162.83 34.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.849 0.833 . . . . 0.0 112.972 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -103.84 116.47 32.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.853 1.661 . . . . 0.0 109.416 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -133.91 154.5 51.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.876 1.27 . . . . 0.0 111.444 -170.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 t -87.87 157.1 19.07 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.6 t -88.59 128.35 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.408 1.483 . . . . 0.0 110.843 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -83.3 -55.78 4.13 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.009 0.524 . . . . 0.0 111.333 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -138.7 152.73 48.26 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.601 1.161 . . . . 0.0 111.627 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -128.01 107.98 10.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.759 1.624 . . . . 0.0 110.411 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -96.31 146.3 24.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.403 1.081 . . . . 0.0 111.706 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 t -136.79 137.04 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.996 0.918 . . . . 0.0 109.192 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -133.95 175.4 9.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.525 2.33 . . . . 0.0 109.256 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -131.6 132.22 43.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.312 1.045 . . . . 0.0 111.751 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 t -141.66 140.27 33.19 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.422 1.089 . . . . 0.0 111.101 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -85.19 -21.98 28.92 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.535 0.734 . . . . 0.0 112.287 165.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -92.87 120.63 33.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.92 0.782 . . . . 0.0 109.495 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.3 mt -126.61 161.96 26.82 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.481 1.134 . . . . 0.0 112.673 174.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 tp -127.83 128.87 45.99 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.461 1.904 . . . . 0.0 109.918 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -113.22 95.9 5.63 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.197 -0.94 . . . . 0.0 109.29 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.0 mt -83.69 145.04 28.99 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.444 -0.785 . . . . 0.0 110.291 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -117.32 120.01 36.89 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -128.12 120.99 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.997 1.319 . . . . 0.0 108.61 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.52 31.12 28.43 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.42 -5.75 83.76 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.221 1.391 . . . . 0.0 116.0 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -94.96 125.93 39.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.236 1.518 . . . . 0.0 109.581 172.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.19 132.42 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.313 0.645 . . . . 0.0 110.998 167.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -123.47 103.32 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.282 1.833 . . . . 0.0 109.072 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -77.67 106.91 9.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.48 2.312 . . . . 0.0 110.766 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 t -137.47 -179.34 5.68 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.156 1.382 . . . . 0.0 112.103 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.0 p -88.25 163.36 16.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.77 1.228 . . . . 0.0 111.91 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -68.45 -25.76 65.17 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.867 -1.146 . . . . 0.0 112.45 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -106.43 9.6 31.67 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.654 0.782 . . . . 0.0 113.006 -171.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -72.19 131.68 84.96 Favored Pre-proline 0 CA--C 1.553 1.066 0 O-C-N 121.369 -0.832 . . . . 0.0 112.717 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.3 120.05 2.83 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.201 3.268 . . . . 0.0 115.575 -175.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -106.88 145.16 32.52 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.462 1.905 . . . . 0.0 111.201 172.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -88.96 131.45 35.15 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.305 1.412 . . . . 0.0 113.506 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.31 133.7 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 127.126 2.171 . . . . 0.0 111.504 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -56.58 127.68 32.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.786 0.834 . . . . 0.0 112.855 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 59.99 15.5 5.09 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.316 1.847 . . . . 0.0 115.488 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.3 t -125.26 -59.15 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 120.833 -1.167 . . . . 0.0 111.09 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.39 -162.47 22.7 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.242 0.925 . . . . 0.0 112.653 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -83.29 146.19 28.67 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.845 1.322 . . . . 0.0 114.143 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.83 145.35 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 127.307 2.243 . . . . 0.0 111.259 -175.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -66.04 136.74 56.44 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.682 0.793 . . . . 0.0 112.485 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.74 -39.32 68.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.489 1.516 . . . . 0.0 113.799 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.35 -17.8 77.84 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.355 -0.84 . . . . 0.0 114.041 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -93.63 -9.76 36.88 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.392 1.477 . . . . 0.0 113.761 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.99 167.76 1.53 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.35 1.06 . . . . 0.0 113.103 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 162.43 27.37 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.463 1.505 . . . . 0.0 110.115 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.97 145.39 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.307 0.575 . . . . 0.0 109.505 167.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.43 4.8 89.26 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.727 -1.041 . . . . 0.0 114.807 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -84.58 158.01 21.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.153 1.476 . . . . 0.0 112.426 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -105.9 104.43 14.14 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.815 1.246 . . . . 0.0 111.591 -162.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.8 mt -101.19 169.37 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.904 1.281 . . . . 0.0 111.11 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -115.49 144.1 44.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.955 1.302 . . . . 0.0 110.634 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.96 -177.11 5.11 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.533 1.133 . . . . 0.0 112.805 168.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.1 p -59.98 -17.42 38.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -97.51 -26.34 14.85 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.837 1.653 . . . . 0.0 112.737 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 104.08 23.4 8.15 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.448 1.499 . . . . 0.0 113.15 -170.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -81.34 151.07 28.18 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.791 1.236 . . . . 0.0 110.649 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.9 t -84.85 133.12 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.124 0.97 . . . . 0.0 112.159 -168.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -118.62 148.74 42.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.575 2.35 . . . . 0.0 111.424 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.56 135.43 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.224 1.01 . . . . 0.0 110.714 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.04 127.21 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 169.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.47 -38.34 8.44 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.329 1.452 . . . . 0.0 112.565 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -161.48 154.82 21.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.29 1.436 . . . . 0.0 111.913 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -120.07 133.21 55.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.458 1.503 . . . . 0.0 110.51 163.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -124.43 153.25 42.22 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.989 2.515 . . . . 0.0 109.965 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 tp -135.11 143.16 46.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.095 1.758 . . . . 0.0 109.942 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.46 157.17 44.37 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.3 mm -108.33 105.24 18.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.656 1.182 . . . . 0.0 108.364 166.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.78 147.51 49.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.899 1.28 . . . . 0.0 113.71 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -74.16 -10.61 59.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.585 1.554 . . . . 0.0 113.972 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -139.65 157.13 70.67 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 127.034 2.134 . . . . 0.0 110.291 166.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.77 119.09 6.04 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.653 2.236 . . . . 0.0 110.492 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.7 t -90.02 136.9 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 126.011 1.725 . . . . 0.0 109.419 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -74.61 138.39 42.92 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.679 0.792 . . . . 0.0 110.226 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.95 142.53 29.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 123.926 0.89 . . . . 0.0 110.764 -174.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -122.08 145.46 48.13 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.032 1.333 . . . . 0.0 110.433 -163.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -153.1 165.54 35.3 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.968 1.307 . . . . 0.0 110.801 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -147.03 164.09 34.13 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.423 -1.423 . . . . 0.0 113.02 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -117.69 141.43 48.39 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.02 147.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.078 1.751 . . . . 0.0 111.556 -168.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.16 -67.65 0.42 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.637 1.175 . . . . 0.0 113.886 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -94.88 -54.57 3.42 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.645 -0.66 . . . . 0.0 112.28 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -83.44 177.63 8.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.856 1.263 . . . . 0.0 111.579 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -131.75 29.2 4.49 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.027 1.331 . . . . 0.0 114.187 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 p -137.04 161.61 35.6 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.992 1.717 . . . . 0.0 112.507 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -156.16 -177.48 6.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.528 1.931 . . . . 0.0 110.751 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -132.24 139.57 48.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.096 1.358 . . . . 0.0 113.176 -168.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.22 144.17 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.375 1.07 . . . . 0.0 113.351 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.13 -179.42 39.13 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.051 1.786 . . . . 0.0 116.642 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.92 -39.15 71.23 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.951 1.301 . . . . 0.0 111.973 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -86.33 2.21 48.24 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 59.78 39.53 20.63 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.24 134.5 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.269 0.627 . . . . 0.0 111.578 -169.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.7 tp -73.76 121.93 21.6 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.859 1.664 . . . . 0.0 112.445 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.13 161.92 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.647 1.579 . . . . 0.0 111.623 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -111.03 143.65 41.4 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -167.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 127.343 2.257 . . . . 0.0 113.262 172.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.07 152.73 37.13 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.495 1.518 . . . . 0.0 111.068 173.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.1 m -68.25 157.43 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.382 0.611 . . . . 0.0 111.707 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.5 150.11 2.83 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.62 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.94 -10.83 45.18 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.269 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.0 m -64.2 123.91 20.32 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 120.901 2.351 . . . . 0.0 110.641 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 mmt -80.26 140.03 36.41 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.284 1.434 . . . . 0.0 111.831 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.6 mm -123.12 135.71 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.367 1.867 . . . . 0.0 109.719 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.53 123.86 26.7 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.653 0.781 . . . . 0.0 111.608 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 p -117.36 177.36 4.77 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.764 1.226 . . . . 0.0 112.71 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.72 -15.01 50.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.092 1.357 . . . . 0.0 114.128 170.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.5 p -124.68 -12.23 7.17 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.43 -115.1 0.65 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.04 0.828 . . . . 0.0 112.726 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 78.7 mt -125.72 139.65 53.36 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.232 1.013 . . . . 0.0 112.799 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -136.38 147.69 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.83 2.052 . . . . 0.0 109.012 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.42 148.11 47.25 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.273 -0.892 . . . . 0.0 111.442 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.0 tt -61.44 -26.29 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 120.682 -1.261 . . . . 0.0 113.496 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -72.27 -9.07 57.99 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.953 1.301 . . . . 0.0 114.198 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -118.7 -10.28 10.04 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.986 1.714 . . . . 0.0 113.332 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -66.91 136.69 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.668 1.122 . . . . 0.0 109.391 162.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -130.07 166.77 19.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.048 1.739 . . . . 0.0 111.182 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.86 134.08 55.01 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.212 -0.93 . . . . 0.0 110.199 165.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.2 -7.84 81.19 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -67.95 167.73 13.17 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.825 1.312 . . . . 0.0 111.496 161.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -124.23 123.84 41.14 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.431 1.492 . . . . 0.0 111.863 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.98 152.76 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.815 1.646 . . . . 0.0 110.227 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -77.79 139.12 19.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.373 0.606 . . . . 0.0 110.543 169.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.23 126.4 28.07 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.413 1.085 . . . . 0.0 108.378 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.4 m -78.93 111.99 15.67 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 159.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -53.63 114.31 6.08 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.655 1.182 . . . . 0.0 112.15 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.75 -12.77 35.62 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.611 2.207 . . . . 0.0 114.29 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.66 -48.85 14.22 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.793 -1.192 . . . . 0.0 111.887 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -129.0 -0.41 5.26 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.036 1.335 . . . . 0.0 114.117 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.324 4.0 m-85 61.72 25.39 15.29 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.046 1.738 . . . . 0.0 115.541 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.79 136.81 53.34 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.416 -0.803 . . . . 0.0 110.251 168.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.31 117.36 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.268 1.027 . . . . 0.0 110.497 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.31 160.9 43.01 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -71.92 132.26 44.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.414 1.085 . . . . 0.0 110.453 166.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.413 ' HE3' ' CE1' ' A' ' 121' ' ' PHE . 70.5 mmtt -135.62 150.13 49.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.535 1.534 . . . . 0.0 110.359 170.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -82.39 155.01 24.92 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.9 t -90.21 131.6 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.86 1.264 . . . . 0.0 111.176 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.98 -45.72 10.51 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.942 0.897 . . . . 0.0 112.476 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -148.83 153.45 38.11 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.38 1.872 . . . . 0.0 110.669 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.7 p -120.73 122.59 40.74 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.238 1.415 . . . . 0.0 111.095 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -104.7 148.05 27.0 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.604 1.562 . . . . 0.0 112.421 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.0 t -143.31 132.22 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.552 1.141 . . . . 0.0 111.251 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -134.14 177.67 7.56 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.258 2.223 . . . . 0.0 111.936 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -139.51 138.8 36.66 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.423 1.489 . . . . 0.0 111.511 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.1 t -155.23 154.29 31.96 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.984 0.914 . . . . 0.0 111.907 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.7 p -87.39 -15.48 37.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.781 1.232 . . . . 0.0 113.424 164.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -98.55 108.26 20.91 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.086 -1.009 . . . . 0.0 110.972 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.3 mt -108.86 174.38 5.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.949 0.899 . . . . 0.0 111.935 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.8 tp -147.76 137.97 22.93 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.214 1.406 . . . . 0.0 110.726 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -124.17 112.91 17.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.863 1.265 . . . . 0.0 110.18 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.9 130.54 54.56 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.801 0.84 . . . . 0.0 109.819 176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -105.52 116.51 32.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.845 1.258 . . . . 0.0 108.542 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -127.77 116.06 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.55 1.54 . . . . 0.0 109.472 -171.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.49 30.82 34.91 Favored Glycine 0 CA--C 1.542 1.774 0 O-C-N 121.628 -0.67 . . . . 0.0 113.97 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.93 -1.61 88.23 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.245 1.403 . . . . 0.0 115.73 -177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.28 120.92 38.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.857 1.829 . . . . 0.0 109.52 170.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -88.57 138.05 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.238 0.615 . . . . 0.0 111.824 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.5 mt -133.67 131.91 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.36 1.864 . . . . 0.0 109.139 -176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -114.05 109.73 18.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.73 1.612 . . . . 0.0 110.607 -165.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 t -140.63 -179.38 6.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.164 1.386 . . . . 0.0 112.668 -158.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.1 p -90.29 155.45 18.97 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.302 1.041 . . . . 0.0 112.287 169.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -59.72 -29.9 68.45 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.107 -0.996 . . . . 0.0 113.442 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -94.52 3.44 55.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -64.54 127.89 92.82 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 120.912 -1.118 . . . . 0.0 112.6 -170.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -81.1 113.2 2.68 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 123.695 2.93 . . . . 0.0 114.292 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -103.63 144.05 31.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.952 1.701 . . . . 0.0 111.64 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -84.89 134.35 34.27 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.307 0.958 . . . . 0.0 112.756 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.9 t -118.71 132.87 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.769 2.028 . . . . 0.0 111.867 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 121.92 4.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.325 1.45 . . . . 0.0 111.899 172.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 56.38 30.07 16.26 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.312 1.445 . . . . 0.0 113.977 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -141.65 -42.11 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 125.373 1.469 . . . . 0.0 112.737 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.66 -148.99 18.77 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.965 0.793 . . . . 0.0 112.848 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -88.06 135.83 33.25 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.8 p -136.84 145.08 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.132 1.773 . . . . 0.0 111.455 -176.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -63.58 131.99 49.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.092 1.357 . . . . 0.0 111.016 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.34 67.34 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.152 -0.967 . . . . 0.0 113.44 -175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.03 -7.28 81.5 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 121.119 -0.988 . . . . 0.0 114.494 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -107.23 -2.47 20.78 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.087 1.755 . . . . 0.0 113.543 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.76 161.7 17.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.992 1.317 . . . . 0.0 112.326 166.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.7 159.32 24.71 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.812 1.245 . . . . 0.0 113.256 160.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.78 130.87 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 159.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.87 -0.89 84.82 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 117.185 -1.897 . . . . 0.0 115.558 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.01 151.42 41.76 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 121.404 2.602 . . . . 0.0 111.509 166.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -102.86 107.87 18.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.028 1.731 . . . . 0.0 112.854 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.9 mt -97.75 167.65 10.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.647 1.179 . . . . 0.0 111.871 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.14 146.8 38.61 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.052 1.341 . . . . 0.0 111.182 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.24 -178.05 3.54 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 172.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.4 p -59.89 -6.6 1.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.77 2.028 . . . . 0.0 116.466 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.51 -17.17 10.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.513 1.925 . . . . 0.0 112.621 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.48 23.88 32.64 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.045 1.783 . . . . 0.0 112.033 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -66.65 148.78 51.44 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.205 0.502 . . . . 0.0 109.768 161.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.3 t -84.16 128.15 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 122.491 0.317 . . . . 0.0 110.381 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.8 mt -108.4 161.07 15.37 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.465 2.706 . . . . 0.0 110.652 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.5 t -134.6 140.4 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.507 1.123 . . . . 0.0 110.605 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.08 129.13 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.361 0.664 . . . . 0.0 109.894 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -96.64 -41.73 8.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.428 2.291 . . . . 0.0 112.011 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -153.53 149.92 28.18 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.807 1.643 . . . . 0.0 110.681 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -132.75 122.73 24.99 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.95 2.1 . . . . 0.0 108.727 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mmtm -134.48 128.71 33.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.492 1.117 . . . . 0.0 112.992 -166.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.1 tp -102.55 134.88 45.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.033 1.733 . . . . 0.0 109.612 173.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -136.09 147.95 48.07 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.361 0.664 . . . . 0.0 111.423 158.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.0 mm -91.7 117.05 34.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 165.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.03 142.19 55.97 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.263 1.025 . . . . 0.0 111.183 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.0 -17.87 62.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.437 0.695 . . . . 0.0 112.738 -176.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -144.38 147.52 37.11 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.373 2.269 . . . . 0.0 110.178 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.11 120.06 7.38 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 124.389 3.393 . . . . 0.0 112.809 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.75 141.7 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.906 1.682 . . . . 0.0 110.441 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -75.14 141.11 43.73 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.494 0.718 . . . . 0.0 111.482 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 m -136.47 144.07 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.938 1.695 . . . . 0.0 110.397 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.47 147.3 49.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.468 1.507 . . . . 0.0 110.644 -166.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -155.38 170.46 21.85 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.721 1.608 . . . . 0.0 111.495 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -154.19 166.1 34.18 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.428 -1.42 . . . . 0.0 113.043 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -120.04 146.13 46.19 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.668 1.187 . . . . 0.0 113.857 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.71 147.09 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.954 1.701 . . . . 0.0 112.44 -162.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.37 -39.56 92.45 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -168.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -133.99 -48.16 0.8 Allowed 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.599 -1.313 . . . . 0.0 113.386 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.413 ' CE1' ' HE3' ' A' ' 39' ' ' LYS . 7.8 m-30 -77.61 168.86 19.29 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 169.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -114.93 17.87 16.7 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.2 1.4 . . . . 0.0 112.669 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 p -141.08 165.16 28.31 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.968 1.707 . . . . 0.0 112.794 -160.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -158.98 178.38 10.13 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.054 1.742 . . . . 0.0 110.662 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -120.41 139.81 52.27 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.038 1.335 . . . . 0.0 112.501 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.0 144.48 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.092 1.357 . . . . 0.0 113.61 -175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.21 173.7 29.73 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.232 1.396 . . . . 0.0 116.034 172.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.13 -27.84 69.65 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.178 -1.189 . . . . 0.0 113.648 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -88.66 -1.34 58.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.346 1.458 . . . . 0.0 113.519 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 59.25 49.8 8.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.182 1.793 . . . . 0.0 113.988 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t -74.91 138.79 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.11 1.364 . . . . 0.0 111.579 -173.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.9 tp -79.78 128.86 33.95 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.575 1.55 . . . . 0.0 113.524 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.5 m -138.06 155.06 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.724 . . . . 0.0 111.356 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -104.23 158.44 16.44 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.47 1.508 . . . . 0.0 110.778 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 C--O 1.254 1.327 0 O-C-N 120.622 -1.299 . . . . 0.0 114.097 172.334 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.101 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.87 154.38 41.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.29 1.436 . . . . 0.0 111.985 169.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.07 161.6 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.242 0.617 . . . . 0.0 112.554 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 150.55 7.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.326 1.05 . . . . 0.0 111.358 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.59 -7.03 9.47 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-O 117.795 -1.558 . . . . 0.0 116.486 -172.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.8 m -61.65 119.36 8.52 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 121.552 2.676 . . . . 0.0 109.685 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -74.62 143.29 44.41 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.851 0.861 . . . . 0.0 111.405 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.3 mm -127.51 135.51 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.796 2.038 . . . . 0.0 109.519 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -78.23 126.36 30.69 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.0 p -117.96 176.39 5.23 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.789 1.235 . . . . 0.0 111.82 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.81 -10.8 59.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 171.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 p -119.46 -16.04 8.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.27 1.828 . . . . 0.0 113.934 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.03 -122.8 1.26 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.089 1.328 . . . . 0.0 111.53 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.5 mt -124.28 142.8 50.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.163 1.385 . . . . 0.0 112.258 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.15 143.08 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.12 1.768 . . . . 0.0 108.613 171.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.57 148.03 51.09 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.999 -1.063 . . . . 0.0 111.352 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 tt -61.34 -26.88 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 O-C-N 120.592 -1.317 . . . . 0.0 113.524 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.82 -16.44 64.11 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -112.54 -12.04 13.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.151 1.78 . . . . 0.0 112.665 -174.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.54 141.12 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.04 0.836 . . . . 0.0 109.837 162.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -128.43 159.77 34.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.443 1.897 . . . . 0.0 112.263 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.72 124.8 21.7 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.485 165.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.65 -0.34 84.76 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.497 1.046 . . . . 0.0 115.392 -170.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -76.8 154.15 34.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.424 1.612 . . . . 0.0 110.539 158.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -108.92 142.89 38.89 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.218 1.407 . . . . 0.0 112.217 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -136.5 159.85 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.376 1.87 . . . . 0.0 111.026 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.9 mm -74.59 137.85 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.966 -0.459 . . . . 0.0 111.898 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.49 123.08 19.75 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.167 0.987 . . . . 0.0 108.657 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.4 m -93.33 103.85 16.05 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 170.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -52.97 113.91 5.2 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.818 1.647 . . . . 0.0 113.18 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.58 -11.24 31.46 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.159 2.573 . . . . 0.0 114.413 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -76.43 -38.9 54.83 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.381 1.072 . . . . 0.0 112.638 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 t -133.96 -6.96 2.73 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.282 1.033 . . . . 0.0 112.516 -172.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.267 2.4 t80 61.99 39.34 13.45 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.31 1.844 . . . . 0.0 113.601 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -95.2 135.75 36.39 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.452 1.501 . . . . 0.0 110.522 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.04 136.71 30.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 122.956 0.502 . . . . 0.0 111.653 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.8 167.99 25.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.379 1.472 . . . . 0.0 111.951 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -89.71 126.88 35.82 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.686 0.794 . . . . 0.0 110.196 164.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -130.23 151.75 50.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.496 1.118 . . . . 0.0 112.123 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -87.53 154.5 20.58 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.42 1.088 . . . . 0.0 113.141 -176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.4 t -89.66 132.68 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.661 1.584 . . . . 0.0 110.753 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.38 -43.19 9.9 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.903 0.881 . . . . 0.0 112.785 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -142.85 153.09 42.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.157 1.383 . . . . 0.0 110.297 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 p -122.1 118.42 28.66 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.9 1.68 . . . . 0.0 108.832 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.02 143.71 28.3 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.424 1.49 . . . . 0.0 112.258 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.5 t -141.13 126.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.751 1.221 . . . . 0.0 110.889 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -132.8 174.77 9.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.825 2.05 . . . . 0.0 109.62 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -132.33 130.2 40.46 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.871 0.868 . . . . 0.0 111.093 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.7 t -140.18 139.54 35.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.522 1.129 . . . . 0.0 110.87 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.0 p -81.12 -19.88 42.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.854 0.862 . . . . 0.0 111.926 166.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -94.2 111.63 23.37 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.383 1.073 . . . . 0.0 110.668 -173.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.0 mt -127.85 157.2 41.13 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 123.409 1.576 . . . . 0.0 113.908 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.4 tp -121.77 136.15 54.93 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.495 1.918 . . . . 0.0 109.956 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -110.39 124.09 51.07 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.712 1.205 . . . . 0.0 109.2 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.0 mt -121.52 137.91 54.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 167.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.7 m -109.25 120.75 43.48 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 167.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.14 122.87 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.463 1.105 . . . . 0.0 108.269 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.64 18.59 16.94 Favored Glycine 0 CA--C 1.547 2.083 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.58 5.08 67.22 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 119.581 1.691 . . . . 0.0 116.323 -171.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -103.52 122.57 45.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.29 1.545 . . . . 0.0 110.296 164.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -77.18 124.03 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.537 0.735 . . . . 0.0 109.407 164.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mt -119.5 100.69 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.175 1.39 . . . . 0.0 109.122 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.57 119.24 21.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.591 1.556 . . . . 0.0 110.49 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -143.05 -179.06 6.14 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.129 0.972 . . . . 0.0 111.305 -168.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.4 p -88.69 155.65 19.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.955 0.883 . . . . 0.0 111.669 167.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.97 -33.59 69.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.536 1.135 . . . . 0.0 112.146 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -85.92 -7.73 58.49 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.634 1.173 . . . . 0.0 113.315 -170.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -64.57 127.48 92.41 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-O 118.213 -0.899 . . . . 0.0 113.177 -166.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.59 108.19 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.373 2.715 . . . . 0.0 114.313 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.26 141.92 34.31 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.625 1.97 . . . . 0.0 111.865 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -85.91 127.13 34.53 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.67 135.86 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 127.601 2.36 . . . . 0.0 111.257 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -52.67 121.22 6.76 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.13 1.372 . . . . 0.0 112.638 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.29 14.06 4.38 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.064 2.146 . . . . 0.0 115.54 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.8 t -122.77 -54.56 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.537 1.135 . . . . 0.0 110.728 -173.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.44 -161.93 16.42 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.586 0.612 . . . . 0.0 113.436 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -84.63 145.12 28.17 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.577 1.188 . . . . 0.0 114.166 -174.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.48 149.62 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.474 1.91 . . . . 0.0 111.263 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -55.73 131.48 46.76 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.743 1.217 . . . . 0.0 111.861 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.05 -35.81 64.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.635 1.174 . . . . 0.0 113.075 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.67 -5.73 88.3 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.63 -1.095 . . . . 0.0 114.898 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -97.93 -4.64 36.01 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.246 1.418 . . . . 0.0 113.519 171.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.52 160.07 33.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.556 0.693 . . . . 0.0 111.278 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -117.35 167.78 10.94 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.494 1.518 . . . . 0.0 110.535 166.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.88 144.71 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.495 -0.753 . . . . 0.0 109.323 155.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.84 1.43 89.54 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.951 -0.916 . . . . 0.0 114.132 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -82.9 152.14 25.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 119.038 1.419 . . . . 0.0 111.385 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -108.45 112.02 24.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.429 1.092 . . . . 0.0 112.484 -163.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.9 mt -107.27 179.41 4.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.341 1.856 . . . . 0.0 110.588 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.89 156.63 44.72 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.026 0.931 . . . . 0.0 113.467 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -98.15 174.04 6.72 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.578 1.151 . . . . 0.0 113.117 166.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.6 t -55.58 -35.38 65.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.782 1.233 . . . . 0.0 113.787 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -75.24 -29.55 60.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.555 1.542 . . . . 0.0 112.727 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.79 24.67 6.87 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.597 1.57 . . . . 0.0 113.499 173.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -78.43 152.94 31.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.441 1.496 . . . . 0.0 110.193 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.12 125.07 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 122.579 0.352 . . . . 0.0 110.992 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.0 mt -106.34 149.75 26.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.277 1.431 . . . . 0.0 111.863 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.0 t -127.23 137.0 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.457 1.103 . . . . 0.0 111.455 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.16 123.7 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.598 1.159 . . . . 0.0 111.074 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -88.63 -32.87 17.84 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.673 2.389 . . . . 0.0 114.48 175.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -152.82 147.92 26.59 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.954 1.302 . . . . 0.0 111.482 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -133.55 132.85 41.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.034 1.733 . . . . 0.0 110.699 168.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -145.77 157.0 43.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.836 2.054 . . . . 0.0 112.388 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tt -149.2 133.64 17.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.808 1.643 . . . . 0.0 109.639 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -146.62 154.51 41.56 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.588 1.155 . . . . 0.0 112.429 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.0 mm -94.53 107.61 19.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.708 0.803 . . . . 0.0 109.121 168.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.51 147.28 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.907 1.283 . . . . 0.0 111.709 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -76.04 -18.86 59.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.76 0.824 . . . . 0.0 112.709 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -127.97 158.21 71.42 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 126.785 2.034 . . . . 0.0 108.879 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -61.92 122.27 10.71 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.212 1.941 . . . . 0.0 110.437 162.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.6 t -93.17 140.44 16.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.288 1.835 . . . . 0.0 108.952 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -73.9 139.21 44.81 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.685 -0.635 . . . . 0.0 110.645 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 m -141.54 147.21 22.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.695 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -128.78 151.11 49.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.391 1.477 . . . . 0.0 110.879 -165.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -155.56 167.55 30.03 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.065 1.346 . . . . 0.0 110.343 168.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -150.42 159.86 44.17 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.54 -1.35 . . . . 0.0 112.973 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -113.86 138.83 49.77 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t -98.23 139.74 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.437 1.895 . . . . 0.0 111.127 -168.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -57.08 -63.99 1.03 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.725 1.21 . . . . 0.0 113.441 -173.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -112.0 -39.22 4.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -89.03 173.32 8.52 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.465 0.706 . . . . 0.0 110.52 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -116.7 7.96 13.64 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.39 1.476 . . . . 0.0 113.536 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 p -134.86 162.33 32.7 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.87 1.668 . . . . 0.0 112.593 -167.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -157.27 -176.84 6.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.072 1.749 . . . . 0.0 109.993 170.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -131.25 137.42 48.87 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.447 1.099 . . . . 0.0 112.891 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.0 145.32 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.034 1.333 . . . . 0.0 112.597 -172.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.91 169.54 31.14 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.105 1.336 . . . . 0.0 115.154 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.74 -37.71 19.66 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.002 1.321 . . . . 0.0 112.988 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -94.91 15.0 19.79 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 63.84 35.13 11.27 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 158.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.33 135.85 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.767 1.227 . . . . 0.0 111.525 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 56.1 tp -79.19 122.57 26.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.042 1.337 . . . . 0.0 113.623 -170.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.01 154.83 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.628 1.571 . . . . 0.0 111.627 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -100.38 146.72 26.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.268 1.027 . . . . 0.0 112.628 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.289 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.959 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -123.91 149.31 46.02 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.39 1.876 . . . . 0.0 111.134 171.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -65.66 158.51 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.378 -0.826 . . . . 0.0 112.172 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.83 148.43 7.56 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.883 0.873 . . . . 0.0 112.04 173.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.55 -10.6 43.7 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 116.358 1.303 . . . . 0.0 116.358 -171.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.8 m -62.07 125.86 25.34 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.863 2.332 . . . . 0.0 110.38 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -77.88 148.34 34.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.452 1.101 . . . . 0.0 112.059 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.1 mm -128.09 136.54 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 127.348 2.259 . . . . 0.0 109.662 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.0 tp -81.8 134.66 35.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.356 1.074 . . . . 0.0 113.363 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.5 p -132.28 176.96 7.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.412 1.485 . . . . 0.0 111.534 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.73 -0.33 26.5 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.675 1.59 . . . . 0.0 114.664 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.4 p -124.46 -16.28 6.38 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.75 1.22 . . . . 0.0 113.375 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.52 -129.92 2.73 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 127.468 2.461 . . . . 0.0 110.683 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.8 151.75 24.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.137 1.375 . . . . 0.0 111.869 168.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.09 146.89 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 127.425 2.29 . . . . 0.0 108.532 169.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.17 45.77 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.679 -1.263 . . . . 0.0 112.154 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 tt -62.72 -28.74 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 120.69 -1.256 . . . . 0.0 113.109 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.47 -2.28 31.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.015 1.326 . . . . 0.0 114.495 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -118.23 -13.09 9.89 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.488 1.515 . . . . 0.0 112.821 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.56 134.93 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.119 0.968 . . . . 0.0 109.664 159.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -134.6 164.94 26.37 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.279 1.832 . . . . 0.0 110.96 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.67 134.08 41.71 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.646 -0.659 . . . . 0.0 111.324 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.68 -15.24 59.44 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.587 1.089 . . . . 0.0 115.692 -175.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -66.49 166.88 11.72 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.431 1.615 . . . . 0.0 111.241 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -118.23 148.19 42.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.24 1.416 . . . . 0.0 113.359 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.19 166.6 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 127.095 2.158 . . . . 0.0 111.123 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -79.86 146.67 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.163 0.585 . . . . 0.0 111.22 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.18 132.28 23.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.354 0.662 . . . . 0.0 109.889 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.6 m -86.33 109.19 18.81 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 163.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -53.24 117.08 10.75 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.577 1.151 . . . . 0.0 112.347 174.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -65.7 -14.33 44.19 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.537 2.158 . . . . 0.0 113.906 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -79.29 -36.28 39.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.487 1.515 . . . . 0.0 113.923 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 t -140.89 0.83 1.62 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.264 1.426 . . . . 0.0 112.884 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.255 1.7 t80 63.17 27.41 15.63 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.744 1.617 . . . . 0.0 114.067 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -78.73 134.32 37.08 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.304 1.042 . . . . 0.0 110.519 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.5 t -94.53 136.63 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.264 0.626 . . . . 0.0 110.289 170.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.35 164.6 35.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.352 1.061 . . . . 0.0 112.35 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -87.6 126.85 35.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.327 1.051 . . . . 0.0 110.277 165.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -136.84 150.98 48.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.979 1.311 . . . . 0.0 112.942 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 t -82.27 157.98 23.67 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -91.98 132.61 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.137 2.175 . . . . 0.0 111.417 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 mt -87.68 -50.34 6.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.569 1.148 . . . . 0.0 112.754 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -143.81 157.22 44.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.159 2.183 . . . . 0.0 110.466 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p -119.38 118.55 31.46 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.025 1.73 . . . . 0.0 110.944 173.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -93.29 139.63 30.43 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.588 1.155 . . . . 0.0 113.084 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.4 t -137.97 130.8 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.752 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -135.3 175.81 9.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.203 2.201 . . . . 0.0 110.264 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -132.32 142.91 49.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.485 1.514 . . . . 0.0 110.746 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -152.97 155.33 36.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.832 0.853 . . . . 0.0 112.033 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.1 p -88.71 -16.23 32.8 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.733 2.013 . . . . 0.0 113.669 170.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -112.74 110.41 20.52 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.099 0.96 . . . . 0.0 110.339 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.8 mt -110.07 173.36 6.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.475 1.11 . . . . 0.0 112.527 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.1 tp -135.28 132.28 37.58 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.128 1.771 . . . . 0.0 109.141 170.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -111.56 115.32 28.98 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.189 0.996 . . . . 0.0 109.245 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.12 143.51 38.39 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.352 0.661 . . . . 0.0 109.862 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.7 m -118.18 120.86 38.99 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 167.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -125.94 116.59 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.628 1.171 . . . . 0.0 109.44 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.74 21.69 37.31 Favored Glycine 0 CA--C 1.545 1.935 0 O-C-N 121.605 -0.684 . . . . 0.0 114.723 -173.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.3 -16.09 61.41 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.576 2.036 . . . . 0.0 115.603 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -79.2 117.6 20.37 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.722 1.261 . . . . 0.0 109.174 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.1 t -75.57 130.04 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 122.974 0.51 . . . . 0.0 110.203 171.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.9 mt -129.86 102.9 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.768 1.627 . . . . 0.0 108.614 171.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -79.37 123.82 27.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.628 1.171 . . . . 0.0 110.581 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.0 t -141.31 174.76 10.24 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.083 1.353 . . . . 0.0 112.113 -167.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.1 p -81.28 145.97 30.65 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.428 -0.795 . . . . 0.0 111.203 165.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -54.74 -26.97 37.58 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.089 1.356 . . . . 0.0 113.334 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -102.9 2.48 35.29 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -62.57 133.06 94.65 Favored Pre-proline 0 CA--C 1.553 1.061 0 O-C-N 121.12 -0.988 . . . . 0.0 113.398 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.26 112.47 2.25 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.376 3.384 . . . . 0.0 114.844 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -101.18 148.46 25.07 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.679 1.992 . . . . 0.0 111.969 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -92.73 129.87 38.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.387 0.994 . . . . 0.0 113.452 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.4 t -108.25 135.57 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.918 2.487 . . . . 0.0 111.06 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.26 132.95 55.13 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.736 0.814 . . . . 0.0 111.127 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 66.62 3.51 2.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.085 1.754 . . . . 0.0 115.174 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.54 -63.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 120.967 -1.083 . . . . 0.0 110.556 -168.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.24 -150.63 18.13 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.647 0.641 . . . . 0.0 112.741 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -88.09 140.24 29.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.794 1.297 . . . . 0.0 113.968 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -145.32 145.9 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.751 1.621 . . . . 0.0 111.996 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -56.71 131.5 49.32 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.788 1.235 . . . . 0.0 112.405 171.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.92 -34.94 68.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.443 1.497 . . . . 0.0 113.672 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.39 -18.79 79.82 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 119.108 -0.829 . . . . 0.0 113.609 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -89.33 -3.52 58.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.366 1.467 . . . . 0.0 113.336 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.44 162.95 24.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.102 0.961 . . . . 0.0 112.236 166.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.35 159.8 30.9 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.044 1.738 . . . . 0.0 110.933 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.53 138.52 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.208 -0.932 . . . . 0.0 109.05 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.03 10.57 86.03 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.846 -0.974 . . . . 0.0 114.894 -171.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -78.68 155.48 29.44 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.47 1.635 . . . . 0.0 112.162 172.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.88 102.3 12.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.851 1.661 . . . . 0.0 111.163 -168.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.6 mt -97.23 179.55 4.86 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.037 0.935 . . . . 0.0 110.859 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.8 mt -131.55 159.83 37.03 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.164 -0.96 . . . . 0.0 113.49 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.0 p30 -118.59 -178.04 3.44 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -65.86 -0.88 2.48 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -102.35 -35.99 8.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.574 1.55 . . . . 0.0 110.874 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.48 17.35 11.44 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.966 1.745 . . . . 0.0 112.776 -170.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -92.37 148.88 21.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.311 1.055 . . . . 0.0 111.881 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.05 114.2 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 mt -88.05 158.4 18.61 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.0 1.32 . . . . 0.0 112.525 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.03 138.72 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.48 1.112 . . . . 0.0 111.705 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.63 121.86 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.867 0.867 . . . . 0.0 109.871 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -94.17 -29.97 14.85 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.913 2.085 . . . . 0.0 112.26 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -155.18 148.4 24.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.217 1.407 . . . . 0.0 112.2 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.1 tttm -132.85 115.85 15.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.402 1.881 . . . . 0.0 108.986 168.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.09 148.89 51.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.606 1.562 . . . . 0.0 112.169 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.2 tp -121.91 134.44 54.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.951 1.3 . . . . 0.0 110.197 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -139.57 150.78 45.45 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.723 0.809 . . . . 0.0 112.367 171.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.9 mm -108.19 111.61 36.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.754 1.222 . . . . 0.0 108.477 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.64 153.09 42.61 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 122.409 1.099 . . . . 0.0 113.531 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.66 -13.35 60.62 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.741 1.217 . . . . 0.0 113.419 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -155.27 160.13 31.14 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 128.302 2.641 . . . . 0.0 110.006 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.65 125.36 12.63 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.674 2.25 . . . . 0.0 111.433 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.43 139.92 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.983 2.113 . . . . 0.0 110.244 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -75.7 142.33 42.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.752 0.821 . . . . 0.0 112.644 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.28 139.17 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.115 1.366 . . . . 0.0 110.974 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -118.52 153.03 34.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.708 2.003 . . . . 0.0 111.944 -171.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -153.65 171.31 19.01 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.868 2.067 . . . . 0.0 109.231 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -152.04 173.86 14.38 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.202 -1.561 . . . . 0.0 112.389 173.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -127.86 142.86 51.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.856 1.262 . . . . 0.0 113.239 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.2 140.64 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.767 1.627 . . . . 0.0 112.611 -164.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.23 -21.75 66.79 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -165.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.48 -63.63 0.98 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.811 0.732 . . . . 0.0 111.209 169.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -70.56 170.47 12.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.694 0.759 . . . . 0.0 111.854 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -113.55 18.89 17.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.724 1.61 . . . . 0.0 112.381 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.0 p -140.3 167.14 22.85 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.11 1.364 . . . . 0.0 112.252 -164.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -160.7 177.31 10.59 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.797 2.039 . . . . 0.0 109.496 167.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -121.39 132.47 54.77 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.226 1.01 . . . . 0.0 111.846 -173.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.9 m -118.06 146.44 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.481 1.512 . . . . 0.0 113.603 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.07 169.63 20.53 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.987 1.279 . . . . 0.0 115.196 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.02 -23.33 66.38 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.993 1.317 . . . . 0.0 112.885 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -89.77 2.1 55.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 114.232 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 63.85 36.33 10.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.375 1.47 . . . . 0.0 114.915 162.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.43 135.61 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.363 1.465 . . . . 0.0 111.886 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.3 tp -78.54 125.25 29.1 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.215 1.406 . . . . 0.0 113.214 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.92 161.04 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.082 1.753 . . . . 0.0 111.591 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -112.0 149.06 32.53 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.012 1.325 . . . . 0.0 112.924 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.9 m120 . . . . . 0 C--O 1.254 1.332 0 C-N-CA 125.939 1.695 . . . . 0.0 112.208 178.612 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.038 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.424 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.8 m-85 -122.63 153.95 38.65 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.455 1.502 . . . . 0.0 111.068 167.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.16 163.12 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.839 -0.538 . . . . 0.0 111.811 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.74 159.27 0.56 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.543 1.163 . . . . 0.0 113.298 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.07 -13.92 4.16 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 117.9 -1.5 . . . . 0.0 115.901 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.9 m -62.95 118.3 7.61 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.497 2.148 . . . . 0.0 110.955 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -79.22 142.31 36.36 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.208 1.403 . . . . 0.0 112.861 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.1 mm -130.7 137.26 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.082 2.153 . . . . 0.0 109.561 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.1 tp -83.56 137.46 33.83 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.368 1.08 . . . . 0.0 113.506 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -135.79 168.97 18.31 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.2 1.4 . . . . 0.0 111.461 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.58 -18.26 64.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 p -106.7 -28.9 9.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.078 1.351 . . . . 0.0 112.944 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.72 -130.42 2.12 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.041 -1.037 . . . . 0.0 112.904 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.58 148.96 29.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.543 1.137 . . . . 0.0 112.184 170.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.4 t -138.97 148.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.083 2.153 . . . . 0.0 108.362 172.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.38 149.9 38.52 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.983 -1.073 . . . . 0.0 111.514 172.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.5 tt -61.16 -23.81 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 O-C-N 120.826 -1.171 . . . . 0.0 113.479 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -70.46 -11.81 61.16 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.113 1.365 . . . . 0.0 114.329 172.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -122.88 -5.26 8.54 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.929 1.692 . . . . 0.0 113.909 -171.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 mm -67.0 137.17 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.014 -1.054 . . . . 0.0 109.077 161.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -134.77 161.2 35.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.719 1.208 . . . . 0.0 112.301 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.42 127.7 32.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.931 0.892 . . . . 0.0 111.718 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.54 -2.32 80.32 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.708 -1.051 . . . . 0.0 115.407 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.22 172.21 13.23 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.088 1.944 . . . . 0.0 111.168 164.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.62 150.04 40.37 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.049 1.74 . . . . 0.0 112.907 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.73 157.87 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 127.165 2.186 . . . . 0.0 109.843 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.8 mm -74.48 140.54 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 O-C-N 121.836 -0.54 . . . . 0.0 110.929 166.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.88 121.48 18.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.6 m -88.52 109.96 20.49 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -53.7 113.37 4.8 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.472 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.14 -9.7 26.0 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.991 1.794 . . . . 0.0 114.455 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -78.31 -40.07 37.82 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.998 -1.064 . . . . 0.0 112.158 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.9 t -132.7 -2.6 3.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.062 0.945 . . . . 0.0 112.756 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.293 20.6 m-85 56.9 35.6 26.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.167 1.787 . . . . 0.0 113.21 -176.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.83 126.51 31.07 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.053 1.341 . . . . 0.0 109.763 173.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.31 113.04 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.777 0.831 . . . . 0.0 110.589 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.56 163.4 29.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.533 1.133 . . . . 0.0 113.031 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -95.93 119.34 34.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.522 1.529 . . . . 0.0 110.757 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -128.39 149.92 50.33 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.748 1.219 . . . . 0.0 111.664 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.2 t -86.36 154.85 20.9 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.8 t -93.14 130.28 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 126.303 1.841 . . . . 0.0 110.444 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.2 mt -89.39 -37.71 14.64 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.288 1.035 . . . . 0.0 113.317 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -153.73 161.39 42.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.283 2.233 . . . . 0.0 109.883 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.8 p -117.34 137.72 52.26 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.902 1.281 . . . . 0.0 111.07 165.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -105.7 142.3 35.67 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.984 1.314 . . . . 0.0 112.569 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.05 138.31 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.737 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 68.4 mmt-85 -142.24 176.42 8.99 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.719 2.008 . . . . 0.0 110.391 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -127.3 137.87 52.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.688 1.195 . . . . 0.0 110.421 167.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.8 t -146.45 148.03 31.84 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.473 1.109 . . . . 0.0 111.473 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -86.11 -20.15 29.12 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.976 1.31 . . . . 0.0 113.416 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -97.17 105.05 17.12 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.338 -0.851 . . . . 0.0 110.086 -169.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.5 mt -124.09 156.86 35.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 123.622 1.677 . . . . 0.0 113.9 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.9 tp -138.44 126.37 22.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.381 -1.736 . . . . 0.0 111.412 -169.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -113.6 111.12 21.33 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.485 1.514 . . . . 0.0 108.723 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -106.6 125.18 50.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.387 1.075 . . . . 0.0 109.938 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -102.74 120.8 41.22 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.0 mt -133.01 116.41 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.928 1.291 . . . . 0.0 108.984 -171.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.94 24.44 34.44 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 115.191 0.836 . . . . 0.0 115.191 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.26 -6.36 68.6 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.576 1.56 . . . . 0.0 116.646 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -101.87 126.67 48.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.893 1.677 . . . . 0.0 109.238 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 p -97.33 133.02 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.841 0.829 . . . . 0.0 112.977 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.3 mt -126.8 133.79 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.761 2.024 . . . . 0.0 108.719 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -116.71 110.9 19.05 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.219 1.007 . . . . 0.0 110.658 -165.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.8 t -141.46 176.82 8.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.755 1.622 . . . . 0.0 113.272 -157.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.8 p -89.91 158.14 17.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.245 1.418 . . . . 0.0 113.01 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -65.82 -18.9 65.65 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.488 1.115 . . . . 0.0 113.649 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -101.11 -2.98 30.1 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.424 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.1 t60 -65.4 129.05 94.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.366 -1.302 . . . . 0.0 111.923 -172.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.67 120.89 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 122.061 1.772 . . . . 0.0 113.691 -169.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.25 141.08 36.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.381 2.272 . . . . 0.0 112.093 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -84.77 127.31 34.06 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -112.41 134.51 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.671 2.389 . . . . 0.0 111.525 -174.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -56.27 127.23 29.81 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.107 1.363 . . . . 0.0 112.499 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 57.17 22.51 7.61 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.961 2.104 . . . . 0.0 115.03 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.3 t -133.97 -58.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.963 -1.086 . . . . 0.0 111.882 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.79 -152.23 17.16 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.02 0.819 . . . . 0.0 112.916 -173.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -91.14 132.57 35.98 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.804 1.302 . . . . 0.0 114.417 -170.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -137.78 141.53 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.183 1.393 . . . . 0.0 112.669 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.03 132.92 54.35 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.809 1.244 . . . . 0.0 112.901 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.59 66.59 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.81 1.644 . . . . 0.0 113.529 -173.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.36 -12.24 84.75 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 121.504 -0.747 . . . . 0.0 113.797 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -90.71 -20.71 22.14 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.121 0.961 . . . . 0.0 112.76 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.95 154.5 2.85 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.417 1.087 . . . . 0.0 112.856 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -117.48 149.53 40.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.066 1.347 . . . . 0.0 110.969 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.83 126.65 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.394 0.678 . . . . 0.0 110.049 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.91 1.4 58.56 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-O 118.501 -1.166 . . . . 0.0 115.326 -172.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -86.95 159.5 18.99 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.833 1.817 . . . . 0.0 112.25 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -104.03 108.36 19.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.161 1.384 . . . . 0.0 111.203 -157.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.49 169.05 8.9 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.696 1.598 . . . . 0.0 111.791 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.22 142.74 43.03 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.351 1.06 . . . . 0.0 111.409 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.02 176.85 6.26 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.65 0.78 . . . . 0.0 112.995 166.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.1 p -52.17 -24.88 7.8 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -97.72 -31.59 12.18 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.888 1.275 . . . . 0.0 111.764 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.38 22.55 5.12 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.884 2.183 . . . . 0.0 113.435 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -64.21 147.26 52.76 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.319 1.059 . . . . 0.0 110.786 167.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.84 110.24 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.924 0.869 . . . . 0.0 110.741 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.5 mt -94.05 160.68 14.6 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.67 1.988 . . . . 0.0 111.289 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.22 141.84 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.64 1.176 . . . . 0.0 110.632 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.13 115.95 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.574 0.749 . . . . 0.0 109.485 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -90.12 -28.35 19.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.011 2.124 . . . . 0.0 112.732 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -160.71 151.74 18.85 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.42 1.488 . . . . 0.0 111.635 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -131.57 111.34 11.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.522 2.329 . . . . 0.0 109.127 171.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.6 mmtm -117.32 125.92 51.85 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.104 1.761 . . . . 0.0 110.94 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 tp -120.0 133.01 55.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.751 1.62 . . . . 0.0 109.941 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -149.21 161.62 41.64 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.3 mm -110.0 107.02 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.112 1.365 . . . . 0.0 108.521 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.02 150.31 42.77 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.253 1.021 . . . . 0.0 113.604 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.77 -26.81 67.89 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.144 1.778 . . . . 0.0 112.321 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -142.68 151.22 56.47 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.943 2.497 . . . . 0.0 108.287 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.27 121.76 8.08 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.415 2.077 . . . . 0.0 110.288 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.03 143.91 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.127 1.771 . . . . 0.0 110.15 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -74.54 139.4 43.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.283 0.633 . . . . 0.0 110.225 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.02 147.12 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 124.526 1.13 . . . . 0.0 111.268 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -128.46 148.0 50.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.683 1.593 . . . . 0.0 110.846 -164.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -150.48 170.96 17.86 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.507 1.523 . . . . 0.0 109.89 167.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -152.27 158.02 42.2 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.532 -1.355 . . . . 0.0 111.515 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -113.49 135.65 53.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.008 0.923 . . . . 0.0 112.969 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -98.89 147.92 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.3 1.84 . . . . 0.0 111.739 -170.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.94 -39.14 91.08 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.61 -45.33 0.36 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.993 0.917 . . . . 0.0 112.661 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -77.55 172.01 14.02 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.435 0.694 . . . . 0.0 109.207 164.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -134.53 30.72 3.47 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.684 1.193 . . . . 0.0 111.934 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.5 p -141.36 158.06 44.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.672 1.589 . . . . 0.0 112.135 -171.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.91 170.34 22.35 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.058 1.343 . . . . 0.0 111.852 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.76 140.08 29.89 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.439 1.895 . . . . 0.0 110.508 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 m -125.29 136.74 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.5 1.12 . . . . 0.0 112.99 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.3 173.3 35.99 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.029 1.3 . . . . 0.0 115.694 169.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -57.15 -37.86 72.67 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.195 -1.179 . . . . 0.0 112.023 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -85.33 9.47 15.33 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.663 1.585 . . . . 0.0 114.867 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 62.65 36.36 13.59 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 165.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.68 138.04 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 121.591 -0.693 . . . . 0.0 111.091 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.9 tp -87.78 128.54 35.32 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.897 1.279 . . . . 0.0 113.143 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.5 m -135.43 151.27 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.201 1.401 . . . . 0.0 112.213 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -93.75 116.5 28.98 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.97 1.708 . . . . 0.0 110.257 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.631 1.172 . . . . 0.0 113.864 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.83 156.3 33.54 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.285 1.434 . . . . 0.0 110.667 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.3 m -67.7 159.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.715 0.769 . . . . 0.0 111.458 171.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.38 154.63 1.7 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.572 0.749 . . . . 0.0 112.77 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.42 -2.32 22.21 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 117.768 -1.573 . . . . 0.0 116.263 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.3 m -64.58 124.61 22.3 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.305 2.052 . . . . 0.0 110.057 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.5 mmt -83.07 139.48 33.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.974 1.31 . . . . 0.0 111.951 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.6 mm -123.26 134.39 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.387 1.875 . . . . 0.0 110.174 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -75.42 121.51 22.41 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.137 0.975 . . . . 0.0 112.668 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.6 p -112.38 177.33 4.68 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.919 1.288 . . . . 0.0 112.001 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.68 -23.47 65.3 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.207 -0.933 . . . . 0.0 113.276 171.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -106.92 -18.81 13.82 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.958 1.303 . . . . 0.0 114.385 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.26 -114.45 0.61 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.987 1.279 . . . . 0.0 113.008 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -129.0 140.96 51.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.2 1.0 . . . . 0.0 113.294 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.2 t -133.45 143.74 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.333 1.853 . . . . 0.0 108.577 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.43 147.96 47.37 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.324 -0.86 . . . . 0.0 110.881 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 tt -61.72 -27.57 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 120.796 -1.19 . . . . 0.0 112.998 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.19 -13.19 61.48 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -112.17 -11.37 13.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.797 2.039 . . . . 0.0 113.153 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.9 mm -64.25 135.85 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.665 0.786 . . . . 0.0 109.261 162.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -125.05 164.85 19.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.489 1.916 . . . . 0.0 111.193 173.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.35 136.65 58.03 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.731 -0.605 . . . . 0.0 110.614 167.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.36 -9.29 75.96 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.482 1.039 . . . . 0.0 114.537 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.78 174.36 6.13 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.771 1.285 . . . . 0.0 111.288 168.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -131.39 142.35 50.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.713 1.205 . . . . 0.0 113.238 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.49 157.71 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.854 2.061 . . . . 0.0 110.757 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.6 mm -76.92 137.01 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.586 -0.696 . . . . 0.0 111.519 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.64 118.92 17.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.789 1.236 . . . . 0.0 108.157 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -89.91 107.45 19.12 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -55.91 113.99 6.72 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.895 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.56 -5.29 16.36 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.125 1.883 . . . . 0.0 114.109 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.16 -38.52 75.48 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.916 -1.115 . . . . 0.0 112.563 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -144.12 -2.11 0.92 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.949 0.9 . . . . 0.0 112.852 -171.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 55.5 44.83 26.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.62 1.168 . . . . 0.0 112.284 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -90.8 139.53 30.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.768 0.827 . . . . 0.0 109.832 167.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.33 124.26 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.749 0.82 . . . . 0.0 110.319 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.61 153.77 48.66 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.782 0.801 . . . . 0.0 112.538 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.67 115.4 23.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.424 1.49 . . . . 0.0 108.674 169.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -126.53 149.15 49.56 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.893 1.277 . . . . 0.0 110.81 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -90.62 157.84 17.27 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -174.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.3 t -89.25 128.61 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.562 1.545 . . . . 0.0 110.645 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.19 -51.43 7.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.359 0.664 . . . . 0.0 111.804 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -146.18 149.97 34.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.39 1.876 . . . . 0.0 109.462 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.4 p -118.65 126.7 52.52 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.049 1.34 . . . . 0.0 110.177 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -105.9 160.38 15.31 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.155 1.382 . . . . 0.0 113.077 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.1 t -134.36 143.91 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.304 2.242 . . . . 0.0 109.302 171.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -137.19 170.84 15.42 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.916 1.687 . . . . 0.0 109.825 166.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -117.68 143.13 46.47 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.424 1.09 . . . . 0.0 110.522 164.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.3 t -148.11 146.26 28.72 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.74 -0.6 . . . . 0.0 111.264 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.1 p -87.72 -18.13 30.16 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.374 0.67 . . . . 0.0 112.617 162.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -93.86 114.19 26.37 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.863 -1.148 . . . . 0.0 111.551 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.1 mt -121.46 171.28 8.9 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.847 1.259 . . . . 0.0 111.63 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.5 tp -145.6 131.18 18.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.518 1.527 . . . . 0.0 110.146 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -106.36 137.46 44.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.274 1.03 . . . . 0.0 109.43 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 mt -129.61 135.13 48.17 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.909 1.284 . . . . 0.0 110.089 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.5 m -104.13 119.97 40.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.91 0.884 . . . . 0.0 109.476 173.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.56 116.29 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.183 1.393 . . . . 0.0 108.781 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.78 35.74 47.75 Favored Glycine 0 CA--C 1.542 1.729 0 O-C-N 121.477 -0.765 . . . . 0.0 114.863 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.38 -14.04 55.9 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.294 1.426 . . . . 0.0 115.507 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -90.91 117.94 29.9 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.805 1.302 . . . . 0.0 109.258 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.46 133.76 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.826 0.85 . . . . 0.0 111.972 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.7 mt -129.01 134.66 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.473 1.909 . . . . 0.0 108.798 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -117.34 112.82 21.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.538 1.535 . . . . 0.0 110.98 -168.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -140.47 178.45 7.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.759 1.224 . . . . 0.0 112.302 -159.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.0 p -84.54 152.4 23.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.175 0.988 . . . . 0.0 111.878 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.98 -20.47 65.31 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.734 1.213 . . . . 0.0 113.41 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -109.61 11.88 24.53 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.407 1.083 . . . . 0.0 113.529 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -67.2 130.3 93.68 Favored Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 120.89 -1.131 . . . . 0.0 112.414 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.84 127.49 5.54 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.515 2.81 . . . . 0.0 114.759 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -118.29 141.48 48.47 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.18 2.192 . . . . 0.0 110.952 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -93.36 129.93 39.3 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.735 1.152 . . . . 0.0 114.034 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.7 t -109.44 133.53 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.995 2.118 . . . . 0.0 111.739 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -51.08 123.69 9.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.641 1.576 . . . . 0.0 113.917 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 54.37 23.55 4.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.388 1.875 . . . . 0.0 114.34 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.7 t -130.19 -54.91 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.951 1.3 . . . . 0.0 110.928 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.94 -165.82 13.53 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.571 0.605 . . . . 0.0 114.047 -175.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -81.41 140.88 34.42 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.385 1.088 . . . . 0.0 113.864 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.19 147.95 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 127.503 2.321 . . . . 0.0 109.475 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -66.86 144.08 56.48 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.529 -0.732 . . . . 0.0 112.176 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.33 -40.22 64.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.811 1.244 . . . . 0.0 113.39 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.43 -20.46 67.7 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.307 -0.87 . . . . 0.0 114.177 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.85 0.96 30.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.096 2.158 . . . . 0.0 113.254 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.1 mt -72.97 161.84 30.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.198 0.599 . . . . 0.0 111.365 168.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.1 162.62 29.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.888 1.275 . . . . 0.0 111.545 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.61 140.48 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.384 1.073 . . . . 0.0 109.611 170.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.78 4.15 89.35 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.188 -0.784 . . . . 0.0 114.439 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -80.82 152.07 28.41 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.126 1.463 . . . . 0.0 110.824 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.2 108.43 19.81 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.762 1.625 . . . . 0.0 113.483 -165.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.4 mt -103.79 164.12 11.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.162 1.385 . . . . 0.0 112.524 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.75 144.96 34.15 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.637 1.175 . . . . 0.0 111.507 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -102.07 -177.25 3.35 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.063 0.945 . . . . 0.0 113.489 169.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.6 p -54.44 -23.48 16.14 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.793 2.037 . . . . 0.0 115.733 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -104.71 -20.76 13.52 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.588 1.555 . . . . 0.0 113.274 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.29 27.42 10.02 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.336 1.922 . . . . 0.0 112.863 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -66.38 149.54 50.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.608 0.363 . . . . 0.0 110.416 162.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.1 99.26 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.217 1.007 . . . . 0.0 110.303 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -80.31 161.31 25.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.188 2.595 . . . . 0.0 112.238 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.62 139.64 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.358 1.063 . . . . 0.0 111.719 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.18 127.73 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.29 1.036 . . . . 0.0 110.925 170.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -97.85 -32.47 11.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.891 2.076 . . . . 0.0 113.357 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -161.5 150.72 16.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.05 0.94 . . . . 0.0 113.013 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -123.13 128.22 49.77 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.438 1.895 . . . . 0.0 109.526 162.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm -127.29 124.69 39.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.374 1.469 . . . . 0.0 110.777 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 tt -121.35 135.54 55.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.756 1.222 . . . . 0.0 110.33 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -141.71 171.11 14.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.36 1.064 . . . . 0.0 111.403 168.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.7 mm -116.97 115.08 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 162.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.66 148.72 19.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.626 1.17 . . . . 0.0 112.197 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -72.62 -24.69 61.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.913 0.885 . . . . 0.0 111.827 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -143.0 152.93 59.78 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.946 2.099 . . . . 0.0 109.517 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.74 123.26 11.7 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.276 2.65 . . . . 0.0 113.188 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.4 t -92.0 143.67 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.459 1.504 . . . . 0.0 110.291 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -76.82 141.87 40.51 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.514 0.673 . . . . 0.0 111.537 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.08 148.44 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.921 1.288 . . . . 0.0 110.368 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -127.74 144.75 51.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.912 1.285 . . . . 0.0 111.856 -169.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -152.18 161.56 42.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.431 1.092 . . . . 0.0 111.252 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -148.02 159.38 43.96 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.797 -1.19 . . . . 0.0 113.508 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -108.89 138.02 45.9 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.73 1.212 . . . . 0.0 113.534 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.49 145.9 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 126.009 1.724 . . . . 0.0 112.474 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.38 -24.18 65.66 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 -167.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -148.6 -49.93 0.16 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.922 1.692 . . . . 0.0 112.067 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -73.07 167.33 21.35 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.63 0.772 . . . . 0.0 110.54 168.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -123.91 24.08 8.42 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.301 1.44 . . . . 0.0 113.937 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 p -135.97 158.07 45.3 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.971 1.708 . . . . 0.0 113.063 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -160.89 -176.01 5.27 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.88 1.672 . . . . 0.0 110.709 171.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -128.59 138.95 52.48 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.361 1.464 . . . . 0.0 113.582 -169.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.32 142.08 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.268 1.427 . . . . 0.0 113.379 -173.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.83 173.22 27.41 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.571 1.558 . . . . 0.0 116.198 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.24 -23.93 67.48 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.736 -1.45 . . . . 0.0 113.917 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -88.99 0.87 56.29 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 58.61 45.75 15.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.17 1.788 . . . . 0.0 114.648 168.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 t -72.43 137.54 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.547 1.539 . . . . 0.0 111.71 -170.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 64.6 tp -79.66 125.26 29.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.681 1.592 . . . . 0.0 113.391 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.52 157.92 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.968 1.707 . . . . 0.0 111.377 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.99 145.5 32.21 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.902 1.281 . . . . 0.0 111.437 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -124.87 157.36 36.11 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.922 1.689 . . . . 0.0 110.493 166.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.1 m -66.23 156.81 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.332 0.587 . . . . 0.0 112.076 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.29 150.49 1.25 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.165 0.986 . . . . 0.0 111.821 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.52 -3.95 22.74 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.5 m -65.51 125.05 23.95 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 120.976 2.388 . . . . 0.0 109.864 171.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -78.99 143.6 35.56 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.233 1.013 . . . . 0.0 111.954 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.31 135.09 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.411 1.884 . . . . 0.0 109.829 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.26 122.09 22.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.796 0.838 . . . . 0.0 112.12 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.0 p -117.23 171.32 8.03 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.307 1.043 . . . . 0.0 111.736 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.8 -17.55 64.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.817 0.847 . . . . 0.0 113.175 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -105.81 -20.3 13.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.992 2.117 . . . . 0.0 113.827 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.06 -105.57 0.27 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.116 1.341 . . . . 0.0 113.06 174.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.8 mt -132.94 140.76 47.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.779 1.632 . . . . 0.0 111.965 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.1 t -135.05 145.6 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.485 1.914 . . . . 0.0 108.543 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.97 147.43 52.45 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.206 -0.934 . . . . 0.0 111.388 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.1 tt -60.32 -29.91 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 120.712 -1.242 . . . . 0.0 112.827 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.29 -17.97 64.41 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -107.72 -10.38 15.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.694 1.998 . . . . 0.0 112.919 -174.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.7 136.74 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.976 161.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -126.29 162.16 26.12 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.939 2.096 . . . . 0.0 111.301 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.94 130.33 43.01 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.435 0.694 . . . . 0.0 110.432 168.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.36 16.94 65.5 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.833 -0.542 . . . . 0.0 113.902 -170.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -96.43 -179.63 4.7 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.155 0.982 . . . . 0.0 110.603 157.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -128.71 145.83 51.06 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.706 1.603 . . . . 0.0 112.341 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.89 158.67 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.037 1.735 . . . . 0.0 110.526 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -76.44 141.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.65 -0.656 . . . . 0.0 111.547 167.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.62 128.04 24.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.001 0.92 . . . . 0.0 109.163 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.0 m -79.44 112.76 17.01 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 160.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -52.66 114.83 6.2 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.235 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.14 -13.18 36.28 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.982 2.455 . . . . 0.0 113.738 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -84.67 -37.26 21.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -172.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -133.39 -6.1 2.95 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.408 1.483 . . . . 0.0 112.922 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.252 15.2 m-85 66.39 30.53 8.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.33 1.852 . . . . 0.0 115.009 -175.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -79.43 130.8 35.77 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.611 1.165 . . . . 0.0 110.155 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.8 128.65 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.889 0.768 . . . . 0.0 110.815 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.95 167.16 28.44 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.316 1.047 . . . . 0.0 112.811 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -78.87 139.7 38.27 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.515 1.126 . . . . 0.0 110.413 163.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -142.48 154.94 44.97 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.493 1.517 . . . . 0.0 110.61 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.8 t -85.35 156.77 20.75 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.79 123.95 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.453 1.901 . . . . 0.0 110.367 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.91 -44.48 16.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.379 0.672 . . . . 0.0 112.736 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -146.14 154.31 41.66 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.486 1.915 . . . . 0.0 110.572 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.7 p -122.22 128.7 51.47 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.949 1.3 . . . . 0.0 111.274 172.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -108.1 149.01 29.03 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.33 1.852 . . . . 0.0 114.38 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.1 t -139.8 140.51 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.375 1.07 . . . . 0.0 112.428 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -138.52 179.83 6.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.58 2.752 . . . . 0.0 112.209 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -131.61 148.35 52.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.636 1.574 . . . . 0.0 112.431 167.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.6 t -152.74 149.24 28.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.423 1.089 . . . . 0.0 111.557 170.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 p -86.36 -17.16 35.18 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.335 1.054 . . . . 0.0 113.3 164.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -105.36 116.17 31.5 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.353 1.061 . . . . 0.0 110.798 -176.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.3 mt -117.8 170.7 8.59 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.651 1.58 . . . . 0.0 112.218 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.7 tp -141.38 134.7 29.57 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.958 1.703 . . . . 0.0 110.062 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -114.75 120.54 40.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.395 1.078 . . . . 0.0 110.067 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.94 130.37 55.45 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.189 -0.945 . . . . 0.0 109.808 173.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.8 m -104.43 118.55 36.89 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.271 1.028 . . . . 0.0 108.582 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -132.02 119.81 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.59 1.556 . . . . 0.0 109.136 -173.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.35 25.11 47.85 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 115.19 0.836 . . . . 0.0 115.19 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.7 -5.39 84.67 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.893 1.711 . . . . 0.0 116.068 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -91.93 132.02 36.81 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.206 1.503 . . . . 0.0 109.483 166.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.82 138.45 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.951 0.9 . . . . 0.0 112.28 163.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.2 mt -132.8 136.12 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 126.126 1.771 . . . . 0.0 109.345 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -117.23 110.39 18.06 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.088 1.355 . . . . 0.0 110.445 -162.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.2 t -138.05 177.13 8.11 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.708 1.203 . . . . 0.0 113.165 -156.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.2 p -86.58 156.5 20.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.74 0.816 . . . . 0.0 111.952 169.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -63.85 -24.69 67.84 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.354 -0.842 . . . . 0.0 113.249 -174.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -99.63 3.63 45.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -60.78 121.3 60.44 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 118.004 -0.998 . . . . 0.0 112.503 -174.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -78.82 115.08 3.52 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.005 1.803 . . . . 0.0 113.056 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.903 1.681 . . . . 0.0 110.797 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -91.37 129.99 37.28 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.5 132.27 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 127.93 2.492 . . . . 0.0 110.731 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -54.49 122.29 10.2 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.261 1.424 . . . . 0.0 111.722 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 t70 53.87 26.7 6.41 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.754 2.422 . . . . 0.0 115.751 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.9 t -129.12 -54.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.939 1.296 . . . . 0.0 110.356 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.02 -155.37 19.77 Favored Glycine 0 N--CA 1.467 0.749 0 CA-C-O 119.499 -0.612 . . . . 0.0 112.027 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -96.57 150.74 20.3 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.053 1.426 . . . . 0.0 114.15 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.78 141.42 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.905 1.682 . . . . 0.0 111.786 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.52 134.91 46.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.61 0.764 . . . . 0.0 112.859 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.05 -37.13 66.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.822 1.249 . . . . 0.0 113.095 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.88 -19.93 72.03 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 121.418 -0.802 . . . . 0.0 113.935 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -97.61 -1.26 44.15 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.836 1.654 . . . . 0.0 114.218 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.26 159.15 29.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.46 0.704 . . . . 0.0 112.377 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -118.97 153.2 35.01 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.556 1.542 . . . . 0.0 110.989 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.4 t -64.86 136.42 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 170.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.75 87.84 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.387 -1.23 . . . . 0.0 115.576 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -84.09 158.2 21.49 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.423 1.612 . . . . 0.0 111.78 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.75 106.79 18.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.557 1.543 . . . . 0.0 112.325 -163.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.5 mt -98.13 -176.79 3.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.683 1.593 . . . . 0.0 111.068 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.6 mt -132.9 154.11 50.72 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.33 177.47 4.85 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 122.886 1.327 . . . . 0.0 114.486 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.6 p -56.79 -6.01 0.29 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.384 2.674 . . . . 0.0 117.318 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -119.17 -18.11 8.76 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.157 1.783 . . . . 0.0 112.221 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.73 18.83 19.48 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.439 1.495 . . . . 0.0 112.885 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -72.65 143.1 48.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.967 0.907 . . . . 0.0 110.457 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.91 114.57 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.195 0.522 . . . . 0.0 110.786 171.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 mt -91.5 157.89 16.78 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.481 1.112 . . . . 0.0 111.188 167.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.0 t -130.98 139.04 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.316 1.046 . . . . 0.0 110.393 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.96 116.38 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 173.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.15 -41.38 28.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.72 1.608 . . . . 0.0 110.84 174.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -159.85 153.58 22.8 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.647 1.179 . . . . 0.0 112.186 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -113.57 134.44 54.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.404 1.482 . . . . 0.0 109.484 159.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -131.45 161.34 32.72 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 128.578 2.751 . . . . 0.0 110.476 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 tt -146.78 139.42 25.08 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.676 1.191 . . . . 0.0 109.927 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -137.51 150.45 47.54 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.043 0.838 . . . . 0.0 112.329 168.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.7 mm -103.41 116.23 46.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.48 145.16 51.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.861 1.264 . . . . 0.0 111.551 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -74.96 -20.5 59.65 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.412 -0.805 . . . . 0.0 112.249 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -140.41 155.86 69.82 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.629 1.972 . . . . 0.0 110.977 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.32 124.74 15.79 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.89 2.393 . . . . 0.0 113.079 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 t -93.95 141.62 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.226 1.811 . . . . 0.0 109.628 172.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -76.22 141.95 41.6 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.553 0.692 . . . . 0.0 111.78 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.82 146.61 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.892 1.277 . . . . 0.0 110.829 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -129.05 150.42 50.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.017 1.327 . . . . 0.0 111.331 -166.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -156.81 169.36 24.92 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.08 1.752 . . . . 0.0 109.548 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -156.09 169.59 24.14 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.346 -1.471 . . . . 0.0 111.947 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -123.84 142.34 51.21 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -100.33 151.71 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.018 1.727 . . . . 0.0 112.893 -170.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.4 -27.86 69.59 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -169.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.12 -34.86 0.09 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 120.212 -1.555 . . . . 0.0 113.638 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -77.67 164.65 25.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 164.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -123.34 33.56 5.33 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.458 1.103 . . . . 0.0 111.959 -174.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.6 p -150.14 162.31 40.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.464 1.506 . . . . 0.0 111.775 -164.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -156.81 174.84 14.89 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.494 1.518 . . . . 0.0 110.612 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -118.94 134.96 54.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.624 1.17 . . . . 0.0 112.432 -176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.71 137.72 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.677 1.591 . . . . 0.0 112.226 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.81 -172.03 45.66 Favored Glycine 0 CA--C 1.544 1.857 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 170.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -84.93 -22.49 29.22 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.719 1.208 . . . . 0.0 112.155 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -84.22 -9.19 58.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.633 1.173 . . . . 0.0 113.382 165.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 60.56 50.74 5.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.529 1.532 . . . . 0.0 113.578 165.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.29 144.66 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.883 1.673 . . . . 0.0 112.078 -173.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.2 tp -84.98 129.46 34.79 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.621 1.568 . . . . 0.0 114.703 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.2 m -138.53 158.19 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 126.403 1.881 . . . . 0.0 112.268 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -117.75 123.3 45.69 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.939 1.295 . . . . 0.0 114.184 -169.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.188 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -174.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.896 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.449 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 96.7 m-85 -125.42 153.28 43.69 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.437 1.495 . . . . 0.0 111.668 172.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 m -68.36 159.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.358 0.599 . . . . 0.0 111.928 173.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.04 152.17 6.14 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.082 0.953 . . . . 0.0 112.487 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.14 -7.11 24.61 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 117.712 -1.605 . . . . 0.0 116.238 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.1 m -61.82 121.88 14.0 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.379 2.089 . . . . 0.0 110.474 174.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -77.2 142.54 39.55 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.69 1.196 . . . . 0.0 112.329 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -121.8 137.07 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.416 2.286 . . . . 0.0 109.494 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.66 127.13 32.37 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 p -127.15 171.1 11.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.834 1.253 . . . . 0.0 112.039 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.3 65.48 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.3 p -103.26 -24.56 13.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.2 -107.9 0.32 Allowed Glycine 0 CA--C 1.522 0.488 0 O-C-N 121.663 -0.648 . . . . 0.0 112.002 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.58 140.04 45.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.961 1.304 . . . . 0.0 111.535 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.5 t -127.19 141.51 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.205 1.402 . . . . 0.0 109.019 172.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.13 147.67 49.65 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.268 -0.895 . . . . 0.0 110.922 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.6 tt -61.03 -26.57 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.025 -1.047 . . . . 0.0 113.351 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.68 -7.09 52.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.496 1.518 . . . . 0.0 114.341 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -117.39 -12.3 10.46 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.902 1.681 . . . . 0.0 112.652 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.7 mm -65.15 132.73 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 119.147 0.885 . . . . 0.0 110.36 164.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -119.21 161.74 19.86 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.431 1.892 . . . . 0.0 111.679 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.65 138.54 58.06 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.09 -1.006 . . . . 0.0 110.63 167.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.95 4.89 89.69 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 114.536 0.574 . . . . 0.0 114.536 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -86.18 157.07 20.08 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.523 1.161 . . . . 0.0 109.84 162.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -116.8 141.24 48.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.75 1.22 . . . . 0.0 111.319 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.95 159.47 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.934 1.694 . . . . 0.0 111.465 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 mm -71.64 143.86 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 122.797 0.439 . . . . 0.0 111.96 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.28 126.25 18.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.78 1.232 . . . . 0.0 109.251 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.468 ' HG1' ' CE1' ' A' ' 125' ' ' HIS . 51.8 m -84.53 111.67 19.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 165.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -56.03 114.64 7.91 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.789 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.18 -8.16 22.85 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.6 2.2 . . . . 0.0 113.94 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -79.49 -39.64 31.63 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.017 -1.052 . . . . 0.0 113.616 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -138.08 -1.29 1.98 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.323 1.049 . . . . 0.0 113.278 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 58.73 40.04 23.61 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.679 1.192 . . . . 0.0 113.407 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.06 138.82 33.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.542 0.737 . . . . 0.0 109.029 165.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -109.11 121.93 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.995 1.318 . . . . 0.0 109.169 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.34 162.79 33.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.456 0.703 . . . . 0.0 112.673 -176.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -93.51 124.66 37.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.797 1.239 . . . . 0.0 109.307 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -132.67 152.67 51.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.416 1.487 . . . . 0.0 111.194 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 t -85.57 152.98 22.73 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.9 t -89.1 130.55 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.98 1.712 . . . . 0.0 110.279 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.6 mt -92.71 -40.76 10.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.811 0.845 . . . . 0.0 112.384 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -143.93 152.52 41.21 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.338 1.455 . . . . 0.0 111.247 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.5 p -124.47 124.66 42.78 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.197 2.199 . . . . 0.0 109.073 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -116.63 159.91 21.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.17 1.788 . . . . 0.0 114.412 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.63 144.56 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.849 1.66 . . . . 0.0 111.426 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -142.49 178.77 7.37 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.024 2.13 . . . . 0.0 112.053 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -131.47 145.23 51.68 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.081 2.152 . . . . 0.0 112.306 173.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -154.72 152.52 30.0 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.967 0.907 . . . . 0.0 111.148 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 p -86.9 -14.55 41.6 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 163.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -101.54 105.53 16.51 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.073 0.851 . . . . 0.0 110.201 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.5 mt -123.49 162.32 23.1 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.85 1.31 . . . . 0.0 113.67 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.3 tp -126.29 131.21 51.92 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.811 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -101.98 134.1 45.72 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.244 1.417 . . . . 0.0 109.442 165.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 mt -126.28 126.59 44.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.874 0.869 . . . . 0.0 109.064 163.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.1 m -93.17 120.35 33.36 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 167.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.4 117.09 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.949 1.3 . . . . 0.0 108.92 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 50.54 38.18 34.75 Favored Glycine 0 CA--C 1.544 1.876 0 N-CA-C 115.186 0.835 . . . . 0.0 115.186 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.73 -0.56 89.18 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 121.297 -1.119 . . . . 0.0 115.701 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -109.06 120.97 44.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.326 1.563 . . . . 0.0 110.442 172.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.48 128.36 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.803 0.811 . . . . 0.0 111.555 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.4 mt -118.09 128.3 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.689 1.596 . . . . 0.0 108.375 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -108.03 110.99 22.82 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.507 1.523 . . . . 0.0 110.27 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 t -139.7 176.14 8.98 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.223 1.009 . . . . 0.0 112.473 -161.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.3 p -82.08 152.28 26.65 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.177 0.989 . . . . 0.0 112.349 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -65.96 -19.97 66.04 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.188 -0.945 . . . . 0.0 113.27 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.337 3.5 p-10 -110.6 17.44 20.7 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 175.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.449 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 3.2 t60 -66.11 132.72 94.59 Favored Pre-proline 0 CA--C 1.555 1.155 0 O-C-N 121.071 -1.018 . . . . 0.0 113.665 176.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.11 118.84 3.05 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.279 3.319 . . . . 0.0 115.096 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -116.89 140.51 49.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.872 2.069 . . . . 0.0 112.216 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -84.2 127.46 33.96 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.049 1.295 . . . . 0.0 114.05 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.91 134.82 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 127.989 2.516 . . . . 0.0 111.355 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -52.24 126.92 20.37 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.919 1.688 . . . . 0.0 111.717 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 57.31 19.42 5.02 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.993 1.717 . . . . 0.0 115.488 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.8 t -130.31 -58.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.893 0.877 . . . . 0.0 111.12 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.32 -159.47 15.88 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.643 0.64 . . . . 0.0 113.43 -171.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -81.06 142.49 33.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 p -141.26 152.19 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.622 1.969 . . . . 0.0 110.884 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.73 129.45 39.8 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.947 0.899 . . . . 0.0 111.868 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.63 -36.67 69.73 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.546 1.138 . . . . 0.0 113.343 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.62 -5.08 88.17 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.909 -1.119 . . . . 0.0 114.134 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -101.89 -2.19 30.42 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.871 1.335 . . . . 0.0 113.319 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.55 161.15 31.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.011 1.324 . . . . 0.0 112.631 167.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.44 164.78 18.24 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.04 2.136 . . . . 0.0 111.572 171.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.32 141.93 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.187 -0.945 . . . . 0.0 109.813 167.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.69 7.83 88.15 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.265 -0.742 . . . . 0.0 114.683 -175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -85.65 152.2 23.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.509 1.155 . . . . 0.0 111.098 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -108.24 109.69 21.12 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.837 1.255 . . . . 0.0 112.323 -163.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.1 mt -106.3 171.38 7.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.927 1.291 . . . . 0.0 111.295 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.7 mt -122.88 159.73 27.58 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -115.63 -174.31 2.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.19 1.796 . . . . 0.0 113.874 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.4 t -58.14 -15.42 9.56 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -97.34 -12.48 22.78 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 119.816 -1.803 . . . . 0.0 113.552 170.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.36 22.1 49.1 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.925 1.25 . . . . 0.0 111.864 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.53 139.65 33.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.878 1.271 . . . . 0.0 112.025 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.92 111.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.092 0.957 . . . . 0.0 112.913 -171.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 63.4 mt -90.35 161.95 15.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.89 2.076 . . . . 0.0 111.374 161.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.72 141.41 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.677 1.191 . . . . 0.0 110.683 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.04 121.6 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.706 0.802 . . . . 0.0 109.459 172.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.27 -36.32 15.66 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.439 1.895 . . . . 0.0 112.142 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -160.49 151.7 19.18 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.648 1.579 . . . . 0.0 111.61 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -129.56 139.48 51.48 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.716 2.006 . . . . 0.0 110.352 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -143.2 139.67 30.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.368 1.467 . . . . 0.0 111.634 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.3 tp -116.87 136.4 52.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.724 2.01 . . . . 0.0 108.636 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -145.65 153.36 40.93 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 171.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.8 mm -91.91 121.41 42.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.037 0.935 . . . . 0.0 109.15 166.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.22 149.79 49.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.001 1.32 . . . . 0.0 113.664 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.65 -30.29 71.26 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.409 1.083 . . . . 0.0 112.851 175.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -148.38 152.62 39.16 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.023 2.529 . . . . 0.0 109.944 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -59.1 120.51 8.42 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.149 3.233 . . . . 0.0 111.985 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.56 137.87 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.107 1.363 . . . . 0.0 109.522 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -74.24 139.2 44.17 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.979 1.312 . . . . 0.0 110.363 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -137.93 143.78 32.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 124.643 1.177 . . . . 0.0 110.611 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -121.82 149.15 43.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.901 1.28 . . . . 0.0 110.9 -169.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -153.22 166.03 33.81 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.806 1.243 . . . . 0.0 111.481 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -150.29 167.39 27.13 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.792 -1.192 . . . . 0.0 112.561 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -116.0 142.83 46.27 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.3 t -99.83 143.52 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.929 2.092 . . . . 0.0 111.195 -173.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -60.02 -76.28 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.216 1.406 . . . . 0.0 113.636 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -118.19 -11.3 10.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -163.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -105.28 170.72 7.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.402 1.481 . . . . 0.0 109.149 163.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -114.67 13.68 17.42 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.832 2.053 . . . . 0.0 113.391 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 p -144.1 162.39 36.38 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.888 -1.133 . . . . 0.0 112.776 -163.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -156.48 172.91 17.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.919 1.688 . . . . 0.0 110.337 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.468 ' CE1' ' HG1' ' A' ' 29' ' ' THR . 27.3 m170 -120.05 136.68 54.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.384 1.074 . . . . 0.0 112.343 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.42 149.0 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.325 1.45 . . . . 0.0 113.71 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.62 175.47 18.88 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.254 1.407 . . . . 0.0 115.044 173.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.7 -28.8 69.67 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -88.63 4.44 47.08 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 60.86 46.54 8.6 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.715 1.206 . . . . 0.0 112.238 166.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -82.33 138.46 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.692 1.997 . . . . 0.0 112.122 -165.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.3 tp -80.49 124.73 29.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.357 1.463 . . . . 0.0 113.983 -173.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.14 159.88 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.969 1.708 . . . . 0.0 111.793 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -99.3 157.53 16.33 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.347 1.059 . . . . 0.0 113.832 -170.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.668 2.387 . . . . 0.0 113.226 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.123 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -121.43 153.66 37.57 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.313 1.445 . . . . 0.0 111.657 170.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.3 m -70.7 158.6 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.672 0.749 . . . . 0.0 112.419 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.87 146.76 7.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.215 1.006 . . . . 0.0 112.782 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.38 -8.67 52.52 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 117.332 -1.816 . . . . 0.0 115.929 -172.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.3 m -61.56 118.13 6.65 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.124 2.462 . . . . 0.0 110.113 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 mmt -75.37 141.35 43.31 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.239 1.016 . . . . 0.0 111.972 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.8 mm -124.78 136.12 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.03 2.132 . . . . 0.0 109.754 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.46 124.32 26.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.381 1.072 . . . . 0.0 112.641 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.9 p -127.15 174.07 9.21 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.527 1.131 . . . . 0.0 111.829 -176.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.9 71.28 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.084 -1.01 . . . . 0.0 111.954 167.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.9 p -77.69 -33.69 53.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.255 1.022 . . . . 0.0 111.968 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.37 -90.01 0.12 Allowed Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.486 1.517 . . . . 0.0 111.619 172.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.1 mt -134.16 140.1 46.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.731 1.612 . . . . 0.0 111.196 170.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -134.36 145.85 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.665 1.986 . . . . 0.0 108.974 174.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.78 146.86 51.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.849 -1.157 . . . . 0.0 111.159 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 tt -60.95 -29.59 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 120.973 -1.08 . . . . 0.0 113.121 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.13 -20.03 64.87 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 173.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -101.67 -17.2 16.42 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.075 1.35 . . . . 0.0 113.022 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.06 126.91 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.595 0.758 . . . . 0.0 109.534 165.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -122.2 154.94 36.81 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.7 1.6 . . . . 0.0 111.733 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.09 126.46 26.09 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.604 -0.685 . . . . 0.0 111.541 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.59 -19.74 41.22 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.001 1.286 . . . . 0.0 114.749 -168.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -71.2 177.23 3.94 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.4 1.6 . . . . 0.0 112.981 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -120.16 154.93 34.08 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.586 1.554 . . . . 0.0 113.429 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -143.54 159.29 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.081 2.152 . . . . 0.0 109.851 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -77.09 139.18 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 O-C-N 121.205 -0.934 . . . . 0.0 110.827 166.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.87 129.25 40.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.5 m -93.38 110.39 21.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -52.67 112.36 3.39 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.633 1.573 . . . . 0.0 112.354 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -69.75 -6.69 19.2 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.156 1.904 . . . . 0.0 113.961 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -77.45 -42.65 35.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.711 -1.243 . . . . 0.0 112.737 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.8 t -138.05 2.68 2.36 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.27 1.028 . . . . 0.0 113.163 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.274 68.8 m-85 58.69 32.34 22.07 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.436 1.494 . . . . 0.0 113.944 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.77 139.87 49.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.05 0.94 . . . . 0.0 109.753 167.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.14 109.15 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.719 1.207 . . . . 0.0 109.885 -168.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.75 157.29 44.78 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.44 125.82 29.93 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.035 1.334 . . . . 0.0 110.06 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 120' ' ' ASP . 29.9 mmmt -129.23 151.21 50.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.999 1.319 . . . . 0.0 110.196 174.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.26 7.0 t -81.63 159.69 23.96 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.189 0.995 . . . . 0.0 113.45 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.1 t -94.54 125.79 47.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 126.584 1.954 . . . . 0.0 109.543 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.7 mt -82.25 -49.09 10.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.602 1.161 . . . . 0.0 111.268 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.59 151.68 39.4 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.684 1.194 . . . . 0.0 111.088 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.0 p -121.68 119.94 33.25 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.112 1.765 . . . . 0.0 110.145 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -108.76 150.44 27.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.124 1.77 . . . . 0.0 113.317 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.74 136.49 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.706 1.602 . . . . 0.0 111.646 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -134.79 175.13 9.84 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.678 1.991 . . . . 0.0 110.475 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -136.65 138.77 41.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.28 1.032 . . . . 0.0 110.411 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.2 t -153.39 147.32 25.42 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.248 -0.907 . . . . 0.0 112.246 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.1 p -86.7 -22.04 26.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.54 1.136 . . . . 0.0 112.855 168.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -100.84 86.0 3.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.134 0.969 . . . . 0.0 110.596 -166.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.23 177.91 5.7 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.756 1.223 . . . . 0.0 112.674 -172.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.1 tp -145.66 143.2 29.68 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.136 1.774 . . . . 0.0 109.649 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -109.37 136.78 48.25 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.024 -1.047 . . . . 0.0 108.43 162.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.2 mt -118.88 144.36 46.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.76 0.824 . . . . 0.0 109.252 161.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.4 m -109.04 123.18 48.74 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.16 120.41 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.378 1.471 . . . . 0.0 108.584 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.49 30.82 42.66 Favored Glycine 0 CA--C 1.543 1.82 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.05 -3.92 82.81 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 118.636 1.218 . . . . 0.0 115.684 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.66 126.88 44.4 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.189 1.395 . . . . 0.0 110.262 171.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.03 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.984 -0.447 . . . . 0.0 110.773 162.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.3 mt -122.23 106.42 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 109.636 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -78.49 117.06 19.33 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.913 2.485 . . . . 0.0 110.812 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 t -145.06 -179.68 6.78 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.552 1.141 . . . . 0.0 113.248 -164.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.2 p -85.62 155.64 21.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.501 1.12 . . . . 0.0 112.159 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -64.32 -28.14 69.5 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.927 -1.108 . . . . 0.0 112.552 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.91 5.26 52.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.06 0.944 . . . . 0.0 113.17 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -68.19 125.82 91.97 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.476 -1.39 . . . . 0.0 112.767 -169.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.22 114.24 3.3 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.501 2.8 . . . . 0.0 114.073 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -102.95 148.85 25.16 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.818 1.647 . . . . 0.0 110.997 170.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -93.83 130.89 39.69 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.196 0.907 . . . . 0.0 112.704 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.4 133.4 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.08 1.752 . . . . 0.0 111.071 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -52.81 126.98 21.86 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.528 1.531 . . . . 0.0 111.032 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.15 16.83 5.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.065 1.746 . . . . 0.0 115.266 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.28 -51.61 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.417 1.487 . . . . 0.0 111.59 -172.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.5 -160.8 13.02 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.027 0.822 . . . . 0.0 113.547 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.251 15.1 p90 -79.46 149.89 31.42 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -171.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 p -150.43 145.53 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.982 2.113 . . . . 0.0 110.999 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -70.19 138.23 51.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.667 1.587 . . . . 0.0 112.129 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.95 -39.92 66.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.812 1.245 . . . . 0.0 113.834 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.27 -10.75 79.05 Favored Glycine 0 CA--C 1.539 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 114.262 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -109.69 -0.49 18.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.456 1.903 . . . . 0.0 113.172 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 mt -67.57 160.1 28.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.507 0.723 . . . . 0.0 111.593 167.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -127.47 155.15 44.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.156 1.382 . . . . 0.0 111.711 172.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.25 137.94 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.801 0.84 . . . . 0.0 110.288 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.33 1.49 81.26 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.413 -1.215 . . . . 0.0 115.472 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -83.92 157.85 21.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.763 1.781 . . . . 0.0 112.089 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.45 98.02 8.41 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.096 1.358 . . . . 0.0 112.031 -166.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.01 179.21 6.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.037 1.335 . . . . 0.0 110.796 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 71.4 mt -131.56 155.75 46.93 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.297 1.039 . . . . 0.0 113.249 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.46 173.31 6.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.025 0.93 . . . . 0.0 112.671 168.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.2 t -51.4 -36.75 45.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -85.83 -11.7 52.7 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.777 1.231 . . . . 0.0 112.848 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.91 16.08 31.8 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 126.077 1.798 . . . . 0.0 112.633 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -72.57 143.43 48.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.636 0.774 . . . . 0.0 110.73 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.52 130.17 36.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 122.616 1.198 . . . . 0.0 111.128 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.7 mt -111.57 151.5 28.64 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.796 1.638 . . . . 0.0 111.33 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -118.89 137.03 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.549 0.74 . . . . 0.0 111.216 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.2 t -71.62 128.76 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.731 0.813 . . . . 0.0 109.593 170.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.59 -29.27 9.26 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.339 1.856 . . . . 0.0 112.485 -176.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -162.21 153.05 17.52 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.032 1.333 . . . . 0.0 112.243 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -120.55 132.41 55.15 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.329 1.852 . . . . 0.0 109.312 157.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -130.43 142.42 50.5 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.827 1.651 . . . . 0.0 110.127 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.7 tp -129.1 133.13 47.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.209 1.404 . . . . 0.0 111.162 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.37 156.31 48.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.295 1.038 . . . . 0.0 112.174 166.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.1 mm -108.79 107.85 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.227 1.411 . . . . 0.0 107.334 168.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.74 143.57 55.83 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.863 0.84 . . . . 0.0 112.804 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.65 -24.0 67.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -140.53 153.71 68.57 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.502 1.921 . . . . 0.0 111.435 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.39 120.09 7.4 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.393 2.729 . . . . 0.0 111.522 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.49 142.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.23 1.412 . . . . 0.0 109.593 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -78.51 140.94 38.52 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.564 0.697 . . . . 0.0 111.519 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.0 m -139.42 145.65 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 124.57 1.148 . . . . 0.0 111.727 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -125.2 148.14 48.76 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.343 1.457 . . . . 0.0 110.723 -166.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -151.7 168.71 24.17 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.38 1.472 . . . . 0.0 110.114 168.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -149.19 173.84 13.01 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.753 -1.217 . . . . 0.0 112.384 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -130.37 146.28 51.92 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.36 144.84 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.679 1.992 . . . . 0.0 113.004 -162.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.74 -18.24 62.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.521 2.729 . . . . 0.0 117.115 -168.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.463 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 4.5 m-20 -148.61 -63.86 0.24 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.915 1.234 . . . . 0.0 110.965 164.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -69.94 108.58 4.08 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.414 1.085 . . . . 0.0 110.74 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -70.02 36.11 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.292 1.837 . . . . 0.0 115.765 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.8 p -131.9 164.05 26.96 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.776 2.03 . . . . 0.0 111.935 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -157.94 -176.06 5.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.545 1.538 . . . . 0.0 110.037 166.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -127.66 141.4 51.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.366 1.066 . . . . 0.0 113.039 -172.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.32 138.24 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.495 1.118 . . . . 0.0 112.373 -175.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.02 179.46 53.08 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -73.7 -23.99 59.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.477 1.111 . . . . 0.0 112.148 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -80.25 1.68 27.53 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 166.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 54.87 39.3 31.43 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.268 1.427 . . . . 0.0 114.352 166.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.63 138.37 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.21 1.804 . . . . 0.0 112.02 -166.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.1 tp -81.65 126.75 32.14 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.408 1.483 . . . . 0.0 114.023 -173.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.29 157.96 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.673 1.589 . . . . 0.0 112.105 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -102.34 143.37 32.18 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.5 1.52 . . . . 0.0 112.02 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 C--O 1.252 1.21 0 C-N-CA 124.15 0.98 . . . . 0.0 112.509 176.688 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.77 154.85 40.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.542 1.537 . . . . 0.0 111.411 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.0 m -71.66 158.62 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.336 0.654 . . . . 0.0 112.431 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.52 147.56 10.77 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.332 1.053 . . . . 0.0 111.191 172.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.37 6.61 62.07 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-O 117.949 -1.473 . . . . 0.0 115.756 -171.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.4 m -70.75 121.73 18.53 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.962 2.381 . . . . 0.0 109.639 164.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -80.08 140.14 36.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.67 1.188 . . . . 0.0 111.505 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.0 mm -125.25 136.29 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.301 2.24 . . . . 0.0 109.946 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.4 tp -78.61 123.65 27.33 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.161 0.984 . . . . 0.0 113.398 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 p -117.83 177.05 4.91 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.24 1.416 . . . . 0.0 111.334 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.09 -21.46 64.96 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.117 -0.989 . . . . 0.0 113.262 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -96.62 -14.33 22.23 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.201 1.8 . . . . 0.0 113.108 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.26 -108.29 0.61 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.789 1.662 . . . . 0.0 111.462 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.2 mt -127.95 142.07 51.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.293 1.037 . . . . 0.0 113.548 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.7 t -130.16 144.41 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.949 2.1 . . . . 0.0 108.887 174.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.93 147.52 48.65 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.114 -0.991 . . . . 0.0 110.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -61.87 -27.75 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 120.457 -1.402 . . . . 0.0 113.124 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.83 -7.15 43.29 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.891 1.276 . . . . 0.0 114.18 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -115.87 -12.14 11.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.185 1.794 . . . . 0.0 113.976 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -63.22 140.26 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 165.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -125.75 159.03 33.39 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.18 1.792 . . . . 0.0 112.401 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.38 123.98 19.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 122.897 0.479 . . . . 0.0 110.317 164.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.73 -6.69 70.44 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.955 1.265 . . . . 0.0 114.646 -172.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -75.03 177.87 6.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.65 1.225 . . . . 0.0 111.24 166.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -134.8 140.78 46.14 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.905 1.282 . . . . 0.0 113.046 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -135.14 159.26 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.124 1.769 . . . . 0.0 111.099 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.6 mm -77.98 136.91 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.972 -0.455 . . . . 0.0 111.803 171.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.6 117.89 20.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.139 1.376 . . . . 0.0 108.596 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.5 m -90.85 104.59 17.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -49.2 113.58 3.25 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.013 0.925 . . . . 0.0 112.008 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.99 -3.66 13.65 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.41 2.74 . . . . 0.0 113.871 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.07 -38.08 25.43 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.841 -1.162 . . . . 0.0 112.841 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -141.83 -2.18 1.2 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -166.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 55.19 37.28 28.65 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.919 1.688 . . . . 0.0 113.747 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.5 131.72 35.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.279 1.432 . . . . 0.0 108.896 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -106.23 125.17 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.441 1.097 . . . . 0.0 109.309 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.72 161.73 37.09 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -78.08 134.79 37.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.512 0.725 . . . . 0.0 109.298 161.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -139.75 150.95 45.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.478 1.111 . . . . 0.0 111.618 170.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 t -85.39 159.74 19.92 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -92.1 129.69 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.997 1.719 . . . . 0.0 110.868 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.5 mt -84.23 -50.01 8.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.38 0.672 . . . . 0.0 112.142 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -145.12 151.84 39.11 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.937 1.695 . . . . 0.0 111.02 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 p -125.81 109.23 12.3 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.425 1.89 . . . . 0.0 110.543 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -98.92 146.8 25.62 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.404 1.082 . . . . 0.0 113.321 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.4 t -139.12 134.51 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.866 1.266 . . . . 0.0 111.751 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -132.03 174.28 10.35 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.222 1.809 . . . . 0.0 111.342 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.89 135.52 49.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.484 1.514 . . . . 0.0 110.151 170.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -146.03 143.06 29.19 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.897 1.279 . . . . 0.0 111.419 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -86.04 -16.0 39.55 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.214 1.006 . . . . 0.0 112.417 164.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -102.45 110.07 21.9 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 120.838 -1.163 . . . . 0.0 109.75 -173.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.6 mt -120.47 172.5 7.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.84 1.256 . . . . 0.0 112.257 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -142.12 140.16 32.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.071 1.748 . . . . 0.0 110.065 175.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -107.53 137.86 44.8 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.188 -0.945 . . . . 0.0 108.84 163.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.8 mt -121.32 142.65 49.76 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.009 0.924 . . . . 0.0 109.266 160.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -110.06 122.29 47.25 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.156 0.982 . . . . 0.0 108.981 172.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.17 121.67 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.978 1.711 . . . . 0.0 108.616 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.02 31.29 58.59 Favored Glycine 0 CA--C 1.543 1.84 0 O-C-N 121.401 -0.812 . . . . 0.0 114.866 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.09 -1.06 88.98 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.252 1.405 . . . . 0.0 115.465 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -106.35 124.13 49.12 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.983 1.713 . . . . 0.0 110.828 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.8 130.52 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.2 1.0 . . . . 0.0 111.196 172.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.0 mt -120.8 102.26 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.417 1.487 . . . . 0.0 108.709 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -79.76 116.46 19.95 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.175 1.79 . . . . 0.0 111.428 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 t -142.18 -176.13 4.7 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.305 1.442 . . . . 0.0 112.015 -163.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 67.3 p -95.04 158.72 15.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.52 1.128 . . . . 0.0 111.768 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -63.94 -26.1 68.44 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.369 -0.832 . . . . 0.0 112.751 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -97.83 4.47 49.72 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -66.58 126.66 92.59 Favored Pre-proline 0 CA--C 1.55 0.97 0 O-C-N 120.511 -1.368 . . . . 0.0 112.98 -173.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.49 116.82 2.99 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.814 2.343 . . . . 0.0 114.266 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -102.01 153.24 20.07 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.187 2.195 . . . . 0.0 111.11 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.59 133.89 42.3 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.491 1.041 . . . . 0.0 113.754 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.7 t -111.24 131.87 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 127.084 2.154 . . . . 0.0 111.528 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -51.9 129.2 26.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.846 1.658 . . . . 0.0 113.027 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 56.27 12.06 0.92 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 127.988 2.515 . . . . 0.0 115.547 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.74 -56.49 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.747 1.219 . . . . 0.0 111.774 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 124.78 -159.98 19.4 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.635 0.636 . . . . 0.0 113.25 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.252 10.6 p90 -81.68 153.88 26.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.87 143.71 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.93 2.092 . . . . 0.0 111.329 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.37 136.01 57.33 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.301 1.041 . . . . 0.0 113.357 170.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.25 -39.65 70.02 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.553 1.541 . . . . 0.0 113.16 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.1 -22.19 70.49 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.739 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.38 -10.64 45.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.9 mt -67.71 154.41 41.57 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.277 0.944 . . . . 0.0 111.576 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -123.08 152.74 40.76 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.193 0.997 . . . . 0.0 110.768 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.5 t -65.5 138.03 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.693 0.797 . . . . 0.0 110.361 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.51 -3.78 85.19 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 115.254 0.862 . . . . 0.0 115.254 -175.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.22 153.48 27.15 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.085 1.442 . . . . 0.0 111.799 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -100.39 107.96 19.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.852 1.261 . . . . 0.0 112.587 -163.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.5 mt -100.91 177.26 5.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.724 1.61 . . . . 0.0 110.343 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.88 157.57 41.18 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.4 -174.32 2.47 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.43 1.492 . . . . 0.0 114.511 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.4 p -56.0 -7.25 0.31 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -119.65 -26.55 5.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.187 1.395 . . . . 0.0 114.55 165.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.16 23.39 4.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.147 1.356 . . . . 0.0 113.404 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -77.0 146.75 37.23 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.324 1.062 . . . . 0.0 111.82 171.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.54 109.43 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.239 0.616 . . . . 0.0 112.225 -173.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.8 mt -93.44 159.31 15.3 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.858 1.663 . . . . 0.0 112.312 173.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.2 t -124.55 139.11 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.111 0.964 . . . . 0.0 111.098 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.2 t -69.2 130.82 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.403 0.681 . . . . 0.0 110.081 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -98.28 -43.33 7.01 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.534 1.933 . . . . 0.0 112.796 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -159.81 154.08 23.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.27 1.028 . . . . 0.0 111.843 -172.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -118.87 135.62 54.46 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.553 1.941 . . . . 0.0 108.865 165.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -130.57 130.09 43.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.817 1.647 . . . . 0.0 109.678 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -129.16 129.75 45.51 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.665 1.186 . . . . 0.0 111.985 -169.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -147.03 163.49 36.09 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.488 1.115 . . . . 0.0 112.879 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 mm -104.63 116.7 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 159.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.21 145.57 50.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.249 1.019 . . . . 0.0 111.672 173.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -75.09 -11.82 60.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.991 1.316 . . . . 0.0 112.464 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -139.84 152.05 67.13 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 127.204 2.202 . . . . 0.0 111.57 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.59 117.69 5.04 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.078 2.519 . . . . 0.0 110.753 172.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.31 139.43 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.033 1.733 . . . . 0.0 110.353 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -76.27 139.31 41.05 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.888 0.875 . . . . 0.0 110.297 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.47 140.8 28.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 124.007 0.923 . . . . 0.0 111.657 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -119.64 153.87 34.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.812 1.645 . . . . 0.0 112.049 -169.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -157.18 170.2 23.04 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.947 1.699 . . . . 0.0 110.816 170.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -152.64 167.56 28.5 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.354 -1.466 . . . . 0.0 113.249 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -117.37 144.84 44.52 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.745 1.218 . . . . 0.0 112.954 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.17 139.54 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.562 1.545 . . . . 0.0 111.48 -168.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -60.22 -34.66 73.96 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -163.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -145.87 -47.27 0.21 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.007 -1.058 . . . . 0.0 112.671 -172.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -76.39 165.99 24.05 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.198 1.399 . . . . 0.0 109.169 163.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -116.88 1.42 12.67 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -168.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.3 p -126.28 163.94 22.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.534 1.534 . . . . 0.0 113.258 -167.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -153.39 -177.08 6.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.749 1.619 . . . . 0.0 110.631 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -130.16 141.85 50.63 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.79 1.236 . . . . 0.0 113.31 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.26 140.23 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.499 1.119 . . . . 0.0 113.688 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.23 176.95 42.45 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.784 1.659 . . . . 0.0 116.496 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -57.21 -36.95 71.5 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.076 1.351 . . . . 0.0 112.775 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -82.95 -1.04 51.32 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 175.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 56.96 51.09 11.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.843 1.657 . . . . 0.0 113.486 168.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.9 t -80.32 141.98 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.215 1.806 . . . . 0.0 112.055 -167.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 48.9 tp -78.58 125.88 29.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.98 1.712 . . . . 0.0 114.216 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.09 158.9 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.257 1.823 . . . . 0.0 111.648 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -111.58 151.97 28.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.708 1.203 . . . . 0.0 112.934 -171.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.755 -1.593 . . . . 0.0 113.926 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.989 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -124.37 154.81 39.8 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.289 1.436 . . . . 0.0 111.833 173.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.97 157.8 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.452 0.644 . . . . 0.0 112.356 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.3 144.31 20.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.539 0.735 . . . . 0.0 111.898 172.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.42 -8.1 69.65 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 116.489 1.355 . . . . 0.0 116.489 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.9 m -64.12 121.27 13.8 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 120.62 2.21 . . . . 0.0 110.6 174.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mmt -78.23 142.93 37.54 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.22 1.408 . . . . 0.0 112.089 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.5 mm -127.79 134.34 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.726 2.011 . . . . 0.0 109.708 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -76.38 128.95 35.85 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 p -123.64 169.67 11.24 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.991 1.316 . . . . 0.0 111.241 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.31 -19.09 65.8 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.777 -1.202 . . . . 0.0 113.294 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 p -119.56 2.66 11.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.861 2.064 . . . . 0.0 113.792 -173.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.16 -116.36 0.81 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.221 1.391 . . . . 0.0 113.982 166.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.98 154.47 45.55 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.771 1.628 . . . . 0.0 110.5 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -143.16 148.19 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 126.439 1.896 . . . . 0.0 108.585 170.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.35 147.02 46.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.017 -1.052 . . . . 0.0 111.306 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 tt -62.11 -27.06 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 120.437 -1.414 . . . . 0.0 113.498 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.58 -14.7 62.6 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 172.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -108.5 -15.06 14.53 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.232 1.813 . . . . 0.0 113.898 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.8 mm -63.04 132.25 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 163.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -133.26 170.76 14.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.523 1.929 . . . . 0.0 109.606 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.12 130.47 15.75 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.189 0.518 . . . . 0.0 111.005 166.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.24 -1.2 88.73 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 116.105 1.202 . . . . 0.0 116.105 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -76.58 155.38 33.64 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.779 1.789 . . . . 0.0 110.666 160.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -111.5 140.36 46.17 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.958 1.303 . . . . 0.0 112.509 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.11 162.16 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.542 1.937 . . . . 0.0 110.292 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.2 mm -78.63 141.73 15.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 121.819 -0.55 . . . . 0.0 110.472 162.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.95 129.3 29.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.7 m -91.53 108.37 19.85 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 165.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -52.43 117.21 10.06 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.223 1.009 . . . . 0.0 112.583 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.43 -12.98 37.7 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.097 2.532 . . . . 0.0 113.907 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -76.4 -40.62 50.37 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.225 1.01 . . . . 0.0 112.523 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.8 t -135.08 -5.26 2.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.339 1.456 . . . . 0.0 113.685 -171.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.3 t80 56.65 43.08 26.08 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.329 1.452 . . . . 0.0 114.034 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -95.71 135.16 37.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.236 1.014 . . . . 0.0 110.151 170.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -105.95 122.54 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.98 0.912 . . . . 0.0 112.339 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.22 160.51 39.26 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.324 1.049 . . . . 0.0 113.077 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -91.12 121.12 32.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.148 1.379 . . . . 0.0 109.466 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -139.05 149.09 44.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.465 1.106 . . . . 0.0 112.931 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.7 t -80.75 161.5 24.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.875 1.27 . . . . 0.0 113.435 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.9 t -98.19 133.62 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 126.236 1.814 . . . . 0.0 111.716 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.02 -45.19 10.4 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.962 1.305 . . . . 0.0 113.298 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -146.88 156.64 43.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.276 1.83 . . . . 0.0 110.614 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.1 p -116.43 135.24 54.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.221 164.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -105.7 147.92 28.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.688 1.595 . . . . 0.0 112.056 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -143.65 128.93 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.501 1.12 . . . . 0.0 111.319 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -126.28 176.05 7.38 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.04 1.736 . . . . 0.0 111.198 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -133.34 133.73 42.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.781 1.233 . . . . 0.0 111.945 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 t -148.16 143.99 27.45 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.957 1.303 . . . . 0.0 111.63 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.7 p -84.35 -21.27 30.96 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.635 0.774 . . . . 0.0 112.689 164.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -96.39 115.81 28.04 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.008 0.923 . . . . 0.0 110.203 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.4 mt -121.05 167.79 12.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.796 1.239 . . . . 0.0 112.276 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.89 134.85 46.16 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.693 1.997 . . . . 0.0 109.689 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -113.88 128.38 56.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.617 1.167 . . . . 0.0 108.866 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.2 mt -124.08 128.77 49.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.518 1.127 . . . . 0.0 110.339 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.8 m -99.04 122.9 42.9 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 169.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.74 119.67 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.895 1.278 . . . . 0.0 109.968 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.86 21.74 17.12 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 115.926 1.131 . . . . 0.0 115.926 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.35 7.64 55.74 Favored Glycine 0 CA--C 1.542 1.768 0 N-CA-C 116.914 1.526 . . . . 0.0 116.914 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -121.76 131.02 53.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.185 1.492 . . . . 0.0 109.869 172.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -97.35 134.69 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.989 0.899 . . . . 0.0 112.983 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.8 mt -130.42 133.81 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.812 2.045 . . . . 0.0 108.794 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -119.08 112.13 19.15 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.245 1.418 . . . . 0.0 110.792 -165.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -141.2 -177.63 5.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.611 1.164 . . . . 0.0 112.426 -161.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.9 p -89.66 153.54 20.65 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.198 0.999 . . . . 0.0 111.923 169.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -58.26 -27.88 64.4 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.925 1.29 . . . . 0.0 113.272 -175.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -107.52 7.44 28.8 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.723 1.209 . . . . 0.0 112.225 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -69.69 128.86 91.77 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.99 112.86 2.37 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 124.683 3.589 . . . . 0.0 115.216 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -94.7 152.99 18.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.369 2.268 . . . . 0.0 111.507 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -97.99 132.02 43.91 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -111.59 138.51 39.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 127.28 2.232 . . . . 0.0 110.226 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.54 127.4 31.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.732 1.213 . . . . 0.0 110.441 175.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t0 56.3 31.52 18.72 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.383 1.873 . . . . 0.0 115.595 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.0 t -144.12 -50.63 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.853 1.261 . . . . 0.0 112.417 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.45 -153.21 16.74 Favored Glycine 0 N--CA 1.468 0.811 0 CA-C-N 119.392 0.997 . . . . 0.0 111.512 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -92.04 147.65 22.79 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -149.14 143.49 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.596 1.958 . . . . 0.0 112.053 -175.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.81 132.33 52.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.872 1.269 . . . . 0.0 112.68 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.84 -36.96 68.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.301 1.44 . . . . 0.0 113.645 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.99 -12.67 83.2 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.561 1.077 . . . . 0.0 114.168 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -102.2 -7.88 21.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.278 1.831 . . . . 0.0 113.544 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 mt -58.49 158.69 7.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.679 0.792 . . . . 0.0 112.405 166.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -114.51 152.82 31.09 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.388 1.475 . . . . 0.0 110.395 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 50.3 t -67.59 132.63 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.351 0.596 . . . . 0.0 109.521 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.1 0.14 68.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.677 1.132 . . . . 0.0 115.201 -171.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -84.22 156.4 22.04 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.127 1.464 . . . . 0.0 111.96 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -106.73 102.41 11.79 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.118 1.367 . . . . 0.0 111.965 -156.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.7 mt -96.3 -175.36 3.33 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.486 1.514 . . . . 0.0 111.041 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.67 149.03 52.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.084 0.954 . . . . 0.0 112.51 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.02 172.46 6.91 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.218 1.007 . . . . 0.0 113.278 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.9 p -56.67 -11.34 1.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -107.37 -30.5 8.65 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.19 1.796 . . . . 0.0 112.344 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.74 19.89 5.92 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.956 1.741 . . . . 0.0 113.79 -177.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -70.59 140.26 51.64 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.658 0.729 . . . . 0.0 110.553 167.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.4 t -77.57 107.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.906 0.883 . . . . 0.0 109.832 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.3 mt -85.96 160.53 19.34 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.274 1.43 . . . . 0.0 111.816 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.89 137.71 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.334 1.053 . . . . 0.0 110.798 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.0 119.66 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.602 0.761 . . . . 0.0 109.05 170.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -96.52 -31.64 12.68 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.392 1.477 . . . . 0.0 112.213 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.93 148.12 20.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.575 1.55 . . . . 0.0 111.324 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -125.66 127.36 46.16 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.441 2.296 . . . . 0.0 109.773 168.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -125.31 156.56 38.45 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.482 2.313 . . . . 0.0 110.748 169.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.15 135.08 26.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.841 1.656 . . . . 0.0 108.266 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -142.75 158.46 43.61 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.9 mm -110.7 101.02 11.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 125.21 1.404 . . . . 0.0 109.903 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.78 146.74 35.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.403 1.481 . . . . 0.0 113.535 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.59 -14.79 61.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.848 1.259 . . . . 0.0 113.372 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -138.3 155.15 74.18 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 127.076 2.15 . . . . 0.0 109.761 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.96 111.42 2.64 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.429 2.086 . . . . 0.0 110.402 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.1 t -81.42 140.24 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.927 1.691 . . . . 0.0 110.015 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -75.64 135.8 40.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.092 0.949 . . . . 0.0 110.39 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.28 136.76 50.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 124.59 1.156 . . . . 0.0 110.61 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -118.91 149.32 41.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.609 1.564 . . . . 0.0 111.16 -167.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -153.36 166.42 32.69 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.763 1.625 . . . . 0.0 109.885 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -152.44 164.72 36.98 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.241 -1.537 . . . . 0.0 112.318 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -121.98 143.17 49.64 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.0 t -98.72 146.51 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.289 1.836 . . . . 0.0 112.364 -168.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.88 -15.13 63.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -168.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -145.35 -47.5 0.22 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.89 0.876 . . . . 0.0 112.109 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -83.41 173.51 11.46 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.36 1.064 . . . . 0.0 112.1 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -112.48 9.22 19.57 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.824 2.05 . . . . 0.0 114.58 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 p -133.08 171.44 13.98 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.104 1.361 . . . . 0.0 113.585 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -157.52 179.91 8.79 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.831 2.053 . . . . 0.0 110.362 163.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -117.24 138.95 51.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.808 1.243 . . . . 0.0 112.604 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.6 m -126.14 142.65 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.381 1.472 . . . . 0.0 113.912 -174.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.22 174.59 28.0 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.431 1.491 . . . . 0.0 115.336 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -26.0 65.9 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.756 -1.438 . . . . 0.0 113.133 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -83.54 -3.78 57.96 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.005 0.922 . . . . 0.0 113.384 170.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 57.38 55.35 5.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.134 1.773 . . . . 0.0 113.857 167.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.88 143.41 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.557 1.543 . . . . 0.0 111.603 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.5 tp -81.34 125.47 30.42 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.726 1.21 . . . . 0.0 114.091 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.6 159.05 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.478 1.511 . . . . 0.0 112.574 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -99.62 149.96 22.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.179 1.392 . . . . 0.0 113.959 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.7 m120 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.265 1.826 . . . . 0.0 112.505 179.469 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.041 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.437 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.8 m-85 -124.78 154.52 40.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.565 1.546 . . . . 0.0 111.121 167.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.49 154.69 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.683 -0.636 . . . . 0.0 111.262 171.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.78 154.56 8.97 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.362 0.601 . . . . 0.0 111.717 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.88 -9.66 29.89 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-O 117.676 -1.625 . . . . 0.0 116.186 -171.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.5 m -62.33 125.31 23.47 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.539 2.17 . . . . 0.0 110.11 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 mmt -85.12 140.66 30.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.693 1.197 . . . . 0.0 111.982 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.66 135.18 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.781 2.033 . . . . 0.0 110.123 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.68 130.8 40.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.902 0.881 . . . . 0.0 113.208 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 p -126.18 174.21 8.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.71 1.604 . . . . 0.0 111.353 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.7 -19.38 64.88 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.26 1.424 . . . . 0.0 113.552 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -110.56 -25.39 10.02 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.17 -113.34 0.54 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.809 0.731 . . . . 0.0 112.825 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.6 mt -130.99 145.9 52.2 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.2 t -133.29 142.73 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.305 1.842 . . . . 0.0 108.941 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.77 144.77 49.08 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.214 -0.929 . . . . 0.0 110.959 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.32 -27.52 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 120.982 -1.074 . . . . 0.0 113.605 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -70.51 -14.06 62.37 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.089 1.356 . . . . 0.0 114.125 173.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -114.28 -11.01 12.64 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.551 1.54 . . . . 0.0 113.203 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.4 mm -61.68 137.23 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.569 -0.707 . . . . 0.0 109.282 163.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -125.55 164.03 21.42 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.369 1.868 . . . . 0.0 111.545 170.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.62 132.42 35.68 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.738 -0.601 . . . . 0.0 111.532 167.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.29 1.13 90.4 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.486 1.041 . . . . 0.0 115.287 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -82.65 154.54 24.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.533 1.167 . . . . 0.0 109.869 164.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -112.13 145.64 39.44 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.693 1.197 . . . . 0.0 112.311 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.03 160.56 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.229 1.811 . . . . 0.0 111.258 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -73.79 143.95 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.475 -0.765 . . . . 0.0 111.722 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.52 128.28 20.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.36 1.064 . . . . 0.0 109.446 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.406 ' HG1' ' CE1' ' A' ' 125' ' ' HIS . 71.4 m -78.62 115.45 18.33 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 162.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -55.21 115.39 9.03 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.231 1.012 . . . . 0.0 112.07 170.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.84 -3.95 13.77 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.9 2.4 . . . . 0.0 114.349 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -81.8 -45.99 14.81 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.309 0.958 . . . . 0.0 112.409 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -136.86 0.95 2.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.342 1.057 . . . . 0.0 112.767 -166.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 55.8 45.99 23.21 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.468 1.127 . . . . 0.0 112.678 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -86.59 134.97 33.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.564 1.546 . . . . 0.0 109.543 165.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 t -110.44 119.64 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 118.733 0.697 . . . . 0.0 109.644 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.35 164.88 33.67 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.792 0.837 . . . . 0.0 112.529 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -88.94 128.84 35.7 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.697 1.599 . . . . 0.0 110.941 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.437 ' HE3' ' CZ ' ' A' ' 121' ' ' PHE . 66.6 mmtt -134.46 148.76 50.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.365 1.066 . . . . 0.0 111.153 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -86.05 154.15 21.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.62 0.724 . . . . 0.0 112.781 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.6 t -90.18 134.86 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.655 1.582 . . . . 0.0 110.599 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.82 -48.37 7.54 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.881 0.872 . . . . 0.0 112.381 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -143.78 160.89 39.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.264 1.826 . . . . 0.0 110.235 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.3 p -116.43 134.05 55.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.562 1.145 . . . . 0.0 110.172 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -109.32 140.78 42.56 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.835 1.654 . . . . 0.0 113.705 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.33 138.45 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.651 1.18 . . . . 0.0 111.062 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -141.19 174.04 10.91 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.474 2.31 . . . . 0.0 109.532 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -130.48 138.85 50.47 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.504 1.522 . . . . 0.0 110.38 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.2 t -147.15 150.7 35.48 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.585 0.707 . . . . 0.0 111.643 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 p -94.17 -14.03 26.06 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.67 1.588 . . . . 0.0 113.848 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -118.55 111.39 18.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.039 0.836 . . . . 0.0 110.745 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.2 mt -110.14 160.79 16.17 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 tp -127.58 130.65 49.41 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 110.852 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -117.4 103.07 9.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.696 1.598 . . . . 0.0 109.413 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.7 mt -98.35 128.1 44.6 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.757 0.823 . . . . 0.0 110.22 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -100.29 119.74 38.86 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.08 116.32 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.321 1.048 . . . . 0.0 109.179 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.12 28.75 34.44 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 123.707 0.67 . . . . 0.0 114.72 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.12 -2.11 87.63 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.915 1.722 . . . . 0.0 116.332 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.4 122.49 41.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.863 1.831 . . . . 0.0 109.507 168.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.1 p -87.32 131.78 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.486 0.66 . . . . 0.0 111.71 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.92 131.04 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.823 2.049 . . . . 0.0 108.86 -175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -113.94 110.19 19.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.608 1.163 . . . . 0.0 110.777 -164.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 t -139.88 177.78 7.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.05 0.94 . . . . 0.0 112.218 -157.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.2 p -87.15 151.31 23.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.129 0.972 . . . . 0.0 112.116 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -58.75 -29.85 67.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.408 1.083 . . . . 0.0 112.845 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -98.21 9.55 42.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.437 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.3 t60 -70.58 125.96 92.13 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 120.909 -1.119 . . . . 0.0 112.475 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.99 119.82 4.04 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.139 2.559 . . . . 0.0 113.963 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -106.92 144.13 34.0 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.71 2.004 . . . . 0.0 111.074 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -83.33 128.61 34.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.464 1.029 . . . . 0.0 113.285 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.9 t -103.84 133.0 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.402 2.281 . . . . 0.0 110.96 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -49.01 118.46 2.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.056 1.743 . . . . 0.0 112.144 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 52.57 24.94 3.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.404 2.682 . . . . 0.0 115.312 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.75 -50.26 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.21 1.404 . . . . 0.0 110.577 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.48 -161.66 13.52 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 123.541 0.591 . . . . 0.0 112.54 -175.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.282 31.1 p90 -85.02 150.01 25.18 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 118.818 1.309 . . . . 0.0 114.162 -175.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.72 144.99 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.008 1.723 . . . . 0.0 110.642 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.41 136.13 57.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.94 0.896 . . . . 0.0 112.108 176.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.25 -36.12 70.56 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.78 1.232 . . . . 0.0 113.961 -171.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.66 -3.74 89.41 Favored Glycine 0 CA--C 1.539 1.561 0 O-C-N 121.027 -1.046 . . . . 0.0 113.611 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -95.77 -4.6 43.68 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.241 1.816 . . . . 0.0 112.314 167.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.0 mt -71.59 154.11 41.66 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.547 -0.721 . . . . 0.0 112.263 166.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -119.72 166.99 12.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.16 1.384 . . . . 0.0 110.976 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.31 138.53 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.57 12.99 82.3 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 115.234 0.854 . . . . 0.0 115.234 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -86.29 150.87 24.05 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.317 -1.107 . . . . 0.0 110.841 169.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -107.44 111.81 24.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.333 1.453 . . . . 0.0 112.056 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.1 mt -104.2 -177.82 3.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.339 1.456 . . . . 0.0 111.06 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -131.46 156.19 46.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.272 1.029 . . . . 0.0 113.518 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.8 p30 -105.15 179.85 4.15 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.914 1.286 . . . . 0.0 113.289 174.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.3 t -66.06 -17.87 64.97 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.871 1.669 . . . . 0.0 114.14 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -85.48 -25.53 26.83 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.261 -1.525 . . . . 0.0 112.171 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.72 25.31 8.16 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.699 2.095 . . . . 0.0 113.224 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.81 142.82 34.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.309 1.444 . . . . 0.0 111.812 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.9 t -57.11 120.3 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.51 1.124 . . . . 0.0 112.248 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -99.71 154.37 18.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.169 1.388 . . . . 0.0 110.901 161.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.42 140.6 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.865 1.266 . . . . 0.0 110.471 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.9 119.54 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.526 0.679 . . . . 0.0 109.237 170.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.02 -35.15 14.81 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.782 2.033 . . . . 0.0 112.626 -176.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -162.91 148.86 12.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.195 1.798 . . . . 0.0 110.817 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -129.41 124.5 34.29 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.932 1.693 . . . . 0.0 110.31 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 mmtm -132.22 151.1 51.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.531 1.532 . . . . 0.0 112.102 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 tp -136.13 137.65 41.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.858 1.663 . . . . 0.0 108.996 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.39 151.13 43.23 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.4 mm -99.77 119.01 47.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.779 170.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.89 149.59 43.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 112.795 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -67.95 -19.06 64.93 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.455 1.502 . . . . 0.0 113.251 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -157.27 156.64 29.56 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.913 2.485 . . . . 0.0 108.961 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -60.59 129.14 28.2 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.452 2.101 . . . . 0.0 112.603 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.83 144.35 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.595 1.558 . . . . 0.0 109.618 173.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -79.69 140.95 36.84 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.618 -0.677 . . . . 0.0 110.643 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.6 m -136.79 137.66 47.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.606 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -111.69 154.15 25.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.721 1.608 . . . . 0.0 111.974 -172.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -155.58 174.01 15.88 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.85 2.46 . . . . 0.0 108.033 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -153.76 170.9 19.8 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.044 -1.66 . . . . 0.0 110.744 173.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -121.94 137.25 54.86 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.774 0.83 . . . . 0.0 112.834 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.6 t -100.05 144.89 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.963 1.305 . . . . 0.0 111.95 -167.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -57.59 -39.07 75.96 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -170.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -139.6 -48.83 0.48 Allowed 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.97 -1.081 . . . . 0.0 113.372 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.437 ' CZ ' ' HE3' ' A' ' 39' ' ' LYS . 5.8 m-30 -69.94 163.87 25.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 168.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -116.29 23.48 12.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.954 1.302 . . . . 0.0 112.103 -171.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 p -147.69 160.64 42.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.553 1.541 . . . . 0.0 111.84 -157.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -160.24 175.89 12.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.836 1.655 . . . . 0.0 110.391 171.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.406 ' CE1' ' HG1' ' A' ' 29' ' ' THR . 27.5 m170 -122.27 134.2 54.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.393 1.077 . . . . 0.0 112.802 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.6 m -122.05 143.42 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.271 1.428 . . . . 0.0 114.663 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.53 176.98 30.14 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 126.118 1.818 . . . . 0.0 116.19 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.15 -34.5 66.19 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 120.92 -1.341 . . . . 0.0 113.237 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -83.02 0.1 46.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 57.35 43.6 23.08 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.027 1.331 . . . . 0.0 113.334 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.25 136.81 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.127 1.371 . . . . 0.0 111.723 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.6 tp -79.22 124.92 28.82 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.829 1.252 . . . . 0.0 113.98 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.4 m -138.27 157.01 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.127 1.771 . . . . 0.0 112.062 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -107.16 129.31 54.86 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.194 1.398 . . . . 0.0 112.823 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.213 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.924 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.44 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 98.4 m-85 -123.62 157.12 34.47 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.14 1.776 . . . . 0.0 110.699 168.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 m -68.79 157.61 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.809 -0.557 . . . . 0.0 111.808 173.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.5 153.36 4.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.364 0.666 . . . . 0.0 111.948 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.8 3.95 30.97 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-O 117.95 -1.472 . . . . 0.0 116.475 -174.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -67.77 125.34 25.95 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 120.922 2.361 . . . . 0.0 109.617 165.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.6 mmt -80.5 142.19 34.44 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.353 1.461 . . . . 0.0 111.858 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -123.29 137.11 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.787 2.035 . . . . 0.0 109.905 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.91 122.14 22.06 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 112.592 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 p -115.21 168.14 10.21 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.115 1.366 . . . . 0.0 110.562 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.28 66.57 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.402 -0.812 . . . . 0.0 112.969 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.0 p -100.05 -31.66 11.32 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.626 0.77 . . . . 0.0 112.547 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.97 -120.09 0.76 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.877 0.751 . . . . 0.0 112.715 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.57 140.83 51.87 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.611 1.164 . . . . 0.0 112.67 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.1 t -132.25 142.64 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.848 1.659 . . . . 0.0 108.747 173.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.38 150.41 48.99 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.103 -0.998 . . . . 0.0 111.725 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.9 tt -62.45 -25.85 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 120.876 -1.14 . . . . 0.0 113.558 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -75.09 -15.28 60.62 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.376 1.07 . . . . 0.0 113.765 171.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -107.97 -16.25 14.34 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.571 1.948 . . . . 0.0 112.401 -176.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.7 mm -63.29 134.66 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 160.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -134.17 160.21 38.51 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.043 1.337 . . . . 0.0 111.604 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.42 120.21 8.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.785 0.434 . . . . 0.0 110.406 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.73 -24.67 23.15 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.535 1.064 . . . . 0.0 115.716 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.86 170.83 8.9 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.394 1.597 . . . . 0.0 111.648 172.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -125.33 146.53 49.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.725 1.61 . . . . 0.0 111.167 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.18 160.55 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.131 1.372 . . . . 0.0 110.455 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -75.09 140.94 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.234 0.54 . . . . 0.0 110.514 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.49 125.78 24.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.222 1.009 . . . . 0.0 108.695 175.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.2 m -79.79 112.3 16.94 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 161.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -53.92 111.44 2.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 118.343 -0.836 . . . . 0.0 110.718 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -69.18 -12.25 33.54 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.35 2.034 . . . . 0.0 112.691 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -77.19 -38.66 51.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.076 1.351 . . . . 0.0 112.828 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.7 t -136.23 -6.1 2.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.01 1.324 . . . . 0.0 112.53 -170.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.259 15.6 m-85 54.5 52.3 12.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.221 1.408 . . . . 0.0 112.185 -175.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -100.64 135.65 41.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.108 1.763 . . . . 0.0 108.889 167.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 t -113.04 128.89 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 119.01 0.823 . . . . 0.0 111.27 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.78 172.19 18.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.91 0.884 . . . . 0.0 113.079 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -74.23 138.04 43.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.71 1.204 . . . . 0.0 111.443 165.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -139.31 152.63 47.37 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.396 1.078 . . . . 0.0 112.23 160.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -79.08 155.32 28.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.668 1.187 . . . . 0.0 114.131 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.7 t -93.12 131.73 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 126.537 1.935 . . . . 0.0 111.318 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.42 -41.05 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.363 1.465 . . . . 0.0 113.508 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -147.37 156.02 42.52 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 127.159 2.184 . . . . 0.0 109.703 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -113.26 135.92 53.31 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.475 1.51 . . . . 0.0 109.14 163.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -112.35 141.83 45.59 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.183 1.393 . . . . 0.0 113.912 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -135.02 138.29 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.056 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -140.15 176.19 8.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.209 2.203 . . . . 0.0 110.112 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.12 133.62 50.36 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.375 1.47 . . . . 0.0 110.973 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 t -142.42 145.11 33.46 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.125 -0.984 . . . . 0.0 113.12 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.8 p -88.27 -14.52 38.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.806 1.642 . . . . 0.0 113.25 167.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -107.66 108.85 20.29 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.005 -1.059 . . . . 0.0 110.9 -172.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.6 mt -116.45 167.96 10.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.251 1.021 . . . . 0.0 112.818 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.1 tp -135.28 133.21 38.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.859 2.064 . . . . 0.0 109.268 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -105.54 130.43 53.6 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.232 -0.918 . . . . 0.0 109.292 170.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.5 mt -114.14 147.53 38.7 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.371 1.069 . . . . 0.0 110.1 169.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.7 m -123.17 124.83 43.92 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.452 0.701 . . . . 0.0 109.627 166.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.1 mt -132.77 123.55 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.84 1.656 . . . . 0.0 109.425 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.08 28.79 50.28 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 115.611 1.005 . . . . 0.0 115.611 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.11 7.51 87.7 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.82 1.2 . . . . 0.0 115.567 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -109.1 137.55 46.83 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.745 1.618 . . . . 0.0 109.567 171.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.61 135.84 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.345 1.058 . . . . 0.0 111.171 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mt -129.7 104.58 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.161 1.784 . . . . 0.0 109.341 173.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -81.94 121.82 26.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.823 1.649 . . . . 0.0 111.429 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.5 t -144.64 175.36 10.21 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.165 -0.96 . . . . 0.0 112.73 -167.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.3 p -79.19 153.86 29.69 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.591 -0.693 . . . . 0.0 111.181 167.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -59.43 -28.83 67.31 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.763 0.825 . . . . 0.0 112.62 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -98.01 1.21 47.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.963 0.905 . . . . 0.0 113.164 -171.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.44 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.2 t60 -64.68 128.07 93.13 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 117.657 -1.163 . . . . 0.0 112.87 -173.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -84.4 127.87 3.97 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.003 1.802 . . . . 0.0 114.673 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -115.93 139.58 50.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.129 2.572 . . . . 0.0 111.407 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -89.6 129.58 36.03 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.0 134.36 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.561 2.344 . . . . 0.0 112.4 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -50.05 126.36 14.27 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.982 1.713 . . . . 0.0 112.779 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 52.5 22.54 2.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.239 2.216 . . . . 0.0 115.259 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.09 -53.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.81 -1.181 . . . . 0.0 111.141 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.92 -159.68 13.57 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.095 0.855 . . . . 0.0 113.014 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -92.57 139.13 30.89 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.159 1.541 . . . . 0.0 115.159 -170.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.57 146.98 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 127.45 2.3 . . . . 0.0 111.987 -172.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.48 135.85 56.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 173.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.48 -40.14 61.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.958 1.703 . . . . 0.0 113.688 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.3 -10.58 66.29 Favored Glycine 0 CA--C 1.539 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 113.683 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -112.14 4.37 17.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.563 2.345 . . . . 0.0 113.04 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.85 159.66 19.14 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.969 -1.082 . . . . 0.0 111.295 163.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.42 156.68 32.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.441 1.096 . . . . 0.0 111.465 172.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.44 132.58 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 165.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.84 11.32 82.92 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 118.404 -1.22 . . . . 0.0 115.706 -172.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.3 165.19 7.82 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.908 1.854 . . . . 0.0 112.097 170.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -117.71 83.28 1.97 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.742 1.217 . . . . 0.0 111.735 -169.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.25 162.96 13.64 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.189 0.996 . . . . 0.0 113.533 -170.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.43 140.75 38.06 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.521 1.128 . . . . 0.0 112.552 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.12 177.14 5.17 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.501 1.12 . . . . 0.0 114.004 171.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.0 p -59.95 -12.08 7.09 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -107.85 -25.91 11.0 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.295 1.838 . . . . 0.0 111.905 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.6 25.14 6.72 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 126.402 1.954 . . . . 0.0 112.719 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -74.83 154.71 38.16 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.709 0.804 . . . . 0.0 110.437 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.8 t -92.83 112.76 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.785 0.834 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.5 mt -84.68 163.11 19.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.755 2.822 . . . . 0.0 112.324 175.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.71 134.78 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.554 1.542 . . . . 0.0 110.033 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.48 131.52 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.685 -0.635 . . . . 0.0 109.542 170.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -105.43 -35.26 7.55 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.613 1.565 . . . . 0.0 112.407 -175.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -157.87 149.24 21.47 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.194 0.998 . . . . 0.0 112.574 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -123.0 128.54 50.33 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.771 2.029 . . . . 0.0 108.743 161.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -130.27 151.61 50.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.116 1.766 . . . . 0.0 111.577 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 tt -138.62 142.99 39.1 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 111.416 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -150.52 161.92 41.61 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.933 0.893 . . . . 0.0 112.555 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mm -111.02 109.93 30.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.991 1.317 . . . . 0.0 108.329 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.47 140.37 58.59 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.318 0.647 . . . . 0.0 110.943 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.88 -21.63 60.89 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.64 -1.288 . . . . 0.0 113.283 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -127.54 151.12 74.61 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 127.221 2.208 . . . . 0.0 109.887 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.05 110.71 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.727 2.285 . . . . 0.0 112.069 -174.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.35 142.1 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.03 1.732 . . . . 0.0 110.18 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -71.2 140.28 50.42 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.081 0.943 . . . . 0.0 112.144 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.1 m -140.04 137.5 38.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.645 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -121.92 149.05 43.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.527 1.531 . . . . 0.0 111.354 -166.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -154.11 173.18 16.41 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.666 1.986 . . . . 0.0 108.413 170.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -150.27 170.71 18.35 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.218 -1.551 . . . . 0.0 111.283 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -119.46 136.52 54.27 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.82 0.848 . . . . 0.0 112.912 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.51 146.61 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.756 1.622 . . . . 0.0 111.491 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.08 -45.26 74.29 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -168.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -127.65 -32.85 2.34 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 119.732 1.151 . . . . 0.0 113.654 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -96.32 169.27 10.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.263 1.425 . . . . 0.0 108.925 167.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -120.97 19.68 11.65 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.742 1.217 . . . . 0.0 113.282 -171.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 p -142.13 164.28 30.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.524 1.53 . . . . 0.0 111.649 -162.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.69 179.31 9.22 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.387 1.475 . . . . 0.0 110.151 170.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -121.81 134.6 54.9 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.538 1.135 . . . . 0.0 111.943 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.19 144.81 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.239 1.416 . . . . 0.0 113.583 -173.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.6 175.16 26.71 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.663 1.601 . . . . 0.0 115.396 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -63.08 -29.44 70.81 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.309 -1.113 . . . . 0.0 112.112 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -86.11 1.72 49.44 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 174.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 58.33 46.24 15.77 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.271 1.428 . . . . 0.0 114.126 166.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.52 140.1 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.505 1.122 . . . . 0.0 111.443 -172.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.3 125.88 30.89 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.379 1.471 . . . . 0.0 113.922 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.05 155.57 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.847 1.659 . . . . 0.0 112.359 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -97.69 136.49 37.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.441 1.496 . . . . 0.0 111.73 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.217 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.977 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -123.49 154.74 38.72 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.973 1.709 . . . . 0.0 110.809 170.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.6 m -69.63 160.74 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.427 0.632 . . . . 0.0 111.772 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 157.78 2.34 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 122.166 0.984 . . . . 0.0 112.921 174.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.78 -8.54 4.34 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 116.965 -2.02 . . . . 0.0 116.258 -171.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -62.6 119.82 9.97 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.039 2.419 . . . . 0.0 110.077 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mmt -78.36 141.37 38.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.55 1.14 . . . . 0.0 111.797 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -125.24 135.68 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.406 1.883 . . . . 0.0 109.785 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 tp -76.73 123.61 26.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.895 1.278 . . . . 0.0 112.623 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -123.54 176.84 5.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.736 1.214 . . . . 0.0 112.146 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.86 68.1 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.353 -0.842 . . . . 0.0 112.804 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 p -100.01 -14.45 18.65 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.297 1.439 . . . . 0.0 113.434 -170.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.99 -107.41 0.41 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.375 1.464 . . . . 0.0 110.754 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.36 150.91 48.26 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.291 1.036 . . . . 0.0 112.455 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.7 t -140.05 146.59 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.116 2.166 . . . . 0.0 107.738 168.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.34 149.49 47.3 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.8 -1.188 . . . . 0.0 111.077 175.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -60.83 -30.81 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 120.63 -1.293 . . . . 0.0 112.887 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -65.58 -18.05 65.04 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.823 1.649 . . . . 0.0 114.179 171.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -116.62 -5.14 11.65 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.644 1.978 . . . . 0.0 112.776 -174.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -65.17 134.53 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.123 -0.986 . . . . 0.0 108.543 158.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -120.54 156.9 30.61 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.777 1.631 . . . . 0.0 111.544 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.45 136.27 58.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 167.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.68 -4.05 86.31 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.212 0.91 . . . . 0.0 113.83 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -74.79 -179.68 4.33 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.683 1.241 . . . . 0.0 111.224 167.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -126.1 141.52 51.91 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.51 1.524 . . . . 0.0 112.103 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.67 153.7 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.608 1.563 . . . . 0.0 110.101 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -71.06 134.89 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 121.676 -0.64 . . . . 0.0 111.175 171.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.94 120.02 20.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.088 1.355 . . . . 0.0 108.014 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.9 m -86.7 107.76 18.36 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -54.52 113.08 4.67 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.84 175.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.37 -8.42 22.04 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 122.604 2.203 . . . . 0.0 114.129 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -72.79 -41.67 64.73 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.181 1.393 . . . . 0.0 112.674 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.8 t -143.36 -4.13 0.9 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.254 1.422 . . . . 0.0 112.49 -165.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 58.54 32.0 21.65 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.02 1.728 . . . . 0.0 114.17 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.71 129.59 40.02 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 169.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.52 107.49 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.887 0.875 . . . . 0.0 109.579 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.19 163.39 33.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.707 1.203 . . . . 0.0 111.535 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.39 135.53 35.15 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.53 -0.731 . . . . 0.0 110.188 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.462 ' HE3' ' CE1' ' A' ' 121' ' ' PHE . 72.2 mmtt -131.62 150.13 52.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.435 1.494 . . . . 0.0 110.657 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.4 t -82.58 156.51 23.9 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.73 126.97 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.733 1.613 . . . . 0.0 110.962 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.75 -47.4 11.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.834 1.254 . . . . 0.0 113.434 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -146.1 156.0 43.14 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.536 1.935 . . . . 0.0 110.376 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.3 p -125.17 118.45 26.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.354 1.862 . . . . 0.0 111.027 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -108.97 152.69 24.61 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.031 1.332 . . . . 0.0 113.57 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.2 141.31 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.582 1.953 . . . . 0.0 110.729 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -141.77 176.54 8.83 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.36 1.864 . . . . 0.0 110.704 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -127.84 139.58 52.55 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.532 1.533 . . . . 0.0 111.614 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 t -147.91 147.17 29.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.138 1.375 . . . . 0.0 111.518 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 p -88.49 -19.37 26.54 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.215 1.006 . . . . 0.0 113.002 164.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -97.48 110.84 23.32 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.477 1.111 . . . . 0.0 109.904 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.9 mt -121.92 169.23 11.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.378 1.071 . . . . 0.0 112.37 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 tp -138.24 130.32 28.6 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.465 1.506 . . . . 0.0 109.425 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -112.51 119.89 39.73 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.426 -0.796 . . . . 0.0 109.168 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.9 mt -108.69 140.18 42.45 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.699 0.799 . . . . 0.0 109.534 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.6 m -110.14 119.68 40.06 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 166.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.75 117.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.515 1.126 . . . . 0.0 109.884 -177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.06 30.3 46.06 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-O 119.5 -0.611 . . . . 0.0 114.442 -175.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.04 -7.49 80.97 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.45 1.5 . . . . 0.0 115.605 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -97.88 118.97 35.65 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.262 1.425 . . . . 0.0 111.073 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.9 133.49 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.139 0.575 . . . . 0.0 111.481 170.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mt -133.98 105.76 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 127.382 2.273 . . . . 0.0 108.656 173.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -87.99 120.72 29.61 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.874 1.669 . . . . 0.0 112.739 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -142.02 175.41 9.75 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.389 1.476 . . . . 0.0 112.581 -164.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.2 p -83.64 153.56 24.2 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.977 0.894 . . . . 0.0 111.293 167.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -62.11 -18.29 60.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.505 1.122 . . . . 0.0 113.328 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -104.01 0.93 30.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.448 1.499 . . . . 0.0 113.902 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.2 127.64 93.06 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 119.619 1.1 . . . . 0.0 112.952 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -79.86 123.82 5.37 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.02 2.48 . . . . 0.0 114.325 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -112.2 143.54 43.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.758 2.423 . . . . 0.0 111.282 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -88.07 126.46 35.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.159 0.89 . . . . 0.0 112.492 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -102.45 135.59 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.642 1.977 . . . . 0.0 110.822 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -53.51 129.15 31.51 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.9 1.28 . . . . 0.0 110.785 174.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.3 t70 61.12 13.43 4.71 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.532 1.933 . . . . 0.0 115.518 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.4 t -135.77 -45.33 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 121.026 -1.047 . . . . 0.0 113.072 -172.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.49 -159.07 17.08 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.999 0.809 . . . . 0.0 113.456 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -77.88 145.24 36.34 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -170.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.0 p -149.78 150.45 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.427 2.291 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.02 140.81 58.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 173.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.47 -40.18 65.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.024 1.73 . . . . 0.0 113.689 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.35 -8.26 87.59 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.966 -1.084 . . . . 0.0 113.966 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -97.21 -5.03 37.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.637 1.575 . . . . 0.0 112.121 171.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.53 155.21 41.01 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.095 -1.003 . . . . 0.0 111.292 164.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -123.27 170.12 10.6 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.579 1.151 . . . . 0.0 110.429 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.35 136.37 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.616 -0.677 . . . . 0.0 109.695 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 5.13 87.93 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.103 -0.832 . . . . 0.0 115.09 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -76.22 153.36 36.12 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.522 1.161 . . . . 0.0 110.599 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.47 107.76 18.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.591 1.157 . . . . 0.0 111.791 -169.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.6 mt -99.95 172.82 6.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.547 1.139 . . . . 0.0 111.047 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.2 mt -123.68 165.23 17.58 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.885 0.874 . . . . 0.0 112.705 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -117.73 -174.51 2.64 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.354 1.462 . . . . 0.0 114.745 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.9 p -58.19 -1.31 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.811 2.444 . . . . 0.0 117.235 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -115.89 -20.91 9.79 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.473 1.509 . . . . 0.0 112.66 170.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.88 13.18 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.98 1.752 . . . . 0.0 112.606 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -96.06 137.56 34.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.689 1.195 . . . . 0.0 112.377 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.4 t -67.45 119.85 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.603 1.161 . . . . 0.0 113.534 -170.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.13 159.41 15.56 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.455 2.302 . . . . 0.0 112.612 169.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 t -126.17 139.14 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.977 1.311 . . . . 0.0 111.582 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.83 125.52 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.92 0.888 . . . . 0.0 109.874 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.28 -30.94 10.78 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 127.357 2.263 . . . . 0.0 112.933 -175.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -156.65 152.96 27.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.497 1.119 . . . . 0.0 111.121 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -136.54 101.31 4.6 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.277 1.831 . . . . 0.0 109.545 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -104.77 130.58 52.84 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.314 1.846 . . . . 0.0 110.909 -171.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.9 tp -120.37 128.79 53.56 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.831 1.252 . . . . 0.0 110.81 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.17 162.1 41.42 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.125 1.37 . . . . 0.0 112.874 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.63 117.73 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.157 1.383 . . . . 0.0 108.86 171.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.88 142.62 53.23 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.583 -0.698 . . . . 0.0 112.2 167.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.6 -26.35 67.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.031 1.332 . . . . 0.0 112.987 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -146.91 150.87 40.38 Favored Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 127.051 2.14 . . . . 0.0 109.988 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -56.63 127.54 26.31 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.473 2.782 . . . . 0.0 112.869 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.3 t -99.04 141.36 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 127.072 2.149 . . . . 0.0 110.095 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -74.19 144.85 44.58 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.893 0.769 . . . . 0.0 112.079 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.78 144.26 27.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.309 1.444 . . . . 0.0 110.565 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -128.8 147.59 50.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.521 1.529 . . . . 0.0 110.41 -166.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -156.46 171.64 19.91 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.537 1.135 . . . . 0.0 111.685 169.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -149.78 163.37 38.16 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.465 -0.772 . . . . 0.0 112.117 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.68 144.24 43.27 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.666 1.186 . . . . 0.0 113.204 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.9 t -104.76 147.84 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.059 1.744 . . . . 0.0 111.676 -168.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.35 -72.4 0.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.8 -19.98 12.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -166.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.462 ' CE1' ' HE3' ' A' ' 39' ' ' LYS . 10.5 m-30 -105.92 175.34 5.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.273 1.829 . . . . 0.0 108.524 165.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -132.21 33.13 3.9 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.164 1.386 . . . . 0.0 112.729 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 p -139.75 159.01 43.16 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.061 1.744 . . . . 0.0 112.17 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -158.29 -173.32 4.26 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.82 1.648 . . . . 0.0 110.768 170.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -131.67 141.4 49.58 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.885 1.274 . . . . 0.0 113.392 -170.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.98 142.39 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.678 1.191 . . . . 0.0 112.625 -173.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.55 173.8 23.41 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.283 1.421 . . . . 0.0 115.697 175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.4 -31.2 72.29 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.982 -1.305 . . . . 0.0 113.367 -176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -84.04 2.19 40.31 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.842 1.257 . . . . 0.0 114.0 173.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.88 46.16 17.25 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.454 1.901 . . . . 0.0 114.551 166.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.84 136.53 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.569 1.148 . . . . 0.0 111.515 -170.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 54.1 tp -77.86 126.19 30.47 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.786 1.634 . . . . 0.0 112.639 -176.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.15 157.2 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.768 1.627 . . . . 0.0 111.142 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -108.28 161.38 15.06 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.531 1.132 . . . . 0.0 112.924 -172.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.663 1.585 . . . . 0.0 112.953 171.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 85.9 m-85 -123.6 154.24 39.58 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.552 1.541 . . . . 0.0 111.276 172.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.92 161.53 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.53 0.681 . . . . 0.0 112.053 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.32 154.23 3.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.206 1.002 . . . . 0.0 112.681 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.96 -9.0 7.04 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 117.546 -1.697 . . . . 0.0 116.3 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.0 m -63.03 121.57 13.91 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 121.179 2.49 . . . . 0.0 110.373 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 mmt -78.35 142.94 37.32 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.694 1.597 . . . . 0.0 111.72 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.8 mm -127.32 132.91 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.697 1.999 . . . . 0.0 109.867 -175.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -77.92 123.07 26.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.699 1.199 . . . . 0.0 112.552 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -117.44 178.87 4.22 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.507 1.123 . . . . 0.0 113.647 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.84 52.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.45 1.1 . . . . 0.0 113.832 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 p -113.82 -28.04 7.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.924 1.29 . . . . 0.0 113.706 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.76 -107.96 0.34 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.271 0.939 . . . . 0.0 111.476 -171.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -127.29 149.2 50.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.483 1.113 . . . . 0.0 113.204 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.9 t -142.35 147.73 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 127.286 2.234 . . . . 0.0 108.389 170.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.6 147.09 41.97 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.888 -1.133 . . . . 0.0 111.27 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 tt -61.34 -29.47 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 120.614 -1.304 . . . . 0.0 112.926 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.46 -8.22 44.86 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.918 1.287 . . . . 0.0 114.434 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -119.4 -8.0 10.11 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.749 1.62 . . . . 0.0 113.489 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.19 136.53 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.117 -0.99 . . . . 0.0 110.052 165.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -117.92 166.31 12.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.907 2.083 . . . . 0.0 110.312 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.9 147.02 54.13 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.479 -0.763 . . . . 0.0 111.032 163.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.37 3.24 82.07 Favored Glycine 0 CA--C 1.54 1.637 0 O-C-N 121.77 -0.581 . . . . 0.0 114.543 -171.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -89.81 152.94 21.04 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.099 0.96 . . . . 0.0 110.292 168.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -115.85 120.9 40.74 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.799 1.239 . . . . 0.0 112.709 -168.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 m -110.32 154.06 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 126.88 2.072 . . . . 0.0 110.257 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.3 mm -75.53 135.16 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 O-C-N 121.604 -0.685 . . . . 0.0 109.773 166.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.99 121.48 28.07 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.2 m -101.46 104.1 15.02 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -55.96 114.75 8.08 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.96 -1.019 . . . . 0.0 111.83 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.96 -5.53 12.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.168 1.912 . . . . 0.0 113.443 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.07 -42.51 76.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.833 0.853 . . . . 0.0 112.538 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.2 t -150.01 5.66 0.58 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.787 0.835 . . . . 0.0 112.928 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.265 21.0 m-85 57.11 41.54 27.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.34 1.456 . . . . 0.0 112.642 -173.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -78.79 131.37 36.5 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 165.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.22 123.93 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.133 0.973 . . . . 0.0 109.912 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.38 153.22 43.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -82.27 117.39 22.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.199 1.0 . . . . 0.0 109.96 168.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -132.28 146.63 52.13 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.707 1.203 . . . . 0.0 112.351 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -83.99 155.65 22.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.367 1.067 . . . . 0.0 113.766 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.7 t -87.22 132.98 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 125.645 1.578 . . . . 0.0 111.295 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.3 mt -90.92 -41.37 11.18 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.207 1.003 . . . . 0.0 112.866 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.25 150.67 35.29 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.247 1.819 . . . . 0.0 110.376 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.3 p -121.48 121.57 37.82 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.441 1.897 . . . . 0.0 109.999 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -106.89 144.33 33.69 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.78 1.632 . . . . 0.0 114.214 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.3 t -141.24 133.0 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.861 0.864 . . . . 0.0 112.126 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.6 mmt-85 -138.16 175.13 9.85 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.512 1.925 . . . . 0.0 110.652 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -136.63 136.29 39.03 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.029 0.931 . . . . 0.0 112.941 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -151.1 150.93 31.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.495 1.118 . . . . 0.0 112.107 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.4 p -90.94 -16.86 27.36 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.177 1.391 . . . . 0.0 113.874 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.39 106.89 17.52 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.363 1.065 . . . . 0.0 109.999 -169.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.3 mt -117.69 162.24 18.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.69 1.233 . . . . 0.0 113.372 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -127.3 132.56 50.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.13 1.772 . . . . 0.0 109.029 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -111.08 125.43 53.76 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.172 0.989 . . . . 0.0 108.875 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 mt -112.44 140.82 46.86 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.594 0.758 . . . . 0.0 109.568 170.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.3 m -113.84 119.04 35.94 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 mt -127.24 117.32 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.111 0.965 . . . . 0.0 108.859 -172.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.88 21.08 28.88 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.79 -4.35 53.25 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.617 1.58 . . . . 0.0 116.306 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -107.08 127.92 53.92 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.128 1.771 . . . . 0.0 110.294 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.5 t -81.71 132.34 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.47 1.108 . . . . 0.0 111.958 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -132.48 103.26 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.897 1.679 . . . . 0.0 109.492 174.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -81.86 121.47 26.5 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.607 1.563 . . . . 0.0 111.706 176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -143.46 176.68 8.99 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.335 1.454 . . . . 0.0 113.477 -165.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.6 p -81.67 151.63 27.48 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.736 0.815 . . . . 0.0 112.255 170.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -64.17 -18.1 64.15 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.163 -0.961 . . . . 0.0 113.186 -174.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -110.98 13.41 22.08 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.0 OUTLIER -65.42 128.73 94.05 Favored Pre-proline 0 CA--C 1.55 0.978 0 O-C-N 120.772 -1.205 . . . . 0.0 111.582 176.255 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.64 125.82 5.72 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.061 2.508 . . . . 0.0 113.714 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -118.46 142.77 47.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.973 2.109 . . . . 0.0 111.788 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -85.31 133.35 34.15 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.371 0.987 . . . . 0.0 113.614 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.88 138.72 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 127.683 2.393 . . . . 0.0 111.293 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.17 130.45 42.11 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.424 0.69 . . . . 0.0 111.12 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 61.3 7.13 1.57 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.596 2.358 . . . . 0.0 116.59 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -130.64 -35.25 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.029 1.331 . . . . 0.0 111.973 -170.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.61 -150.96 22.85 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 123.938 0.78 . . . . 0.0 111.62 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.292 12.3 p90 -77.4 145.69 37.07 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.78 150.02 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 128.523 2.729 . . . . 0.0 109.683 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -64.48 137.87 58.11 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.115 -0.99 . . . . 0.0 113.415 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.72 67.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.804 1.641 . . . . 0.0 113.304 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.35 -7.46 68.11 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.373 -0.83 . . . . 0.0 114.362 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -102.76 -6.41 22.65 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.251 1.42 . . . . 0.0 113.171 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -67.94 164.28 20.25 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.089 1.356 . . . . 0.0 112.834 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.27 162.79 27.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.611 1.564 . . . . 0.0 112.881 168.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.94 123.63 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 165.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.0 1.98 61.15 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.868 -1.518 . . . . 0.0 114.988 -170.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -76.74 152.95 35.46 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.754 2.277 . . . . 0.0 111.367 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -110.6 101.82 10.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.681 1.192 . . . . 0.0 112.413 -170.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.3 mt -91.81 170.5 9.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.929 1.692 . . . . 0.0 110.654 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.9 mt -119.32 155.73 31.32 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 170.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.3 176.87 5.56 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.908 1.283 . . . . 0.0 113.879 176.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.8 p -54.34 -22.4 12.06 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -106.79 -10.05 16.2 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.542 1.937 . . . . 0.0 112.616 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.59 13.29 28.42 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.422 1.963 . . . . 0.0 113.183 171.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -79.17 145.84 33.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.719 1.208 . . . . 0.0 111.384 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.2 t -74.69 127.9 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.565 0.746 . . . . 0.0 111.322 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.1 mt -114.26 150.79 33.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.14 2.176 . . . . 0.0 112.03 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.3 t -118.23 137.71 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 125.183 1.393 . . . . 0.0 110.474 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.4 t -73.7 119.06 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.957 0.903 . . . . 0.0 109.452 169.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -94.29 -27.88 15.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.852 2.461 . . . . 0.0 112.853 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -155.03 147.33 23.91 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.778 1.631 . . . . 0.0 110.248 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -132.85 116.18 16.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.946 1.699 . . . . 0.0 109.308 168.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -127.76 151.59 48.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.359 2.264 . . . . 0.0 110.822 -171.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.02 133.81 25.32 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.15 1.38 . . . . 0.0 109.584 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -144.68 151.21 38.6 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.1 mm -98.2 103.3 14.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.895 1.278 . . . . 0.0 108.38 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.86 150.87 31.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.09 0.956 . . . . 0.0 111.954 174.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.05 -18.81 63.3 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.14 -0.975 . . . . 0.0 112.983 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -137.68 154.68 75.06 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 126.762 2.025 . . . . 0.0 111.339 -172.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.33 110.09 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.547 2.165 . . . . 0.0 110.013 170.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.2 t -83.5 141.66 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.013 1.725 . . . . 0.0 109.631 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -77.6 139.56 39.54 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.839 0.855 . . . . 0.0 110.397 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.2 m -138.34 142.83 34.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 125.006 1.322 . . . . 0.0 111.345 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -121.79 152.46 39.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.514 1.526 . . . . 0.0 111.707 -167.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -156.5 165.91 34.92 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.38 2.272 . . . . 0.0 109.767 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -156.97 165.36 36.38 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.304 -1.497 . . . . 0.0 111.248 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -120.2 145.9 46.54 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.27 145.86 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.293 1.437 . . . . 0.0 112.867 -166.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -64.43 -47.34 79.47 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -170.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -109.49 -66.31 1.07 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 120.056 1.298 . . . . 0.0 109.957 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -72.71 175.93 5.99 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.667 1.187 . . . . 0.0 112.153 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -115.94 3.9 13.75 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.501 1.52 . . . . 0.0 113.349 -172.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.4 p -124.74 160.66 28.1 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.308 1.443 . . . . 0.0 113.981 -168.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.07 -179.62 8.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.843 2.057 . . . . 0.0 109.875 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -132.12 140.68 48.88 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.352 1.061 . . . . 0.0 113.183 -168.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.6 142.02 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -170.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.25 173.44 25.74 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.928 1.728 . . . . 0.0 115.346 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.1 -25.42 67.7 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.11 -1.229 . . . . 0.0 113.11 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -90.41 5.22 48.38 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.578 1.551 . . . . 0.0 114.667 172.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 56.11 46.5 21.44 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 164.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.53 140.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.379 1.072 . . . . 0.0 111.779 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.06 126.22 31.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.749 1.62 . . . . 0.0 113.491 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.6 m -145.82 162.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.542 1.937 . . . . 0.0 111.429 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -116.92 141.07 48.71 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.431 1.492 . . . . 0.0 113.049 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.209 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.435 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 98.6 m-85 -124.73 154.64 40.55 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.1 1.36 . . . . 0.0 111.071 172.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.51 158.0 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.203 0.525 . . . . 0.0 111.661 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.1 151.8 0.92 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.218 1.007 . . . . 0.0 112.371 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.07 -17.26 7.55 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.437 -1.757 . . . . 0.0 116.077 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.6 m -61.89 124.19 20.1 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 120.707 2.253 . . . . 0.0 110.11 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -82.12 141.62 32.95 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.879 1.272 . . . . 0.0 111.538 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.0 mm -117.33 133.32 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.619 1.968 . . . . 0.0 109.577 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.7 tp -71.28 127.18 31.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.678 0.752 . . . . 0.0 112.969 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 p -127.81 166.02 19.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.02 1.328 . . . . 0.0 110.423 174.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.04 70.12 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.503 -0.748 . . . . 0.0 112.126 168.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.8 p -80.02 -25.99 39.99 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.199 1.4 . . . . 0.0 112.677 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.72 -99.11 0.19 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.84 2.162 . . . . 0.0 111.039 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.0 mt -134.98 149.28 50.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.745 1.218 . . . . 0.0 111.855 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.63 143.69 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.633 1.573 . . . . 0.0 108.552 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.45 146.12 53.47 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.022 -1.048 . . . . 0.0 111.127 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 tt -60.8 -30.59 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 120.942 -1.099 . . . . 0.0 113.107 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.27 -16.77 63.65 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.471 1.109 . . . . 0.0 113.836 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -109.37 -12.55 14.73 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.794 1.638 . . . . 0.0 113.117 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.7 mm -63.03 135.64 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.09 0.859 . . . . 0.0 109.421 164.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -127.75 156.09 42.98 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.885 1.674 . . . . 0.0 111.442 175.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.93 135.27 56.01 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.223 -0.923 . . . . 0.0 111.457 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.11 -19.54 54.05 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.712 -1.049 . . . . 0.0 115.166 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -68.42 166.11 17.44 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.899 1.349 . . . . 0.0 111.121 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -124.21 138.67 54.38 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.077 1.351 . . . . 0.0 112.836 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.04 163.88 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.206 1.802 . . . . 0.0 111.203 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -80.09 145.88 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.227 0.536 . . . . 0.0 111.56 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.55 132.3 21.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 m -97.43 112.03 24.04 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.5 0.667 . . . . 0.0 109.864 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -52.76 114.83 6.26 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.448 1.499 . . . . 0.0 113.288 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.75 -7.07 19.52 Favored 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 122.877 2.385 . . . . 0.0 115.299 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -79.44 -38.67 34.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.257 1.423 . . . . 0.0 113.261 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.6 t -141.76 -1.8 1.24 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.784 1.234 . . . . 0.0 112.873 -168.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.26 33.8 m-85 55.13 33.78 21.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.915 2.086 . . . . 0.0 114.244 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -77.95 135.02 37.76 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.632 -0.668 . . . . 0.0 110.342 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.02 122.07 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.317 1.047 . . . . 0.0 110.927 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.13 151.7 41.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.765 0.793 . . . . 0.0 112.872 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -90.14 124.6 34.96 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.213 1.405 . . . . 0.0 109.291 174.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -134.44 150.89 50.88 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.584 1.154 . . . . 0.0 111.424 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.3 t -79.76 153.58 29.11 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -88.83 133.0 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.32 1.848 . . . . 0.0 110.624 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 mt -90.73 -44.21 9.61 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.66 0.784 . . . . 0.0 112.682 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -141.58 157.81 44.64 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.503 1.521 . . . . 0.0 110.641 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.7 p -130.98 116.34 17.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.842 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -103.48 157.94 16.69 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.989 1.315 . . . . 0.0 113.309 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.74 142.52 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.883 2.073 . . . . 0.0 110.204 175.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.1 mmt-85 -140.38 172.81 12.21 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.239 2.215 . . . . 0.0 109.933 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -141.34 135.05 30.12 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.95 -1.094 . . . . 0.0 113.064 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.3 t -151.01 152.59 33.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.875 0.87 . . . . 0.0 112.019 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.7 p -86.24 -15.48 40.66 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.988 1.315 . . . . 0.0 113.43 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -105.75 108.35 19.81 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.205 0.911 . . . . 0.0 112.262 -171.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.6 mt -116.67 160.53 20.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.358 1.075 . . . . 0.0 113.658 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -123.69 138.57 54.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.123 1.769 . . . . 0.0 109.945 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.1 m170 -115.93 128.13 55.53 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.656 1.582 . . . . 0.0 109.253 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.3 mt -128.92 132.76 47.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.233 1.013 . . . . 0.0 110.182 175.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -99.13 113.01 25.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 169.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 mp -107.74 113.19 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.462 1.105 . . . . 0.0 108.469 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.73 -28.67 0.14 Allowed Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.744 2.116 . . . . 0.0 116.751 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.26 -0.35 0.32 Allowed Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.723 1.63 . . . . 0.0 114.073 -165.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -112.31 124.27 52.11 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.511 1.524 . . . . 0.0 109.533 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.56 114.17 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.331 0.652 . . . . 0.0 109.674 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mt -106.31 101.34 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.412 1.085 . . . . 0.0 109.12 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.99 122.18 21.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.019 1.328 . . . . 0.0 110.65 168.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 t -146.91 175.68 10.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.306 1.043 . . . . 0.0 112.639 -168.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.4 p -78.18 146.49 34.98 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.521 -0.737 . . . . 0.0 111.137 169.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.84 -28.45 66.08 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.022 -1.049 . . . . 0.0 112.442 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -96.83 0.14 48.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.56 1.544 . . . . 0.0 113.305 -171.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.435 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.3 t60 -64.8 129.15 94.26 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.473 1.509 . . . . 0.0 113.305 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.52 113.68 2.62 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.463 2.775 . . . . 0.0 114.093 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -103.25 143.69 32.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.133 2.173 . . . . 0.0 111.408 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -89.33 126.18 35.42 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -103.95 135.75 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.489 1.515 . . . . 0.0 111.213 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -57.04 129.12 40.34 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.633 1.173 . . . . 0.0 112.936 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.8 t0 56.19 23.8 7.41 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.172 1.789 . . . . 0.0 114.45 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.5 t -140.74 -50.39 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.799 1.239 . . . . 0.0 111.92 -172.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.21 -169.17 22.53 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.727 0.68 . . . . 0.0 114.201 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -75.8 146.77 39.7 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -162.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.1 p -150.68 146.91 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.89 1.676 . . . . 0.0 111.854 -173.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -54.55 133.31 46.2 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.556 0.742 . . . . 0.0 112.664 171.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.26 -36.7 66.34 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.607 1.563 . . . . 0.0 113.137 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.4 -4.89 81.02 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.03 -1.044 . . . . 0.0 114.739 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -107.45 -4.44 18.48 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.228 1.811 . . . . 0.0 112.553 176.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.59 151.52 46.26 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.449 -0.782 . . . . 0.0 110.428 155.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -118.34 173.78 6.62 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.064 1.346 . . . . 0.0 110.375 170.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.36 139.92 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 165.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.93 9.62 86.93 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 119.099 -0.834 . . . . 0.0 114.565 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -86.38 154.91 20.84 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.28 1.54 . . . . 0.0 110.228 169.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -113.56 115.57 28.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.322 1.049 . . . . 0.0 113.606 -164.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.9 mt -104.98 -176.85 3.19 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.022 2.129 . . . . 0.0 111.441 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.9 mt -131.01 158.89 39.07 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.605 1.162 . . . . 0.0 113.193 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -109.49 172.29 6.94 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.728 1.211 . . . . 0.0 113.395 169.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 t -45.54 -36.88 4.9 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.146 1.779 . . . . 0.0 114.116 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -88.63 -16.92 31.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.054 1.742 . . . . 0.0 113.114 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.46 20.56 10.81 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.914 1.721 . . . . 0.0 112.763 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -83.26 141.02 32.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.444 0.698 . . . . 0.0 110.582 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.93 115.45 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.641 0.776 . . . . 0.0 110.08 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.9 mt -97.01 161.41 13.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.427 1.491 . . . . 0.0 111.449 170.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.84 144.85 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.07 0.948 . . . . 0.0 110.643 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.54 130.99 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.426 0.69 . . . . 0.0 109.66 170.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -108.27 -28.08 9.65 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.838 2.055 . . . . 0.0 112.079 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -157.75 149.59 22.01 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.129 1.772 . . . . 0.0 110.384 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -131.73 130.84 42.46 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.701 2.0 . . . . 0.0 109.629 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -143.2 155.06 44.44 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.023 1.729 . . . . 0.0 111.513 -175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 tp -132.8 144.14 50.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.89 1.676 . . . . 0.0 109.267 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.45 153.81 41.57 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.372 0.987 . . . . 0.0 113.183 166.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 mm -101.4 121.04 51.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.5 152.78 44.5 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.198 0.999 . . . . 0.0 112.953 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -69.63 -28.7 66.13 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.702 -1.249 . . . . 0.0 111.838 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -144.34 148.35 40.48 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.983 2.113 . . . . 0.0 110.123 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -54.69 120.0 7.37 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.489 3.459 . . . . 0.0 112.576 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.73 139.54 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.359 1.463 . . . . 0.0 109.496 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -76.89 139.19 40.15 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.936 0.874 . . . . 0.0 111.212 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.37 147.93 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.279 1.432 . . . . 0.0 110.516 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.72 148.22 50.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.849 1.26 . . . . 0.0 110.893 -165.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -157.54 168.38 27.47 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.462 1.105 . . . . 0.0 111.803 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -153.19 163.66 39.49 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.838 -1.164 . . . . 0.0 112.972 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -113.97 143.86 44.03 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.69 136.13 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 125.528 1.531 . . . . 0.0 112.974 -166.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.18 -28.41 69.11 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -141.62 -44.23 0.36 Allowed 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.978 -1.076 . . . . 0.0 112.607 173.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -71.45 171.67 10.88 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.441 1.115 . . . . 0.0 111.973 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -124.84 12.29 8.46 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.854 2.061 . . . . 0.0 112.715 -169.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.4 p -142.53 168.87 18.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.497 2.319 . . . . 0.0 111.519 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -160.64 175.13 13.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.118 2.167 . . . . 0.0 109.617 166.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -122.74 135.57 54.61 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.046 0.939 . . . . 0.0 113.141 -170.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.94 140.74 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.555 1.542 . . . . 0.0 112.429 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.73 170.15 20.27 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.671 1.605 . . . . 0.0 115.46 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.85 -22.49 66.54 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.693 -1.475 . . . . 0.0 113.023 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -81.49 2.78 27.35 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.182 1.393 . . . . 0.0 114.445 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 61.27 38.94 16.16 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.701 1.2 . . . . 0.0 113.345 164.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.63 137.36 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.668 1.587 . . . . 0.0 112.019 -164.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.2 tp -83.14 120.43 25.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.154 1.382 . . . . 0.0 113.848 -171.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.94 157.46 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.644 1.578 . . . . 0.0 112.052 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -106.87 128.94 54.72 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -167.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--O 1.25 1.098 0 C-N-CA 125.74 1.616 . . . . 0.0 111.993 172.461 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 30.1 m . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 121.363 0.601 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 42.5 ttm -73.3 141.25 47.15 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.82 -1.175 . . . . 0.0 110.117 164.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -126.23 84.82 2.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.165 1.386 . . . . 0.0 110.713 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -148.62 170.64 17.66 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 99.1 m-85 -126.12 154.03 43.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.837 1.655 . . . . 0.0 111.415 172.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -70.64 162.14 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.495 0.664 . . . . 0.0 112.327 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.47 150.26 5.05 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.439 1.096 . . . . 0.0 112.639 173.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.18 -6.22 22.76 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 117.877 -1.513 . . . . 0.0 116.788 -173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.5 m -63.1 120.38 11.34 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.81 2.305 . . . . 0.0 110.147 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.0 mmt -76.02 146.44 39.48 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.915 1.286 . . . . 0.0 112.224 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 mm -131.64 134.1 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 127.685 2.394 . . . . 0.0 109.918 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 tp -78.91 127.01 31.46 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -120.63 173.89 6.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.667 1.587 . . . . 0.0 111.792 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.87 -24.85 67.66 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.939 -1.1 . . . . 0.0 113.429 175.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 p -107.31 -19.31 13.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.539 1.135 . . . . 0.0 113.518 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.89 -115.34 0.61 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.439 1.019 . . . . 0.0 113.363 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -122.8 153.32 39.7 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.048 1.739 . . . . 0.0 111.799 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.1 p -136.53 152.29 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.929 1.691 . . . . 0.0 110.268 168.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.26 146.09 37.1 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.773 -1.204 . . . . 0.0 110.819 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.2 tt -62.65 -29.49 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 121.044 -1.035 . . . . 0.0 112.664 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -65.39 -11.12 39.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.689 1.196 . . . . 0.0 113.729 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -120.13 -3.65 10.07 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.914 1.685 . . . . 0.0 113.371 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.1 mm -61.43 137.89 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 120.018 1.281 . . . . 0.0 108.806 166.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -124.16 159.05 30.91 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.021 1.328 . . . . 0.0 112.027 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.62 131.71 47.06 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.792 -1.193 . . . . 0.0 110.579 165.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.88 -4.44 82.68 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.601 1.095 . . . . 0.0 115.046 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.92 155.55 37.32 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.148 1.474 . . . . 0.0 111.542 163.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -109.48 150.76 27.64 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.362 1.465 . . . . 0.0 112.393 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.23 157.78 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.567 1.947 . . . . 0.0 110.072 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -73.97 137.9 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.795 -0.566 . . . . 0.0 110.712 165.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.41 118.24 16.19 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -98.05 111.88 24.03 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -54.47 114.76 7.25 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.873 1.269 . . . . 0.0 112.365 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.89 -4.52 14.96 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.711 2.274 . . . . 0.0 114.09 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -77.19 -46.87 21.87 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.682 1.193 . . . . 0.0 112.234 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 t -141.22 6.37 1.93 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.143 0.977 . . . . 0.0 112.84 -168.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 54.68 33.0 18.42 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.573 1.549 . . . . 0.0 114.037 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -71.05 125.85 27.98 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 167.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -96.66 120.13 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 124.227 1.011 . . . . 0.0 109.029 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.6 154.73 50.59 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.2 133.62 36.04 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.078 0.951 . . . . 0.0 108.998 162.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -138.92 152.54 47.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.078 0.951 . . . . 0.0 110.878 171.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 t -89.09 160.16 17.19 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.0 t -96.12 133.73 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.463 1.905 . . . . 0.0 111.575 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 mt -90.8 -43.0 10.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.932 0.893 . . . . 0.0 113.355 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -148.94 156.12 41.82 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.796 2.038 . . . . 0.0 111.138 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.4 p -132.34 103.49 6.24 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.08 1.752 . . . . 0.0 110.416 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -91.06 150.73 21.3 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.6 1.56 . . . . 0.0 112.727 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.8 t -143.02 129.57 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.342 1.057 . . . . 0.0 110.453 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -122.89 175.54 6.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.307 1.843 . . . . 0.0 110.931 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -128.2 137.44 52.04 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.679 1.192 . . . . 0.0 111.323 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.9 t -148.35 149.34 31.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.691 1.196 . . . . 0.0 111.88 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.2 p -91.21 -14.74 30.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.895 1.278 . . . . 0.0 113.863 170.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -100.32 111.34 23.6 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.384 -0.822 . . . . 0.0 111.399 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -120.5 157.83 28.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 122.939 1.352 . . . . 0.0 112.922 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 tp -126.39 133.31 51.33 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.535 1.934 . . . . 0.0 109.259 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -110.4 124.86 52.51 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.215 1.006 . . . . 0.0 108.773 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.8 mt -118.24 138.76 52.13 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.977 0.911 . . . . 0.0 109.779 171.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.6 m -106.54 122.34 46.11 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.99 117.97 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.075 1.35 . . . . 0.0 108.515 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.65 28.24 51.22 Favored Glycine 0 CA--C 1.544 1.888 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.7 -9.3 78.08 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.35 1.452 . . . . 0.0 115.737 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -92.79 122.93 35.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.002 1.401 . . . . 0.0 110.068 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.0 t -78.98 125.81 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.566 0.746 . . . . 0.0 110.617 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mt -121.77 103.77 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.979 1.711 . . . . 0.0 109.352 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -80.58 122.55 27.19 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.11 1.764 . . . . 0.0 111.035 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 t -146.16 178.22 8.39 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.629 1.172 . . . . 0.0 112.702 -167.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.8 p -82.23 152.75 26.25 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.048 0.927 . . . . 0.0 112.472 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -65.69 -19.38 65.88 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.44 9.38 31.71 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.976 1.311 . . . . 0.0 113.616 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.1 t60 -65.56 129.84 94.46 Favored Pre-proline 0 CA--C 1.552 1.053 0 O-C-N 120.465 -1.397 . . . . 0.0 113.042 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.7 119.92 4.97 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.98 3.12 . . . . 0.0 114.732 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -112.2 150.04 31.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.963 2.105 . . . . 0.0 111.223 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -93.86 130.8 39.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.275 0.943 . . . . 0.0 113.382 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.14 134.32 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 127.499 2.319 . . . . 0.0 111.339 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -58.06 130.26 45.75 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.733 1.213 . . . . 0.0 111.677 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 60.88 16.41 6.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.779 1.632 . . . . 0.0 114.555 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.9 t -133.8 -58.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.255 1.022 . . . . 0.0 111.231 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.93 -152.12 17.16 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.925 0.774 . . . . 0.0 113.714 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -86.75 139.16 30.99 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -170.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.12 149.01 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.249 1.82 . . . . 0.0 111.666 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.93 134.03 51.19 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.482 1.113 . . . . 0.0 112.632 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.95 -36.61 72.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.343 1.457 . . . . 0.0 112.856 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.72 -8.28 81.47 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.508 -1.162 . . . . 0.0 114.559 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -103.02 -12.88 17.12 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.025 1.412 . . . . 0.0 113.731 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.2 mt -56.97 163.08 2.13 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.27 1.428 . . . . 0.0 113.543 170.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.97 164.53 18.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.614 1.565 . . . . 0.0 110.727 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.5 t -67.92 143.73 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 122.39 1.09 . . . . 0.0 110.347 167.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.59 3.69 89.0 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.716 -1.047 . . . . 0.0 114.315 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -84.95 160.56 20.06 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.641 1.72 . . . . 0.0 111.471 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -104.84 103.71 13.36 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.399 1.08 . . . . 0.0 112.458 -160.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.8 mt -93.56 175.84 6.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.07 0.948 . . . . 0.0 110.453 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -122.19 158.85 28.5 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.76 -178.0 3.53 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.398 1.479 . . . . 0.0 113.871 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.1 p -61.25 -17.66 54.48 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -90.33 -25.57 20.41 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.243 1.383 . . . . 0.0 111.603 170.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.73 19.31 18.04 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.796 1.665 . . . . 0.0 112.369 -176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -88.4 155.61 19.59 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.007 1.723 . . . . 0.0 110.793 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -80.73 128.11 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -169.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.6 mt -107.48 162.72 13.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.094 2.158 . . . . 0.0 112.231 169.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.83 139.71 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.365 1.066 . . . . 0.0 111.195 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.5 t -73.73 124.95 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.427 0.691 . . . . 0.0 109.44 171.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -94.83 -33.63 12.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.425 1.89 . . . . 0.0 112.912 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -156.73 149.01 23.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.929 1.291 . . . . 0.0 111.292 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -124.73 127.43 47.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.836 2.054 . . . . 0.0 110.3 166.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -140.37 154.06 46.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.667 1.987 . . . . 0.0 111.505 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 tp -140.43 148.67 41.56 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.554 1.542 . . . . 0.0 110.083 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -155.28 164.86 38.2 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.718 0.807 . . . . 0.0 113.102 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mm -96.11 124.62 48.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 123.751 0.82 . . . . 0.0 109.188 161.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.95 150.65 45.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.744 1.218 . . . . 0.0 112.638 172.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -78.4 -13.02 60.03 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.685 1.594 . . . . 0.0 113.075 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -146.87 153.32 45.91 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.55 2.34 . . . . 0.0 110.132 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.48 114.76 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.916 2.411 . . . . 0.0 111.131 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.5 t -85.55 142.8 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.382 1.473 . . . . 0.0 109.989 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -79.71 139.39 37.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.119 0.962 . . . . 0.0 111.613 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.1 m -141.46 141.43 30.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.005 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -120.18 146.61 45.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.241 1.417 . . . . 0.0 110.77 -165.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -153.9 159.57 41.81 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.868 1.267 . . . . 0.0 111.397 173.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -150.72 163.14 39.29 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.434 -1.416 . . . . 0.0 113.568 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -120.26 138.85 53.43 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.72 149.42 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 127.557 2.343 . . . . 0.0 111.898 -168.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.89 -33.86 76.18 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 -168.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -143.81 -53.25 0.35 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.895 1.225 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -66.24 165.95 12.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.684 0.754 . . . . 0.0 110.297 167.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -133.51 27.64 4.04 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.429 1.492 . . . . 0.0 112.25 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.5 p -128.66 164.69 22.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.239 1.816 . . . . 0.0 111.881 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -159.03 -176.59 5.95 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.455 1.902 . . . . 0.0 109.922 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -127.24 138.37 53.09 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.395 1.078 . . . . 0.0 112.95 -171.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.47 143.6 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.194 0.997 . . . . 0.0 113.612 -171.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.35 168.83 20.07 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.615 1.579 . . . . 0.0 114.657 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.36 -22.8 61.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.175 1.39 . . . . 0.0 113.279 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -91.27 -0.9 57.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.762 1.625 . . . . 0.0 114.786 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 62.67 44.25 6.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.9 t -71.64 137.9 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.094 1.358 . . . . 0.0 111.406 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 57.2 tp -80.69 125.63 30.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.704 1.601 . . . . 0.0 113.247 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.49 160.07 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.894 1.678 . . . . 0.0 111.696 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -102.31 156.9 17.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.019 1.328 . . . . 0.0 113.06 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.088 1.755 . . . . 0.0 113.651 171.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 119.251 -0.404 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 10.5 ttt -109.94 117.94 35.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.327 0.651 . . . . 0.0 112.157 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -131.07 100.34 5.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.662 1.185 . . . . 0.0 110.867 -168.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.02 174.53 12.9 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.917 1.287 . . . . 0.0 112.863 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 91.6 m-85 -121.26 156.02 33.39 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.332 1.453 . . . . 0.0 111.511 169.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.95 160.78 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.34 0.591 . . . . 0.0 112.054 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.59 152.5 2.71 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.905 0.86 . . . . 0.0 112.95 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.18 -9.16 20.69 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-O 117.349 -1.806 . . . . 0.0 116.696 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -62.91 123.55 18.79 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 120.878 2.339 . . . . 0.0 110.811 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -80.57 141.91 34.61 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.426 1.49 . . . . 0.0 112.294 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.81 134.85 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.87 2.068 . . . . 0.0 110.036 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.06 126.84 31.62 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.297 1.039 . . . . 0.0 113.032 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.8 p -121.9 172.75 7.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.025 1.33 . . . . 0.0 111.487 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.8 -20.32 65.69 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 120.844 -1.16 . . . . 0.0 113.268 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 p -109.41 -13.07 14.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.913 2.085 . . . . 0.0 113.759 -170.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.24 -112.75 0.64 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 126.087 1.803 . . . . 0.0 112.443 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -133.33 141.67 48.06 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.222 1.009 . . . . 0.0 112.583 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -133.06 144.29 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.446 1.899 . . . . 0.0 109.111 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.59 147.8 47.25 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.274 -0.891 . . . . 0.0 111.027 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -62.9 -27.6 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 120.315 -1.491 . . . . 0.0 113.043 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.58 -16.35 63.83 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.206 1.003 . . . . 0.0 113.457 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -110.61 -10.41 14.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.293 1.837 . . . . 0.0 113.146 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.4 mm -65.12 137.47 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 119.407 1.003 . . . . 0.0 108.921 162.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -127.65 166.06 18.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.915 2.086 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.53 133.67 46.18 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.89 -0.506 . . . . 0.0 110.511 160.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.29 6.73 89.09 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.972 1.272 . . . . 0.0 115.674 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -85.38 155.44 21.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.295 1.048 . . . . 0.0 110.333 165.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.59 135.25 52.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.311 1.044 . . . . 0.0 112.539 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.8 157.13 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.016 1.726 . . . . 0.0 110.652 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.3 mm -76.1 142.38 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.75 0.31 . . . . 0.0 111.275 168.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.63 126.73 22.66 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.904 0.881 . . . . 0.0 109.144 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.435 ' HG1' ' CE1' ' A' ' 125' ' ' HIS . 95.0 m -88.41 107.95 19.12 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 165.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -52.94 116.35 9.03 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.529 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.11 -11.22 28.72 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.673 2.249 . . . . 0.0 114.272 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -78.23 -49.1 14.38 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.748 1.219 . . . . 0.0 111.766 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 t -121.67 -7.88 9.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.525 1.13 . . . . 0.0 112.677 -167.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.276 12.9 m-85 53.5 43.02 31.83 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.703 1.601 . . . . 0.0 112.12 -173.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -81.44 131.37 35.28 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.927 0.891 . . . . 0.0 108.755 165.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.17 123.38 47.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 123.232 0.613 . . . . 0.0 110.621 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.2 159.22 42.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.311 1.045 . . . . 0.0 112.502 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -92.14 126.06 37.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.64 1.176 . . . . 0.0 108.87 164.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -137.84 152.83 49.48 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.189 0.996 . . . . 0.0 111.153 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -83.56 156.08 22.96 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.311 1.045 . . . . 0.0 113.058 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.8 t -87.58 134.55 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.706 1.602 . . . . 0.0 111.071 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.6 mt -84.21 -49.03 9.18 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.426 1.09 . . . . 0.0 112.508 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -151.28 159.77 44.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.694 1.998 . . . . 0.0 110.38 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.5 p -120.17 122.96 42.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.919 2.088 . . . . 0.0 109.571 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -101.46 147.02 26.85 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.89 0.876 . . . . 0.0 112.998 173.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.03 135.09 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.06 1.344 . . . . 0.0 110.077 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -126.86 170.93 11.71 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.028 2.131 . . . . 0.0 109.246 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -131.56 136.59 47.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.426 0.69 . . . . 0.0 111.714 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 t -154.57 146.93 23.91 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.598 0.759 . . . . 0.0 111.348 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.7 p -84.24 -18.32 36.89 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.716 0.806 . . . . 0.0 111.884 162.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -99.47 110.03 22.54 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 120.857 -1.152 . . . . 0.0 110.766 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.1 mt -121.5 172.53 8.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.767 1.627 . . . . 0.0 111.383 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.7 tp -141.32 130.48 23.43 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.893 1.277 . . . . 0.0 111.321 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -112.19 106.9 15.61 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.019 -1.05 . . . . 0.0 109.971 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.8 142.25 29.8 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.458 -0.776 . . . . 0.0 110.376 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.6 m -115.45 120.83 40.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.951 0.901 . . . . 0.0 109.471 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.02 117.37 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 126.32 1.848 . . . . 0.0 108.634 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.57 30.09 41.51 Favored Glycine 0 CA--C 1.543 1.789 0 N-CA-C 115.717 1.047 . . . . 0.0 115.717 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.08 6.4 84.8 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -102.37 129.38 48.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.881 1.341 . . . . 0.0 110.149 165.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -86.71 129.02 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.895 0.878 . . . . 0.0 110.287 164.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mt -121.7 101.51 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.07 1.348 . . . . 0.0 109.201 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.87 117.16 15.32 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.819 1.648 . . . . 0.0 110.732 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 t -142.72 -179.97 6.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.886 1.274 . . . . 0.0 112.464 -165.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.0 p -87.72 156.98 19.18 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 122.135 0.969 . . . . 0.0 112.353 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -59.45 -31.38 69.26 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.534 1.134 . . . . 0.0 113.082 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -101.05 8.96 42.67 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.5 t60 -64.08 128.12 92.68 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.474 1.034 . . . . 0.0 112.871 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.12 119.07 2.74 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.181 2.587 . . . . 0.0 114.947 -175.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -108.74 150.3 27.79 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.98 2.112 . . . . 0.0 111.472 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -98.19 130.04 44.94 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.517 1.053 . . . . 0.0 113.556 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.97 137.1 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.762 2.425 . . . . 0.0 111.392 -173.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -57.59 121.93 11.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.767 2.027 . . . . 0.0 112.671 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 53.03 30.04 8.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.616 1.967 . . . . 0.0 114.262 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.5 t -136.29 -50.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.469 1.508 . . . . 0.0 112.009 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.71 -153.58 17.53 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.046 0.831 . . . . 0.0 113.783 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -87.57 141.24 28.77 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.415 -1.05 . . . . 0.0 113.667 -173.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.95 145.28 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.284 1.433 . . . . 0.0 111.808 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.25 137.12 57.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.949 1.3 . . . . 0.0 112.098 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.18 -35.77 69.99 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.346 1.058 . . . . 0.0 113.64 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.04 -16.82 67.04 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 121.299 -0.876 . . . . 0.0 114.02 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -103.29 -2.04 27.8 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.467 1.907 . . . . 0.0 113.512 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.28 151.82 39.52 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.676 -0.64 . . . . 0.0 110.836 162.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.21 157.87 39.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.894 1.678 . . . . 0.0 109.623 170.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.53 136.8 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.07 4.78 88.17 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-O 118.856 -0.969 . . . . 0.0 115.441 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -83.29 150.17 26.32 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.546 1.673 . . . . 0.0 110.098 170.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -108.6 113.54 26.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.561 1.544 . . . . 0.0 112.631 -165.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.6 165.49 11.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.645 1.578 . . . . 0.0 112.627 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.71 142.42 36.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.667 1.587 . . . . 0.0 110.892 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -96.11 -178.13 4.23 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.986 0.915 . . . . 0.0 113.203 166.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.7 p -62.57 -1.77 0.91 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.628 1.971 . . . . 0.0 116.257 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.7 mtm-85 -117.8 -27.49 6.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.101 2.161 . . . . 0.0 111.565 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 104.43 17.32 15.67 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.813 2.149 . . . . 0.0 113.449 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -69.28 159.3 33.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.891 0.876 . . . . 0.0 111.14 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.3 t -75.87 131.41 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.747 0.784 . . . . 0.0 110.786 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.6 mt -117.5 158.47 24.49 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.931 2.092 . . . . 0.0 109.699 161.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.4 142.26 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.408 0.683 . . . . 0.0 111.277 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.48 129.4 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.429 1.091 . . . . 0.0 110.352 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -102.45 -33.91 9.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.351 2.26 . . . . 0.0 112.966 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -159.52 152.19 21.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.795 1.638 . . . . 0.0 111.797 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -124.92 124.06 41.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.053 2.141 . . . . 0.0 109.816 159.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -118.59 140.17 50.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.891 2.076 . . . . 0.0 109.868 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 tp -121.31 125.59 47.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.884 1.274 . . . . 0.0 110.637 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.66 159.34 39.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.582 0.706 . . . . 0.0 112.268 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.7 mm -111.36 114.07 46.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 166.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.36 150.7 42.8 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 122.103 0.954 . . . . 0.0 111.723 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.04 -22.09 60.69 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.944 1.298 . . . . 0.0 112.819 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -134.74 151.88 76.56 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 126.292 1.837 . . . . 0.0 111.131 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.91 111.28 3.0 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.683 2.256 . . . . 0.0 110.899 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.16 141.5 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 126.245 1.818 . . . . 0.0 109.674 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -75.28 134.27 41.12 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.297 1.046 . . . . 0.0 110.247 172.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.44 130.49 67.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.226 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -112.36 148.18 34.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.012 1.725 . . . . 0.0 110.959 -166.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -153.35 169.02 24.13 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.327 1.451 . . . . 0.0 109.867 171.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -148.73 171.74 15.73 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 120.398 -1.439 . . . . 0.0 111.674 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -128.52 139.55 52.26 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.817 0.847 . . . . 0.0 112.682 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.413 ' H ' ' ND2' ' A' ' 135' ' ' ASN . 89.9 t -98.47 145.43 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.982 1.713 . . . . 0.0 111.62 -169.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.13 -40.62 86.04 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -166.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -133.6 -36.9 0.95 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.035 0.934 . . . . 0.0 112.57 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.76 160.45 29.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.933 0.873 . . . . 0.0 110.533 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -114.95 11.52 16.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.202 1.401 . . . . 0.0 112.832 -171.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 p -145.5 166.51 25.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.191 1.797 . . . . 0.0 112.381 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -156.42 -179.01 7.76 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.768 1.627 . . . . 0.0 110.774 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.435 ' CE1' ' HG1' ' A' ' 29' ' ' THR . 25.0 m170 -122.79 138.54 54.61 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.161 1.384 . . . . 0.0 112.413 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -123.3 141.46 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.323 1.449 . . . . 0.0 111.962 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.96 -176.22 53.21 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 168.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.53 -34.66 72.54 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.995 1.718 . . . . 0.0 112.41 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -82.73 -4.54 58.03 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.362 1.065 . . . . 0.0 113.471 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 59.14 47.17 12.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.202 1.801 . . . . 0.0 114.093 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 t -72.96 137.15 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.916 1.286 . . . . 0.0 111.316 -170.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 52.7 tp -81.43 125.98 31.09 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.167 1.387 . . . . 0.0 113.104 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.1 m -138.33 156.72 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.956 1.702 . . . . 0.0 111.301 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -105.81 146.66 29.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.851 1.26 . . . . 0.0 112.129 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 118' ' ' VAL . 18.3 m-20 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.177 0.991 . . . . 0.0 111.835 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.494 0.188 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 3.4 ttt -151.82 -45.9 0.11 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.03 1.332 . . . . 0.0 112.639 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 63.2 mttm 43.48 62.79 1.75 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.487 1.915 . . . . 0.0 114.394 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -132.46 173.51 11.23 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -171.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.431 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 96.9 m-85 -128.02 153.23 47.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.408 1.483 . . . . 0.0 112.168 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 m -69.07 154.72 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.15 139.69 28.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.816 0.847 . . . . 0.0 111.55 171.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.72 -6.09 81.7 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.113 -1.382 . . . . 0.0 116.156 -170.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.9 m -64.3 123.43 19.12 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 121.163 2.482 . . . . 0.0 110.336 172.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.5 mmt -83.16 142.12 31.44 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.337 1.055 . . . . 0.0 112.08 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.19 135.03 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.369 2.267 . . . . 0.0 109.642 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.69 133.41 42.07 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 p -137.23 165.84 25.19 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.281 1.432 . . . . 0.0 111.195 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.56 -19.33 63.57 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.44 1.096 . . . . 0.0 113.372 170.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.4 p -86.57 -32.73 20.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.955 1.302 . . . . 0.0 111.64 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.71 -98.79 0.19 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.211 1.862 . . . . 0.0 110.612 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.4 mt -130.48 149.29 52.22 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.153 0.981 . . . . 0.0 111.867 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.5 141.25 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.859 1.663 . . . . 0.0 108.884 169.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.18 148.79 49.39 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.122 -0.986 . . . . 0.0 110.75 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.1 tt -61.48 -28.17 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 120.752 -1.217 . . . . 0.0 112.847 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.98 -6.64 46.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.905 1.282 . . . . 0.0 113.96 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -117.59 -7.96 11.0 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.121 1.769 . . . . 0.0 114.322 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.1 mm -66.81 139.41 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.928 0.785 . . . . 0.0 109.545 161.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -120.42 162.73 19.02 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.614 1.966 . . . . 0.0 110.32 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.5 135.54 54.37 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.093 0.473 . . . . 0.0 110.139 155.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.04 11.6 83.52 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.728 -1.04 . . . . 0.0 115.192 -176.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -96.86 158.0 15.64 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.846 1.323 . . . . 0.0 110.947 162.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -112.55 137.95 50.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.997 1.719 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -135.07 161.25 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.199 1.799 . . . . 0.0 111.163 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -76.52 143.11 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.661 0.664 . . . . 0.0 111.425 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.84 132.06 23.3 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.49 172.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.9 m -79.69 112.98 17.5 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 162.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -52.9 123.49 32.76 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 124.585 1.154 . . . . 0.0 112.392 171.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.0 -2.46 11.78 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 123.076 2.517 . . . . 0.0 114.778 -174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -90.78 -48.86 6.78 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.687 1.195 . . . . 0.0 112.004 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 t -127.67 1.56 6.13 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -166.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 61.02 27.41 17.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.339 1.456 . . . . 0.0 114.365 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.85 120.13 15.13 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.422 1.489 . . . . 0.0 109.157 170.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.5 t -100.56 120.48 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.454 0.701 . . . . 0.0 109.163 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.24 164.94 33.37 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.833 0.853 . . . . 0.0 112.089 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.56 137.82 48.34 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.692 0.397 . . . . 0.0 110.416 159.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -135.71 153.04 51.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.687 1.195 . . . . 0.0 111.117 161.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 t -78.12 154.46 31.24 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.2 t -91.93 135.0 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 127.039 2.136 . . . . 0.0 110.393 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.1 mt -87.56 -49.48 7.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.579 1.151 . . . . 0.0 112.33 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -146.57 156.66 43.4 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.179 1.392 . . . . 0.0 111.132 -175.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.5 p -124.86 119.51 29.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.238 1.815 . . . . 0.0 109.071 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -106.72 149.45 27.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.522 1.129 . . . . 0.0 113.316 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.6 t -139.03 142.32 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.2 1.4 . . . . 0.0 111.379 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -139.96 178.22 7.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.419 2.287 . . . . 0.0 111.988 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -129.65 141.09 50.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.05 1.74 . . . . 0.0 111.992 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 t -155.2 153.1 30.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.64 1.176 . . . . 0.0 111.639 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 p -90.0 -18.41 26.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.435 1.094 . . . . 0.0 113.296 164.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -95.0 106.98 19.0 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.391 -0.818 . . . . 0.0 111.725 -177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.7 mt -118.72 168.51 10.66 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.854 1.262 . . . . 0.0 112.571 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 tp -139.04 133.95 32.35 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.715 1.606 . . . . 0.0 110.967 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -106.06 138.1 42.83 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.469 1.508 . . . . 0.0 109.889 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.2 mt -127.21 130.53 49.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.309 1.043 . . . . 0.0 109.961 167.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.9 m -96.73 124.1 40.61 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 167.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.57 117.53 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.362 1.465 . . . . 0.0 109.289 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.53 29.36 31.56 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.09 7.75 79.86 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 116.856 1.502 . . . . 0.0 116.856 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -112.04 140.33 46.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.844 1.822 . . . . 0.0 108.519 163.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -108.49 134.4 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 124.612 1.165 . . . . 0.0 111.837 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 57.9 mt -129.17 136.45 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.858 1.663 . . . . 0.0 109.278 -171.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -120.44 107.21 12.62 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.249 1.42 . . . . 0.0 109.905 -162.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -138.73 175.65 9.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.223 1.409 . . . . 0.0 113.241 -157.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 p -82.87 152.16 25.7 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.922 0.868 . . . . 0.0 111.472 166.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -56.87 -31.02 64.41 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.652 1.181 . . . . 0.0 112.702 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -95.4 1.64 54.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.022 1.329 . . . . 0.0 114.109 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.431 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.0 t60 -65.69 126.64 92.03 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 118.509 -0.758 . . . . 0.0 112.602 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.28 117.37 2.8 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.732 2.288 . . . . 0.0 114.508 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -100.98 143.21 31.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.004 2.121 . . . . 0.0 111.046 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -89.15 127.48 35.73 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.537 1.062 . . . . 0.0 112.432 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.41 136.53 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.472 1.909 . . . . 0.0 110.395 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.2 tptt -50.85 130.75 25.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.772 1.629 . . . . 0.0 110.658 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t70 58.7 10.09 1.34 Allowed 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.5 t -131.55 -47.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.406 -1.433 . . . . 0.0 111.567 -167.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.63 -162.59 14.83 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.791 0.71 . . . . 0.0 113.3 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -76.72 147.5 37.34 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -172.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.91 145.8 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.102 2.161 . . . . 0.0 111.014 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.15 136.72 58.11 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.771 0.828 . . . . 0.0 112.839 172.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.88 -39.47 62.69 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.455 1.502 . . . . 0.0 113.41 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.34 -17.42 74.26 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 121.217 -0.927 . . . . 0.0 114.199 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -104.7 5.32 33.38 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.167 2.187 . . . . 0.0 113.806 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.04 160.89 30.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.632 0.651 . . . . 0.0 110.544 165.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -125.01 150.31 46.85 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.54 1.136 . . . . 0.0 111.58 172.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.72 134.85 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.26 4.35 81.14 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.791 -1.005 . . . . 0.0 114.956 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -92.33 159.53 15.55 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.247 1.524 . . . . 0.0 112.396 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -108.88 109.01 20.0 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.915 1.286 . . . . 0.0 112.47 -157.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 mt -103.14 -177.69 3.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.702 1.601 . . . . 0.0 111.725 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.1 mt -134.53 156.75 48.08 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.445 1.098 . . . . 0.0 113.274 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.96 -175.7 2.79 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.485 1.514 . . . . 0.0 114.413 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -64.62 -6.51 7.84 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -103.44 -16.02 15.71 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.104 1.762 . . . . 0.0 112.605 167.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.04 19.54 50.33 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.442 1.496 . . . . 0.0 112.238 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -84.2 145.94 28.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.46 1.104 . . . . 0.0 110.278 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.9 t -76.0 115.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.087 0.47 . . . . 0.0 110.985 -174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.6 mt -93.37 157.64 16.13 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.973 1.709 . . . . 0.0 111.388 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 t -123.04 138.78 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.294 1.037 . . . . 0.0 110.841 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.16 126.01 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.664 0.786 . . . . 0.0 109.414 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -106.35 -25.25 12.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.759 2.024 . . . . 0.0 113.089 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -163.07 150.81 13.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.933 1.293 . . . . 0.0 111.857 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -120.59 128.37 52.98 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.739 2.016 . . . . 0.0 109.466 161.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -130.85 123.78 29.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.985 1.314 . . . . 0.0 110.964 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.3 tp -102.26 129.32 48.64 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.033 1.333 . . . . 0.0 109.795 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -126.88 149.59 49.69 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.105 0.955 . . . . 0.0 112.961 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.2 mm -111.68 105.6 19.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 171.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.65 154.55 32.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.25 1.02 . . . . 0.0 111.369 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.43 -21.31 28.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.912 0.885 . . . . 0.0 112.054 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -136.95 140.39 31.44 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.43 1.492 . . . . 0.0 110.321 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.12 117.63 4.43 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.019 3.146 . . . . 0.0 111.886 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.04 137.04 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.557 1.543 . . . . 0.0 110.001 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -74.98 135.52 41.33 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.98 0.895 . . . . 0.0 110.566 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -132.6 133.84 59.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 125.096 1.358 . . . . 0.0 110.946 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -117.2 153.94 32.0 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.713 1.605 . . . . 0.0 111.273 -166.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -152.49 155.71 38.0 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.332 2.253 . . . . 0.0 109.348 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -150.46 161.04 43.28 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.57 -1.331 . . . . 0.0 112.614 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.4 148.39 43.84 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.26 144.85 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 125.806 1.643 . . . . 0.0 112.819 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.74 -29.22 63.15 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -164.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -138.63 -41.08 0.5 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.792 -1.192 . . . . 0.0 113.144 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -75.88 165.36 25.11 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.706 -0.621 . . . . 0.0 110.134 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -124.99 32.05 5.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.376 1.471 . . . . 0.0 110.747 -170.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -156.85 164.02 38.54 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.588 1.555 . . . . 0.0 111.268 -162.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -161.97 174.3 13.26 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.189 1.796 . . . . 0.0 110.447 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -121.07 136.34 55.0 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.767 1.227 . . . . 0.0 112.975 -173.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.9 m -127.27 144.91 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.712 1.605 . . . . 0.0 113.91 -173.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.72 172.94 30.13 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 126.038 1.78 . . . . 0.0 115.063 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.63 -20.03 63.62 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.48 -1.6 . . . . 0.0 113.236 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -85.08 -2.18 57.7 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 169.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 57.33 51.52 9.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.664 1.585 . . . . 0.0 112.694 163.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.02 140.1 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.845 2.058 . . . . 0.0 111.697 -168.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 46.0 tp -79.07 127.37 31.91 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.134 1.373 . . . . 0.0 114.33 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.48 154.71 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.858 1.663 . . . . 0.0 111.377 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -103.04 141.63 35.48 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.086 0.954 . . . . 0.0 113.272 -169.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.27 0 CA-C-O 116.322 -1.799 . . . . 0.0 111.242 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 119.879 -0.105 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 35.0 ttm -56.83 143.52 36.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.563 2.345 . . . . 0.0 114.277 -168.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -125.34 76.39 1.55 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.002 1.721 . . . . 0.0 110.161 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.86 169.6 17.32 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.339 1.055 . . . . 0.0 112.759 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.415 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.4 m-85 -122.35 154.14 38.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.088 1.355 . . . . 0.0 111.491 172.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 m -69.3 154.69 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.0 0.429 . . . . 0.0 111.998 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.21 140.58 20.91 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.034 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.53 -9.46 71.47 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.544 2.021 . . . . 0.0 114.662 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 59.0 m -67.4 126.46 29.35 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.367 1.583 . . . . 0.0 111.5 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.4 mmt -78.1 143.6 37.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.858 1.663 . . . . 0.0 112.487 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.0 mm -129.61 139.0 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.608 1.963 . . . . 0.0 110.431 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.92 129.77 34.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.262 1.425 . . . . 0.0 113.066 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.8 p -134.66 173.03 12.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.777 1.231 . . . . 0.0 113.71 -167.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.07 -13.12 32.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.55 1.54 . . . . 0.0 113.794 171.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.7 p -124.33 1.89 8.43 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.7 -117.89 2.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.396 1.951 . . . . 0.0 110.758 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.51 142.54 46.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.496 1.118 . . . . 0.0 112.634 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.97 148.91 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 127.269 2.227 . . . . 0.0 108.94 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.87 147.33 51.86 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.313 -0.867 . . . . 0.0 112.027 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.5 tt -62.48 -33.31 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 120.936 -1.103 . . . . 0.0 112.514 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.8 pm0 -68.71 -16.5 63.84 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -104.78 -14.74 15.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.039 1.336 . . . . 0.0 112.571 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.2 mm -58.66 133.96 23.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 O-C-N 121.126 -0.984 . . . . 0.0 109.432 164.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -119.81 161.67 20.4 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.386 1.874 . . . . 0.0 112.357 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.38 133.74 53.18 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.84 -0.538 . . . . 0.0 110.556 167.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.13 -6.54 81.22 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.869 1.223 . . . . 0.0 114.785 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.96 150.72 40.61 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.099 1.45 . . . . 0.0 109.628 168.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.87 120.6 42.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.87 0.868 . . . . 0.0 111.2 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.5 m -106.06 151.46 8.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 125.195 1.398 . . . . 0.0 110.083 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.6 mm -81.67 137.08 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.52 116.23 13.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 m -93.07 111.41 23.04 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -52.95 115.01 6.62 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.897 1.279 . . . . 0.0 112.24 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -74.61 -1.61 11.32 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.054 2.503 . . . . 0.0 115.285 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -85.67 -46.75 10.45 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.785 -1.197 . . . . 0.0 112.317 170.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -126.31 -7.4 6.43 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.166 0.986 . . . . 0.0 113.127 -163.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.279 95.5 m-85 58.13 30.41 19.31 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.344 2.257 . . . . 0.0 115.017 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.92 130.05 39.12 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.57 0.748 . . . . 0.0 109.238 170.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -92.37 128.34 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.766 0.826 . . . . 0.0 109.501 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.37 149.36 39.29 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -69.3 136.11 51.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.389 0.676 . . . . 0.0 110.235 156.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 149.01 44.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.886 1.274 . . . . 0.0 110.026 159.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -78.06 153.58 32.16 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.898 0.856 . . . . 0.0 113.176 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.0 t -85.88 120.62 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.7 1.6 . . . . 0.0 109.757 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.71 -52.05 23.49 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.32 0.648 . . . . 0.0 111.12 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -146.24 156.58 43.48 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.266 1.426 . . . . 0.0 111.9 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 p -117.73 118.47 32.15 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.266 1.827 . . . . 0.0 111.148 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -104.52 151.93 23.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.693 1.597 . . . . 0.0 113.316 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.4 140.98 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.0 1.72 . . . . 0.0 109.016 173.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -140.76 176.54 8.71 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.081 1.752 . . . . 0.0 109.889 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -131.61 134.32 45.89 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.576 1.15 . . . . 0.0 111.271 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -144.21 152.03 40.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.211 1.004 . . . . 0.0 110.926 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.7 p -96.76 -15.03 21.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.219 1.407 . . . . 0.0 113.658 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -109.17 106.05 15.77 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.824 0.85 . . . . 0.0 110.682 -170.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.3 mt -116.78 163.94 15.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 122.369 1.081 . . . . 0.0 113.817 -172.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -137.26 129.14 28.97 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.694 1.597 . . . . 0.0 111.853 -176.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -110.51 103.83 12.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.616 1.566 . . . . 0.0 111.188 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.21 141.29 28.59 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.057 0.943 . . . . 0.0 110.058 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.0 m -114.18 125.26 53.73 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 167.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.06 119.46 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.953 1.301 . . . . 0.0 109.891 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.05 24.55 35.64 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.158 0.885 . . . . 0.0 115.149 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.89 -0.36 69.62 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.042 1.306 . . . . 0.0 116.285 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -108.74 125.54 52.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.592 1.696 . . . . 0.0 110.292 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -91.7 134.74 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.143 0.977 . . . . 0.0 112.64 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 mt -133.9 132.21 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.642 1.977 . . . . 0.0 108.828 -170.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -120.99 105.92 11.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.154 0.982 . . . . 0.0 109.538 -159.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 t -140.05 175.75 9.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.916 0.887 . . . . 0.0 113.328 -156.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.0 p -80.54 152.39 28.67 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.897 0.879 . . . . 0.0 112.182 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -61.18 -29.37 69.76 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.974 -1.079 . . . . 0.0 112.656 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -94.19 2.4 55.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.397 1.079 . . . . 0.0 113.456 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.415 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.1 t60 -64.52 128.73 93.72 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 120.97 -1.081 . . . . 0.0 112.826 -172.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -79.93 112.39 2.86 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.561 2.841 . . . . 0.0 114.45 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -102.64 145.59 29.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.18 1.792 . . . . 0.0 111.956 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -93.3 132.04 37.88 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -116.65 135.63 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 127.303 2.241 . . . . 0.0 111.395 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -55.39 129.38 38.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.154 0.982 . . . . 0.0 110.982 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 64.66 9.01 4.83 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.47 1.908 . . . . 0.0 115.588 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.4 t -132.06 -44.66 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 120.882 -1.136 . . . . 0.0 112.344 -172.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.23 -147.75 17.83 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.213 -0.771 . . . . 0.0 112.377 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.28 53.4 p90 -91.26 143.12 26.98 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -144.63 147.98 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.829 2.052 . . . . 0.0 111.922 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -59.37 135.04 57.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.911 0.885 . . . . 0.0 112.63 171.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.58 -37.15 72.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.738 1.215 . . . . 0.0 113.014 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.36 -18.32 71.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.997 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -97.06 -1.94 44.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.629 1.572 . . . . 0.0 113.943 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.9 mt -70.51 156.59 39.19 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.651 0.78 . . . . 0.0 112.46 171.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -118.26 156.91 28.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.789 1.636 . . . . 0.0 111.433 170.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.36 132.33 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.883 0.873 . . . . 0.0 110.065 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.76 60.87 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.98 1.276 . . . . 0.0 115.655 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -86.97 159.03 19.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.489 1.645 . . . . 0.0 113.047 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -101.89 102.92 13.56 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.448 1.499 . . . . 0.0 112.361 -159.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.7 mt -95.81 166.84 11.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.528 1.131 . . . . 0.0 111.67 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.62 153.44 22.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.92 1.288 . . . . 0.0 110.306 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -109.89 -174.35 2.47 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 172.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.9 p -57.59 -12.75 3.03 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -103.7 -26.6 12.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.171 1.389 . . . . 0.0 111.342 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.83 22.2 24.04 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.335 1.922 . . . . 0.0 111.819 -167.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -76.75 159.58 30.03 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.764 0.826 . . . . 0.0 109.898 167.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.26 130.73 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.528 0.68 . . . . 0.0 112.328 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.4 158.65 20.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.036 2.934 . . . . 0.0 111.227 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.13 139.24 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.212 1.005 . . . . 0.0 111.266 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.2 t -73.71 125.75 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.539 0.736 . . . . 0.0 110.23 172.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -100.96 -26.71 13.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.621 2.369 . . . . 0.0 113.515 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -161.77 152.4 17.63 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.203 1.401 . . . . 0.0 111.565 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -127.17 132.8 50.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.737 1.615 . . . . 0.0 111.067 156.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -132.12 154.83 49.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 128.524 2.73 . . . . 0.0 110.023 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 tt -142.6 137.18 29.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.509 1.524 . . . . 0.0 110.436 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -135.1 149.89 50.13 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.1 mm -106.58 105.67 19.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.954 1.302 . . . . 0.0 108.6 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.62 148.35 49.47 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.754 1.222 . . . . 0.0 113.221 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.19 -14.61 60.15 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.748 1.219 . . . . 0.0 113.354 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -151.25 153.52 32.72 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 126.708 2.003 . . . . 0.0 110.69 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.18 122.92 11.31 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.328 2.686 . . . . 0.0 112.861 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.97 142.04 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.8 1.64 . . . . 0.0 109.837 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -79.81 140.62 36.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.797 0.839 . . . . 0.0 111.269 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.2 m -143.75 150.59 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.307 1.043 . . . . 0.0 111.162 -173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -128.1 147.15 50.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.712 1.205 . . . . 0.0 111.265 -165.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -155.94 166.79 32.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.257 1.823 . . . . 0.0 109.129 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -150.54 172.33 15.66 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.329 -1.482 . . . . 0.0 111.655 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -122.02 132.7 54.65 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.47 138.23 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.948 1.699 . . . . 0.0 111.486 -172.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.38 -33.33 65.63 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -148.28 -37.08 0.19 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.025 -1.047 . . . . 0.0 113.689 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -73.71 166.65 22.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.987 0.915 . . . . 0.0 110.424 172.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -133.77 28.58 3.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.448 1.499 . . . . 0.0 112.791 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.7 p -136.34 161.24 36.34 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.075 1.75 . . . . 0.0 111.511 175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -157.6 -179.28 8.02 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.287 1.835 . . . . 0.0 109.814 167.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -132.95 139.33 47.25 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.26 1.024 . . . . 0.0 112.841 -168.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.78 141.4 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -170.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.36 172.55 31.59 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.39 1.472 . . . . 0.0 115.709 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.33 -19.23 65.31 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.927 -1.337 . . . . 0.0 113.808 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -93.77 1.51 56.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.402 1.481 . . . . 0.0 114.154 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 57.74 46.17 17.64 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.861 1.664 . . . . 0.0 114.217 166.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.26 138.09 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.397 1.079 . . . . 0.0 111.632 -171.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.66 124.96 28.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.799 1.639 . . . . 0.0 112.498 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.97 151.82 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.311 1.444 . . . . 0.0 110.845 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -81.69 146.76 29.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.976 0.51 . . . . 0.0 110.569 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 C--O 1.251 1.18 0 C-N-CA 124.788 1.235 . . . . 0.0 113.592 178.254 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 44.6 ttm -148.94 145.13 27.23 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.278 -0.889 . . . . 0.0 111.764 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -122.37 50.02 1.53 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.764 1.626 . . . . 0.0 113.264 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -128.34 163.4 24.9 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -166.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -119.45 151.22 38.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.842 1.257 . . . . 0.0 110.915 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.82 158.73 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.272 0.558 . . . . 0.0 111.918 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.21 150.6 4.45 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.089 0.947 . . . . 0.0 111.63 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.47 -18.97 15.96 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 117.272 -1.849 . . . . 0.0 116.357 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.9 m -63.6 121.41 13.83 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.202 2.501 . . . . 0.0 110.718 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -77.76 143.77 37.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.476 1.111 . . . . 0.0 112.387 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.2 mm -126.81 136.46 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 127.548 2.339 . . . . 0.0 109.828 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -78.5 129.09 34.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.518 1.127 . . . . 0.0 113.441 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -127.52 173.59 9.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.57 1.548 . . . . 0.0 111.751 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.53 -15.1 63.14 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.851 -1.156 . . . . 0.0 113.371 172.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 p -109.03 -8.74 15.14 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.898 1.679 . . . . 0.0 114.21 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.38 -113.98 0.97 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.408 1.48 . . . . 0.0 111.412 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.8 mt -120.66 153.97 36.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.625 1.17 . . . . 0.0 111.584 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -137.63 144.99 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.667 1.987 . . . . 0.0 108.029 166.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.75 148.32 46.46 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.756 -1.215 . . . . 0.0 111.316 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 tt -63.32 -27.4 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 120.42 -1.425 . . . . 0.0 113.056 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -70.46 -7.15 41.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.964 1.306 . . . . 0.0 114.351 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -118.17 -15.37 9.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.644 1.578 . . . . 0.0 113.084 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.02 135.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.918 1.235 . . . . 0.0 110.295 169.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -120.75 159.06 26.18 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.644 1.578 . . . . 0.0 112.375 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 137.89 55.5 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.421 -0.8 . . . . 0.0 110.533 167.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.61 -6.67 72.4 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.376 0.989 . . . . 0.0 115.133 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -67.95 177.65 2.08 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.812 1.306 . . . . 0.0 110.99 167.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -120.14 153.45 36.17 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.9 -1.125 . . . . 0.0 112.584 168.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 m -141.45 160.83 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.754 1.622 . . . . 0.0 110.609 175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.2 mm -77.99 135.87 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 122.041 -0.412 . . . . 0.0 111.2 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.2 120.82 21.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.754 1.222 . . . . 0.0 107.71 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.2 m -96.65 103.18 15.07 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -47.84 118.91 6.55 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.027 1.331 . . . . 0.0 112.479 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.46 -10.37 28.47 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.27 1.98 . . . . 0.0 114.107 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -77.54 -34.96 53.71 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.791 1.636 . . . . 0.0 113.315 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.7 t -144.91 -3.91 0.76 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.142 1.377 . . . . 0.0 112.702 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 54.73 40.23 31.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.598 1.559 . . . . 0.0 113.565 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -77.87 124.22 27.73 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.505 1.122 . . . . 0.0 109.494 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -85.92 123.85 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.083 0.553 . . . . 0.0 110.779 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.35 162.83 34.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.849 0.833 . . . . 0.0 112.972 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -103.84 116.47 32.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.853 1.661 . . . . 0.0 109.416 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -133.91 154.5 51.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.876 1.27 . . . . 0.0 111.444 -170.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 t -87.87 157.1 19.07 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.6 t -88.59 128.35 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.408 1.483 . . . . 0.0 110.843 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -83.3 -55.78 4.13 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.009 0.524 . . . . 0.0 111.333 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -138.7 152.73 48.26 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.601 1.161 . . . . 0.0 111.627 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -128.01 107.98 10.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.759 1.624 . . . . 0.0 110.411 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -96.31 146.3 24.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.403 1.081 . . . . 0.0 111.706 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 t -136.79 137.04 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.996 0.918 . . . . 0.0 109.192 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -133.95 175.4 9.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.525 2.33 . . . . 0.0 109.256 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -131.6 132.22 43.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.312 1.045 . . . . 0.0 111.751 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 t -141.66 140.27 33.19 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.422 1.089 . . . . 0.0 111.101 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -85.19 -21.98 28.92 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.535 0.734 . . . . 0.0 112.287 165.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -92.87 120.63 33.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.92 0.782 . . . . 0.0 109.495 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.3 mt -126.61 161.96 26.82 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.481 1.134 . . . . 0.0 112.673 174.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 tp -127.83 128.87 45.99 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.461 1.904 . . . . 0.0 109.918 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -113.22 95.9 5.63 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.197 -0.94 . . . . 0.0 109.29 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.0 mt -83.69 145.04 28.99 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.444 -0.785 . . . . 0.0 110.291 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -117.32 120.01 36.89 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -128.12 120.99 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.997 1.319 . . . . 0.0 108.61 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.52 31.12 28.43 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.42 -5.75 83.76 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.221 1.391 . . . . 0.0 116.0 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -94.96 125.93 39.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.236 1.518 . . . . 0.0 109.581 172.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.19 132.42 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.313 0.645 . . . . 0.0 110.998 167.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -123.47 103.32 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.282 1.833 . . . . 0.0 109.072 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -77.67 106.91 9.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.48 2.312 . . . . 0.0 110.766 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 t -137.47 -179.34 5.68 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.156 1.382 . . . . 0.0 112.103 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.0 p -88.25 163.36 16.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.77 1.228 . . . . 0.0 111.91 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -68.45 -25.76 65.17 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.867 -1.146 . . . . 0.0 112.45 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -106.43 9.6 31.67 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.654 0.782 . . . . 0.0 113.006 -171.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -72.19 131.68 84.96 Favored Pre-proline 0 CA--C 1.553 1.066 0 O-C-N 121.369 -0.832 . . . . 0.0 112.717 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.3 120.05 2.83 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.201 3.268 . . . . 0.0 115.575 -175.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -106.88 145.16 32.52 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.462 1.905 . . . . 0.0 111.201 172.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -88.96 131.45 35.15 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.305 1.412 . . . . 0.0 113.506 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.31 133.7 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 127.126 2.171 . . . . 0.0 111.504 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -56.58 127.68 32.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.786 0.834 . . . . 0.0 112.855 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 59.99 15.5 5.09 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.316 1.847 . . . . 0.0 115.488 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.3 t -125.26 -59.15 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 120.833 -1.167 . . . . 0.0 111.09 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.39 -162.47 22.7 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.242 0.925 . . . . 0.0 112.653 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -83.29 146.19 28.67 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.845 1.322 . . . . 0.0 114.143 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.83 145.35 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 127.307 2.243 . . . . 0.0 111.259 -175.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -66.04 136.74 56.44 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.682 0.793 . . . . 0.0 112.485 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.74 -39.32 68.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.489 1.516 . . . . 0.0 113.799 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.35 -17.8 77.84 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.355 -0.84 . . . . 0.0 114.041 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -93.63 -9.76 36.88 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.392 1.477 . . . . 0.0 113.761 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.99 167.76 1.53 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.35 1.06 . . . . 0.0 113.103 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 162.43 27.37 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.463 1.505 . . . . 0.0 110.115 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.97 145.39 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.307 0.575 . . . . 0.0 109.505 167.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.43 4.8 89.26 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.727 -1.041 . . . . 0.0 114.807 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -84.58 158.01 21.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.153 1.476 . . . . 0.0 112.426 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -105.9 104.43 14.14 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.815 1.246 . . . . 0.0 111.591 -162.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.8 mt -101.19 169.37 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.904 1.281 . . . . 0.0 111.11 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -115.49 144.1 44.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.955 1.302 . . . . 0.0 110.634 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.96 -177.11 5.11 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.533 1.133 . . . . 0.0 112.805 168.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.1 p -59.98 -17.42 38.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -97.51 -26.34 14.85 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.837 1.653 . . . . 0.0 112.737 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 104.08 23.4 8.15 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.448 1.499 . . . . 0.0 113.15 -170.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -81.34 151.07 28.18 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.791 1.236 . . . . 0.0 110.649 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.9 t -84.85 133.12 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.124 0.97 . . . . 0.0 112.159 -168.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -118.62 148.74 42.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.575 2.35 . . . . 0.0 111.424 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.56 135.43 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.224 1.01 . . . . 0.0 110.714 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.04 127.21 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 169.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.47 -38.34 8.44 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.329 1.452 . . . . 0.0 112.565 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -161.48 154.82 21.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.29 1.436 . . . . 0.0 111.913 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -120.07 133.21 55.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.458 1.503 . . . . 0.0 110.51 163.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -124.43 153.25 42.22 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.989 2.515 . . . . 0.0 109.965 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 tp -135.11 143.16 46.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.095 1.758 . . . . 0.0 109.942 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.46 157.17 44.37 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.3 mm -108.33 105.24 18.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.656 1.182 . . . . 0.0 108.364 166.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.78 147.51 49.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.899 1.28 . . . . 0.0 113.71 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -74.16 -10.61 59.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.585 1.554 . . . . 0.0 113.972 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -139.65 157.13 70.67 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 127.034 2.134 . . . . 0.0 110.291 166.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.77 119.09 6.04 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.653 2.236 . . . . 0.0 110.492 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.7 t -90.02 136.9 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 126.011 1.725 . . . . 0.0 109.419 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -74.61 138.39 42.92 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.679 0.792 . . . . 0.0 110.226 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.95 142.53 29.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 123.926 0.89 . . . . 0.0 110.764 -174.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -122.08 145.46 48.13 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.032 1.333 . . . . 0.0 110.433 -163.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -153.1 165.54 35.3 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.968 1.307 . . . . 0.0 110.801 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -147.03 164.09 34.13 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.423 -1.423 . . . . 0.0 113.02 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -117.69 141.43 48.39 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.02 147.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.078 1.751 . . . . 0.0 111.556 -168.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.16 -67.65 0.42 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.637 1.175 . . . . 0.0 113.886 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -94.88 -54.57 3.42 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.645 -0.66 . . . . 0.0 112.28 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -83.44 177.63 8.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.856 1.263 . . . . 0.0 111.579 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -131.75 29.2 4.49 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.027 1.331 . . . . 0.0 114.187 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 p -137.04 161.61 35.6 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.992 1.717 . . . . 0.0 112.507 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -156.16 -177.48 6.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.528 1.931 . . . . 0.0 110.751 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -132.24 139.57 48.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.096 1.358 . . . . 0.0 113.176 -168.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.22 144.17 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.375 1.07 . . . . 0.0 113.351 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.13 -179.42 39.13 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.051 1.786 . . . . 0.0 116.642 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.92 -39.15 71.23 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.951 1.301 . . . . 0.0 111.973 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -86.33 2.21 48.24 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 59.78 39.53 20.63 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.24 134.5 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.269 0.627 . . . . 0.0 111.578 -169.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.7 tp -73.76 121.93 21.6 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.859 1.664 . . . . 0.0 112.445 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.13 161.92 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.647 1.579 . . . . 0.0 111.623 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -111.03 143.65 41.4 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -167.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 127.343 2.257 . . . . 0.0 113.262 172.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 7.5 ttt -147.24 126.69 13.18 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.37 1.441 . . . . 0.0 111.416 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -134.57 75.93 1.61 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.365 1.466 . . . . 0.0 112.125 -164.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -144.12 172.27 13.13 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.07 152.73 37.13 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.495 1.518 . . . . 0.0 111.068 173.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.1 m -68.25 157.43 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.382 0.611 . . . . 0.0 111.707 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.5 150.11 2.83 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.62 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.94 -10.83 45.18 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.269 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.0 m -64.2 123.91 20.32 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 120.901 2.351 . . . . 0.0 110.641 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 mmt -80.26 140.03 36.41 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.284 1.434 . . . . 0.0 111.831 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.6 mm -123.12 135.71 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.367 1.867 . . . . 0.0 109.719 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.53 123.86 26.7 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.653 0.781 . . . . 0.0 111.608 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 p -117.36 177.36 4.77 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.764 1.226 . . . . 0.0 112.71 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.72 -15.01 50.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.092 1.357 . . . . 0.0 114.128 170.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.5 p -124.68 -12.23 7.17 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.43 -115.1 0.65 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.04 0.828 . . . . 0.0 112.726 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 78.7 mt -125.72 139.65 53.36 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.232 1.013 . . . . 0.0 112.799 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -136.38 147.69 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.83 2.052 . . . . 0.0 109.012 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.42 148.11 47.25 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.273 -0.892 . . . . 0.0 111.442 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.0 tt -61.44 -26.29 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 120.682 -1.261 . . . . 0.0 113.496 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -72.27 -9.07 57.99 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.953 1.301 . . . . 0.0 114.198 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -118.7 -10.28 10.04 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.986 1.714 . . . . 0.0 113.332 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -66.91 136.69 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.668 1.122 . . . . 0.0 109.391 162.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -130.07 166.77 19.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.048 1.739 . . . . 0.0 111.182 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.86 134.08 55.01 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.212 -0.93 . . . . 0.0 110.199 165.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.2 -7.84 81.19 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -67.95 167.73 13.17 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.825 1.312 . . . . 0.0 111.496 161.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -124.23 123.84 41.14 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.431 1.492 . . . . 0.0 111.863 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.98 152.76 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.815 1.646 . . . . 0.0 110.227 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -77.79 139.12 19.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.373 0.606 . . . . 0.0 110.543 169.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.23 126.4 28.07 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.413 1.085 . . . . 0.0 108.378 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.4 m -78.93 111.99 15.67 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 159.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -53.63 114.31 6.08 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.655 1.182 . . . . 0.0 112.15 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.75 -12.77 35.62 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.611 2.207 . . . . 0.0 114.29 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.66 -48.85 14.22 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.793 -1.192 . . . . 0.0 111.887 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -129.0 -0.41 5.26 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.036 1.335 . . . . 0.0 114.117 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.324 4.0 m-85 61.72 25.39 15.29 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.046 1.738 . . . . 0.0 115.541 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.79 136.81 53.34 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.416 -0.803 . . . . 0.0 110.251 168.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.31 117.36 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.268 1.027 . . . . 0.0 110.497 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.31 160.9 43.01 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -71.92 132.26 44.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.414 1.085 . . . . 0.0 110.453 166.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.413 ' HE3' ' CE1' ' A' ' 121' ' ' PHE . 70.5 mmtt -135.62 150.13 49.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.535 1.534 . . . . 0.0 110.359 170.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -82.39 155.01 24.92 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.9 t -90.21 131.6 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.86 1.264 . . . . 0.0 111.176 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.98 -45.72 10.51 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.942 0.897 . . . . 0.0 112.476 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -148.83 153.45 38.11 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.38 1.872 . . . . 0.0 110.669 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.7 p -120.73 122.59 40.74 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.238 1.415 . . . . 0.0 111.095 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -104.7 148.05 27.0 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.604 1.562 . . . . 0.0 112.421 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.0 t -143.31 132.22 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.552 1.141 . . . . 0.0 111.251 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -134.14 177.67 7.56 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.258 2.223 . . . . 0.0 111.936 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -139.51 138.8 36.66 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.423 1.489 . . . . 0.0 111.511 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.1 t -155.23 154.29 31.96 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.984 0.914 . . . . 0.0 111.907 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.7 p -87.39 -15.48 37.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.781 1.232 . . . . 0.0 113.424 164.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -98.55 108.26 20.91 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.086 -1.009 . . . . 0.0 110.972 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.3 mt -108.86 174.38 5.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.949 0.899 . . . . 0.0 111.935 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.8 tp -147.76 137.97 22.93 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.214 1.406 . . . . 0.0 110.726 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -124.17 112.91 17.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.863 1.265 . . . . 0.0 110.18 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.9 130.54 54.56 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.801 0.84 . . . . 0.0 109.819 176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -105.52 116.51 32.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.845 1.258 . . . . 0.0 108.542 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -127.77 116.06 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.55 1.54 . . . . 0.0 109.472 -171.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.49 30.82 34.91 Favored Glycine 0 CA--C 1.542 1.774 0 O-C-N 121.628 -0.67 . . . . 0.0 113.97 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.93 -1.61 88.23 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.245 1.403 . . . . 0.0 115.73 -177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.28 120.92 38.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.857 1.829 . . . . 0.0 109.52 170.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -88.57 138.05 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.238 0.615 . . . . 0.0 111.824 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.5 mt -133.67 131.91 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.36 1.864 . . . . 0.0 109.139 -176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -114.05 109.73 18.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.73 1.612 . . . . 0.0 110.607 -165.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 t -140.63 -179.38 6.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.164 1.386 . . . . 0.0 112.668 -158.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.1 p -90.29 155.45 18.97 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.302 1.041 . . . . 0.0 112.287 169.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -59.72 -29.9 68.45 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.107 -0.996 . . . . 0.0 113.442 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -94.52 3.44 55.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -64.54 127.89 92.82 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 120.912 -1.118 . . . . 0.0 112.6 -170.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -81.1 113.2 2.68 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 123.695 2.93 . . . . 0.0 114.292 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -103.63 144.05 31.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.952 1.701 . . . . 0.0 111.64 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -84.89 134.35 34.27 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.307 0.958 . . . . 0.0 112.756 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.9 t -118.71 132.87 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.769 2.028 . . . . 0.0 111.867 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 121.92 4.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.325 1.45 . . . . 0.0 111.899 172.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 56.38 30.07 16.26 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.312 1.445 . . . . 0.0 113.977 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -141.65 -42.11 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 125.373 1.469 . . . . 0.0 112.737 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.66 -148.99 18.77 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.965 0.793 . . . . 0.0 112.848 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -88.06 135.83 33.25 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.8 p -136.84 145.08 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.132 1.773 . . . . 0.0 111.455 -176.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -63.58 131.99 49.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.092 1.357 . . . . 0.0 111.016 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.34 67.34 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.152 -0.967 . . . . 0.0 113.44 -175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.03 -7.28 81.5 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 121.119 -0.988 . . . . 0.0 114.494 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -107.23 -2.47 20.78 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.087 1.755 . . . . 0.0 113.543 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.76 161.7 17.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.992 1.317 . . . . 0.0 112.326 166.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.7 159.32 24.71 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.812 1.245 . . . . 0.0 113.256 160.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.78 130.87 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 159.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.87 -0.89 84.82 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 117.185 -1.897 . . . . 0.0 115.558 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.01 151.42 41.76 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 121.404 2.602 . . . . 0.0 111.509 166.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -102.86 107.87 18.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.028 1.731 . . . . 0.0 112.854 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.9 mt -97.75 167.65 10.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.647 1.179 . . . . 0.0 111.871 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.14 146.8 38.61 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.052 1.341 . . . . 0.0 111.182 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.24 -178.05 3.54 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 172.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.4 p -59.89 -6.6 1.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.77 2.028 . . . . 0.0 116.466 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.51 -17.17 10.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.513 1.925 . . . . 0.0 112.621 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.48 23.88 32.64 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.045 1.783 . . . . 0.0 112.033 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -66.65 148.78 51.44 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.205 0.502 . . . . 0.0 109.768 161.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.3 t -84.16 128.15 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 122.491 0.317 . . . . 0.0 110.381 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.8 mt -108.4 161.07 15.37 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.465 2.706 . . . . 0.0 110.652 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.5 t -134.6 140.4 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.507 1.123 . . . . 0.0 110.605 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.08 129.13 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.361 0.664 . . . . 0.0 109.894 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -96.64 -41.73 8.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.428 2.291 . . . . 0.0 112.011 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -153.53 149.92 28.18 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.807 1.643 . . . . 0.0 110.681 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -132.75 122.73 24.99 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.95 2.1 . . . . 0.0 108.727 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mmtm -134.48 128.71 33.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.492 1.117 . . . . 0.0 112.992 -166.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.1 tp -102.55 134.88 45.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.033 1.733 . . . . 0.0 109.612 173.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -136.09 147.95 48.07 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.361 0.664 . . . . 0.0 111.423 158.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.0 mm -91.7 117.05 34.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 165.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.03 142.19 55.97 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.263 1.025 . . . . 0.0 111.183 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.0 -17.87 62.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.437 0.695 . . . . 0.0 112.738 -176.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -144.38 147.52 37.11 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.373 2.269 . . . . 0.0 110.178 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.11 120.06 7.38 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 124.389 3.393 . . . . 0.0 112.809 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.75 141.7 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.906 1.682 . . . . 0.0 110.441 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -75.14 141.11 43.73 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.494 0.718 . . . . 0.0 111.482 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 m -136.47 144.07 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.938 1.695 . . . . 0.0 110.397 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.47 147.3 49.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.468 1.507 . . . . 0.0 110.644 -166.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -155.38 170.46 21.85 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.721 1.608 . . . . 0.0 111.495 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -154.19 166.1 34.18 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.428 -1.42 . . . . 0.0 113.043 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -120.04 146.13 46.19 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.668 1.187 . . . . 0.0 113.857 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.71 147.09 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.954 1.701 . . . . 0.0 112.44 -162.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.37 -39.56 92.45 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -168.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -133.99 -48.16 0.8 Allowed 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.599 -1.313 . . . . 0.0 113.386 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.413 ' CE1' ' HE3' ' A' ' 39' ' ' LYS . 7.8 m-30 -77.61 168.86 19.29 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 169.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -114.93 17.87 16.7 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.2 1.4 . . . . 0.0 112.669 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 p -141.08 165.16 28.31 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.968 1.707 . . . . 0.0 112.794 -160.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -158.98 178.38 10.13 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.054 1.742 . . . . 0.0 110.662 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -120.41 139.81 52.27 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.038 1.335 . . . . 0.0 112.501 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.0 144.48 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.092 1.357 . . . . 0.0 113.61 -175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.21 173.7 29.73 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.232 1.396 . . . . 0.0 116.034 172.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.13 -27.84 69.65 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.178 -1.189 . . . . 0.0 113.648 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -88.66 -1.34 58.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.346 1.458 . . . . 0.0 113.519 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 59.25 49.8 8.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.182 1.793 . . . . 0.0 113.988 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t -74.91 138.79 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.11 1.364 . . . . 0.0 111.579 -173.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.9 tp -79.78 128.86 33.95 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.575 1.55 . . . . 0.0 113.524 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.5 m -138.06 155.06 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.724 . . . . 0.0 111.356 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -104.23 158.44 16.44 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.47 1.508 . . . . 0.0 110.778 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 C--O 1.254 1.327 0 O-C-N 120.622 -1.299 . . . . 0.0 114.097 172.334 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.679 0.276 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 43.9 ttm -146.81 136.47 23.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 110.752 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -109.24 102.75 11.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.4 1.48 . . . . 0.0 109.366 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -156.32 172.26 18.8 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.514 1.126 . . . . 0.0 112.677 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.87 154.38 41.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.29 1.436 . . . . 0.0 111.985 169.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.07 161.6 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.242 0.617 . . . . 0.0 112.554 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 150.55 7.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.326 1.05 . . . . 0.0 111.358 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.59 -7.03 9.47 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-O 117.795 -1.558 . . . . 0.0 116.486 -172.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.8 m -61.65 119.36 8.52 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 121.552 2.676 . . . . 0.0 109.685 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -74.62 143.29 44.41 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.851 0.861 . . . . 0.0 111.405 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.3 mm -127.51 135.51 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.796 2.038 . . . . 0.0 109.519 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -78.23 126.36 30.69 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.0 p -117.96 176.39 5.23 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.789 1.235 . . . . 0.0 111.82 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.81 -10.8 59.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 171.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 p -119.46 -16.04 8.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.27 1.828 . . . . 0.0 113.934 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.03 -122.8 1.26 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.089 1.328 . . . . 0.0 111.53 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.5 mt -124.28 142.8 50.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.163 1.385 . . . . 0.0 112.258 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.15 143.08 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.12 1.768 . . . . 0.0 108.613 171.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.57 148.03 51.09 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.999 -1.063 . . . . 0.0 111.352 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 tt -61.34 -26.88 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 O-C-N 120.592 -1.317 . . . . 0.0 113.524 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.82 -16.44 64.11 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -112.54 -12.04 13.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.151 1.78 . . . . 0.0 112.665 -174.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.54 141.12 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.04 0.836 . . . . 0.0 109.837 162.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -128.43 159.77 34.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.443 1.897 . . . . 0.0 112.263 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.72 124.8 21.7 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.485 165.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.65 -0.34 84.76 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.497 1.046 . . . . 0.0 115.392 -170.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -76.8 154.15 34.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.424 1.612 . . . . 0.0 110.539 158.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -108.92 142.89 38.89 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.218 1.407 . . . . 0.0 112.217 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -136.5 159.85 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.376 1.87 . . . . 0.0 111.026 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.9 mm -74.59 137.85 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.966 -0.459 . . . . 0.0 111.898 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.49 123.08 19.75 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.167 0.987 . . . . 0.0 108.657 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.4 m -93.33 103.85 16.05 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 170.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -52.97 113.91 5.2 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.818 1.647 . . . . 0.0 113.18 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.58 -11.24 31.46 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.159 2.573 . . . . 0.0 114.413 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -76.43 -38.9 54.83 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.381 1.072 . . . . 0.0 112.638 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 t -133.96 -6.96 2.73 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.282 1.033 . . . . 0.0 112.516 -172.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.267 2.4 t80 61.99 39.34 13.45 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.31 1.844 . . . . 0.0 113.601 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -95.2 135.75 36.39 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.452 1.501 . . . . 0.0 110.522 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.04 136.71 30.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 122.956 0.502 . . . . 0.0 111.653 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.8 167.99 25.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.379 1.472 . . . . 0.0 111.951 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -89.71 126.88 35.82 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.686 0.794 . . . . 0.0 110.196 164.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -130.23 151.75 50.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.496 1.118 . . . . 0.0 112.123 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -87.53 154.5 20.58 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.42 1.088 . . . . 0.0 113.141 -176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.4 t -89.66 132.68 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.661 1.584 . . . . 0.0 110.753 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.38 -43.19 9.9 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.903 0.881 . . . . 0.0 112.785 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -142.85 153.09 42.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.157 1.383 . . . . 0.0 110.297 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 p -122.1 118.42 28.66 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.9 1.68 . . . . 0.0 108.832 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.02 143.71 28.3 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.424 1.49 . . . . 0.0 112.258 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.5 t -141.13 126.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.751 1.221 . . . . 0.0 110.889 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -132.8 174.77 9.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.825 2.05 . . . . 0.0 109.62 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -132.33 130.2 40.46 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.871 0.868 . . . . 0.0 111.093 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.7 t -140.18 139.54 35.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.522 1.129 . . . . 0.0 110.87 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.0 p -81.12 -19.88 42.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.854 0.862 . . . . 0.0 111.926 166.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -94.2 111.63 23.37 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.383 1.073 . . . . 0.0 110.668 -173.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.0 mt -127.85 157.2 41.13 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 123.409 1.576 . . . . 0.0 113.908 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.4 tp -121.77 136.15 54.93 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.495 1.918 . . . . 0.0 109.956 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -110.39 124.09 51.07 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.712 1.205 . . . . 0.0 109.2 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.0 mt -121.52 137.91 54.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 167.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.7 m -109.25 120.75 43.48 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 167.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.14 122.87 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.463 1.105 . . . . 0.0 108.269 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.64 18.59 16.94 Favored Glycine 0 CA--C 1.547 2.083 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.58 5.08 67.22 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 119.581 1.691 . . . . 0.0 116.323 -171.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -103.52 122.57 45.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.29 1.545 . . . . 0.0 110.296 164.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -77.18 124.03 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.537 0.735 . . . . 0.0 109.407 164.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mt -119.5 100.69 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.175 1.39 . . . . 0.0 109.122 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.57 119.24 21.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.591 1.556 . . . . 0.0 110.49 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -143.05 -179.06 6.14 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.129 0.972 . . . . 0.0 111.305 -168.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.4 p -88.69 155.65 19.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.955 0.883 . . . . 0.0 111.669 167.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.97 -33.59 69.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.536 1.135 . . . . 0.0 112.146 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -85.92 -7.73 58.49 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.634 1.173 . . . . 0.0 113.315 -170.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -64.57 127.48 92.41 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-O 118.213 -0.899 . . . . 0.0 113.177 -166.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.59 108.19 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.373 2.715 . . . . 0.0 114.313 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.26 141.92 34.31 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.625 1.97 . . . . 0.0 111.865 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -85.91 127.13 34.53 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.67 135.86 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 127.601 2.36 . . . . 0.0 111.257 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -52.67 121.22 6.76 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.13 1.372 . . . . 0.0 112.638 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.29 14.06 4.38 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.064 2.146 . . . . 0.0 115.54 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.8 t -122.77 -54.56 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.537 1.135 . . . . 0.0 110.728 -173.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.44 -161.93 16.42 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.586 0.612 . . . . 0.0 113.436 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -84.63 145.12 28.17 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.577 1.188 . . . . 0.0 114.166 -174.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.48 149.62 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.474 1.91 . . . . 0.0 111.263 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -55.73 131.48 46.76 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.743 1.217 . . . . 0.0 111.861 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.05 -35.81 64.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.635 1.174 . . . . 0.0 113.075 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.67 -5.73 88.3 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.63 -1.095 . . . . 0.0 114.898 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -97.93 -4.64 36.01 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.246 1.418 . . . . 0.0 113.519 171.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.52 160.07 33.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.556 0.693 . . . . 0.0 111.278 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -117.35 167.78 10.94 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.494 1.518 . . . . 0.0 110.535 166.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.88 144.71 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.495 -0.753 . . . . 0.0 109.323 155.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.84 1.43 89.54 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.951 -0.916 . . . . 0.0 114.132 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -82.9 152.14 25.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 119.038 1.419 . . . . 0.0 111.385 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -108.45 112.02 24.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.429 1.092 . . . . 0.0 112.484 -163.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.9 mt -107.27 179.41 4.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.341 1.856 . . . . 0.0 110.588 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.89 156.63 44.72 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.026 0.931 . . . . 0.0 113.467 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -98.15 174.04 6.72 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.578 1.151 . . . . 0.0 113.117 166.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.6 t -55.58 -35.38 65.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.782 1.233 . . . . 0.0 113.787 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -75.24 -29.55 60.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.555 1.542 . . . . 0.0 112.727 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.79 24.67 6.87 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.597 1.57 . . . . 0.0 113.499 173.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -78.43 152.94 31.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.441 1.496 . . . . 0.0 110.193 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.12 125.07 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 122.579 0.352 . . . . 0.0 110.992 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.0 mt -106.34 149.75 26.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.277 1.431 . . . . 0.0 111.863 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.0 t -127.23 137.0 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.457 1.103 . . . . 0.0 111.455 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.16 123.7 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.598 1.159 . . . . 0.0 111.074 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -88.63 -32.87 17.84 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.673 2.389 . . . . 0.0 114.48 175.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -152.82 147.92 26.59 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.954 1.302 . . . . 0.0 111.482 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -133.55 132.85 41.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.034 1.733 . . . . 0.0 110.699 168.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -145.77 157.0 43.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.836 2.054 . . . . 0.0 112.388 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tt -149.2 133.64 17.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.808 1.643 . . . . 0.0 109.639 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -146.62 154.51 41.56 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.588 1.155 . . . . 0.0 112.429 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.0 mm -94.53 107.61 19.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.708 0.803 . . . . 0.0 109.121 168.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.51 147.28 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.907 1.283 . . . . 0.0 111.709 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -76.04 -18.86 59.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.76 0.824 . . . . 0.0 112.709 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -127.97 158.21 71.42 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 126.785 2.034 . . . . 0.0 108.879 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -61.92 122.27 10.71 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.212 1.941 . . . . 0.0 110.437 162.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.6 t -93.17 140.44 16.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.288 1.835 . . . . 0.0 108.952 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -73.9 139.21 44.81 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.685 -0.635 . . . . 0.0 110.645 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 m -141.54 147.21 22.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.695 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -128.78 151.11 49.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.391 1.477 . . . . 0.0 110.879 -165.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -155.56 167.55 30.03 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.065 1.346 . . . . 0.0 110.343 168.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -150.42 159.86 44.17 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.54 -1.35 . . . . 0.0 112.973 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -113.86 138.83 49.77 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t -98.23 139.74 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.437 1.895 . . . . 0.0 111.127 -168.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -57.08 -63.99 1.03 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.725 1.21 . . . . 0.0 113.441 -173.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -112.0 -39.22 4.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -89.03 173.32 8.52 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.465 0.706 . . . . 0.0 110.52 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -116.7 7.96 13.64 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.39 1.476 . . . . 0.0 113.536 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 p -134.86 162.33 32.7 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.87 1.668 . . . . 0.0 112.593 -167.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -157.27 -176.84 6.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.072 1.749 . . . . 0.0 109.993 170.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -131.25 137.42 48.87 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.447 1.099 . . . . 0.0 112.891 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.0 145.32 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.034 1.333 . . . . 0.0 112.597 -172.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.91 169.54 31.14 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.105 1.336 . . . . 0.0 115.154 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.74 -37.71 19.66 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.002 1.321 . . . . 0.0 112.988 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -94.91 15.0 19.79 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 63.84 35.13 11.27 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 158.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.33 135.85 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.767 1.227 . . . . 0.0 111.525 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 56.1 tp -79.19 122.57 26.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.042 1.337 . . . . 0.0 113.623 -170.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.01 154.83 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.628 1.571 . . . . 0.0 111.627 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -100.38 146.72 26.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.268 1.027 . . . . 0.0 112.628 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.289 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 111.164 0.061 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 8.8 ttt -72.25 120.79 18.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.378 0.671 . . . . 0.0 111.189 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -120.66 108.83 14.49 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.818 1.247 . . . . 0.0 109.836 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -164.97 170.06 15.67 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -123.91 149.31 46.02 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.39 1.876 . . . . 0.0 111.134 171.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -65.66 158.51 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.378 -0.826 . . . . 0.0 112.172 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.83 148.43 7.56 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.883 0.873 . . . . 0.0 112.04 173.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.55 -10.6 43.7 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 116.358 1.303 . . . . 0.0 116.358 -171.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.8 m -62.07 125.86 25.34 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.863 2.332 . . . . 0.0 110.38 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -77.88 148.34 34.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.452 1.101 . . . . 0.0 112.059 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.1 mm -128.09 136.54 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 127.348 2.259 . . . . 0.0 109.662 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.0 tp -81.8 134.66 35.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.356 1.074 . . . . 0.0 113.363 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.5 p -132.28 176.96 7.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.412 1.485 . . . . 0.0 111.534 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.73 -0.33 26.5 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.675 1.59 . . . . 0.0 114.664 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.4 p -124.46 -16.28 6.38 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.75 1.22 . . . . 0.0 113.375 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.52 -129.92 2.73 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 127.468 2.461 . . . . 0.0 110.683 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.8 151.75 24.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.137 1.375 . . . . 0.0 111.869 168.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.09 146.89 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 127.425 2.29 . . . . 0.0 108.532 169.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.17 45.77 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.679 -1.263 . . . . 0.0 112.154 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 tt -62.72 -28.74 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 120.69 -1.256 . . . . 0.0 113.109 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.47 -2.28 31.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.015 1.326 . . . . 0.0 114.495 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -118.23 -13.09 9.89 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.488 1.515 . . . . 0.0 112.821 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.56 134.93 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.119 0.968 . . . . 0.0 109.664 159.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -134.6 164.94 26.37 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.279 1.832 . . . . 0.0 110.96 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.67 134.08 41.71 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.646 -0.659 . . . . 0.0 111.324 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.68 -15.24 59.44 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.587 1.089 . . . . 0.0 115.692 -175.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -66.49 166.88 11.72 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.431 1.615 . . . . 0.0 111.241 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -118.23 148.19 42.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.24 1.416 . . . . 0.0 113.359 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.19 166.6 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 127.095 2.158 . . . . 0.0 111.123 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -79.86 146.67 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.163 0.585 . . . . 0.0 111.22 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.18 132.28 23.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.354 0.662 . . . . 0.0 109.889 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.6 m -86.33 109.19 18.81 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 163.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -53.24 117.08 10.75 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.577 1.151 . . . . 0.0 112.347 174.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -65.7 -14.33 44.19 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.537 2.158 . . . . 0.0 113.906 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -79.29 -36.28 39.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.487 1.515 . . . . 0.0 113.923 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 t -140.89 0.83 1.62 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.264 1.426 . . . . 0.0 112.884 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.255 1.7 t80 63.17 27.41 15.63 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.744 1.617 . . . . 0.0 114.067 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -78.73 134.32 37.08 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.304 1.042 . . . . 0.0 110.519 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.5 t -94.53 136.63 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.264 0.626 . . . . 0.0 110.289 170.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.35 164.6 35.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.352 1.061 . . . . 0.0 112.35 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -87.6 126.85 35.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.327 1.051 . . . . 0.0 110.277 165.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -136.84 150.98 48.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.979 1.311 . . . . 0.0 112.942 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 t -82.27 157.98 23.67 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -91.98 132.61 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.137 2.175 . . . . 0.0 111.417 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 mt -87.68 -50.34 6.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.569 1.148 . . . . 0.0 112.754 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -143.81 157.22 44.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.159 2.183 . . . . 0.0 110.466 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p -119.38 118.55 31.46 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.025 1.73 . . . . 0.0 110.944 173.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -93.29 139.63 30.43 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.588 1.155 . . . . 0.0 113.084 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.4 t -137.97 130.8 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.752 176.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -135.3 175.81 9.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.203 2.201 . . . . 0.0 110.264 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -132.32 142.91 49.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.485 1.514 . . . . 0.0 110.746 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -152.97 155.33 36.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.832 0.853 . . . . 0.0 112.033 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.1 p -88.71 -16.23 32.8 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.733 2.013 . . . . 0.0 113.669 170.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -112.74 110.41 20.52 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.099 0.96 . . . . 0.0 110.339 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.8 mt -110.07 173.36 6.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.475 1.11 . . . . 0.0 112.527 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.1 tp -135.28 132.28 37.58 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.128 1.771 . . . . 0.0 109.141 170.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -111.56 115.32 28.98 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.189 0.996 . . . . 0.0 109.245 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.12 143.51 38.39 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.352 0.661 . . . . 0.0 109.862 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.7 m -118.18 120.86 38.99 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 167.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -125.94 116.59 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.628 1.171 . . . . 0.0 109.44 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.74 21.69 37.31 Favored Glycine 0 CA--C 1.545 1.935 0 O-C-N 121.605 -0.684 . . . . 0.0 114.723 -173.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.3 -16.09 61.41 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.576 2.036 . . . . 0.0 115.603 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -79.2 117.6 20.37 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.722 1.261 . . . . 0.0 109.174 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.1 t -75.57 130.04 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 122.974 0.51 . . . . 0.0 110.203 171.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.9 mt -129.86 102.9 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.768 1.627 . . . . 0.0 108.614 171.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -79.37 123.82 27.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.628 1.171 . . . . 0.0 110.581 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.0 t -141.31 174.76 10.24 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.083 1.353 . . . . 0.0 112.113 -167.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.1 p -81.28 145.97 30.65 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.428 -0.795 . . . . 0.0 111.203 165.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -54.74 -26.97 37.58 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.089 1.356 . . . . 0.0 113.334 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -102.9 2.48 35.29 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -62.57 133.06 94.65 Favored Pre-proline 0 CA--C 1.553 1.061 0 O-C-N 121.12 -0.988 . . . . 0.0 113.398 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.26 112.47 2.25 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.376 3.384 . . . . 0.0 114.844 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -101.18 148.46 25.07 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.679 1.992 . . . . 0.0 111.969 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -92.73 129.87 38.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.387 0.994 . . . . 0.0 113.452 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.4 t -108.25 135.57 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.918 2.487 . . . . 0.0 111.06 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.26 132.95 55.13 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.736 0.814 . . . . 0.0 111.127 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 66.62 3.51 2.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.085 1.754 . . . . 0.0 115.174 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.54 -63.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 120.967 -1.083 . . . . 0.0 110.556 -168.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.24 -150.63 18.13 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.647 0.641 . . . . 0.0 112.741 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -88.09 140.24 29.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.794 1.297 . . . . 0.0 113.968 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -145.32 145.9 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.751 1.621 . . . . 0.0 111.996 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -56.71 131.5 49.32 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.788 1.235 . . . . 0.0 112.405 171.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.92 -34.94 68.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.443 1.497 . . . . 0.0 113.672 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.39 -18.79 79.82 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 119.108 -0.829 . . . . 0.0 113.609 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -89.33 -3.52 58.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.366 1.467 . . . . 0.0 113.336 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.44 162.95 24.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.102 0.961 . . . . 0.0 112.236 166.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.35 159.8 30.9 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.044 1.738 . . . . 0.0 110.933 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.53 138.52 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.208 -0.932 . . . . 0.0 109.05 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.03 10.57 86.03 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.846 -0.974 . . . . 0.0 114.894 -171.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -78.68 155.48 29.44 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.47 1.635 . . . . 0.0 112.162 172.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.88 102.3 12.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.851 1.661 . . . . 0.0 111.163 -168.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.6 mt -97.23 179.55 4.86 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.037 0.935 . . . . 0.0 110.859 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.8 mt -131.55 159.83 37.03 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.164 -0.96 . . . . 0.0 113.49 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.0 p30 -118.59 -178.04 3.44 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -65.86 -0.88 2.48 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -102.35 -35.99 8.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.574 1.55 . . . . 0.0 110.874 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.48 17.35 11.44 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.966 1.745 . . . . 0.0 112.776 -170.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -92.37 148.88 21.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.311 1.055 . . . . 0.0 111.881 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.05 114.2 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 mt -88.05 158.4 18.61 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.0 1.32 . . . . 0.0 112.525 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.03 138.72 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.48 1.112 . . . . 0.0 111.705 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.63 121.86 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.867 0.867 . . . . 0.0 109.871 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -94.17 -29.97 14.85 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.913 2.085 . . . . 0.0 112.26 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -155.18 148.4 24.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.217 1.407 . . . . 0.0 112.2 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.1 tttm -132.85 115.85 15.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.402 1.881 . . . . 0.0 108.986 168.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.09 148.89 51.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.606 1.562 . . . . 0.0 112.169 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.2 tp -121.91 134.44 54.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.951 1.3 . . . . 0.0 110.197 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -139.57 150.78 45.45 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.723 0.809 . . . . 0.0 112.367 171.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.9 mm -108.19 111.61 36.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.754 1.222 . . . . 0.0 108.477 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.64 153.09 42.61 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 122.409 1.099 . . . . 0.0 113.531 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.66 -13.35 60.62 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.741 1.217 . . . . 0.0 113.419 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -155.27 160.13 31.14 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 128.302 2.641 . . . . 0.0 110.006 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.65 125.36 12.63 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.674 2.25 . . . . 0.0 111.433 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.43 139.92 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.983 2.113 . . . . 0.0 110.244 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -75.7 142.33 42.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.752 0.821 . . . . 0.0 112.644 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.28 139.17 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.115 1.366 . . . . 0.0 110.974 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -118.52 153.03 34.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.708 2.003 . . . . 0.0 111.944 -171.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -153.65 171.31 19.01 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.868 2.067 . . . . 0.0 109.231 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -152.04 173.86 14.38 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.202 -1.561 . . . . 0.0 112.389 173.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -127.86 142.86 51.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.856 1.262 . . . . 0.0 113.239 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.2 140.64 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.767 1.627 . . . . 0.0 112.611 -164.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.23 -21.75 66.79 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -165.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.48 -63.63 0.98 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.811 0.732 . . . . 0.0 111.209 169.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -70.56 170.47 12.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.694 0.759 . . . . 0.0 111.854 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -113.55 18.89 17.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.724 1.61 . . . . 0.0 112.381 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.0 p -140.3 167.14 22.85 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.11 1.364 . . . . 0.0 112.252 -164.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -160.7 177.31 10.59 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.797 2.039 . . . . 0.0 109.496 167.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -121.39 132.47 54.77 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.226 1.01 . . . . 0.0 111.846 -173.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.9 m -118.06 146.44 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.481 1.512 . . . . 0.0 113.603 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.07 169.63 20.53 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.987 1.279 . . . . 0.0 115.196 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.02 -23.33 66.38 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.993 1.317 . . . . 0.0 112.885 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -89.77 2.1 55.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 114.232 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 63.85 36.33 10.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.375 1.47 . . . . 0.0 114.915 162.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.43 135.61 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.363 1.465 . . . . 0.0 111.886 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.3 tp -78.54 125.25 29.1 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.215 1.406 . . . . 0.0 113.214 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.92 161.04 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.082 1.753 . . . . 0.0 111.591 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -112.0 149.06 32.53 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.012 1.325 . . . . 0.0 112.924 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.9 m120 . . . . . 0 C--O 1.254 1.332 0 C-N-CA 125.939 1.695 . . . . 0.0 112.208 178.612 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 43.7 ttm -147.13 131.72 17.79 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.925 0.89 . . . . 0.0 112.135 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -106.13 103.01 12.39 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.536 1.534 . . . . 0.0 110.313 170.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -156.05 168.54 26.94 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.424 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.8 m-85 -122.63 153.95 38.65 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.455 1.502 . . . . 0.0 111.068 167.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.16 163.12 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.839 -0.538 . . . . 0.0 111.811 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.74 159.27 0.56 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.543 1.163 . . . . 0.0 113.298 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.07 -13.92 4.16 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 117.9 -1.5 . . . . 0.0 115.901 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.9 m -62.95 118.3 7.61 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.497 2.148 . . . . 0.0 110.955 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -79.22 142.31 36.36 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.208 1.403 . . . . 0.0 112.861 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.1 mm -130.7 137.26 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.082 2.153 . . . . 0.0 109.561 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.1 tp -83.56 137.46 33.83 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.368 1.08 . . . . 0.0 113.506 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -135.79 168.97 18.31 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.2 1.4 . . . . 0.0 111.461 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.58 -18.26 64.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 p -106.7 -28.9 9.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.078 1.351 . . . . 0.0 112.944 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.72 -130.42 2.12 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.041 -1.037 . . . . 0.0 112.904 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.58 148.96 29.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.543 1.137 . . . . 0.0 112.184 170.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.4 t -138.97 148.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.083 2.153 . . . . 0.0 108.362 172.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.38 149.9 38.52 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.983 -1.073 . . . . 0.0 111.514 172.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.5 tt -61.16 -23.81 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 O-C-N 120.826 -1.171 . . . . 0.0 113.479 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -70.46 -11.81 61.16 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.113 1.365 . . . . 0.0 114.329 172.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -122.88 -5.26 8.54 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.929 1.692 . . . . 0.0 113.909 -171.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 mm -67.0 137.17 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.014 -1.054 . . . . 0.0 109.077 161.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -134.77 161.2 35.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.719 1.208 . . . . 0.0 112.301 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.42 127.7 32.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.931 0.892 . . . . 0.0 111.718 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.54 -2.32 80.32 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.708 -1.051 . . . . 0.0 115.407 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.22 172.21 13.23 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.088 1.944 . . . . 0.0 111.168 164.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.62 150.04 40.37 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.049 1.74 . . . . 0.0 112.907 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.73 157.87 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 127.165 2.186 . . . . 0.0 109.843 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.8 mm -74.48 140.54 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 O-C-N 121.836 -0.54 . . . . 0.0 110.929 166.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.88 121.48 18.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.6 m -88.52 109.96 20.49 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -53.7 113.37 4.8 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.472 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.14 -9.7 26.0 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.991 1.794 . . . . 0.0 114.455 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -78.31 -40.07 37.82 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.998 -1.064 . . . . 0.0 112.158 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.9 t -132.7 -2.6 3.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.062 0.945 . . . . 0.0 112.756 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.293 20.6 m-85 56.9 35.6 26.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.167 1.787 . . . . 0.0 113.21 -176.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.83 126.51 31.07 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.053 1.341 . . . . 0.0 109.763 173.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.31 113.04 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.777 0.831 . . . . 0.0 110.589 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.56 163.4 29.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.533 1.133 . . . . 0.0 113.031 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -95.93 119.34 34.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.522 1.529 . . . . 0.0 110.757 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -128.39 149.92 50.33 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.748 1.219 . . . . 0.0 111.664 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.2 t -86.36 154.85 20.9 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.8 t -93.14 130.28 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 126.303 1.841 . . . . 0.0 110.444 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.2 mt -89.39 -37.71 14.64 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.288 1.035 . . . . 0.0 113.317 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -153.73 161.39 42.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.283 2.233 . . . . 0.0 109.883 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.8 p -117.34 137.72 52.26 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.902 1.281 . . . . 0.0 111.07 165.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -105.7 142.3 35.67 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.984 1.314 . . . . 0.0 112.569 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.05 138.31 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.737 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 68.4 mmt-85 -142.24 176.42 8.99 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.719 2.008 . . . . 0.0 110.391 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -127.3 137.87 52.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.688 1.195 . . . . 0.0 110.421 167.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.8 t -146.45 148.03 31.84 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.473 1.109 . . . . 0.0 111.473 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -86.11 -20.15 29.12 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.976 1.31 . . . . 0.0 113.416 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -97.17 105.05 17.12 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.338 -0.851 . . . . 0.0 110.086 -169.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.5 mt -124.09 156.86 35.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 123.622 1.677 . . . . 0.0 113.9 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.9 tp -138.44 126.37 22.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.381 -1.736 . . . . 0.0 111.412 -169.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -113.6 111.12 21.33 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.485 1.514 . . . . 0.0 108.723 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -106.6 125.18 50.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.387 1.075 . . . . 0.0 109.938 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -102.74 120.8 41.22 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.0 mt -133.01 116.41 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.928 1.291 . . . . 0.0 108.984 -171.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.94 24.44 34.44 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 115.191 0.836 . . . . 0.0 115.191 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.26 -6.36 68.6 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.576 1.56 . . . . 0.0 116.646 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -101.87 126.67 48.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.893 1.677 . . . . 0.0 109.238 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 p -97.33 133.02 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.841 0.829 . . . . 0.0 112.977 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.3 mt -126.8 133.79 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.761 2.024 . . . . 0.0 108.719 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -116.71 110.9 19.05 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.219 1.007 . . . . 0.0 110.658 -165.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.8 t -141.46 176.82 8.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.755 1.622 . . . . 0.0 113.272 -157.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.8 p -89.91 158.14 17.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.245 1.418 . . . . 0.0 113.01 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -65.82 -18.9 65.65 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.488 1.115 . . . . 0.0 113.649 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -101.11 -2.98 30.1 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.424 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.1 t60 -65.4 129.05 94.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.366 -1.302 . . . . 0.0 111.923 -172.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.67 120.89 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 122.061 1.772 . . . . 0.0 113.691 -169.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.25 141.08 36.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.381 2.272 . . . . 0.0 112.093 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -84.77 127.31 34.06 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -112.41 134.51 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.671 2.389 . . . . 0.0 111.525 -174.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -56.27 127.23 29.81 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.107 1.363 . . . . 0.0 112.499 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 57.17 22.51 7.61 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.961 2.104 . . . . 0.0 115.03 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.3 t -133.97 -58.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.963 -1.086 . . . . 0.0 111.882 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.79 -152.23 17.16 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.02 0.819 . . . . 0.0 112.916 -173.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -91.14 132.57 35.98 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.804 1.302 . . . . 0.0 114.417 -170.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -137.78 141.53 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.183 1.393 . . . . 0.0 112.669 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.03 132.92 54.35 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.809 1.244 . . . . 0.0 112.901 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.59 66.59 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.81 1.644 . . . . 0.0 113.529 -173.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.36 -12.24 84.75 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 121.504 -0.747 . . . . 0.0 113.797 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -90.71 -20.71 22.14 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.121 0.961 . . . . 0.0 112.76 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.95 154.5 2.85 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.417 1.087 . . . . 0.0 112.856 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -117.48 149.53 40.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.066 1.347 . . . . 0.0 110.969 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.83 126.65 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.394 0.678 . . . . 0.0 110.049 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.91 1.4 58.56 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-O 118.501 -1.166 . . . . 0.0 115.326 -172.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -86.95 159.5 18.99 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.833 1.817 . . . . 0.0 112.25 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -104.03 108.36 19.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.161 1.384 . . . . 0.0 111.203 -157.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.49 169.05 8.9 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.696 1.598 . . . . 0.0 111.791 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.22 142.74 43.03 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.351 1.06 . . . . 0.0 111.409 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.02 176.85 6.26 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.65 0.78 . . . . 0.0 112.995 166.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.1 p -52.17 -24.88 7.8 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -97.72 -31.59 12.18 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.888 1.275 . . . . 0.0 111.764 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.38 22.55 5.12 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.884 2.183 . . . . 0.0 113.435 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -64.21 147.26 52.76 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.319 1.059 . . . . 0.0 110.786 167.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.84 110.24 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.924 0.869 . . . . 0.0 110.741 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.5 mt -94.05 160.68 14.6 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.67 1.988 . . . . 0.0 111.289 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.22 141.84 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.64 1.176 . . . . 0.0 110.632 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.13 115.95 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.574 0.749 . . . . 0.0 109.485 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -90.12 -28.35 19.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.011 2.124 . . . . 0.0 112.732 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -160.71 151.74 18.85 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.42 1.488 . . . . 0.0 111.635 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -131.57 111.34 11.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.522 2.329 . . . . 0.0 109.127 171.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.6 mmtm -117.32 125.92 51.85 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.104 1.761 . . . . 0.0 110.94 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 tp -120.0 133.01 55.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.751 1.62 . . . . 0.0 109.941 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -149.21 161.62 41.64 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.3 mm -110.0 107.02 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.112 1.365 . . . . 0.0 108.521 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.02 150.31 42.77 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.253 1.021 . . . . 0.0 113.604 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.77 -26.81 67.89 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.144 1.778 . . . . 0.0 112.321 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -142.68 151.22 56.47 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.943 2.497 . . . . 0.0 108.287 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.27 121.76 8.08 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.415 2.077 . . . . 0.0 110.288 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.03 143.91 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.127 1.771 . . . . 0.0 110.15 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -74.54 139.4 43.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.283 0.633 . . . . 0.0 110.225 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.02 147.12 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 124.526 1.13 . . . . 0.0 111.268 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -128.46 148.0 50.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.683 1.593 . . . . 0.0 110.846 -164.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -150.48 170.96 17.86 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.507 1.523 . . . . 0.0 109.89 167.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -152.27 158.02 42.2 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.532 -1.355 . . . . 0.0 111.515 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -113.49 135.65 53.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.008 0.923 . . . . 0.0 112.969 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -98.89 147.92 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.3 1.84 . . . . 0.0 111.739 -170.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.94 -39.14 91.08 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.61 -45.33 0.36 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.993 0.917 . . . . 0.0 112.661 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -77.55 172.01 14.02 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.435 0.694 . . . . 0.0 109.207 164.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -134.53 30.72 3.47 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.684 1.193 . . . . 0.0 111.934 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.5 p -141.36 158.06 44.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.672 1.589 . . . . 0.0 112.135 -171.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.91 170.34 22.35 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.058 1.343 . . . . 0.0 111.852 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.76 140.08 29.89 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.439 1.895 . . . . 0.0 110.508 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 m -125.29 136.74 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.5 1.12 . . . . 0.0 112.99 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.3 173.3 35.99 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.029 1.3 . . . . 0.0 115.694 169.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -57.15 -37.86 72.67 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.195 -1.179 . . . . 0.0 112.023 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -85.33 9.47 15.33 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.663 1.585 . . . . 0.0 114.867 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 62.65 36.36 13.59 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 165.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.68 138.04 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 121.591 -0.693 . . . . 0.0 111.091 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.9 tp -87.78 128.54 35.32 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.897 1.279 . . . . 0.0 113.143 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.5 m -135.43 151.27 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.201 1.401 . . . . 0.0 112.213 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -93.75 116.5 28.98 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.97 1.708 . . . . 0.0 110.257 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.631 1.172 . . . . 0.0 113.864 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 3.2 ttt -87.25 121.54 29.83 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.374 -0.829 . . . . 0.0 109.836 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -136.51 62.7 1.6 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.778 1.631 . . . . 0.0 110.363 -164.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -133.34 170.71 15.06 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.053 0.941 . . . . 0.0 113.24 -171.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.83 156.3 33.54 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.285 1.434 . . . . 0.0 110.667 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.3 m -67.7 159.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.715 0.769 . . . . 0.0 111.458 171.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.38 154.63 1.7 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.572 0.749 . . . . 0.0 112.77 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.42 -2.32 22.21 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 117.768 -1.573 . . . . 0.0 116.263 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.3 m -64.58 124.61 22.3 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.305 2.052 . . . . 0.0 110.057 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.5 mmt -83.07 139.48 33.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.974 1.31 . . . . 0.0 111.951 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.6 mm -123.26 134.39 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.387 1.875 . . . . 0.0 110.174 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -75.42 121.51 22.41 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.137 0.975 . . . . 0.0 112.668 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.6 p -112.38 177.33 4.68 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.919 1.288 . . . . 0.0 112.001 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.68 -23.47 65.3 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.207 -0.933 . . . . 0.0 113.276 171.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -106.92 -18.81 13.82 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.958 1.303 . . . . 0.0 114.385 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.26 -114.45 0.61 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.987 1.279 . . . . 0.0 113.008 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -129.0 140.96 51.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.2 1.0 . . . . 0.0 113.294 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.2 t -133.45 143.74 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.333 1.853 . . . . 0.0 108.577 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.43 147.96 47.37 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.324 -0.86 . . . . 0.0 110.881 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 tt -61.72 -27.57 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 120.796 -1.19 . . . . 0.0 112.998 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.19 -13.19 61.48 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -112.17 -11.37 13.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.797 2.039 . . . . 0.0 113.153 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.9 mm -64.25 135.85 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.665 0.786 . . . . 0.0 109.261 162.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -125.05 164.85 19.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.489 1.916 . . . . 0.0 111.193 173.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.35 136.65 58.03 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.731 -0.605 . . . . 0.0 110.614 167.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.36 -9.29 75.96 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.482 1.039 . . . . 0.0 114.537 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.78 174.36 6.13 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.771 1.285 . . . . 0.0 111.288 168.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -131.39 142.35 50.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.713 1.205 . . . . 0.0 113.238 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.49 157.71 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.854 2.061 . . . . 0.0 110.757 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.6 mm -76.92 137.01 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.586 -0.696 . . . . 0.0 111.519 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.64 118.92 17.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.789 1.236 . . . . 0.0 108.157 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -89.91 107.45 19.12 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -55.91 113.99 6.72 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.895 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.56 -5.29 16.36 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.125 1.883 . . . . 0.0 114.109 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.16 -38.52 75.48 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.916 -1.115 . . . . 0.0 112.563 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -144.12 -2.11 0.92 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.949 0.9 . . . . 0.0 112.852 -171.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 55.5 44.83 26.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.62 1.168 . . . . 0.0 112.284 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -90.8 139.53 30.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.768 0.827 . . . . 0.0 109.832 167.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.33 124.26 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.749 0.82 . . . . 0.0 110.319 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.61 153.77 48.66 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.782 0.801 . . . . 0.0 112.538 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.67 115.4 23.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.424 1.49 . . . . 0.0 108.674 169.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -126.53 149.15 49.56 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.893 1.277 . . . . 0.0 110.81 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -90.62 157.84 17.27 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -174.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.3 t -89.25 128.61 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.562 1.545 . . . . 0.0 110.645 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.19 -51.43 7.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.359 0.664 . . . . 0.0 111.804 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -146.18 149.97 34.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.39 1.876 . . . . 0.0 109.462 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.4 p -118.65 126.7 52.52 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.049 1.34 . . . . 0.0 110.177 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -105.9 160.38 15.31 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.155 1.382 . . . . 0.0 113.077 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.1 t -134.36 143.91 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.304 2.242 . . . . 0.0 109.302 171.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -137.19 170.84 15.42 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.916 1.687 . . . . 0.0 109.825 166.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -117.68 143.13 46.47 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.424 1.09 . . . . 0.0 110.522 164.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.3 t -148.11 146.26 28.72 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.74 -0.6 . . . . 0.0 111.264 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.1 p -87.72 -18.13 30.16 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.374 0.67 . . . . 0.0 112.617 162.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -93.86 114.19 26.37 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.863 -1.148 . . . . 0.0 111.551 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.1 mt -121.46 171.28 8.9 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.847 1.259 . . . . 0.0 111.63 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.5 tp -145.6 131.18 18.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.518 1.527 . . . . 0.0 110.146 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -106.36 137.46 44.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.274 1.03 . . . . 0.0 109.43 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 mt -129.61 135.13 48.17 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.909 1.284 . . . . 0.0 110.089 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.5 m -104.13 119.97 40.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.91 0.884 . . . . 0.0 109.476 173.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.56 116.29 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.183 1.393 . . . . 0.0 108.781 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.78 35.74 47.75 Favored Glycine 0 CA--C 1.542 1.729 0 O-C-N 121.477 -0.765 . . . . 0.0 114.863 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.38 -14.04 55.9 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.294 1.426 . . . . 0.0 115.507 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -90.91 117.94 29.9 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.805 1.302 . . . . 0.0 109.258 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.46 133.76 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.826 0.85 . . . . 0.0 111.972 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.7 mt -129.01 134.66 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.473 1.909 . . . . 0.0 108.798 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -117.34 112.82 21.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.538 1.535 . . . . 0.0 110.98 -168.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -140.47 178.45 7.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.759 1.224 . . . . 0.0 112.302 -159.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.0 p -84.54 152.4 23.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.175 0.988 . . . . 0.0 111.878 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.98 -20.47 65.31 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.734 1.213 . . . . 0.0 113.41 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -109.61 11.88 24.53 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.407 1.083 . . . . 0.0 113.529 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -67.2 130.3 93.68 Favored Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 120.89 -1.131 . . . . 0.0 112.414 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.84 127.49 5.54 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.515 2.81 . . . . 0.0 114.759 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -118.29 141.48 48.47 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.18 2.192 . . . . 0.0 110.952 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -93.36 129.93 39.3 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.735 1.152 . . . . 0.0 114.034 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.7 t -109.44 133.53 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.995 2.118 . . . . 0.0 111.739 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -51.08 123.69 9.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.641 1.576 . . . . 0.0 113.917 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 54.37 23.55 4.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.388 1.875 . . . . 0.0 114.34 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.7 t -130.19 -54.91 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.951 1.3 . . . . 0.0 110.928 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.94 -165.82 13.53 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.571 0.605 . . . . 0.0 114.047 -175.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -81.41 140.88 34.42 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.385 1.088 . . . . 0.0 113.864 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.19 147.95 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 127.503 2.321 . . . . 0.0 109.475 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -66.86 144.08 56.48 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.529 -0.732 . . . . 0.0 112.176 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.33 -40.22 64.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.811 1.244 . . . . 0.0 113.39 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.43 -20.46 67.7 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.307 -0.87 . . . . 0.0 114.177 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.85 0.96 30.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.096 2.158 . . . . 0.0 113.254 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.1 mt -72.97 161.84 30.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.198 0.599 . . . . 0.0 111.365 168.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.1 162.62 29.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.888 1.275 . . . . 0.0 111.545 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.61 140.48 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.384 1.073 . . . . 0.0 109.611 170.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.78 4.15 89.35 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.188 -0.784 . . . . 0.0 114.439 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -80.82 152.07 28.41 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.126 1.463 . . . . 0.0 110.824 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.2 108.43 19.81 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.762 1.625 . . . . 0.0 113.483 -165.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.4 mt -103.79 164.12 11.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.162 1.385 . . . . 0.0 112.524 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.75 144.96 34.15 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.637 1.175 . . . . 0.0 111.507 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -102.07 -177.25 3.35 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.063 0.945 . . . . 0.0 113.489 169.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.6 p -54.44 -23.48 16.14 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.793 2.037 . . . . 0.0 115.733 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -104.71 -20.76 13.52 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.588 1.555 . . . . 0.0 113.274 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.29 27.42 10.02 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.336 1.922 . . . . 0.0 112.863 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -66.38 149.54 50.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.608 0.363 . . . . 0.0 110.416 162.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.1 99.26 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.217 1.007 . . . . 0.0 110.303 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -80.31 161.31 25.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.188 2.595 . . . . 0.0 112.238 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.62 139.64 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.358 1.063 . . . . 0.0 111.719 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.18 127.73 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.29 1.036 . . . . 0.0 110.925 170.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -97.85 -32.47 11.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.891 2.076 . . . . 0.0 113.357 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -161.5 150.72 16.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.05 0.94 . . . . 0.0 113.013 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -123.13 128.22 49.77 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.438 1.895 . . . . 0.0 109.526 162.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm -127.29 124.69 39.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.374 1.469 . . . . 0.0 110.777 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 tt -121.35 135.54 55.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.756 1.222 . . . . 0.0 110.33 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -141.71 171.11 14.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.36 1.064 . . . . 0.0 111.403 168.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 15.7 mm -116.97 115.08 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 162.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.66 148.72 19.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.626 1.17 . . . . 0.0 112.197 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -72.62 -24.69 61.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.913 0.885 . . . . 0.0 111.827 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -143.0 152.93 59.78 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.946 2.099 . . . . 0.0 109.517 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.74 123.26 11.7 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.276 2.65 . . . . 0.0 113.188 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.4 t -92.0 143.67 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.459 1.504 . . . . 0.0 110.291 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -76.82 141.87 40.51 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.514 0.673 . . . . 0.0 111.537 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.08 148.44 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.921 1.288 . . . . 0.0 110.368 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -127.74 144.75 51.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.912 1.285 . . . . 0.0 111.856 -169.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -152.18 161.56 42.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.431 1.092 . . . . 0.0 111.252 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -148.02 159.38 43.96 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.797 -1.19 . . . . 0.0 113.508 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -108.89 138.02 45.9 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.73 1.212 . . . . 0.0 113.534 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.49 145.9 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 126.009 1.724 . . . . 0.0 112.474 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.38 -24.18 65.66 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 -167.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -148.6 -49.93 0.16 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.922 1.692 . . . . 0.0 112.067 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -73.07 167.33 21.35 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.63 0.772 . . . . 0.0 110.54 168.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -123.91 24.08 8.42 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.301 1.44 . . . . 0.0 113.937 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 p -135.97 158.07 45.3 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.971 1.708 . . . . 0.0 113.063 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -160.89 -176.01 5.27 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.88 1.672 . . . . 0.0 110.709 171.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -128.59 138.95 52.48 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.361 1.464 . . . . 0.0 113.582 -169.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.32 142.08 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.268 1.427 . . . . 0.0 113.379 -173.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.83 173.22 27.41 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.571 1.558 . . . . 0.0 116.198 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.24 -23.93 67.48 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.736 -1.45 . . . . 0.0 113.917 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -88.99 0.87 56.29 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 58.61 45.75 15.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.17 1.788 . . . . 0.0 114.648 168.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 t -72.43 137.54 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.547 1.539 . . . . 0.0 111.71 -170.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 64.6 tp -79.66 125.26 29.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.681 1.592 . . . . 0.0 113.391 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.52 157.92 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.968 1.707 . . . . 0.0 111.377 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.99 145.5 32.21 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.902 1.281 . . . . 0.0 111.437 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 10.7 ttt -130.32 130.79 44.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.261 1.024 . . . . 0.0 111.585 -169.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -127.3 103.75 7.56 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.777 0.831 . . . . 0.0 112.969 -172.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.1 178.4 8.31 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -124.87 157.36 36.11 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.922 1.689 . . . . 0.0 110.493 166.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.1 m -66.23 156.81 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.332 0.587 . . . . 0.0 112.076 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.29 150.49 1.25 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.165 0.986 . . . . 0.0 111.821 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.52 -3.95 22.74 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.5 m -65.51 125.05 23.95 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 120.976 2.388 . . . . 0.0 109.864 171.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -78.99 143.6 35.56 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.233 1.013 . . . . 0.0 111.954 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.31 135.09 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.411 1.884 . . . . 0.0 109.829 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.26 122.09 22.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.796 0.838 . . . . 0.0 112.12 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.0 p -117.23 171.32 8.03 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.307 1.043 . . . . 0.0 111.736 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.8 -17.55 64.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.817 0.847 . . . . 0.0 113.175 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -105.81 -20.3 13.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.992 2.117 . . . . 0.0 113.827 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.06 -105.57 0.27 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.116 1.341 . . . . 0.0 113.06 174.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.8 mt -132.94 140.76 47.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.779 1.632 . . . . 0.0 111.965 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.1 t -135.05 145.6 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.485 1.914 . . . . 0.0 108.543 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.97 147.43 52.45 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.206 -0.934 . . . . 0.0 111.388 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.1 tt -60.32 -29.91 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 120.712 -1.242 . . . . 0.0 112.827 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.29 -17.97 64.41 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -107.72 -10.38 15.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.694 1.998 . . . . 0.0 112.919 -174.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.7 136.74 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.976 161.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -126.29 162.16 26.12 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.939 2.096 . . . . 0.0 111.301 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.94 130.33 43.01 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.435 0.694 . . . . 0.0 110.432 168.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.36 16.94 65.5 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.833 -0.542 . . . . 0.0 113.902 -170.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -96.43 -179.63 4.7 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.155 0.982 . . . . 0.0 110.603 157.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -128.71 145.83 51.06 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.706 1.603 . . . . 0.0 112.341 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.89 158.67 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.037 1.735 . . . . 0.0 110.526 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -76.44 141.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.65 -0.656 . . . . 0.0 111.547 167.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.62 128.04 24.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.001 0.92 . . . . 0.0 109.163 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.0 m -79.44 112.76 17.01 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 160.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -52.66 114.83 6.2 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.235 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.14 -13.18 36.28 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.982 2.455 . . . . 0.0 113.738 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -84.67 -37.26 21.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -172.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -133.39 -6.1 2.95 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.408 1.483 . . . . 0.0 112.922 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.252 15.2 m-85 66.39 30.53 8.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.33 1.852 . . . . 0.0 115.009 -175.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -79.43 130.8 35.77 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.611 1.165 . . . . 0.0 110.155 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.8 128.65 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.889 0.768 . . . . 0.0 110.815 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.95 167.16 28.44 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.316 1.047 . . . . 0.0 112.811 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -78.87 139.7 38.27 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.515 1.126 . . . . 0.0 110.413 163.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -142.48 154.94 44.97 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.493 1.517 . . . . 0.0 110.61 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.8 t -85.35 156.77 20.75 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.79 123.95 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.453 1.901 . . . . 0.0 110.367 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.91 -44.48 16.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.379 0.672 . . . . 0.0 112.736 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -146.14 154.31 41.66 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.486 1.915 . . . . 0.0 110.572 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.7 p -122.22 128.7 51.47 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.949 1.3 . . . . 0.0 111.274 172.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -108.1 149.01 29.03 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.33 1.852 . . . . 0.0 114.38 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.1 t -139.8 140.51 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.375 1.07 . . . . 0.0 112.428 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -138.52 179.83 6.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.58 2.752 . . . . 0.0 112.209 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -131.61 148.35 52.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.636 1.574 . . . . 0.0 112.431 167.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.6 t -152.74 149.24 28.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.423 1.089 . . . . 0.0 111.557 170.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 p -86.36 -17.16 35.18 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.335 1.054 . . . . 0.0 113.3 164.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -105.36 116.17 31.5 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.353 1.061 . . . . 0.0 110.798 -176.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.3 mt -117.8 170.7 8.59 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.651 1.58 . . . . 0.0 112.218 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.7 tp -141.38 134.7 29.57 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.958 1.703 . . . . 0.0 110.062 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -114.75 120.54 40.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.395 1.078 . . . . 0.0 110.067 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.94 130.37 55.45 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.189 -0.945 . . . . 0.0 109.808 173.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.8 m -104.43 118.55 36.89 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.271 1.028 . . . . 0.0 108.582 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -132.02 119.81 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.59 1.556 . . . . 0.0 109.136 -173.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.35 25.11 47.85 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 115.19 0.836 . . . . 0.0 115.19 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.7 -5.39 84.67 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.893 1.711 . . . . 0.0 116.068 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -91.93 132.02 36.81 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.206 1.503 . . . . 0.0 109.483 166.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.82 138.45 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.951 0.9 . . . . 0.0 112.28 163.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.2 mt -132.8 136.12 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 126.126 1.771 . . . . 0.0 109.345 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -117.23 110.39 18.06 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.088 1.355 . . . . 0.0 110.445 -162.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.2 t -138.05 177.13 8.11 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.708 1.203 . . . . 0.0 113.165 -156.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.2 p -86.58 156.5 20.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.74 0.816 . . . . 0.0 111.952 169.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -63.85 -24.69 67.84 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.354 -0.842 . . . . 0.0 113.249 -174.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -99.63 3.63 45.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -60.78 121.3 60.44 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 118.004 -0.998 . . . . 0.0 112.503 -174.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -78.82 115.08 3.52 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.005 1.803 . . . . 0.0 113.056 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.903 1.681 . . . . 0.0 110.797 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -91.37 129.99 37.28 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.5 132.27 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 127.93 2.492 . . . . 0.0 110.731 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -54.49 122.29 10.2 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.261 1.424 . . . . 0.0 111.722 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 t70 53.87 26.7 6.41 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.754 2.422 . . . . 0.0 115.751 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.9 t -129.12 -54.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.939 1.296 . . . . 0.0 110.356 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.02 -155.37 19.77 Favored Glycine 0 N--CA 1.467 0.749 0 CA-C-O 119.499 -0.612 . . . . 0.0 112.027 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -96.57 150.74 20.3 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.053 1.426 . . . . 0.0 114.15 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.78 141.42 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.905 1.682 . . . . 0.0 111.786 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.52 134.91 46.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.61 0.764 . . . . 0.0 112.859 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.05 -37.13 66.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.822 1.249 . . . . 0.0 113.095 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.88 -19.93 72.03 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 121.418 -0.802 . . . . 0.0 113.935 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -97.61 -1.26 44.15 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.836 1.654 . . . . 0.0 114.218 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.26 159.15 29.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.46 0.704 . . . . 0.0 112.377 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -118.97 153.2 35.01 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.556 1.542 . . . . 0.0 110.989 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.4 t -64.86 136.42 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 170.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.75 87.84 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.387 -1.23 . . . . 0.0 115.576 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -84.09 158.2 21.49 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.423 1.612 . . . . 0.0 111.78 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.75 106.79 18.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.557 1.543 . . . . 0.0 112.325 -163.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.5 mt -98.13 -176.79 3.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.683 1.593 . . . . 0.0 111.068 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.6 mt -132.9 154.11 50.72 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.33 177.47 4.85 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 122.886 1.327 . . . . 0.0 114.486 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.6 p -56.79 -6.01 0.29 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.384 2.674 . . . . 0.0 117.318 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -119.17 -18.11 8.76 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.157 1.783 . . . . 0.0 112.221 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.73 18.83 19.48 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.439 1.495 . . . . 0.0 112.885 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -72.65 143.1 48.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.967 0.907 . . . . 0.0 110.457 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.91 114.57 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.195 0.522 . . . . 0.0 110.786 171.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 mt -91.5 157.89 16.78 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.481 1.112 . . . . 0.0 111.188 167.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.0 t -130.98 139.04 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.316 1.046 . . . . 0.0 110.393 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.96 116.38 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 173.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.15 -41.38 28.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.72 1.608 . . . . 0.0 110.84 174.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -159.85 153.58 22.8 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.647 1.179 . . . . 0.0 112.186 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -113.57 134.44 54.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.404 1.482 . . . . 0.0 109.484 159.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -131.45 161.34 32.72 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 128.578 2.751 . . . . 0.0 110.476 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 tt -146.78 139.42 25.08 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.676 1.191 . . . . 0.0 109.927 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -137.51 150.45 47.54 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.043 0.838 . . . . 0.0 112.329 168.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.7 mm -103.41 116.23 46.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.48 145.16 51.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.861 1.264 . . . . 0.0 111.551 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -74.96 -20.5 59.65 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.412 -0.805 . . . . 0.0 112.249 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -140.41 155.86 69.82 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.629 1.972 . . . . 0.0 110.977 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.32 124.74 15.79 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.89 2.393 . . . . 0.0 113.079 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 t -93.95 141.62 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.226 1.811 . . . . 0.0 109.628 172.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -76.22 141.95 41.6 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.553 0.692 . . . . 0.0 111.78 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.82 146.61 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.892 1.277 . . . . 0.0 110.829 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -129.05 150.42 50.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.017 1.327 . . . . 0.0 111.331 -166.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -156.81 169.36 24.92 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.08 1.752 . . . . 0.0 109.548 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -156.09 169.59 24.14 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.346 -1.471 . . . . 0.0 111.947 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -123.84 142.34 51.21 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -100.33 151.71 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.018 1.727 . . . . 0.0 112.893 -170.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.4 -27.86 69.59 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -169.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.12 -34.86 0.09 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 120.212 -1.555 . . . . 0.0 113.638 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -77.67 164.65 25.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 164.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -123.34 33.56 5.33 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.458 1.103 . . . . 0.0 111.959 -174.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.6 p -150.14 162.31 40.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.464 1.506 . . . . 0.0 111.775 -164.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -156.81 174.84 14.89 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.494 1.518 . . . . 0.0 110.612 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -118.94 134.96 54.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.624 1.17 . . . . 0.0 112.432 -176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.71 137.72 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.677 1.591 . . . . 0.0 112.226 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.81 -172.03 45.66 Favored Glycine 0 CA--C 1.544 1.857 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 170.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -84.93 -22.49 29.22 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.719 1.208 . . . . 0.0 112.155 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -84.22 -9.19 58.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.633 1.173 . . . . 0.0 113.382 165.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 60.56 50.74 5.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.529 1.532 . . . . 0.0 113.578 165.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.29 144.66 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.883 1.673 . . . . 0.0 112.078 -173.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.2 tp -84.98 129.46 34.79 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.621 1.568 . . . . 0.0 114.703 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.2 m -138.53 158.19 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 126.403 1.881 . . . . 0.0 112.268 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -117.75 123.3 45.69 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.939 1.295 . . . . 0.0 114.184 -169.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.188 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -174.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.224 0.535 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 9.2 ttt -154.51 114.67 3.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.258 1.823 . . . . 0.0 107.381 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -131.25 77.29 1.77 Allowed 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.292 -0.88 . . . . 0.0 111.073 -162.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -141.29 174.31 10.66 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.733 1.213 . . . . 0.0 113.455 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.449 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 96.7 m-85 -125.42 153.28 43.69 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.437 1.495 . . . . 0.0 111.668 172.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 m -68.36 159.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.358 0.599 . . . . 0.0 111.928 173.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.04 152.17 6.14 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.082 0.953 . . . . 0.0 112.487 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.14 -7.11 24.61 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 117.712 -1.605 . . . . 0.0 116.238 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.1 m -61.82 121.88 14.0 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.379 2.089 . . . . 0.0 110.474 174.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -77.2 142.54 39.55 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.69 1.196 . . . . 0.0 112.329 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -121.8 137.07 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.416 2.286 . . . . 0.0 109.494 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.66 127.13 32.37 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 p -127.15 171.1 11.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.834 1.253 . . . . 0.0 112.039 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.3 65.48 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.3 p -103.26 -24.56 13.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.2 -107.9 0.32 Allowed Glycine 0 CA--C 1.522 0.488 0 O-C-N 121.663 -0.648 . . . . 0.0 112.002 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.58 140.04 45.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.961 1.304 . . . . 0.0 111.535 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.5 t -127.19 141.51 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.205 1.402 . . . . 0.0 109.019 172.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.13 147.67 49.65 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.268 -0.895 . . . . 0.0 110.922 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.6 tt -61.03 -26.57 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.025 -1.047 . . . . 0.0 113.351 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.68 -7.09 52.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.496 1.518 . . . . 0.0 114.341 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -117.39 -12.3 10.46 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.902 1.681 . . . . 0.0 112.652 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.7 mm -65.15 132.73 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 119.147 0.885 . . . . 0.0 110.36 164.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -119.21 161.74 19.86 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.431 1.892 . . . . 0.0 111.679 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.65 138.54 58.06 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.09 -1.006 . . . . 0.0 110.63 167.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.95 4.89 89.69 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 114.536 0.574 . . . . 0.0 114.536 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -86.18 157.07 20.08 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.523 1.161 . . . . 0.0 109.84 162.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -116.8 141.24 48.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.75 1.22 . . . . 0.0 111.319 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.95 159.47 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.934 1.694 . . . . 0.0 111.465 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 mm -71.64 143.86 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 122.797 0.439 . . . . 0.0 111.96 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.28 126.25 18.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.78 1.232 . . . . 0.0 109.251 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.468 ' HG1' ' CE1' ' A' ' 125' ' ' HIS . 51.8 m -84.53 111.67 19.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 165.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -56.03 114.64 7.91 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.789 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.18 -8.16 22.85 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.6 2.2 . . . . 0.0 113.94 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -79.49 -39.64 31.63 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.017 -1.052 . . . . 0.0 113.616 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -138.08 -1.29 1.98 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.323 1.049 . . . . 0.0 113.278 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 58.73 40.04 23.61 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.679 1.192 . . . . 0.0 113.407 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.06 138.82 33.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.542 0.737 . . . . 0.0 109.029 165.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -109.11 121.93 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.995 1.318 . . . . 0.0 109.169 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.34 162.79 33.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.456 0.703 . . . . 0.0 112.673 -176.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -93.51 124.66 37.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.797 1.239 . . . . 0.0 109.307 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -132.67 152.67 51.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.416 1.487 . . . . 0.0 111.194 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 t -85.57 152.98 22.73 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.9 t -89.1 130.55 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.98 1.712 . . . . 0.0 110.279 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.6 mt -92.71 -40.76 10.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.811 0.845 . . . . 0.0 112.384 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -143.93 152.52 41.21 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.338 1.455 . . . . 0.0 111.247 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.5 p -124.47 124.66 42.78 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.197 2.199 . . . . 0.0 109.073 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -116.63 159.91 21.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.17 1.788 . . . . 0.0 114.412 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.63 144.56 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.849 1.66 . . . . 0.0 111.426 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -142.49 178.77 7.37 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.024 2.13 . . . . 0.0 112.053 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -131.47 145.23 51.68 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.081 2.152 . . . . 0.0 112.306 173.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -154.72 152.52 30.0 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.967 0.907 . . . . 0.0 111.148 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 p -86.9 -14.55 41.6 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 163.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -101.54 105.53 16.51 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.073 0.851 . . . . 0.0 110.201 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.5 mt -123.49 162.32 23.1 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.85 1.31 . . . . 0.0 113.67 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.3 tp -126.29 131.21 51.92 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.811 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -101.98 134.1 45.72 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.244 1.417 . . . . 0.0 109.442 165.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 mt -126.28 126.59 44.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.874 0.869 . . . . 0.0 109.064 163.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.1 m -93.17 120.35 33.36 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 167.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.4 117.09 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.949 1.3 . . . . 0.0 108.92 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 50.54 38.18 34.75 Favored Glycine 0 CA--C 1.544 1.876 0 N-CA-C 115.186 0.835 . . . . 0.0 115.186 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.73 -0.56 89.18 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 121.297 -1.119 . . . . 0.0 115.701 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -109.06 120.97 44.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.326 1.563 . . . . 0.0 110.442 172.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.48 128.36 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.803 0.811 . . . . 0.0 111.555 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.4 mt -118.09 128.3 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.689 1.596 . . . . 0.0 108.375 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -108.03 110.99 22.82 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.507 1.523 . . . . 0.0 110.27 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 t -139.7 176.14 8.98 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.223 1.009 . . . . 0.0 112.473 -161.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.3 p -82.08 152.28 26.65 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.177 0.989 . . . . 0.0 112.349 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -65.96 -19.97 66.04 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.188 -0.945 . . . . 0.0 113.27 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.337 3.5 p-10 -110.6 17.44 20.7 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 175.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.449 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 3.2 t60 -66.11 132.72 94.59 Favored Pre-proline 0 CA--C 1.555 1.155 0 O-C-N 121.071 -1.018 . . . . 0.0 113.665 176.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.11 118.84 3.05 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.279 3.319 . . . . 0.0 115.096 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -116.89 140.51 49.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.872 2.069 . . . . 0.0 112.216 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -84.2 127.46 33.96 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.049 1.295 . . . . 0.0 114.05 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.91 134.82 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 127.989 2.516 . . . . 0.0 111.355 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -52.24 126.92 20.37 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.919 1.688 . . . . 0.0 111.717 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 57.31 19.42 5.02 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.993 1.717 . . . . 0.0 115.488 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.8 t -130.31 -58.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.893 0.877 . . . . 0.0 111.12 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.32 -159.47 15.88 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.643 0.64 . . . . 0.0 113.43 -171.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -81.06 142.49 33.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 p -141.26 152.19 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.622 1.969 . . . . 0.0 110.884 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.73 129.45 39.8 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.947 0.899 . . . . 0.0 111.868 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.63 -36.67 69.73 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.546 1.138 . . . . 0.0 113.343 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.62 -5.08 88.17 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.909 -1.119 . . . . 0.0 114.134 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -101.89 -2.19 30.42 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.871 1.335 . . . . 0.0 113.319 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.55 161.15 31.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.011 1.324 . . . . 0.0 112.631 167.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.44 164.78 18.24 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.04 2.136 . . . . 0.0 111.572 171.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.32 141.93 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.187 -0.945 . . . . 0.0 109.813 167.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.69 7.83 88.15 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.265 -0.742 . . . . 0.0 114.683 -175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -85.65 152.2 23.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.509 1.155 . . . . 0.0 111.098 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -108.24 109.69 21.12 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.837 1.255 . . . . 0.0 112.323 -163.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.1 mt -106.3 171.38 7.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.927 1.291 . . . . 0.0 111.295 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.7 mt -122.88 159.73 27.58 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -115.63 -174.31 2.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.19 1.796 . . . . 0.0 113.874 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.4 t -58.14 -15.42 9.56 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -97.34 -12.48 22.78 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 119.816 -1.803 . . . . 0.0 113.552 170.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.36 22.1 49.1 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.925 1.25 . . . . 0.0 111.864 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.53 139.65 33.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.878 1.271 . . . . 0.0 112.025 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.92 111.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.092 0.957 . . . . 0.0 112.913 -171.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 63.4 mt -90.35 161.95 15.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.89 2.076 . . . . 0.0 111.374 161.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.72 141.41 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.677 1.191 . . . . 0.0 110.683 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.04 121.6 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.706 0.802 . . . . 0.0 109.459 172.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.27 -36.32 15.66 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.439 1.895 . . . . 0.0 112.142 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -160.49 151.7 19.18 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.648 1.579 . . . . 0.0 111.61 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -129.56 139.48 51.48 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.716 2.006 . . . . 0.0 110.352 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -143.2 139.67 30.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.368 1.467 . . . . 0.0 111.634 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.3 tp -116.87 136.4 52.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.724 2.01 . . . . 0.0 108.636 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -145.65 153.36 40.93 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 171.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.8 mm -91.91 121.41 42.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.037 0.935 . . . . 0.0 109.15 166.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.22 149.79 49.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.001 1.32 . . . . 0.0 113.664 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.65 -30.29 71.26 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.409 1.083 . . . . 0.0 112.851 175.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -148.38 152.62 39.16 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.023 2.529 . . . . 0.0 109.944 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -59.1 120.51 8.42 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.149 3.233 . . . . 0.0 111.985 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.56 137.87 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.107 1.363 . . . . 0.0 109.522 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -74.24 139.2 44.17 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.979 1.312 . . . . 0.0 110.363 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -137.93 143.78 32.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 124.643 1.177 . . . . 0.0 110.611 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -121.82 149.15 43.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.901 1.28 . . . . 0.0 110.9 -169.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -153.22 166.03 33.81 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.806 1.243 . . . . 0.0 111.481 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -150.29 167.39 27.13 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.792 -1.192 . . . . 0.0 112.561 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -116.0 142.83 46.27 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.3 t -99.83 143.52 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.929 2.092 . . . . 0.0 111.195 -173.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -60.02 -76.28 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.216 1.406 . . . . 0.0 113.636 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -118.19 -11.3 10.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -163.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -105.28 170.72 7.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.402 1.481 . . . . 0.0 109.149 163.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -114.67 13.68 17.42 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.832 2.053 . . . . 0.0 113.391 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 p -144.1 162.39 36.38 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.888 -1.133 . . . . 0.0 112.776 -163.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -156.48 172.91 17.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.919 1.688 . . . . 0.0 110.337 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.468 ' CE1' ' HG1' ' A' ' 29' ' ' THR . 27.3 m170 -120.05 136.68 54.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.384 1.074 . . . . 0.0 112.343 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.42 149.0 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.325 1.45 . . . . 0.0 113.71 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.62 175.47 18.88 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.254 1.407 . . . . 0.0 115.044 173.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.7 -28.8 69.67 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -88.63 4.44 47.08 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 60.86 46.54 8.6 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.715 1.206 . . . . 0.0 112.238 166.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -82.33 138.46 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.692 1.997 . . . . 0.0 112.122 -165.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.3 tp -80.49 124.73 29.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.357 1.463 . . . . 0.0 113.983 -173.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.14 159.88 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.969 1.708 . . . . 0.0 111.793 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -99.3 157.53 16.33 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.347 1.059 . . . . 0.0 113.832 -170.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.668 2.387 . . . . 0.0 113.226 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 46.9 ttm -147.49 135.88 21.66 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.117 0.567 . . . . 0.0 112.34 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -115.29 94.73 4.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.22 1.408 . . . . 0.0 110.537 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -157.94 165.56 34.87 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.921 0.888 . . . . 0.0 113.124 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -121.43 153.66 37.57 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.313 1.445 . . . . 0.0 111.657 170.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.3 m -70.7 158.6 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.672 0.749 . . . . 0.0 112.419 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.87 146.76 7.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.215 1.006 . . . . 0.0 112.782 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.38 -8.67 52.52 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 117.332 -1.816 . . . . 0.0 115.929 -172.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.3 m -61.56 118.13 6.65 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.124 2.462 . . . . 0.0 110.113 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 mmt -75.37 141.35 43.31 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.239 1.016 . . . . 0.0 111.972 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.8 mm -124.78 136.12 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.03 2.132 . . . . 0.0 109.754 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.46 124.32 26.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.381 1.072 . . . . 0.0 112.641 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.9 p -127.15 174.07 9.21 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.527 1.131 . . . . 0.0 111.829 -176.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.9 71.28 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.084 -1.01 . . . . 0.0 111.954 167.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.9 p -77.69 -33.69 53.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.255 1.022 . . . . 0.0 111.968 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.37 -90.01 0.12 Allowed Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.486 1.517 . . . . 0.0 111.619 172.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.1 mt -134.16 140.1 46.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.731 1.612 . . . . 0.0 111.196 170.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -134.36 145.85 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.665 1.986 . . . . 0.0 108.974 174.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.78 146.86 51.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.849 -1.157 . . . . 0.0 111.159 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 tt -60.95 -29.59 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 120.973 -1.08 . . . . 0.0 113.121 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.13 -20.03 64.87 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 173.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -101.67 -17.2 16.42 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.075 1.35 . . . . 0.0 113.022 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.06 126.91 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.595 0.758 . . . . 0.0 109.534 165.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -122.2 154.94 36.81 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.7 1.6 . . . . 0.0 111.733 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.09 126.46 26.09 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.604 -0.685 . . . . 0.0 111.541 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.59 -19.74 41.22 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.001 1.286 . . . . 0.0 114.749 -168.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -71.2 177.23 3.94 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.4 1.6 . . . . 0.0 112.981 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -120.16 154.93 34.08 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.586 1.554 . . . . 0.0 113.429 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -143.54 159.29 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.081 2.152 . . . . 0.0 109.851 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -77.09 139.18 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 O-C-N 121.205 -0.934 . . . . 0.0 110.827 166.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.87 129.25 40.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.5 m -93.38 110.39 21.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -52.67 112.36 3.39 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.633 1.573 . . . . 0.0 112.354 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -69.75 -6.69 19.2 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.156 1.904 . . . . 0.0 113.961 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -77.45 -42.65 35.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.711 -1.243 . . . . 0.0 112.737 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.8 t -138.05 2.68 2.36 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.27 1.028 . . . . 0.0 113.163 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.274 68.8 m-85 58.69 32.34 22.07 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.436 1.494 . . . . 0.0 113.944 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.77 139.87 49.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.05 0.94 . . . . 0.0 109.753 167.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.14 109.15 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.719 1.207 . . . . 0.0 109.885 -168.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.75 157.29 44.78 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.44 125.82 29.93 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.035 1.334 . . . . 0.0 110.06 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 120' ' ' ASP . 29.9 mmmt -129.23 151.21 50.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.999 1.319 . . . . 0.0 110.196 174.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.26 7.0 t -81.63 159.69 23.96 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.189 0.995 . . . . 0.0 113.45 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.1 t -94.54 125.79 47.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 126.584 1.954 . . . . 0.0 109.543 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.7 mt -82.25 -49.09 10.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.602 1.161 . . . . 0.0 111.268 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.59 151.68 39.4 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.684 1.194 . . . . 0.0 111.088 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.0 p -121.68 119.94 33.25 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.112 1.765 . . . . 0.0 110.145 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -108.76 150.44 27.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.124 1.77 . . . . 0.0 113.317 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.74 136.49 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.706 1.602 . . . . 0.0 111.646 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -134.79 175.13 9.84 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.678 1.991 . . . . 0.0 110.475 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -136.65 138.77 41.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.28 1.032 . . . . 0.0 110.411 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.2 t -153.39 147.32 25.42 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.248 -0.907 . . . . 0.0 112.246 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.1 p -86.7 -22.04 26.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.54 1.136 . . . . 0.0 112.855 168.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -100.84 86.0 3.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.134 0.969 . . . . 0.0 110.596 -166.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.23 177.91 5.7 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.756 1.223 . . . . 0.0 112.674 -172.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.1 tp -145.66 143.2 29.68 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.136 1.774 . . . . 0.0 109.649 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -109.37 136.78 48.25 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.024 -1.047 . . . . 0.0 108.43 162.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.2 mt -118.88 144.36 46.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.76 0.824 . . . . 0.0 109.252 161.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.4 m -109.04 123.18 48.74 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.16 120.41 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.378 1.471 . . . . 0.0 108.584 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.49 30.82 42.66 Favored Glycine 0 CA--C 1.543 1.82 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.05 -3.92 82.81 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 118.636 1.218 . . . . 0.0 115.684 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.66 126.88 44.4 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.189 1.395 . . . . 0.0 110.262 171.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.03 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.984 -0.447 . . . . 0.0 110.773 162.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.3 mt -122.23 106.42 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 109.636 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -78.49 117.06 19.33 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.913 2.485 . . . . 0.0 110.812 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 t -145.06 -179.68 6.78 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.552 1.141 . . . . 0.0 113.248 -164.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.2 p -85.62 155.64 21.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.501 1.12 . . . . 0.0 112.159 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -64.32 -28.14 69.5 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.927 -1.108 . . . . 0.0 112.552 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.91 5.26 52.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.06 0.944 . . . . 0.0 113.17 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -68.19 125.82 91.97 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.476 -1.39 . . . . 0.0 112.767 -169.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.22 114.24 3.3 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.501 2.8 . . . . 0.0 114.073 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -102.95 148.85 25.16 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.818 1.647 . . . . 0.0 110.997 170.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -93.83 130.89 39.69 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.196 0.907 . . . . 0.0 112.704 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.4 133.4 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.08 1.752 . . . . 0.0 111.071 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -52.81 126.98 21.86 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.528 1.531 . . . . 0.0 111.032 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.15 16.83 5.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.065 1.746 . . . . 0.0 115.266 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.28 -51.61 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.417 1.487 . . . . 0.0 111.59 -172.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.5 -160.8 13.02 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.027 0.822 . . . . 0.0 113.547 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.251 15.1 p90 -79.46 149.89 31.42 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -171.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 p -150.43 145.53 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.982 2.113 . . . . 0.0 110.999 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -70.19 138.23 51.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.667 1.587 . . . . 0.0 112.129 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.95 -39.92 66.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.812 1.245 . . . . 0.0 113.834 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.27 -10.75 79.05 Favored Glycine 0 CA--C 1.539 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 114.262 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -109.69 -0.49 18.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.456 1.903 . . . . 0.0 113.172 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 mt -67.57 160.1 28.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.507 0.723 . . . . 0.0 111.593 167.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -127.47 155.15 44.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.156 1.382 . . . . 0.0 111.711 172.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.25 137.94 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.801 0.84 . . . . 0.0 110.288 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.33 1.49 81.26 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.413 -1.215 . . . . 0.0 115.472 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -83.92 157.85 21.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.763 1.781 . . . . 0.0 112.089 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.45 98.02 8.41 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.096 1.358 . . . . 0.0 112.031 -166.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.01 179.21 6.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.037 1.335 . . . . 0.0 110.796 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 71.4 mt -131.56 155.75 46.93 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.297 1.039 . . . . 0.0 113.249 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.46 173.31 6.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.025 0.93 . . . . 0.0 112.671 168.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.2 t -51.4 -36.75 45.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -85.83 -11.7 52.7 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.777 1.231 . . . . 0.0 112.848 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.91 16.08 31.8 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 126.077 1.798 . . . . 0.0 112.633 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -72.57 143.43 48.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.636 0.774 . . . . 0.0 110.73 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.52 130.17 36.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 122.616 1.198 . . . . 0.0 111.128 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.7 mt -111.57 151.5 28.64 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.796 1.638 . . . . 0.0 111.33 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -118.89 137.03 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.549 0.74 . . . . 0.0 111.216 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.2 t -71.62 128.76 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.731 0.813 . . . . 0.0 109.593 170.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.59 -29.27 9.26 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.339 1.856 . . . . 0.0 112.485 -176.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -162.21 153.05 17.52 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.032 1.333 . . . . 0.0 112.243 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -120.55 132.41 55.15 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.329 1.852 . . . . 0.0 109.312 157.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -130.43 142.42 50.5 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.827 1.651 . . . . 0.0 110.127 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.7 tp -129.1 133.13 47.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.209 1.404 . . . . 0.0 111.162 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.37 156.31 48.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.295 1.038 . . . . 0.0 112.174 166.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.1 mm -108.79 107.85 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.227 1.411 . . . . 0.0 107.334 168.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.74 143.57 55.83 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.863 0.84 . . . . 0.0 112.804 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.65 -24.0 67.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -140.53 153.71 68.57 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.502 1.921 . . . . 0.0 111.435 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.39 120.09 7.4 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.393 2.729 . . . . 0.0 111.522 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.49 142.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.23 1.412 . . . . 0.0 109.593 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -78.51 140.94 38.52 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.564 0.697 . . . . 0.0 111.519 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.0 m -139.42 145.65 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 124.57 1.148 . . . . 0.0 111.727 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -125.2 148.14 48.76 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.343 1.457 . . . . 0.0 110.723 -166.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -151.7 168.71 24.17 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.38 1.472 . . . . 0.0 110.114 168.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -149.19 173.84 13.01 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.753 -1.217 . . . . 0.0 112.384 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -130.37 146.28 51.92 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.36 144.84 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.679 1.992 . . . . 0.0 113.004 -162.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.74 -18.24 62.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.521 2.729 . . . . 0.0 117.115 -168.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.463 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 4.5 m-20 -148.61 -63.86 0.24 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.915 1.234 . . . . 0.0 110.965 164.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -69.94 108.58 4.08 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.414 1.085 . . . . 0.0 110.74 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -70.02 36.11 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.292 1.837 . . . . 0.0 115.765 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.8 p -131.9 164.05 26.96 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.776 2.03 . . . . 0.0 111.935 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -157.94 -176.06 5.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.545 1.538 . . . . 0.0 110.037 166.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -127.66 141.4 51.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.366 1.066 . . . . 0.0 113.039 -172.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.32 138.24 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.495 1.118 . . . . 0.0 112.373 -175.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.02 179.46 53.08 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -73.7 -23.99 59.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.477 1.111 . . . . 0.0 112.148 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -80.25 1.68 27.53 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 166.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 54.87 39.3 31.43 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.268 1.427 . . . . 0.0 114.352 166.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.63 138.37 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.21 1.804 . . . . 0.0 112.02 -166.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.1 tp -81.65 126.75 32.14 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.408 1.483 . . . . 0.0 114.023 -173.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.29 157.96 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.673 1.589 . . . . 0.0 112.105 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -102.34 143.37 32.18 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.5 1.52 . . . . 0.0 112.02 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 C--O 1.252 1.21 0 C-N-CA 124.15 0.98 . . . . 0.0 112.509 176.688 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 117.382 -1.294 . . . . 0.0 113.796 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 44.1 ttm -145.94 137.03 24.64 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.84 2.109 . . . . 0.0 114.288 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -120.4 99.13 6.39 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.747 1.619 . . . . 0.0 110.469 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -155.52 172.24 18.59 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.846 0.858 . . . . 0.0 113.16 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.77 154.85 40.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.542 1.537 . . . . 0.0 111.411 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.0 m -71.66 158.62 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.336 0.654 . . . . 0.0 112.431 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.52 147.56 10.77 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.332 1.053 . . . . 0.0 111.191 172.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.37 6.61 62.07 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-O 117.949 -1.473 . . . . 0.0 115.756 -171.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.4 m -70.75 121.73 18.53 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.962 2.381 . . . . 0.0 109.639 164.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -80.08 140.14 36.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.67 1.188 . . . . 0.0 111.505 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.0 mm -125.25 136.29 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.301 2.24 . . . . 0.0 109.946 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.4 tp -78.61 123.65 27.33 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.161 0.984 . . . . 0.0 113.398 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 p -117.83 177.05 4.91 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.24 1.416 . . . . 0.0 111.334 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.09 -21.46 64.96 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.117 -0.989 . . . . 0.0 113.262 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -96.62 -14.33 22.23 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.201 1.8 . . . . 0.0 113.108 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.26 -108.29 0.61 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.789 1.662 . . . . 0.0 111.462 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.2 mt -127.95 142.07 51.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.293 1.037 . . . . 0.0 113.548 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.7 t -130.16 144.41 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.949 2.1 . . . . 0.0 108.887 174.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.93 147.52 48.65 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.114 -0.991 . . . . 0.0 110.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -61.87 -27.75 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 120.457 -1.402 . . . . 0.0 113.124 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.83 -7.15 43.29 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.891 1.276 . . . . 0.0 114.18 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -115.87 -12.14 11.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.185 1.794 . . . . 0.0 113.976 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -63.22 140.26 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 165.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -125.75 159.03 33.39 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.18 1.792 . . . . 0.0 112.401 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.38 123.98 19.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 122.897 0.479 . . . . 0.0 110.317 164.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.73 -6.69 70.44 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.955 1.265 . . . . 0.0 114.646 -172.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -75.03 177.87 6.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.65 1.225 . . . . 0.0 111.24 166.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -134.8 140.78 46.14 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.905 1.282 . . . . 0.0 113.046 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -135.14 159.26 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.124 1.769 . . . . 0.0 111.099 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.6 mm -77.98 136.91 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.972 -0.455 . . . . 0.0 111.803 171.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.6 117.89 20.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.139 1.376 . . . . 0.0 108.596 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.5 m -90.85 104.59 17.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -49.2 113.58 3.25 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.013 0.925 . . . . 0.0 112.008 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.99 -3.66 13.65 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.41 2.74 . . . . 0.0 113.871 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.07 -38.08 25.43 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.841 -1.162 . . . . 0.0 112.841 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -141.83 -2.18 1.2 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -166.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 55.19 37.28 28.65 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.919 1.688 . . . . 0.0 113.747 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.5 131.72 35.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.279 1.432 . . . . 0.0 108.896 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -106.23 125.17 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.441 1.097 . . . . 0.0 109.309 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.72 161.73 37.09 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -78.08 134.79 37.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.512 0.725 . . . . 0.0 109.298 161.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -139.75 150.95 45.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.478 1.111 . . . . 0.0 111.618 170.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 t -85.39 159.74 19.92 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -92.1 129.69 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.997 1.719 . . . . 0.0 110.868 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.5 mt -84.23 -50.01 8.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.38 0.672 . . . . 0.0 112.142 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -145.12 151.84 39.11 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.937 1.695 . . . . 0.0 111.02 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 p -125.81 109.23 12.3 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.425 1.89 . . . . 0.0 110.543 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -98.92 146.8 25.62 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.404 1.082 . . . . 0.0 113.321 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.4 t -139.12 134.51 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.866 1.266 . . . . 0.0 111.751 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -132.03 174.28 10.35 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.222 1.809 . . . . 0.0 111.342 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.89 135.52 49.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.484 1.514 . . . . 0.0 110.151 170.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -146.03 143.06 29.19 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.897 1.279 . . . . 0.0 111.419 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -86.04 -16.0 39.55 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.214 1.006 . . . . 0.0 112.417 164.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -102.45 110.07 21.9 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 120.838 -1.163 . . . . 0.0 109.75 -173.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.6 mt -120.47 172.5 7.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.84 1.256 . . . . 0.0 112.257 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -142.12 140.16 32.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.071 1.748 . . . . 0.0 110.065 175.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -107.53 137.86 44.8 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.188 -0.945 . . . . 0.0 108.84 163.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.8 mt -121.32 142.65 49.76 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.009 0.924 . . . . 0.0 109.266 160.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -110.06 122.29 47.25 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.156 0.982 . . . . 0.0 108.981 172.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.17 121.67 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.978 1.711 . . . . 0.0 108.616 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.02 31.29 58.59 Favored Glycine 0 CA--C 1.543 1.84 0 O-C-N 121.401 -0.812 . . . . 0.0 114.866 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.09 -1.06 88.98 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.252 1.405 . . . . 0.0 115.465 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -106.35 124.13 49.12 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.983 1.713 . . . . 0.0 110.828 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.8 130.52 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.2 1.0 . . . . 0.0 111.196 172.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.0 mt -120.8 102.26 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.417 1.487 . . . . 0.0 108.709 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -79.76 116.46 19.95 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.175 1.79 . . . . 0.0 111.428 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 t -142.18 -176.13 4.7 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.305 1.442 . . . . 0.0 112.015 -163.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 67.3 p -95.04 158.72 15.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.52 1.128 . . . . 0.0 111.768 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -63.94 -26.1 68.44 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.369 -0.832 . . . . 0.0 112.751 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -97.83 4.47 49.72 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -66.58 126.66 92.59 Favored Pre-proline 0 CA--C 1.55 0.97 0 O-C-N 120.511 -1.368 . . . . 0.0 112.98 -173.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.49 116.82 2.99 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.814 2.343 . . . . 0.0 114.266 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -102.01 153.24 20.07 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.187 2.195 . . . . 0.0 111.11 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.59 133.89 42.3 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.491 1.041 . . . . 0.0 113.754 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.7 t -111.24 131.87 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 127.084 2.154 . . . . 0.0 111.528 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -51.9 129.2 26.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.846 1.658 . . . . 0.0 113.027 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 56.27 12.06 0.92 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 127.988 2.515 . . . . 0.0 115.547 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.74 -56.49 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.747 1.219 . . . . 0.0 111.774 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 124.78 -159.98 19.4 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.635 0.636 . . . . 0.0 113.25 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.252 10.6 p90 -81.68 153.88 26.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.87 143.71 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.93 2.092 . . . . 0.0 111.329 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.37 136.01 57.33 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.301 1.041 . . . . 0.0 113.357 170.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.25 -39.65 70.02 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.553 1.541 . . . . 0.0 113.16 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.1 -22.19 70.49 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.739 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.38 -10.64 45.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.9 mt -67.71 154.41 41.57 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.277 0.944 . . . . 0.0 111.576 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -123.08 152.74 40.76 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.193 0.997 . . . . 0.0 110.768 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.5 t -65.5 138.03 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.693 0.797 . . . . 0.0 110.361 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.51 -3.78 85.19 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 115.254 0.862 . . . . 0.0 115.254 -175.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.22 153.48 27.15 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.085 1.442 . . . . 0.0 111.799 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -100.39 107.96 19.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.852 1.261 . . . . 0.0 112.587 -163.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.5 mt -100.91 177.26 5.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.724 1.61 . . . . 0.0 110.343 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.88 157.57 41.18 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.4 -174.32 2.47 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.43 1.492 . . . . 0.0 114.511 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.4 p -56.0 -7.25 0.31 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -119.65 -26.55 5.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.187 1.395 . . . . 0.0 114.55 165.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.16 23.39 4.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.147 1.356 . . . . 0.0 113.404 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -77.0 146.75 37.23 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.324 1.062 . . . . 0.0 111.82 171.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.54 109.43 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.239 0.616 . . . . 0.0 112.225 -173.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.8 mt -93.44 159.31 15.3 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.858 1.663 . . . . 0.0 112.312 173.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.2 t -124.55 139.11 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.111 0.964 . . . . 0.0 111.098 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.2 t -69.2 130.82 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.403 0.681 . . . . 0.0 110.081 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -98.28 -43.33 7.01 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.534 1.933 . . . . 0.0 112.796 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -159.81 154.08 23.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.27 1.028 . . . . 0.0 111.843 -172.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -118.87 135.62 54.46 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.553 1.941 . . . . 0.0 108.865 165.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -130.57 130.09 43.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.817 1.647 . . . . 0.0 109.678 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -129.16 129.75 45.51 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.665 1.186 . . . . 0.0 111.985 -169.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -147.03 163.49 36.09 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.488 1.115 . . . . 0.0 112.879 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 mm -104.63 116.7 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 159.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.21 145.57 50.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.249 1.019 . . . . 0.0 111.672 173.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -75.09 -11.82 60.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.991 1.316 . . . . 0.0 112.464 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -139.84 152.05 67.13 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 127.204 2.202 . . . . 0.0 111.57 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.59 117.69 5.04 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.078 2.519 . . . . 0.0 110.753 172.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.31 139.43 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.033 1.733 . . . . 0.0 110.353 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -76.27 139.31 41.05 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.888 0.875 . . . . 0.0 110.297 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.47 140.8 28.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 124.007 0.923 . . . . 0.0 111.657 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -119.64 153.87 34.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.812 1.645 . . . . 0.0 112.049 -169.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -157.18 170.2 23.04 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.947 1.699 . . . . 0.0 110.816 170.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -152.64 167.56 28.5 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.354 -1.466 . . . . 0.0 113.249 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -117.37 144.84 44.52 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.745 1.218 . . . . 0.0 112.954 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.17 139.54 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.562 1.545 . . . . 0.0 111.48 -168.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -60.22 -34.66 73.96 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -163.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -145.87 -47.27 0.21 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.007 -1.058 . . . . 0.0 112.671 -172.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -76.39 165.99 24.05 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.198 1.399 . . . . 0.0 109.169 163.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -116.88 1.42 12.67 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -168.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.3 p -126.28 163.94 22.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.534 1.534 . . . . 0.0 113.258 -167.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -153.39 -177.08 6.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.749 1.619 . . . . 0.0 110.631 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -130.16 141.85 50.63 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.79 1.236 . . . . 0.0 113.31 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.26 140.23 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.499 1.119 . . . . 0.0 113.688 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.23 176.95 42.45 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.784 1.659 . . . . 0.0 116.496 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -57.21 -36.95 71.5 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.076 1.351 . . . . 0.0 112.775 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -82.95 -1.04 51.32 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 175.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 56.96 51.09 11.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.843 1.657 . . . . 0.0 113.486 168.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.9 t -80.32 141.98 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.215 1.806 . . . . 0.0 112.055 -167.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 48.9 tp -78.58 125.88 29.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.98 1.712 . . . . 0.0 114.216 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.09 158.9 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.257 1.823 . . . . 0.0 111.648 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -111.58 151.97 28.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.708 1.203 . . . . 0.0 112.934 -171.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.755 -1.593 . . . . 0.0 113.926 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 9.9 ttt -154.54 121.97 5.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.239 1.381 . . . . 0.0 111.056 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -139.79 98.0 3.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.462 1.105 . . . . 0.0 109.601 -164.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -164.17 173.57 12.25 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -124.37 154.81 39.8 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.289 1.436 . . . . 0.0 111.833 173.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.97 157.8 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.452 0.644 . . . . 0.0 112.356 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.3 144.31 20.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.539 0.735 . . . . 0.0 111.898 172.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.42 -8.1 69.65 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 116.489 1.355 . . . . 0.0 116.489 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.9 m -64.12 121.27 13.8 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 120.62 2.21 . . . . 0.0 110.6 174.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mmt -78.23 142.93 37.54 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.22 1.408 . . . . 0.0 112.089 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.5 mm -127.79 134.34 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.726 2.011 . . . . 0.0 109.708 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -76.38 128.95 35.85 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 p -123.64 169.67 11.24 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.991 1.316 . . . . 0.0 111.241 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.31 -19.09 65.8 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.777 -1.202 . . . . 0.0 113.294 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 p -119.56 2.66 11.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.861 2.064 . . . . 0.0 113.792 -173.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.16 -116.36 0.81 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.221 1.391 . . . . 0.0 113.982 166.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.98 154.47 45.55 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.771 1.628 . . . . 0.0 110.5 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -143.16 148.19 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 126.439 1.896 . . . . 0.0 108.585 170.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.35 147.02 46.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.017 -1.052 . . . . 0.0 111.306 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 tt -62.11 -27.06 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 120.437 -1.414 . . . . 0.0 113.498 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.58 -14.7 62.6 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 172.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -108.5 -15.06 14.53 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.232 1.813 . . . . 0.0 113.898 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.8 mm -63.04 132.25 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 163.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -133.26 170.76 14.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.523 1.929 . . . . 0.0 109.606 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.12 130.47 15.75 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.189 0.518 . . . . 0.0 111.005 166.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.24 -1.2 88.73 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 116.105 1.202 . . . . 0.0 116.105 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -76.58 155.38 33.64 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.779 1.789 . . . . 0.0 110.666 160.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -111.5 140.36 46.17 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.958 1.303 . . . . 0.0 112.509 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.11 162.16 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.542 1.937 . . . . 0.0 110.292 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.2 mm -78.63 141.73 15.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 121.819 -0.55 . . . . 0.0 110.472 162.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.95 129.3 29.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.7 m -91.53 108.37 19.85 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 165.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -52.43 117.21 10.06 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.223 1.009 . . . . 0.0 112.583 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.43 -12.98 37.7 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.097 2.532 . . . . 0.0 113.907 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -76.4 -40.62 50.37 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.225 1.01 . . . . 0.0 112.523 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.8 t -135.08 -5.26 2.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.339 1.456 . . . . 0.0 113.685 -171.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.3 t80 56.65 43.08 26.08 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.329 1.452 . . . . 0.0 114.034 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -95.71 135.16 37.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.236 1.014 . . . . 0.0 110.151 170.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -105.95 122.54 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.98 0.912 . . . . 0.0 112.339 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.22 160.51 39.26 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.324 1.049 . . . . 0.0 113.077 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -91.12 121.12 32.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.148 1.379 . . . . 0.0 109.466 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -139.05 149.09 44.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.465 1.106 . . . . 0.0 112.931 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.7 t -80.75 161.5 24.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.875 1.27 . . . . 0.0 113.435 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.9 t -98.19 133.62 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 126.236 1.814 . . . . 0.0 111.716 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.02 -45.19 10.4 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.962 1.305 . . . . 0.0 113.298 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -146.88 156.64 43.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.276 1.83 . . . . 0.0 110.614 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.1 p -116.43 135.24 54.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.221 164.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -105.7 147.92 28.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.688 1.595 . . . . 0.0 112.056 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -143.65 128.93 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.501 1.12 . . . . 0.0 111.319 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -126.28 176.05 7.38 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.04 1.736 . . . . 0.0 111.198 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -133.34 133.73 42.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.781 1.233 . . . . 0.0 111.945 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 t -148.16 143.99 27.45 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.957 1.303 . . . . 0.0 111.63 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.7 p -84.35 -21.27 30.96 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.635 0.774 . . . . 0.0 112.689 164.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -96.39 115.81 28.04 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.008 0.923 . . . . 0.0 110.203 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.4 mt -121.05 167.79 12.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.796 1.239 . . . . 0.0 112.276 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.89 134.85 46.16 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.693 1.997 . . . . 0.0 109.689 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -113.88 128.38 56.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.617 1.167 . . . . 0.0 108.866 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.2 mt -124.08 128.77 49.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.518 1.127 . . . . 0.0 110.339 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.8 m -99.04 122.9 42.9 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 169.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.74 119.67 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.895 1.278 . . . . 0.0 109.968 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.86 21.74 17.12 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 115.926 1.131 . . . . 0.0 115.926 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.35 7.64 55.74 Favored Glycine 0 CA--C 1.542 1.768 0 N-CA-C 116.914 1.526 . . . . 0.0 116.914 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -121.76 131.02 53.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.185 1.492 . . . . 0.0 109.869 172.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -97.35 134.69 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.989 0.899 . . . . 0.0 112.983 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.8 mt -130.42 133.81 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.812 2.045 . . . . 0.0 108.794 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -119.08 112.13 19.15 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.245 1.418 . . . . 0.0 110.792 -165.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -141.2 -177.63 5.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.611 1.164 . . . . 0.0 112.426 -161.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.9 p -89.66 153.54 20.65 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.198 0.999 . . . . 0.0 111.923 169.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -58.26 -27.88 64.4 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.925 1.29 . . . . 0.0 113.272 -175.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -107.52 7.44 28.8 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.723 1.209 . . . . 0.0 112.225 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -69.69 128.86 91.77 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.99 112.86 2.37 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 124.683 3.589 . . . . 0.0 115.216 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -94.7 152.99 18.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.369 2.268 . . . . 0.0 111.507 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -97.99 132.02 43.91 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -111.59 138.51 39.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 127.28 2.232 . . . . 0.0 110.226 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.54 127.4 31.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.732 1.213 . . . . 0.0 110.441 175.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t0 56.3 31.52 18.72 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.383 1.873 . . . . 0.0 115.595 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.0 t -144.12 -50.63 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.853 1.261 . . . . 0.0 112.417 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.45 -153.21 16.74 Favored Glycine 0 N--CA 1.468 0.811 0 CA-C-N 119.392 0.997 . . . . 0.0 111.512 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -92.04 147.65 22.79 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -149.14 143.49 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.596 1.958 . . . . 0.0 112.053 -175.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.81 132.33 52.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.872 1.269 . . . . 0.0 112.68 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.84 -36.96 68.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.301 1.44 . . . . 0.0 113.645 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.99 -12.67 83.2 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.561 1.077 . . . . 0.0 114.168 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -102.2 -7.88 21.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.278 1.831 . . . . 0.0 113.544 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 mt -58.49 158.69 7.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.679 0.792 . . . . 0.0 112.405 166.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -114.51 152.82 31.09 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.388 1.475 . . . . 0.0 110.395 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 50.3 t -67.59 132.63 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.351 0.596 . . . . 0.0 109.521 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.1 0.14 68.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.677 1.132 . . . . 0.0 115.201 -171.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -84.22 156.4 22.04 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.127 1.464 . . . . 0.0 111.96 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -106.73 102.41 11.79 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.118 1.367 . . . . 0.0 111.965 -156.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.7 mt -96.3 -175.36 3.33 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.486 1.514 . . . . 0.0 111.041 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.67 149.03 52.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.084 0.954 . . . . 0.0 112.51 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.02 172.46 6.91 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.218 1.007 . . . . 0.0 113.278 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.9 p -56.67 -11.34 1.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -107.37 -30.5 8.65 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.19 1.796 . . . . 0.0 112.344 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.74 19.89 5.92 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.956 1.741 . . . . 0.0 113.79 -177.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -70.59 140.26 51.64 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.658 0.729 . . . . 0.0 110.553 167.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.4 t -77.57 107.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.906 0.883 . . . . 0.0 109.832 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.3 mt -85.96 160.53 19.34 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.274 1.43 . . . . 0.0 111.816 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.89 137.71 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.334 1.053 . . . . 0.0 110.798 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.0 119.66 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.602 0.761 . . . . 0.0 109.05 170.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -96.52 -31.64 12.68 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.392 1.477 . . . . 0.0 112.213 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.93 148.12 20.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.575 1.55 . . . . 0.0 111.324 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -125.66 127.36 46.16 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.441 2.296 . . . . 0.0 109.773 168.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -125.31 156.56 38.45 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.482 2.313 . . . . 0.0 110.748 169.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.15 135.08 26.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.841 1.656 . . . . 0.0 108.266 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -142.75 158.46 43.61 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.9 mm -110.7 101.02 11.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 125.21 1.404 . . . . 0.0 109.903 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.78 146.74 35.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.403 1.481 . . . . 0.0 113.535 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.59 -14.79 61.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.848 1.259 . . . . 0.0 113.372 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -138.3 155.15 74.18 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 127.076 2.15 . . . . 0.0 109.761 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.96 111.42 2.64 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.429 2.086 . . . . 0.0 110.402 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.1 t -81.42 140.24 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.927 1.691 . . . . 0.0 110.015 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -75.64 135.8 40.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.092 0.949 . . . . 0.0 110.39 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.28 136.76 50.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 124.59 1.156 . . . . 0.0 110.61 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -118.91 149.32 41.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.609 1.564 . . . . 0.0 111.16 -167.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -153.36 166.42 32.69 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.763 1.625 . . . . 0.0 109.885 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -152.44 164.72 36.98 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.241 -1.537 . . . . 0.0 112.318 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -121.98 143.17 49.64 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.0 t -98.72 146.51 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.289 1.836 . . . . 0.0 112.364 -168.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.88 -15.13 63.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -168.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -145.35 -47.5 0.22 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.89 0.876 . . . . 0.0 112.109 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -83.41 173.51 11.46 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.36 1.064 . . . . 0.0 112.1 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -112.48 9.22 19.57 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.824 2.05 . . . . 0.0 114.58 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 p -133.08 171.44 13.98 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.104 1.361 . . . . 0.0 113.585 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -157.52 179.91 8.79 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.831 2.053 . . . . 0.0 110.362 163.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -117.24 138.95 51.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.808 1.243 . . . . 0.0 112.604 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.6 m -126.14 142.65 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.381 1.472 . . . . 0.0 113.912 -174.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.22 174.59 28.0 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.431 1.491 . . . . 0.0 115.336 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -26.0 65.9 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.756 -1.438 . . . . 0.0 113.133 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -83.54 -3.78 57.96 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.005 0.922 . . . . 0.0 113.384 170.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 57.38 55.35 5.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.134 1.773 . . . . 0.0 113.857 167.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.88 143.41 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.557 1.543 . . . . 0.0 111.603 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.5 tp -81.34 125.47 30.42 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.726 1.21 . . . . 0.0 114.091 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.6 159.05 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.478 1.511 . . . . 0.0 112.574 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -99.62 149.96 22.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.179 1.392 . . . . 0.0 113.959 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.7 m120 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.265 1.826 . . . . 0.0 112.505 179.469 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 51.7 ttm -138.16 139.15 39.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.319 0.648 . . . . 0.0 112.401 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -115.03 98.73 6.97 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.071 1.748 . . . . 0.0 110.356 171.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -157.38 168.99 25.76 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.808 0.843 . . . . 0.0 113.094 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.437 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.8 m-85 -124.78 154.52 40.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.565 1.546 . . . . 0.0 111.121 167.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.49 154.69 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.683 -0.636 . . . . 0.0 111.262 171.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.78 154.56 8.97 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.362 0.601 . . . . 0.0 111.717 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.88 -9.66 29.89 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-O 117.676 -1.625 . . . . 0.0 116.186 -171.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.5 m -62.33 125.31 23.47 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.539 2.17 . . . . 0.0 110.11 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 mmt -85.12 140.66 30.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.693 1.197 . . . . 0.0 111.982 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.66 135.18 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.781 2.033 . . . . 0.0 110.123 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.68 130.8 40.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.902 0.881 . . . . 0.0 113.208 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 p -126.18 174.21 8.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.71 1.604 . . . . 0.0 111.353 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.7 -19.38 64.88 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.26 1.424 . . . . 0.0 113.552 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -110.56 -25.39 10.02 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.17 -113.34 0.54 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.809 0.731 . . . . 0.0 112.825 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.6 mt -130.99 145.9 52.2 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.2 t -133.29 142.73 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.305 1.842 . . . . 0.0 108.941 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.77 144.77 49.08 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.214 -0.929 . . . . 0.0 110.959 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.32 -27.52 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 120.982 -1.074 . . . . 0.0 113.605 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -70.51 -14.06 62.37 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.089 1.356 . . . . 0.0 114.125 173.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -114.28 -11.01 12.64 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.551 1.54 . . . . 0.0 113.203 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.4 mm -61.68 137.23 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.569 -0.707 . . . . 0.0 109.282 163.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -125.55 164.03 21.42 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.369 1.868 . . . . 0.0 111.545 170.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.62 132.42 35.68 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.738 -0.601 . . . . 0.0 111.532 167.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.29 1.13 90.4 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.486 1.041 . . . . 0.0 115.287 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -82.65 154.54 24.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.533 1.167 . . . . 0.0 109.869 164.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -112.13 145.64 39.44 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.693 1.197 . . . . 0.0 112.311 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.03 160.56 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.229 1.811 . . . . 0.0 111.258 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -73.79 143.95 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.475 -0.765 . . . . 0.0 111.722 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.52 128.28 20.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.36 1.064 . . . . 0.0 109.446 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.406 ' HG1' ' CE1' ' A' ' 125' ' ' HIS . 71.4 m -78.62 115.45 18.33 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 162.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -55.21 115.39 9.03 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.231 1.012 . . . . 0.0 112.07 170.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.84 -3.95 13.77 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.9 2.4 . . . . 0.0 114.349 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -81.8 -45.99 14.81 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.309 0.958 . . . . 0.0 112.409 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -136.86 0.95 2.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.342 1.057 . . . . 0.0 112.767 -166.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 55.8 45.99 23.21 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.468 1.127 . . . . 0.0 112.678 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -86.59 134.97 33.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.564 1.546 . . . . 0.0 109.543 165.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 t -110.44 119.64 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 118.733 0.697 . . . . 0.0 109.644 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.35 164.88 33.67 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.792 0.837 . . . . 0.0 112.529 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -88.94 128.84 35.7 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.697 1.599 . . . . 0.0 110.941 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.437 ' HE3' ' CZ ' ' A' ' 121' ' ' PHE . 66.6 mmtt -134.46 148.76 50.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.365 1.066 . . . . 0.0 111.153 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -86.05 154.15 21.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.62 0.724 . . . . 0.0 112.781 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.6 t -90.18 134.86 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.655 1.582 . . . . 0.0 110.599 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.82 -48.37 7.54 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.881 0.872 . . . . 0.0 112.381 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -143.78 160.89 39.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.264 1.826 . . . . 0.0 110.235 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.3 p -116.43 134.05 55.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.562 1.145 . . . . 0.0 110.172 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -109.32 140.78 42.56 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.835 1.654 . . . . 0.0 113.705 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.33 138.45 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.651 1.18 . . . . 0.0 111.062 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -141.19 174.04 10.91 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.474 2.31 . . . . 0.0 109.532 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -130.48 138.85 50.47 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.504 1.522 . . . . 0.0 110.38 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.2 t -147.15 150.7 35.48 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.585 0.707 . . . . 0.0 111.643 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 p -94.17 -14.03 26.06 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.67 1.588 . . . . 0.0 113.848 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -118.55 111.39 18.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.039 0.836 . . . . 0.0 110.745 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.2 mt -110.14 160.79 16.17 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 tp -127.58 130.65 49.41 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 110.852 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -117.4 103.07 9.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.696 1.598 . . . . 0.0 109.413 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.7 mt -98.35 128.1 44.6 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.757 0.823 . . . . 0.0 110.22 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -100.29 119.74 38.86 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.08 116.32 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.321 1.048 . . . . 0.0 109.179 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.12 28.75 34.44 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 123.707 0.67 . . . . 0.0 114.72 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.12 -2.11 87.63 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.915 1.722 . . . . 0.0 116.332 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.4 122.49 41.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.863 1.831 . . . . 0.0 109.507 168.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.1 p -87.32 131.78 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.486 0.66 . . . . 0.0 111.71 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.92 131.04 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.823 2.049 . . . . 0.0 108.86 -175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -113.94 110.19 19.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.608 1.163 . . . . 0.0 110.777 -164.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 t -139.88 177.78 7.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.05 0.94 . . . . 0.0 112.218 -157.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.2 p -87.15 151.31 23.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.129 0.972 . . . . 0.0 112.116 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -58.75 -29.85 67.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.408 1.083 . . . . 0.0 112.845 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -98.21 9.55 42.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.437 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.3 t60 -70.58 125.96 92.13 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 120.909 -1.119 . . . . 0.0 112.475 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.99 119.82 4.04 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.139 2.559 . . . . 0.0 113.963 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -106.92 144.13 34.0 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.71 2.004 . . . . 0.0 111.074 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -83.33 128.61 34.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.464 1.029 . . . . 0.0 113.285 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.9 t -103.84 133.0 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.402 2.281 . . . . 0.0 110.96 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -49.01 118.46 2.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.056 1.743 . . . . 0.0 112.144 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 52.57 24.94 3.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.404 2.682 . . . . 0.0 115.312 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.75 -50.26 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.21 1.404 . . . . 0.0 110.577 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.48 -161.66 13.52 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 123.541 0.591 . . . . 0.0 112.54 -175.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.282 31.1 p90 -85.02 150.01 25.18 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 118.818 1.309 . . . . 0.0 114.162 -175.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.72 144.99 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.008 1.723 . . . . 0.0 110.642 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.41 136.13 57.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.94 0.896 . . . . 0.0 112.108 176.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.25 -36.12 70.56 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.78 1.232 . . . . 0.0 113.961 -171.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.66 -3.74 89.41 Favored Glycine 0 CA--C 1.539 1.561 0 O-C-N 121.027 -1.046 . . . . 0.0 113.611 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -95.77 -4.6 43.68 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.241 1.816 . . . . 0.0 112.314 167.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.0 mt -71.59 154.11 41.66 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.547 -0.721 . . . . 0.0 112.263 166.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -119.72 166.99 12.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.16 1.384 . . . . 0.0 110.976 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.31 138.53 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.57 12.99 82.3 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 115.234 0.854 . . . . 0.0 115.234 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -86.29 150.87 24.05 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.317 -1.107 . . . . 0.0 110.841 169.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -107.44 111.81 24.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.333 1.453 . . . . 0.0 112.056 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.1 mt -104.2 -177.82 3.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.339 1.456 . . . . 0.0 111.06 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -131.46 156.19 46.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.272 1.029 . . . . 0.0 113.518 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.8 p30 -105.15 179.85 4.15 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.914 1.286 . . . . 0.0 113.289 174.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.3 t -66.06 -17.87 64.97 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.871 1.669 . . . . 0.0 114.14 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -85.48 -25.53 26.83 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.261 -1.525 . . . . 0.0 112.171 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.72 25.31 8.16 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.699 2.095 . . . . 0.0 113.224 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.81 142.82 34.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.309 1.444 . . . . 0.0 111.812 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.9 t -57.11 120.3 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.51 1.124 . . . . 0.0 112.248 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -99.71 154.37 18.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.169 1.388 . . . . 0.0 110.901 161.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.42 140.6 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.865 1.266 . . . . 0.0 110.471 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.9 119.54 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.526 0.679 . . . . 0.0 109.237 170.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.02 -35.15 14.81 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.782 2.033 . . . . 0.0 112.626 -176.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -162.91 148.86 12.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.195 1.798 . . . . 0.0 110.817 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -129.41 124.5 34.29 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.932 1.693 . . . . 0.0 110.31 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 mmtm -132.22 151.1 51.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.531 1.532 . . . . 0.0 112.102 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 tp -136.13 137.65 41.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.858 1.663 . . . . 0.0 108.996 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.39 151.13 43.23 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.4 mm -99.77 119.01 47.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.779 170.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.89 149.59 43.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 112.795 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -67.95 -19.06 64.93 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.455 1.502 . . . . 0.0 113.251 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -157.27 156.64 29.56 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.913 2.485 . . . . 0.0 108.961 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -60.59 129.14 28.2 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.452 2.101 . . . . 0.0 112.603 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.83 144.35 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.595 1.558 . . . . 0.0 109.618 173.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -79.69 140.95 36.84 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.618 -0.677 . . . . 0.0 110.643 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.6 m -136.79 137.66 47.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.606 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -111.69 154.15 25.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.721 1.608 . . . . 0.0 111.974 -172.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -155.58 174.01 15.88 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.85 2.46 . . . . 0.0 108.033 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -153.76 170.9 19.8 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.044 -1.66 . . . . 0.0 110.744 173.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -121.94 137.25 54.86 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.774 0.83 . . . . 0.0 112.834 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.6 t -100.05 144.89 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.963 1.305 . . . . 0.0 111.95 -167.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -57.59 -39.07 75.96 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -170.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -139.6 -48.83 0.48 Allowed 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.97 -1.081 . . . . 0.0 113.372 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.437 ' CZ ' ' HE3' ' A' ' 39' ' ' LYS . 5.8 m-30 -69.94 163.87 25.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 168.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -116.29 23.48 12.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.954 1.302 . . . . 0.0 112.103 -171.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 p -147.69 160.64 42.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.553 1.541 . . . . 0.0 111.84 -157.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -160.24 175.89 12.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.836 1.655 . . . . 0.0 110.391 171.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.406 ' CE1' ' HG1' ' A' ' 29' ' ' THR . 27.5 m170 -122.27 134.2 54.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.393 1.077 . . . . 0.0 112.802 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.6 m -122.05 143.42 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.271 1.428 . . . . 0.0 114.663 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.53 176.98 30.14 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 126.118 1.818 . . . . 0.0 116.19 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.15 -34.5 66.19 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 120.92 -1.341 . . . . 0.0 113.237 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -83.02 0.1 46.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 57.35 43.6 23.08 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.027 1.331 . . . . 0.0 113.334 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.25 136.81 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.127 1.371 . . . . 0.0 111.723 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.6 tp -79.22 124.92 28.82 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.829 1.252 . . . . 0.0 113.98 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.4 m -138.27 157.01 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.127 1.771 . . . . 0.0 112.062 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -107.16 129.31 54.86 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.194 1.398 . . . . 0.0 112.823 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.213 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 118.966 -0.54 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 8.6 ttt -162.74 128.65 3.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.278 1.431 . . . . 0.0 111.381 170.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -133.38 97.4 3.95 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.093 0.957 . . . . 0.0 111.696 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.85 176.04 12.83 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.44 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 98.4 m-85 -123.62 157.12 34.47 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.14 1.776 . . . . 0.0 110.699 168.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 m -68.79 157.61 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.809 -0.557 . . . . 0.0 111.808 173.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.5 153.36 4.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.364 0.666 . . . . 0.0 111.948 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.8 3.95 30.97 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-O 117.95 -1.472 . . . . 0.0 116.475 -174.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -67.77 125.34 25.95 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 120.922 2.361 . . . . 0.0 109.617 165.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.6 mmt -80.5 142.19 34.44 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.353 1.461 . . . . 0.0 111.858 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -123.29 137.11 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.787 2.035 . . . . 0.0 109.905 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.91 122.14 22.06 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 112.592 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 p -115.21 168.14 10.21 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.115 1.366 . . . . 0.0 110.562 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.28 66.57 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.402 -0.812 . . . . 0.0 112.969 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.0 p -100.05 -31.66 11.32 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.626 0.77 . . . . 0.0 112.547 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.97 -120.09 0.76 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.877 0.751 . . . . 0.0 112.715 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.57 140.83 51.87 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.611 1.164 . . . . 0.0 112.67 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.1 t -132.25 142.64 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.848 1.659 . . . . 0.0 108.747 173.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.38 150.41 48.99 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.103 -0.998 . . . . 0.0 111.725 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.9 tt -62.45 -25.85 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 120.876 -1.14 . . . . 0.0 113.558 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -75.09 -15.28 60.62 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.376 1.07 . . . . 0.0 113.765 171.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -107.97 -16.25 14.34 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.571 1.948 . . . . 0.0 112.401 -176.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.7 mm -63.29 134.66 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 160.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -134.17 160.21 38.51 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.043 1.337 . . . . 0.0 111.604 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.42 120.21 8.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.785 0.434 . . . . 0.0 110.406 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.73 -24.67 23.15 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.535 1.064 . . . . 0.0 115.716 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.86 170.83 8.9 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.394 1.597 . . . . 0.0 111.648 172.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -125.33 146.53 49.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.725 1.61 . . . . 0.0 111.167 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.18 160.55 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.131 1.372 . . . . 0.0 110.455 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -75.09 140.94 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.234 0.54 . . . . 0.0 110.514 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.49 125.78 24.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.222 1.009 . . . . 0.0 108.695 175.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.2 m -79.79 112.3 16.94 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 161.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -53.92 111.44 2.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 118.343 -0.836 . . . . 0.0 110.718 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -69.18 -12.25 33.54 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.35 2.034 . . . . 0.0 112.691 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -77.19 -38.66 51.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.076 1.351 . . . . 0.0 112.828 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.7 t -136.23 -6.1 2.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.01 1.324 . . . . 0.0 112.53 -170.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.259 15.6 m-85 54.5 52.3 12.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.221 1.408 . . . . 0.0 112.185 -175.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -100.64 135.65 41.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.108 1.763 . . . . 0.0 108.889 167.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 t -113.04 128.89 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 119.01 0.823 . . . . 0.0 111.27 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.78 172.19 18.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.91 0.884 . . . . 0.0 113.079 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -74.23 138.04 43.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.71 1.204 . . . . 0.0 111.443 165.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -139.31 152.63 47.37 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.396 1.078 . . . . 0.0 112.23 160.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -79.08 155.32 28.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.668 1.187 . . . . 0.0 114.131 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.7 t -93.12 131.73 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 126.537 1.935 . . . . 0.0 111.318 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.42 -41.05 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.363 1.465 . . . . 0.0 113.508 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -147.37 156.02 42.52 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 127.159 2.184 . . . . 0.0 109.703 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -113.26 135.92 53.31 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.475 1.51 . . . . 0.0 109.14 163.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -112.35 141.83 45.59 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.183 1.393 . . . . 0.0 113.912 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -135.02 138.29 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.056 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -140.15 176.19 8.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.209 2.203 . . . . 0.0 110.112 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.12 133.62 50.36 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.375 1.47 . . . . 0.0 110.973 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 t -142.42 145.11 33.46 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.125 -0.984 . . . . 0.0 113.12 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.8 p -88.27 -14.52 38.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.806 1.642 . . . . 0.0 113.25 167.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -107.66 108.85 20.29 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.005 -1.059 . . . . 0.0 110.9 -172.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.6 mt -116.45 167.96 10.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.251 1.021 . . . . 0.0 112.818 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.1 tp -135.28 133.21 38.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.859 2.064 . . . . 0.0 109.268 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -105.54 130.43 53.6 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.232 -0.918 . . . . 0.0 109.292 170.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.5 mt -114.14 147.53 38.7 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.371 1.069 . . . . 0.0 110.1 169.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.7 m -123.17 124.83 43.92 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.452 0.701 . . . . 0.0 109.627 166.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.1 mt -132.77 123.55 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.84 1.656 . . . . 0.0 109.425 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.08 28.79 50.28 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 115.611 1.005 . . . . 0.0 115.611 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.11 7.51 87.7 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.82 1.2 . . . . 0.0 115.567 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -109.1 137.55 46.83 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.745 1.618 . . . . 0.0 109.567 171.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.61 135.84 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.345 1.058 . . . . 0.0 111.171 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mt -129.7 104.58 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.161 1.784 . . . . 0.0 109.341 173.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -81.94 121.82 26.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.823 1.649 . . . . 0.0 111.429 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.5 t -144.64 175.36 10.21 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.165 -0.96 . . . . 0.0 112.73 -167.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.3 p -79.19 153.86 29.69 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.591 -0.693 . . . . 0.0 111.181 167.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -59.43 -28.83 67.31 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.763 0.825 . . . . 0.0 112.62 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -98.01 1.21 47.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.963 0.905 . . . . 0.0 113.164 -171.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.44 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.2 t60 -64.68 128.07 93.13 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 117.657 -1.163 . . . . 0.0 112.87 -173.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -84.4 127.87 3.97 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.003 1.802 . . . . 0.0 114.673 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -115.93 139.58 50.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.129 2.572 . . . . 0.0 111.407 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -89.6 129.58 36.03 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.0 134.36 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.561 2.344 . . . . 0.0 112.4 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -50.05 126.36 14.27 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.982 1.713 . . . . 0.0 112.779 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 52.5 22.54 2.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.239 2.216 . . . . 0.0 115.259 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.09 -53.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.81 -1.181 . . . . 0.0 111.141 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.92 -159.68 13.57 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.095 0.855 . . . . 0.0 113.014 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -92.57 139.13 30.89 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.159 1.541 . . . . 0.0 115.159 -170.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.57 146.98 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 127.45 2.3 . . . . 0.0 111.987 -172.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.48 135.85 56.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 173.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.48 -40.14 61.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.958 1.703 . . . . 0.0 113.688 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.3 -10.58 66.29 Favored Glycine 0 CA--C 1.539 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 113.683 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -112.14 4.37 17.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.563 2.345 . . . . 0.0 113.04 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.85 159.66 19.14 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.969 -1.082 . . . . 0.0 111.295 163.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.42 156.68 32.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.441 1.096 . . . . 0.0 111.465 172.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.44 132.58 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 165.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.84 11.32 82.92 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 118.404 -1.22 . . . . 0.0 115.706 -172.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.3 165.19 7.82 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.908 1.854 . . . . 0.0 112.097 170.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -117.71 83.28 1.97 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.742 1.217 . . . . 0.0 111.735 -169.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.25 162.96 13.64 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.189 0.996 . . . . 0.0 113.533 -170.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.43 140.75 38.06 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.521 1.128 . . . . 0.0 112.552 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.12 177.14 5.17 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.501 1.12 . . . . 0.0 114.004 171.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.0 p -59.95 -12.08 7.09 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -107.85 -25.91 11.0 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.295 1.838 . . . . 0.0 111.905 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.6 25.14 6.72 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 126.402 1.954 . . . . 0.0 112.719 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -74.83 154.71 38.16 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.709 0.804 . . . . 0.0 110.437 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.8 t -92.83 112.76 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.785 0.834 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.5 mt -84.68 163.11 19.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.755 2.822 . . . . 0.0 112.324 175.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.71 134.78 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.554 1.542 . . . . 0.0 110.033 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.48 131.52 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.685 -0.635 . . . . 0.0 109.542 170.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -105.43 -35.26 7.55 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.613 1.565 . . . . 0.0 112.407 -175.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -157.87 149.24 21.47 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.194 0.998 . . . . 0.0 112.574 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -123.0 128.54 50.33 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.771 2.029 . . . . 0.0 108.743 161.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -130.27 151.61 50.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.116 1.766 . . . . 0.0 111.577 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 tt -138.62 142.99 39.1 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 111.416 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -150.52 161.92 41.61 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.933 0.893 . . . . 0.0 112.555 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mm -111.02 109.93 30.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.991 1.317 . . . . 0.0 108.329 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.47 140.37 58.59 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.318 0.647 . . . . 0.0 110.943 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.88 -21.63 60.89 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.64 -1.288 . . . . 0.0 113.283 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -127.54 151.12 74.61 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 127.221 2.208 . . . . 0.0 109.887 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.05 110.71 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.727 2.285 . . . . 0.0 112.069 -174.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.35 142.1 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.03 1.732 . . . . 0.0 110.18 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -71.2 140.28 50.42 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.081 0.943 . . . . 0.0 112.144 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.1 m -140.04 137.5 38.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.645 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -121.92 149.05 43.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.527 1.531 . . . . 0.0 111.354 -166.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -154.11 173.18 16.41 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.666 1.986 . . . . 0.0 108.413 170.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -150.27 170.71 18.35 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.218 -1.551 . . . . 0.0 111.283 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -119.46 136.52 54.27 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.82 0.848 . . . . 0.0 112.912 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.51 146.61 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.756 1.622 . . . . 0.0 111.491 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.08 -45.26 74.29 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -168.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -127.65 -32.85 2.34 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 119.732 1.151 . . . . 0.0 113.654 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -96.32 169.27 10.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.263 1.425 . . . . 0.0 108.925 167.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -120.97 19.68 11.65 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.742 1.217 . . . . 0.0 113.282 -171.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 p -142.13 164.28 30.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.524 1.53 . . . . 0.0 111.649 -162.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.69 179.31 9.22 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.387 1.475 . . . . 0.0 110.151 170.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -121.81 134.6 54.9 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.538 1.135 . . . . 0.0 111.943 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.19 144.81 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.239 1.416 . . . . 0.0 113.583 -173.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.6 175.16 26.71 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.663 1.601 . . . . 0.0 115.396 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -63.08 -29.44 70.81 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.309 -1.113 . . . . 0.0 112.112 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -86.11 1.72 49.44 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 174.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 58.33 46.24 15.77 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.271 1.428 . . . . 0.0 114.126 166.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.52 140.1 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.505 1.122 . . . . 0.0 111.443 -172.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.3 125.88 30.89 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.379 1.471 . . . . 0.0 113.922 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.05 155.57 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.847 1.659 . . . . 0.0 112.359 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -97.69 136.49 37.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.441 1.496 . . . . 0.0 111.73 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.217 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 6.0 ttt -154.41 -40.49 0.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.136 1.774 . . . . 0.0 112.523 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt 51.43 63.74 2.12 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.655 1.982 . . . . 0.0 115.657 163.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -140.61 174.17 10.78 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -123.49 154.74 38.72 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.973 1.709 . . . . 0.0 110.809 170.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.6 m -69.63 160.74 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.427 0.632 . . . . 0.0 111.772 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 157.78 2.34 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 122.166 0.984 . . . . 0.0 112.921 174.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.78 -8.54 4.34 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 116.965 -2.02 . . . . 0.0 116.258 -171.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -62.6 119.82 9.97 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.039 2.419 . . . . 0.0 110.077 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mmt -78.36 141.37 38.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.55 1.14 . . . . 0.0 111.797 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -125.24 135.68 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.406 1.883 . . . . 0.0 109.785 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 tp -76.73 123.61 26.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.895 1.278 . . . . 0.0 112.623 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -123.54 176.84 5.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.736 1.214 . . . . 0.0 112.146 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.86 68.1 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.353 -0.842 . . . . 0.0 112.804 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 p -100.01 -14.45 18.65 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.297 1.439 . . . . 0.0 113.434 -170.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.99 -107.41 0.41 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.375 1.464 . . . . 0.0 110.754 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.36 150.91 48.26 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.291 1.036 . . . . 0.0 112.455 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.7 t -140.05 146.59 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.116 2.166 . . . . 0.0 107.738 168.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.34 149.49 47.3 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.8 -1.188 . . . . 0.0 111.077 175.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -60.83 -30.81 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 120.63 -1.293 . . . . 0.0 112.887 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -65.58 -18.05 65.04 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.823 1.649 . . . . 0.0 114.179 171.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -116.62 -5.14 11.65 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.644 1.978 . . . . 0.0 112.776 -174.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -65.17 134.53 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.123 -0.986 . . . . 0.0 108.543 158.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -120.54 156.9 30.61 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.777 1.631 . . . . 0.0 111.544 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.45 136.27 58.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 167.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.68 -4.05 86.31 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.212 0.91 . . . . 0.0 113.83 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -74.79 -179.68 4.33 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.683 1.241 . . . . 0.0 111.224 167.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -126.1 141.52 51.91 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.51 1.524 . . . . 0.0 112.103 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.67 153.7 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.608 1.563 . . . . 0.0 110.101 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -71.06 134.89 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 121.676 -0.64 . . . . 0.0 111.175 171.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.94 120.02 20.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.088 1.355 . . . . 0.0 108.014 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.9 m -86.7 107.76 18.36 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -54.52 113.08 4.67 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.84 175.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.37 -8.42 22.04 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 122.604 2.203 . . . . 0.0 114.129 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -72.79 -41.67 64.73 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.181 1.393 . . . . 0.0 112.674 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.8 t -143.36 -4.13 0.9 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.254 1.422 . . . . 0.0 112.49 -165.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 58.54 32.0 21.65 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.02 1.728 . . . . 0.0 114.17 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.71 129.59 40.02 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 169.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.52 107.49 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.887 0.875 . . . . 0.0 109.579 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.19 163.39 33.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.707 1.203 . . . . 0.0 111.535 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.39 135.53 35.15 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.53 -0.731 . . . . 0.0 110.188 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.462 ' HE3' ' CE1' ' A' ' 121' ' ' PHE . 72.2 mmtt -131.62 150.13 52.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.435 1.494 . . . . 0.0 110.657 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.4 t -82.58 156.51 23.9 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.73 126.97 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.733 1.613 . . . . 0.0 110.962 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.75 -47.4 11.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.834 1.254 . . . . 0.0 113.434 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -146.1 156.0 43.14 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.536 1.935 . . . . 0.0 110.376 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.3 p -125.17 118.45 26.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.354 1.862 . . . . 0.0 111.027 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -108.97 152.69 24.61 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.031 1.332 . . . . 0.0 113.57 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.2 141.31 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.582 1.953 . . . . 0.0 110.729 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -141.77 176.54 8.83 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.36 1.864 . . . . 0.0 110.704 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -127.84 139.58 52.55 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.532 1.533 . . . . 0.0 111.614 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 t -147.91 147.17 29.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.138 1.375 . . . . 0.0 111.518 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 p -88.49 -19.37 26.54 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.215 1.006 . . . . 0.0 113.002 164.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -97.48 110.84 23.32 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.477 1.111 . . . . 0.0 109.904 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.9 mt -121.92 169.23 11.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.378 1.071 . . . . 0.0 112.37 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 tp -138.24 130.32 28.6 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.465 1.506 . . . . 0.0 109.425 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -112.51 119.89 39.73 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.426 -0.796 . . . . 0.0 109.168 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.9 mt -108.69 140.18 42.45 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.699 0.799 . . . . 0.0 109.534 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.6 m -110.14 119.68 40.06 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 166.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.75 117.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.515 1.126 . . . . 0.0 109.884 -177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.06 30.3 46.06 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-O 119.5 -0.611 . . . . 0.0 114.442 -175.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.04 -7.49 80.97 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.45 1.5 . . . . 0.0 115.605 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -97.88 118.97 35.65 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.262 1.425 . . . . 0.0 111.073 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.9 133.49 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.139 0.575 . . . . 0.0 111.481 170.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mt -133.98 105.76 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 127.382 2.273 . . . . 0.0 108.656 173.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -87.99 120.72 29.61 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.874 1.669 . . . . 0.0 112.739 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -142.02 175.41 9.75 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.389 1.476 . . . . 0.0 112.581 -164.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.2 p -83.64 153.56 24.2 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.977 0.894 . . . . 0.0 111.293 167.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -62.11 -18.29 60.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.505 1.122 . . . . 0.0 113.328 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -104.01 0.93 30.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.448 1.499 . . . . 0.0 113.902 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.2 127.64 93.06 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 119.619 1.1 . . . . 0.0 112.952 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -79.86 123.82 5.37 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.02 2.48 . . . . 0.0 114.325 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -112.2 143.54 43.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.758 2.423 . . . . 0.0 111.282 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -88.07 126.46 35.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.159 0.89 . . . . 0.0 112.492 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -102.45 135.59 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.642 1.977 . . . . 0.0 110.822 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -53.51 129.15 31.51 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.9 1.28 . . . . 0.0 110.785 174.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.3 t70 61.12 13.43 4.71 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.532 1.933 . . . . 0.0 115.518 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.4 t -135.77 -45.33 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 121.026 -1.047 . . . . 0.0 113.072 -172.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.49 -159.07 17.08 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.999 0.809 . . . . 0.0 113.456 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -77.88 145.24 36.34 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -170.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.0 p -149.78 150.45 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.427 2.291 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.02 140.81 58.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 173.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.47 -40.18 65.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.024 1.73 . . . . 0.0 113.689 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.35 -8.26 87.59 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.966 -1.084 . . . . 0.0 113.966 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -97.21 -5.03 37.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.637 1.575 . . . . 0.0 112.121 171.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.53 155.21 41.01 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.095 -1.003 . . . . 0.0 111.292 164.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -123.27 170.12 10.6 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.579 1.151 . . . . 0.0 110.429 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.35 136.37 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.616 -0.677 . . . . 0.0 109.695 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 5.13 87.93 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.103 -0.832 . . . . 0.0 115.09 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -76.22 153.36 36.12 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.522 1.161 . . . . 0.0 110.599 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.47 107.76 18.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.591 1.157 . . . . 0.0 111.791 -169.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.6 mt -99.95 172.82 6.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.547 1.139 . . . . 0.0 111.047 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.2 mt -123.68 165.23 17.58 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.885 0.874 . . . . 0.0 112.705 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -117.73 -174.51 2.64 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.354 1.462 . . . . 0.0 114.745 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.9 p -58.19 -1.31 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.811 2.444 . . . . 0.0 117.235 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -115.89 -20.91 9.79 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.473 1.509 . . . . 0.0 112.66 170.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.88 13.18 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.98 1.752 . . . . 0.0 112.606 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -96.06 137.56 34.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.689 1.195 . . . . 0.0 112.377 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.4 t -67.45 119.85 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.603 1.161 . . . . 0.0 113.534 -170.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.13 159.41 15.56 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.455 2.302 . . . . 0.0 112.612 169.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 t -126.17 139.14 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.977 1.311 . . . . 0.0 111.582 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.83 125.52 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.92 0.888 . . . . 0.0 109.874 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.28 -30.94 10.78 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 127.357 2.263 . . . . 0.0 112.933 -175.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -156.65 152.96 27.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.497 1.119 . . . . 0.0 111.121 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -136.54 101.31 4.6 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.277 1.831 . . . . 0.0 109.545 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -104.77 130.58 52.84 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.314 1.846 . . . . 0.0 110.909 -171.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.9 tp -120.37 128.79 53.56 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.831 1.252 . . . . 0.0 110.81 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.17 162.1 41.42 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.125 1.37 . . . . 0.0 112.874 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.63 117.73 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.157 1.383 . . . . 0.0 108.86 171.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.88 142.62 53.23 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.583 -0.698 . . . . 0.0 112.2 167.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.6 -26.35 67.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.031 1.332 . . . . 0.0 112.987 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -146.91 150.87 40.38 Favored Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 127.051 2.14 . . . . 0.0 109.988 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -56.63 127.54 26.31 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.473 2.782 . . . . 0.0 112.869 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.3 t -99.04 141.36 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 127.072 2.149 . . . . 0.0 110.095 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -74.19 144.85 44.58 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.893 0.769 . . . . 0.0 112.079 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.78 144.26 27.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.309 1.444 . . . . 0.0 110.565 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -128.8 147.59 50.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.521 1.529 . . . . 0.0 110.41 -166.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -156.46 171.64 19.91 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.537 1.135 . . . . 0.0 111.685 169.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -149.78 163.37 38.16 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.465 -0.772 . . . . 0.0 112.117 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.68 144.24 43.27 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.666 1.186 . . . . 0.0 113.204 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.9 t -104.76 147.84 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.059 1.744 . . . . 0.0 111.676 -168.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.35 -72.4 0.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.8 -19.98 12.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -166.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.462 ' CE1' ' HE3' ' A' ' 39' ' ' LYS . 10.5 m-30 -105.92 175.34 5.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.273 1.829 . . . . 0.0 108.524 165.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -132.21 33.13 3.9 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.164 1.386 . . . . 0.0 112.729 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 p -139.75 159.01 43.16 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.061 1.744 . . . . 0.0 112.17 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -158.29 -173.32 4.26 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.82 1.648 . . . . 0.0 110.768 170.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -131.67 141.4 49.58 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.885 1.274 . . . . 0.0 113.392 -170.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.98 142.39 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.678 1.191 . . . . 0.0 112.625 -173.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.55 173.8 23.41 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.283 1.421 . . . . 0.0 115.697 175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.4 -31.2 72.29 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.982 -1.305 . . . . 0.0 113.367 -176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -84.04 2.19 40.31 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.842 1.257 . . . . 0.0 114.0 173.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.88 46.16 17.25 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.454 1.901 . . . . 0.0 114.551 166.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.84 136.53 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.569 1.148 . . . . 0.0 111.515 -170.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 54.1 tp -77.86 126.19 30.47 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.786 1.634 . . . . 0.0 112.639 -176.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.15 157.2 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.768 1.627 . . . . 0.0 111.142 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -108.28 161.38 15.06 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.531 1.132 . . . . 0.0 112.924 -172.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.663 1.585 . . . . 0.0 112.953 171.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 7.7 ttm -76.84 125.8 29.9 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.344 1.458 . . . . 0.0 111.116 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -133.07 73.12 1.5 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.909 2.084 . . . . 0.0 110.178 -168.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.8 167.27 21.48 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -171.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 85.9 m-85 -123.6 154.24 39.58 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.552 1.541 . . . . 0.0 111.276 172.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.92 161.53 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.53 0.681 . . . . 0.0 112.053 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.32 154.23 3.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.206 1.002 . . . . 0.0 112.681 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.96 -9.0 7.04 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 117.546 -1.697 . . . . 0.0 116.3 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.0 m -63.03 121.57 13.91 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 121.179 2.49 . . . . 0.0 110.373 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 mmt -78.35 142.94 37.32 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.694 1.597 . . . . 0.0 111.72 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.8 mm -127.32 132.91 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.697 1.999 . . . . 0.0 109.867 -175.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -77.92 123.07 26.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.699 1.199 . . . . 0.0 112.552 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -117.44 178.87 4.22 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.507 1.123 . . . . 0.0 113.647 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.84 52.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.45 1.1 . . . . 0.0 113.832 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 p -113.82 -28.04 7.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.924 1.29 . . . . 0.0 113.706 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.76 -107.96 0.34 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.271 0.939 . . . . 0.0 111.476 -171.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -127.29 149.2 50.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.483 1.113 . . . . 0.0 113.204 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.9 t -142.35 147.73 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 127.286 2.234 . . . . 0.0 108.389 170.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.6 147.09 41.97 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.888 -1.133 . . . . 0.0 111.27 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 tt -61.34 -29.47 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 120.614 -1.304 . . . . 0.0 112.926 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.46 -8.22 44.86 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.918 1.287 . . . . 0.0 114.434 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -119.4 -8.0 10.11 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.749 1.62 . . . . 0.0 113.489 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.19 136.53 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.117 -0.99 . . . . 0.0 110.052 165.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -117.92 166.31 12.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.907 2.083 . . . . 0.0 110.312 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.9 147.02 54.13 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.479 -0.763 . . . . 0.0 111.032 163.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.37 3.24 82.07 Favored Glycine 0 CA--C 1.54 1.637 0 O-C-N 121.77 -0.581 . . . . 0.0 114.543 -171.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -89.81 152.94 21.04 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.099 0.96 . . . . 0.0 110.292 168.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -115.85 120.9 40.74 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.799 1.239 . . . . 0.0 112.709 -168.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 m -110.32 154.06 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 126.88 2.072 . . . . 0.0 110.257 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.3 mm -75.53 135.16 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 O-C-N 121.604 -0.685 . . . . 0.0 109.773 166.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.99 121.48 28.07 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.2 m -101.46 104.1 15.02 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -55.96 114.75 8.08 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.96 -1.019 . . . . 0.0 111.83 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.96 -5.53 12.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.168 1.912 . . . . 0.0 113.443 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.07 -42.51 76.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.833 0.853 . . . . 0.0 112.538 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.2 t -150.01 5.66 0.58 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.787 0.835 . . . . 0.0 112.928 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.265 21.0 m-85 57.11 41.54 27.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.34 1.456 . . . . 0.0 112.642 -173.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -78.79 131.37 36.5 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 165.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.22 123.93 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.133 0.973 . . . . 0.0 109.912 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.38 153.22 43.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -82.27 117.39 22.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.199 1.0 . . . . 0.0 109.96 168.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -132.28 146.63 52.13 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.707 1.203 . . . . 0.0 112.351 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -83.99 155.65 22.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.367 1.067 . . . . 0.0 113.766 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.7 t -87.22 132.98 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 125.645 1.578 . . . . 0.0 111.295 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.3 mt -90.92 -41.37 11.18 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.207 1.003 . . . . 0.0 112.866 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.25 150.67 35.29 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.247 1.819 . . . . 0.0 110.376 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.3 p -121.48 121.57 37.82 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.441 1.897 . . . . 0.0 109.999 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -106.89 144.33 33.69 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.78 1.632 . . . . 0.0 114.214 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.3 t -141.24 133.0 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.861 0.864 . . . . 0.0 112.126 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.6 mmt-85 -138.16 175.13 9.85 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.512 1.925 . . . . 0.0 110.652 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -136.63 136.29 39.03 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.029 0.931 . . . . 0.0 112.941 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -151.1 150.93 31.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.495 1.118 . . . . 0.0 112.107 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.4 p -90.94 -16.86 27.36 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.177 1.391 . . . . 0.0 113.874 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.39 106.89 17.52 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.363 1.065 . . . . 0.0 109.999 -169.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.3 mt -117.69 162.24 18.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.69 1.233 . . . . 0.0 113.372 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -127.3 132.56 50.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.13 1.772 . . . . 0.0 109.029 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -111.08 125.43 53.76 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.172 0.989 . . . . 0.0 108.875 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 mt -112.44 140.82 46.86 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.594 0.758 . . . . 0.0 109.568 170.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.3 m -113.84 119.04 35.94 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 mt -127.24 117.32 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.111 0.965 . . . . 0.0 108.859 -172.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.88 21.08 28.88 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.79 -4.35 53.25 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.617 1.58 . . . . 0.0 116.306 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -107.08 127.92 53.92 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.128 1.771 . . . . 0.0 110.294 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.5 t -81.71 132.34 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.47 1.108 . . . . 0.0 111.958 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -132.48 103.26 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.897 1.679 . . . . 0.0 109.492 174.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -81.86 121.47 26.5 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.607 1.563 . . . . 0.0 111.706 176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -143.46 176.68 8.99 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.335 1.454 . . . . 0.0 113.477 -165.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.6 p -81.67 151.63 27.48 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.736 0.815 . . . . 0.0 112.255 170.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -64.17 -18.1 64.15 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.163 -0.961 . . . . 0.0 113.186 -174.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -110.98 13.41 22.08 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.0 OUTLIER -65.42 128.73 94.05 Favored Pre-proline 0 CA--C 1.55 0.978 0 O-C-N 120.772 -1.205 . . . . 0.0 111.582 176.255 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.64 125.82 5.72 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.061 2.508 . . . . 0.0 113.714 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -118.46 142.77 47.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.973 2.109 . . . . 0.0 111.788 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -85.31 133.35 34.15 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.371 0.987 . . . . 0.0 113.614 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.88 138.72 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 127.683 2.393 . . . . 0.0 111.293 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.17 130.45 42.11 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.424 0.69 . . . . 0.0 111.12 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 61.3 7.13 1.57 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.596 2.358 . . . . 0.0 116.59 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -130.64 -35.25 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.029 1.331 . . . . 0.0 111.973 -170.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.61 -150.96 22.85 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 123.938 0.78 . . . . 0.0 111.62 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.292 12.3 p90 -77.4 145.69 37.07 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.78 150.02 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 128.523 2.729 . . . . 0.0 109.683 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -64.48 137.87 58.11 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.115 -0.99 . . . . 0.0 113.415 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.72 67.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.804 1.641 . . . . 0.0 113.304 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.35 -7.46 68.11 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.373 -0.83 . . . . 0.0 114.362 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -102.76 -6.41 22.65 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.251 1.42 . . . . 0.0 113.171 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -67.94 164.28 20.25 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.089 1.356 . . . . 0.0 112.834 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.27 162.79 27.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.611 1.564 . . . . 0.0 112.881 168.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.94 123.63 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 165.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.0 1.98 61.15 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.868 -1.518 . . . . 0.0 114.988 -170.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -76.74 152.95 35.46 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.754 2.277 . . . . 0.0 111.367 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -110.6 101.82 10.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.681 1.192 . . . . 0.0 112.413 -170.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.3 mt -91.81 170.5 9.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.929 1.692 . . . . 0.0 110.654 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.9 mt -119.32 155.73 31.32 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 170.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.3 176.87 5.56 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.908 1.283 . . . . 0.0 113.879 176.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.8 p -54.34 -22.4 12.06 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -106.79 -10.05 16.2 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.542 1.937 . . . . 0.0 112.616 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.59 13.29 28.42 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.422 1.963 . . . . 0.0 113.183 171.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -79.17 145.84 33.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.719 1.208 . . . . 0.0 111.384 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.2 t -74.69 127.9 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.565 0.746 . . . . 0.0 111.322 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.1 mt -114.26 150.79 33.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.14 2.176 . . . . 0.0 112.03 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.3 t -118.23 137.71 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 125.183 1.393 . . . . 0.0 110.474 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.4 t -73.7 119.06 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.957 0.903 . . . . 0.0 109.452 169.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -94.29 -27.88 15.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.852 2.461 . . . . 0.0 112.853 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -155.03 147.33 23.91 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.778 1.631 . . . . 0.0 110.248 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -132.85 116.18 16.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.946 1.699 . . . . 0.0 109.308 168.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -127.76 151.59 48.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.359 2.264 . . . . 0.0 110.822 -171.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.02 133.81 25.32 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.15 1.38 . . . . 0.0 109.584 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -144.68 151.21 38.6 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.1 mm -98.2 103.3 14.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.895 1.278 . . . . 0.0 108.38 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.86 150.87 31.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.09 0.956 . . . . 0.0 111.954 174.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.05 -18.81 63.3 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.14 -0.975 . . . . 0.0 112.983 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -137.68 154.68 75.06 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 126.762 2.025 . . . . 0.0 111.339 -172.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.33 110.09 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.547 2.165 . . . . 0.0 110.013 170.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.2 t -83.5 141.66 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.013 1.725 . . . . 0.0 109.631 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -77.6 139.56 39.54 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.839 0.855 . . . . 0.0 110.397 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.2 m -138.34 142.83 34.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 125.006 1.322 . . . . 0.0 111.345 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -121.79 152.46 39.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.514 1.526 . . . . 0.0 111.707 -167.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -156.5 165.91 34.92 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.38 2.272 . . . . 0.0 109.767 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -156.97 165.36 36.38 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.304 -1.497 . . . . 0.0 111.248 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -120.2 145.9 46.54 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.27 145.86 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.293 1.437 . . . . 0.0 112.867 -166.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -64.43 -47.34 79.47 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -170.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -109.49 -66.31 1.07 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 120.056 1.298 . . . . 0.0 109.957 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -72.71 175.93 5.99 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.667 1.187 . . . . 0.0 112.153 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -115.94 3.9 13.75 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.501 1.52 . . . . 0.0 113.349 -172.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.4 p -124.74 160.66 28.1 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.308 1.443 . . . . 0.0 113.981 -168.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.07 -179.62 8.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.843 2.057 . . . . 0.0 109.875 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -132.12 140.68 48.88 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.352 1.061 . . . . 0.0 113.183 -168.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.6 142.02 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -170.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.25 173.44 25.74 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.928 1.728 . . . . 0.0 115.346 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.1 -25.42 67.7 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.11 -1.229 . . . . 0.0 113.11 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -90.41 5.22 48.38 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.578 1.551 . . . . 0.0 114.667 172.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 56.11 46.5 21.44 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 164.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.53 140.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.379 1.072 . . . . 0.0 111.779 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.06 126.22 31.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.749 1.62 . . . . 0.0 113.491 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.6 m -145.82 162.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.542 1.937 . . . . 0.0 111.429 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -116.92 141.07 48.71 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.431 1.492 . . . . 0.0 113.049 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.209 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 49.1 p . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 7.8 ttt -163.45 123.8 2.24 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.122 0.569 . . . . 0.0 110.184 -174.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -127.58 79.07 1.87 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.304 -0.872 . . . . 0.0 111.017 -170.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -146.72 174.73 11.2 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.21 1.004 . . . . 0.0 112.801 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.435 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 98.6 m-85 -124.73 154.64 40.55 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.1 1.36 . . . . 0.0 111.071 172.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.51 158.0 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.203 0.525 . . . . 0.0 111.661 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.1 151.8 0.92 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.218 1.007 . . . . 0.0 112.371 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.07 -17.26 7.55 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.437 -1.757 . . . . 0.0 116.077 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.6 m -61.89 124.19 20.1 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 120.707 2.253 . . . . 0.0 110.11 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -82.12 141.62 32.95 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.879 1.272 . . . . 0.0 111.538 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.0 mm -117.33 133.32 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.619 1.968 . . . . 0.0 109.577 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.7 tp -71.28 127.18 31.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.678 0.752 . . . . 0.0 112.969 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 p -127.81 166.02 19.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.02 1.328 . . . . 0.0 110.423 174.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.04 70.12 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.503 -0.748 . . . . 0.0 112.126 168.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.8 p -80.02 -25.99 39.99 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.199 1.4 . . . . 0.0 112.677 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.72 -99.11 0.19 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.84 2.162 . . . . 0.0 111.039 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.0 mt -134.98 149.28 50.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.745 1.218 . . . . 0.0 111.855 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.63 143.69 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.633 1.573 . . . . 0.0 108.552 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.45 146.12 53.47 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.022 -1.048 . . . . 0.0 111.127 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 tt -60.8 -30.59 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 120.942 -1.099 . . . . 0.0 113.107 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.27 -16.77 63.65 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.471 1.109 . . . . 0.0 113.836 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -109.37 -12.55 14.73 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.794 1.638 . . . . 0.0 113.117 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.7 mm -63.03 135.64 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.09 0.859 . . . . 0.0 109.421 164.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -127.75 156.09 42.98 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.885 1.674 . . . . 0.0 111.442 175.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.93 135.27 56.01 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.223 -0.923 . . . . 0.0 111.457 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.11 -19.54 54.05 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.712 -1.049 . . . . 0.0 115.166 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -68.42 166.11 17.44 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.899 1.349 . . . . 0.0 111.121 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -124.21 138.67 54.38 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.077 1.351 . . . . 0.0 112.836 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.04 163.88 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.206 1.802 . . . . 0.0 111.203 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -80.09 145.88 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.227 0.536 . . . . 0.0 111.56 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.55 132.3 21.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 m -97.43 112.03 24.04 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.5 0.667 . . . . 0.0 109.864 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -52.76 114.83 6.26 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.448 1.499 . . . . 0.0 113.288 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.75 -7.07 19.52 Favored 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 122.877 2.385 . . . . 0.0 115.299 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -79.44 -38.67 34.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.257 1.423 . . . . 0.0 113.261 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.6 t -141.76 -1.8 1.24 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.784 1.234 . . . . 0.0 112.873 -168.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.26 33.8 m-85 55.13 33.78 21.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.915 2.086 . . . . 0.0 114.244 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -77.95 135.02 37.76 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.632 -0.668 . . . . 0.0 110.342 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.02 122.07 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.317 1.047 . . . . 0.0 110.927 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.13 151.7 41.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.765 0.793 . . . . 0.0 112.872 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -90.14 124.6 34.96 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.213 1.405 . . . . 0.0 109.291 174.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -134.44 150.89 50.88 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.584 1.154 . . . . 0.0 111.424 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.3 t -79.76 153.58 29.11 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -88.83 133.0 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.32 1.848 . . . . 0.0 110.624 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 mt -90.73 -44.21 9.61 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.66 0.784 . . . . 0.0 112.682 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -141.58 157.81 44.64 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.503 1.521 . . . . 0.0 110.641 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.7 p -130.98 116.34 17.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.842 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -103.48 157.94 16.69 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.989 1.315 . . . . 0.0 113.309 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.74 142.52 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.883 2.073 . . . . 0.0 110.204 175.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.1 mmt-85 -140.38 172.81 12.21 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.239 2.215 . . . . 0.0 109.933 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -141.34 135.05 30.12 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.95 -1.094 . . . . 0.0 113.064 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.3 t -151.01 152.59 33.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.875 0.87 . . . . 0.0 112.019 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.7 p -86.24 -15.48 40.66 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.988 1.315 . . . . 0.0 113.43 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -105.75 108.35 19.81 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.205 0.911 . . . . 0.0 112.262 -171.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.6 mt -116.67 160.53 20.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.358 1.075 . . . . 0.0 113.658 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -123.69 138.57 54.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.123 1.769 . . . . 0.0 109.945 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.1 m170 -115.93 128.13 55.53 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.656 1.582 . . . . 0.0 109.253 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.3 mt -128.92 132.76 47.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.233 1.013 . . . . 0.0 110.182 175.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -99.13 113.01 25.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 169.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 mp -107.74 113.19 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.462 1.105 . . . . 0.0 108.469 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.73 -28.67 0.14 Allowed Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.744 2.116 . . . . 0.0 116.751 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.26 -0.35 0.32 Allowed Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.723 1.63 . . . . 0.0 114.073 -165.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -112.31 124.27 52.11 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.511 1.524 . . . . 0.0 109.533 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.56 114.17 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.331 0.652 . . . . 0.0 109.674 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mt -106.31 101.34 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.412 1.085 . . . . 0.0 109.12 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.99 122.18 21.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.019 1.328 . . . . 0.0 110.65 168.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 t -146.91 175.68 10.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.306 1.043 . . . . 0.0 112.639 -168.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.4 p -78.18 146.49 34.98 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.521 -0.737 . . . . 0.0 111.137 169.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.84 -28.45 66.08 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.022 -1.049 . . . . 0.0 112.442 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -96.83 0.14 48.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.56 1.544 . . . . 0.0 113.305 -171.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.435 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.3 t60 -64.8 129.15 94.26 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.473 1.509 . . . . 0.0 113.305 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.52 113.68 2.62 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.463 2.775 . . . . 0.0 114.093 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -103.25 143.69 32.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.133 2.173 . . . . 0.0 111.408 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -89.33 126.18 35.42 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -103.95 135.75 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.489 1.515 . . . . 0.0 111.213 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -57.04 129.12 40.34 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.633 1.173 . . . . 0.0 112.936 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.8 t0 56.19 23.8 7.41 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.172 1.789 . . . . 0.0 114.45 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.5 t -140.74 -50.39 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.799 1.239 . . . . 0.0 111.92 -172.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.21 -169.17 22.53 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.727 0.68 . . . . 0.0 114.201 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -75.8 146.77 39.7 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -162.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.1 p -150.68 146.91 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.89 1.676 . . . . 0.0 111.854 -173.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -54.55 133.31 46.2 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.556 0.742 . . . . 0.0 112.664 171.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.26 -36.7 66.34 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.607 1.563 . . . . 0.0 113.137 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.4 -4.89 81.02 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.03 -1.044 . . . . 0.0 114.739 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -107.45 -4.44 18.48 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.228 1.811 . . . . 0.0 112.553 176.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.59 151.52 46.26 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.449 -0.782 . . . . 0.0 110.428 155.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -118.34 173.78 6.62 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.064 1.346 . . . . 0.0 110.375 170.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.36 139.92 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 165.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.93 9.62 86.93 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 119.099 -0.834 . . . . 0.0 114.565 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -86.38 154.91 20.84 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.28 1.54 . . . . 0.0 110.228 169.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -113.56 115.57 28.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.322 1.049 . . . . 0.0 113.606 -164.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.9 mt -104.98 -176.85 3.19 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.022 2.129 . . . . 0.0 111.441 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.9 mt -131.01 158.89 39.07 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.605 1.162 . . . . 0.0 113.193 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -109.49 172.29 6.94 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.728 1.211 . . . . 0.0 113.395 169.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 t -45.54 -36.88 4.9 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.146 1.779 . . . . 0.0 114.116 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -88.63 -16.92 31.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.054 1.742 . . . . 0.0 113.114 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.46 20.56 10.81 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.914 1.721 . . . . 0.0 112.763 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -83.26 141.02 32.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.444 0.698 . . . . 0.0 110.582 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.93 115.45 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.641 0.776 . . . . 0.0 110.08 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.9 mt -97.01 161.41 13.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.427 1.491 . . . . 0.0 111.449 170.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.84 144.85 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.07 0.948 . . . . 0.0 110.643 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.54 130.99 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.426 0.69 . . . . 0.0 109.66 170.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -108.27 -28.08 9.65 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.838 2.055 . . . . 0.0 112.079 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -157.75 149.59 22.01 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.129 1.772 . . . . 0.0 110.384 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -131.73 130.84 42.46 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.701 2.0 . . . . 0.0 109.629 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -143.2 155.06 44.44 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.023 1.729 . . . . 0.0 111.513 -175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 tp -132.8 144.14 50.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.89 1.676 . . . . 0.0 109.267 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.45 153.81 41.57 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.372 0.987 . . . . 0.0 113.183 166.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 mm -101.4 121.04 51.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.5 152.78 44.5 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.198 0.999 . . . . 0.0 112.953 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -69.63 -28.7 66.13 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.702 -1.249 . . . . 0.0 111.838 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -144.34 148.35 40.48 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.983 2.113 . . . . 0.0 110.123 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -54.69 120.0 7.37 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.489 3.459 . . . . 0.0 112.576 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.73 139.54 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.359 1.463 . . . . 0.0 109.496 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -76.89 139.19 40.15 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.936 0.874 . . . . 0.0 111.212 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.37 147.93 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.279 1.432 . . . . 0.0 110.516 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.72 148.22 50.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.849 1.26 . . . . 0.0 110.893 -165.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -157.54 168.38 27.47 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.462 1.105 . . . . 0.0 111.803 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -153.19 163.66 39.49 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.838 -1.164 . . . . 0.0 112.972 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -113.97 143.86 44.03 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.69 136.13 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 125.528 1.531 . . . . 0.0 112.974 -166.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.18 -28.41 69.11 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -141.62 -44.23 0.36 Allowed 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.978 -1.076 . . . . 0.0 112.607 173.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -71.45 171.67 10.88 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.441 1.115 . . . . 0.0 111.973 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -124.84 12.29 8.46 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.854 2.061 . . . . 0.0 112.715 -169.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.4 p -142.53 168.87 18.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.497 2.319 . . . . 0.0 111.519 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -160.64 175.13 13.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.118 2.167 . . . . 0.0 109.617 166.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -122.74 135.57 54.61 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.046 0.939 . . . . 0.0 113.141 -170.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.94 140.74 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.555 1.542 . . . . 0.0 112.429 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.73 170.15 20.27 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.671 1.605 . . . . 0.0 115.46 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.85 -22.49 66.54 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.693 -1.475 . . . . 0.0 113.023 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -81.49 2.78 27.35 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.182 1.393 . . . . 0.0 114.445 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 61.27 38.94 16.16 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.701 1.2 . . . . 0.0 113.345 164.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.63 137.36 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.668 1.587 . . . . 0.0 112.019 -164.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.2 tp -83.14 120.43 25.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.154 1.382 . . . . 0.0 113.848 -171.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.94 157.46 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.644 1.578 . . . . 0.0 112.052 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -106.87 128.94 54.72 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -167.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--O 1.25 1.098 0 C-N-CA 125.74 1.616 . . . . 0.0 111.993 172.461 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.041 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 99.1 m-85 -126.12 154.03 43.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.837 1.655 . . . . 0.0 111.415 172.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -70.64 162.14 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.495 0.664 . . . . 0.0 112.327 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.47 150.26 5.05 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.439 1.096 . . . . 0.0 112.639 173.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.18 -6.22 22.76 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 117.877 -1.513 . . . . 0.0 116.788 -173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.5 m -63.1 120.38 11.34 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.81 2.305 . . . . 0.0 110.147 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.0 mmt -76.02 146.44 39.48 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.915 1.286 . . . . 0.0 112.224 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 mm -131.64 134.1 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 127.685 2.394 . . . . 0.0 109.918 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 tp -78.91 127.01 31.46 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -120.63 173.89 6.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.667 1.587 . . . . 0.0 111.792 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.87 -24.85 67.66 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.939 -1.1 . . . . 0.0 113.429 175.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 p -107.31 -19.31 13.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.539 1.135 . . . . 0.0 113.518 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.89 -115.34 0.61 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.439 1.019 . . . . 0.0 113.363 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -122.8 153.32 39.7 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.048 1.739 . . . . 0.0 111.799 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.1 p -136.53 152.29 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.929 1.691 . . . . 0.0 110.268 168.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.26 146.09 37.1 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.773 -1.204 . . . . 0.0 110.819 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.2 tt -62.65 -29.49 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 121.044 -1.035 . . . . 0.0 112.664 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -65.39 -11.12 39.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.689 1.196 . . . . 0.0 113.729 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -120.13 -3.65 10.07 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.914 1.685 . . . . 0.0 113.371 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.1 mm -61.43 137.89 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 120.018 1.281 . . . . 0.0 108.806 166.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -124.16 159.05 30.91 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.021 1.328 . . . . 0.0 112.027 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.62 131.71 47.06 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.792 -1.193 . . . . 0.0 110.579 165.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.88 -4.44 82.68 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.601 1.095 . . . . 0.0 115.046 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.92 155.55 37.32 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.148 1.474 . . . . 0.0 111.542 163.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -109.48 150.76 27.64 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.362 1.465 . . . . 0.0 112.393 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.23 157.78 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.567 1.947 . . . . 0.0 110.072 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -73.97 137.9 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.795 -0.566 . . . . 0.0 110.712 165.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.41 118.24 16.19 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -98.05 111.88 24.03 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -54.47 114.76 7.25 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.873 1.269 . . . . 0.0 112.365 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.89 -4.52 14.96 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.711 2.274 . . . . 0.0 114.09 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -77.19 -46.87 21.87 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.682 1.193 . . . . 0.0 112.234 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 t -141.22 6.37 1.93 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.143 0.977 . . . . 0.0 112.84 -168.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 54.68 33.0 18.42 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.573 1.549 . . . . 0.0 114.037 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -71.05 125.85 27.98 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 167.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -96.66 120.13 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 124.227 1.011 . . . . 0.0 109.029 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.6 154.73 50.59 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.2 133.62 36.04 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.078 0.951 . . . . 0.0 108.998 162.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -138.92 152.54 47.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.078 0.951 . . . . 0.0 110.878 171.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 t -89.09 160.16 17.19 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.0 t -96.12 133.73 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.463 1.905 . . . . 0.0 111.575 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 mt -90.8 -43.0 10.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.932 0.893 . . . . 0.0 113.355 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -148.94 156.12 41.82 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.796 2.038 . . . . 0.0 111.138 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.4 p -132.34 103.49 6.24 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.08 1.752 . . . . 0.0 110.416 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -91.06 150.73 21.3 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.6 1.56 . . . . 0.0 112.727 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.8 t -143.02 129.57 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.342 1.057 . . . . 0.0 110.453 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -122.89 175.54 6.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.307 1.843 . . . . 0.0 110.931 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -128.2 137.44 52.04 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.679 1.192 . . . . 0.0 111.323 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.9 t -148.35 149.34 31.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.691 1.196 . . . . 0.0 111.88 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.2 p -91.21 -14.74 30.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.895 1.278 . . . . 0.0 113.863 170.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -100.32 111.34 23.6 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.384 -0.822 . . . . 0.0 111.399 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -120.5 157.83 28.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 122.939 1.352 . . . . 0.0 112.922 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.431 HD11 ' HE2' ' A' ' 102' ' ' LYS . 16.2 tp -126.39 133.31 51.33 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.535 1.934 . . . . 0.0 109.259 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -110.4 124.86 52.51 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.215 1.006 . . . . 0.0 108.773 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.8 mt -118.24 138.76 52.13 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.977 0.911 . . . . 0.0 109.779 171.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.6 m -106.54 122.34 46.11 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.99 117.97 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.075 1.35 . . . . 0.0 108.515 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.65 28.24 51.22 Favored Glycine 0 CA--C 1.544 1.888 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.7 -9.3 78.08 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.35 1.452 . . . . 0.0 115.737 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -92.79 122.93 35.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.002 1.401 . . . . 0.0 110.068 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.0 t -78.98 125.81 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.566 0.746 . . . . 0.0 110.617 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mt -121.77 103.77 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.979 1.711 . . . . 0.0 109.352 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -80.58 122.55 27.19 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.11 1.764 . . . . 0.0 111.035 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 t -146.16 178.22 8.39 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.629 1.172 . . . . 0.0 112.702 -167.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.8 p -82.23 152.75 26.25 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.048 0.927 . . . . 0.0 112.472 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -65.69 -19.38 65.88 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.44 9.38 31.71 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.976 1.311 . . . . 0.0 113.616 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.1 t60 -65.56 129.84 94.46 Favored Pre-proline 0 CA--C 1.552 1.053 0 O-C-N 120.465 -1.397 . . . . 0.0 113.042 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.7 119.92 4.97 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.98 3.12 . . . . 0.0 114.732 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -112.2 150.04 31.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.963 2.105 . . . . 0.0 111.223 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -93.86 130.8 39.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.275 0.943 . . . . 0.0 113.382 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.14 134.32 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 127.499 2.319 . . . . 0.0 111.339 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -58.06 130.26 45.75 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.733 1.213 . . . . 0.0 111.677 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 60.88 16.41 6.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.779 1.632 . . . . 0.0 114.555 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.9 t -133.8 -58.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.255 1.022 . . . . 0.0 111.231 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.93 -152.12 17.16 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.925 0.774 . . . . 0.0 113.714 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -86.75 139.16 30.99 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -170.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.12 149.01 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.249 1.82 . . . . 0.0 111.666 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.93 134.03 51.19 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.482 1.113 . . . . 0.0 112.632 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.95 -36.61 72.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.343 1.457 . . . . 0.0 112.856 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.72 -8.28 81.47 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.508 -1.162 . . . . 0.0 114.559 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -103.02 -12.88 17.12 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.025 1.412 . . . . 0.0 113.731 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.2 mt -56.97 163.08 2.13 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.27 1.428 . . . . 0.0 113.543 170.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.97 164.53 18.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.614 1.565 . . . . 0.0 110.727 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.5 t -67.92 143.73 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 122.39 1.09 . . . . 0.0 110.347 167.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.59 3.69 89.0 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.716 -1.047 . . . . 0.0 114.315 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -84.95 160.56 20.06 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.641 1.72 . . . . 0.0 111.471 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -104.84 103.71 13.36 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.399 1.08 . . . . 0.0 112.458 -160.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.8 mt -93.56 175.84 6.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.07 0.948 . . . . 0.0 110.453 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -122.19 158.85 28.5 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.76 -178.0 3.53 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.398 1.479 . . . . 0.0 113.871 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.1 p -61.25 -17.66 54.48 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -90.33 -25.57 20.41 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.243 1.383 . . . . 0.0 111.603 170.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.73 19.31 18.04 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.796 1.665 . . . . 0.0 112.369 -176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -88.4 155.61 19.59 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.007 1.723 . . . . 0.0 110.793 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -80.73 128.11 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -169.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.6 mt -107.48 162.72 13.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.094 2.158 . . . . 0.0 112.231 169.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.83 139.71 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.365 1.066 . . . . 0.0 111.195 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.5 t -73.73 124.95 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.427 0.691 . . . . 0.0 109.44 171.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -94.83 -33.63 12.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.425 1.89 . . . . 0.0 112.912 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -156.73 149.01 23.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.929 1.291 . . . . 0.0 111.292 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.431 ' HE2' HD11 ' A' ' 53' ' ' LEU . 34.8 tttm -124.73 127.43 47.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.836 2.054 . . . . 0.0 110.3 166.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -140.37 154.06 46.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.667 1.987 . . . . 0.0 111.505 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 tp -140.43 148.67 41.56 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.554 1.542 . . . . 0.0 110.083 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -155.28 164.86 38.2 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.718 0.807 . . . . 0.0 113.102 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mm -96.11 124.62 48.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 123.751 0.82 . . . . 0.0 109.188 161.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.95 150.65 45.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.744 1.218 . . . . 0.0 112.638 172.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -78.4 -13.02 60.03 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.685 1.594 . . . . 0.0 113.075 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -146.87 153.32 45.91 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.55 2.34 . . . . 0.0 110.132 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.48 114.76 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.916 2.411 . . . . 0.0 111.131 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.5 t -85.55 142.8 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.382 1.473 . . . . 0.0 109.989 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -79.71 139.39 37.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.119 0.962 . . . . 0.0 111.613 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.1 m -141.46 141.43 30.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.005 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -120.18 146.61 45.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.241 1.417 . . . . 0.0 110.77 -165.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -153.9 159.57 41.81 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.868 1.267 . . . . 0.0 111.397 173.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -150.72 163.14 39.29 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.434 -1.416 . . . . 0.0 113.568 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -120.26 138.85 53.43 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.72 149.42 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 127.557 2.343 . . . . 0.0 111.898 -168.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.89 -33.86 76.18 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 -168.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -143.81 -53.25 0.35 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.895 1.225 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -66.24 165.95 12.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.684 0.754 . . . . 0.0 110.297 167.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -133.51 27.64 4.04 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.429 1.492 . . . . 0.0 112.25 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.5 p -128.66 164.69 22.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.239 1.816 . . . . 0.0 111.881 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -159.03 -176.59 5.95 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.455 1.902 . . . . 0.0 109.922 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -127.24 138.37 53.09 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.395 1.078 . . . . 0.0 112.95 -171.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.47 143.6 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.194 0.997 . . . . 0.0 113.612 -171.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.35 168.83 20.07 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.615 1.579 . . . . 0.0 114.657 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.36 -22.8 61.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.175 1.39 . . . . 0.0 113.279 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -91.27 -0.9 57.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.762 1.625 . . . . 0.0 114.786 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 62.67 44.25 6.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.9 t -71.64 137.9 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.094 1.358 . . . . 0.0 111.406 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 57.2 tp -80.69 125.63 30.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.704 1.601 . . . . 0.0 113.247 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.49 160.07 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.894 1.678 . . . . 0.0 111.696 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -102.31 156.9 17.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.019 1.328 . . . . 0.0 113.06 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.088 1.755 . . . . 0.0 113.651 171.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.086 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 91.6 m-85 -121.26 156.02 33.39 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.332 1.453 . . . . 0.0 111.511 169.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.95 160.78 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.34 0.591 . . . . 0.0 112.054 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.59 152.5 2.71 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.905 0.86 . . . . 0.0 112.95 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.18 -9.16 20.69 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-O 117.349 -1.806 . . . . 0.0 116.696 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -62.91 123.55 18.79 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 120.878 2.339 . . . . 0.0 110.811 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -80.57 141.91 34.61 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.426 1.49 . . . . 0.0 112.294 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.81 134.85 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.87 2.068 . . . . 0.0 110.036 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.06 126.84 31.62 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.297 1.039 . . . . 0.0 113.032 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.8 p -121.9 172.75 7.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.025 1.33 . . . . 0.0 111.487 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.8 -20.32 65.69 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 120.844 -1.16 . . . . 0.0 113.268 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 p -109.41 -13.07 14.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.913 2.085 . . . . 0.0 113.759 -170.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.24 -112.75 0.64 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 126.087 1.803 . . . . 0.0 112.443 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -133.33 141.67 48.06 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.222 1.009 . . . . 0.0 112.583 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -133.06 144.29 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.446 1.899 . . . . 0.0 109.111 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.59 147.8 47.25 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.274 -0.891 . . . . 0.0 111.027 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -62.9 -27.6 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 120.315 -1.491 . . . . 0.0 113.043 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.58 -16.35 63.83 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.206 1.003 . . . . 0.0 113.457 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -110.61 -10.41 14.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.293 1.837 . . . . 0.0 113.146 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.4 mm -65.12 137.47 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 119.407 1.003 . . . . 0.0 108.921 162.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -127.65 166.06 18.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.915 2.086 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.53 133.67 46.18 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.89 -0.506 . . . . 0.0 110.511 160.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.29 6.73 89.09 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.972 1.272 . . . . 0.0 115.674 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -85.38 155.44 21.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.295 1.048 . . . . 0.0 110.333 165.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.59 135.25 52.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.311 1.044 . . . . 0.0 112.539 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.8 157.13 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.016 1.726 . . . . 0.0 110.652 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.3 mm -76.1 142.38 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.75 0.31 . . . . 0.0 111.275 168.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.63 126.73 22.66 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.904 0.881 . . . . 0.0 109.144 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.0 m -88.41 107.95 19.12 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 165.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -52.94 116.35 9.03 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.529 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.11 -11.22 28.72 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.673 2.249 . . . . 0.0 114.272 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -78.23 -49.1 14.38 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.748 1.219 . . . . 0.0 111.766 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 t -121.67 -7.88 9.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.525 1.13 . . . . 0.0 112.677 -167.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.276 12.9 m-85 53.5 43.02 31.83 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.703 1.601 . . . . 0.0 112.12 -173.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -81.44 131.37 35.28 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.927 0.891 . . . . 0.0 108.755 165.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.17 123.38 47.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 123.232 0.613 . . . . 0.0 110.621 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.2 159.22 42.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.311 1.045 . . . . 0.0 112.502 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -92.14 126.06 37.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.64 1.176 . . . . 0.0 108.87 164.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -137.84 152.83 49.48 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.189 0.996 . . . . 0.0 111.153 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -83.56 156.08 22.96 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.311 1.045 . . . . 0.0 113.058 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.8 t -87.58 134.55 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.706 1.602 . . . . 0.0 111.071 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.6 mt -84.21 -49.03 9.18 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.426 1.09 . . . . 0.0 112.508 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -151.28 159.77 44.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.694 1.998 . . . . 0.0 110.38 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.5 p -120.17 122.96 42.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.919 2.088 . . . . 0.0 109.571 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -101.46 147.02 26.85 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.89 0.876 . . . . 0.0 112.998 173.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.03 135.09 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.06 1.344 . . . . 0.0 110.077 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -126.86 170.93 11.71 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.028 2.131 . . . . 0.0 109.246 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -131.56 136.59 47.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.426 0.69 . . . . 0.0 111.714 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 t -154.57 146.93 23.91 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.598 0.759 . . . . 0.0 111.348 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.7 p -84.24 -18.32 36.89 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.716 0.806 . . . . 0.0 111.884 162.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -99.47 110.03 22.54 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 120.857 -1.152 . . . . 0.0 110.766 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.1 mt -121.5 172.53 8.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.767 1.627 . . . . 0.0 111.383 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.7 tp -141.32 130.48 23.43 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.893 1.277 . . . . 0.0 111.321 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -112.19 106.9 15.61 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.019 -1.05 . . . . 0.0 109.971 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.8 142.25 29.8 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.458 -0.776 . . . . 0.0 110.376 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.6 m -115.45 120.83 40.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.951 0.901 . . . . 0.0 109.471 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.02 117.37 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 126.32 1.848 . . . . 0.0 108.634 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.57 30.09 41.51 Favored Glycine 0 CA--C 1.543 1.789 0 N-CA-C 115.717 1.047 . . . . 0.0 115.717 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.08 6.4 84.8 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -102.37 129.38 48.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.881 1.341 . . . . 0.0 110.149 165.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -86.71 129.02 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.895 0.878 . . . . 0.0 110.287 164.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mt -121.7 101.51 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.07 1.348 . . . . 0.0 109.201 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.87 117.16 15.32 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.819 1.648 . . . . 0.0 110.732 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 t -142.72 -179.97 6.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.886 1.274 . . . . 0.0 112.464 -165.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.0 p -87.72 156.98 19.18 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 122.135 0.969 . . . . 0.0 112.353 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -59.45 -31.38 69.26 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.534 1.134 . . . . 0.0 113.082 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -101.05 8.96 42.67 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.5 t60 -64.08 128.12 92.68 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.474 1.034 . . . . 0.0 112.871 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.12 119.07 2.74 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.181 2.587 . . . . 0.0 114.947 -175.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -108.74 150.3 27.79 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.98 2.112 . . . . 0.0 111.472 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -98.19 130.04 44.94 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.517 1.053 . . . . 0.0 113.556 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.97 137.1 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.762 2.425 . . . . 0.0 111.392 -173.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -57.59 121.93 11.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.767 2.027 . . . . 0.0 112.671 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 53.03 30.04 8.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.616 1.967 . . . . 0.0 114.262 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.5 t -136.29 -50.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.469 1.508 . . . . 0.0 112.009 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.71 -153.58 17.53 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.046 0.831 . . . . 0.0 113.783 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -87.57 141.24 28.77 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.415 -1.05 . . . . 0.0 113.667 -173.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.95 145.28 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.284 1.433 . . . . 0.0 111.808 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.25 137.12 57.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.949 1.3 . . . . 0.0 112.098 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.18 -35.77 69.99 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.346 1.058 . . . . 0.0 113.64 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.04 -16.82 67.04 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 121.299 -0.876 . . . . 0.0 114.02 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -103.29 -2.04 27.8 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.467 1.907 . . . . 0.0 113.512 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.28 151.82 39.52 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.676 -0.64 . . . . 0.0 110.836 162.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.21 157.87 39.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.894 1.678 . . . . 0.0 109.623 170.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.53 136.8 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.07 4.78 88.17 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-O 118.856 -0.969 . . . . 0.0 115.441 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -83.29 150.17 26.32 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.546 1.673 . . . . 0.0 110.098 170.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -108.6 113.54 26.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.561 1.544 . . . . 0.0 112.631 -165.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.6 165.49 11.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.645 1.578 . . . . 0.0 112.627 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.71 142.42 36.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.667 1.587 . . . . 0.0 110.892 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -96.11 -178.13 4.23 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.986 0.915 . . . . 0.0 113.203 166.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.7 p -62.57 -1.77 0.91 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.628 1.971 . . . . 0.0 116.257 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.7 mtm-85 -117.8 -27.49 6.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.101 2.161 . . . . 0.0 111.565 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 104.43 17.32 15.67 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.813 2.149 . . . . 0.0 113.449 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -69.28 159.3 33.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.891 0.876 . . . . 0.0 111.14 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.3 t -75.87 131.41 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.747 0.784 . . . . 0.0 110.786 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.6 mt -117.5 158.47 24.49 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.931 2.092 . . . . 0.0 109.699 161.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.4 142.26 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.408 0.683 . . . . 0.0 111.277 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.48 129.4 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.429 1.091 . . . . 0.0 110.352 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -102.45 -33.91 9.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.351 2.26 . . . . 0.0 112.966 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -159.52 152.19 21.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.795 1.638 . . . . 0.0 111.797 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -124.92 124.06 41.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.053 2.141 . . . . 0.0 109.816 159.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -118.59 140.17 50.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.891 2.076 . . . . 0.0 109.868 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 tp -121.31 125.59 47.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.884 1.274 . . . . 0.0 110.637 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.66 159.34 39.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.582 0.706 . . . . 0.0 112.268 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.7 mm -111.36 114.07 46.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 166.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.36 150.7 42.8 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 122.103 0.954 . . . . 0.0 111.723 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.04 -22.09 60.69 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.944 1.298 . . . . 0.0 112.819 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -134.74 151.88 76.56 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 126.292 1.837 . . . . 0.0 111.131 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.91 111.28 3.0 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.683 2.256 . . . . 0.0 110.899 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.16 141.5 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 126.245 1.818 . . . . 0.0 109.674 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -75.28 134.27 41.12 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.297 1.046 . . . . 0.0 110.247 172.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.44 130.49 67.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.226 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -112.36 148.18 34.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.012 1.725 . . . . 0.0 110.959 -166.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -153.35 169.02 24.13 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.327 1.451 . . . . 0.0 109.867 171.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -148.73 171.74 15.73 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 120.398 -1.439 . . . . 0.0 111.674 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -128.52 139.55 52.26 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.817 0.847 . . . . 0.0 112.682 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.47 145.43 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.982 1.713 . . . . 0.0 111.62 -169.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.13 -40.62 86.04 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -166.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -133.6 -36.9 0.95 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.035 0.934 . . . . 0.0 112.57 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.76 160.45 29.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.933 0.873 . . . . 0.0 110.533 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -114.95 11.52 16.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.202 1.401 . . . . 0.0 112.832 -171.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 p -145.5 166.51 25.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.191 1.797 . . . . 0.0 112.381 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -156.42 -179.01 7.76 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.768 1.627 . . . . 0.0 110.774 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -122.79 138.54 54.61 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.161 1.384 . . . . 0.0 112.413 -175.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -123.3 141.46 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.323 1.449 . . . . 0.0 111.962 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.96 -176.22 53.21 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 168.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.53 -34.66 72.54 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.995 1.718 . . . . 0.0 112.41 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -82.73 -4.54 58.03 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.362 1.065 . . . . 0.0 113.471 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 59.14 47.17 12.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.202 1.801 . . . . 0.0 114.093 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 t -72.96 137.15 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.916 1.286 . . . . 0.0 111.316 -170.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 52.7 tp -81.43 125.98 31.09 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.167 1.387 . . . . 0.0 113.104 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.1 m -138.33 156.72 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.956 1.702 . . . . 0.0 111.301 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -105.81 146.66 29.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.851 1.26 . . . . 0.0 112.129 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.3 m120 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.177 0.991 . . . . 0.0 111.835 173.253 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.025 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.431 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 96.9 m-85 -128.02 153.23 47.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.408 1.483 . . . . 0.0 112.168 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 m -69.07 154.72 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.15 139.69 28.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.816 0.847 . . . . 0.0 111.55 171.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.72 -6.09 81.7 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.113 -1.382 . . . . 0.0 116.156 -170.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.9 m -64.3 123.43 19.12 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 121.163 2.482 . . . . 0.0 110.336 172.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.5 mmt -83.16 142.12 31.44 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.337 1.055 . . . . 0.0 112.08 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.19 135.03 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.369 2.267 . . . . 0.0 109.642 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.69 133.41 42.07 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 p -137.23 165.84 25.19 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.281 1.432 . . . . 0.0 111.195 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.56 -19.33 63.57 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.44 1.096 . . . . 0.0 113.372 170.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.4 p -86.57 -32.73 20.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.955 1.302 . . . . 0.0 111.64 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.71 -98.79 0.19 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.211 1.862 . . . . 0.0 110.612 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.4 mt -130.48 149.29 52.22 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.153 0.981 . . . . 0.0 111.867 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.5 141.25 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.859 1.663 . . . . 0.0 108.884 169.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.18 148.79 49.39 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.122 -0.986 . . . . 0.0 110.75 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.1 tt -61.48 -28.17 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 120.752 -1.217 . . . . 0.0 112.847 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.98 -6.64 46.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.905 1.282 . . . . 0.0 113.96 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -117.59 -7.96 11.0 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.121 1.769 . . . . 0.0 114.322 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.1 mm -66.81 139.41 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.928 0.785 . . . . 0.0 109.545 161.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -120.42 162.73 19.02 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.614 1.966 . . . . 0.0 110.32 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.5 135.54 54.37 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.093 0.473 . . . . 0.0 110.139 155.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.04 11.6 83.52 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.728 -1.04 . . . . 0.0 115.192 -176.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -96.86 158.0 15.64 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.846 1.323 . . . . 0.0 110.947 162.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -112.55 137.95 50.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.997 1.719 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -135.07 161.25 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.199 1.799 . . . . 0.0 111.163 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -76.52 143.11 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.661 0.664 . . . . 0.0 111.425 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.84 132.06 23.3 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.49 172.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.9 m -79.69 112.98 17.5 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 162.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -52.9 123.49 32.76 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 124.585 1.154 . . . . 0.0 112.392 171.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.0 -2.46 11.78 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 123.076 2.517 . . . . 0.0 114.778 -174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -90.78 -48.86 6.78 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.687 1.195 . . . . 0.0 112.004 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 t -127.67 1.56 6.13 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -166.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 61.02 27.41 17.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.339 1.456 . . . . 0.0 114.365 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.85 120.13 15.13 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.422 1.489 . . . . 0.0 109.157 170.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.5 t -100.56 120.48 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.454 0.701 . . . . 0.0 109.163 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.24 164.94 33.37 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.833 0.853 . . . . 0.0 112.089 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.56 137.82 48.34 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.692 0.397 . . . . 0.0 110.416 159.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -135.71 153.04 51.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.687 1.195 . . . . 0.0 111.117 161.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 t -78.12 154.46 31.24 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.2 t -91.93 135.0 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 127.039 2.136 . . . . 0.0 110.393 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.1 mt -87.56 -49.48 7.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.579 1.151 . . . . 0.0 112.33 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -146.57 156.66 43.4 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.179 1.392 . . . . 0.0 111.132 -175.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.5 p -124.86 119.51 29.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.238 1.815 . . . . 0.0 109.071 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -106.72 149.45 27.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.522 1.129 . . . . 0.0 113.316 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.6 t -139.03 142.32 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.2 1.4 . . . . 0.0 111.379 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -139.96 178.22 7.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.419 2.287 . . . . 0.0 111.988 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -129.65 141.09 50.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.05 1.74 . . . . 0.0 111.992 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 t -155.2 153.1 30.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.64 1.176 . . . . 0.0 111.639 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 p -90.0 -18.41 26.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.435 1.094 . . . . 0.0 113.296 164.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -95.0 106.98 19.0 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.391 -0.818 . . . . 0.0 111.725 -177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.7 mt -118.72 168.51 10.66 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.854 1.262 . . . . 0.0 112.571 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 tp -139.04 133.95 32.35 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.715 1.606 . . . . 0.0 110.967 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -106.06 138.1 42.83 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.469 1.508 . . . . 0.0 109.889 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.2 mt -127.21 130.53 49.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.309 1.043 . . . . 0.0 109.961 167.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.9 m -96.73 124.1 40.61 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 167.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.57 117.53 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.362 1.465 . . . . 0.0 109.289 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.53 29.36 31.56 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.09 7.75 79.86 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 116.856 1.502 . . . . 0.0 116.856 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -112.04 140.33 46.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.844 1.822 . . . . 0.0 108.519 163.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -108.49 134.4 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 124.612 1.165 . . . . 0.0 111.837 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 57.9 mt -129.17 136.45 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.858 1.663 . . . . 0.0 109.278 -171.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -120.44 107.21 12.62 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.249 1.42 . . . . 0.0 109.905 -162.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -138.73 175.65 9.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.223 1.409 . . . . 0.0 113.241 -157.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 p -82.87 152.16 25.7 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.922 0.868 . . . . 0.0 111.472 166.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -56.87 -31.02 64.41 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.652 1.181 . . . . 0.0 112.702 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -95.4 1.64 54.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.022 1.329 . . . . 0.0 114.109 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.431 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.0 t60 -65.69 126.64 92.03 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 118.509 -0.758 . . . . 0.0 112.602 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.28 117.37 2.8 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.732 2.288 . . . . 0.0 114.508 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -100.98 143.21 31.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.004 2.121 . . . . 0.0 111.046 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -89.15 127.48 35.73 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.537 1.062 . . . . 0.0 112.432 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.41 136.53 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.472 1.909 . . . . 0.0 110.395 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.2 tptt -50.85 130.75 25.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.772 1.629 . . . . 0.0 110.658 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t70 58.7 10.09 1.34 Allowed 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.5 t -131.55 -47.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.406 -1.433 . . . . 0.0 111.567 -167.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.63 -162.59 14.83 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.791 0.71 . . . . 0.0 113.3 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -76.72 147.5 37.34 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -172.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.91 145.8 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.102 2.161 . . . . 0.0 111.014 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.15 136.72 58.11 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.771 0.828 . . . . 0.0 112.839 172.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.88 -39.47 62.69 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.455 1.502 . . . . 0.0 113.41 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.34 -17.42 74.26 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 121.217 -0.927 . . . . 0.0 114.199 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -104.7 5.32 33.38 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.167 2.187 . . . . 0.0 113.806 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.04 160.89 30.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.632 0.651 . . . . 0.0 110.544 165.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -125.01 150.31 46.85 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.54 1.136 . . . . 0.0 111.58 172.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.72 134.85 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.26 4.35 81.14 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.791 -1.005 . . . . 0.0 114.956 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -92.33 159.53 15.55 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.247 1.524 . . . . 0.0 112.396 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -108.88 109.01 20.0 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.915 1.286 . . . . 0.0 112.47 -157.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 mt -103.14 -177.69 3.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.702 1.601 . . . . 0.0 111.725 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.1 mt -134.53 156.75 48.08 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.445 1.098 . . . . 0.0 113.274 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.96 -175.7 2.79 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.485 1.514 . . . . 0.0 114.413 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -64.62 -6.51 7.84 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -103.44 -16.02 15.71 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.104 1.762 . . . . 0.0 112.605 167.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.04 19.54 50.33 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.442 1.496 . . . . 0.0 112.238 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -84.2 145.94 28.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.46 1.104 . . . . 0.0 110.278 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.9 t -76.0 115.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.087 0.47 . . . . 0.0 110.985 -174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.6 mt -93.37 157.64 16.13 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.973 1.709 . . . . 0.0 111.388 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 t -123.04 138.78 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.294 1.037 . . . . 0.0 110.841 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.16 126.01 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.664 0.786 . . . . 0.0 109.414 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -106.35 -25.25 12.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.759 2.024 . . . . 0.0 113.089 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -163.07 150.81 13.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.933 1.293 . . . . 0.0 111.857 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -120.59 128.37 52.98 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.739 2.016 . . . . 0.0 109.466 161.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -130.85 123.78 29.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.985 1.314 . . . . 0.0 110.964 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.3 tp -102.26 129.32 48.64 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.033 1.333 . . . . 0.0 109.795 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -126.88 149.59 49.69 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.105 0.955 . . . . 0.0 112.961 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.2 mm -111.68 105.6 19.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 171.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.65 154.55 32.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.25 1.02 . . . . 0.0 111.369 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.43 -21.31 28.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.912 0.885 . . . . 0.0 112.054 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -136.95 140.39 31.44 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.43 1.492 . . . . 0.0 110.321 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.12 117.63 4.43 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.019 3.146 . . . . 0.0 111.886 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.04 137.04 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.557 1.543 . . . . 0.0 110.001 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -74.98 135.52 41.33 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.98 0.895 . . . . 0.0 110.566 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -132.6 133.84 59.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 125.096 1.358 . . . . 0.0 110.946 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -117.2 153.94 32.0 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.713 1.605 . . . . 0.0 111.273 -166.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -152.49 155.71 38.0 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.332 2.253 . . . . 0.0 109.348 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -150.46 161.04 43.28 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.57 -1.331 . . . . 0.0 112.614 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.4 148.39 43.84 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.26 144.85 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 125.806 1.643 . . . . 0.0 112.819 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.74 -29.22 63.15 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -164.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -138.63 -41.08 0.5 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.792 -1.192 . . . . 0.0 113.144 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -75.88 165.36 25.11 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.706 -0.621 . . . . 0.0 110.134 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -124.99 32.05 5.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.376 1.471 . . . . 0.0 110.747 -170.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -156.85 164.02 38.54 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.588 1.555 . . . . 0.0 111.268 -162.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -161.97 174.3 13.26 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.189 1.796 . . . . 0.0 110.447 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -121.07 136.34 55.0 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.767 1.227 . . . . 0.0 112.975 -173.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.9 m -127.27 144.91 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.712 1.605 . . . . 0.0 113.91 -173.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.72 172.94 30.13 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 126.038 1.78 . . . . 0.0 115.063 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.63 -20.03 63.62 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.48 -1.6 . . . . 0.0 113.236 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -85.08 -2.18 57.7 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 169.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 57.33 51.52 9.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.664 1.585 . . . . 0.0 112.694 163.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.02 140.1 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.845 2.058 . . . . 0.0 111.697 -168.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 46.0 tp -79.07 127.37 31.91 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.134 1.373 . . . . 0.0 114.33 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.48 154.71 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.858 1.663 . . . . 0.0 111.377 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -103.04 141.63 35.48 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.086 0.954 . . . . 0.0 113.272 -169.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.27 0 CA-C-O 116.322 -1.799 . . . . 0.0 111.242 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.982 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.415 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.4 m-85 -122.35 154.14 38.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.088 1.355 . . . . 0.0 111.491 172.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 m -69.3 154.69 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.0 0.429 . . . . 0.0 111.998 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.21 140.58 20.91 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.034 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.53 -9.46 71.47 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.544 2.021 . . . . 0.0 114.662 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 59.0 m -67.4 126.46 29.35 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.367 1.583 . . . . 0.0 111.5 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.4 mmt -78.1 143.6 37.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.858 1.663 . . . . 0.0 112.487 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.0 mm -129.61 139.0 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.608 1.963 . . . . 0.0 110.431 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.92 129.77 34.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.262 1.425 . . . . 0.0 113.066 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.8 p -134.66 173.03 12.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.777 1.231 . . . . 0.0 113.71 -167.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.07 -13.12 32.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.55 1.54 . . . . 0.0 113.794 171.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.7 p -124.33 1.89 8.43 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.7 -117.89 2.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.396 1.951 . . . . 0.0 110.758 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.51 142.54 46.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.496 1.118 . . . . 0.0 112.634 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.97 148.91 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 127.269 2.227 . . . . 0.0 108.94 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.87 147.33 51.86 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.313 -0.867 . . . . 0.0 112.027 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.5 tt -62.48 -33.31 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 120.936 -1.103 . . . . 0.0 112.514 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.8 pm0 -68.71 -16.5 63.84 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -104.78 -14.74 15.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.039 1.336 . . . . 0.0 112.571 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.2 mm -58.66 133.96 23.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 O-C-N 121.126 -0.984 . . . . 0.0 109.432 164.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -119.81 161.67 20.4 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.386 1.874 . . . . 0.0 112.357 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.38 133.74 53.18 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.84 -0.538 . . . . 0.0 110.556 167.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.13 -6.54 81.22 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.869 1.223 . . . . 0.0 114.785 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.96 150.72 40.61 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.099 1.45 . . . . 0.0 109.628 168.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.87 120.6 42.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.87 0.868 . . . . 0.0 111.2 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.5 m -106.06 151.46 8.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 125.195 1.398 . . . . 0.0 110.083 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.6 mm -81.67 137.08 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.52 116.23 13.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 m -93.07 111.41 23.04 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -52.95 115.01 6.62 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.897 1.279 . . . . 0.0 112.24 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -74.61 -1.61 11.32 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.054 2.503 . . . . 0.0 115.285 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -85.67 -46.75 10.45 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.785 -1.197 . . . . 0.0 112.317 170.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -126.31 -7.4 6.43 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.166 0.986 . . . . 0.0 113.127 -163.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.279 95.5 m-85 58.13 30.41 19.31 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.344 2.257 . . . . 0.0 115.017 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.92 130.05 39.12 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.57 0.748 . . . . 0.0 109.238 170.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -92.37 128.34 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.766 0.826 . . . . 0.0 109.501 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.37 149.36 39.29 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -69.3 136.11 51.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.389 0.676 . . . . 0.0 110.235 156.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 149.01 44.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.886 1.274 . . . . 0.0 110.026 159.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -78.06 153.58 32.16 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.898 0.856 . . . . 0.0 113.176 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.0 t -85.88 120.62 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.7 1.6 . . . . 0.0 109.757 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.71 -52.05 23.49 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.32 0.648 . . . . 0.0 111.12 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -146.24 156.58 43.48 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.266 1.426 . . . . 0.0 111.9 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 p -117.73 118.47 32.15 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.266 1.827 . . . . 0.0 111.148 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -104.52 151.93 23.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.693 1.597 . . . . 0.0 113.316 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 114' ' ' TYR . 16.3 t -136.4 140.98 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.0 1.72 . . . . 0.0 109.016 173.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -140.76 176.54 8.71 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.081 1.752 . . . . 0.0 109.889 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -131.61 134.32 45.89 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.576 1.15 . . . . 0.0 111.271 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -144.21 152.03 40.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.211 1.004 . . . . 0.0 110.926 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.7 p -96.76 -15.03 21.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.219 1.407 . . . . 0.0 113.658 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -109.17 106.05 15.77 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.824 0.85 . . . . 0.0 110.682 -170.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.3 mt -116.78 163.94 15.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 122.369 1.081 . . . . 0.0 113.817 -172.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.4 HD11 ' HD2' ' A' ' 102' ' ' LYS . 14.8 tp -137.26 129.14 28.97 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.694 1.597 . . . . 0.0 111.853 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -110.51 103.83 12.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.616 1.566 . . . . 0.0 111.188 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.21 141.29 28.59 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.057 0.943 . . . . 0.0 110.058 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.0 m -114.18 125.26 53.73 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 167.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.06 119.46 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.953 1.301 . . . . 0.0 109.891 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.05 24.55 35.64 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.158 0.885 . . . . 0.0 115.149 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.89 -0.36 69.62 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.042 1.306 . . . . 0.0 116.285 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -108.74 125.54 52.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.592 1.696 . . . . 0.0 110.292 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -91.7 134.74 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.143 0.977 . . . . 0.0 112.64 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 mt -133.9 132.21 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.642 1.977 . . . . 0.0 108.828 -170.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -120.99 105.92 11.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.154 0.982 . . . . 0.0 109.538 -159.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 t -140.05 175.75 9.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.916 0.887 . . . . 0.0 113.328 -156.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.0 p -80.54 152.39 28.67 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.897 0.879 . . . . 0.0 112.182 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -61.18 -29.37 69.76 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.974 -1.079 . . . . 0.0 112.656 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -94.19 2.4 55.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.397 1.079 . . . . 0.0 113.456 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.415 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.1 t60 -64.52 128.73 93.72 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 120.97 -1.081 . . . . 0.0 112.826 -172.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -79.93 112.39 2.86 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.561 2.841 . . . . 0.0 114.45 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -102.64 145.59 29.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.18 1.792 . . . . 0.0 111.956 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -93.3 132.04 37.88 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -116.65 135.63 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 127.303 2.241 . . . . 0.0 111.395 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -55.39 129.38 38.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.154 0.982 . . . . 0.0 110.982 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 64.66 9.01 4.83 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.47 1.908 . . . . 0.0 115.588 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.4 t -132.06 -44.66 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 120.882 -1.136 . . . . 0.0 112.344 -172.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.23 -147.75 17.83 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.213 -0.771 . . . . 0.0 112.377 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.28 53.4 p90 -91.26 143.12 26.98 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -144.63 147.98 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.829 2.052 . . . . 0.0 111.922 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -59.37 135.04 57.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.911 0.885 . . . . 0.0 112.63 171.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.58 -37.15 72.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.738 1.215 . . . . 0.0 113.014 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.36 -18.32 71.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.997 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -97.06 -1.94 44.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.629 1.572 . . . . 0.0 113.943 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.9 mt -70.51 156.59 39.19 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.651 0.78 . . . . 0.0 112.46 171.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -118.26 156.91 28.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.789 1.636 . . . . 0.0 111.433 170.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.36 132.33 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.883 0.873 . . . . 0.0 110.065 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.76 60.87 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.98 1.276 . . . . 0.0 115.655 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -86.97 159.03 19.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.489 1.645 . . . . 0.0 113.047 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -101.89 102.92 13.56 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.448 1.499 . . . . 0.0 112.361 -159.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.7 mt -95.81 166.84 11.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.528 1.131 . . . . 0.0 111.67 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.62 153.44 22.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.92 1.288 . . . . 0.0 110.306 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -109.89 -174.35 2.47 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 172.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.9 p -57.59 -12.75 3.03 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -103.7 -26.6 12.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.171 1.389 . . . . 0.0 111.342 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.83 22.2 24.04 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.335 1.922 . . . . 0.0 111.819 -167.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -76.75 159.58 30.03 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.764 0.826 . . . . 0.0 109.898 167.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.26 130.73 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.528 0.68 . . . . 0.0 112.328 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.4 158.65 20.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.036 2.934 . . . . 0.0 111.227 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.13 139.24 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.212 1.005 . . . . 0.0 111.266 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.2 t -73.71 125.75 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.539 0.736 . . . . 0.0 110.23 172.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -100.96 -26.71 13.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.621 2.369 . . . . 0.0 113.515 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -161.77 152.4 17.63 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.203 1.401 . . . . 0.0 111.565 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.4 ' HD2' HD11 ' A' ' 53' ' ' LEU . 20.3 ttpp -127.17 132.8 50.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.737 1.615 . . . . 0.0 111.067 156.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -132.12 154.83 49.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 128.524 2.73 . . . . 0.0 110.023 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 tt -142.6 137.18 29.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.509 1.524 . . . . 0.0 110.436 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -135.1 149.89 50.13 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.1 mm -106.58 105.67 19.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.954 1.302 . . . . 0.0 108.6 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.62 148.35 49.47 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.754 1.222 . . . . 0.0 113.221 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.19 -14.61 60.15 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.748 1.219 . . . . 0.0 113.354 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -151.25 153.52 32.72 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 126.708 2.003 . . . . 0.0 110.69 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.18 122.92 11.31 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.328 2.686 . . . . 0.0 112.861 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.97 142.04 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.8 1.64 . . . . 0.0 109.837 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -79.81 140.62 36.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.797 0.839 . . . . 0.0 111.269 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.2 m -143.75 150.59 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.307 1.043 . . . . 0.0 111.162 -173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.463 ' CD2' HG22 ' A' ' 46' ' ' VAL . 64.4 m-85 -128.1 147.15 50.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.712 1.205 . . . . 0.0 111.265 -165.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -155.94 166.79 32.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.257 1.823 . . . . 0.0 109.129 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -150.54 172.33 15.66 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.329 -1.482 . . . . 0.0 111.655 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -122.02 132.7 54.65 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.47 138.23 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.948 1.699 . . . . 0.0 111.486 -172.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.38 -33.33 65.63 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -148.28 -37.08 0.19 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.025 -1.047 . . . . 0.0 113.689 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -73.71 166.65 22.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.987 0.915 . . . . 0.0 110.424 172.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -133.77 28.58 3.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.448 1.499 . . . . 0.0 112.791 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.7 p -136.34 161.24 36.34 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.075 1.75 . . . . 0.0 111.511 175.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -157.6 -179.28 8.02 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.287 1.835 . . . . 0.0 109.814 167.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -132.95 139.33 47.25 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.26 1.024 . . . . 0.0 112.841 -168.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.78 141.4 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -170.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.36 172.55 31.59 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.39 1.472 . . . . 0.0 115.709 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.33 -19.23 65.31 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.927 -1.337 . . . . 0.0 113.808 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -93.77 1.51 56.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.402 1.481 . . . . 0.0 114.154 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 57.74 46.17 17.64 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.861 1.664 . . . . 0.0 114.217 166.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.26 138.09 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.397 1.079 . . . . 0.0 111.632 -171.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.66 124.96 28.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.799 1.639 . . . . 0.0 112.498 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.97 151.82 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.311 1.444 . . . . 0.0 110.845 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -81.69 146.76 29.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.976 0.51 . . . . 0.0 110.569 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 C--O 1.251 1.18 0 C-N-CA 124.788 1.235 . . . . 0.0 113.592 178.254 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.966 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -119.45 151.22 38.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.842 1.257 . . . . 0.0 110.915 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.82 158.73 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.272 0.558 . . . . 0.0 111.918 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.21 150.6 4.45 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.089 0.947 . . . . 0.0 111.63 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.47 -18.97 15.96 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 117.272 -1.849 . . . . 0.0 116.357 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.9 m -63.6 121.41 13.83 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.202 2.501 . . . . 0.0 110.718 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -77.76 143.77 37.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.476 1.111 . . . . 0.0 112.387 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.2 mm -126.81 136.46 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 127.548 2.339 . . . . 0.0 109.828 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -78.5 129.09 34.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.518 1.127 . . . . 0.0 113.441 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -127.52 173.59 9.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.57 1.548 . . . . 0.0 111.751 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.53 -15.1 63.14 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.851 -1.156 . . . . 0.0 113.371 172.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 p -109.03 -8.74 15.14 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.898 1.679 . . . . 0.0 114.21 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.38 -113.98 0.97 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.408 1.48 . . . . 0.0 111.412 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.8 mt -120.66 153.97 36.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.625 1.17 . . . . 0.0 111.584 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -137.63 144.99 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.667 1.987 . . . . 0.0 108.029 166.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.75 148.32 46.46 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.756 -1.215 . . . . 0.0 111.316 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 tt -63.32 -27.4 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 120.42 -1.425 . . . . 0.0 113.056 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -70.46 -7.15 41.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.964 1.306 . . . . 0.0 114.351 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -118.17 -15.37 9.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.644 1.578 . . . . 0.0 113.084 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.02 135.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.918 1.235 . . . . 0.0 110.295 169.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -120.75 159.06 26.18 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.644 1.578 . . . . 0.0 112.375 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 137.89 55.5 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.421 -0.8 . . . . 0.0 110.533 167.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.61 -6.67 72.4 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.376 0.989 . . . . 0.0 115.133 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -67.95 177.65 2.08 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.812 1.306 . . . . 0.0 110.99 167.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -120.14 153.45 36.17 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.9 -1.125 . . . . 0.0 112.584 168.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 m -141.45 160.83 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.754 1.622 . . . . 0.0 110.609 175.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.2 mm -77.99 135.87 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 122.041 -0.412 . . . . 0.0 111.2 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.2 120.82 21.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.754 1.222 . . . . 0.0 107.71 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.2 m -96.65 103.18 15.07 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -47.84 118.91 6.55 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.027 1.331 . . . . 0.0 112.479 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.46 -10.37 28.47 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.27 1.98 . . . . 0.0 114.107 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -77.54 -34.96 53.71 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.791 1.636 . . . . 0.0 113.315 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.7 t -144.91 -3.91 0.76 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.142 1.377 . . . . 0.0 112.702 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 54.73 40.23 31.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.598 1.559 . . . . 0.0 113.565 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -77.87 124.22 27.73 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.505 1.122 . . . . 0.0 109.494 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -85.92 123.85 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.083 0.553 . . . . 0.0 110.779 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.35 162.83 34.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.849 0.833 . . . . 0.0 112.972 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -103.84 116.47 32.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.853 1.661 . . . . 0.0 109.416 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -133.91 154.5 51.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.876 1.27 . . . . 0.0 111.444 -170.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 t -87.87 157.1 19.07 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.6 t -88.59 128.35 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.408 1.483 . . . . 0.0 110.843 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -83.3 -55.78 4.13 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.009 0.524 . . . . 0.0 111.333 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -138.7 152.73 48.26 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.601 1.161 . . . . 0.0 111.627 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -128.01 107.98 10.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.759 1.624 . . . . 0.0 110.411 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -96.31 146.3 24.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.403 1.081 . . . . 0.0 111.706 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 t -136.79 137.04 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.996 0.918 . . . . 0.0 109.192 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -133.95 175.4 9.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.525 2.33 . . . . 0.0 109.256 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -131.6 132.22 43.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.312 1.045 . . . . 0.0 111.751 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 t -141.66 140.27 33.19 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.422 1.089 . . . . 0.0 111.101 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -85.19 -21.98 28.92 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.535 0.734 . . . . 0.0 112.287 165.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -92.87 120.63 33.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.92 0.782 . . . . 0.0 109.495 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.3 mt -126.61 161.96 26.82 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.481 1.134 . . . . 0.0 112.673 174.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 tp -127.83 128.87 45.99 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.461 1.904 . . . . 0.0 109.918 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -113.22 95.9 5.63 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.197 -0.94 . . . . 0.0 109.29 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.0 mt -83.69 145.04 28.99 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.444 -0.785 . . . . 0.0 110.291 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -117.32 120.01 36.89 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -128.12 120.99 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.997 1.319 . . . . 0.0 108.61 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.52 31.12 28.43 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.42 -5.75 83.76 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.221 1.391 . . . . 0.0 116.0 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -94.96 125.93 39.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.236 1.518 . . . . 0.0 109.581 172.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.19 132.42 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.313 0.645 . . . . 0.0 110.998 167.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -123.47 103.32 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.282 1.833 . . . . 0.0 109.072 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -77.67 106.91 9.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.48 2.312 . . . . 0.0 110.766 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 t -137.47 -179.34 5.68 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.156 1.382 . . . . 0.0 112.103 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.0 p -88.25 163.36 16.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.77 1.228 . . . . 0.0 111.91 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -68.45 -25.76 65.17 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.867 -1.146 . . . . 0.0 112.45 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -106.43 9.6 31.67 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.654 0.782 . . . . 0.0 113.006 -171.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -72.19 131.68 84.96 Favored Pre-proline 0 CA--C 1.553 1.066 0 O-C-N 121.369 -0.832 . . . . 0.0 112.717 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.3 120.05 2.83 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.201 3.268 . . . . 0.0 115.575 -175.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -106.88 145.16 32.52 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.462 1.905 . . . . 0.0 111.201 172.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -88.96 131.45 35.15 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.305 1.412 . . . . 0.0 113.506 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.31 133.7 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 127.126 2.171 . . . . 0.0 111.504 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -56.58 127.68 32.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.786 0.834 . . . . 0.0 112.855 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 59.99 15.5 5.09 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.316 1.847 . . . . 0.0 115.488 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.3 t -125.26 -59.15 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 120.833 -1.167 . . . . 0.0 111.09 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.39 -162.47 22.7 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.242 0.925 . . . . 0.0 112.653 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -83.29 146.19 28.67 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.845 1.322 . . . . 0.0 114.143 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.83 145.35 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 127.307 2.243 . . . . 0.0 111.259 -175.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -66.04 136.74 56.44 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.682 0.793 . . . . 0.0 112.485 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.74 -39.32 68.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.489 1.516 . . . . 0.0 113.799 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.35 -17.8 77.84 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.355 -0.84 . . . . 0.0 114.041 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -93.63 -9.76 36.88 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.392 1.477 . . . . 0.0 113.761 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.99 167.76 1.53 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.35 1.06 . . . . 0.0 113.103 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 162.43 27.37 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.463 1.505 . . . . 0.0 110.115 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.97 145.39 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.307 0.575 . . . . 0.0 109.505 167.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.43 4.8 89.26 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.727 -1.041 . . . . 0.0 114.807 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -84.58 158.01 21.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.153 1.476 . . . . 0.0 112.426 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -105.9 104.43 14.14 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.815 1.246 . . . . 0.0 111.591 -162.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.8 mt -101.19 169.37 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.904 1.281 . . . . 0.0 111.11 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -115.49 144.1 44.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.955 1.302 . . . . 0.0 110.634 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.96 -177.11 5.11 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.533 1.133 . . . . 0.0 112.805 168.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.1 p -59.98 -17.42 38.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -97.51 -26.34 14.85 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.837 1.653 . . . . 0.0 112.737 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 104.08 23.4 8.15 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.448 1.499 . . . . 0.0 113.15 -170.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -81.34 151.07 28.18 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.791 1.236 . . . . 0.0 110.649 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.9 t -84.85 133.12 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.124 0.97 . . . . 0.0 112.159 -168.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -118.62 148.74 42.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.575 2.35 . . . . 0.0 111.424 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.56 135.43 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.224 1.01 . . . . 0.0 110.714 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.04 127.21 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 169.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.47 -38.34 8.44 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.329 1.452 . . . . 0.0 112.565 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -161.48 154.82 21.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.29 1.436 . . . . 0.0 111.913 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -120.07 133.21 55.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.458 1.503 . . . . 0.0 110.51 163.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -124.43 153.25 42.22 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.989 2.515 . . . . 0.0 109.965 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 tp -135.11 143.16 46.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.095 1.758 . . . . 0.0 109.942 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.46 157.17 44.37 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.3 mm -108.33 105.24 18.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.656 1.182 . . . . 0.0 108.364 166.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.78 147.51 49.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.899 1.28 . . . . 0.0 113.71 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -74.16 -10.61 59.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.585 1.554 . . . . 0.0 113.972 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -139.65 157.13 70.67 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 127.034 2.134 . . . . 0.0 110.291 166.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.77 119.09 6.04 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.653 2.236 . . . . 0.0 110.492 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.7 t -90.02 136.9 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 126.011 1.725 . . . . 0.0 109.419 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -74.61 138.39 42.92 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.679 0.792 . . . . 0.0 110.226 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.95 142.53 29.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 123.926 0.89 . . . . 0.0 110.764 -174.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -122.08 145.46 48.13 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.032 1.333 . . . . 0.0 110.433 -163.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -153.1 165.54 35.3 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.968 1.307 . . . . 0.0 110.801 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -147.03 164.09 34.13 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.423 -1.423 . . . . 0.0 113.02 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -117.69 141.43 48.39 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.02 147.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.078 1.751 . . . . 0.0 111.556 -168.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.16 -67.65 0.42 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.637 1.175 . . . . 0.0 113.886 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -94.88 -54.57 3.42 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.645 -0.66 . . . . 0.0 112.28 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -83.44 177.63 8.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.856 1.263 . . . . 0.0 111.579 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -131.75 29.2 4.49 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.027 1.331 . . . . 0.0 114.187 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 p -137.04 161.61 35.6 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.992 1.717 . . . . 0.0 112.507 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -156.16 -177.48 6.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.528 1.931 . . . . 0.0 110.751 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -132.24 139.57 48.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.096 1.358 . . . . 0.0 113.176 -168.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.22 144.17 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.375 1.07 . . . . 0.0 113.351 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.13 -179.42 39.13 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.051 1.786 . . . . 0.0 116.642 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.92 -39.15 71.23 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.951 1.301 . . . . 0.0 111.973 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -86.33 2.21 48.24 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 59.78 39.53 20.63 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.24 134.5 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.269 0.627 . . . . 0.0 111.578 -169.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.7 tp -73.76 121.93 21.6 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.859 1.664 . . . . 0.0 112.445 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.13 161.92 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.647 1.579 . . . . 0.0 111.623 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -111.03 143.65 41.4 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -167.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 127.343 2.257 . . . . 0.0 113.262 172.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.07 152.73 37.13 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.495 1.518 . . . . 0.0 111.068 173.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.1 m -68.25 157.43 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.382 0.611 . . . . 0.0 111.707 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.5 150.11 2.83 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.62 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.94 -10.83 45.18 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.269 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.0 m -64.2 123.91 20.32 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 120.901 2.351 . . . . 0.0 110.641 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 mmt -80.26 140.03 36.41 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.284 1.434 . . . . 0.0 111.831 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.6 mm -123.12 135.71 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.367 1.867 . . . . 0.0 109.719 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.53 123.86 26.7 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.653 0.781 . . . . 0.0 111.608 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 p -117.36 177.36 4.77 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.764 1.226 . . . . 0.0 112.71 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.72 -15.01 50.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.092 1.357 . . . . 0.0 114.128 170.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.5 p -124.68 -12.23 7.17 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.43 -115.1 0.65 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.04 0.828 . . . . 0.0 112.726 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 78.7 mt -125.72 139.65 53.36 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.232 1.013 . . . . 0.0 112.799 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -136.38 147.69 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.83 2.052 . . . . 0.0 109.012 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.42 148.11 47.25 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.273 -0.892 . . . . 0.0 111.442 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.0 tt -61.44 -26.29 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 120.682 -1.261 . . . . 0.0 113.496 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -72.27 -9.07 57.99 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.953 1.301 . . . . 0.0 114.198 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -118.7 -10.28 10.04 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.986 1.714 . . . . 0.0 113.332 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -66.91 136.69 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.668 1.122 . . . . 0.0 109.391 162.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -130.07 166.77 19.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.048 1.739 . . . . 0.0 111.182 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.86 134.08 55.01 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.212 -0.93 . . . . 0.0 110.199 165.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.2 -7.84 81.19 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -67.95 167.73 13.17 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.825 1.312 . . . . 0.0 111.496 161.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -124.23 123.84 41.14 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.431 1.492 . . . . 0.0 111.863 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.98 152.76 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.815 1.646 . . . . 0.0 110.227 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -77.79 139.12 19.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.373 0.606 . . . . 0.0 110.543 169.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.23 126.4 28.07 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.413 1.085 . . . . 0.0 108.378 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.4 m -78.93 111.99 15.67 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 159.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -53.63 114.31 6.08 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.655 1.182 . . . . 0.0 112.15 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.75 -12.77 35.62 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.611 2.207 . . . . 0.0 114.29 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.66 -48.85 14.22 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.793 -1.192 . . . . 0.0 111.887 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -129.0 -0.41 5.26 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.036 1.335 . . . . 0.0 114.117 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.324 4.0 m-85 61.72 25.39 15.29 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.046 1.738 . . . . 0.0 115.541 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.79 136.81 53.34 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.416 -0.803 . . . . 0.0 110.251 168.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.31 117.36 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.268 1.027 . . . . 0.0 110.497 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.31 160.9 43.01 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -71.92 132.26 44.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.414 1.085 . . . . 0.0 110.453 166.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HE3' ' CE1' ' A' ' 121' ' ' PHE . 70.5 mmtt -135.62 150.13 49.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.535 1.534 . . . . 0.0 110.359 170.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -82.39 155.01 24.92 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.9 t -90.21 131.6 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.86 1.264 . . . . 0.0 111.176 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.98 -45.72 10.51 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.942 0.897 . . . . 0.0 112.476 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -148.83 153.45 38.11 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.38 1.872 . . . . 0.0 110.669 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.7 p -120.73 122.59 40.74 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.238 1.415 . . . . 0.0 111.095 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -104.7 148.05 27.0 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.604 1.562 . . . . 0.0 112.421 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.0 t -143.31 132.22 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.552 1.141 . . . . 0.0 111.251 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -134.14 177.67 7.56 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.258 2.223 . . . . 0.0 111.936 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -139.51 138.8 36.66 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.423 1.489 . . . . 0.0 111.511 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.1 t -155.23 154.29 31.96 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.984 0.914 . . . . 0.0 111.907 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.7 p -87.39 -15.48 37.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.781 1.232 . . . . 0.0 113.424 164.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -98.55 108.26 20.91 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.086 -1.009 . . . . 0.0 110.972 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.3 mt -108.86 174.38 5.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.949 0.899 . . . . 0.0 111.935 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.8 tp -147.76 137.97 22.93 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.214 1.406 . . . . 0.0 110.726 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -124.17 112.91 17.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.863 1.265 . . . . 0.0 110.18 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.9 130.54 54.56 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.801 0.84 . . . . 0.0 109.819 176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -105.52 116.51 32.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.845 1.258 . . . . 0.0 108.542 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -127.77 116.06 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.55 1.54 . . . . 0.0 109.472 -171.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.49 30.82 34.91 Favored Glycine 0 CA--C 1.542 1.774 0 O-C-N 121.628 -0.67 . . . . 0.0 113.97 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.93 -1.61 88.23 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.245 1.403 . . . . 0.0 115.73 -177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.28 120.92 38.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.857 1.829 . . . . 0.0 109.52 170.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -88.57 138.05 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.238 0.615 . . . . 0.0 111.824 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.5 mt -133.67 131.91 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.36 1.864 . . . . 0.0 109.139 -176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -114.05 109.73 18.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.73 1.612 . . . . 0.0 110.607 -165.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 t -140.63 -179.38 6.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.164 1.386 . . . . 0.0 112.668 -158.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.1 p -90.29 155.45 18.97 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.302 1.041 . . . . 0.0 112.287 169.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -59.72 -29.9 68.45 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.107 -0.996 . . . . 0.0 113.442 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -94.52 3.44 55.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -64.54 127.89 92.82 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 120.912 -1.118 . . . . 0.0 112.6 -170.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -81.1 113.2 2.68 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 123.695 2.93 . . . . 0.0 114.292 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -103.63 144.05 31.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.952 1.701 . . . . 0.0 111.64 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -84.89 134.35 34.27 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.307 0.958 . . . . 0.0 112.756 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.9 t -118.71 132.87 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.769 2.028 . . . . 0.0 111.867 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 121.92 4.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.325 1.45 . . . . 0.0 111.899 172.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 56.38 30.07 16.26 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.312 1.445 . . . . 0.0 113.977 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -141.65 -42.11 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 125.373 1.469 . . . . 0.0 112.737 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.66 -148.99 18.77 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.965 0.793 . . . . 0.0 112.848 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -88.06 135.83 33.25 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.8 p -136.84 145.08 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.132 1.773 . . . . 0.0 111.455 -176.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -63.58 131.99 49.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.092 1.357 . . . . 0.0 111.016 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.34 67.34 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.152 -0.967 . . . . 0.0 113.44 -175.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.03 -7.28 81.5 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 121.119 -0.988 . . . . 0.0 114.494 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -107.23 -2.47 20.78 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.087 1.755 . . . . 0.0 113.543 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.76 161.7 17.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.992 1.317 . . . . 0.0 112.326 166.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.7 159.32 24.71 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.812 1.245 . . . . 0.0 113.256 160.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.78 130.87 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 159.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.87 -0.89 84.82 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 117.185 -1.897 . . . . 0.0 115.558 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.01 151.42 41.76 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 121.404 2.602 . . . . 0.0 111.509 166.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -102.86 107.87 18.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.028 1.731 . . . . 0.0 112.854 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.9 mt -97.75 167.65 10.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.647 1.179 . . . . 0.0 111.871 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.14 146.8 38.61 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.052 1.341 . . . . 0.0 111.182 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.24 -178.05 3.54 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 172.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.4 p -59.89 -6.6 1.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.77 2.028 . . . . 0.0 116.466 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.51 -17.17 10.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.513 1.925 . . . . 0.0 112.621 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.48 23.88 32.64 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.045 1.783 . . . . 0.0 112.033 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -66.65 148.78 51.44 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.205 0.502 . . . . 0.0 109.768 161.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.3 t -84.16 128.15 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 122.491 0.317 . . . . 0.0 110.381 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.8 mt -108.4 161.07 15.37 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.465 2.706 . . . . 0.0 110.652 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.5 t -134.6 140.4 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.507 1.123 . . . . 0.0 110.605 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.08 129.13 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.361 0.664 . . . . 0.0 109.894 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -96.64 -41.73 8.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.428 2.291 . . . . 0.0 112.011 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -153.53 149.92 28.18 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.807 1.643 . . . . 0.0 110.681 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -132.75 122.73 24.99 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.95 2.1 . . . . 0.0 108.727 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mmtm -134.48 128.71 33.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.492 1.117 . . . . 0.0 112.992 -166.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.1 tp -102.55 134.88 45.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.033 1.733 . . . . 0.0 109.612 173.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -136.09 147.95 48.07 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.361 0.664 . . . . 0.0 111.423 158.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.0 mm -91.7 117.05 34.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 165.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.03 142.19 55.97 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.263 1.025 . . . . 0.0 111.183 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.0 -17.87 62.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.437 0.695 . . . . 0.0 112.738 -176.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -144.38 147.52 37.11 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.373 2.269 . . . . 0.0 110.178 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.11 120.06 7.38 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 124.389 3.393 . . . . 0.0 112.809 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.75 141.7 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.906 1.682 . . . . 0.0 110.441 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -75.14 141.11 43.73 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.494 0.718 . . . . 0.0 111.482 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 m -136.47 144.07 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.938 1.695 . . . . 0.0 110.397 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.47 147.3 49.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.468 1.507 . . . . 0.0 110.644 -166.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -155.38 170.46 21.85 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.721 1.608 . . . . 0.0 111.495 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -154.19 166.1 34.18 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.428 -1.42 . . . . 0.0 113.043 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -120.04 146.13 46.19 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.668 1.187 . . . . 0.0 113.857 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.71 147.09 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.954 1.701 . . . . 0.0 112.44 -162.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.37 -39.56 92.45 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -168.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -133.99 -48.16 0.8 Allowed 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.599 -1.313 . . . . 0.0 113.386 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.414 ' CE1' ' HE3' ' A' ' 39' ' ' LYS . 7.8 m-30 -77.61 168.86 19.29 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 169.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -114.93 17.87 16.7 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.2 1.4 . . . . 0.0 112.669 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 p -141.08 165.16 28.31 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.968 1.707 . . . . 0.0 112.794 -160.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -158.98 178.38 10.13 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.054 1.742 . . . . 0.0 110.662 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -120.41 139.81 52.27 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.038 1.335 . . . . 0.0 112.501 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.0 144.48 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.092 1.357 . . . . 0.0 113.61 -175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.21 173.7 29.73 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.232 1.396 . . . . 0.0 116.034 172.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.13 -27.84 69.65 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.178 -1.189 . . . . 0.0 113.648 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -88.66 -1.34 58.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.346 1.458 . . . . 0.0 113.519 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 59.25 49.8 8.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.182 1.793 . . . . 0.0 113.988 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t -74.91 138.79 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.11 1.364 . . . . 0.0 111.579 -173.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.9 tp -79.78 128.86 33.95 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.575 1.55 . . . . 0.0 113.524 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.5 m -138.06 155.06 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.724 . . . . 0.0 111.356 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -104.23 158.44 16.44 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.47 1.508 . . . . 0.0 110.778 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 C--O 1.254 1.327 0 O-C-N 120.622 -1.299 . . . . 0.0 114.097 172.334 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.101 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.87 154.38 41.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.29 1.436 . . . . 0.0 111.985 169.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.07 161.6 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.242 0.617 . . . . 0.0 112.554 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 150.55 7.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.326 1.05 . . . . 0.0 111.358 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.59 -7.03 9.47 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-O 117.795 -1.558 . . . . 0.0 116.486 -172.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.8 m -61.65 119.36 8.52 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 121.552 2.676 . . . . 0.0 109.685 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -74.62 143.29 44.41 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.851 0.861 . . . . 0.0 111.405 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.3 mm -127.51 135.51 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.796 2.038 . . . . 0.0 109.519 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -78.23 126.36 30.69 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.0 p -117.96 176.39 5.23 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.789 1.235 . . . . 0.0 111.82 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.81 -10.8 59.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 171.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 p -119.46 -16.04 8.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.27 1.828 . . . . 0.0 113.934 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.03 -122.8 1.26 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.089 1.328 . . . . 0.0 111.53 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.5 mt -124.28 142.8 50.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.163 1.385 . . . . 0.0 112.258 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.15 143.08 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.12 1.768 . . . . 0.0 108.613 171.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.57 148.03 51.09 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.999 -1.063 . . . . 0.0 111.352 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 tt -61.34 -26.88 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 O-C-N 120.592 -1.317 . . . . 0.0 113.524 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.82 -16.44 64.11 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -112.54 -12.04 13.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.151 1.78 . . . . 0.0 112.665 -174.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.54 141.12 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.04 0.836 . . . . 0.0 109.837 162.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -128.43 159.77 34.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.443 1.897 . . . . 0.0 112.263 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.72 124.8 21.7 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.485 165.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.65 -0.34 84.76 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.497 1.046 . . . . 0.0 115.392 -170.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -76.8 154.15 34.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.424 1.612 . . . . 0.0 110.539 158.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -108.92 142.89 38.89 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.218 1.407 . . . . 0.0 112.217 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -136.5 159.85 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.376 1.87 . . . . 0.0 111.026 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.9 mm -74.59 137.85 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.966 -0.459 . . . . 0.0 111.898 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.49 123.08 19.75 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.167 0.987 . . . . 0.0 108.657 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.4 m -93.33 103.85 16.05 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 170.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -52.97 113.91 5.2 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.818 1.647 . . . . 0.0 113.18 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.58 -11.24 31.46 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.159 2.573 . . . . 0.0 114.413 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -76.43 -38.9 54.83 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.381 1.072 . . . . 0.0 112.638 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 t -133.96 -6.96 2.73 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.282 1.033 . . . . 0.0 112.516 -172.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.267 2.4 t80 61.99 39.34 13.45 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.31 1.844 . . . . 0.0 113.601 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -95.2 135.75 36.39 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.452 1.501 . . . . 0.0 110.522 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.04 136.71 30.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 122.956 0.502 . . . . 0.0 111.653 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.8 167.99 25.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.379 1.472 . . . . 0.0 111.951 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -89.71 126.88 35.82 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.686 0.794 . . . . 0.0 110.196 164.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -130.23 151.75 50.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.496 1.118 . . . . 0.0 112.123 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -87.53 154.5 20.58 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.42 1.088 . . . . 0.0 113.141 -176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.4 t -89.66 132.68 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.661 1.584 . . . . 0.0 110.753 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.38 -43.19 9.9 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.903 0.881 . . . . 0.0 112.785 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -142.85 153.09 42.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.157 1.383 . . . . 0.0 110.297 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 p -122.1 118.42 28.66 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.9 1.68 . . . . 0.0 108.832 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.02 143.71 28.3 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.424 1.49 . . . . 0.0 112.258 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.41 HG22 ' CD2' ' A' ' 114' ' ' TYR . 41.5 t -141.13 126.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.751 1.221 . . . . 0.0 110.889 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -132.8 174.77 9.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.825 2.05 . . . . 0.0 109.62 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -132.33 130.2 40.46 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.871 0.868 . . . . 0.0 111.093 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.7 t -140.18 139.54 35.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.522 1.129 . . . . 0.0 110.87 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.0 p -81.12 -19.88 42.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.854 0.862 . . . . 0.0 111.926 166.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -94.2 111.63 23.37 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.383 1.073 . . . . 0.0 110.668 -173.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.0 mt -127.85 157.2 41.13 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 123.409 1.576 . . . . 0.0 113.908 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.4 tp -121.77 136.15 54.93 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.495 1.918 . . . . 0.0 109.956 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -110.39 124.09 51.07 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.712 1.205 . . . . 0.0 109.2 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.0 mt -121.52 137.91 54.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 167.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.7 m -109.25 120.75 43.48 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 167.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.14 122.87 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.463 1.105 . . . . 0.0 108.269 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.64 18.59 16.94 Favored Glycine 0 CA--C 1.547 2.083 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.58 5.08 67.22 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 119.581 1.691 . . . . 0.0 116.323 -171.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -103.52 122.57 45.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.29 1.545 . . . . 0.0 110.296 164.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -77.18 124.03 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.537 0.735 . . . . 0.0 109.407 164.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mt -119.5 100.69 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.175 1.39 . . . . 0.0 109.122 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.57 119.24 21.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.591 1.556 . . . . 0.0 110.49 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -143.05 -179.06 6.14 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.129 0.972 . . . . 0.0 111.305 -168.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.4 p -88.69 155.65 19.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.955 0.883 . . . . 0.0 111.669 167.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.97 -33.59 69.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.536 1.135 . . . . 0.0 112.146 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -85.92 -7.73 58.49 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.634 1.173 . . . . 0.0 113.315 -170.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -64.57 127.48 92.41 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-O 118.213 -0.899 . . . . 0.0 113.177 -166.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.59 108.19 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.373 2.715 . . . . 0.0 114.313 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.26 141.92 34.31 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.625 1.97 . . . . 0.0 111.865 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -85.91 127.13 34.53 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.67 135.86 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 127.601 2.36 . . . . 0.0 111.257 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -52.67 121.22 6.76 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.13 1.372 . . . . 0.0 112.638 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.29 14.06 4.38 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.064 2.146 . . . . 0.0 115.54 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.8 t -122.77 -54.56 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.537 1.135 . . . . 0.0 110.728 -173.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.44 -161.93 16.42 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.586 0.612 . . . . 0.0 113.436 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -84.63 145.12 28.17 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.577 1.188 . . . . 0.0 114.166 -174.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.48 149.62 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.474 1.91 . . . . 0.0 111.263 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -55.73 131.48 46.76 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.743 1.217 . . . . 0.0 111.861 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.05 -35.81 64.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.635 1.174 . . . . 0.0 113.075 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.67 -5.73 88.3 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.63 -1.095 . . . . 0.0 114.898 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -97.93 -4.64 36.01 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.246 1.418 . . . . 0.0 113.519 171.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.52 160.07 33.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.556 0.693 . . . . 0.0 111.278 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -117.35 167.78 10.94 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.494 1.518 . . . . 0.0 110.535 166.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.88 144.71 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.495 -0.753 . . . . 0.0 109.323 155.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.84 1.43 89.54 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.951 -0.916 . . . . 0.0 114.132 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -82.9 152.14 25.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 119.038 1.419 . . . . 0.0 111.385 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -108.45 112.02 24.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.429 1.092 . . . . 0.0 112.484 -163.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.9 mt -107.27 179.41 4.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.341 1.856 . . . . 0.0 110.588 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.89 156.63 44.72 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.026 0.931 . . . . 0.0 113.467 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -98.15 174.04 6.72 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.578 1.151 . . . . 0.0 113.117 166.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.6 t -55.58 -35.38 65.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.782 1.233 . . . . 0.0 113.787 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -75.24 -29.55 60.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.555 1.542 . . . . 0.0 112.727 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.79 24.67 6.87 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.597 1.57 . . . . 0.0 113.499 173.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -78.43 152.94 31.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.441 1.496 . . . . 0.0 110.193 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.12 125.07 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 122.579 0.352 . . . . 0.0 110.992 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.0 mt -106.34 149.75 26.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.277 1.431 . . . . 0.0 111.863 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.0 t -127.23 137.0 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.457 1.103 . . . . 0.0 111.455 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.16 123.7 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.598 1.159 . . . . 0.0 111.074 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -88.63 -32.87 17.84 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.673 2.389 . . . . 0.0 114.48 175.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -152.82 147.92 26.59 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.954 1.302 . . . . 0.0 111.482 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -133.55 132.85 41.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.034 1.733 . . . . 0.0 110.699 168.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -145.77 157.0 43.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.836 2.054 . . . . 0.0 112.388 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tt -149.2 133.64 17.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.808 1.643 . . . . 0.0 109.639 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -146.62 154.51 41.56 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.588 1.155 . . . . 0.0 112.429 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.0 mm -94.53 107.61 19.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.708 0.803 . . . . 0.0 109.121 168.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.51 147.28 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.907 1.283 . . . . 0.0 111.709 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -76.04 -18.86 59.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.76 0.824 . . . . 0.0 112.709 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -127.97 158.21 71.42 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 126.785 2.034 . . . . 0.0 108.879 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -61.92 122.27 10.71 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.212 1.941 . . . . 0.0 110.437 162.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.6 t -93.17 140.44 16.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.288 1.835 . . . . 0.0 108.952 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -73.9 139.21 44.81 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.685 -0.635 . . . . 0.0 110.645 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 m -141.54 147.21 22.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.695 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' A' ' 46' ' ' VAL . 41.9 m-85 -128.78 151.11 49.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.391 1.477 . . . . 0.0 110.879 -165.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -155.56 167.55 30.03 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.065 1.346 . . . . 0.0 110.343 168.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -150.42 159.86 44.17 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.54 -1.35 . . . . 0.0 112.973 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -113.86 138.83 49.77 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t -98.23 139.74 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.437 1.895 . . . . 0.0 111.127 -168.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -57.08 -63.99 1.03 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.725 1.21 . . . . 0.0 113.441 -173.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -112.0 -39.22 4.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -89.03 173.32 8.52 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.465 0.706 . . . . 0.0 110.52 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -116.7 7.96 13.64 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.39 1.476 . . . . 0.0 113.536 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 p -134.86 162.33 32.7 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.87 1.668 . . . . 0.0 112.593 -167.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -157.27 -176.84 6.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.072 1.749 . . . . 0.0 109.993 170.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -131.25 137.42 48.87 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.447 1.099 . . . . 0.0 112.891 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.0 145.32 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.034 1.333 . . . . 0.0 112.597 -172.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.91 169.54 31.14 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.105 1.336 . . . . 0.0 115.154 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.74 -37.71 19.66 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.002 1.321 . . . . 0.0 112.988 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -94.91 15.0 19.79 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 63.84 35.13 11.27 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 158.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.33 135.85 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.767 1.227 . . . . 0.0 111.525 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 56.1 tp -79.19 122.57 26.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.042 1.337 . . . . 0.0 113.623 -170.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.01 154.83 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.628 1.571 . . . . 0.0 111.627 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -100.38 146.72 26.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.268 1.027 . . . . 0.0 112.628 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.289 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.959 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -123.91 149.31 46.02 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.39 1.876 . . . . 0.0 111.134 171.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -65.66 158.51 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.378 -0.826 . . . . 0.0 112.172 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.83 148.43 7.56 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.883 0.873 . . . . 0.0 112.04 173.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.55 -10.6 43.7 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 116.358 1.303 . . . . 0.0 116.358 -171.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.8 m -62.07 125.86 25.34 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.863 2.332 . . . . 0.0 110.38 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -77.88 148.34 34.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.452 1.101 . . . . 0.0 112.059 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.1 mm -128.09 136.54 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 127.348 2.259 . . . . 0.0 109.662 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.0 tp -81.8 134.66 35.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.356 1.074 . . . . 0.0 113.363 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.5 p -132.28 176.96 7.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.412 1.485 . . . . 0.0 111.534 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.73 -0.33 26.5 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.675 1.59 . . . . 0.0 114.664 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.4 p -124.46 -16.28 6.38 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.75 1.22 . . . . 0.0 113.375 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.52 -129.92 2.73 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 127.468 2.461 . . . . 0.0 110.683 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.8 151.75 24.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.137 1.375 . . . . 0.0 111.869 168.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.09 146.89 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 127.425 2.29 . . . . 0.0 108.532 169.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.17 45.77 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.679 -1.263 . . . . 0.0 112.154 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 tt -62.72 -28.74 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 120.69 -1.256 . . . . 0.0 113.109 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.47 -2.28 31.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.015 1.326 . . . . 0.0 114.495 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -118.23 -13.09 9.89 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.488 1.515 . . . . 0.0 112.821 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.56 134.93 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.119 0.968 . . . . 0.0 109.664 159.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -134.6 164.94 26.37 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.279 1.832 . . . . 0.0 110.96 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.67 134.08 41.71 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.646 -0.659 . . . . 0.0 111.324 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.68 -15.24 59.44 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.587 1.089 . . . . 0.0 115.692 -175.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -66.49 166.88 11.72 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.431 1.615 . . . . 0.0 111.241 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -118.23 148.19 42.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.24 1.416 . . . . 0.0 113.359 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.19 166.6 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 127.095 2.158 . . . . 0.0 111.123 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -79.86 146.67 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.163 0.585 . . . . 0.0 111.22 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.18 132.28 23.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.354 0.662 . . . . 0.0 109.889 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.6 m -86.33 109.19 18.81 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 163.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -53.24 117.08 10.75 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.577 1.151 . . . . 0.0 112.347 174.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -65.7 -14.33 44.19 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.537 2.158 . . . . 0.0 113.906 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -79.29 -36.28 39.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.487 1.515 . . . . 0.0 113.923 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 t -140.89 0.83 1.62 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.264 1.426 . . . . 0.0 112.884 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.255 1.7 t80 63.17 27.41 15.63 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.744 1.617 . . . . 0.0 114.067 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -78.73 134.32 37.08 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.304 1.042 . . . . 0.0 110.519 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.5 t -94.53 136.63 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.264 0.626 . . . . 0.0 110.289 170.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.35 164.6 35.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.352 1.061 . . . . 0.0 112.35 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -87.6 126.85 35.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.327 1.051 . . . . 0.0 110.277 165.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -136.84 150.98 48.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.979 1.311 . . . . 0.0 112.942 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 t -82.27 157.98 23.67 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -91.98 132.61 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.137 2.175 . . . . 0.0 111.417 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 mt -87.68 -50.34 6.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.569 1.148 . . . . 0.0 112.754 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -143.81 157.22 44.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.159 2.183 . . . . 0.0 110.466 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p -119.38 118.55 31.46 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.025 1.73 . . . . 0.0 110.944 173.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -93.29 139.63 30.43 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.588 1.155 . . . . 0.0 113.084 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.469 HG22 ' CD2' ' A' ' 114' ' ' TYR . 18.4 t -137.97 130.8 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.752 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -135.3 175.81 9.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.203 2.201 . . . . 0.0 110.264 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -132.32 142.91 49.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.485 1.514 . . . . 0.0 110.746 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -152.97 155.33 36.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.832 0.853 . . . . 0.0 112.033 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.1 p -88.71 -16.23 32.8 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.733 2.013 . . . . 0.0 113.669 170.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -112.74 110.41 20.52 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.099 0.96 . . . . 0.0 110.339 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.8 mt -110.07 173.36 6.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.475 1.11 . . . . 0.0 112.527 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.1 tp -135.28 132.28 37.58 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.128 1.771 . . . . 0.0 109.141 170.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -111.56 115.32 28.98 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.189 0.996 . . . . 0.0 109.245 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.12 143.51 38.39 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.352 0.661 . . . . 0.0 109.862 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.7 m -118.18 120.86 38.99 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 167.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -125.94 116.59 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.628 1.171 . . . . 0.0 109.44 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.74 21.69 37.31 Favored Glycine 0 CA--C 1.545 1.935 0 O-C-N 121.605 -0.684 . . . . 0.0 114.723 -173.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.3 -16.09 61.41 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.576 2.036 . . . . 0.0 115.603 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -79.2 117.6 20.37 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.722 1.261 . . . . 0.0 109.174 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.1 t -75.57 130.04 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 122.974 0.51 . . . . 0.0 110.203 171.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.9 mt -129.86 102.9 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.768 1.627 . . . . 0.0 108.614 171.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -79.37 123.82 27.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.628 1.171 . . . . 0.0 110.581 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.0 t -141.31 174.76 10.24 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.083 1.353 . . . . 0.0 112.113 -167.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.1 p -81.28 145.97 30.65 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.428 -0.795 . . . . 0.0 111.203 165.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -54.74 -26.97 37.58 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.089 1.356 . . . . 0.0 113.334 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -102.9 2.48 35.29 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -62.57 133.06 94.65 Favored Pre-proline 0 CA--C 1.553 1.061 0 O-C-N 121.12 -0.988 . . . . 0.0 113.398 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.26 112.47 2.25 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.376 3.384 . . . . 0.0 114.844 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -101.18 148.46 25.07 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.679 1.992 . . . . 0.0 111.969 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -92.73 129.87 38.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.387 0.994 . . . . 0.0 113.452 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.4 t -108.25 135.57 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.918 2.487 . . . . 0.0 111.06 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.26 132.95 55.13 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.736 0.814 . . . . 0.0 111.127 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 66.62 3.51 2.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.085 1.754 . . . . 0.0 115.174 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.54 -63.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 120.967 -1.083 . . . . 0.0 110.556 -168.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.24 -150.63 18.13 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.647 0.641 . . . . 0.0 112.741 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -88.09 140.24 29.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.794 1.297 . . . . 0.0 113.968 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -145.32 145.9 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.751 1.621 . . . . 0.0 111.996 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -56.71 131.5 49.32 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.788 1.235 . . . . 0.0 112.405 171.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.92 -34.94 68.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.443 1.497 . . . . 0.0 113.672 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.39 -18.79 79.82 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 119.108 -0.829 . . . . 0.0 113.609 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -89.33 -3.52 58.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.366 1.467 . . . . 0.0 113.336 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.44 162.95 24.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.102 0.961 . . . . 0.0 112.236 166.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.35 159.8 30.9 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.044 1.738 . . . . 0.0 110.933 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.53 138.52 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.208 -0.932 . . . . 0.0 109.05 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.03 10.57 86.03 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.846 -0.974 . . . . 0.0 114.894 -171.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -78.68 155.48 29.44 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.47 1.635 . . . . 0.0 112.162 172.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.88 102.3 12.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.851 1.661 . . . . 0.0 111.163 -168.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.6 mt -97.23 179.55 4.86 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.037 0.935 . . . . 0.0 110.859 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.8 mt -131.55 159.83 37.03 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.164 -0.96 . . . . 0.0 113.49 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.0 p30 -118.59 -178.04 3.44 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -65.86 -0.88 2.48 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -102.35 -35.99 8.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.574 1.55 . . . . 0.0 110.874 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.48 17.35 11.44 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.966 1.745 . . . . 0.0 112.776 -170.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -92.37 148.88 21.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.311 1.055 . . . . 0.0 111.881 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.05 114.2 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 mt -88.05 158.4 18.61 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.0 1.32 . . . . 0.0 112.525 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.03 138.72 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.48 1.112 . . . . 0.0 111.705 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.63 121.86 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.867 0.867 . . . . 0.0 109.871 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -94.17 -29.97 14.85 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.913 2.085 . . . . 0.0 112.26 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -155.18 148.4 24.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.217 1.407 . . . . 0.0 112.2 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.1 tttm -132.85 115.85 15.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.402 1.881 . . . . 0.0 108.986 168.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.09 148.89 51.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.606 1.562 . . . . 0.0 112.169 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.2 tp -121.91 134.44 54.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.951 1.3 . . . . 0.0 110.197 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -139.57 150.78 45.45 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.723 0.809 . . . . 0.0 112.367 171.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.9 mm -108.19 111.61 36.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.754 1.222 . . . . 0.0 108.477 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.64 153.09 42.61 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 122.409 1.099 . . . . 0.0 113.531 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.66 -13.35 60.62 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.741 1.217 . . . . 0.0 113.419 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -155.27 160.13 31.14 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 128.302 2.641 . . . . 0.0 110.006 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.65 125.36 12.63 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.674 2.25 . . . . 0.0 111.433 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.43 139.92 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.983 2.113 . . . . 0.0 110.244 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -75.7 142.33 42.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.752 0.821 . . . . 0.0 112.644 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.28 139.17 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.115 1.366 . . . . 0.0 110.974 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.469 ' CD2' HG22 ' A' ' 46' ' ' VAL . 33.4 m-85 -118.52 153.03 34.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.708 2.003 . . . . 0.0 111.944 -171.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -153.65 171.31 19.01 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.868 2.067 . . . . 0.0 109.231 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -152.04 173.86 14.38 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.202 -1.561 . . . . 0.0 112.389 173.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -127.86 142.86 51.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.856 1.262 . . . . 0.0 113.239 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.2 140.64 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.767 1.627 . . . . 0.0 112.611 -164.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.23 -21.75 66.79 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -165.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.48 -63.63 0.98 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.811 0.732 . . . . 0.0 111.209 169.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -70.56 170.47 12.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.694 0.759 . . . . 0.0 111.854 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -113.55 18.89 17.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.724 1.61 . . . . 0.0 112.381 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.0 p -140.3 167.14 22.85 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.11 1.364 . . . . 0.0 112.252 -164.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -160.7 177.31 10.59 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.797 2.039 . . . . 0.0 109.496 167.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -121.39 132.47 54.77 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.226 1.01 . . . . 0.0 111.846 -173.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.9 m -118.06 146.44 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.481 1.512 . . . . 0.0 113.603 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.07 169.63 20.53 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.987 1.279 . . . . 0.0 115.196 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.02 -23.33 66.38 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.993 1.317 . . . . 0.0 112.885 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -89.77 2.1 55.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 114.232 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 63.85 36.33 10.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.375 1.47 . . . . 0.0 114.915 162.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.43 135.61 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.363 1.465 . . . . 0.0 111.886 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.3 tp -78.54 125.25 29.1 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.215 1.406 . . . . 0.0 113.214 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.92 161.04 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.082 1.753 . . . . 0.0 111.591 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -112.0 149.06 32.53 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.012 1.325 . . . . 0.0 112.924 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.9 m120 . . . . . 0 C--O 1.254 1.332 0 C-N-CA 125.939 1.695 . . . . 0.0 112.208 178.612 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.038 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.424 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.8 m-85 -122.63 153.95 38.65 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.455 1.502 . . . . 0.0 111.068 167.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.16 163.12 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.839 -0.538 . . . . 0.0 111.811 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.74 159.27 0.56 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.543 1.163 . . . . 0.0 113.298 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.07 -13.92 4.16 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 117.9 -1.5 . . . . 0.0 115.901 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.9 m -62.95 118.3 7.61 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.497 2.148 . . . . 0.0 110.955 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -79.22 142.31 36.36 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.208 1.403 . . . . 0.0 112.861 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.1 mm -130.7 137.26 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.082 2.153 . . . . 0.0 109.561 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.1 tp -83.56 137.46 33.83 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.368 1.08 . . . . 0.0 113.506 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -135.79 168.97 18.31 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.2 1.4 . . . . 0.0 111.461 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.58 -18.26 64.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 p -106.7 -28.9 9.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.078 1.351 . . . . 0.0 112.944 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.72 -130.42 2.12 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.041 -1.037 . . . . 0.0 112.904 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.58 148.96 29.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.543 1.137 . . . . 0.0 112.184 170.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.4 t -138.97 148.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.083 2.153 . . . . 0.0 108.362 172.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.38 149.9 38.52 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.983 -1.073 . . . . 0.0 111.514 172.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.5 tt -61.16 -23.81 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 O-C-N 120.826 -1.171 . . . . 0.0 113.479 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -70.46 -11.81 61.16 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.113 1.365 . . . . 0.0 114.329 172.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -122.88 -5.26 8.54 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.929 1.692 . . . . 0.0 113.909 -171.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 mm -67.0 137.17 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.014 -1.054 . . . . 0.0 109.077 161.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -134.77 161.2 35.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.719 1.208 . . . . 0.0 112.301 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.42 127.7 32.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.931 0.892 . . . . 0.0 111.718 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.54 -2.32 80.32 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.708 -1.051 . . . . 0.0 115.407 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.22 172.21 13.23 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.088 1.944 . . . . 0.0 111.168 164.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.62 150.04 40.37 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.049 1.74 . . . . 0.0 112.907 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.73 157.87 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 127.165 2.186 . . . . 0.0 109.843 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.8 mm -74.48 140.54 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 O-C-N 121.836 -0.54 . . . . 0.0 110.929 166.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.88 121.48 18.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.6 m -88.52 109.96 20.49 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -53.7 113.37 4.8 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.472 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.14 -9.7 26.0 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.991 1.794 . . . . 0.0 114.455 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -78.31 -40.07 37.82 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.998 -1.064 . . . . 0.0 112.158 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.9 t -132.7 -2.6 3.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.062 0.945 . . . . 0.0 112.756 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.293 20.6 m-85 56.9 35.6 26.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.167 1.787 . . . . 0.0 113.21 -176.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.83 126.51 31.07 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.053 1.341 . . . . 0.0 109.763 173.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.31 113.04 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.777 0.831 . . . . 0.0 110.589 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.56 163.4 29.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.533 1.133 . . . . 0.0 113.031 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -95.93 119.34 34.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.522 1.529 . . . . 0.0 110.757 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -128.39 149.92 50.33 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.748 1.219 . . . . 0.0 111.664 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.2 t -86.36 154.85 20.9 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.8 t -93.14 130.28 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 126.303 1.841 . . . . 0.0 110.444 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.2 mt -89.39 -37.71 14.64 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.288 1.035 . . . . 0.0 113.317 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -153.73 161.39 42.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.283 2.233 . . . . 0.0 109.883 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.8 p -117.34 137.72 52.26 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.902 1.281 . . . . 0.0 111.07 165.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -105.7 142.3 35.67 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.984 1.314 . . . . 0.0 112.569 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.05 138.31 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.737 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 68.4 mmt-85 -142.24 176.42 8.99 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.719 2.008 . . . . 0.0 110.391 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -127.3 137.87 52.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.688 1.195 . . . . 0.0 110.421 167.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.8 t -146.45 148.03 31.84 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.473 1.109 . . . . 0.0 111.473 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -86.11 -20.15 29.12 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.976 1.31 . . . . 0.0 113.416 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -97.17 105.05 17.12 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.338 -0.851 . . . . 0.0 110.086 -169.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.5 mt -124.09 156.86 35.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 123.622 1.677 . . . . 0.0 113.9 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.9 tp -138.44 126.37 22.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.381 -1.736 . . . . 0.0 111.412 -169.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -113.6 111.12 21.33 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.485 1.514 . . . . 0.0 108.723 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -106.6 125.18 50.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.387 1.075 . . . . 0.0 109.938 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -102.74 120.8 41.22 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.0 mt -133.01 116.41 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.928 1.291 . . . . 0.0 108.984 -171.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.94 24.44 34.44 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 115.191 0.836 . . . . 0.0 115.191 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.26 -6.36 68.6 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.576 1.56 . . . . 0.0 116.646 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -101.87 126.67 48.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.893 1.677 . . . . 0.0 109.238 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 p -97.33 133.02 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.841 0.829 . . . . 0.0 112.977 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.3 mt -126.8 133.79 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.761 2.024 . . . . 0.0 108.719 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -116.71 110.9 19.05 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.219 1.007 . . . . 0.0 110.658 -165.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.8 t -141.46 176.82 8.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.755 1.622 . . . . 0.0 113.272 -157.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.8 p -89.91 158.14 17.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.245 1.418 . . . . 0.0 113.01 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -65.82 -18.9 65.65 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.488 1.115 . . . . 0.0 113.649 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -101.11 -2.98 30.1 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.424 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.1 t60 -65.4 129.05 94.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.366 -1.302 . . . . 0.0 111.923 -172.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.67 120.89 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 122.061 1.772 . . . . 0.0 113.691 -169.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.25 141.08 36.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.381 2.272 . . . . 0.0 112.093 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -84.77 127.31 34.06 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -112.41 134.51 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.671 2.389 . . . . 0.0 111.525 -174.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -56.27 127.23 29.81 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.107 1.363 . . . . 0.0 112.499 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 57.17 22.51 7.61 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.961 2.104 . . . . 0.0 115.03 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.3 t -133.97 -58.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.963 -1.086 . . . . 0.0 111.882 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.79 -152.23 17.16 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.02 0.819 . . . . 0.0 112.916 -173.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -91.14 132.57 35.98 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.804 1.302 . . . . 0.0 114.417 -170.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -137.78 141.53 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.183 1.393 . . . . 0.0 112.669 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.03 132.92 54.35 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.809 1.244 . . . . 0.0 112.901 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.59 66.59 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.81 1.644 . . . . 0.0 113.529 -173.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.36 -12.24 84.75 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 121.504 -0.747 . . . . 0.0 113.797 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -90.71 -20.71 22.14 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.121 0.961 . . . . 0.0 112.76 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.95 154.5 2.85 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.417 1.087 . . . . 0.0 112.856 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -117.48 149.53 40.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.066 1.347 . . . . 0.0 110.969 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.83 126.65 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.394 0.678 . . . . 0.0 110.049 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.91 1.4 58.56 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-O 118.501 -1.166 . . . . 0.0 115.326 -172.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -86.95 159.5 18.99 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.833 1.817 . . . . 0.0 112.25 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -104.03 108.36 19.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.161 1.384 . . . . 0.0 111.203 -157.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.49 169.05 8.9 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.696 1.598 . . . . 0.0 111.791 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.22 142.74 43.03 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.351 1.06 . . . . 0.0 111.409 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.02 176.85 6.26 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.65 0.78 . . . . 0.0 112.995 166.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.1 p -52.17 -24.88 7.8 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -97.72 -31.59 12.18 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.888 1.275 . . . . 0.0 111.764 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.38 22.55 5.12 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.884 2.183 . . . . 0.0 113.435 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -64.21 147.26 52.76 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.319 1.059 . . . . 0.0 110.786 167.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.84 110.24 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.924 0.869 . . . . 0.0 110.741 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.5 mt -94.05 160.68 14.6 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.67 1.988 . . . . 0.0 111.289 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.22 141.84 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.64 1.176 . . . . 0.0 110.632 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.13 115.95 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.574 0.749 . . . . 0.0 109.485 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -90.12 -28.35 19.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.011 2.124 . . . . 0.0 112.732 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -160.71 151.74 18.85 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.42 1.488 . . . . 0.0 111.635 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -131.57 111.34 11.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.522 2.329 . . . . 0.0 109.127 171.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.6 mmtm -117.32 125.92 51.85 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.104 1.761 . . . . 0.0 110.94 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 tp -120.0 133.01 55.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.751 1.62 . . . . 0.0 109.941 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -149.21 161.62 41.64 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.3 mm -110.0 107.02 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.112 1.365 . . . . 0.0 108.521 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.02 150.31 42.77 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.253 1.021 . . . . 0.0 113.604 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.77 -26.81 67.89 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.144 1.778 . . . . 0.0 112.321 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -142.68 151.22 56.47 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.943 2.497 . . . . 0.0 108.287 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.27 121.76 8.08 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.415 2.077 . . . . 0.0 110.288 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.03 143.91 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.127 1.771 . . . . 0.0 110.15 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -74.54 139.4 43.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.283 0.633 . . . . 0.0 110.225 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.02 147.12 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 124.526 1.13 . . . . 0.0 111.268 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -128.46 148.0 50.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.683 1.593 . . . . 0.0 110.846 -164.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -150.48 170.96 17.86 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.507 1.523 . . . . 0.0 109.89 167.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -152.27 158.02 42.2 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.532 -1.355 . . . . 0.0 111.515 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -113.49 135.65 53.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.008 0.923 . . . . 0.0 112.969 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -98.89 147.92 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.3 1.84 . . . . 0.0 111.739 -170.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.94 -39.14 91.08 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.61 -45.33 0.36 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.993 0.917 . . . . 0.0 112.661 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -77.55 172.01 14.02 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.435 0.694 . . . . 0.0 109.207 164.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -134.53 30.72 3.47 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.684 1.193 . . . . 0.0 111.934 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.5 p -141.36 158.06 44.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.672 1.589 . . . . 0.0 112.135 -171.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.91 170.34 22.35 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.058 1.343 . . . . 0.0 111.852 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.76 140.08 29.89 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.439 1.895 . . . . 0.0 110.508 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 m -125.29 136.74 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.5 1.12 . . . . 0.0 112.99 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.3 173.3 35.99 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.029 1.3 . . . . 0.0 115.694 169.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -57.15 -37.86 72.67 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.195 -1.179 . . . . 0.0 112.023 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -85.33 9.47 15.33 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.663 1.585 . . . . 0.0 114.867 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 62.65 36.36 13.59 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 165.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.68 138.04 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 121.591 -0.693 . . . . 0.0 111.091 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.9 tp -87.78 128.54 35.32 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.897 1.279 . . . . 0.0 113.143 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.5 m -135.43 151.27 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.201 1.401 . . . . 0.0 112.213 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -93.75 116.5 28.98 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.97 1.708 . . . . 0.0 110.257 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.631 1.172 . . . . 0.0 113.864 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.83 156.3 33.54 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.285 1.434 . . . . 0.0 110.667 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.3 m -67.7 159.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.715 0.769 . . . . 0.0 111.458 171.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.38 154.63 1.7 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.572 0.749 . . . . 0.0 112.77 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.42 -2.32 22.21 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 117.768 -1.573 . . . . 0.0 116.263 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.3 m -64.58 124.61 22.3 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.305 2.052 . . . . 0.0 110.057 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.5 mmt -83.07 139.48 33.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.974 1.31 . . . . 0.0 111.951 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.6 mm -123.26 134.39 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.387 1.875 . . . . 0.0 110.174 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -75.42 121.51 22.41 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.137 0.975 . . . . 0.0 112.668 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.6 p -112.38 177.33 4.68 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.919 1.288 . . . . 0.0 112.001 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.68 -23.47 65.3 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.207 -0.933 . . . . 0.0 113.276 171.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -106.92 -18.81 13.82 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.958 1.303 . . . . 0.0 114.385 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.26 -114.45 0.61 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.987 1.279 . . . . 0.0 113.008 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -129.0 140.96 51.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.2 1.0 . . . . 0.0 113.294 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.2 t -133.45 143.74 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.333 1.853 . . . . 0.0 108.577 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.43 147.96 47.37 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.324 -0.86 . . . . 0.0 110.881 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 tt -61.72 -27.57 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 120.796 -1.19 . . . . 0.0 112.998 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.19 -13.19 61.48 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -112.17 -11.37 13.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.797 2.039 . . . . 0.0 113.153 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.9 mm -64.25 135.85 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.665 0.786 . . . . 0.0 109.261 162.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -125.05 164.85 19.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.489 1.916 . . . . 0.0 111.193 173.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.35 136.65 58.03 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.731 -0.605 . . . . 0.0 110.614 167.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.36 -9.29 75.96 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.482 1.039 . . . . 0.0 114.537 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.78 174.36 6.13 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.771 1.285 . . . . 0.0 111.288 168.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -131.39 142.35 50.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.713 1.205 . . . . 0.0 113.238 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.49 157.71 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.854 2.061 . . . . 0.0 110.757 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.6 mm -76.92 137.01 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.586 -0.696 . . . . 0.0 111.519 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.64 118.92 17.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.789 1.236 . . . . 0.0 108.157 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -89.91 107.45 19.12 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -55.91 113.99 6.72 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.895 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.56 -5.29 16.36 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.125 1.883 . . . . 0.0 114.109 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.16 -38.52 75.48 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.916 -1.115 . . . . 0.0 112.563 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -144.12 -2.11 0.92 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.949 0.9 . . . . 0.0 112.852 -171.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 55.5 44.83 26.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.62 1.168 . . . . 0.0 112.284 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -90.8 139.53 30.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.768 0.827 . . . . 0.0 109.832 167.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.33 124.26 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.749 0.82 . . . . 0.0 110.319 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.61 153.77 48.66 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.782 0.801 . . . . 0.0 112.538 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.67 115.4 23.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.424 1.49 . . . . 0.0 108.674 169.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -126.53 149.15 49.56 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.893 1.277 . . . . 0.0 110.81 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -90.62 157.84 17.27 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -174.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.3 t -89.25 128.61 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.562 1.545 . . . . 0.0 110.645 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.19 -51.43 7.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.359 0.664 . . . . 0.0 111.804 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -146.18 149.97 34.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.39 1.876 . . . . 0.0 109.462 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.4 p -118.65 126.7 52.52 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.049 1.34 . . . . 0.0 110.177 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -105.9 160.38 15.31 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.155 1.382 . . . . 0.0 113.077 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.1 t -134.36 143.91 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.304 2.242 . . . . 0.0 109.302 171.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -137.19 170.84 15.42 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.916 1.687 . . . . 0.0 109.825 166.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -117.68 143.13 46.47 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.424 1.09 . . . . 0.0 110.522 164.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.3 t -148.11 146.26 28.72 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.74 -0.6 . . . . 0.0 111.264 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.1 p -87.72 -18.13 30.16 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.374 0.67 . . . . 0.0 112.617 162.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HG2' HD12 ' A' ' 106' ' ' ILE . 56.6 mt-10 -93.86 114.19 26.37 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.863 -1.148 . . . . 0.0 111.551 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.1 mt -121.46 171.28 8.9 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.847 1.259 . . . . 0.0 111.63 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.5 tp -145.6 131.18 18.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.518 1.527 . . . . 0.0 110.146 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -106.36 137.46 44.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.274 1.03 . . . . 0.0 109.43 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 mt -129.61 135.13 48.17 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.909 1.284 . . . . 0.0 110.089 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.5 m -104.13 119.97 40.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.91 0.884 . . . . 0.0 109.476 173.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.56 116.29 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.183 1.393 . . . . 0.0 108.781 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.78 35.74 47.75 Favored Glycine 0 CA--C 1.542 1.729 0 O-C-N 121.477 -0.765 . . . . 0.0 114.863 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.38 -14.04 55.9 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.294 1.426 . . . . 0.0 115.507 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -90.91 117.94 29.9 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.805 1.302 . . . . 0.0 109.258 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.46 133.76 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.826 0.85 . . . . 0.0 111.972 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.7 mt -129.01 134.66 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.473 1.909 . . . . 0.0 108.798 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -117.34 112.82 21.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.538 1.535 . . . . 0.0 110.98 -168.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -140.47 178.45 7.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.759 1.224 . . . . 0.0 112.302 -159.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.0 p -84.54 152.4 23.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.175 0.988 . . . . 0.0 111.878 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.98 -20.47 65.31 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.734 1.213 . . . . 0.0 113.41 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -109.61 11.88 24.53 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.407 1.083 . . . . 0.0 113.529 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -67.2 130.3 93.68 Favored Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 120.89 -1.131 . . . . 0.0 112.414 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.84 127.49 5.54 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.515 2.81 . . . . 0.0 114.759 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -118.29 141.48 48.47 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.18 2.192 . . . . 0.0 110.952 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.405 ' CE2' ' HA2' ' A' ' 76' ' ' GLY . 47.9 t80 -93.36 129.93 39.3 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.735 1.152 . . . . 0.0 114.034 -176.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.7 t -109.44 133.53 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.995 2.118 . . . . 0.0 111.739 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -51.08 123.69 9.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.641 1.576 . . . . 0.0 113.917 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 54.37 23.55 4.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.388 1.875 . . . . 0.0 114.34 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.7 t -130.19 -54.91 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.951 1.3 . . . . 0.0 110.928 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 71' ' ' TYR . . . 119.94 -165.82 13.53 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.571 0.605 . . . . 0.0 114.047 -175.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -81.41 140.88 34.42 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.385 1.088 . . . . 0.0 113.864 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.19 147.95 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 127.503 2.321 . . . . 0.0 109.475 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -66.86 144.08 56.48 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.529 -0.732 . . . . 0.0 112.176 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.33 -40.22 64.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.811 1.244 . . . . 0.0 113.39 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.43 -20.46 67.7 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.307 -0.87 . . . . 0.0 114.177 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.85 0.96 30.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.096 2.158 . . . . 0.0 113.254 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.1 mt -72.97 161.84 30.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.198 0.599 . . . . 0.0 111.365 168.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.1 162.62 29.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.888 1.275 . . . . 0.0 111.545 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.61 140.48 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.384 1.073 . . . . 0.0 109.611 170.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.78 4.15 89.35 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.188 -0.784 . . . . 0.0 114.439 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -80.82 152.07 28.41 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.126 1.463 . . . . 0.0 110.824 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.2 108.43 19.81 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.762 1.625 . . . . 0.0 113.483 -165.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.4 mt -103.79 164.12 11.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.162 1.385 . . . . 0.0 112.524 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.75 144.96 34.15 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.637 1.175 . . . . 0.0 111.507 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -102.07 -177.25 3.35 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.063 0.945 . . . . 0.0 113.489 169.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.6 p -54.44 -23.48 16.14 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.793 2.037 . . . . 0.0 115.733 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -104.71 -20.76 13.52 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.588 1.555 . . . . 0.0 113.274 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.29 27.42 10.02 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.336 1.922 . . . . 0.0 112.863 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -66.38 149.54 50.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.608 0.363 . . . . 0.0 110.416 162.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.1 99.26 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.217 1.007 . . . . 0.0 110.303 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -80.31 161.31 25.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.188 2.595 . . . . 0.0 112.238 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.62 139.64 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.358 1.063 . . . . 0.0 111.719 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.18 127.73 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.29 1.036 . . . . 0.0 110.925 170.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -97.85 -32.47 11.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.891 2.076 . . . . 0.0 113.357 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -161.5 150.72 16.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.05 0.94 . . . . 0.0 113.013 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -123.13 128.22 49.77 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.438 1.895 . . . . 0.0 109.526 162.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm -127.29 124.69 39.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.374 1.469 . . . . 0.0 110.777 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 tt -121.35 135.54 55.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.756 1.222 . . . . 0.0 110.33 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -141.71 171.11 14.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.36 1.064 . . . . 0.0 111.403 168.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.428 HD12 ' HG2' ' A' ' 51' ' ' GLU . 15.7 mm -116.97 115.08 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 162.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.66 148.72 19.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.626 1.17 . . . . 0.0 112.197 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -72.62 -24.69 61.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.913 0.885 . . . . 0.0 111.827 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -143.0 152.93 59.78 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.946 2.099 . . . . 0.0 109.517 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.74 123.26 11.7 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.276 2.65 . . . . 0.0 113.188 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.4 t -92.0 143.67 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.459 1.504 . . . . 0.0 110.291 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -76.82 141.87 40.51 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.514 0.673 . . . . 0.0 111.537 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.08 148.44 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.921 1.288 . . . . 0.0 110.368 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -127.74 144.75 51.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.912 1.285 . . . . 0.0 111.856 -169.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -152.18 161.56 42.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.431 1.092 . . . . 0.0 111.252 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -148.02 159.38 43.96 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.797 -1.19 . . . . 0.0 113.508 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -108.89 138.02 45.9 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.73 1.212 . . . . 0.0 113.534 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.49 145.9 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 126.009 1.724 . . . . 0.0 112.474 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.38 -24.18 65.66 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 -167.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -148.6 -49.93 0.16 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.922 1.692 . . . . 0.0 112.067 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -73.07 167.33 21.35 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.63 0.772 . . . . 0.0 110.54 168.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -123.91 24.08 8.42 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.301 1.44 . . . . 0.0 113.937 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 p -135.97 158.07 45.3 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.971 1.708 . . . . 0.0 113.063 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -160.89 -176.01 5.27 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.88 1.672 . . . . 0.0 110.709 171.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -128.59 138.95 52.48 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.361 1.464 . . . . 0.0 113.582 -169.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.32 142.08 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.268 1.427 . . . . 0.0 113.379 -173.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.83 173.22 27.41 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.571 1.558 . . . . 0.0 116.198 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.24 -23.93 67.48 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.736 -1.45 . . . . 0.0 113.917 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -88.99 0.87 56.29 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 58.61 45.75 15.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.17 1.788 . . . . 0.0 114.648 168.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 t -72.43 137.54 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.547 1.539 . . . . 0.0 111.71 -170.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 64.6 tp -79.66 125.26 29.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.681 1.592 . . . . 0.0 113.391 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.52 157.92 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.968 1.707 . . . . 0.0 111.377 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.99 145.5 32.21 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.902 1.281 . . . . 0.0 111.437 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -124.87 157.36 36.11 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.922 1.689 . . . . 0.0 110.493 166.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.1 m -66.23 156.81 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.332 0.587 . . . . 0.0 112.076 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.29 150.49 1.25 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.165 0.986 . . . . 0.0 111.821 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.52 -3.95 22.74 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.5 m -65.51 125.05 23.95 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 120.976 2.388 . . . . 0.0 109.864 171.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -78.99 143.6 35.56 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.233 1.013 . . . . 0.0 111.954 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.31 135.09 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.411 1.884 . . . . 0.0 109.829 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.26 122.09 22.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.796 0.838 . . . . 0.0 112.12 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.0 p -117.23 171.32 8.03 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.307 1.043 . . . . 0.0 111.736 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.8 -17.55 64.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.817 0.847 . . . . 0.0 113.175 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -105.81 -20.3 13.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.992 2.117 . . . . 0.0 113.827 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.06 -105.57 0.27 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.116 1.341 . . . . 0.0 113.06 174.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.8 mt -132.94 140.76 47.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.779 1.632 . . . . 0.0 111.965 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.1 t -135.05 145.6 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.485 1.914 . . . . 0.0 108.543 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.97 147.43 52.45 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.206 -0.934 . . . . 0.0 111.388 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.1 tt -60.32 -29.91 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 120.712 -1.242 . . . . 0.0 112.827 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.29 -17.97 64.41 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -107.72 -10.38 15.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.694 1.998 . . . . 0.0 112.919 -174.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.7 136.74 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.976 161.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -126.29 162.16 26.12 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.939 2.096 . . . . 0.0 111.301 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.94 130.33 43.01 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.435 0.694 . . . . 0.0 110.432 168.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.36 16.94 65.5 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.833 -0.542 . . . . 0.0 113.902 -170.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -96.43 -179.63 4.7 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.155 0.982 . . . . 0.0 110.603 157.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -128.71 145.83 51.06 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.706 1.603 . . . . 0.0 112.341 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.89 158.67 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.037 1.735 . . . . 0.0 110.526 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -76.44 141.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.65 -0.656 . . . . 0.0 111.547 167.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.62 128.04 24.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.001 0.92 . . . . 0.0 109.163 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.0 m -79.44 112.76 17.01 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 160.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -52.66 114.83 6.2 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.235 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.14 -13.18 36.28 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.982 2.455 . . . . 0.0 113.738 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -84.67 -37.26 21.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -172.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -133.39 -6.1 2.95 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.408 1.483 . . . . 0.0 112.922 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.252 15.2 m-85 66.39 30.53 8.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.33 1.852 . . . . 0.0 115.009 -175.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -79.43 130.8 35.77 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.611 1.165 . . . . 0.0 110.155 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.8 128.65 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.889 0.768 . . . . 0.0 110.815 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.95 167.16 28.44 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.316 1.047 . . . . 0.0 112.811 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -78.87 139.7 38.27 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.515 1.126 . . . . 0.0 110.413 163.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -142.48 154.94 44.97 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.493 1.517 . . . . 0.0 110.61 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.8 t -85.35 156.77 20.75 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.79 123.95 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.453 1.901 . . . . 0.0 110.367 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.91 -44.48 16.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.379 0.672 . . . . 0.0 112.736 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -146.14 154.31 41.66 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.486 1.915 . . . . 0.0 110.572 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.7 p -122.22 128.7 51.47 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.949 1.3 . . . . 0.0 111.274 172.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -108.1 149.01 29.03 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.33 1.852 . . . . 0.0 114.38 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 114' ' ' TYR . 45.1 t -139.8 140.51 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.375 1.07 . . . . 0.0 112.428 177.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -138.52 179.83 6.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.58 2.752 . . . . 0.0 112.209 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -131.61 148.35 52.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.636 1.574 . . . . 0.0 112.431 167.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.6 t -152.74 149.24 28.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.423 1.089 . . . . 0.0 111.557 170.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 p -86.36 -17.16 35.18 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.335 1.054 . . . . 0.0 113.3 164.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HG2' HD12 ' A' ' 106' ' ' ILE . 52.7 mt-10 -105.36 116.17 31.5 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.353 1.061 . . . . 0.0 110.798 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.3 mt -117.8 170.7 8.59 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.651 1.58 . . . . 0.0 112.218 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.7 tp -141.38 134.7 29.57 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.958 1.703 . . . . 0.0 110.062 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -114.75 120.54 40.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.395 1.078 . . . . 0.0 110.067 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.94 130.37 55.45 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.189 -0.945 . . . . 0.0 109.808 173.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.8 m -104.43 118.55 36.89 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.271 1.028 . . . . 0.0 108.582 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -132.02 119.81 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.59 1.556 . . . . 0.0 109.136 -173.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.35 25.11 47.85 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 115.19 0.836 . . . . 0.0 115.19 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.7 -5.39 84.67 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.893 1.711 . . . . 0.0 116.068 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -91.93 132.02 36.81 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.206 1.503 . . . . 0.0 109.483 166.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.82 138.45 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.951 0.9 . . . . 0.0 112.28 163.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.2 mt -132.8 136.12 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 126.126 1.771 . . . . 0.0 109.345 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -117.23 110.39 18.06 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.088 1.355 . . . . 0.0 110.445 -162.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.2 t -138.05 177.13 8.11 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.708 1.203 . . . . 0.0 113.165 -156.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.2 p -86.58 156.5 20.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.74 0.816 . . . . 0.0 111.952 169.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -63.85 -24.69 67.84 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.354 -0.842 . . . . 0.0 113.249 -174.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -99.63 3.63 45.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -60.78 121.3 60.44 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 118.004 -0.998 . . . . 0.0 112.503 -174.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -78.82 115.08 3.52 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.005 1.803 . . . . 0.0 113.056 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.903 1.681 . . . . 0.0 110.797 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -91.37 129.99 37.28 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.5 132.27 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 127.93 2.492 . . . . 0.0 110.731 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -54.49 122.29 10.2 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.261 1.424 . . . . 0.0 111.722 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 t70 53.87 26.7 6.41 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.754 2.422 . . . . 0.0 115.751 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.9 t -129.12 -54.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.939 1.296 . . . . 0.0 110.356 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.02 -155.37 19.77 Favored Glycine 0 N--CA 1.467 0.749 0 CA-C-O 119.499 -0.612 . . . . 0.0 112.027 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -96.57 150.74 20.3 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.053 1.426 . . . . 0.0 114.15 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.78 141.42 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.905 1.682 . . . . 0.0 111.786 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.52 134.91 46.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.61 0.764 . . . . 0.0 112.859 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.05 -37.13 66.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.822 1.249 . . . . 0.0 113.095 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.88 -19.93 72.03 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 121.418 -0.802 . . . . 0.0 113.935 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -97.61 -1.26 44.15 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.836 1.654 . . . . 0.0 114.218 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.26 159.15 29.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.46 0.704 . . . . 0.0 112.377 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -118.97 153.2 35.01 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.556 1.542 . . . . 0.0 110.989 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.4 t -64.86 136.42 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 170.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.75 87.84 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.387 -1.23 . . . . 0.0 115.576 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -84.09 158.2 21.49 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.423 1.612 . . . . 0.0 111.78 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.75 106.79 18.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.557 1.543 . . . . 0.0 112.325 -163.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.5 mt -98.13 -176.79 3.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.683 1.593 . . . . 0.0 111.068 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.6 mt -132.9 154.11 50.72 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.33 177.47 4.85 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 122.886 1.327 . . . . 0.0 114.486 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.6 p -56.79 -6.01 0.29 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.384 2.674 . . . . 0.0 117.318 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -119.17 -18.11 8.76 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.157 1.783 . . . . 0.0 112.221 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.73 18.83 19.48 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.439 1.495 . . . . 0.0 112.885 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -72.65 143.1 48.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.967 0.907 . . . . 0.0 110.457 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.91 114.57 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.195 0.522 . . . . 0.0 110.786 171.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 mt -91.5 157.89 16.78 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.481 1.112 . . . . 0.0 111.188 167.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.0 t -130.98 139.04 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.316 1.046 . . . . 0.0 110.393 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.96 116.38 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 173.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.15 -41.38 28.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.72 1.608 . . . . 0.0 110.84 174.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -159.85 153.58 22.8 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.647 1.179 . . . . 0.0 112.186 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -113.57 134.44 54.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.404 1.482 . . . . 0.0 109.484 159.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -131.45 161.34 32.72 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 128.578 2.751 . . . . 0.0 110.476 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 tt -146.78 139.42 25.08 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.676 1.191 . . . . 0.0 109.927 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -137.51 150.45 47.54 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.043 0.838 . . . . 0.0 112.329 168.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.403 HD12 ' HG2' ' A' ' 51' ' ' GLU . 5.7 mm -103.41 116.23 46.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.48 145.16 51.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.861 1.264 . . . . 0.0 111.551 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -74.96 -20.5 59.65 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.412 -0.805 . . . . 0.0 112.249 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -140.41 155.86 69.82 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.629 1.972 . . . . 0.0 110.977 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.32 124.74 15.79 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.89 2.393 . . . . 0.0 113.079 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 t -93.95 141.62 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.226 1.811 . . . . 0.0 109.628 172.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -76.22 141.95 41.6 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.553 0.692 . . . . 0.0 111.78 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.82 146.61 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.892 1.277 . . . . 0.0 110.829 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.402 ' CD2' HG22 ' A' ' 46' ' ' VAL . 61.2 m-85 -129.05 150.42 50.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.017 1.327 . . . . 0.0 111.331 -166.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -156.81 169.36 24.92 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.08 1.752 . . . . 0.0 109.548 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -156.09 169.59 24.14 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.346 -1.471 . . . . 0.0 111.947 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -123.84 142.34 51.21 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -100.33 151.71 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.018 1.727 . . . . 0.0 112.893 -170.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.4 -27.86 69.59 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -169.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.12 -34.86 0.09 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 120.212 -1.555 . . . . 0.0 113.638 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -77.67 164.65 25.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 164.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -123.34 33.56 5.33 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.458 1.103 . . . . 0.0 111.959 -174.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.6 p -150.14 162.31 40.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.464 1.506 . . . . 0.0 111.775 -164.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -156.81 174.84 14.89 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.494 1.518 . . . . 0.0 110.612 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -118.94 134.96 54.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.624 1.17 . . . . 0.0 112.432 -176.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.71 137.72 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.677 1.591 . . . . 0.0 112.226 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.81 -172.03 45.66 Favored Glycine 0 CA--C 1.544 1.857 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 170.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -84.93 -22.49 29.22 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.719 1.208 . . . . 0.0 112.155 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -84.22 -9.19 58.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.633 1.173 . . . . 0.0 113.382 165.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 60.56 50.74 5.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.529 1.532 . . . . 0.0 113.578 165.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.29 144.66 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.883 1.673 . . . . 0.0 112.078 -173.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.2 tp -84.98 129.46 34.79 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.621 1.568 . . . . 0.0 114.703 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.2 m -138.53 158.19 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 126.403 1.881 . . . . 0.0 112.268 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -117.75 123.3 45.69 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.939 1.295 . . . . 0.0 114.184 -169.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.188 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -174.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.896 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.449 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 96.7 m-85 -125.42 153.28 43.69 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.437 1.495 . . . . 0.0 111.668 172.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 m -68.36 159.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.358 0.599 . . . . 0.0 111.928 173.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.04 152.17 6.14 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.082 0.953 . . . . 0.0 112.487 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.14 -7.11 24.61 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 117.712 -1.605 . . . . 0.0 116.238 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.1 m -61.82 121.88 14.0 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.379 2.089 . . . . 0.0 110.474 174.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -77.2 142.54 39.55 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.69 1.196 . . . . 0.0 112.329 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -121.8 137.07 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.416 2.286 . . . . 0.0 109.494 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.66 127.13 32.37 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 p -127.15 171.1 11.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.834 1.253 . . . . 0.0 112.039 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.3 65.48 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.3 p -103.26 -24.56 13.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.2 -107.9 0.32 Allowed Glycine 0 CA--C 1.522 0.488 0 O-C-N 121.663 -0.648 . . . . 0.0 112.002 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.58 140.04 45.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.961 1.304 . . . . 0.0 111.535 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.5 t -127.19 141.51 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.205 1.402 . . . . 0.0 109.019 172.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.13 147.67 49.65 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.268 -0.895 . . . . 0.0 110.922 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.6 tt -61.03 -26.57 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.025 -1.047 . . . . 0.0 113.351 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.68 -7.09 52.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.496 1.518 . . . . 0.0 114.341 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -117.39 -12.3 10.46 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.902 1.681 . . . . 0.0 112.652 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.7 mm -65.15 132.73 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 119.147 0.885 . . . . 0.0 110.36 164.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -119.21 161.74 19.86 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.431 1.892 . . . . 0.0 111.679 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.65 138.54 58.06 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.09 -1.006 . . . . 0.0 110.63 167.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.95 4.89 89.69 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 114.536 0.574 . . . . 0.0 114.536 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -86.18 157.07 20.08 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.523 1.161 . . . . 0.0 109.84 162.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -116.8 141.24 48.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.75 1.22 . . . . 0.0 111.319 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.95 159.47 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.934 1.694 . . . . 0.0 111.465 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 mm -71.64 143.86 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 122.797 0.439 . . . . 0.0 111.96 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.28 126.25 18.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.78 1.232 . . . . 0.0 109.251 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.8 m -84.53 111.67 19.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 165.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -56.03 114.64 7.91 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.789 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.18 -8.16 22.85 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.6 2.2 . . . . 0.0 113.94 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -79.49 -39.64 31.63 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.017 -1.052 . . . . 0.0 113.616 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -138.08 -1.29 1.98 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.323 1.049 . . . . 0.0 113.278 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 58.73 40.04 23.61 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.679 1.192 . . . . 0.0 113.407 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.06 138.82 33.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.542 0.737 . . . . 0.0 109.029 165.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -109.11 121.93 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.995 1.318 . . . . 0.0 109.169 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.34 162.79 33.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.456 0.703 . . . . 0.0 112.673 -176.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -93.51 124.66 37.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.797 1.239 . . . . 0.0 109.307 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -132.67 152.67 51.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.416 1.487 . . . . 0.0 111.194 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 t -85.57 152.98 22.73 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.9 t -89.1 130.55 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.98 1.712 . . . . 0.0 110.279 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.6 mt -92.71 -40.76 10.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.811 0.845 . . . . 0.0 112.384 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -143.93 152.52 41.21 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.338 1.455 . . . . 0.0 111.247 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.5 p -124.47 124.66 42.78 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.197 2.199 . . . . 0.0 109.073 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -116.63 159.91 21.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.17 1.788 . . . . 0.0 114.412 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 114' ' ' TYR . 21.8 t -143.63 144.56 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.849 1.66 . . . . 0.0 111.426 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -142.49 178.77 7.37 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.024 2.13 . . . . 0.0 112.053 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -131.47 145.23 51.68 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.081 2.152 . . . . 0.0 112.306 173.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -154.72 152.52 30.0 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.967 0.907 . . . . 0.0 111.148 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 p -86.9 -14.55 41.6 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 163.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -101.54 105.53 16.51 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.073 0.851 . . . . 0.0 110.201 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.5 mt -123.49 162.32 23.1 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.85 1.31 . . . . 0.0 113.67 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.3 tp -126.29 131.21 51.92 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.811 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.98 134.1 45.72 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.244 1.417 . . . . 0.0 109.442 165.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 mt -126.28 126.59 44.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.874 0.869 . . . . 0.0 109.064 163.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.1 m -93.17 120.35 33.36 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 167.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.4 117.09 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.949 1.3 . . . . 0.0 108.92 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 50.54 38.18 34.75 Favored Glycine 0 CA--C 1.544 1.876 0 N-CA-C 115.186 0.835 . . . . 0.0 115.186 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.73 -0.56 89.18 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 121.297 -1.119 . . . . 0.0 115.701 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -109.06 120.97 44.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.326 1.563 . . . . 0.0 110.442 172.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.48 128.36 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.803 0.811 . . . . 0.0 111.555 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.4 mt -118.09 128.3 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.689 1.596 . . . . 0.0 108.375 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -108.03 110.99 22.82 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.507 1.523 . . . . 0.0 110.27 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 t -139.7 176.14 8.98 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.223 1.009 . . . . 0.0 112.473 -161.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.3 p -82.08 152.28 26.65 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.177 0.989 . . . . 0.0 112.349 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -65.96 -19.97 66.04 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.188 -0.945 . . . . 0.0 113.27 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.337 3.5 p-10 -110.6 17.44 20.7 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 175.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.449 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 3.2 t60 -66.11 132.72 94.59 Favored Pre-proline 0 CA--C 1.555 1.155 0 O-C-N 121.071 -1.018 . . . . 0.0 113.665 176.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.11 118.84 3.05 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.279 3.319 . . . . 0.0 115.096 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -116.89 140.51 49.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.872 2.069 . . . . 0.0 112.216 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -84.2 127.46 33.96 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.049 1.295 . . . . 0.0 114.05 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.91 134.82 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 127.989 2.516 . . . . 0.0 111.355 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -52.24 126.92 20.37 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.919 1.688 . . . . 0.0 111.717 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 57.31 19.42 5.02 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.993 1.717 . . . . 0.0 115.488 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.8 t -130.31 -58.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.893 0.877 . . . . 0.0 111.12 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.32 -159.47 15.88 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.643 0.64 . . . . 0.0 113.43 -171.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -81.06 142.49 33.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 p -141.26 152.19 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.622 1.969 . . . . 0.0 110.884 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.73 129.45 39.8 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.947 0.899 . . . . 0.0 111.868 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.63 -36.67 69.73 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.546 1.138 . . . . 0.0 113.343 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.62 -5.08 88.17 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.909 -1.119 . . . . 0.0 114.134 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -101.89 -2.19 30.42 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.871 1.335 . . . . 0.0 113.319 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.55 161.15 31.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.011 1.324 . . . . 0.0 112.631 167.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.44 164.78 18.24 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.04 2.136 . . . . 0.0 111.572 171.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.32 141.93 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.187 -0.945 . . . . 0.0 109.813 167.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.69 7.83 88.15 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.265 -0.742 . . . . 0.0 114.683 -175.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -85.65 152.2 23.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.509 1.155 . . . . 0.0 111.098 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -108.24 109.69 21.12 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.837 1.255 . . . . 0.0 112.323 -163.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.1 mt -106.3 171.38 7.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.927 1.291 . . . . 0.0 111.295 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.7 mt -122.88 159.73 27.58 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -115.63 -174.31 2.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.19 1.796 . . . . 0.0 113.874 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.4 t -58.14 -15.42 9.56 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -97.34 -12.48 22.78 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 119.816 -1.803 . . . . 0.0 113.552 170.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.36 22.1 49.1 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.925 1.25 . . . . 0.0 111.864 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.53 139.65 33.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.878 1.271 . . . . 0.0 112.025 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.92 111.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.092 0.957 . . . . 0.0 112.913 -171.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 63.4 mt -90.35 161.95 15.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.89 2.076 . . . . 0.0 111.374 161.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.72 141.41 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.677 1.191 . . . . 0.0 110.683 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.04 121.6 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.706 0.802 . . . . 0.0 109.459 172.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.27 -36.32 15.66 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.439 1.895 . . . . 0.0 112.142 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -160.49 151.7 19.18 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.648 1.579 . . . . 0.0 111.61 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -129.56 139.48 51.48 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.716 2.006 . . . . 0.0 110.352 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -143.2 139.67 30.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.368 1.467 . . . . 0.0 111.634 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.3 tp -116.87 136.4 52.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.724 2.01 . . . . 0.0 108.636 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -145.65 153.36 40.93 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 171.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.8 mm -91.91 121.41 42.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.037 0.935 . . . . 0.0 109.15 166.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.22 149.79 49.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.001 1.32 . . . . 0.0 113.664 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.65 -30.29 71.26 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.409 1.083 . . . . 0.0 112.851 175.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -148.38 152.62 39.16 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.023 2.529 . . . . 0.0 109.944 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -59.1 120.51 8.42 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.149 3.233 . . . . 0.0 111.985 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.56 137.87 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.107 1.363 . . . . 0.0 109.522 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -74.24 139.2 44.17 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.979 1.312 . . . . 0.0 110.363 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -137.93 143.78 32.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 124.643 1.177 . . . . 0.0 110.611 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.42 ' CD2' HG22 ' A' ' 46' ' ' VAL . 71.5 m-85 -121.82 149.15 43.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.901 1.28 . . . . 0.0 110.9 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -153.22 166.03 33.81 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.806 1.243 . . . . 0.0 111.481 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -150.29 167.39 27.13 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.792 -1.192 . . . . 0.0 112.561 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -116.0 142.83 46.27 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.3 t -99.83 143.52 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.929 2.092 . . . . 0.0 111.195 -173.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -60.02 -76.28 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.216 1.406 . . . . 0.0 113.636 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -118.19 -11.3 10.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -163.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -105.28 170.72 7.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.402 1.481 . . . . 0.0 109.149 163.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -114.67 13.68 17.42 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.832 2.053 . . . . 0.0 113.391 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 p -144.1 162.39 36.38 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.888 -1.133 . . . . 0.0 112.776 -163.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -156.48 172.91 17.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.919 1.688 . . . . 0.0 110.337 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -120.05 136.68 54.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.384 1.074 . . . . 0.0 112.343 -174.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.42 149.0 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.325 1.45 . . . . 0.0 113.71 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.62 175.47 18.88 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.254 1.407 . . . . 0.0 115.044 173.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.7 -28.8 69.67 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -88.63 4.44 47.08 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 60.86 46.54 8.6 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.715 1.206 . . . . 0.0 112.238 166.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -82.33 138.46 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.692 1.997 . . . . 0.0 112.122 -165.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.3 tp -80.49 124.73 29.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.357 1.463 . . . . 0.0 113.983 -173.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.14 159.88 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.969 1.708 . . . . 0.0 111.793 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -99.3 157.53 16.33 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.347 1.059 . . . . 0.0 113.832 -170.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.668 2.387 . . . . 0.0 113.226 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.123 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -121.43 153.66 37.57 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.313 1.445 . . . . 0.0 111.657 170.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.3 m -70.7 158.6 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.672 0.749 . . . . 0.0 112.419 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.87 146.76 7.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.215 1.006 . . . . 0.0 112.782 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.38 -8.67 52.52 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 117.332 -1.816 . . . . 0.0 115.929 -172.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.3 m -61.56 118.13 6.65 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.124 2.462 . . . . 0.0 110.113 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 mmt -75.37 141.35 43.31 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.239 1.016 . . . . 0.0 111.972 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.8 mm -124.78 136.12 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.03 2.132 . . . . 0.0 109.754 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.46 124.32 26.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.381 1.072 . . . . 0.0 112.641 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.9 p -127.15 174.07 9.21 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.527 1.131 . . . . 0.0 111.829 -176.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.9 71.28 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.084 -1.01 . . . . 0.0 111.954 167.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.9 p -77.69 -33.69 53.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.255 1.022 . . . . 0.0 111.968 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.37 -90.01 0.12 Allowed Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.486 1.517 . . . . 0.0 111.619 172.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.1 mt -134.16 140.1 46.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.731 1.612 . . . . 0.0 111.196 170.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -134.36 145.85 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.665 1.986 . . . . 0.0 108.974 174.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.78 146.86 51.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.849 -1.157 . . . . 0.0 111.159 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 tt -60.95 -29.59 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 120.973 -1.08 . . . . 0.0 113.121 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.13 -20.03 64.87 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 173.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -101.67 -17.2 16.42 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.075 1.35 . . . . 0.0 113.022 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.06 126.91 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.595 0.758 . . . . 0.0 109.534 165.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -122.2 154.94 36.81 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.7 1.6 . . . . 0.0 111.733 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.09 126.46 26.09 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.604 -0.685 . . . . 0.0 111.541 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.59 -19.74 41.22 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.001 1.286 . . . . 0.0 114.749 -168.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -71.2 177.23 3.94 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.4 1.6 . . . . 0.0 112.981 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -120.16 154.93 34.08 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.586 1.554 . . . . 0.0 113.429 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -143.54 159.29 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.081 2.152 . . . . 0.0 109.851 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -77.09 139.18 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 O-C-N 121.205 -0.934 . . . . 0.0 110.827 166.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.87 129.25 40.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.5 m -93.38 110.39 21.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -52.67 112.36 3.39 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.633 1.573 . . . . 0.0 112.354 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -69.75 -6.69 19.2 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.156 1.904 . . . . 0.0 113.961 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -77.45 -42.65 35.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.711 -1.243 . . . . 0.0 112.737 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.8 t -138.05 2.68 2.36 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.27 1.028 . . . . 0.0 113.163 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.274 68.8 m-85 58.69 32.34 22.07 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.436 1.494 . . . . 0.0 113.944 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.77 139.87 49.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.05 0.94 . . . . 0.0 109.753 167.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.14 109.15 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.719 1.207 . . . . 0.0 109.885 -168.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.75 157.29 44.78 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.44 125.82 29.93 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.035 1.334 . . . . 0.0 110.06 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HE2' ' HB2' ' A' ' 120' ' ' ASP . 29.9 mmmt -129.23 151.21 50.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.999 1.319 . . . . 0.0 110.196 174.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.26 7.0 t -81.63 159.69 23.96 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.189 0.995 . . . . 0.0 113.45 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.1 t -94.54 125.79 47.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 126.584 1.954 . . . . 0.0 109.543 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.7 mt -82.25 -49.09 10.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.602 1.161 . . . . 0.0 111.268 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.59 151.68 39.4 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.684 1.194 . . . . 0.0 111.088 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.0 p -121.68 119.94 33.25 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.112 1.765 . . . . 0.0 110.145 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -108.76 150.44 27.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.124 1.77 . . . . 0.0 113.317 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.74 136.49 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.706 1.602 . . . . 0.0 111.646 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -134.79 175.13 9.84 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.678 1.991 . . . . 0.0 110.475 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -136.65 138.77 41.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.28 1.032 . . . . 0.0 110.411 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.2 t -153.39 147.32 25.42 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.248 -0.907 . . . . 0.0 112.246 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.1 p -86.7 -22.04 26.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.54 1.136 . . . . 0.0 112.855 168.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -100.84 86.0 3.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.134 0.969 . . . . 0.0 110.596 -166.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.23 177.91 5.7 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.756 1.223 . . . . 0.0 112.674 -172.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.1 tp -145.66 143.2 29.68 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.136 1.774 . . . . 0.0 109.649 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -109.37 136.78 48.25 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.024 -1.047 . . . . 0.0 108.43 162.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.2 mt -118.88 144.36 46.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.76 0.824 . . . . 0.0 109.252 161.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.4 m -109.04 123.18 48.74 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.16 120.41 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.378 1.471 . . . . 0.0 108.584 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.49 30.82 42.66 Favored Glycine 0 CA--C 1.543 1.82 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.05 -3.92 82.81 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 118.636 1.218 . . . . 0.0 115.684 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.66 126.88 44.4 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.189 1.395 . . . . 0.0 110.262 171.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.03 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.984 -0.447 . . . . 0.0 110.773 162.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.3 mt -122.23 106.42 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 109.636 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -78.49 117.06 19.33 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.913 2.485 . . . . 0.0 110.812 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 t -145.06 -179.68 6.78 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.552 1.141 . . . . 0.0 113.248 -164.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.2 p -85.62 155.64 21.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.501 1.12 . . . . 0.0 112.159 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -64.32 -28.14 69.5 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.927 -1.108 . . . . 0.0 112.552 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.91 5.26 52.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.06 0.944 . . . . 0.0 113.17 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -68.19 125.82 91.97 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.476 -1.39 . . . . 0.0 112.767 -169.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.22 114.24 3.3 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.501 2.8 . . . . 0.0 114.073 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -102.95 148.85 25.16 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.818 1.647 . . . . 0.0 110.997 170.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -93.83 130.89 39.69 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.196 0.907 . . . . 0.0 112.704 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.4 133.4 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.08 1.752 . . . . 0.0 111.071 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -52.81 126.98 21.86 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.528 1.531 . . . . 0.0 111.032 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.15 16.83 5.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.065 1.746 . . . . 0.0 115.266 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.28 -51.61 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.417 1.487 . . . . 0.0 111.59 -172.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.5 -160.8 13.02 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.027 0.822 . . . . 0.0 113.547 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.251 15.1 p90 -79.46 149.89 31.42 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -171.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 p -150.43 145.53 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.982 2.113 . . . . 0.0 110.999 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -70.19 138.23 51.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.667 1.587 . . . . 0.0 112.129 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.95 -39.92 66.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.812 1.245 . . . . 0.0 113.834 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.27 -10.75 79.05 Favored Glycine 0 CA--C 1.539 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 114.262 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -109.69 -0.49 18.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.456 1.903 . . . . 0.0 113.172 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 mt -67.57 160.1 28.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.507 0.723 . . . . 0.0 111.593 167.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -127.47 155.15 44.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.156 1.382 . . . . 0.0 111.711 172.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.25 137.94 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.801 0.84 . . . . 0.0 110.288 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.33 1.49 81.26 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.413 -1.215 . . . . 0.0 115.472 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -83.92 157.85 21.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.763 1.781 . . . . 0.0 112.089 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.45 98.02 8.41 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.096 1.358 . . . . 0.0 112.031 -166.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.01 179.21 6.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.037 1.335 . . . . 0.0 110.796 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 71.4 mt -131.56 155.75 46.93 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.297 1.039 . . . . 0.0 113.249 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.46 173.31 6.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.025 0.93 . . . . 0.0 112.671 168.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.2 t -51.4 -36.75 45.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -85.83 -11.7 52.7 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.777 1.231 . . . . 0.0 112.848 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.91 16.08 31.8 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 126.077 1.798 . . . . 0.0 112.633 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -72.57 143.43 48.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.636 0.774 . . . . 0.0 110.73 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.52 130.17 36.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 122.616 1.198 . . . . 0.0 111.128 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.7 mt -111.57 151.5 28.64 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.796 1.638 . . . . 0.0 111.33 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -118.89 137.03 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.549 0.74 . . . . 0.0 111.216 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.2 t -71.62 128.76 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.731 0.813 . . . . 0.0 109.593 170.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.59 -29.27 9.26 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.339 1.856 . . . . 0.0 112.485 -176.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -162.21 153.05 17.52 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.032 1.333 . . . . 0.0 112.243 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -120.55 132.41 55.15 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.329 1.852 . . . . 0.0 109.312 157.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -130.43 142.42 50.5 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.827 1.651 . . . . 0.0 110.127 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.7 tp -129.1 133.13 47.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.209 1.404 . . . . 0.0 111.162 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.37 156.31 48.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.295 1.038 . . . . 0.0 112.174 166.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.1 mm -108.79 107.85 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.227 1.411 . . . . 0.0 107.334 168.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.74 143.57 55.83 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.863 0.84 . . . . 0.0 112.804 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.65 -24.0 67.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -140.53 153.71 68.57 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.502 1.921 . . . . 0.0 111.435 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.39 120.09 7.4 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.393 2.729 . . . . 0.0 111.522 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.49 142.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.23 1.412 . . . . 0.0 109.593 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -78.51 140.94 38.52 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.564 0.697 . . . . 0.0 111.519 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.0 m -139.42 145.65 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 124.57 1.148 . . . . 0.0 111.727 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -125.2 148.14 48.76 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.343 1.457 . . . . 0.0 110.723 -166.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -151.7 168.71 24.17 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.38 1.472 . . . . 0.0 110.114 168.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -149.19 173.84 13.01 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.753 -1.217 . . . . 0.0 112.384 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -130.37 146.28 51.92 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.36 144.84 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.679 1.992 . . . . 0.0 113.004 -162.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.74 -18.24 62.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.521 2.729 . . . . 0.0 117.115 -168.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 4.5 m-20 -148.61 -63.86 0.24 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.915 1.234 . . . . 0.0 110.965 164.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -69.94 108.58 4.08 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.414 1.085 . . . . 0.0 110.74 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -70.02 36.11 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.292 1.837 . . . . 0.0 115.765 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.8 p -131.9 164.05 26.96 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.776 2.03 . . . . 0.0 111.935 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -157.94 -176.06 5.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.545 1.538 . . . . 0.0 110.037 166.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -127.66 141.4 51.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.366 1.066 . . . . 0.0 113.039 -172.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.32 138.24 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.495 1.118 . . . . 0.0 112.373 -175.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.02 179.46 53.08 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -73.7 -23.99 59.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.477 1.111 . . . . 0.0 112.148 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -80.25 1.68 27.53 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 166.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 54.87 39.3 31.43 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.268 1.427 . . . . 0.0 114.352 166.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.63 138.37 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.21 1.804 . . . . 0.0 112.02 -166.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.1 tp -81.65 126.75 32.14 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.408 1.483 . . . . 0.0 114.023 -173.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.29 157.96 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.673 1.589 . . . . 0.0 112.105 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -102.34 143.37 32.18 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.5 1.52 . . . . 0.0 112.02 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 C--O 1.252 1.21 0 C-N-CA 124.15 0.98 . . . . 0.0 112.509 176.688 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.77 154.85 40.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.542 1.537 . . . . 0.0 111.411 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.0 m -71.66 158.62 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.336 0.654 . . . . 0.0 112.431 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.52 147.56 10.77 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.332 1.053 . . . . 0.0 111.191 172.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.37 6.61 62.07 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-O 117.949 -1.473 . . . . 0.0 115.756 -171.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.4 m -70.75 121.73 18.53 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.962 2.381 . . . . 0.0 109.639 164.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -80.08 140.14 36.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.67 1.188 . . . . 0.0 111.505 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.0 mm -125.25 136.29 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.301 2.24 . . . . 0.0 109.946 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.4 tp -78.61 123.65 27.33 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.161 0.984 . . . . 0.0 113.398 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 p -117.83 177.05 4.91 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.24 1.416 . . . . 0.0 111.334 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.09 -21.46 64.96 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.117 -0.989 . . . . 0.0 113.262 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -96.62 -14.33 22.23 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.201 1.8 . . . . 0.0 113.108 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.26 -108.29 0.61 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.789 1.662 . . . . 0.0 111.462 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.2 mt -127.95 142.07 51.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.293 1.037 . . . . 0.0 113.548 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.7 t -130.16 144.41 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.949 2.1 . . . . 0.0 108.887 174.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.93 147.52 48.65 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.114 -0.991 . . . . 0.0 110.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -61.87 -27.75 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 120.457 -1.402 . . . . 0.0 113.124 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.83 -7.15 43.29 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.891 1.276 . . . . 0.0 114.18 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -115.87 -12.14 11.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.185 1.794 . . . . 0.0 113.976 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -63.22 140.26 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 165.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -125.75 159.03 33.39 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.18 1.792 . . . . 0.0 112.401 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.38 123.98 19.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 122.897 0.479 . . . . 0.0 110.317 164.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.73 -6.69 70.44 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.955 1.265 . . . . 0.0 114.646 -172.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -75.03 177.87 6.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.65 1.225 . . . . 0.0 111.24 166.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -134.8 140.78 46.14 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.905 1.282 . . . . 0.0 113.046 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -135.14 159.26 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.124 1.769 . . . . 0.0 111.099 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.6 mm -77.98 136.91 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.972 -0.455 . . . . 0.0 111.803 171.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.6 117.89 20.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.139 1.376 . . . . 0.0 108.596 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.5 m -90.85 104.59 17.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -49.2 113.58 3.25 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.013 0.925 . . . . 0.0 112.008 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.99 -3.66 13.65 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.41 2.74 . . . . 0.0 113.871 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.07 -38.08 25.43 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.841 -1.162 . . . . 0.0 112.841 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -141.83 -2.18 1.2 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -166.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 55.19 37.28 28.65 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.919 1.688 . . . . 0.0 113.747 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.5 131.72 35.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.279 1.432 . . . . 0.0 108.896 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -106.23 125.17 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.441 1.097 . . . . 0.0 109.309 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.72 161.73 37.09 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -78.08 134.79 37.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.512 0.725 . . . . 0.0 109.298 161.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -139.75 150.95 45.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.478 1.111 . . . . 0.0 111.618 170.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 t -85.39 159.74 19.92 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -92.1 129.69 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.997 1.719 . . . . 0.0 110.868 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.5 mt -84.23 -50.01 8.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.38 0.672 . . . . 0.0 112.142 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -145.12 151.84 39.11 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.937 1.695 . . . . 0.0 111.02 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 p -125.81 109.23 12.3 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.425 1.89 . . . . 0.0 110.543 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -98.92 146.8 25.62 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.404 1.082 . . . . 0.0 113.321 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 114' ' ' TYR . 39.4 t -139.12 134.51 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.866 1.266 . . . . 0.0 111.751 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -132.03 174.28 10.35 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.222 1.809 . . . . 0.0 111.342 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.89 135.52 49.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.484 1.514 . . . . 0.0 110.151 170.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -146.03 143.06 29.19 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.897 1.279 . . . . 0.0 111.419 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -86.04 -16.0 39.55 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.214 1.006 . . . . 0.0 112.417 164.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -102.45 110.07 21.9 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 120.838 -1.163 . . . . 0.0 109.75 -173.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.6 mt -120.47 172.5 7.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.84 1.256 . . . . 0.0 112.257 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -142.12 140.16 32.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.071 1.748 . . . . 0.0 110.065 175.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -107.53 137.86 44.8 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.188 -0.945 . . . . 0.0 108.84 163.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.8 mt -121.32 142.65 49.76 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.009 0.924 . . . . 0.0 109.266 160.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -110.06 122.29 47.25 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.156 0.982 . . . . 0.0 108.981 172.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.17 121.67 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.978 1.711 . . . . 0.0 108.616 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.02 31.29 58.59 Favored Glycine 0 CA--C 1.543 1.84 0 O-C-N 121.401 -0.812 . . . . 0.0 114.866 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.09 -1.06 88.98 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.252 1.405 . . . . 0.0 115.465 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -106.35 124.13 49.12 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.983 1.713 . . . . 0.0 110.828 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.8 130.52 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.2 1.0 . . . . 0.0 111.196 172.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.0 mt -120.8 102.26 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.417 1.487 . . . . 0.0 108.709 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -79.76 116.46 19.95 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.175 1.79 . . . . 0.0 111.428 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 t -142.18 -176.13 4.7 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.305 1.442 . . . . 0.0 112.015 -163.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 67.3 p -95.04 158.72 15.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.52 1.128 . . . . 0.0 111.768 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -63.94 -26.1 68.44 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.369 -0.832 . . . . 0.0 112.751 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -97.83 4.47 49.72 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -66.58 126.66 92.59 Favored Pre-proline 0 CA--C 1.55 0.97 0 O-C-N 120.511 -1.368 . . . . 0.0 112.98 -173.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.49 116.82 2.99 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.814 2.343 . . . . 0.0 114.266 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -102.01 153.24 20.07 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.187 2.195 . . . . 0.0 111.11 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.59 133.89 42.3 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.491 1.041 . . . . 0.0 113.754 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.7 t -111.24 131.87 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 127.084 2.154 . . . . 0.0 111.528 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -51.9 129.2 26.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.846 1.658 . . . . 0.0 113.027 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 56.27 12.06 0.92 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 127.988 2.515 . . . . 0.0 115.547 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.74 -56.49 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.747 1.219 . . . . 0.0 111.774 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 124.78 -159.98 19.4 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.635 0.636 . . . . 0.0 113.25 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.252 10.6 p90 -81.68 153.88 26.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.87 143.71 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.93 2.092 . . . . 0.0 111.329 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.37 136.01 57.33 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.301 1.041 . . . . 0.0 113.357 170.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.25 -39.65 70.02 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.553 1.541 . . . . 0.0 113.16 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.1 -22.19 70.49 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.739 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.38 -10.64 45.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.9 mt -67.71 154.41 41.57 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.277 0.944 . . . . 0.0 111.576 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -123.08 152.74 40.76 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.193 0.997 . . . . 0.0 110.768 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.5 t -65.5 138.03 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.693 0.797 . . . . 0.0 110.361 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.51 -3.78 85.19 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 115.254 0.862 . . . . 0.0 115.254 -175.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.22 153.48 27.15 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.085 1.442 . . . . 0.0 111.799 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -100.39 107.96 19.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.852 1.261 . . . . 0.0 112.587 -163.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.5 mt -100.91 177.26 5.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.724 1.61 . . . . 0.0 110.343 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.88 157.57 41.18 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.4 -174.32 2.47 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.43 1.492 . . . . 0.0 114.511 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.4 p -56.0 -7.25 0.31 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -119.65 -26.55 5.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.187 1.395 . . . . 0.0 114.55 165.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.16 23.39 4.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.147 1.356 . . . . 0.0 113.404 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -77.0 146.75 37.23 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.324 1.062 . . . . 0.0 111.82 171.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.54 109.43 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.239 0.616 . . . . 0.0 112.225 -173.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.8 mt -93.44 159.31 15.3 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.858 1.663 . . . . 0.0 112.312 173.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.2 t -124.55 139.11 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.111 0.964 . . . . 0.0 111.098 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.2 t -69.2 130.82 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.403 0.681 . . . . 0.0 110.081 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -98.28 -43.33 7.01 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.534 1.933 . . . . 0.0 112.796 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -159.81 154.08 23.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.27 1.028 . . . . 0.0 111.843 -172.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -118.87 135.62 54.46 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.553 1.941 . . . . 0.0 108.865 165.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -130.57 130.09 43.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.817 1.647 . . . . 0.0 109.678 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -129.16 129.75 45.51 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.665 1.186 . . . . 0.0 111.985 -169.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -147.03 163.49 36.09 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.488 1.115 . . . . 0.0 112.879 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 mm -104.63 116.7 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 159.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.21 145.57 50.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.249 1.019 . . . . 0.0 111.672 173.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -75.09 -11.82 60.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.991 1.316 . . . . 0.0 112.464 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -139.84 152.05 67.13 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 127.204 2.202 . . . . 0.0 111.57 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.59 117.69 5.04 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.078 2.519 . . . . 0.0 110.753 172.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.31 139.43 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.033 1.733 . . . . 0.0 110.353 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -76.27 139.31 41.05 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.888 0.875 . . . . 0.0 110.297 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.47 140.8 28.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 124.007 0.923 . . . . 0.0 111.657 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.438 ' CD2' HG22 ' A' ' 46' ' ' VAL . 76.3 m-85 -119.64 153.87 34.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.812 1.645 . . . . 0.0 112.049 -169.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -157.18 170.2 23.04 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.947 1.699 . . . . 0.0 110.816 170.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -152.64 167.56 28.5 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.354 -1.466 . . . . 0.0 113.249 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -117.37 144.84 44.52 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.745 1.218 . . . . 0.0 112.954 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.17 139.54 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.562 1.545 . . . . 0.0 111.48 -168.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -60.22 -34.66 73.96 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -163.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -145.87 -47.27 0.21 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.007 -1.058 . . . . 0.0 112.671 -172.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -76.39 165.99 24.05 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.198 1.399 . . . . 0.0 109.169 163.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -116.88 1.42 12.67 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -168.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.3 p -126.28 163.94 22.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.534 1.534 . . . . 0.0 113.258 -167.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -153.39 -177.08 6.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.749 1.619 . . . . 0.0 110.631 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -130.16 141.85 50.63 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.79 1.236 . . . . 0.0 113.31 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.26 140.23 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.499 1.119 . . . . 0.0 113.688 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.23 176.95 42.45 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.784 1.659 . . . . 0.0 116.496 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -57.21 -36.95 71.5 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.076 1.351 . . . . 0.0 112.775 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -82.95 -1.04 51.32 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 175.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 56.96 51.09 11.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.843 1.657 . . . . 0.0 113.486 168.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.9 t -80.32 141.98 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.215 1.806 . . . . 0.0 112.055 -167.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 48.9 tp -78.58 125.88 29.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.98 1.712 . . . . 0.0 114.216 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.09 158.9 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.257 1.823 . . . . 0.0 111.648 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -111.58 151.97 28.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.708 1.203 . . . . 0.0 112.934 -171.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.755 -1.593 . . . . 0.0 113.926 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.989 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -124.37 154.81 39.8 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.289 1.436 . . . . 0.0 111.833 173.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.97 157.8 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.452 0.644 . . . . 0.0 112.356 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.3 144.31 20.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.539 0.735 . . . . 0.0 111.898 172.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.42 -8.1 69.65 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 116.489 1.355 . . . . 0.0 116.489 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.9 m -64.12 121.27 13.8 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 120.62 2.21 . . . . 0.0 110.6 174.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mmt -78.23 142.93 37.54 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.22 1.408 . . . . 0.0 112.089 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.5 mm -127.79 134.34 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.726 2.011 . . . . 0.0 109.708 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -76.38 128.95 35.85 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 p -123.64 169.67 11.24 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.991 1.316 . . . . 0.0 111.241 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.31 -19.09 65.8 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.777 -1.202 . . . . 0.0 113.294 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 p -119.56 2.66 11.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.861 2.064 . . . . 0.0 113.792 -173.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.16 -116.36 0.81 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.221 1.391 . . . . 0.0 113.982 166.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.98 154.47 45.55 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.771 1.628 . . . . 0.0 110.5 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -143.16 148.19 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 126.439 1.896 . . . . 0.0 108.585 170.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.35 147.02 46.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.017 -1.052 . . . . 0.0 111.306 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 tt -62.11 -27.06 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 120.437 -1.414 . . . . 0.0 113.498 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.58 -14.7 62.6 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 172.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -108.5 -15.06 14.53 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.232 1.813 . . . . 0.0 113.898 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.8 mm -63.04 132.25 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 163.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -133.26 170.76 14.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.523 1.929 . . . . 0.0 109.606 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.12 130.47 15.75 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.189 0.518 . . . . 0.0 111.005 166.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.24 -1.2 88.73 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 116.105 1.202 . . . . 0.0 116.105 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -76.58 155.38 33.64 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.779 1.789 . . . . 0.0 110.666 160.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -111.5 140.36 46.17 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.958 1.303 . . . . 0.0 112.509 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.11 162.16 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.542 1.937 . . . . 0.0 110.292 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.2 mm -78.63 141.73 15.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 121.819 -0.55 . . . . 0.0 110.472 162.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.95 129.3 29.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.7 m -91.53 108.37 19.85 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 165.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -52.43 117.21 10.06 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.223 1.009 . . . . 0.0 112.583 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.43 -12.98 37.7 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.097 2.532 . . . . 0.0 113.907 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -76.4 -40.62 50.37 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.225 1.01 . . . . 0.0 112.523 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.8 t -135.08 -5.26 2.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.339 1.456 . . . . 0.0 113.685 -171.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.3 t80 56.65 43.08 26.08 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.329 1.452 . . . . 0.0 114.034 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -95.71 135.16 37.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.236 1.014 . . . . 0.0 110.151 170.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -105.95 122.54 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.98 0.912 . . . . 0.0 112.339 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.22 160.51 39.26 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.324 1.049 . . . . 0.0 113.077 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -91.12 121.12 32.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.148 1.379 . . . . 0.0 109.466 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -139.05 149.09 44.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.465 1.106 . . . . 0.0 112.931 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.7 t -80.75 161.5 24.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.875 1.27 . . . . 0.0 113.435 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.9 t -98.19 133.62 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 126.236 1.814 . . . . 0.0 111.716 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.02 -45.19 10.4 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.962 1.305 . . . . 0.0 113.298 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -146.88 156.64 43.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.276 1.83 . . . . 0.0 110.614 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.1 p -116.43 135.24 54.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.221 164.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -105.7 147.92 28.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.688 1.595 . . . . 0.0 112.056 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -143.65 128.93 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.501 1.12 . . . . 0.0 111.319 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -126.28 176.05 7.38 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.04 1.736 . . . . 0.0 111.198 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -133.34 133.73 42.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.781 1.233 . . . . 0.0 111.945 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 t -148.16 143.99 27.45 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.957 1.303 . . . . 0.0 111.63 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.7 p -84.35 -21.27 30.96 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.635 0.774 . . . . 0.0 112.689 164.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -96.39 115.81 28.04 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.008 0.923 . . . . 0.0 110.203 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.4 mt -121.05 167.79 12.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.796 1.239 . . . . 0.0 112.276 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.89 134.85 46.16 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.693 1.997 . . . . 0.0 109.689 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -113.88 128.38 56.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.617 1.167 . . . . 0.0 108.866 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.2 mt -124.08 128.77 49.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.518 1.127 . . . . 0.0 110.339 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.8 m -99.04 122.9 42.9 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 169.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.74 119.67 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.895 1.278 . . . . 0.0 109.968 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.86 21.74 17.12 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 115.926 1.131 . . . . 0.0 115.926 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.35 7.64 55.74 Favored Glycine 0 CA--C 1.542 1.768 0 N-CA-C 116.914 1.526 . . . . 0.0 116.914 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -121.76 131.02 53.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.185 1.492 . . . . 0.0 109.869 172.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -97.35 134.69 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.989 0.899 . . . . 0.0 112.983 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.8 mt -130.42 133.81 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.812 2.045 . . . . 0.0 108.794 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -119.08 112.13 19.15 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.245 1.418 . . . . 0.0 110.792 -165.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -141.2 -177.63 5.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.611 1.164 . . . . 0.0 112.426 -161.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.9 p -89.66 153.54 20.65 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.198 0.999 . . . . 0.0 111.923 169.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -58.26 -27.88 64.4 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.925 1.29 . . . . 0.0 113.272 -175.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -107.52 7.44 28.8 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.723 1.209 . . . . 0.0 112.225 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -69.69 128.86 91.77 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.99 112.86 2.37 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 124.683 3.589 . . . . 0.0 115.216 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -94.7 152.99 18.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.369 2.268 . . . . 0.0 111.507 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -97.99 132.02 43.91 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -111.59 138.51 39.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 127.28 2.232 . . . . 0.0 110.226 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.54 127.4 31.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.732 1.213 . . . . 0.0 110.441 175.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t0 56.3 31.52 18.72 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.383 1.873 . . . . 0.0 115.595 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.0 t -144.12 -50.63 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.853 1.261 . . . . 0.0 112.417 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.45 -153.21 16.74 Favored Glycine 0 N--CA 1.468 0.811 0 CA-C-N 119.392 0.997 . . . . 0.0 111.512 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -92.04 147.65 22.79 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -149.14 143.49 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.596 1.958 . . . . 0.0 112.053 -175.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.81 132.33 52.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.872 1.269 . . . . 0.0 112.68 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.84 -36.96 68.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.301 1.44 . . . . 0.0 113.645 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.99 -12.67 83.2 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.561 1.077 . . . . 0.0 114.168 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -102.2 -7.88 21.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.278 1.831 . . . . 0.0 113.544 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 mt -58.49 158.69 7.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.679 0.792 . . . . 0.0 112.405 166.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -114.51 152.82 31.09 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.388 1.475 . . . . 0.0 110.395 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 50.3 t -67.59 132.63 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.351 0.596 . . . . 0.0 109.521 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.1 0.14 68.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.677 1.132 . . . . 0.0 115.201 -171.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -84.22 156.4 22.04 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.127 1.464 . . . . 0.0 111.96 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -106.73 102.41 11.79 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.118 1.367 . . . . 0.0 111.965 -156.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.7 mt -96.3 -175.36 3.33 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.486 1.514 . . . . 0.0 111.041 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.67 149.03 52.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.084 0.954 . . . . 0.0 112.51 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.02 172.46 6.91 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.218 1.007 . . . . 0.0 113.278 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.9 p -56.67 -11.34 1.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -107.37 -30.5 8.65 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.19 1.796 . . . . 0.0 112.344 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.74 19.89 5.92 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.956 1.741 . . . . 0.0 113.79 -177.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -70.59 140.26 51.64 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.658 0.729 . . . . 0.0 110.553 167.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.4 t -77.57 107.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.906 0.883 . . . . 0.0 109.832 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.3 mt -85.96 160.53 19.34 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.274 1.43 . . . . 0.0 111.816 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.89 137.71 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.334 1.053 . . . . 0.0 110.798 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.0 119.66 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.602 0.761 . . . . 0.0 109.05 170.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -96.52 -31.64 12.68 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.392 1.477 . . . . 0.0 112.213 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.93 148.12 20.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.575 1.55 . . . . 0.0 111.324 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -125.66 127.36 46.16 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.441 2.296 . . . . 0.0 109.773 168.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -125.31 156.56 38.45 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.482 2.313 . . . . 0.0 110.748 169.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.15 135.08 26.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.841 1.656 . . . . 0.0 108.266 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -142.75 158.46 43.61 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.9 mm -110.7 101.02 11.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 125.21 1.404 . . . . 0.0 109.903 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.78 146.74 35.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.403 1.481 . . . . 0.0 113.535 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.59 -14.79 61.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.848 1.259 . . . . 0.0 113.372 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -138.3 155.15 74.18 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 127.076 2.15 . . . . 0.0 109.761 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.96 111.42 2.64 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.429 2.086 . . . . 0.0 110.402 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.1 t -81.42 140.24 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.927 1.691 . . . . 0.0 110.015 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -75.64 135.8 40.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.092 0.949 . . . . 0.0 110.39 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.28 136.76 50.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 124.59 1.156 . . . . 0.0 110.61 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -118.91 149.32 41.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.609 1.564 . . . . 0.0 111.16 -167.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -153.36 166.42 32.69 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.763 1.625 . . . . 0.0 109.885 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -152.44 164.72 36.98 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.241 -1.537 . . . . 0.0 112.318 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -121.98 143.17 49.64 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.0 t -98.72 146.51 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.289 1.836 . . . . 0.0 112.364 -168.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.88 -15.13 63.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -168.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -145.35 -47.5 0.22 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.89 0.876 . . . . 0.0 112.109 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -83.41 173.51 11.46 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.36 1.064 . . . . 0.0 112.1 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -112.48 9.22 19.57 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.824 2.05 . . . . 0.0 114.58 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 p -133.08 171.44 13.98 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.104 1.361 . . . . 0.0 113.585 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -157.52 179.91 8.79 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.831 2.053 . . . . 0.0 110.362 163.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -117.24 138.95 51.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.808 1.243 . . . . 0.0 112.604 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.6 m -126.14 142.65 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.381 1.472 . . . . 0.0 113.912 -174.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.22 174.59 28.0 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.431 1.491 . . . . 0.0 115.336 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -26.0 65.9 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.756 -1.438 . . . . 0.0 113.133 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -83.54 -3.78 57.96 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.005 0.922 . . . . 0.0 113.384 170.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 57.38 55.35 5.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.134 1.773 . . . . 0.0 113.857 167.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.88 143.41 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.557 1.543 . . . . 0.0 111.603 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.5 tp -81.34 125.47 30.42 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.726 1.21 . . . . 0.0 114.091 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.6 159.05 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.478 1.511 . . . . 0.0 112.574 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -99.62 149.96 22.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.179 1.392 . . . . 0.0 113.959 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.7 m120 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.265 1.826 . . . . 0.0 112.505 179.469 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.041 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.437 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.8 m-85 -124.78 154.52 40.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.565 1.546 . . . . 0.0 111.121 167.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.49 154.69 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.683 -0.636 . . . . 0.0 111.262 171.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.78 154.56 8.97 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.362 0.601 . . . . 0.0 111.717 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.88 -9.66 29.89 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-O 117.676 -1.625 . . . . 0.0 116.186 -171.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.5 m -62.33 125.31 23.47 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.539 2.17 . . . . 0.0 110.11 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 mmt -85.12 140.66 30.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.693 1.197 . . . . 0.0 111.982 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.66 135.18 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.781 2.033 . . . . 0.0 110.123 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.68 130.8 40.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.902 0.881 . . . . 0.0 113.208 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 p -126.18 174.21 8.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.71 1.604 . . . . 0.0 111.353 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.7 -19.38 64.88 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.26 1.424 . . . . 0.0 113.552 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -110.56 -25.39 10.02 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.17 -113.34 0.54 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.809 0.731 . . . . 0.0 112.825 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.6 mt -130.99 145.9 52.2 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.2 t -133.29 142.73 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.305 1.842 . . . . 0.0 108.941 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.77 144.77 49.08 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.214 -0.929 . . . . 0.0 110.959 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.32 -27.52 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 120.982 -1.074 . . . . 0.0 113.605 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -70.51 -14.06 62.37 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.089 1.356 . . . . 0.0 114.125 173.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -114.28 -11.01 12.64 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.551 1.54 . . . . 0.0 113.203 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.4 mm -61.68 137.23 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.569 -0.707 . . . . 0.0 109.282 163.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -125.55 164.03 21.42 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.369 1.868 . . . . 0.0 111.545 170.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.62 132.42 35.68 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.738 -0.601 . . . . 0.0 111.532 167.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.29 1.13 90.4 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.486 1.041 . . . . 0.0 115.287 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -82.65 154.54 24.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.533 1.167 . . . . 0.0 109.869 164.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -112.13 145.64 39.44 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.693 1.197 . . . . 0.0 112.311 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.03 160.56 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.229 1.811 . . . . 0.0 111.258 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -73.79 143.95 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.475 -0.765 . . . . 0.0 111.722 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.52 128.28 20.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.36 1.064 . . . . 0.0 109.446 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.4 m -78.62 115.45 18.33 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 162.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -55.21 115.39 9.03 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.231 1.012 . . . . 0.0 112.07 170.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.84 -3.95 13.77 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.9 2.4 . . . . 0.0 114.349 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -81.8 -45.99 14.81 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.309 0.958 . . . . 0.0 112.409 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -136.86 0.95 2.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.342 1.057 . . . . 0.0 112.767 -166.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 55.8 45.99 23.21 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.468 1.127 . . . . 0.0 112.678 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -86.59 134.97 33.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.564 1.546 . . . . 0.0 109.543 165.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 t -110.44 119.64 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 118.733 0.697 . . . . 0.0 109.644 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.35 164.88 33.67 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.792 0.837 . . . . 0.0 112.529 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -88.94 128.84 35.7 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.697 1.599 . . . . 0.0 110.941 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.444 ' HE3' ' CZ ' ' A' ' 121' ' ' PHE . 66.6 mmtt -134.46 148.76 50.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.365 1.066 . . . . 0.0 111.153 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -86.05 154.15 21.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.62 0.724 . . . . 0.0 112.781 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.6 t -90.18 134.86 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.655 1.582 . . . . 0.0 110.599 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.82 -48.37 7.54 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.881 0.872 . . . . 0.0 112.381 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -143.78 160.89 39.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.264 1.826 . . . . 0.0 110.235 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.3 p -116.43 134.05 55.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.562 1.145 . . . . 0.0 110.172 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -109.32 140.78 42.56 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.835 1.654 . . . . 0.0 113.705 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.33 138.45 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.651 1.18 . . . . 0.0 111.062 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -141.19 174.04 10.91 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.474 2.31 . . . . 0.0 109.532 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -130.48 138.85 50.47 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.504 1.522 . . . . 0.0 110.38 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.2 t -147.15 150.7 35.48 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.585 0.707 . . . . 0.0 111.643 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 p -94.17 -14.03 26.06 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.67 1.588 . . . . 0.0 113.848 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -118.55 111.39 18.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.039 0.836 . . . . 0.0 110.745 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.2 mt -110.14 160.79 16.17 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 tp -127.58 130.65 49.41 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 110.852 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -117.4 103.07 9.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.696 1.598 . . . . 0.0 109.413 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.7 mt -98.35 128.1 44.6 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.757 0.823 . . . . 0.0 110.22 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -100.29 119.74 38.86 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.08 116.32 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.321 1.048 . . . . 0.0 109.179 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.12 28.75 34.44 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 123.707 0.67 . . . . 0.0 114.72 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.12 -2.11 87.63 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.915 1.722 . . . . 0.0 116.332 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.4 122.49 41.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.863 1.831 . . . . 0.0 109.507 168.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.1 p -87.32 131.78 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.486 0.66 . . . . 0.0 111.71 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.92 131.04 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.823 2.049 . . . . 0.0 108.86 -175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -113.94 110.19 19.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.608 1.163 . . . . 0.0 110.777 -164.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 t -139.88 177.78 7.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.05 0.94 . . . . 0.0 112.218 -157.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.2 p -87.15 151.31 23.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.129 0.972 . . . . 0.0 112.116 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -58.75 -29.85 67.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.408 1.083 . . . . 0.0 112.845 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -98.21 9.55 42.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.437 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.3 t60 -70.58 125.96 92.13 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 120.909 -1.119 . . . . 0.0 112.475 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.99 119.82 4.04 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.139 2.559 . . . . 0.0 113.963 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -106.92 144.13 34.0 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.71 2.004 . . . . 0.0 111.074 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -83.33 128.61 34.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.464 1.029 . . . . 0.0 113.285 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.9 t -103.84 133.0 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.402 2.281 . . . . 0.0 110.96 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -49.01 118.46 2.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.056 1.743 . . . . 0.0 112.144 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 52.57 24.94 3.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.404 2.682 . . . . 0.0 115.312 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.75 -50.26 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.21 1.404 . . . . 0.0 110.577 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.48 -161.66 13.52 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 123.541 0.591 . . . . 0.0 112.54 -175.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.282 31.1 p90 -85.02 150.01 25.18 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 118.818 1.309 . . . . 0.0 114.162 -175.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.72 144.99 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.008 1.723 . . . . 0.0 110.642 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.41 136.13 57.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.94 0.896 . . . . 0.0 112.108 176.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.25 -36.12 70.56 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.78 1.232 . . . . 0.0 113.961 -171.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.66 -3.74 89.41 Favored Glycine 0 CA--C 1.539 1.561 0 O-C-N 121.027 -1.046 . . . . 0.0 113.611 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -95.77 -4.6 43.68 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.241 1.816 . . . . 0.0 112.314 167.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.0 mt -71.59 154.11 41.66 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.547 -0.721 . . . . 0.0 112.263 166.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -119.72 166.99 12.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.16 1.384 . . . . 0.0 110.976 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.31 138.53 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.57 12.99 82.3 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 115.234 0.854 . . . . 0.0 115.234 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -86.29 150.87 24.05 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.317 -1.107 . . . . 0.0 110.841 169.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -107.44 111.81 24.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.333 1.453 . . . . 0.0 112.056 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.1 mt -104.2 -177.82 3.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.339 1.456 . . . . 0.0 111.06 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -131.46 156.19 46.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.272 1.029 . . . . 0.0 113.518 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.8 p30 -105.15 179.85 4.15 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.914 1.286 . . . . 0.0 113.289 174.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.3 t -66.06 -17.87 64.97 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.871 1.669 . . . . 0.0 114.14 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -85.48 -25.53 26.83 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.261 -1.525 . . . . 0.0 112.171 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.72 25.31 8.16 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.699 2.095 . . . . 0.0 113.224 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.81 142.82 34.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.309 1.444 . . . . 0.0 111.812 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.9 t -57.11 120.3 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.51 1.124 . . . . 0.0 112.248 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -99.71 154.37 18.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.169 1.388 . . . . 0.0 110.901 161.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.42 140.6 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.865 1.266 . . . . 0.0 110.471 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.9 119.54 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.526 0.679 . . . . 0.0 109.237 170.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.02 -35.15 14.81 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.782 2.033 . . . . 0.0 112.626 -176.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -162.91 148.86 12.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.195 1.798 . . . . 0.0 110.817 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -129.41 124.5 34.29 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.932 1.693 . . . . 0.0 110.31 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 mmtm -132.22 151.1 51.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.531 1.532 . . . . 0.0 112.102 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 tp -136.13 137.65 41.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.858 1.663 . . . . 0.0 108.996 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.39 151.13 43.23 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.4 mm -99.77 119.01 47.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.779 170.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.89 149.59 43.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 112.795 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -67.95 -19.06 64.93 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.455 1.502 . . . . 0.0 113.251 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -157.27 156.64 29.56 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.913 2.485 . . . . 0.0 108.961 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -60.59 129.14 28.2 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.452 2.101 . . . . 0.0 112.603 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.83 144.35 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.595 1.558 . . . . 0.0 109.618 173.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -79.69 140.95 36.84 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.618 -0.677 . . . . 0.0 110.643 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.6 m -136.79 137.66 47.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.606 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -111.69 154.15 25.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.721 1.608 . . . . 0.0 111.974 -172.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -155.58 174.01 15.88 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.85 2.46 . . . . 0.0 108.033 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -153.76 170.9 19.8 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.044 -1.66 . . . . 0.0 110.744 173.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -121.94 137.25 54.86 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.774 0.83 . . . . 0.0 112.834 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.6 t -100.05 144.89 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.963 1.305 . . . . 0.0 111.95 -167.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -57.59 -39.07 75.96 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -170.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -139.6 -48.83 0.48 Allowed 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.97 -1.081 . . . . 0.0 113.372 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.444 ' CZ ' ' HE3' ' A' ' 39' ' ' LYS . 5.8 m-30 -69.94 163.87 25.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 168.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -116.29 23.48 12.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.954 1.302 . . . . 0.0 112.103 -171.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 p -147.69 160.64 42.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.553 1.541 . . . . 0.0 111.84 -157.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -160.24 175.89 12.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.836 1.655 . . . . 0.0 110.391 171.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -122.27 134.2 54.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.393 1.077 . . . . 0.0 112.802 -171.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.6 m -122.05 143.42 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.271 1.428 . . . . 0.0 114.663 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.53 176.98 30.14 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 126.118 1.818 . . . . 0.0 116.19 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.15 -34.5 66.19 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 120.92 -1.341 . . . . 0.0 113.237 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -83.02 0.1 46.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 57.35 43.6 23.08 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.027 1.331 . . . . 0.0 113.334 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.25 136.81 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.127 1.371 . . . . 0.0 111.723 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.6 tp -79.22 124.92 28.82 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.829 1.252 . . . . 0.0 113.98 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.4 m -138.27 157.01 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.127 1.771 . . . . 0.0 112.062 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -107.16 129.31 54.86 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.194 1.398 . . . . 0.0 112.823 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.213 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.924 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.44 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 98.4 m-85 -123.62 157.12 34.47 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.14 1.776 . . . . 0.0 110.699 168.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 m -68.79 157.61 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.809 -0.557 . . . . 0.0 111.808 173.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.5 153.36 4.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.364 0.666 . . . . 0.0 111.948 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.8 3.95 30.97 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-O 117.95 -1.472 . . . . 0.0 116.475 -174.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -67.77 125.34 25.95 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 120.922 2.361 . . . . 0.0 109.617 165.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.6 mmt -80.5 142.19 34.44 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.353 1.461 . . . . 0.0 111.858 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -123.29 137.11 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.787 2.035 . . . . 0.0 109.905 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.91 122.14 22.06 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 112.592 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 p -115.21 168.14 10.21 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.115 1.366 . . . . 0.0 110.562 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.28 66.57 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.402 -0.812 . . . . 0.0 112.969 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.0 p -100.05 -31.66 11.32 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.626 0.77 . . . . 0.0 112.547 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.97 -120.09 0.76 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.877 0.751 . . . . 0.0 112.715 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.57 140.83 51.87 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.611 1.164 . . . . 0.0 112.67 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.1 t -132.25 142.64 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.848 1.659 . . . . 0.0 108.747 173.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.38 150.41 48.99 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.103 -0.998 . . . . 0.0 111.725 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.9 tt -62.45 -25.85 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 120.876 -1.14 . . . . 0.0 113.558 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -75.09 -15.28 60.62 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.376 1.07 . . . . 0.0 113.765 171.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -107.97 -16.25 14.34 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.571 1.948 . . . . 0.0 112.401 -176.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.7 mm -63.29 134.66 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 160.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -134.17 160.21 38.51 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.043 1.337 . . . . 0.0 111.604 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.42 120.21 8.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.785 0.434 . . . . 0.0 110.406 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.73 -24.67 23.15 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.535 1.064 . . . . 0.0 115.716 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.86 170.83 8.9 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.394 1.597 . . . . 0.0 111.648 172.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -125.33 146.53 49.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.725 1.61 . . . . 0.0 111.167 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.18 160.55 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.131 1.372 . . . . 0.0 110.455 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -75.09 140.94 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.234 0.54 . . . . 0.0 110.514 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.49 125.78 24.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.222 1.009 . . . . 0.0 108.695 175.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.2 m -79.79 112.3 16.94 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 161.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -53.92 111.44 2.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 118.343 -0.836 . . . . 0.0 110.718 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -69.18 -12.25 33.54 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.35 2.034 . . . . 0.0 112.691 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -77.19 -38.66 51.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.076 1.351 . . . . 0.0 112.828 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.7 t -136.23 -6.1 2.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.01 1.324 . . . . 0.0 112.53 -170.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.259 15.6 m-85 54.5 52.3 12.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.221 1.408 . . . . 0.0 112.185 -175.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -100.64 135.65 41.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.108 1.763 . . . . 0.0 108.889 167.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 t -113.04 128.89 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 119.01 0.823 . . . . 0.0 111.27 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.78 172.19 18.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.91 0.884 . . . . 0.0 113.079 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -74.23 138.04 43.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.71 1.204 . . . . 0.0 111.443 165.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -139.31 152.63 47.37 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.396 1.078 . . . . 0.0 112.23 160.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -79.08 155.32 28.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.668 1.187 . . . . 0.0 114.131 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.7 t -93.12 131.73 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 126.537 1.935 . . . . 0.0 111.318 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.42 -41.05 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.363 1.465 . . . . 0.0 113.508 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -147.37 156.02 42.52 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 127.159 2.184 . . . . 0.0 109.703 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -113.26 135.92 53.31 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.475 1.51 . . . . 0.0 109.14 163.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -112.35 141.83 45.59 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.183 1.393 . . . . 0.0 113.912 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -135.02 138.29 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.056 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -140.15 176.19 8.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.209 2.203 . . . . 0.0 110.112 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.12 133.62 50.36 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.375 1.47 . . . . 0.0 110.973 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 t -142.42 145.11 33.46 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.125 -0.984 . . . . 0.0 113.12 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.8 p -88.27 -14.52 38.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.806 1.642 . . . . 0.0 113.25 167.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -107.66 108.85 20.29 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.005 -1.059 . . . . 0.0 110.9 -172.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.6 mt -116.45 167.96 10.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.251 1.021 . . . . 0.0 112.818 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.1 tp -135.28 133.21 38.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.859 2.064 . . . . 0.0 109.268 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -105.54 130.43 53.6 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.232 -0.918 . . . . 0.0 109.292 170.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.5 mt -114.14 147.53 38.7 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.371 1.069 . . . . 0.0 110.1 169.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.7 m -123.17 124.83 43.92 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.452 0.701 . . . . 0.0 109.627 166.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.1 mt -132.77 123.55 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.84 1.656 . . . . 0.0 109.425 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.08 28.79 50.28 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 115.611 1.005 . . . . 0.0 115.611 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.11 7.51 87.7 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.82 1.2 . . . . 0.0 115.567 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -109.1 137.55 46.83 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.745 1.618 . . . . 0.0 109.567 171.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.61 135.84 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.345 1.058 . . . . 0.0 111.171 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mt -129.7 104.58 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.161 1.784 . . . . 0.0 109.341 173.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -81.94 121.82 26.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.823 1.649 . . . . 0.0 111.429 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.5 t -144.64 175.36 10.21 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.165 -0.96 . . . . 0.0 112.73 -167.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.3 p -79.19 153.86 29.69 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.591 -0.693 . . . . 0.0 111.181 167.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -59.43 -28.83 67.31 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.763 0.825 . . . . 0.0 112.62 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -98.01 1.21 47.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.963 0.905 . . . . 0.0 113.164 -171.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.44 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.2 t60 -64.68 128.07 93.13 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 117.657 -1.163 . . . . 0.0 112.87 -173.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 68' ' ' HIS . 7.6 Cg_exo -84.4 127.87 3.97 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.003 1.802 . . . . 0.0 114.673 -175.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -115.93 139.58 50.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.129 2.572 . . . . 0.0 111.407 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -89.6 129.58 36.03 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.0 134.36 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.561 2.344 . . . . 0.0 112.4 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -50.05 126.36 14.27 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.982 1.713 . . . . 0.0 112.779 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 52.5 22.54 2.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.239 2.216 . . . . 0.0 115.259 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.09 -53.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.81 -1.181 . . . . 0.0 111.141 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.92 -159.68 13.57 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.095 0.855 . . . . 0.0 113.014 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -92.57 139.13 30.89 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.159 1.541 . . . . 0.0 115.159 -170.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.57 146.98 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 127.45 2.3 . . . . 0.0 111.987 -172.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.48 135.85 56.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 173.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.48 -40.14 61.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.958 1.703 . . . . 0.0 113.688 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.3 -10.58 66.29 Favored Glycine 0 CA--C 1.539 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 113.683 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -112.14 4.37 17.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.563 2.345 . . . . 0.0 113.04 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.85 159.66 19.14 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.969 -1.082 . . . . 0.0 111.295 163.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.42 156.68 32.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.441 1.096 . . . . 0.0 111.465 172.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.44 132.58 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 165.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.84 11.32 82.92 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 118.404 -1.22 . . . . 0.0 115.706 -172.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.3 165.19 7.82 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.908 1.854 . . . . 0.0 112.097 170.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -117.71 83.28 1.97 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.742 1.217 . . . . 0.0 111.735 -169.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.25 162.96 13.64 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.189 0.996 . . . . 0.0 113.533 -170.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.43 140.75 38.06 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.521 1.128 . . . . 0.0 112.552 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.12 177.14 5.17 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.501 1.12 . . . . 0.0 114.004 171.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.0 p -59.95 -12.08 7.09 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -107.85 -25.91 11.0 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.295 1.838 . . . . 0.0 111.905 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.6 25.14 6.72 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 126.402 1.954 . . . . 0.0 112.719 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -74.83 154.71 38.16 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.709 0.804 . . . . 0.0 110.437 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.8 t -92.83 112.76 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.785 0.834 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.5 mt -84.68 163.11 19.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.755 2.822 . . . . 0.0 112.324 175.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.71 134.78 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.554 1.542 . . . . 0.0 110.033 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.48 131.52 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.685 -0.635 . . . . 0.0 109.542 170.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -105.43 -35.26 7.55 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.613 1.565 . . . . 0.0 112.407 -175.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -157.87 149.24 21.47 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.194 0.998 . . . . 0.0 112.574 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -123.0 128.54 50.33 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.771 2.029 . . . . 0.0 108.743 161.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -130.27 151.61 50.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.116 1.766 . . . . 0.0 111.577 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 tt -138.62 142.99 39.1 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 111.416 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -150.52 161.92 41.61 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.933 0.893 . . . . 0.0 112.555 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mm -111.02 109.93 30.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.991 1.317 . . . . 0.0 108.329 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.47 140.37 58.59 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.318 0.647 . . . . 0.0 110.943 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.88 -21.63 60.89 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.64 -1.288 . . . . 0.0 113.283 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -127.54 151.12 74.61 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 127.221 2.208 . . . . 0.0 109.887 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.05 110.71 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.727 2.285 . . . . 0.0 112.069 -174.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.35 142.1 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.03 1.732 . . . . 0.0 110.18 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -71.2 140.28 50.42 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.081 0.943 . . . . 0.0 112.144 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.1 m -140.04 137.5 38.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.645 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -121.92 149.05 43.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.527 1.531 . . . . 0.0 111.354 -166.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -154.11 173.18 16.41 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.666 1.986 . . . . 0.0 108.413 170.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -150.27 170.71 18.35 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.218 -1.551 . . . . 0.0 111.283 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -119.46 136.52 54.27 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.82 0.848 . . . . 0.0 112.912 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.51 146.61 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.756 1.622 . . . . 0.0 111.491 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.08 -45.26 74.29 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -168.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -127.65 -32.85 2.34 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 119.732 1.151 . . . . 0.0 113.654 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -96.32 169.27 10.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.263 1.425 . . . . 0.0 108.925 167.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -120.97 19.68 11.65 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.742 1.217 . . . . 0.0 113.282 -171.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 p -142.13 164.28 30.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.524 1.53 . . . . 0.0 111.649 -162.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.69 179.31 9.22 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.387 1.475 . . . . 0.0 110.151 170.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -121.81 134.6 54.9 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.538 1.135 . . . . 0.0 111.943 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.19 144.81 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.239 1.416 . . . . 0.0 113.583 -173.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.6 175.16 26.71 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.663 1.601 . . . . 0.0 115.396 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -63.08 -29.44 70.81 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.309 -1.113 . . . . 0.0 112.112 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -86.11 1.72 49.44 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 174.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 58.33 46.24 15.77 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.271 1.428 . . . . 0.0 114.126 166.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.52 140.1 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.505 1.122 . . . . 0.0 111.443 -172.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.3 125.88 30.89 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.379 1.471 . . . . 0.0 113.922 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.05 155.57 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.847 1.659 . . . . 0.0 112.359 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -97.69 136.49 37.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.441 1.496 . . . . 0.0 111.73 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.217 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.977 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -123.49 154.74 38.72 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.973 1.709 . . . . 0.0 110.809 170.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.6 m -69.63 160.74 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.427 0.632 . . . . 0.0 111.772 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 157.78 2.34 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 122.166 0.984 . . . . 0.0 112.921 174.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.78 -8.54 4.34 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 116.965 -2.02 . . . . 0.0 116.258 -171.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -62.6 119.82 9.97 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.039 2.419 . . . . 0.0 110.077 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mmt -78.36 141.37 38.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.55 1.14 . . . . 0.0 111.797 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -125.24 135.68 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.406 1.883 . . . . 0.0 109.785 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 tp -76.73 123.61 26.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.895 1.278 . . . . 0.0 112.623 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -123.54 176.84 5.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.736 1.214 . . . . 0.0 112.146 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.86 68.1 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.353 -0.842 . . . . 0.0 112.804 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 p -100.01 -14.45 18.65 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.297 1.439 . . . . 0.0 113.434 -170.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.99 -107.41 0.41 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.375 1.464 . . . . 0.0 110.754 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.36 150.91 48.26 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.291 1.036 . . . . 0.0 112.455 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.7 t -140.05 146.59 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.116 2.166 . . . . 0.0 107.738 168.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.34 149.49 47.3 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.8 -1.188 . . . . 0.0 111.077 175.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -60.83 -30.81 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 120.63 -1.293 . . . . 0.0 112.887 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -65.58 -18.05 65.04 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.823 1.649 . . . . 0.0 114.179 171.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -116.62 -5.14 11.65 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.644 1.978 . . . . 0.0 112.776 -174.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -65.17 134.53 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.123 -0.986 . . . . 0.0 108.543 158.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -120.54 156.9 30.61 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.777 1.631 . . . . 0.0 111.544 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.45 136.27 58.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 167.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.68 -4.05 86.31 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.212 0.91 . . . . 0.0 113.83 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -74.79 -179.68 4.33 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.683 1.241 . . . . 0.0 111.224 167.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -126.1 141.52 51.91 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.51 1.524 . . . . 0.0 112.103 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.67 153.7 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.608 1.563 . . . . 0.0 110.101 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -71.06 134.89 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 121.676 -0.64 . . . . 0.0 111.175 171.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.94 120.02 20.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.088 1.355 . . . . 0.0 108.014 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.9 m -86.7 107.76 18.36 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -54.52 113.08 4.67 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.84 175.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.37 -8.42 22.04 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 122.604 2.203 . . . . 0.0 114.129 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -72.79 -41.67 64.73 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.181 1.393 . . . . 0.0 112.674 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.8 t -143.36 -4.13 0.9 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.254 1.422 . . . . 0.0 112.49 -165.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 58.54 32.0 21.65 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.02 1.728 . . . . 0.0 114.17 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.71 129.59 40.02 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 169.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.52 107.49 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.887 0.875 . . . . 0.0 109.579 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.19 163.39 33.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.707 1.203 . . . . 0.0 111.535 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.39 135.53 35.15 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.53 -0.731 . . . . 0.0 110.188 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HE3' ' CE1' ' A' ' 121' ' ' PHE . 72.2 mmtt -131.62 150.13 52.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.435 1.494 . . . . 0.0 110.657 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.4 t -82.58 156.51 23.9 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.73 126.97 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.733 1.613 . . . . 0.0 110.962 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.75 -47.4 11.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.834 1.254 . . . . 0.0 113.434 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -146.1 156.0 43.14 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.536 1.935 . . . . 0.0 110.376 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.3 p -125.17 118.45 26.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.354 1.862 . . . . 0.0 111.027 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -108.97 152.69 24.61 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.031 1.332 . . . . 0.0 113.57 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.2 141.31 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.582 1.953 . . . . 0.0 110.729 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -141.77 176.54 8.83 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.36 1.864 . . . . 0.0 110.704 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -127.84 139.58 52.55 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.532 1.533 . . . . 0.0 111.614 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 t -147.91 147.17 29.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.138 1.375 . . . . 0.0 111.518 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 p -88.49 -19.37 26.54 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.215 1.006 . . . . 0.0 113.002 164.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -97.48 110.84 23.32 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.477 1.111 . . . . 0.0 109.904 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.9 mt -121.92 169.23 11.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.378 1.071 . . . . 0.0 112.37 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 tp -138.24 130.32 28.6 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.465 1.506 . . . . 0.0 109.425 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -112.51 119.89 39.73 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.426 -0.796 . . . . 0.0 109.168 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.9 mt -108.69 140.18 42.45 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.699 0.799 . . . . 0.0 109.534 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.6 m -110.14 119.68 40.06 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 166.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.75 117.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.515 1.126 . . . . 0.0 109.884 -177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.06 30.3 46.06 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-O 119.5 -0.611 . . . . 0.0 114.442 -175.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.04 -7.49 80.97 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.45 1.5 . . . . 0.0 115.605 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -97.88 118.97 35.65 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.262 1.425 . . . . 0.0 111.073 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.9 133.49 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.139 0.575 . . . . 0.0 111.481 170.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mt -133.98 105.76 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 127.382 2.273 . . . . 0.0 108.656 173.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -87.99 120.72 29.61 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.874 1.669 . . . . 0.0 112.739 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -142.02 175.41 9.75 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.389 1.476 . . . . 0.0 112.581 -164.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.2 p -83.64 153.56 24.2 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.977 0.894 . . . . 0.0 111.293 167.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -62.11 -18.29 60.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.505 1.122 . . . . 0.0 113.328 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -104.01 0.93 30.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.448 1.499 . . . . 0.0 113.902 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.2 127.64 93.06 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 119.619 1.1 . . . . 0.0 112.952 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -79.86 123.82 5.37 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.02 2.48 . . . . 0.0 114.325 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -112.2 143.54 43.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.758 2.423 . . . . 0.0 111.282 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -88.07 126.46 35.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.159 0.89 . . . . 0.0 112.492 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -102.45 135.59 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.642 1.977 . . . . 0.0 110.822 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -53.51 129.15 31.51 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.9 1.28 . . . . 0.0 110.785 174.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.3 t70 61.12 13.43 4.71 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.532 1.933 . . . . 0.0 115.518 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.4 t -135.77 -45.33 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 121.026 -1.047 . . . . 0.0 113.072 -172.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.49 -159.07 17.08 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.999 0.809 . . . . 0.0 113.456 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -77.88 145.24 36.34 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -170.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.0 p -149.78 150.45 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.427 2.291 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.02 140.81 58.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 173.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.47 -40.18 65.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.024 1.73 . . . . 0.0 113.689 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.35 -8.26 87.59 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.966 -1.084 . . . . 0.0 113.966 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -97.21 -5.03 37.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.637 1.575 . . . . 0.0 112.121 171.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.53 155.21 41.01 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.095 -1.003 . . . . 0.0 111.292 164.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -123.27 170.12 10.6 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.579 1.151 . . . . 0.0 110.429 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.35 136.37 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.616 -0.677 . . . . 0.0 109.695 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 5.13 87.93 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.103 -0.832 . . . . 0.0 115.09 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -76.22 153.36 36.12 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.522 1.161 . . . . 0.0 110.599 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.47 107.76 18.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.591 1.157 . . . . 0.0 111.791 -169.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.6 mt -99.95 172.82 6.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.547 1.139 . . . . 0.0 111.047 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.2 mt -123.68 165.23 17.58 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.885 0.874 . . . . 0.0 112.705 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -117.73 -174.51 2.64 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.354 1.462 . . . . 0.0 114.745 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.9 p -58.19 -1.31 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.811 2.444 . . . . 0.0 117.235 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -115.89 -20.91 9.79 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.473 1.509 . . . . 0.0 112.66 170.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.88 13.18 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.98 1.752 . . . . 0.0 112.606 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -96.06 137.56 34.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.689 1.195 . . . . 0.0 112.377 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.4 t -67.45 119.85 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.603 1.161 . . . . 0.0 113.534 -170.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.13 159.41 15.56 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.455 2.302 . . . . 0.0 112.612 169.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 t -126.17 139.14 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.977 1.311 . . . . 0.0 111.582 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.83 125.52 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.92 0.888 . . . . 0.0 109.874 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.28 -30.94 10.78 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 127.357 2.263 . . . . 0.0 112.933 -175.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -156.65 152.96 27.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.497 1.119 . . . . 0.0 111.121 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -136.54 101.31 4.6 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.277 1.831 . . . . 0.0 109.545 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -104.77 130.58 52.84 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.314 1.846 . . . . 0.0 110.909 -171.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.9 tp -120.37 128.79 53.56 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.831 1.252 . . . . 0.0 110.81 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.17 162.1 41.42 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.125 1.37 . . . . 0.0 112.874 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.63 117.73 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.157 1.383 . . . . 0.0 108.86 171.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.88 142.62 53.23 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.583 -0.698 . . . . 0.0 112.2 167.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.6 -26.35 67.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.031 1.332 . . . . 0.0 112.987 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -146.91 150.87 40.38 Favored Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 127.051 2.14 . . . . 0.0 109.988 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -56.63 127.54 26.31 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.473 2.782 . . . . 0.0 112.869 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.3 t -99.04 141.36 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 127.072 2.149 . . . . 0.0 110.095 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -74.19 144.85 44.58 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.893 0.769 . . . . 0.0 112.079 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.78 144.26 27.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.309 1.444 . . . . 0.0 110.565 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -128.8 147.59 50.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.521 1.529 . . . . 0.0 110.41 -166.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -156.46 171.64 19.91 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.537 1.135 . . . . 0.0 111.685 169.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -149.78 163.37 38.16 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.465 -0.772 . . . . 0.0 112.117 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.68 144.24 43.27 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.666 1.186 . . . . 0.0 113.204 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.9 t -104.76 147.84 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.059 1.744 . . . . 0.0 111.676 -168.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.35 -72.4 0.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.8 -19.98 12.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -166.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.47 ' CE1' ' HE3' ' A' ' 39' ' ' LYS . 10.5 m-30 -105.92 175.34 5.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.273 1.829 . . . . 0.0 108.524 165.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -132.21 33.13 3.9 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.164 1.386 . . . . 0.0 112.729 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 p -139.75 159.01 43.16 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.061 1.744 . . . . 0.0 112.17 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -158.29 -173.32 4.26 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.82 1.648 . . . . 0.0 110.768 170.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -131.67 141.4 49.58 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.885 1.274 . . . . 0.0 113.392 -170.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.98 142.39 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.678 1.191 . . . . 0.0 112.625 -173.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.55 173.8 23.41 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.283 1.421 . . . . 0.0 115.697 175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.4 -31.2 72.29 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.982 -1.305 . . . . 0.0 113.367 -176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -84.04 2.19 40.31 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.842 1.257 . . . . 0.0 114.0 173.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.88 46.16 17.25 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.454 1.901 . . . . 0.0 114.551 166.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.84 136.53 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.569 1.148 . . . . 0.0 111.515 -170.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 54.1 tp -77.86 126.19 30.47 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.786 1.634 . . . . 0.0 112.639 -176.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.15 157.2 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.768 1.627 . . . . 0.0 111.142 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -108.28 161.38 15.06 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.531 1.132 . . . . 0.0 112.924 -172.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.663 1.585 . . . . 0.0 112.953 171.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 85.9 m-85 -123.6 154.24 39.58 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.552 1.541 . . . . 0.0 111.276 172.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.92 161.53 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.53 0.681 . . . . 0.0 112.053 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.32 154.23 3.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.206 1.002 . . . . 0.0 112.681 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.96 -9.0 7.04 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 117.546 -1.697 . . . . 0.0 116.3 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.0 m -63.03 121.57 13.91 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 121.179 2.49 . . . . 0.0 110.373 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 mmt -78.35 142.94 37.32 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.694 1.597 . . . . 0.0 111.72 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.8 mm -127.32 132.91 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.697 1.999 . . . . 0.0 109.867 -175.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -77.92 123.07 26.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.699 1.199 . . . . 0.0 112.552 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -117.44 178.87 4.22 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.507 1.123 . . . . 0.0 113.647 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.84 52.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.45 1.1 . . . . 0.0 113.832 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 p -113.82 -28.04 7.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.924 1.29 . . . . 0.0 113.706 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.76 -107.96 0.34 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.271 0.939 . . . . 0.0 111.476 -171.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -127.29 149.2 50.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.483 1.113 . . . . 0.0 113.204 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.9 t -142.35 147.73 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 127.286 2.234 . . . . 0.0 108.389 170.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.6 147.09 41.97 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.888 -1.133 . . . . 0.0 111.27 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 tt -61.34 -29.47 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 120.614 -1.304 . . . . 0.0 112.926 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.46 -8.22 44.86 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.918 1.287 . . . . 0.0 114.434 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -119.4 -8.0 10.11 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.749 1.62 . . . . 0.0 113.489 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.19 136.53 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.117 -0.99 . . . . 0.0 110.052 165.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -117.92 166.31 12.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.907 2.083 . . . . 0.0 110.312 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.9 147.02 54.13 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.479 -0.763 . . . . 0.0 111.032 163.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.37 3.24 82.07 Favored Glycine 0 CA--C 1.54 1.637 0 O-C-N 121.77 -0.581 . . . . 0.0 114.543 -171.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -89.81 152.94 21.04 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.099 0.96 . . . . 0.0 110.292 168.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -115.85 120.9 40.74 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.799 1.239 . . . . 0.0 112.709 -168.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 m -110.32 154.06 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 126.88 2.072 . . . . 0.0 110.257 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.3 mm -75.53 135.16 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 O-C-N 121.604 -0.685 . . . . 0.0 109.773 166.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.99 121.48 28.07 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.2 m -101.46 104.1 15.02 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -55.96 114.75 8.08 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.96 -1.019 . . . . 0.0 111.83 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.96 -5.53 12.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.168 1.912 . . . . 0.0 113.443 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.07 -42.51 76.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.833 0.853 . . . . 0.0 112.538 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.2 t -150.01 5.66 0.58 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.787 0.835 . . . . 0.0 112.928 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.265 21.0 m-85 57.11 41.54 27.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.34 1.456 . . . . 0.0 112.642 -173.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -78.79 131.37 36.5 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 165.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.22 123.93 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.133 0.973 . . . . 0.0 109.912 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.38 153.22 43.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -82.27 117.39 22.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.199 1.0 . . . . 0.0 109.96 168.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -132.28 146.63 52.13 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.707 1.203 . . . . 0.0 112.351 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -83.99 155.65 22.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.367 1.067 . . . . 0.0 113.766 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.7 t -87.22 132.98 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 125.645 1.578 . . . . 0.0 111.295 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.3 mt -90.92 -41.37 11.18 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.207 1.003 . . . . 0.0 112.866 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.25 150.67 35.29 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.247 1.819 . . . . 0.0 110.376 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.3 p -121.48 121.57 37.82 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.441 1.897 . . . . 0.0 109.999 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -106.89 144.33 33.69 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.78 1.632 . . . . 0.0 114.214 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.3 t -141.24 133.0 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.861 0.864 . . . . 0.0 112.126 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.6 mmt-85 -138.16 175.13 9.85 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.512 1.925 . . . . 0.0 110.652 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -136.63 136.29 39.03 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.029 0.931 . . . . 0.0 112.941 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -151.1 150.93 31.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.495 1.118 . . . . 0.0 112.107 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.4 p -90.94 -16.86 27.36 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.177 1.391 . . . . 0.0 113.874 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.39 106.89 17.52 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.363 1.065 . . . . 0.0 109.999 -169.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.3 mt -117.69 162.24 18.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.69 1.233 . . . . 0.0 113.372 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -127.3 132.56 50.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.13 1.772 . . . . 0.0 109.029 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -111.08 125.43 53.76 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.172 0.989 . . . . 0.0 108.875 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 mt -112.44 140.82 46.86 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.594 0.758 . . . . 0.0 109.568 170.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.3 m -113.84 119.04 35.94 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 mt -127.24 117.32 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.111 0.965 . . . . 0.0 108.859 -172.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.88 21.08 28.88 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.79 -4.35 53.25 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.617 1.58 . . . . 0.0 116.306 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -107.08 127.92 53.92 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.128 1.771 . . . . 0.0 110.294 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.5 t -81.71 132.34 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.47 1.108 . . . . 0.0 111.958 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -132.48 103.26 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.897 1.679 . . . . 0.0 109.492 174.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -81.86 121.47 26.5 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.607 1.563 . . . . 0.0 111.706 176.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -143.46 176.68 8.99 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.335 1.454 . . . . 0.0 113.477 -165.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.6 p -81.67 151.63 27.48 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.736 0.815 . . . . 0.0 112.255 170.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -64.17 -18.1 64.15 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.163 -0.961 . . . . 0.0 113.186 -174.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -110.98 13.41 22.08 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.0 OUTLIER -65.42 128.73 94.05 Favored Pre-proline 0 CA--C 1.55 0.978 0 O-C-N 120.772 -1.205 . . . . 0.0 111.582 176.255 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.64 125.82 5.72 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.061 2.508 . . . . 0.0 113.714 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -118.46 142.77 47.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.973 2.109 . . . . 0.0 111.788 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -85.31 133.35 34.15 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.371 0.987 . . . . 0.0 113.614 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.88 138.72 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 127.683 2.393 . . . . 0.0 111.293 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.17 130.45 42.11 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.424 0.69 . . . . 0.0 111.12 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 61.3 7.13 1.57 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.596 2.358 . . . . 0.0 116.59 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -130.64 -35.25 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.029 1.331 . . . . 0.0 111.973 -170.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.61 -150.96 22.85 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 123.938 0.78 . . . . 0.0 111.62 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.292 12.3 p90 -77.4 145.69 37.07 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.78 150.02 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 128.523 2.729 . . . . 0.0 109.683 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -64.48 137.87 58.11 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.115 -0.99 . . . . 0.0 113.415 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.72 67.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.804 1.641 . . . . 0.0 113.304 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.35 -7.46 68.11 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.373 -0.83 . . . . 0.0 114.362 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -102.76 -6.41 22.65 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.251 1.42 . . . . 0.0 113.171 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -67.94 164.28 20.25 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.089 1.356 . . . . 0.0 112.834 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.27 162.79 27.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.611 1.564 . . . . 0.0 112.881 168.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.94 123.63 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 165.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.0 1.98 61.15 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.868 -1.518 . . . . 0.0 114.988 -170.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -76.74 152.95 35.46 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.754 2.277 . . . . 0.0 111.367 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -110.6 101.82 10.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.681 1.192 . . . . 0.0 112.413 -170.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.3 mt -91.81 170.5 9.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.929 1.692 . . . . 0.0 110.654 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.9 mt -119.32 155.73 31.32 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 170.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.3 176.87 5.56 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.908 1.283 . . . . 0.0 113.879 176.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.8 p -54.34 -22.4 12.06 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -106.79 -10.05 16.2 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.542 1.937 . . . . 0.0 112.616 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.59 13.29 28.42 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.422 1.963 . . . . 0.0 113.183 171.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -79.17 145.84 33.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.719 1.208 . . . . 0.0 111.384 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.2 t -74.69 127.9 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.565 0.746 . . . . 0.0 111.322 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.1 mt -114.26 150.79 33.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.14 2.176 . . . . 0.0 112.03 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.3 t -118.23 137.71 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 125.183 1.393 . . . . 0.0 110.474 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.4 t -73.7 119.06 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.957 0.903 . . . . 0.0 109.452 169.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -94.29 -27.88 15.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.852 2.461 . . . . 0.0 112.853 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -155.03 147.33 23.91 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.778 1.631 . . . . 0.0 110.248 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -132.85 116.18 16.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.946 1.699 . . . . 0.0 109.308 168.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -127.76 151.59 48.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.359 2.264 . . . . 0.0 110.822 -171.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.02 133.81 25.32 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.15 1.38 . . . . 0.0 109.584 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -144.68 151.21 38.6 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.1 mm -98.2 103.3 14.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.895 1.278 . . . . 0.0 108.38 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.86 150.87 31.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.09 0.956 . . . . 0.0 111.954 174.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.05 -18.81 63.3 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.14 -0.975 . . . . 0.0 112.983 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -137.68 154.68 75.06 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 126.762 2.025 . . . . 0.0 111.339 -172.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.33 110.09 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.547 2.165 . . . . 0.0 110.013 170.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.2 t -83.5 141.66 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.013 1.725 . . . . 0.0 109.631 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -77.6 139.56 39.54 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.839 0.855 . . . . 0.0 110.397 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.2 m -138.34 142.83 34.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 125.006 1.322 . . . . 0.0 111.345 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -121.79 152.46 39.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.514 1.526 . . . . 0.0 111.707 -167.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -156.5 165.91 34.92 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.38 2.272 . . . . 0.0 109.767 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -156.97 165.36 36.38 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.304 -1.497 . . . . 0.0 111.248 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -120.2 145.9 46.54 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.27 145.86 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.293 1.437 . . . . 0.0 112.867 -166.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -64.43 -47.34 79.47 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -170.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -109.49 -66.31 1.07 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 120.056 1.298 . . . . 0.0 109.957 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -72.71 175.93 5.99 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.667 1.187 . . . . 0.0 112.153 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -115.94 3.9 13.75 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.501 1.52 . . . . 0.0 113.349 -172.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.4 p -124.74 160.66 28.1 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.308 1.443 . . . . 0.0 113.981 -168.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.07 -179.62 8.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.843 2.057 . . . . 0.0 109.875 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -132.12 140.68 48.88 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.352 1.061 . . . . 0.0 113.183 -168.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.6 142.02 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -170.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.25 173.44 25.74 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.928 1.728 . . . . 0.0 115.346 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.1 -25.42 67.7 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.11 -1.229 . . . . 0.0 113.11 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -90.41 5.22 48.38 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.578 1.551 . . . . 0.0 114.667 172.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 56.11 46.5 21.44 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 164.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.53 140.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.379 1.072 . . . . 0.0 111.779 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.06 126.22 31.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.749 1.62 . . . . 0.0 113.491 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.6 m -145.82 162.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.542 1.937 . . . . 0.0 111.429 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -116.92 141.07 48.71 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.431 1.492 . . . . 0.0 113.049 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.209 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.435 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 98.6 m-85 -124.73 154.64 40.55 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.1 1.36 . . . . 0.0 111.071 172.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.51 158.0 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.203 0.525 . . . . 0.0 111.661 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.1 151.8 0.92 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.218 1.007 . . . . 0.0 112.371 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.07 -17.26 7.55 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.437 -1.757 . . . . 0.0 116.077 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.6 m -61.89 124.19 20.1 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 120.707 2.253 . . . . 0.0 110.11 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -82.12 141.62 32.95 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.879 1.272 . . . . 0.0 111.538 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.0 mm -117.33 133.32 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.619 1.968 . . . . 0.0 109.577 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.7 tp -71.28 127.18 31.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.678 0.752 . . . . 0.0 112.969 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 p -127.81 166.02 19.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.02 1.328 . . . . 0.0 110.423 174.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.04 70.12 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.503 -0.748 . . . . 0.0 112.126 168.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.8 p -80.02 -25.99 39.99 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.199 1.4 . . . . 0.0 112.677 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.72 -99.11 0.19 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.84 2.162 . . . . 0.0 111.039 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.0 mt -134.98 149.28 50.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.745 1.218 . . . . 0.0 111.855 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.63 143.69 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.633 1.573 . . . . 0.0 108.552 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.45 146.12 53.47 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.022 -1.048 . . . . 0.0 111.127 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 tt -60.8 -30.59 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 120.942 -1.099 . . . . 0.0 113.107 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.27 -16.77 63.65 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.471 1.109 . . . . 0.0 113.836 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -109.37 -12.55 14.73 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.794 1.638 . . . . 0.0 113.117 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.7 mm -63.03 135.64 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.09 0.859 . . . . 0.0 109.421 164.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -127.75 156.09 42.98 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.885 1.674 . . . . 0.0 111.442 175.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.93 135.27 56.01 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.223 -0.923 . . . . 0.0 111.457 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.11 -19.54 54.05 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.712 -1.049 . . . . 0.0 115.166 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -68.42 166.11 17.44 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.899 1.349 . . . . 0.0 111.121 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -124.21 138.67 54.38 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.077 1.351 . . . . 0.0 112.836 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.04 163.88 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.206 1.802 . . . . 0.0 111.203 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -80.09 145.88 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.227 0.536 . . . . 0.0 111.56 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.55 132.3 21.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 m -97.43 112.03 24.04 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.5 0.667 . . . . 0.0 109.864 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -52.76 114.83 6.26 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.448 1.499 . . . . 0.0 113.288 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.75 -7.07 19.52 Favored 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 122.877 2.385 . . . . 0.0 115.299 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -79.44 -38.67 34.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.257 1.423 . . . . 0.0 113.261 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.6 t -141.76 -1.8 1.24 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.784 1.234 . . . . 0.0 112.873 -168.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.26 33.8 m-85 55.13 33.78 21.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.915 2.086 . . . . 0.0 114.244 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -77.95 135.02 37.76 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.632 -0.668 . . . . 0.0 110.342 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.02 122.07 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.317 1.047 . . . . 0.0 110.927 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.13 151.7 41.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.765 0.793 . . . . 0.0 112.872 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -90.14 124.6 34.96 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.213 1.405 . . . . 0.0 109.291 174.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -134.44 150.89 50.88 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.584 1.154 . . . . 0.0 111.424 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.3 t -79.76 153.58 29.11 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -88.83 133.0 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.32 1.848 . . . . 0.0 110.624 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 mt -90.73 -44.21 9.61 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.66 0.784 . . . . 0.0 112.682 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -141.58 157.81 44.64 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.503 1.521 . . . . 0.0 110.641 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.7 p -130.98 116.34 17.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.842 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -103.48 157.94 16.69 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.989 1.315 . . . . 0.0 113.309 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.74 142.52 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.883 2.073 . . . . 0.0 110.204 175.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.1 mmt-85 -140.38 172.81 12.21 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.239 2.215 . . . . 0.0 109.933 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -141.34 135.05 30.12 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.95 -1.094 . . . . 0.0 113.064 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.3 t -151.01 152.59 33.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.875 0.87 . . . . 0.0 112.019 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.7 p -86.24 -15.48 40.66 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.988 1.315 . . . . 0.0 113.43 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -105.75 108.35 19.81 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.205 0.911 . . . . 0.0 112.262 -171.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.6 mt -116.67 160.53 20.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.358 1.075 . . . . 0.0 113.658 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -123.69 138.57 54.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.123 1.769 . . . . 0.0 109.945 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -115.93 128.13 55.53 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.656 1.582 . . . . 0.0 109.253 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.3 mt -128.92 132.76 47.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.233 1.013 . . . . 0.0 110.182 175.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -99.13 113.01 25.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 169.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 mp -107.74 113.19 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.462 1.105 . . . . 0.0 108.469 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.73 -28.67 0.14 Allowed Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.744 2.116 . . . . 0.0 116.751 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.26 -0.35 0.32 Allowed Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.723 1.63 . . . . 0.0 114.073 -165.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -112.31 124.27 52.11 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.511 1.524 . . . . 0.0 109.533 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.56 114.17 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.331 0.652 . . . . 0.0 109.674 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mt -106.31 101.34 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.412 1.085 . . . . 0.0 109.12 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.99 122.18 21.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.019 1.328 . . . . 0.0 110.65 168.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 t -146.91 175.68 10.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.306 1.043 . . . . 0.0 112.639 -168.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.4 p -78.18 146.49 34.98 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.521 -0.737 . . . . 0.0 111.137 169.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.84 -28.45 66.08 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.022 -1.049 . . . . 0.0 112.442 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -96.83 0.14 48.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.56 1.544 . . . . 0.0 113.305 -171.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.435 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.3 t60 -64.8 129.15 94.26 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.473 1.509 . . . . 0.0 113.305 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.52 113.68 2.62 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.463 2.775 . . . . 0.0 114.093 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -103.25 143.69 32.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.133 2.173 . . . . 0.0 111.408 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -89.33 126.18 35.42 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -103.95 135.75 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.489 1.515 . . . . 0.0 111.213 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -57.04 129.12 40.34 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.633 1.173 . . . . 0.0 112.936 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.8 t0 56.19 23.8 7.41 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.172 1.789 . . . . 0.0 114.45 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.5 t -140.74 -50.39 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.799 1.239 . . . . 0.0 111.92 -172.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.21 -169.17 22.53 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.727 0.68 . . . . 0.0 114.201 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -75.8 146.77 39.7 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -162.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.1 p -150.68 146.91 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.89 1.676 . . . . 0.0 111.854 -173.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -54.55 133.31 46.2 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.556 0.742 . . . . 0.0 112.664 171.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.26 -36.7 66.34 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.607 1.563 . . . . 0.0 113.137 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.4 -4.89 81.02 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.03 -1.044 . . . . 0.0 114.739 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -107.45 -4.44 18.48 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.228 1.811 . . . . 0.0 112.553 176.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.59 151.52 46.26 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.449 -0.782 . . . . 0.0 110.428 155.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -118.34 173.78 6.62 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.064 1.346 . . . . 0.0 110.375 170.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.36 139.92 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 165.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.93 9.62 86.93 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 119.099 -0.834 . . . . 0.0 114.565 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -86.38 154.91 20.84 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.28 1.54 . . . . 0.0 110.228 169.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -113.56 115.57 28.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.322 1.049 . . . . 0.0 113.606 -164.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.9 mt -104.98 -176.85 3.19 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.022 2.129 . . . . 0.0 111.441 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.9 mt -131.01 158.89 39.07 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.605 1.162 . . . . 0.0 113.193 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -109.49 172.29 6.94 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.728 1.211 . . . . 0.0 113.395 169.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 t -45.54 -36.88 4.9 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.146 1.779 . . . . 0.0 114.116 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -88.63 -16.92 31.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.054 1.742 . . . . 0.0 113.114 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.46 20.56 10.81 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.914 1.721 . . . . 0.0 112.763 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -83.26 141.02 32.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.444 0.698 . . . . 0.0 110.582 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.93 115.45 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.641 0.776 . . . . 0.0 110.08 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.9 mt -97.01 161.41 13.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.427 1.491 . . . . 0.0 111.449 170.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.84 144.85 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.07 0.948 . . . . 0.0 110.643 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.54 130.99 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.426 0.69 . . . . 0.0 109.66 170.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -108.27 -28.08 9.65 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.838 2.055 . . . . 0.0 112.079 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -157.75 149.59 22.01 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.129 1.772 . . . . 0.0 110.384 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -131.73 130.84 42.46 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.701 2.0 . . . . 0.0 109.629 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -143.2 155.06 44.44 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.023 1.729 . . . . 0.0 111.513 -175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 tp -132.8 144.14 50.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.89 1.676 . . . . 0.0 109.267 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.45 153.81 41.57 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.372 0.987 . . . . 0.0 113.183 166.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 mm -101.4 121.04 51.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.5 152.78 44.5 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.198 0.999 . . . . 0.0 112.953 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -69.63 -28.7 66.13 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.702 -1.249 . . . . 0.0 111.838 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -144.34 148.35 40.48 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.983 2.113 . . . . 0.0 110.123 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -54.69 120.0 7.37 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.489 3.459 . . . . 0.0 112.576 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.73 139.54 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.359 1.463 . . . . 0.0 109.496 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -76.89 139.19 40.15 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.936 0.874 . . . . 0.0 111.212 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.37 147.93 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.279 1.432 . . . . 0.0 110.516 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.72 148.22 50.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.849 1.26 . . . . 0.0 110.893 -165.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -157.54 168.38 27.47 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.462 1.105 . . . . 0.0 111.803 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -153.19 163.66 39.49 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.838 -1.164 . . . . 0.0 112.972 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -113.97 143.86 44.03 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.69 136.13 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 125.528 1.531 . . . . 0.0 112.974 -166.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.18 -28.41 69.11 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -141.62 -44.23 0.36 Allowed 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.978 -1.076 . . . . 0.0 112.607 173.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -71.45 171.67 10.88 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.441 1.115 . . . . 0.0 111.973 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -124.84 12.29 8.46 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.854 2.061 . . . . 0.0 112.715 -169.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.4 p -142.53 168.87 18.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.497 2.319 . . . . 0.0 111.519 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -160.64 175.13 13.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.118 2.167 . . . . 0.0 109.617 166.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -122.74 135.57 54.61 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.046 0.939 . . . . 0.0 113.141 -170.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.94 140.74 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.555 1.542 . . . . 0.0 112.429 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.73 170.15 20.27 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.671 1.605 . . . . 0.0 115.46 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.85 -22.49 66.54 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.693 -1.475 . . . . 0.0 113.023 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -81.49 2.78 27.35 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.182 1.393 . . . . 0.0 114.445 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 61.27 38.94 16.16 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.701 1.2 . . . . 0.0 113.345 164.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.63 137.36 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.668 1.587 . . . . 0.0 112.019 -164.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.2 tp -83.14 120.43 25.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.154 1.382 . . . . 0.0 113.848 -171.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.94 157.46 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.644 1.578 . . . . 0.0 112.052 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -106.87 128.94 54.72 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -167.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--O 1.25 1.098 0 C-N-CA 125.74 1.616 . . . . 0.0 111.993 172.461 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 30.1 m . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 121.363 0.601 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 42.5 ttm -73.3 141.25 47.15 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.82 -1.175 . . . . 0.0 110.117 164.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -126.23 84.82 2.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.165 1.386 . . . . 0.0 110.713 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -148.62 170.64 17.66 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -174.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 99.1 m-85 -126.12 154.03 43.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.837 1.655 . . . . 0.0 111.415 172.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -70.64 162.14 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.495 0.664 . . . . 0.0 112.327 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.47 150.26 5.05 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.439 1.096 . . . . 0.0 112.639 173.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.18 -6.22 22.76 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 117.877 -1.513 . . . . 0.0 116.788 -173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.5 m -63.1 120.38 11.34 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.81 2.305 . . . . 0.0 110.147 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.0 mmt -76.02 146.44 39.48 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.915 1.286 . . . . 0.0 112.224 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 mm -131.64 134.1 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 127.685 2.394 . . . . 0.0 109.918 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 tp -78.91 127.01 31.46 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -120.63 173.89 6.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.667 1.587 . . . . 0.0 111.792 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.87 -24.85 67.66 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.939 -1.1 . . . . 0.0 113.429 175.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 p -107.31 -19.31 13.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.539 1.135 . . . . 0.0 113.518 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.89 -115.34 0.61 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.439 1.019 . . . . 0.0 113.363 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -122.8 153.32 39.7 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.048 1.739 . . . . 0.0 111.799 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.1 p -136.53 152.29 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.929 1.691 . . . . 0.0 110.268 168.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.26 146.09 37.1 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.773 -1.204 . . . . 0.0 110.819 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.2 tt -62.65 -29.49 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 121.044 -1.035 . . . . 0.0 112.664 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -65.39 -11.12 39.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.689 1.196 . . . . 0.0 113.729 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -120.13 -3.65 10.07 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.914 1.685 . . . . 0.0 113.371 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.1 mm -61.43 137.89 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 120.018 1.281 . . . . 0.0 108.806 166.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -124.16 159.05 30.91 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.021 1.328 . . . . 0.0 112.027 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.62 131.71 47.06 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.792 -1.193 . . . . 0.0 110.579 165.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.88 -4.44 82.68 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.601 1.095 . . . . 0.0 115.046 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.92 155.55 37.32 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.148 1.474 . . . . 0.0 111.542 163.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -109.48 150.76 27.64 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.362 1.465 . . . . 0.0 112.393 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.23 157.78 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.567 1.947 . . . . 0.0 110.072 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -73.97 137.9 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.795 -0.566 . . . . 0.0 110.712 165.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.41 118.24 16.19 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -98.05 111.88 24.03 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -54.47 114.76 7.25 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.873 1.269 . . . . 0.0 112.365 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.89 -4.52 14.96 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.711 2.274 . . . . 0.0 114.09 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -77.19 -46.87 21.87 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.682 1.193 . . . . 0.0 112.234 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 t -141.22 6.37 1.93 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.143 0.977 . . . . 0.0 112.84 -168.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 54.68 33.0 18.42 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.573 1.549 . . . . 0.0 114.037 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -71.05 125.85 27.98 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 167.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -96.66 120.13 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 124.227 1.011 . . . . 0.0 109.029 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.6 154.73 50.59 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.2 133.62 36.04 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.078 0.951 . . . . 0.0 108.998 162.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -138.92 152.54 47.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.078 0.951 . . . . 0.0 110.878 171.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 t -89.09 160.16 17.19 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.0 t -96.12 133.73 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.463 1.905 . . . . 0.0 111.575 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 mt -90.8 -43.0 10.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.932 0.893 . . . . 0.0 113.355 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -148.94 156.12 41.82 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.796 2.038 . . . . 0.0 111.138 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.4 p -132.34 103.49 6.24 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.08 1.752 . . . . 0.0 110.416 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -91.06 150.73 21.3 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.6 1.56 . . . . 0.0 112.727 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.8 t -143.02 129.57 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.342 1.057 . . . . 0.0 110.453 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -122.89 175.54 6.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.307 1.843 . . . . 0.0 110.931 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -128.2 137.44 52.04 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.679 1.192 . . . . 0.0 111.323 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.9 t -148.35 149.34 31.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.691 1.196 . . . . 0.0 111.88 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.2 p -91.21 -14.74 30.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.895 1.278 . . . . 0.0 113.863 170.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -100.32 111.34 23.6 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.384 -0.822 . . . . 0.0 111.399 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -120.5 157.83 28.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 122.939 1.352 . . . . 0.0 112.922 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.431 HD11 ' HE2' ' A' ' 102' ' ' LYS . 16.2 tp -126.39 133.31 51.33 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.535 1.934 . . . . 0.0 109.259 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -110.4 124.86 52.51 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.215 1.006 . . . . 0.0 108.773 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.8 mt -118.24 138.76 52.13 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.977 0.911 . . . . 0.0 109.779 171.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.6 m -106.54 122.34 46.11 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.99 117.97 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.075 1.35 . . . . 0.0 108.515 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.65 28.24 51.22 Favored Glycine 0 CA--C 1.544 1.888 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.7 -9.3 78.08 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.35 1.452 . . . . 0.0 115.737 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -92.79 122.93 35.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.002 1.401 . . . . 0.0 110.068 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.0 t -78.98 125.81 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.566 0.746 . . . . 0.0 110.617 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mt -121.77 103.77 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.979 1.711 . . . . 0.0 109.352 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -80.58 122.55 27.19 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.11 1.764 . . . . 0.0 111.035 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 t -146.16 178.22 8.39 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.629 1.172 . . . . 0.0 112.702 -167.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.8 p -82.23 152.75 26.25 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.048 0.927 . . . . 0.0 112.472 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -65.69 -19.38 65.88 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.44 9.38 31.71 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.976 1.311 . . . . 0.0 113.616 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.1 t60 -65.56 129.84 94.46 Favored Pre-proline 0 CA--C 1.552 1.053 0 O-C-N 120.465 -1.397 . . . . 0.0 113.042 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.7 119.92 4.97 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.98 3.12 . . . . 0.0 114.732 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -112.2 150.04 31.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.963 2.105 . . . . 0.0 111.223 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -93.86 130.8 39.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.275 0.943 . . . . 0.0 113.382 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.14 134.32 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 127.499 2.319 . . . . 0.0 111.339 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -58.06 130.26 45.75 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.733 1.213 . . . . 0.0 111.677 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 60.88 16.41 6.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.779 1.632 . . . . 0.0 114.555 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.9 t -133.8 -58.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.255 1.022 . . . . 0.0 111.231 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.93 -152.12 17.16 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.925 0.774 . . . . 0.0 113.714 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -86.75 139.16 30.99 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -170.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.12 149.01 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.249 1.82 . . . . 0.0 111.666 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.93 134.03 51.19 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.482 1.113 . . . . 0.0 112.632 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.95 -36.61 72.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.343 1.457 . . . . 0.0 112.856 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.72 -8.28 81.47 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.508 -1.162 . . . . 0.0 114.559 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -103.02 -12.88 17.12 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.025 1.412 . . . . 0.0 113.731 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.2 mt -56.97 163.08 2.13 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.27 1.428 . . . . 0.0 113.543 170.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.97 164.53 18.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.614 1.565 . . . . 0.0 110.727 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.5 t -67.92 143.73 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 122.39 1.09 . . . . 0.0 110.347 167.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.59 3.69 89.0 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.716 -1.047 . . . . 0.0 114.315 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -84.95 160.56 20.06 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.641 1.72 . . . . 0.0 111.471 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -104.84 103.71 13.36 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.399 1.08 . . . . 0.0 112.458 -160.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.8 mt -93.56 175.84 6.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.07 0.948 . . . . 0.0 110.453 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -122.19 158.85 28.5 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.76 -178.0 3.53 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.398 1.479 . . . . 0.0 113.871 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.1 p -61.25 -17.66 54.48 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -90.33 -25.57 20.41 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.243 1.383 . . . . 0.0 111.603 170.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.73 19.31 18.04 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.796 1.665 . . . . 0.0 112.369 -176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -88.4 155.61 19.59 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.007 1.723 . . . . 0.0 110.793 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -80.73 128.11 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -169.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.6 mt -107.48 162.72 13.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.094 2.158 . . . . 0.0 112.231 169.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.83 139.71 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.365 1.066 . . . . 0.0 111.195 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.5 t -73.73 124.95 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.427 0.691 . . . . 0.0 109.44 171.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -94.83 -33.63 12.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.425 1.89 . . . . 0.0 112.912 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -156.73 149.01 23.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.929 1.291 . . . . 0.0 111.292 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.431 ' HE2' HD11 ' A' ' 53' ' ' LEU . 34.8 tttm -124.73 127.43 47.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.836 2.054 . . . . 0.0 110.3 166.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -140.37 154.06 46.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.667 1.987 . . . . 0.0 111.505 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 tp -140.43 148.67 41.56 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.554 1.542 . . . . 0.0 110.083 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -155.28 164.86 38.2 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.718 0.807 . . . . 0.0 113.102 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mm -96.11 124.62 48.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 123.751 0.82 . . . . 0.0 109.188 161.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.95 150.65 45.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.744 1.218 . . . . 0.0 112.638 172.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -78.4 -13.02 60.03 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.685 1.594 . . . . 0.0 113.075 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -146.87 153.32 45.91 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.55 2.34 . . . . 0.0 110.132 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.48 114.76 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.916 2.411 . . . . 0.0 111.131 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.5 t -85.55 142.8 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.382 1.473 . . . . 0.0 109.989 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -79.71 139.39 37.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.119 0.962 . . . . 0.0 111.613 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.1 m -141.46 141.43 30.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.005 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -120.18 146.61 45.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.241 1.417 . . . . 0.0 110.77 -165.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -153.9 159.57 41.81 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.868 1.267 . . . . 0.0 111.397 173.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -150.72 163.14 39.29 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.434 -1.416 . . . . 0.0 113.568 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -120.26 138.85 53.43 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.72 149.42 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 127.557 2.343 . . . . 0.0 111.898 -168.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.89 -33.86 76.18 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 -168.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -143.81 -53.25 0.35 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.895 1.225 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -66.24 165.95 12.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.684 0.754 . . . . 0.0 110.297 167.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -133.51 27.64 4.04 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.429 1.492 . . . . 0.0 112.25 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.5 p -128.66 164.69 22.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.239 1.816 . . . . 0.0 111.881 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -159.03 -176.59 5.95 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.455 1.902 . . . . 0.0 109.922 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -127.24 138.37 53.09 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.395 1.078 . . . . 0.0 112.95 -171.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.47 143.6 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.194 0.997 . . . . 0.0 113.612 -171.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.35 168.83 20.07 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.615 1.579 . . . . 0.0 114.657 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.36 -22.8 61.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.175 1.39 . . . . 0.0 113.279 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -91.27 -0.9 57.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.762 1.625 . . . . 0.0 114.786 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 62.67 44.25 6.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.9 t -71.64 137.9 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.094 1.358 . . . . 0.0 111.406 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 57.2 tp -80.69 125.63 30.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.704 1.601 . . . . 0.0 113.247 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.49 160.07 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.894 1.678 . . . . 0.0 111.696 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -102.31 156.9 17.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.019 1.328 . . . . 0.0 113.06 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.088 1.755 . . . . 0.0 113.651 171.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 119.251 -0.404 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 10.5 ttt -109.94 117.94 35.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.327 0.651 . . . . 0.0 112.157 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -131.07 100.34 5.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.662 1.185 . . . . 0.0 110.867 -168.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.02 174.53 12.9 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.917 1.287 . . . . 0.0 112.863 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 91.6 m-85 -121.26 156.02 33.39 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.332 1.453 . . . . 0.0 111.511 169.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.95 160.78 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.34 0.591 . . . . 0.0 112.054 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.59 152.5 2.71 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.905 0.86 . . . . 0.0 112.95 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.18 -9.16 20.69 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-O 117.349 -1.806 . . . . 0.0 116.696 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -62.91 123.55 18.79 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 120.878 2.339 . . . . 0.0 110.811 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -80.57 141.91 34.61 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.426 1.49 . . . . 0.0 112.294 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.81 134.85 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.87 2.068 . . . . 0.0 110.036 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.06 126.84 31.62 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.297 1.039 . . . . 0.0 113.032 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.8 p -121.9 172.75 7.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.025 1.33 . . . . 0.0 111.487 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.8 -20.32 65.69 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 120.844 -1.16 . . . . 0.0 113.268 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 p -109.41 -13.07 14.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.913 2.085 . . . . 0.0 113.759 -170.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.24 -112.75 0.64 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 126.087 1.803 . . . . 0.0 112.443 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -133.33 141.67 48.06 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.222 1.009 . . . . 0.0 112.583 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -133.06 144.29 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.446 1.899 . . . . 0.0 109.111 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.59 147.8 47.25 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.274 -0.891 . . . . 0.0 111.027 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -62.9 -27.6 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 120.315 -1.491 . . . . 0.0 113.043 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.58 -16.35 63.83 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.206 1.003 . . . . 0.0 113.457 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -110.61 -10.41 14.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.293 1.837 . . . . 0.0 113.146 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.4 mm -65.12 137.47 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 119.407 1.003 . . . . 0.0 108.921 162.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -127.65 166.06 18.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.915 2.086 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.53 133.67 46.18 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.89 -0.506 . . . . 0.0 110.511 160.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.29 6.73 89.09 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.972 1.272 . . . . 0.0 115.674 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -85.38 155.44 21.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.295 1.048 . . . . 0.0 110.333 165.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.59 135.25 52.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.311 1.044 . . . . 0.0 112.539 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.8 157.13 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.016 1.726 . . . . 0.0 110.652 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.3 mm -76.1 142.38 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.75 0.31 . . . . 0.0 111.275 168.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.63 126.73 22.66 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.904 0.881 . . . . 0.0 109.144 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.0 m -88.41 107.95 19.12 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 165.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -52.94 116.35 9.03 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.529 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.11 -11.22 28.72 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.673 2.249 . . . . 0.0 114.272 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -78.23 -49.1 14.38 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.748 1.219 . . . . 0.0 111.766 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 t -121.67 -7.88 9.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.525 1.13 . . . . 0.0 112.677 -167.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.276 12.9 m-85 53.5 43.02 31.83 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.703 1.601 . . . . 0.0 112.12 -173.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -81.44 131.37 35.28 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.927 0.891 . . . . 0.0 108.755 165.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.17 123.38 47.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 123.232 0.613 . . . . 0.0 110.621 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.2 159.22 42.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.311 1.045 . . . . 0.0 112.502 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -92.14 126.06 37.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.64 1.176 . . . . 0.0 108.87 164.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -137.84 152.83 49.48 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.189 0.996 . . . . 0.0 111.153 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -83.56 156.08 22.96 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.311 1.045 . . . . 0.0 113.058 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.8 t -87.58 134.55 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.706 1.602 . . . . 0.0 111.071 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.6 mt -84.21 -49.03 9.18 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.426 1.09 . . . . 0.0 112.508 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -151.28 159.77 44.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.694 1.998 . . . . 0.0 110.38 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.5 p -120.17 122.96 42.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.919 2.088 . . . . 0.0 109.571 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -101.46 147.02 26.85 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.89 0.876 . . . . 0.0 112.998 173.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.03 135.09 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.06 1.344 . . . . 0.0 110.077 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -126.86 170.93 11.71 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.028 2.131 . . . . 0.0 109.246 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -131.56 136.59 47.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.426 0.69 . . . . 0.0 111.714 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 t -154.57 146.93 23.91 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.598 0.759 . . . . 0.0 111.348 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.7 p -84.24 -18.32 36.89 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.716 0.806 . . . . 0.0 111.884 162.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -99.47 110.03 22.54 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 120.857 -1.152 . . . . 0.0 110.766 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.1 mt -121.5 172.53 8.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.767 1.627 . . . . 0.0 111.383 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.7 tp -141.32 130.48 23.43 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.893 1.277 . . . . 0.0 111.321 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -112.19 106.9 15.61 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.019 -1.05 . . . . 0.0 109.971 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.8 142.25 29.8 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.458 -0.776 . . . . 0.0 110.376 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.6 m -115.45 120.83 40.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.951 0.901 . . . . 0.0 109.471 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.02 117.37 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 126.32 1.848 . . . . 0.0 108.634 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.57 30.09 41.51 Favored Glycine 0 CA--C 1.543 1.789 0 N-CA-C 115.717 1.047 . . . . 0.0 115.717 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.08 6.4 84.8 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -102.37 129.38 48.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.881 1.341 . . . . 0.0 110.149 165.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -86.71 129.02 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.895 0.878 . . . . 0.0 110.287 164.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mt -121.7 101.51 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.07 1.348 . . . . 0.0 109.201 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.87 117.16 15.32 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.819 1.648 . . . . 0.0 110.732 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 t -142.72 -179.97 6.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.886 1.274 . . . . 0.0 112.464 -165.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.0 p -87.72 156.98 19.18 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 122.135 0.969 . . . . 0.0 112.353 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -59.45 -31.38 69.26 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.534 1.134 . . . . 0.0 113.082 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -101.05 8.96 42.67 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.5 t60 -64.08 128.12 92.68 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.474 1.034 . . . . 0.0 112.871 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.12 119.07 2.74 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.181 2.587 . . . . 0.0 114.947 -175.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -108.74 150.3 27.79 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.98 2.112 . . . . 0.0 111.472 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -98.19 130.04 44.94 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.517 1.053 . . . . 0.0 113.556 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.97 137.1 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.762 2.425 . . . . 0.0 111.392 -173.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -57.59 121.93 11.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.767 2.027 . . . . 0.0 112.671 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 53.03 30.04 8.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.616 1.967 . . . . 0.0 114.262 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.5 t -136.29 -50.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.469 1.508 . . . . 0.0 112.009 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.71 -153.58 17.53 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.046 0.831 . . . . 0.0 113.783 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -87.57 141.24 28.77 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.415 -1.05 . . . . 0.0 113.667 -173.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.95 145.28 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.284 1.433 . . . . 0.0 111.808 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.25 137.12 57.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.949 1.3 . . . . 0.0 112.098 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.18 -35.77 69.99 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.346 1.058 . . . . 0.0 113.64 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.04 -16.82 67.04 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 121.299 -0.876 . . . . 0.0 114.02 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -103.29 -2.04 27.8 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.467 1.907 . . . . 0.0 113.512 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.28 151.82 39.52 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.676 -0.64 . . . . 0.0 110.836 162.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.21 157.87 39.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.894 1.678 . . . . 0.0 109.623 170.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.53 136.8 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.07 4.78 88.17 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-O 118.856 -0.969 . . . . 0.0 115.441 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -83.29 150.17 26.32 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.546 1.673 . . . . 0.0 110.098 170.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -108.6 113.54 26.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.561 1.544 . . . . 0.0 112.631 -165.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.6 165.49 11.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.645 1.578 . . . . 0.0 112.627 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.71 142.42 36.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.667 1.587 . . . . 0.0 110.892 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -96.11 -178.13 4.23 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.986 0.915 . . . . 0.0 113.203 166.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.7 p -62.57 -1.77 0.91 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.628 1.971 . . . . 0.0 116.257 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.7 mtm-85 -117.8 -27.49 6.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.101 2.161 . . . . 0.0 111.565 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 104.43 17.32 15.67 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.813 2.149 . . . . 0.0 113.449 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -69.28 159.3 33.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.891 0.876 . . . . 0.0 111.14 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.3 t -75.87 131.41 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.747 0.784 . . . . 0.0 110.786 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.6 mt -117.5 158.47 24.49 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.931 2.092 . . . . 0.0 109.699 161.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.4 142.26 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.408 0.683 . . . . 0.0 111.277 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.48 129.4 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.429 1.091 . . . . 0.0 110.352 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -102.45 -33.91 9.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.351 2.26 . . . . 0.0 112.966 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -159.52 152.19 21.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.795 1.638 . . . . 0.0 111.797 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -124.92 124.06 41.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.053 2.141 . . . . 0.0 109.816 159.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -118.59 140.17 50.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.891 2.076 . . . . 0.0 109.868 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 tp -121.31 125.59 47.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.884 1.274 . . . . 0.0 110.637 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.66 159.34 39.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.582 0.706 . . . . 0.0 112.268 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.7 mm -111.36 114.07 46.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 166.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.36 150.7 42.8 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 122.103 0.954 . . . . 0.0 111.723 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.04 -22.09 60.69 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.944 1.298 . . . . 0.0 112.819 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -134.74 151.88 76.56 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 126.292 1.837 . . . . 0.0 111.131 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.91 111.28 3.0 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.683 2.256 . . . . 0.0 110.899 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.16 141.5 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 126.245 1.818 . . . . 0.0 109.674 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -75.28 134.27 41.12 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.297 1.046 . . . . 0.0 110.247 172.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.44 130.49 67.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.226 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -112.36 148.18 34.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.012 1.725 . . . . 0.0 110.959 -166.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -153.35 169.02 24.13 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.327 1.451 . . . . 0.0 109.867 171.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -148.73 171.74 15.73 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 120.398 -1.439 . . . . 0.0 111.674 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -128.52 139.55 52.26 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.817 0.847 . . . . 0.0 112.682 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.47 145.43 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.982 1.713 . . . . 0.0 111.62 -169.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.13 -40.62 86.04 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -166.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -133.6 -36.9 0.95 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.035 0.934 . . . . 0.0 112.57 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.76 160.45 29.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.933 0.873 . . . . 0.0 110.533 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -114.95 11.52 16.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.202 1.401 . . . . 0.0 112.832 -171.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 p -145.5 166.51 25.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.191 1.797 . . . . 0.0 112.381 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -156.42 -179.01 7.76 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.768 1.627 . . . . 0.0 110.774 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -122.79 138.54 54.61 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.161 1.384 . . . . 0.0 112.413 -175.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -123.3 141.46 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.323 1.449 . . . . 0.0 111.962 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.96 -176.22 53.21 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 168.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.53 -34.66 72.54 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.995 1.718 . . . . 0.0 112.41 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -82.73 -4.54 58.03 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.362 1.065 . . . . 0.0 113.471 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 59.14 47.17 12.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.202 1.801 . . . . 0.0 114.093 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 t -72.96 137.15 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.916 1.286 . . . . 0.0 111.316 -170.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 52.7 tp -81.43 125.98 31.09 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.167 1.387 . . . . 0.0 113.104 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.1 m -138.33 156.72 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.956 1.702 . . . . 0.0 111.301 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -105.81 146.66 29.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.851 1.26 . . . . 0.0 112.129 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.3 m120 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.177 0.991 . . . . 0.0 111.835 173.253 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.494 0.188 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 3.4 ttt -151.82 -45.9 0.11 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.03 1.332 . . . . 0.0 112.639 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 63.2 mttm 43.48 62.79 1.75 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.487 1.915 . . . . 0.0 114.394 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -132.46 173.51 11.23 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -171.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.431 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 96.9 m-85 -128.02 153.23 47.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.408 1.483 . . . . 0.0 112.168 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 m -69.07 154.72 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.15 139.69 28.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.816 0.847 . . . . 0.0 111.55 171.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.72 -6.09 81.7 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.113 -1.382 . . . . 0.0 116.156 -170.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.9 m -64.3 123.43 19.12 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 121.163 2.482 . . . . 0.0 110.336 172.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.5 mmt -83.16 142.12 31.44 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.337 1.055 . . . . 0.0 112.08 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.19 135.03 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.369 2.267 . . . . 0.0 109.642 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.69 133.41 42.07 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 p -137.23 165.84 25.19 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.281 1.432 . . . . 0.0 111.195 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.56 -19.33 63.57 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.44 1.096 . . . . 0.0 113.372 170.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.4 p -86.57 -32.73 20.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.955 1.302 . . . . 0.0 111.64 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.71 -98.79 0.19 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.211 1.862 . . . . 0.0 110.612 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.4 mt -130.48 149.29 52.22 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.153 0.981 . . . . 0.0 111.867 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.5 141.25 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.859 1.663 . . . . 0.0 108.884 169.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.18 148.79 49.39 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.122 -0.986 . . . . 0.0 110.75 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.1 tt -61.48 -28.17 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 120.752 -1.217 . . . . 0.0 112.847 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.98 -6.64 46.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.905 1.282 . . . . 0.0 113.96 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -117.59 -7.96 11.0 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.121 1.769 . . . . 0.0 114.322 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.1 mm -66.81 139.41 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.928 0.785 . . . . 0.0 109.545 161.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -120.42 162.73 19.02 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.614 1.966 . . . . 0.0 110.32 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.5 135.54 54.37 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.093 0.473 . . . . 0.0 110.139 155.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.04 11.6 83.52 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.728 -1.04 . . . . 0.0 115.192 -176.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -96.86 158.0 15.64 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.846 1.323 . . . . 0.0 110.947 162.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -112.55 137.95 50.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.997 1.719 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -135.07 161.25 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.199 1.799 . . . . 0.0 111.163 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -76.52 143.11 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.661 0.664 . . . . 0.0 111.425 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.84 132.06 23.3 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.49 172.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.9 m -79.69 112.98 17.5 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 162.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -52.9 123.49 32.76 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 124.585 1.154 . . . . 0.0 112.392 171.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.0 -2.46 11.78 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 123.076 2.517 . . . . 0.0 114.778 -174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -90.78 -48.86 6.78 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.687 1.195 . . . . 0.0 112.004 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 t -127.67 1.56 6.13 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -166.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 61.02 27.41 17.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.339 1.456 . . . . 0.0 114.365 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.85 120.13 15.13 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.422 1.489 . . . . 0.0 109.157 170.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.5 t -100.56 120.48 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.454 0.701 . . . . 0.0 109.163 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.24 164.94 33.37 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.833 0.853 . . . . 0.0 112.089 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.56 137.82 48.34 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.692 0.397 . . . . 0.0 110.416 159.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -135.71 153.04 51.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.687 1.195 . . . . 0.0 111.117 161.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 t -78.12 154.46 31.24 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.2 t -91.93 135.0 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 127.039 2.136 . . . . 0.0 110.393 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.1 mt -87.56 -49.48 7.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.579 1.151 . . . . 0.0 112.33 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -146.57 156.66 43.4 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.179 1.392 . . . . 0.0 111.132 -175.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.5 p -124.86 119.51 29.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.238 1.815 . . . . 0.0 109.071 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -106.72 149.45 27.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.522 1.129 . . . . 0.0 113.316 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.6 t -139.03 142.32 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.2 1.4 . . . . 0.0 111.379 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -139.96 178.22 7.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.419 2.287 . . . . 0.0 111.988 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -129.65 141.09 50.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.05 1.74 . . . . 0.0 111.992 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 t -155.2 153.1 30.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.64 1.176 . . . . 0.0 111.639 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 p -90.0 -18.41 26.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.435 1.094 . . . . 0.0 113.296 164.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -95.0 106.98 19.0 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.391 -0.818 . . . . 0.0 111.725 -177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.7 mt -118.72 168.51 10.66 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.854 1.262 . . . . 0.0 112.571 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 tp -139.04 133.95 32.35 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.715 1.606 . . . . 0.0 110.967 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -106.06 138.1 42.83 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.469 1.508 . . . . 0.0 109.889 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.2 mt -127.21 130.53 49.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.309 1.043 . . . . 0.0 109.961 167.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.9 m -96.73 124.1 40.61 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 167.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.57 117.53 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.362 1.465 . . . . 0.0 109.289 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.53 29.36 31.56 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.09 7.75 79.86 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 116.856 1.502 . . . . 0.0 116.856 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -112.04 140.33 46.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.844 1.822 . . . . 0.0 108.519 163.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -108.49 134.4 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 124.612 1.165 . . . . 0.0 111.837 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 57.9 mt -129.17 136.45 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.858 1.663 . . . . 0.0 109.278 -171.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -120.44 107.21 12.62 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.249 1.42 . . . . 0.0 109.905 -162.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -138.73 175.65 9.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.223 1.409 . . . . 0.0 113.241 -157.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 p -82.87 152.16 25.7 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.922 0.868 . . . . 0.0 111.472 166.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -56.87 -31.02 64.41 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.652 1.181 . . . . 0.0 112.702 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -95.4 1.64 54.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.022 1.329 . . . . 0.0 114.109 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.431 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.0 t60 -65.69 126.64 92.03 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 118.509 -0.758 . . . . 0.0 112.602 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.28 117.37 2.8 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.732 2.288 . . . . 0.0 114.508 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -100.98 143.21 31.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.004 2.121 . . . . 0.0 111.046 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -89.15 127.48 35.73 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.537 1.062 . . . . 0.0 112.432 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.41 136.53 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.472 1.909 . . . . 0.0 110.395 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.2 tptt -50.85 130.75 25.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.772 1.629 . . . . 0.0 110.658 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t70 58.7 10.09 1.34 Allowed 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.5 t -131.55 -47.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.406 -1.433 . . . . 0.0 111.567 -167.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.63 -162.59 14.83 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.791 0.71 . . . . 0.0 113.3 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -76.72 147.5 37.34 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -172.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.91 145.8 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.102 2.161 . . . . 0.0 111.014 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.15 136.72 58.11 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.771 0.828 . . . . 0.0 112.839 172.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.88 -39.47 62.69 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.455 1.502 . . . . 0.0 113.41 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.34 -17.42 74.26 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 121.217 -0.927 . . . . 0.0 114.199 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -104.7 5.32 33.38 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.167 2.187 . . . . 0.0 113.806 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.04 160.89 30.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.632 0.651 . . . . 0.0 110.544 165.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -125.01 150.31 46.85 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.54 1.136 . . . . 0.0 111.58 172.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.72 134.85 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.26 4.35 81.14 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.791 -1.005 . . . . 0.0 114.956 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -92.33 159.53 15.55 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.247 1.524 . . . . 0.0 112.396 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -108.88 109.01 20.0 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.915 1.286 . . . . 0.0 112.47 -157.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 mt -103.14 -177.69 3.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.702 1.601 . . . . 0.0 111.725 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.1 mt -134.53 156.75 48.08 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.445 1.098 . . . . 0.0 113.274 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.96 -175.7 2.79 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.485 1.514 . . . . 0.0 114.413 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -64.62 -6.51 7.84 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -103.44 -16.02 15.71 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.104 1.762 . . . . 0.0 112.605 167.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.04 19.54 50.33 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.442 1.496 . . . . 0.0 112.238 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -84.2 145.94 28.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.46 1.104 . . . . 0.0 110.278 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.9 t -76.0 115.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.087 0.47 . . . . 0.0 110.985 -174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.6 mt -93.37 157.64 16.13 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.973 1.709 . . . . 0.0 111.388 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 t -123.04 138.78 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.294 1.037 . . . . 0.0 110.841 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.16 126.01 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.664 0.786 . . . . 0.0 109.414 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -106.35 -25.25 12.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.759 2.024 . . . . 0.0 113.089 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -163.07 150.81 13.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.933 1.293 . . . . 0.0 111.857 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -120.59 128.37 52.98 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.739 2.016 . . . . 0.0 109.466 161.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -130.85 123.78 29.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.985 1.314 . . . . 0.0 110.964 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.3 tp -102.26 129.32 48.64 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.033 1.333 . . . . 0.0 109.795 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -126.88 149.59 49.69 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.105 0.955 . . . . 0.0 112.961 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.2 mm -111.68 105.6 19.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 171.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.65 154.55 32.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.25 1.02 . . . . 0.0 111.369 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.43 -21.31 28.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.912 0.885 . . . . 0.0 112.054 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -136.95 140.39 31.44 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.43 1.492 . . . . 0.0 110.321 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.12 117.63 4.43 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.019 3.146 . . . . 0.0 111.886 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.04 137.04 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.557 1.543 . . . . 0.0 110.001 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -74.98 135.52 41.33 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.98 0.895 . . . . 0.0 110.566 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -132.6 133.84 59.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 125.096 1.358 . . . . 0.0 110.946 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -117.2 153.94 32.0 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.713 1.605 . . . . 0.0 111.273 -166.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -152.49 155.71 38.0 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.332 2.253 . . . . 0.0 109.348 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -150.46 161.04 43.28 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.57 -1.331 . . . . 0.0 112.614 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.4 148.39 43.84 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.26 144.85 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 125.806 1.643 . . . . 0.0 112.819 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.74 -29.22 63.15 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -164.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -138.63 -41.08 0.5 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.792 -1.192 . . . . 0.0 113.144 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -75.88 165.36 25.11 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.706 -0.621 . . . . 0.0 110.134 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -124.99 32.05 5.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.376 1.471 . . . . 0.0 110.747 -170.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -156.85 164.02 38.54 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.588 1.555 . . . . 0.0 111.268 -162.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -161.97 174.3 13.26 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.189 1.796 . . . . 0.0 110.447 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -121.07 136.34 55.0 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.767 1.227 . . . . 0.0 112.975 -173.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.9 m -127.27 144.91 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.712 1.605 . . . . 0.0 113.91 -173.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.72 172.94 30.13 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 126.038 1.78 . . . . 0.0 115.063 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.63 -20.03 63.62 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.48 -1.6 . . . . 0.0 113.236 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -85.08 -2.18 57.7 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 169.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 57.33 51.52 9.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.664 1.585 . . . . 0.0 112.694 163.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.02 140.1 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.845 2.058 . . . . 0.0 111.697 -168.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 46.0 tp -79.07 127.37 31.91 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.134 1.373 . . . . 0.0 114.33 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.48 154.71 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.858 1.663 . . . . 0.0 111.377 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -103.04 141.63 35.48 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.086 0.954 . . . . 0.0 113.272 -169.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.27 0 CA-C-O 116.322 -1.799 . . . . 0.0 111.242 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 119.879 -0.105 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 35.0 ttm -56.83 143.52 36.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.563 2.345 . . . . 0.0 114.277 -168.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -125.34 76.39 1.55 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.002 1.721 . . . . 0.0 110.161 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.86 169.6 17.32 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.339 1.055 . . . . 0.0 112.759 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -122.35 154.14 38.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.088 1.355 . . . . 0.0 111.491 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 m -69.3 154.69 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.0 0.429 . . . . 0.0 111.998 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.21 140.58 20.91 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.034 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.53 -9.46 71.47 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.544 2.021 . . . . 0.0 114.662 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 59.0 m -67.4 126.46 29.35 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.367 1.583 . . . . 0.0 111.5 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.4 mmt -78.1 143.6 37.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.858 1.663 . . . . 0.0 112.487 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.0 mm -129.61 139.0 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.608 1.963 . . . . 0.0 110.431 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.92 129.77 34.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.262 1.425 . . . . 0.0 113.066 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.8 p -134.66 173.03 12.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.777 1.231 . . . . 0.0 113.71 -167.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.07 -13.12 32.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.55 1.54 . . . . 0.0 113.794 171.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.7 p -124.33 1.89 8.43 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.7 -117.89 2.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.396 1.951 . . . . 0.0 110.758 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.51 142.54 46.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.496 1.118 . . . . 0.0 112.634 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.97 148.91 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 127.269 2.227 . . . . 0.0 108.94 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.87 147.33 51.86 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.313 -0.867 . . . . 0.0 112.027 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.5 tt -62.48 -33.31 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 120.936 -1.103 . . . . 0.0 112.514 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.8 pm0 -68.71 -16.5 63.84 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -104.78 -14.74 15.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.039 1.336 . . . . 0.0 112.571 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.2 mm -58.66 133.96 23.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 O-C-N 121.126 -0.984 . . . . 0.0 109.432 164.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -119.81 161.67 20.4 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.386 1.874 . . . . 0.0 112.357 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.38 133.74 53.18 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.84 -0.538 . . . . 0.0 110.556 167.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.13 -6.54 81.22 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.869 1.223 . . . . 0.0 114.785 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.96 150.72 40.61 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.099 1.45 . . . . 0.0 109.628 168.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.87 120.6 42.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.87 0.868 . . . . 0.0 111.2 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.5 m -106.06 151.46 8.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 125.195 1.398 . . . . 0.0 110.083 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.6 mm -81.67 137.08 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.52 116.23 13.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 m -93.07 111.41 23.04 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -52.95 115.01 6.62 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.897 1.279 . . . . 0.0 112.24 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -74.61 -1.61 11.32 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.054 2.503 . . . . 0.0 115.285 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -85.67 -46.75 10.45 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.785 -1.197 . . . . 0.0 112.317 170.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -126.31 -7.4 6.43 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.166 0.986 . . . . 0.0 113.127 -163.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.279 95.5 m-85 58.13 30.41 19.31 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.344 2.257 . . . . 0.0 115.017 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.92 130.05 39.12 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.57 0.748 . . . . 0.0 109.238 170.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -92.37 128.34 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.766 0.826 . . . . 0.0 109.501 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.37 149.36 39.29 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -69.3 136.11 51.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.389 0.676 . . . . 0.0 110.235 156.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 149.01 44.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.886 1.274 . . . . 0.0 110.026 159.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -78.06 153.58 32.16 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.898 0.856 . . . . 0.0 113.176 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.0 t -85.88 120.62 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.7 1.6 . . . . 0.0 109.757 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.71 -52.05 23.49 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.32 0.648 . . . . 0.0 111.12 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -146.24 156.58 43.48 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.266 1.426 . . . . 0.0 111.9 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 p -117.73 118.47 32.15 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.266 1.827 . . . . 0.0 111.148 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -104.52 151.93 23.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.693 1.597 . . . . 0.0 113.316 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 114' ' ' TYR . 16.3 t -136.4 140.98 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.0 1.72 . . . . 0.0 109.016 173.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -140.76 176.54 8.71 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.081 1.752 . . . . 0.0 109.889 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -131.61 134.32 45.89 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.576 1.15 . . . . 0.0 111.271 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -144.21 152.03 40.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.211 1.004 . . . . 0.0 110.926 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.7 p -96.76 -15.03 21.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.219 1.407 . . . . 0.0 113.658 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -109.17 106.05 15.77 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.824 0.85 . . . . 0.0 110.682 -170.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.3 mt -116.78 163.94 15.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 122.369 1.081 . . . . 0.0 113.817 -172.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.4 HD11 ' HD2' ' A' ' 102' ' ' LYS . 14.8 tp -137.26 129.14 28.97 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.694 1.597 . . . . 0.0 111.853 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -110.51 103.83 12.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.616 1.566 . . . . 0.0 111.188 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.21 141.29 28.59 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.057 0.943 . . . . 0.0 110.058 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.0 m -114.18 125.26 53.73 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 167.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.06 119.46 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.953 1.301 . . . . 0.0 109.891 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.05 24.55 35.64 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.158 0.885 . . . . 0.0 115.149 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.89 -0.36 69.62 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.042 1.306 . . . . 0.0 116.285 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -108.74 125.54 52.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.592 1.696 . . . . 0.0 110.292 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -91.7 134.74 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.143 0.977 . . . . 0.0 112.64 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 mt -133.9 132.21 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.642 1.977 . . . . 0.0 108.828 -170.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -120.99 105.92 11.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.154 0.982 . . . . 0.0 109.538 -159.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 t -140.05 175.75 9.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.916 0.887 . . . . 0.0 113.328 -156.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.0 p -80.54 152.39 28.67 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.897 0.879 . . . . 0.0 112.182 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -61.18 -29.37 69.76 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.974 -1.079 . . . . 0.0 112.656 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -94.19 2.4 55.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.397 1.079 . . . . 0.0 113.456 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -64.52 128.73 93.72 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 120.97 -1.081 . . . . 0.0 112.826 -172.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -79.93 112.39 2.86 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.561 2.841 . . . . 0.0 114.45 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -102.64 145.59 29.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.18 1.792 . . . . 0.0 111.956 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -93.3 132.04 37.88 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -116.65 135.63 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 127.303 2.241 . . . . 0.0 111.395 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -55.39 129.38 38.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.154 0.982 . . . . 0.0 110.982 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 64.66 9.01 4.83 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.47 1.908 . . . . 0.0 115.588 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.4 t -132.06 -44.66 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 120.882 -1.136 . . . . 0.0 112.344 -172.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.23 -147.75 17.83 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.213 -0.771 . . . . 0.0 112.377 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.28 53.4 p90 -91.26 143.12 26.98 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -144.63 147.98 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.829 2.052 . . . . 0.0 111.922 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -59.37 135.04 57.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.911 0.885 . . . . 0.0 112.63 171.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.58 -37.15 72.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.738 1.215 . . . . 0.0 113.014 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.36 -18.32 71.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.997 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -97.06 -1.94 44.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.629 1.572 . . . . 0.0 113.943 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.9 mt -70.51 156.59 39.19 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.651 0.78 . . . . 0.0 112.46 171.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -118.26 156.91 28.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.789 1.636 . . . . 0.0 111.433 170.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.36 132.33 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.883 0.873 . . . . 0.0 110.065 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.76 60.87 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.98 1.276 . . . . 0.0 115.655 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -86.97 159.03 19.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.489 1.645 . . . . 0.0 113.047 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -101.89 102.92 13.56 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.448 1.499 . . . . 0.0 112.361 -159.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.7 mt -95.81 166.84 11.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.528 1.131 . . . . 0.0 111.67 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.62 153.44 22.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.92 1.288 . . . . 0.0 110.306 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -109.89 -174.35 2.47 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 172.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.9 p -57.59 -12.75 3.03 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -103.7 -26.6 12.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.171 1.389 . . . . 0.0 111.342 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.83 22.2 24.04 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.335 1.922 . . . . 0.0 111.819 -167.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -76.75 159.58 30.03 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.764 0.826 . . . . 0.0 109.898 167.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.26 130.73 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.528 0.68 . . . . 0.0 112.328 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.4 158.65 20.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.036 2.934 . . . . 0.0 111.227 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.13 139.24 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.212 1.005 . . . . 0.0 111.266 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.2 t -73.71 125.75 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.539 0.736 . . . . 0.0 110.23 172.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -100.96 -26.71 13.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.621 2.369 . . . . 0.0 113.515 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -161.77 152.4 17.63 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.203 1.401 . . . . 0.0 111.565 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.4 ' HD2' HD11 ' A' ' 53' ' ' LEU . 20.3 ttpp -127.17 132.8 50.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.737 1.615 . . . . 0.0 111.067 156.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -132.12 154.83 49.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 128.524 2.73 . . . . 0.0 110.023 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 tt -142.6 137.18 29.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.509 1.524 . . . . 0.0 110.436 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -135.1 149.89 50.13 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.1 mm -106.58 105.67 19.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.954 1.302 . . . . 0.0 108.6 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.62 148.35 49.47 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.754 1.222 . . . . 0.0 113.221 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.19 -14.61 60.15 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.748 1.219 . . . . 0.0 113.354 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -151.25 153.52 32.72 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 126.708 2.003 . . . . 0.0 110.69 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.18 122.92 11.31 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.328 2.686 . . . . 0.0 112.861 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.97 142.04 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.8 1.64 . . . . 0.0 109.837 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -79.81 140.62 36.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.797 0.839 . . . . 0.0 111.269 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.2 m -143.75 150.59 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.307 1.043 . . . . 0.0 111.162 -173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.463 ' CD2' HG22 ' A' ' 46' ' ' VAL . 64.4 m-85 -128.1 147.15 50.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.712 1.205 . . . . 0.0 111.265 -165.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -155.94 166.79 32.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.257 1.823 . . . . 0.0 109.129 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -150.54 172.33 15.66 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.329 -1.482 . . . . 0.0 111.655 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -122.02 132.7 54.65 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.47 138.23 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.948 1.699 . . . . 0.0 111.486 -172.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.38 -33.33 65.63 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -148.28 -37.08 0.19 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.025 -1.047 . . . . 0.0 113.689 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -73.71 166.65 22.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.987 0.915 . . . . 0.0 110.424 172.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -133.77 28.58 3.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.448 1.499 . . . . 0.0 112.791 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.7 p -136.34 161.24 36.34 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.075 1.75 . . . . 0.0 111.511 175.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -157.6 -179.28 8.02 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.287 1.835 . . . . 0.0 109.814 167.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -132.95 139.33 47.25 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.26 1.024 . . . . 0.0 112.841 -168.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.78 141.4 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -170.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.36 172.55 31.59 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.39 1.472 . . . . 0.0 115.709 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.33 -19.23 65.31 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.927 -1.337 . . . . 0.0 113.808 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -93.77 1.51 56.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.402 1.481 . . . . 0.0 114.154 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 57.74 46.17 17.64 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.861 1.664 . . . . 0.0 114.217 166.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.26 138.09 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.397 1.079 . . . . 0.0 111.632 -171.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.66 124.96 28.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.799 1.639 . . . . 0.0 112.498 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.97 151.82 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.311 1.444 . . . . 0.0 110.845 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -81.69 146.76 29.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.976 0.51 . . . . 0.0 110.569 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 C--O 1.251 1.18 0 C-N-CA 124.788 1.235 . . . . 0.0 113.592 178.254 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 44.6 ttm -148.94 145.13 27.23 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.278 -0.889 . . . . 0.0 111.764 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -122.37 50.02 1.53 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.764 1.626 . . . . 0.0 113.264 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -128.34 163.4 24.9 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -166.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -119.45 151.22 38.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.842 1.257 . . . . 0.0 110.915 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.82 158.73 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.272 0.558 . . . . 0.0 111.918 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.21 150.6 4.45 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.089 0.947 . . . . 0.0 111.63 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.47 -18.97 15.96 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 117.272 -1.849 . . . . 0.0 116.357 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.9 m -63.6 121.41 13.83 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.202 2.501 . . . . 0.0 110.718 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -77.76 143.77 37.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.476 1.111 . . . . 0.0 112.387 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.2 mm -126.81 136.46 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 127.548 2.339 . . . . 0.0 109.828 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -78.5 129.09 34.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.518 1.127 . . . . 0.0 113.441 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -127.52 173.59 9.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.57 1.548 . . . . 0.0 111.751 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.53 -15.1 63.14 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.851 -1.156 . . . . 0.0 113.371 172.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 p -109.03 -8.74 15.14 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.898 1.679 . . . . 0.0 114.21 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.38 -113.98 0.97 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.408 1.48 . . . . 0.0 111.412 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.8 mt -120.66 153.97 36.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.625 1.17 . . . . 0.0 111.584 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -137.63 144.99 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.667 1.987 . . . . 0.0 108.029 166.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.75 148.32 46.46 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.756 -1.215 . . . . 0.0 111.316 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 tt -63.32 -27.4 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 120.42 -1.425 . . . . 0.0 113.056 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -70.46 -7.15 41.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.964 1.306 . . . . 0.0 114.351 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -118.17 -15.37 9.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.644 1.578 . . . . 0.0 113.084 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.02 135.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.918 1.235 . . . . 0.0 110.295 169.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -120.75 159.06 26.18 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.644 1.578 . . . . 0.0 112.375 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 137.89 55.5 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.421 -0.8 . . . . 0.0 110.533 167.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.61 -6.67 72.4 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.376 0.989 . . . . 0.0 115.133 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -67.95 177.65 2.08 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.812 1.306 . . . . 0.0 110.99 167.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -120.14 153.45 36.17 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.9 -1.125 . . . . 0.0 112.584 168.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 m -141.45 160.83 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.754 1.622 . . . . 0.0 110.609 175.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.2 mm -77.99 135.87 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 122.041 -0.412 . . . . 0.0 111.2 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.2 120.82 21.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.754 1.222 . . . . 0.0 107.71 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.2 m -96.65 103.18 15.07 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -47.84 118.91 6.55 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.027 1.331 . . . . 0.0 112.479 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.46 -10.37 28.47 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.27 1.98 . . . . 0.0 114.107 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -77.54 -34.96 53.71 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.791 1.636 . . . . 0.0 113.315 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.7 t -144.91 -3.91 0.76 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.142 1.377 . . . . 0.0 112.702 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 54.73 40.23 31.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.598 1.559 . . . . 0.0 113.565 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -77.87 124.22 27.73 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.505 1.122 . . . . 0.0 109.494 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -85.92 123.85 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.083 0.553 . . . . 0.0 110.779 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.35 162.83 34.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.849 0.833 . . . . 0.0 112.972 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -103.84 116.47 32.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.853 1.661 . . . . 0.0 109.416 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -133.91 154.5 51.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.876 1.27 . . . . 0.0 111.444 -170.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 t -87.87 157.1 19.07 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.6 t -88.59 128.35 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.408 1.483 . . . . 0.0 110.843 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -83.3 -55.78 4.13 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.009 0.524 . . . . 0.0 111.333 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -138.7 152.73 48.26 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.601 1.161 . . . . 0.0 111.627 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -128.01 107.98 10.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.759 1.624 . . . . 0.0 110.411 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -96.31 146.3 24.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.403 1.081 . . . . 0.0 111.706 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 t -136.79 137.04 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.996 0.918 . . . . 0.0 109.192 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -133.95 175.4 9.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.525 2.33 . . . . 0.0 109.256 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -131.6 132.22 43.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.312 1.045 . . . . 0.0 111.751 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 t -141.66 140.27 33.19 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.422 1.089 . . . . 0.0 111.101 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -85.19 -21.98 28.92 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.535 0.734 . . . . 0.0 112.287 165.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -92.87 120.63 33.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.92 0.782 . . . . 0.0 109.495 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.3 mt -126.61 161.96 26.82 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.481 1.134 . . . . 0.0 112.673 174.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 tp -127.83 128.87 45.99 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.461 1.904 . . . . 0.0 109.918 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -113.22 95.9 5.63 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.197 -0.94 . . . . 0.0 109.29 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.0 mt -83.69 145.04 28.99 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.444 -0.785 . . . . 0.0 110.291 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -117.32 120.01 36.89 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -128.12 120.99 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.997 1.319 . . . . 0.0 108.61 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.52 31.12 28.43 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.42 -5.75 83.76 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.221 1.391 . . . . 0.0 116.0 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -94.96 125.93 39.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.236 1.518 . . . . 0.0 109.581 172.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.19 132.42 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.313 0.645 . . . . 0.0 110.998 167.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -123.47 103.32 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.282 1.833 . . . . 0.0 109.072 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -77.67 106.91 9.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.48 2.312 . . . . 0.0 110.766 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 t -137.47 -179.34 5.68 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.156 1.382 . . . . 0.0 112.103 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.0 p -88.25 163.36 16.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.77 1.228 . . . . 0.0 111.91 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -68.45 -25.76 65.17 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.867 -1.146 . . . . 0.0 112.45 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -106.43 9.6 31.67 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.654 0.782 . . . . 0.0 113.006 -171.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -72.19 131.68 84.96 Favored Pre-proline 0 CA--C 1.553 1.066 0 O-C-N 121.369 -0.832 . . . . 0.0 112.717 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.3 120.05 2.83 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.201 3.268 . . . . 0.0 115.575 -175.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -106.88 145.16 32.52 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.462 1.905 . . . . 0.0 111.201 172.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -88.96 131.45 35.15 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.305 1.412 . . . . 0.0 113.506 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.31 133.7 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 127.126 2.171 . . . . 0.0 111.504 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -56.58 127.68 32.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.786 0.834 . . . . 0.0 112.855 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 59.99 15.5 5.09 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.316 1.847 . . . . 0.0 115.488 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.3 t -125.26 -59.15 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 120.833 -1.167 . . . . 0.0 111.09 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.39 -162.47 22.7 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.242 0.925 . . . . 0.0 112.653 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -83.29 146.19 28.67 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.845 1.322 . . . . 0.0 114.143 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.83 145.35 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 127.307 2.243 . . . . 0.0 111.259 -175.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -66.04 136.74 56.44 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.682 0.793 . . . . 0.0 112.485 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.74 -39.32 68.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.489 1.516 . . . . 0.0 113.799 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.35 -17.8 77.84 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.355 -0.84 . . . . 0.0 114.041 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -93.63 -9.76 36.88 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.392 1.477 . . . . 0.0 113.761 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.99 167.76 1.53 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.35 1.06 . . . . 0.0 113.103 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 162.43 27.37 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.463 1.505 . . . . 0.0 110.115 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.97 145.39 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.307 0.575 . . . . 0.0 109.505 167.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.43 4.8 89.26 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.727 -1.041 . . . . 0.0 114.807 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -84.58 158.01 21.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.153 1.476 . . . . 0.0 112.426 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -105.9 104.43 14.14 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.815 1.246 . . . . 0.0 111.591 -162.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.8 mt -101.19 169.37 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.904 1.281 . . . . 0.0 111.11 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -115.49 144.1 44.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.955 1.302 . . . . 0.0 110.634 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.96 -177.11 5.11 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.533 1.133 . . . . 0.0 112.805 168.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.1 p -59.98 -17.42 38.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -97.51 -26.34 14.85 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.837 1.653 . . . . 0.0 112.737 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 104.08 23.4 8.15 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.448 1.499 . . . . 0.0 113.15 -170.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -81.34 151.07 28.18 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.791 1.236 . . . . 0.0 110.649 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.9 t -84.85 133.12 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.124 0.97 . . . . 0.0 112.159 -168.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -118.62 148.74 42.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.575 2.35 . . . . 0.0 111.424 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.56 135.43 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.224 1.01 . . . . 0.0 110.714 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.04 127.21 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 169.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.47 -38.34 8.44 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.329 1.452 . . . . 0.0 112.565 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -161.48 154.82 21.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.29 1.436 . . . . 0.0 111.913 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -120.07 133.21 55.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.458 1.503 . . . . 0.0 110.51 163.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -124.43 153.25 42.22 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.989 2.515 . . . . 0.0 109.965 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 tp -135.11 143.16 46.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.095 1.758 . . . . 0.0 109.942 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.46 157.17 44.37 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.3 mm -108.33 105.24 18.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.656 1.182 . . . . 0.0 108.364 166.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.78 147.51 49.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.899 1.28 . . . . 0.0 113.71 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -74.16 -10.61 59.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.585 1.554 . . . . 0.0 113.972 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -139.65 157.13 70.67 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 127.034 2.134 . . . . 0.0 110.291 166.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.77 119.09 6.04 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.653 2.236 . . . . 0.0 110.492 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.7 t -90.02 136.9 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 126.011 1.725 . . . . 0.0 109.419 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -74.61 138.39 42.92 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.679 0.792 . . . . 0.0 110.226 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.95 142.53 29.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 123.926 0.89 . . . . 0.0 110.764 -174.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -122.08 145.46 48.13 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.032 1.333 . . . . 0.0 110.433 -163.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -153.1 165.54 35.3 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.968 1.307 . . . . 0.0 110.801 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -147.03 164.09 34.13 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.423 -1.423 . . . . 0.0 113.02 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -117.69 141.43 48.39 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.02 147.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.078 1.751 . . . . 0.0 111.556 -168.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.16 -67.65 0.42 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.637 1.175 . . . . 0.0 113.886 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -94.88 -54.57 3.42 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.645 -0.66 . . . . 0.0 112.28 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -83.44 177.63 8.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.856 1.263 . . . . 0.0 111.579 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -131.75 29.2 4.49 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.027 1.331 . . . . 0.0 114.187 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 p -137.04 161.61 35.6 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.992 1.717 . . . . 0.0 112.507 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -156.16 -177.48 6.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.528 1.931 . . . . 0.0 110.751 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -132.24 139.57 48.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.096 1.358 . . . . 0.0 113.176 -168.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.22 144.17 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.375 1.07 . . . . 0.0 113.351 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.13 -179.42 39.13 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.051 1.786 . . . . 0.0 116.642 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.92 -39.15 71.23 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.951 1.301 . . . . 0.0 111.973 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -86.33 2.21 48.24 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 59.78 39.53 20.63 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.24 134.5 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.269 0.627 . . . . 0.0 111.578 -169.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.7 tp -73.76 121.93 21.6 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.859 1.664 . . . . 0.0 112.445 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.13 161.92 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.647 1.579 . . . . 0.0 111.623 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -111.03 143.65 41.4 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -167.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 127.343 2.257 . . . . 0.0 113.262 172.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 7.5 ttt -147.24 126.69 13.18 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.37 1.441 . . . . 0.0 111.416 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -134.57 75.93 1.61 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.365 1.466 . . . . 0.0 112.125 -164.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -144.12 172.27 13.13 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.07 152.73 37.13 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.495 1.518 . . . . 0.0 111.068 173.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.1 m -68.25 157.43 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.382 0.611 . . . . 0.0 111.707 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.5 150.11 2.83 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.62 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.94 -10.83 45.18 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.269 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.0 m -64.2 123.91 20.32 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 120.901 2.351 . . . . 0.0 110.641 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 mmt -80.26 140.03 36.41 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.284 1.434 . . . . 0.0 111.831 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.6 mm -123.12 135.71 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.367 1.867 . . . . 0.0 109.719 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.53 123.86 26.7 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.653 0.781 . . . . 0.0 111.608 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 p -117.36 177.36 4.77 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.764 1.226 . . . . 0.0 112.71 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.72 -15.01 50.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.092 1.357 . . . . 0.0 114.128 170.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.5 p -124.68 -12.23 7.17 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.43 -115.1 0.65 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.04 0.828 . . . . 0.0 112.726 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 78.7 mt -125.72 139.65 53.36 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.232 1.013 . . . . 0.0 112.799 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -136.38 147.69 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.83 2.052 . . . . 0.0 109.012 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.42 148.11 47.25 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.273 -0.892 . . . . 0.0 111.442 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.0 tt -61.44 -26.29 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 120.682 -1.261 . . . . 0.0 113.496 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -72.27 -9.07 57.99 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.953 1.301 . . . . 0.0 114.198 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -118.7 -10.28 10.04 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.986 1.714 . . . . 0.0 113.332 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -66.91 136.69 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.668 1.122 . . . . 0.0 109.391 162.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -130.07 166.77 19.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.048 1.739 . . . . 0.0 111.182 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.86 134.08 55.01 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.212 -0.93 . . . . 0.0 110.199 165.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.2 -7.84 81.19 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -67.95 167.73 13.17 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.825 1.312 . . . . 0.0 111.496 161.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -124.23 123.84 41.14 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.431 1.492 . . . . 0.0 111.863 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.98 152.76 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.815 1.646 . . . . 0.0 110.227 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -77.79 139.12 19.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.373 0.606 . . . . 0.0 110.543 169.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.23 126.4 28.07 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.413 1.085 . . . . 0.0 108.378 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.4 m -78.93 111.99 15.67 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 159.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -53.63 114.31 6.08 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.655 1.182 . . . . 0.0 112.15 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.75 -12.77 35.62 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.611 2.207 . . . . 0.0 114.29 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.66 -48.85 14.22 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.793 -1.192 . . . . 0.0 111.887 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -129.0 -0.41 5.26 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.036 1.335 . . . . 0.0 114.117 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.324 4.0 m-85 61.72 25.39 15.29 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.046 1.738 . . . . 0.0 115.541 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.79 136.81 53.34 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.416 -0.803 . . . . 0.0 110.251 168.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.31 117.36 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.268 1.027 . . . . 0.0 110.497 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.31 160.9 43.01 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -71.92 132.26 44.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.414 1.085 . . . . 0.0 110.453 166.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HE3' ' CE1' ' A' ' 121' ' ' PHE . 70.5 mmtt -135.62 150.13 49.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.535 1.534 . . . . 0.0 110.359 170.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -82.39 155.01 24.92 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.9 t -90.21 131.6 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.86 1.264 . . . . 0.0 111.176 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.98 -45.72 10.51 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.942 0.897 . . . . 0.0 112.476 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -148.83 153.45 38.11 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.38 1.872 . . . . 0.0 110.669 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.7 p -120.73 122.59 40.74 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.238 1.415 . . . . 0.0 111.095 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -104.7 148.05 27.0 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.604 1.562 . . . . 0.0 112.421 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.0 t -143.31 132.22 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.552 1.141 . . . . 0.0 111.251 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -134.14 177.67 7.56 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.258 2.223 . . . . 0.0 111.936 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -139.51 138.8 36.66 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.423 1.489 . . . . 0.0 111.511 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.1 t -155.23 154.29 31.96 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.984 0.914 . . . . 0.0 111.907 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.7 p -87.39 -15.48 37.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.781 1.232 . . . . 0.0 113.424 164.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -98.55 108.26 20.91 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.086 -1.009 . . . . 0.0 110.972 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.3 mt -108.86 174.38 5.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.949 0.899 . . . . 0.0 111.935 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.8 tp -147.76 137.97 22.93 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.214 1.406 . . . . 0.0 110.726 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -124.17 112.91 17.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.863 1.265 . . . . 0.0 110.18 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.9 130.54 54.56 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.801 0.84 . . . . 0.0 109.819 176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -105.52 116.51 32.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.845 1.258 . . . . 0.0 108.542 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -127.77 116.06 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.55 1.54 . . . . 0.0 109.472 -171.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.49 30.82 34.91 Favored Glycine 0 CA--C 1.542 1.774 0 O-C-N 121.628 -0.67 . . . . 0.0 113.97 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.93 -1.61 88.23 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.245 1.403 . . . . 0.0 115.73 -177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.28 120.92 38.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.857 1.829 . . . . 0.0 109.52 170.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -88.57 138.05 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.238 0.615 . . . . 0.0 111.824 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.5 mt -133.67 131.91 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.36 1.864 . . . . 0.0 109.139 -176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -114.05 109.73 18.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.73 1.612 . . . . 0.0 110.607 -165.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 t -140.63 -179.38 6.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.164 1.386 . . . . 0.0 112.668 -158.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.1 p -90.29 155.45 18.97 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.302 1.041 . . . . 0.0 112.287 169.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -59.72 -29.9 68.45 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.107 -0.996 . . . . 0.0 113.442 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -94.52 3.44 55.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -64.54 127.89 92.82 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 120.912 -1.118 . . . . 0.0 112.6 -170.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -81.1 113.2 2.68 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 123.695 2.93 . . . . 0.0 114.292 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -103.63 144.05 31.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.952 1.701 . . . . 0.0 111.64 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -84.89 134.35 34.27 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.307 0.958 . . . . 0.0 112.756 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.9 t -118.71 132.87 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.769 2.028 . . . . 0.0 111.867 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 121.92 4.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.325 1.45 . . . . 0.0 111.899 172.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 56.38 30.07 16.26 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.312 1.445 . . . . 0.0 113.977 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -141.65 -42.11 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 125.373 1.469 . . . . 0.0 112.737 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.66 -148.99 18.77 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.965 0.793 . . . . 0.0 112.848 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -88.06 135.83 33.25 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.8 p -136.84 145.08 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.132 1.773 . . . . 0.0 111.455 -176.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -63.58 131.99 49.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.092 1.357 . . . . 0.0 111.016 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.34 67.34 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.152 -0.967 . . . . 0.0 113.44 -175.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.03 -7.28 81.5 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 121.119 -0.988 . . . . 0.0 114.494 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -107.23 -2.47 20.78 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.087 1.755 . . . . 0.0 113.543 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.76 161.7 17.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.992 1.317 . . . . 0.0 112.326 166.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.7 159.32 24.71 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.812 1.245 . . . . 0.0 113.256 160.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.78 130.87 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 159.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.87 -0.89 84.82 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 117.185 -1.897 . . . . 0.0 115.558 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.01 151.42 41.76 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 121.404 2.602 . . . . 0.0 111.509 166.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -102.86 107.87 18.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.028 1.731 . . . . 0.0 112.854 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.9 mt -97.75 167.65 10.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.647 1.179 . . . . 0.0 111.871 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.14 146.8 38.61 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.052 1.341 . . . . 0.0 111.182 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.24 -178.05 3.54 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 172.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.4 p -59.89 -6.6 1.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.77 2.028 . . . . 0.0 116.466 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.51 -17.17 10.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.513 1.925 . . . . 0.0 112.621 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.48 23.88 32.64 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.045 1.783 . . . . 0.0 112.033 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -66.65 148.78 51.44 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.205 0.502 . . . . 0.0 109.768 161.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.3 t -84.16 128.15 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 122.491 0.317 . . . . 0.0 110.381 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.8 mt -108.4 161.07 15.37 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.465 2.706 . . . . 0.0 110.652 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.5 t -134.6 140.4 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.507 1.123 . . . . 0.0 110.605 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.08 129.13 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.361 0.664 . . . . 0.0 109.894 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -96.64 -41.73 8.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.428 2.291 . . . . 0.0 112.011 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -153.53 149.92 28.18 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.807 1.643 . . . . 0.0 110.681 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -132.75 122.73 24.99 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.95 2.1 . . . . 0.0 108.727 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mmtm -134.48 128.71 33.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.492 1.117 . . . . 0.0 112.992 -166.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.1 tp -102.55 134.88 45.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.033 1.733 . . . . 0.0 109.612 173.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -136.09 147.95 48.07 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.361 0.664 . . . . 0.0 111.423 158.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.0 mm -91.7 117.05 34.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 165.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.03 142.19 55.97 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.263 1.025 . . . . 0.0 111.183 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.0 -17.87 62.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.437 0.695 . . . . 0.0 112.738 -176.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -144.38 147.52 37.11 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.373 2.269 . . . . 0.0 110.178 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.11 120.06 7.38 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 124.389 3.393 . . . . 0.0 112.809 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.75 141.7 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.906 1.682 . . . . 0.0 110.441 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -75.14 141.11 43.73 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.494 0.718 . . . . 0.0 111.482 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 m -136.47 144.07 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.938 1.695 . . . . 0.0 110.397 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.47 147.3 49.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.468 1.507 . . . . 0.0 110.644 -166.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -155.38 170.46 21.85 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.721 1.608 . . . . 0.0 111.495 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -154.19 166.1 34.18 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.428 -1.42 . . . . 0.0 113.043 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -120.04 146.13 46.19 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.668 1.187 . . . . 0.0 113.857 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.71 147.09 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.954 1.701 . . . . 0.0 112.44 -162.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.37 -39.56 92.45 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -168.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -133.99 -48.16 0.8 Allowed 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.599 -1.313 . . . . 0.0 113.386 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.414 ' CE1' ' HE3' ' A' ' 39' ' ' LYS . 7.8 m-30 -77.61 168.86 19.29 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 169.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -114.93 17.87 16.7 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.2 1.4 . . . . 0.0 112.669 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 p -141.08 165.16 28.31 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.968 1.707 . . . . 0.0 112.794 -160.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -158.98 178.38 10.13 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.054 1.742 . . . . 0.0 110.662 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -120.41 139.81 52.27 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.038 1.335 . . . . 0.0 112.501 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.0 144.48 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.092 1.357 . . . . 0.0 113.61 -175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.21 173.7 29.73 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.232 1.396 . . . . 0.0 116.034 172.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.13 -27.84 69.65 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.178 -1.189 . . . . 0.0 113.648 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -88.66 -1.34 58.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.346 1.458 . . . . 0.0 113.519 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 59.25 49.8 8.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.182 1.793 . . . . 0.0 113.988 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t -74.91 138.79 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.11 1.364 . . . . 0.0 111.579 -173.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.9 tp -79.78 128.86 33.95 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.575 1.55 . . . . 0.0 113.524 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.5 m -138.06 155.06 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.724 . . . . 0.0 111.356 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -104.23 158.44 16.44 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.47 1.508 . . . . 0.0 110.778 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 C--O 1.254 1.327 0 O-C-N 120.622 -1.299 . . . . 0.0 114.097 172.334 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.679 0.276 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 43.9 ttm -146.81 136.47 23.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 110.752 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -109.24 102.75 11.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.4 1.48 . . . . 0.0 109.366 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -156.32 172.26 18.8 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.514 1.126 . . . . 0.0 112.677 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.87 154.38 41.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.29 1.436 . . . . 0.0 111.985 169.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.07 161.6 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.242 0.617 . . . . 0.0 112.554 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 150.55 7.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.326 1.05 . . . . 0.0 111.358 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.59 -7.03 9.47 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-O 117.795 -1.558 . . . . 0.0 116.486 -172.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.8 m -61.65 119.36 8.52 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 121.552 2.676 . . . . 0.0 109.685 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -74.62 143.29 44.41 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.851 0.861 . . . . 0.0 111.405 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.3 mm -127.51 135.51 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.796 2.038 . . . . 0.0 109.519 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -78.23 126.36 30.69 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.0 p -117.96 176.39 5.23 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.789 1.235 . . . . 0.0 111.82 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.81 -10.8 59.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 171.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 p -119.46 -16.04 8.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.27 1.828 . . . . 0.0 113.934 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.03 -122.8 1.26 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.089 1.328 . . . . 0.0 111.53 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.5 mt -124.28 142.8 50.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.163 1.385 . . . . 0.0 112.258 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.15 143.08 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.12 1.768 . . . . 0.0 108.613 171.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.57 148.03 51.09 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.999 -1.063 . . . . 0.0 111.352 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 tt -61.34 -26.88 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 O-C-N 120.592 -1.317 . . . . 0.0 113.524 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.82 -16.44 64.11 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -112.54 -12.04 13.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.151 1.78 . . . . 0.0 112.665 -174.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.54 141.12 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.04 0.836 . . . . 0.0 109.837 162.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -128.43 159.77 34.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.443 1.897 . . . . 0.0 112.263 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.72 124.8 21.7 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.485 165.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.65 -0.34 84.76 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.497 1.046 . . . . 0.0 115.392 -170.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -76.8 154.15 34.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.424 1.612 . . . . 0.0 110.539 158.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -108.92 142.89 38.89 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.218 1.407 . . . . 0.0 112.217 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -136.5 159.85 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.376 1.87 . . . . 0.0 111.026 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.9 mm -74.59 137.85 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.966 -0.459 . . . . 0.0 111.898 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.49 123.08 19.75 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.167 0.987 . . . . 0.0 108.657 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.4 m -93.33 103.85 16.05 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 170.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -52.97 113.91 5.2 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.818 1.647 . . . . 0.0 113.18 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.58 -11.24 31.46 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.159 2.573 . . . . 0.0 114.413 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -76.43 -38.9 54.83 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.381 1.072 . . . . 0.0 112.638 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 t -133.96 -6.96 2.73 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.282 1.033 . . . . 0.0 112.516 -172.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.267 2.4 t80 61.99 39.34 13.45 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.31 1.844 . . . . 0.0 113.601 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -95.2 135.75 36.39 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.452 1.501 . . . . 0.0 110.522 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.04 136.71 30.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 122.956 0.502 . . . . 0.0 111.653 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.8 167.99 25.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.379 1.472 . . . . 0.0 111.951 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -89.71 126.88 35.82 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.686 0.794 . . . . 0.0 110.196 164.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -130.23 151.75 50.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.496 1.118 . . . . 0.0 112.123 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -87.53 154.5 20.58 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.42 1.088 . . . . 0.0 113.141 -176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.4 t -89.66 132.68 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.661 1.584 . . . . 0.0 110.753 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.38 -43.19 9.9 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.903 0.881 . . . . 0.0 112.785 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -142.85 153.09 42.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.157 1.383 . . . . 0.0 110.297 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 p -122.1 118.42 28.66 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.9 1.68 . . . . 0.0 108.832 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.02 143.71 28.3 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.424 1.49 . . . . 0.0 112.258 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.41 HG22 ' CD2' ' A' ' 114' ' ' TYR . 41.5 t -141.13 126.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.751 1.221 . . . . 0.0 110.889 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -132.8 174.77 9.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.825 2.05 . . . . 0.0 109.62 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -132.33 130.2 40.46 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.871 0.868 . . . . 0.0 111.093 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.7 t -140.18 139.54 35.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.522 1.129 . . . . 0.0 110.87 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.0 p -81.12 -19.88 42.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.854 0.862 . . . . 0.0 111.926 166.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -94.2 111.63 23.37 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.383 1.073 . . . . 0.0 110.668 -173.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.0 mt -127.85 157.2 41.13 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 123.409 1.576 . . . . 0.0 113.908 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.4 tp -121.77 136.15 54.93 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.495 1.918 . . . . 0.0 109.956 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -110.39 124.09 51.07 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.712 1.205 . . . . 0.0 109.2 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.0 mt -121.52 137.91 54.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 167.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.7 m -109.25 120.75 43.48 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 167.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.14 122.87 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.463 1.105 . . . . 0.0 108.269 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.64 18.59 16.94 Favored Glycine 0 CA--C 1.547 2.083 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.58 5.08 67.22 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 119.581 1.691 . . . . 0.0 116.323 -171.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -103.52 122.57 45.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.29 1.545 . . . . 0.0 110.296 164.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -77.18 124.03 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.537 0.735 . . . . 0.0 109.407 164.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mt -119.5 100.69 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.175 1.39 . . . . 0.0 109.122 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.57 119.24 21.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.591 1.556 . . . . 0.0 110.49 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -143.05 -179.06 6.14 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.129 0.972 . . . . 0.0 111.305 -168.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.4 p -88.69 155.65 19.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.955 0.883 . . . . 0.0 111.669 167.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.97 -33.59 69.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.536 1.135 . . . . 0.0 112.146 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -85.92 -7.73 58.49 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.634 1.173 . . . . 0.0 113.315 -170.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -64.57 127.48 92.41 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-O 118.213 -0.899 . . . . 0.0 113.177 -166.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.59 108.19 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.373 2.715 . . . . 0.0 114.313 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.26 141.92 34.31 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.625 1.97 . . . . 0.0 111.865 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -85.91 127.13 34.53 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.67 135.86 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 127.601 2.36 . . . . 0.0 111.257 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -52.67 121.22 6.76 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.13 1.372 . . . . 0.0 112.638 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.29 14.06 4.38 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.064 2.146 . . . . 0.0 115.54 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.8 t -122.77 -54.56 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.537 1.135 . . . . 0.0 110.728 -173.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.44 -161.93 16.42 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.586 0.612 . . . . 0.0 113.436 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -84.63 145.12 28.17 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.577 1.188 . . . . 0.0 114.166 -174.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.48 149.62 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.474 1.91 . . . . 0.0 111.263 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -55.73 131.48 46.76 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.743 1.217 . . . . 0.0 111.861 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.05 -35.81 64.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.635 1.174 . . . . 0.0 113.075 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.67 -5.73 88.3 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.63 -1.095 . . . . 0.0 114.898 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -97.93 -4.64 36.01 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.246 1.418 . . . . 0.0 113.519 171.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.52 160.07 33.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.556 0.693 . . . . 0.0 111.278 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -117.35 167.78 10.94 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.494 1.518 . . . . 0.0 110.535 166.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.88 144.71 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.495 -0.753 . . . . 0.0 109.323 155.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.84 1.43 89.54 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.951 -0.916 . . . . 0.0 114.132 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -82.9 152.14 25.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 119.038 1.419 . . . . 0.0 111.385 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -108.45 112.02 24.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.429 1.092 . . . . 0.0 112.484 -163.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.9 mt -107.27 179.41 4.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.341 1.856 . . . . 0.0 110.588 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.89 156.63 44.72 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.026 0.931 . . . . 0.0 113.467 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -98.15 174.04 6.72 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.578 1.151 . . . . 0.0 113.117 166.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.6 t -55.58 -35.38 65.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.782 1.233 . . . . 0.0 113.787 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -75.24 -29.55 60.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.555 1.542 . . . . 0.0 112.727 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.79 24.67 6.87 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.597 1.57 . . . . 0.0 113.499 173.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -78.43 152.94 31.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.441 1.496 . . . . 0.0 110.193 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.12 125.07 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 122.579 0.352 . . . . 0.0 110.992 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.0 mt -106.34 149.75 26.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.277 1.431 . . . . 0.0 111.863 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.0 t -127.23 137.0 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.457 1.103 . . . . 0.0 111.455 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.16 123.7 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.598 1.159 . . . . 0.0 111.074 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -88.63 -32.87 17.84 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.673 2.389 . . . . 0.0 114.48 175.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -152.82 147.92 26.59 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.954 1.302 . . . . 0.0 111.482 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -133.55 132.85 41.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.034 1.733 . . . . 0.0 110.699 168.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -145.77 157.0 43.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.836 2.054 . . . . 0.0 112.388 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tt -149.2 133.64 17.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.808 1.643 . . . . 0.0 109.639 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -146.62 154.51 41.56 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.588 1.155 . . . . 0.0 112.429 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.0 mm -94.53 107.61 19.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.708 0.803 . . . . 0.0 109.121 168.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.51 147.28 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.907 1.283 . . . . 0.0 111.709 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -76.04 -18.86 59.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.76 0.824 . . . . 0.0 112.709 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -127.97 158.21 71.42 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 126.785 2.034 . . . . 0.0 108.879 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -61.92 122.27 10.71 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.212 1.941 . . . . 0.0 110.437 162.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.6 t -93.17 140.44 16.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.288 1.835 . . . . 0.0 108.952 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -73.9 139.21 44.81 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.685 -0.635 . . . . 0.0 110.645 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 m -141.54 147.21 22.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.695 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' A' ' 46' ' ' VAL . 41.9 m-85 -128.78 151.11 49.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.391 1.477 . . . . 0.0 110.879 -165.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -155.56 167.55 30.03 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.065 1.346 . . . . 0.0 110.343 168.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -150.42 159.86 44.17 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.54 -1.35 . . . . 0.0 112.973 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -113.86 138.83 49.77 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t -98.23 139.74 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.437 1.895 . . . . 0.0 111.127 -168.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -57.08 -63.99 1.03 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.725 1.21 . . . . 0.0 113.441 -173.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -112.0 -39.22 4.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -89.03 173.32 8.52 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.465 0.706 . . . . 0.0 110.52 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -116.7 7.96 13.64 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.39 1.476 . . . . 0.0 113.536 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 p -134.86 162.33 32.7 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.87 1.668 . . . . 0.0 112.593 -167.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -157.27 -176.84 6.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.072 1.749 . . . . 0.0 109.993 170.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -131.25 137.42 48.87 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.447 1.099 . . . . 0.0 112.891 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.0 145.32 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.034 1.333 . . . . 0.0 112.597 -172.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.91 169.54 31.14 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.105 1.336 . . . . 0.0 115.154 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.74 -37.71 19.66 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.002 1.321 . . . . 0.0 112.988 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -94.91 15.0 19.79 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 63.84 35.13 11.27 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 158.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.33 135.85 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.767 1.227 . . . . 0.0 111.525 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 56.1 tp -79.19 122.57 26.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.042 1.337 . . . . 0.0 113.623 -170.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.01 154.83 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.628 1.571 . . . . 0.0 111.627 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -100.38 146.72 26.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.268 1.027 . . . . 0.0 112.628 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.289 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 111.164 0.061 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 8.8 ttt -72.25 120.79 18.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.378 0.671 . . . . 0.0 111.189 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -120.66 108.83 14.49 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.818 1.247 . . . . 0.0 109.836 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -164.97 170.06 15.67 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -123.91 149.31 46.02 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.39 1.876 . . . . 0.0 111.134 171.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -65.66 158.51 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.378 -0.826 . . . . 0.0 112.172 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.83 148.43 7.56 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.883 0.873 . . . . 0.0 112.04 173.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.55 -10.6 43.7 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 116.358 1.303 . . . . 0.0 116.358 -171.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.8 m -62.07 125.86 25.34 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.863 2.332 . . . . 0.0 110.38 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -77.88 148.34 34.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.452 1.101 . . . . 0.0 112.059 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.1 mm -128.09 136.54 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 127.348 2.259 . . . . 0.0 109.662 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.0 tp -81.8 134.66 35.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.356 1.074 . . . . 0.0 113.363 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.5 p -132.28 176.96 7.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.412 1.485 . . . . 0.0 111.534 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.73 -0.33 26.5 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.675 1.59 . . . . 0.0 114.664 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.4 p -124.46 -16.28 6.38 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.75 1.22 . . . . 0.0 113.375 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.52 -129.92 2.73 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 127.468 2.461 . . . . 0.0 110.683 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.8 151.75 24.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.137 1.375 . . . . 0.0 111.869 168.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.09 146.89 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 127.425 2.29 . . . . 0.0 108.532 169.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.17 45.77 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.679 -1.263 . . . . 0.0 112.154 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 tt -62.72 -28.74 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 120.69 -1.256 . . . . 0.0 113.109 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.47 -2.28 31.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.015 1.326 . . . . 0.0 114.495 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -118.23 -13.09 9.89 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.488 1.515 . . . . 0.0 112.821 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.56 134.93 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.119 0.968 . . . . 0.0 109.664 159.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -134.6 164.94 26.37 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.279 1.832 . . . . 0.0 110.96 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.67 134.08 41.71 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.646 -0.659 . . . . 0.0 111.324 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.68 -15.24 59.44 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.587 1.089 . . . . 0.0 115.692 -175.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -66.49 166.88 11.72 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.431 1.615 . . . . 0.0 111.241 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -118.23 148.19 42.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.24 1.416 . . . . 0.0 113.359 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.19 166.6 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 127.095 2.158 . . . . 0.0 111.123 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -79.86 146.67 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.163 0.585 . . . . 0.0 111.22 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.18 132.28 23.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.354 0.662 . . . . 0.0 109.889 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.6 m -86.33 109.19 18.81 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 163.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -53.24 117.08 10.75 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.577 1.151 . . . . 0.0 112.347 174.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -65.7 -14.33 44.19 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.537 2.158 . . . . 0.0 113.906 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -79.29 -36.28 39.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.487 1.515 . . . . 0.0 113.923 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 t -140.89 0.83 1.62 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.264 1.426 . . . . 0.0 112.884 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.255 1.7 t80 63.17 27.41 15.63 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.744 1.617 . . . . 0.0 114.067 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -78.73 134.32 37.08 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.304 1.042 . . . . 0.0 110.519 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.5 t -94.53 136.63 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.264 0.626 . . . . 0.0 110.289 170.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.35 164.6 35.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.352 1.061 . . . . 0.0 112.35 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -87.6 126.85 35.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.327 1.051 . . . . 0.0 110.277 165.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -136.84 150.98 48.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.979 1.311 . . . . 0.0 112.942 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 t -82.27 157.98 23.67 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -91.98 132.61 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.137 2.175 . . . . 0.0 111.417 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 mt -87.68 -50.34 6.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.569 1.148 . . . . 0.0 112.754 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -143.81 157.22 44.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.159 2.183 . . . . 0.0 110.466 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p -119.38 118.55 31.46 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.025 1.73 . . . . 0.0 110.944 173.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -93.29 139.63 30.43 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.588 1.155 . . . . 0.0 113.084 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.469 HG22 ' CD2' ' A' ' 114' ' ' TYR . 18.4 t -137.97 130.8 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.752 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -135.3 175.81 9.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.203 2.201 . . . . 0.0 110.264 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -132.32 142.91 49.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.485 1.514 . . . . 0.0 110.746 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -152.97 155.33 36.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.832 0.853 . . . . 0.0 112.033 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.1 p -88.71 -16.23 32.8 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.733 2.013 . . . . 0.0 113.669 170.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -112.74 110.41 20.52 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.099 0.96 . . . . 0.0 110.339 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.8 mt -110.07 173.36 6.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.475 1.11 . . . . 0.0 112.527 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.1 tp -135.28 132.28 37.58 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.128 1.771 . . . . 0.0 109.141 170.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -111.56 115.32 28.98 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.189 0.996 . . . . 0.0 109.245 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.12 143.51 38.39 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.352 0.661 . . . . 0.0 109.862 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.7 m -118.18 120.86 38.99 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 167.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -125.94 116.59 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.628 1.171 . . . . 0.0 109.44 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.74 21.69 37.31 Favored Glycine 0 CA--C 1.545 1.935 0 O-C-N 121.605 -0.684 . . . . 0.0 114.723 -173.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.3 -16.09 61.41 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.576 2.036 . . . . 0.0 115.603 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -79.2 117.6 20.37 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.722 1.261 . . . . 0.0 109.174 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.1 t -75.57 130.04 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 122.974 0.51 . . . . 0.0 110.203 171.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.9 mt -129.86 102.9 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.768 1.627 . . . . 0.0 108.614 171.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -79.37 123.82 27.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.628 1.171 . . . . 0.0 110.581 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.0 t -141.31 174.76 10.24 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.083 1.353 . . . . 0.0 112.113 -167.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.1 p -81.28 145.97 30.65 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.428 -0.795 . . . . 0.0 111.203 165.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -54.74 -26.97 37.58 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.089 1.356 . . . . 0.0 113.334 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -102.9 2.48 35.29 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -62.57 133.06 94.65 Favored Pre-proline 0 CA--C 1.553 1.061 0 O-C-N 121.12 -0.988 . . . . 0.0 113.398 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.26 112.47 2.25 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.376 3.384 . . . . 0.0 114.844 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -101.18 148.46 25.07 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.679 1.992 . . . . 0.0 111.969 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -92.73 129.87 38.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.387 0.994 . . . . 0.0 113.452 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.4 t -108.25 135.57 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.918 2.487 . . . . 0.0 111.06 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.26 132.95 55.13 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.736 0.814 . . . . 0.0 111.127 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 66.62 3.51 2.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.085 1.754 . . . . 0.0 115.174 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.54 -63.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 120.967 -1.083 . . . . 0.0 110.556 -168.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.24 -150.63 18.13 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.647 0.641 . . . . 0.0 112.741 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -88.09 140.24 29.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.794 1.297 . . . . 0.0 113.968 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -145.32 145.9 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.751 1.621 . . . . 0.0 111.996 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -56.71 131.5 49.32 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.788 1.235 . . . . 0.0 112.405 171.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.92 -34.94 68.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.443 1.497 . . . . 0.0 113.672 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.39 -18.79 79.82 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 119.108 -0.829 . . . . 0.0 113.609 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -89.33 -3.52 58.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.366 1.467 . . . . 0.0 113.336 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.44 162.95 24.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.102 0.961 . . . . 0.0 112.236 166.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.35 159.8 30.9 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.044 1.738 . . . . 0.0 110.933 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.53 138.52 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.208 -0.932 . . . . 0.0 109.05 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.03 10.57 86.03 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.846 -0.974 . . . . 0.0 114.894 -171.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -78.68 155.48 29.44 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.47 1.635 . . . . 0.0 112.162 172.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.88 102.3 12.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.851 1.661 . . . . 0.0 111.163 -168.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.6 mt -97.23 179.55 4.86 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.037 0.935 . . . . 0.0 110.859 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.8 mt -131.55 159.83 37.03 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.164 -0.96 . . . . 0.0 113.49 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.0 p30 -118.59 -178.04 3.44 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -65.86 -0.88 2.48 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -102.35 -35.99 8.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.574 1.55 . . . . 0.0 110.874 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.48 17.35 11.44 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.966 1.745 . . . . 0.0 112.776 -170.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -92.37 148.88 21.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.311 1.055 . . . . 0.0 111.881 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.05 114.2 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 mt -88.05 158.4 18.61 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.0 1.32 . . . . 0.0 112.525 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.03 138.72 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.48 1.112 . . . . 0.0 111.705 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.63 121.86 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.867 0.867 . . . . 0.0 109.871 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -94.17 -29.97 14.85 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.913 2.085 . . . . 0.0 112.26 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -155.18 148.4 24.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.217 1.407 . . . . 0.0 112.2 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.1 tttm -132.85 115.85 15.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.402 1.881 . . . . 0.0 108.986 168.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.09 148.89 51.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.606 1.562 . . . . 0.0 112.169 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.2 tp -121.91 134.44 54.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.951 1.3 . . . . 0.0 110.197 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -139.57 150.78 45.45 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.723 0.809 . . . . 0.0 112.367 171.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.9 mm -108.19 111.61 36.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.754 1.222 . . . . 0.0 108.477 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.64 153.09 42.61 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 122.409 1.099 . . . . 0.0 113.531 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.66 -13.35 60.62 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.741 1.217 . . . . 0.0 113.419 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -155.27 160.13 31.14 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 128.302 2.641 . . . . 0.0 110.006 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.65 125.36 12.63 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.674 2.25 . . . . 0.0 111.433 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.43 139.92 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.983 2.113 . . . . 0.0 110.244 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -75.7 142.33 42.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.752 0.821 . . . . 0.0 112.644 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.28 139.17 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.115 1.366 . . . . 0.0 110.974 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.469 ' CD2' HG22 ' A' ' 46' ' ' VAL . 33.4 m-85 -118.52 153.03 34.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.708 2.003 . . . . 0.0 111.944 -171.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -153.65 171.31 19.01 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.868 2.067 . . . . 0.0 109.231 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -152.04 173.86 14.38 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.202 -1.561 . . . . 0.0 112.389 173.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -127.86 142.86 51.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.856 1.262 . . . . 0.0 113.239 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.2 140.64 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.767 1.627 . . . . 0.0 112.611 -164.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.23 -21.75 66.79 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -165.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.48 -63.63 0.98 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.811 0.732 . . . . 0.0 111.209 169.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -70.56 170.47 12.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.694 0.759 . . . . 0.0 111.854 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -113.55 18.89 17.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.724 1.61 . . . . 0.0 112.381 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.0 p -140.3 167.14 22.85 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.11 1.364 . . . . 0.0 112.252 -164.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -160.7 177.31 10.59 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.797 2.039 . . . . 0.0 109.496 167.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -121.39 132.47 54.77 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.226 1.01 . . . . 0.0 111.846 -173.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.9 m -118.06 146.44 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.481 1.512 . . . . 0.0 113.603 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.07 169.63 20.53 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.987 1.279 . . . . 0.0 115.196 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.02 -23.33 66.38 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.993 1.317 . . . . 0.0 112.885 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -89.77 2.1 55.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 114.232 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 63.85 36.33 10.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.375 1.47 . . . . 0.0 114.915 162.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.43 135.61 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.363 1.465 . . . . 0.0 111.886 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.3 tp -78.54 125.25 29.1 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.215 1.406 . . . . 0.0 113.214 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.92 161.04 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.082 1.753 . . . . 0.0 111.591 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -112.0 149.06 32.53 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.012 1.325 . . . . 0.0 112.924 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.9 m120 . . . . . 0 C--O 1.254 1.332 0 C-N-CA 125.939 1.695 . . . . 0.0 112.208 178.612 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 43.7 ttm -147.13 131.72 17.79 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.925 0.89 . . . . 0.0 112.135 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -106.13 103.01 12.39 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.536 1.534 . . . . 0.0 110.313 170.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -156.05 168.54 26.94 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.424 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.8 m-85 -122.63 153.95 38.65 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.455 1.502 . . . . 0.0 111.068 167.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.16 163.12 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.839 -0.538 . . . . 0.0 111.811 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.74 159.27 0.56 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.543 1.163 . . . . 0.0 113.298 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.07 -13.92 4.16 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 117.9 -1.5 . . . . 0.0 115.901 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.9 m -62.95 118.3 7.61 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.497 2.148 . . . . 0.0 110.955 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -79.22 142.31 36.36 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.208 1.403 . . . . 0.0 112.861 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.1 mm -130.7 137.26 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.082 2.153 . . . . 0.0 109.561 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.1 tp -83.56 137.46 33.83 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.368 1.08 . . . . 0.0 113.506 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -135.79 168.97 18.31 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.2 1.4 . . . . 0.0 111.461 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.58 -18.26 64.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 p -106.7 -28.9 9.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.078 1.351 . . . . 0.0 112.944 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.72 -130.42 2.12 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.041 -1.037 . . . . 0.0 112.904 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.58 148.96 29.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.543 1.137 . . . . 0.0 112.184 170.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.4 t -138.97 148.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.083 2.153 . . . . 0.0 108.362 172.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.38 149.9 38.52 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.983 -1.073 . . . . 0.0 111.514 172.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.5 tt -61.16 -23.81 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 O-C-N 120.826 -1.171 . . . . 0.0 113.479 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -70.46 -11.81 61.16 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.113 1.365 . . . . 0.0 114.329 172.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -122.88 -5.26 8.54 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.929 1.692 . . . . 0.0 113.909 -171.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 mm -67.0 137.17 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.014 -1.054 . . . . 0.0 109.077 161.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -134.77 161.2 35.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.719 1.208 . . . . 0.0 112.301 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.42 127.7 32.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.931 0.892 . . . . 0.0 111.718 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.54 -2.32 80.32 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.708 -1.051 . . . . 0.0 115.407 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.22 172.21 13.23 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.088 1.944 . . . . 0.0 111.168 164.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.62 150.04 40.37 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.049 1.74 . . . . 0.0 112.907 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.73 157.87 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 127.165 2.186 . . . . 0.0 109.843 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.8 mm -74.48 140.54 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 O-C-N 121.836 -0.54 . . . . 0.0 110.929 166.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.88 121.48 18.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.6 m -88.52 109.96 20.49 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -53.7 113.37 4.8 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.472 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.14 -9.7 26.0 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.991 1.794 . . . . 0.0 114.455 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -78.31 -40.07 37.82 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.998 -1.064 . . . . 0.0 112.158 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.9 t -132.7 -2.6 3.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.062 0.945 . . . . 0.0 112.756 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.293 20.6 m-85 56.9 35.6 26.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.167 1.787 . . . . 0.0 113.21 -176.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.83 126.51 31.07 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.053 1.341 . . . . 0.0 109.763 173.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.31 113.04 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.777 0.831 . . . . 0.0 110.589 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.56 163.4 29.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.533 1.133 . . . . 0.0 113.031 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -95.93 119.34 34.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.522 1.529 . . . . 0.0 110.757 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -128.39 149.92 50.33 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.748 1.219 . . . . 0.0 111.664 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.2 t -86.36 154.85 20.9 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.8 t -93.14 130.28 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 126.303 1.841 . . . . 0.0 110.444 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.2 mt -89.39 -37.71 14.64 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.288 1.035 . . . . 0.0 113.317 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -153.73 161.39 42.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.283 2.233 . . . . 0.0 109.883 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.8 p -117.34 137.72 52.26 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.902 1.281 . . . . 0.0 111.07 165.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -105.7 142.3 35.67 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.984 1.314 . . . . 0.0 112.569 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.05 138.31 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.737 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 68.4 mmt-85 -142.24 176.42 8.99 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.719 2.008 . . . . 0.0 110.391 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -127.3 137.87 52.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.688 1.195 . . . . 0.0 110.421 167.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.8 t -146.45 148.03 31.84 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.473 1.109 . . . . 0.0 111.473 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -86.11 -20.15 29.12 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.976 1.31 . . . . 0.0 113.416 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -97.17 105.05 17.12 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.338 -0.851 . . . . 0.0 110.086 -169.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.5 mt -124.09 156.86 35.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 123.622 1.677 . . . . 0.0 113.9 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.9 tp -138.44 126.37 22.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.381 -1.736 . . . . 0.0 111.412 -169.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -113.6 111.12 21.33 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.485 1.514 . . . . 0.0 108.723 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -106.6 125.18 50.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.387 1.075 . . . . 0.0 109.938 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -102.74 120.8 41.22 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.0 mt -133.01 116.41 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.928 1.291 . . . . 0.0 108.984 -171.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.94 24.44 34.44 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 115.191 0.836 . . . . 0.0 115.191 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.26 -6.36 68.6 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.576 1.56 . . . . 0.0 116.646 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -101.87 126.67 48.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.893 1.677 . . . . 0.0 109.238 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 p -97.33 133.02 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.841 0.829 . . . . 0.0 112.977 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.3 mt -126.8 133.79 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.761 2.024 . . . . 0.0 108.719 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -116.71 110.9 19.05 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.219 1.007 . . . . 0.0 110.658 -165.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.8 t -141.46 176.82 8.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.755 1.622 . . . . 0.0 113.272 -157.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.8 p -89.91 158.14 17.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.245 1.418 . . . . 0.0 113.01 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -65.82 -18.9 65.65 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.488 1.115 . . . . 0.0 113.649 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -101.11 -2.98 30.1 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.424 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.1 t60 -65.4 129.05 94.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.366 -1.302 . . . . 0.0 111.923 -172.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.67 120.89 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 122.061 1.772 . . . . 0.0 113.691 -169.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.25 141.08 36.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.381 2.272 . . . . 0.0 112.093 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -84.77 127.31 34.06 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -112.41 134.51 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.671 2.389 . . . . 0.0 111.525 -174.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -56.27 127.23 29.81 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.107 1.363 . . . . 0.0 112.499 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 57.17 22.51 7.61 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.961 2.104 . . . . 0.0 115.03 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.3 t -133.97 -58.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.963 -1.086 . . . . 0.0 111.882 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.79 -152.23 17.16 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.02 0.819 . . . . 0.0 112.916 -173.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -91.14 132.57 35.98 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.804 1.302 . . . . 0.0 114.417 -170.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -137.78 141.53 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.183 1.393 . . . . 0.0 112.669 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.03 132.92 54.35 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.809 1.244 . . . . 0.0 112.901 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.59 66.59 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.81 1.644 . . . . 0.0 113.529 -173.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.36 -12.24 84.75 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 121.504 -0.747 . . . . 0.0 113.797 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -90.71 -20.71 22.14 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.121 0.961 . . . . 0.0 112.76 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.95 154.5 2.85 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.417 1.087 . . . . 0.0 112.856 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -117.48 149.53 40.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.066 1.347 . . . . 0.0 110.969 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.83 126.65 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.394 0.678 . . . . 0.0 110.049 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.91 1.4 58.56 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-O 118.501 -1.166 . . . . 0.0 115.326 -172.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -86.95 159.5 18.99 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.833 1.817 . . . . 0.0 112.25 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -104.03 108.36 19.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.161 1.384 . . . . 0.0 111.203 -157.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.49 169.05 8.9 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.696 1.598 . . . . 0.0 111.791 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.22 142.74 43.03 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.351 1.06 . . . . 0.0 111.409 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.02 176.85 6.26 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.65 0.78 . . . . 0.0 112.995 166.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.1 p -52.17 -24.88 7.8 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -97.72 -31.59 12.18 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.888 1.275 . . . . 0.0 111.764 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.38 22.55 5.12 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.884 2.183 . . . . 0.0 113.435 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -64.21 147.26 52.76 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.319 1.059 . . . . 0.0 110.786 167.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.84 110.24 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.924 0.869 . . . . 0.0 110.741 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.5 mt -94.05 160.68 14.6 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.67 1.988 . . . . 0.0 111.289 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.22 141.84 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.64 1.176 . . . . 0.0 110.632 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.13 115.95 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.574 0.749 . . . . 0.0 109.485 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -90.12 -28.35 19.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.011 2.124 . . . . 0.0 112.732 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -160.71 151.74 18.85 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.42 1.488 . . . . 0.0 111.635 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -131.57 111.34 11.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.522 2.329 . . . . 0.0 109.127 171.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.6 mmtm -117.32 125.92 51.85 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.104 1.761 . . . . 0.0 110.94 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 tp -120.0 133.01 55.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.751 1.62 . . . . 0.0 109.941 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -149.21 161.62 41.64 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.3 mm -110.0 107.02 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.112 1.365 . . . . 0.0 108.521 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.02 150.31 42.77 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.253 1.021 . . . . 0.0 113.604 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.77 -26.81 67.89 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.144 1.778 . . . . 0.0 112.321 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -142.68 151.22 56.47 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.943 2.497 . . . . 0.0 108.287 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.27 121.76 8.08 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.415 2.077 . . . . 0.0 110.288 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.03 143.91 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.127 1.771 . . . . 0.0 110.15 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -74.54 139.4 43.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.283 0.633 . . . . 0.0 110.225 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.02 147.12 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 124.526 1.13 . . . . 0.0 111.268 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -128.46 148.0 50.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.683 1.593 . . . . 0.0 110.846 -164.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -150.48 170.96 17.86 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.507 1.523 . . . . 0.0 109.89 167.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -152.27 158.02 42.2 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.532 -1.355 . . . . 0.0 111.515 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -113.49 135.65 53.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.008 0.923 . . . . 0.0 112.969 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -98.89 147.92 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.3 1.84 . . . . 0.0 111.739 -170.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.94 -39.14 91.08 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.61 -45.33 0.36 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.993 0.917 . . . . 0.0 112.661 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -77.55 172.01 14.02 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.435 0.694 . . . . 0.0 109.207 164.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -134.53 30.72 3.47 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.684 1.193 . . . . 0.0 111.934 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.5 p -141.36 158.06 44.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.672 1.589 . . . . 0.0 112.135 -171.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.91 170.34 22.35 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.058 1.343 . . . . 0.0 111.852 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.76 140.08 29.89 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.439 1.895 . . . . 0.0 110.508 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 m -125.29 136.74 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.5 1.12 . . . . 0.0 112.99 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.3 173.3 35.99 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.029 1.3 . . . . 0.0 115.694 169.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -57.15 -37.86 72.67 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.195 -1.179 . . . . 0.0 112.023 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -85.33 9.47 15.33 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.663 1.585 . . . . 0.0 114.867 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 62.65 36.36 13.59 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 165.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.68 138.04 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 121.591 -0.693 . . . . 0.0 111.091 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.9 tp -87.78 128.54 35.32 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.897 1.279 . . . . 0.0 113.143 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.5 m -135.43 151.27 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.201 1.401 . . . . 0.0 112.213 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -93.75 116.5 28.98 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.97 1.708 . . . . 0.0 110.257 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.631 1.172 . . . . 0.0 113.864 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 3.2 ttt -87.25 121.54 29.83 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.374 -0.829 . . . . 0.0 109.836 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -136.51 62.7 1.6 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.778 1.631 . . . . 0.0 110.363 -164.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -133.34 170.71 15.06 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.053 0.941 . . . . 0.0 113.24 -171.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.83 156.3 33.54 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.285 1.434 . . . . 0.0 110.667 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.3 m -67.7 159.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.715 0.769 . . . . 0.0 111.458 171.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.38 154.63 1.7 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.572 0.749 . . . . 0.0 112.77 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.42 -2.32 22.21 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 117.768 -1.573 . . . . 0.0 116.263 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.3 m -64.58 124.61 22.3 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.305 2.052 . . . . 0.0 110.057 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.5 mmt -83.07 139.48 33.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.974 1.31 . . . . 0.0 111.951 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.6 mm -123.26 134.39 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.387 1.875 . . . . 0.0 110.174 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -75.42 121.51 22.41 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.137 0.975 . . . . 0.0 112.668 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.6 p -112.38 177.33 4.68 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.919 1.288 . . . . 0.0 112.001 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.68 -23.47 65.3 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.207 -0.933 . . . . 0.0 113.276 171.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -106.92 -18.81 13.82 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.958 1.303 . . . . 0.0 114.385 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.26 -114.45 0.61 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.987 1.279 . . . . 0.0 113.008 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -129.0 140.96 51.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.2 1.0 . . . . 0.0 113.294 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.2 t -133.45 143.74 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.333 1.853 . . . . 0.0 108.577 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.43 147.96 47.37 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.324 -0.86 . . . . 0.0 110.881 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 tt -61.72 -27.57 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 120.796 -1.19 . . . . 0.0 112.998 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.19 -13.19 61.48 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -112.17 -11.37 13.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.797 2.039 . . . . 0.0 113.153 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.9 mm -64.25 135.85 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.665 0.786 . . . . 0.0 109.261 162.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -125.05 164.85 19.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.489 1.916 . . . . 0.0 111.193 173.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.35 136.65 58.03 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.731 -0.605 . . . . 0.0 110.614 167.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.36 -9.29 75.96 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.482 1.039 . . . . 0.0 114.537 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.78 174.36 6.13 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.771 1.285 . . . . 0.0 111.288 168.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -131.39 142.35 50.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.713 1.205 . . . . 0.0 113.238 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.49 157.71 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.854 2.061 . . . . 0.0 110.757 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.6 mm -76.92 137.01 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.586 -0.696 . . . . 0.0 111.519 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.64 118.92 17.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.789 1.236 . . . . 0.0 108.157 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -89.91 107.45 19.12 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -55.91 113.99 6.72 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.895 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.56 -5.29 16.36 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.125 1.883 . . . . 0.0 114.109 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.16 -38.52 75.48 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.916 -1.115 . . . . 0.0 112.563 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -144.12 -2.11 0.92 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.949 0.9 . . . . 0.0 112.852 -171.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 55.5 44.83 26.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.62 1.168 . . . . 0.0 112.284 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -90.8 139.53 30.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.768 0.827 . . . . 0.0 109.832 167.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.33 124.26 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.749 0.82 . . . . 0.0 110.319 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.61 153.77 48.66 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.782 0.801 . . . . 0.0 112.538 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.67 115.4 23.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.424 1.49 . . . . 0.0 108.674 169.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -126.53 149.15 49.56 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.893 1.277 . . . . 0.0 110.81 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -90.62 157.84 17.27 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -174.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.3 t -89.25 128.61 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.562 1.545 . . . . 0.0 110.645 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.19 -51.43 7.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.359 0.664 . . . . 0.0 111.804 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -146.18 149.97 34.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.39 1.876 . . . . 0.0 109.462 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.4 p -118.65 126.7 52.52 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.049 1.34 . . . . 0.0 110.177 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -105.9 160.38 15.31 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.155 1.382 . . . . 0.0 113.077 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.1 t -134.36 143.91 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.304 2.242 . . . . 0.0 109.302 171.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -137.19 170.84 15.42 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.916 1.687 . . . . 0.0 109.825 166.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -117.68 143.13 46.47 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.424 1.09 . . . . 0.0 110.522 164.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.3 t -148.11 146.26 28.72 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.74 -0.6 . . . . 0.0 111.264 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.1 p -87.72 -18.13 30.16 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.374 0.67 . . . . 0.0 112.617 162.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HG2' HD12 ' A' ' 106' ' ' ILE . 56.6 mt-10 -93.86 114.19 26.37 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.863 -1.148 . . . . 0.0 111.551 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.1 mt -121.46 171.28 8.9 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.847 1.259 . . . . 0.0 111.63 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.5 tp -145.6 131.18 18.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.518 1.527 . . . . 0.0 110.146 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -106.36 137.46 44.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.274 1.03 . . . . 0.0 109.43 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 mt -129.61 135.13 48.17 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.909 1.284 . . . . 0.0 110.089 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.5 m -104.13 119.97 40.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.91 0.884 . . . . 0.0 109.476 173.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.56 116.29 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.183 1.393 . . . . 0.0 108.781 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.78 35.74 47.75 Favored Glycine 0 CA--C 1.542 1.729 0 O-C-N 121.477 -0.765 . . . . 0.0 114.863 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.38 -14.04 55.9 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.294 1.426 . . . . 0.0 115.507 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -90.91 117.94 29.9 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.805 1.302 . . . . 0.0 109.258 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.46 133.76 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.826 0.85 . . . . 0.0 111.972 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.7 mt -129.01 134.66 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.473 1.909 . . . . 0.0 108.798 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -117.34 112.82 21.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.538 1.535 . . . . 0.0 110.98 -168.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -140.47 178.45 7.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.759 1.224 . . . . 0.0 112.302 -159.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.0 p -84.54 152.4 23.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.175 0.988 . . . . 0.0 111.878 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.98 -20.47 65.31 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.734 1.213 . . . . 0.0 113.41 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -109.61 11.88 24.53 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.407 1.083 . . . . 0.0 113.529 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -67.2 130.3 93.68 Favored Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 120.89 -1.131 . . . . 0.0 112.414 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.84 127.49 5.54 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.515 2.81 . . . . 0.0 114.759 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -118.29 141.48 48.47 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.18 2.192 . . . . 0.0 110.952 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.405 ' CE2' ' HA2' ' A' ' 76' ' ' GLY . 47.9 t80 -93.36 129.93 39.3 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.735 1.152 . . . . 0.0 114.034 -176.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.7 t -109.44 133.53 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.995 2.118 . . . . 0.0 111.739 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -51.08 123.69 9.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.641 1.576 . . . . 0.0 113.917 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 54.37 23.55 4.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.388 1.875 . . . . 0.0 114.34 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.7 t -130.19 -54.91 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.951 1.3 . . . . 0.0 110.928 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 71' ' ' TYR . . . 119.94 -165.82 13.53 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.571 0.605 . . . . 0.0 114.047 -175.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -81.41 140.88 34.42 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.385 1.088 . . . . 0.0 113.864 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.19 147.95 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 127.503 2.321 . . . . 0.0 109.475 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -66.86 144.08 56.48 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.529 -0.732 . . . . 0.0 112.176 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.33 -40.22 64.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.811 1.244 . . . . 0.0 113.39 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.43 -20.46 67.7 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.307 -0.87 . . . . 0.0 114.177 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.85 0.96 30.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.096 2.158 . . . . 0.0 113.254 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.1 mt -72.97 161.84 30.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.198 0.599 . . . . 0.0 111.365 168.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.1 162.62 29.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.888 1.275 . . . . 0.0 111.545 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.61 140.48 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.384 1.073 . . . . 0.0 109.611 170.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.78 4.15 89.35 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.188 -0.784 . . . . 0.0 114.439 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -80.82 152.07 28.41 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.126 1.463 . . . . 0.0 110.824 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.2 108.43 19.81 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.762 1.625 . . . . 0.0 113.483 -165.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.4 mt -103.79 164.12 11.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.162 1.385 . . . . 0.0 112.524 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.75 144.96 34.15 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.637 1.175 . . . . 0.0 111.507 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -102.07 -177.25 3.35 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.063 0.945 . . . . 0.0 113.489 169.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.6 p -54.44 -23.48 16.14 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.793 2.037 . . . . 0.0 115.733 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -104.71 -20.76 13.52 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.588 1.555 . . . . 0.0 113.274 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.29 27.42 10.02 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.336 1.922 . . . . 0.0 112.863 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -66.38 149.54 50.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.608 0.363 . . . . 0.0 110.416 162.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.1 99.26 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.217 1.007 . . . . 0.0 110.303 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -80.31 161.31 25.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.188 2.595 . . . . 0.0 112.238 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.62 139.64 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.358 1.063 . . . . 0.0 111.719 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.18 127.73 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.29 1.036 . . . . 0.0 110.925 170.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -97.85 -32.47 11.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.891 2.076 . . . . 0.0 113.357 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -161.5 150.72 16.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.05 0.94 . . . . 0.0 113.013 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -123.13 128.22 49.77 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.438 1.895 . . . . 0.0 109.526 162.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm -127.29 124.69 39.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.374 1.469 . . . . 0.0 110.777 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 tt -121.35 135.54 55.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.756 1.222 . . . . 0.0 110.33 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -141.71 171.11 14.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.36 1.064 . . . . 0.0 111.403 168.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.428 HD12 ' HG2' ' A' ' 51' ' ' GLU . 15.7 mm -116.97 115.08 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 162.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.66 148.72 19.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.626 1.17 . . . . 0.0 112.197 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -72.62 -24.69 61.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.913 0.885 . . . . 0.0 111.827 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -143.0 152.93 59.78 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.946 2.099 . . . . 0.0 109.517 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.74 123.26 11.7 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.276 2.65 . . . . 0.0 113.188 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.4 t -92.0 143.67 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.459 1.504 . . . . 0.0 110.291 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -76.82 141.87 40.51 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.514 0.673 . . . . 0.0 111.537 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.08 148.44 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.921 1.288 . . . . 0.0 110.368 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -127.74 144.75 51.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.912 1.285 . . . . 0.0 111.856 -169.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -152.18 161.56 42.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.431 1.092 . . . . 0.0 111.252 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -148.02 159.38 43.96 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.797 -1.19 . . . . 0.0 113.508 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -108.89 138.02 45.9 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.73 1.212 . . . . 0.0 113.534 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.49 145.9 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 126.009 1.724 . . . . 0.0 112.474 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.38 -24.18 65.66 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 -167.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -148.6 -49.93 0.16 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.922 1.692 . . . . 0.0 112.067 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -73.07 167.33 21.35 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.63 0.772 . . . . 0.0 110.54 168.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -123.91 24.08 8.42 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.301 1.44 . . . . 0.0 113.937 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 p -135.97 158.07 45.3 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.971 1.708 . . . . 0.0 113.063 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -160.89 -176.01 5.27 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.88 1.672 . . . . 0.0 110.709 171.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -128.59 138.95 52.48 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.361 1.464 . . . . 0.0 113.582 -169.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.32 142.08 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.268 1.427 . . . . 0.0 113.379 -173.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.83 173.22 27.41 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.571 1.558 . . . . 0.0 116.198 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.24 -23.93 67.48 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.736 -1.45 . . . . 0.0 113.917 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -88.99 0.87 56.29 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 58.61 45.75 15.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.17 1.788 . . . . 0.0 114.648 168.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 t -72.43 137.54 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.547 1.539 . . . . 0.0 111.71 -170.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 64.6 tp -79.66 125.26 29.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.681 1.592 . . . . 0.0 113.391 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.52 157.92 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.968 1.707 . . . . 0.0 111.377 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.99 145.5 32.21 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.902 1.281 . . . . 0.0 111.437 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 10.7 ttt -130.32 130.79 44.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.261 1.024 . . . . 0.0 111.585 -169.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -127.3 103.75 7.56 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.777 0.831 . . . . 0.0 112.969 -172.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.1 178.4 8.31 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -124.87 157.36 36.11 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.922 1.689 . . . . 0.0 110.493 166.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.1 m -66.23 156.81 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.332 0.587 . . . . 0.0 112.076 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.29 150.49 1.25 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.165 0.986 . . . . 0.0 111.821 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.52 -3.95 22.74 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.5 m -65.51 125.05 23.95 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 120.976 2.388 . . . . 0.0 109.864 171.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -78.99 143.6 35.56 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.233 1.013 . . . . 0.0 111.954 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.31 135.09 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.411 1.884 . . . . 0.0 109.829 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.26 122.09 22.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.796 0.838 . . . . 0.0 112.12 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.0 p -117.23 171.32 8.03 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.307 1.043 . . . . 0.0 111.736 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.8 -17.55 64.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.817 0.847 . . . . 0.0 113.175 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -105.81 -20.3 13.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.992 2.117 . . . . 0.0 113.827 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.06 -105.57 0.27 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.116 1.341 . . . . 0.0 113.06 174.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.8 mt -132.94 140.76 47.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.779 1.632 . . . . 0.0 111.965 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.1 t -135.05 145.6 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.485 1.914 . . . . 0.0 108.543 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.97 147.43 52.45 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.206 -0.934 . . . . 0.0 111.388 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.1 tt -60.32 -29.91 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 120.712 -1.242 . . . . 0.0 112.827 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.29 -17.97 64.41 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -107.72 -10.38 15.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.694 1.998 . . . . 0.0 112.919 -174.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.7 136.74 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.976 161.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -126.29 162.16 26.12 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.939 2.096 . . . . 0.0 111.301 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.94 130.33 43.01 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.435 0.694 . . . . 0.0 110.432 168.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.36 16.94 65.5 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.833 -0.542 . . . . 0.0 113.902 -170.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -96.43 -179.63 4.7 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.155 0.982 . . . . 0.0 110.603 157.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -128.71 145.83 51.06 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.706 1.603 . . . . 0.0 112.341 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.89 158.67 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.037 1.735 . . . . 0.0 110.526 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -76.44 141.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.65 -0.656 . . . . 0.0 111.547 167.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.62 128.04 24.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.001 0.92 . . . . 0.0 109.163 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.0 m -79.44 112.76 17.01 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 160.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -52.66 114.83 6.2 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.235 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.14 -13.18 36.28 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.982 2.455 . . . . 0.0 113.738 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -84.67 -37.26 21.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -172.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -133.39 -6.1 2.95 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.408 1.483 . . . . 0.0 112.922 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.252 15.2 m-85 66.39 30.53 8.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.33 1.852 . . . . 0.0 115.009 -175.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -79.43 130.8 35.77 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.611 1.165 . . . . 0.0 110.155 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.8 128.65 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.889 0.768 . . . . 0.0 110.815 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.95 167.16 28.44 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.316 1.047 . . . . 0.0 112.811 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -78.87 139.7 38.27 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.515 1.126 . . . . 0.0 110.413 163.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -142.48 154.94 44.97 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.493 1.517 . . . . 0.0 110.61 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.8 t -85.35 156.77 20.75 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.79 123.95 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.453 1.901 . . . . 0.0 110.367 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.91 -44.48 16.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.379 0.672 . . . . 0.0 112.736 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -146.14 154.31 41.66 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.486 1.915 . . . . 0.0 110.572 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.7 p -122.22 128.7 51.47 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.949 1.3 . . . . 0.0 111.274 172.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -108.1 149.01 29.03 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.33 1.852 . . . . 0.0 114.38 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 114' ' ' TYR . 45.1 t -139.8 140.51 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.375 1.07 . . . . 0.0 112.428 177.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -138.52 179.83 6.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.58 2.752 . . . . 0.0 112.209 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -131.61 148.35 52.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.636 1.574 . . . . 0.0 112.431 167.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.6 t -152.74 149.24 28.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.423 1.089 . . . . 0.0 111.557 170.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 p -86.36 -17.16 35.18 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.335 1.054 . . . . 0.0 113.3 164.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HG2' HD12 ' A' ' 106' ' ' ILE . 52.7 mt-10 -105.36 116.17 31.5 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.353 1.061 . . . . 0.0 110.798 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.3 mt -117.8 170.7 8.59 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.651 1.58 . . . . 0.0 112.218 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.7 tp -141.38 134.7 29.57 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.958 1.703 . . . . 0.0 110.062 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -114.75 120.54 40.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.395 1.078 . . . . 0.0 110.067 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.94 130.37 55.45 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.189 -0.945 . . . . 0.0 109.808 173.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.8 m -104.43 118.55 36.89 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.271 1.028 . . . . 0.0 108.582 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -132.02 119.81 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.59 1.556 . . . . 0.0 109.136 -173.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.35 25.11 47.85 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 115.19 0.836 . . . . 0.0 115.19 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.7 -5.39 84.67 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.893 1.711 . . . . 0.0 116.068 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -91.93 132.02 36.81 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.206 1.503 . . . . 0.0 109.483 166.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.82 138.45 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.951 0.9 . . . . 0.0 112.28 163.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.2 mt -132.8 136.12 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 126.126 1.771 . . . . 0.0 109.345 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -117.23 110.39 18.06 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.088 1.355 . . . . 0.0 110.445 -162.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.2 t -138.05 177.13 8.11 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.708 1.203 . . . . 0.0 113.165 -156.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.2 p -86.58 156.5 20.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.74 0.816 . . . . 0.0 111.952 169.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -63.85 -24.69 67.84 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.354 -0.842 . . . . 0.0 113.249 -174.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -99.63 3.63 45.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -60.78 121.3 60.44 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 118.004 -0.998 . . . . 0.0 112.503 -174.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -78.82 115.08 3.52 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.005 1.803 . . . . 0.0 113.056 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.903 1.681 . . . . 0.0 110.797 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -91.37 129.99 37.28 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.5 132.27 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 127.93 2.492 . . . . 0.0 110.731 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -54.49 122.29 10.2 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.261 1.424 . . . . 0.0 111.722 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 t70 53.87 26.7 6.41 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.754 2.422 . . . . 0.0 115.751 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.9 t -129.12 -54.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.939 1.296 . . . . 0.0 110.356 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.02 -155.37 19.77 Favored Glycine 0 N--CA 1.467 0.749 0 CA-C-O 119.499 -0.612 . . . . 0.0 112.027 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -96.57 150.74 20.3 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.053 1.426 . . . . 0.0 114.15 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.78 141.42 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.905 1.682 . . . . 0.0 111.786 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.52 134.91 46.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.61 0.764 . . . . 0.0 112.859 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.05 -37.13 66.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.822 1.249 . . . . 0.0 113.095 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.88 -19.93 72.03 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 121.418 -0.802 . . . . 0.0 113.935 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -97.61 -1.26 44.15 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.836 1.654 . . . . 0.0 114.218 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.26 159.15 29.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.46 0.704 . . . . 0.0 112.377 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -118.97 153.2 35.01 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.556 1.542 . . . . 0.0 110.989 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.4 t -64.86 136.42 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 170.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.75 87.84 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.387 -1.23 . . . . 0.0 115.576 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -84.09 158.2 21.49 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.423 1.612 . . . . 0.0 111.78 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.75 106.79 18.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.557 1.543 . . . . 0.0 112.325 -163.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.5 mt -98.13 -176.79 3.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.683 1.593 . . . . 0.0 111.068 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.6 mt -132.9 154.11 50.72 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.33 177.47 4.85 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 122.886 1.327 . . . . 0.0 114.486 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.6 p -56.79 -6.01 0.29 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.384 2.674 . . . . 0.0 117.318 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -119.17 -18.11 8.76 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.157 1.783 . . . . 0.0 112.221 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.73 18.83 19.48 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.439 1.495 . . . . 0.0 112.885 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -72.65 143.1 48.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.967 0.907 . . . . 0.0 110.457 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.91 114.57 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.195 0.522 . . . . 0.0 110.786 171.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 mt -91.5 157.89 16.78 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.481 1.112 . . . . 0.0 111.188 167.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.0 t -130.98 139.04 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.316 1.046 . . . . 0.0 110.393 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.96 116.38 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 173.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.15 -41.38 28.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.72 1.608 . . . . 0.0 110.84 174.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -159.85 153.58 22.8 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.647 1.179 . . . . 0.0 112.186 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -113.57 134.44 54.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.404 1.482 . . . . 0.0 109.484 159.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -131.45 161.34 32.72 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 128.578 2.751 . . . . 0.0 110.476 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 tt -146.78 139.42 25.08 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.676 1.191 . . . . 0.0 109.927 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -137.51 150.45 47.54 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.043 0.838 . . . . 0.0 112.329 168.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.403 HD12 ' HG2' ' A' ' 51' ' ' GLU . 5.7 mm -103.41 116.23 46.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.48 145.16 51.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.861 1.264 . . . . 0.0 111.551 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -74.96 -20.5 59.65 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.412 -0.805 . . . . 0.0 112.249 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -140.41 155.86 69.82 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.629 1.972 . . . . 0.0 110.977 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.32 124.74 15.79 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.89 2.393 . . . . 0.0 113.079 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 t -93.95 141.62 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.226 1.811 . . . . 0.0 109.628 172.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -76.22 141.95 41.6 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.553 0.692 . . . . 0.0 111.78 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.82 146.61 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.892 1.277 . . . . 0.0 110.829 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.402 ' CD2' HG22 ' A' ' 46' ' ' VAL . 61.2 m-85 -129.05 150.42 50.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.017 1.327 . . . . 0.0 111.331 -166.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -156.81 169.36 24.92 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.08 1.752 . . . . 0.0 109.548 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -156.09 169.59 24.14 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.346 -1.471 . . . . 0.0 111.947 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -123.84 142.34 51.21 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -100.33 151.71 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.018 1.727 . . . . 0.0 112.893 -170.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.4 -27.86 69.59 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -169.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.12 -34.86 0.09 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 120.212 -1.555 . . . . 0.0 113.638 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -77.67 164.65 25.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 164.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -123.34 33.56 5.33 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.458 1.103 . . . . 0.0 111.959 -174.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.6 p -150.14 162.31 40.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.464 1.506 . . . . 0.0 111.775 -164.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -156.81 174.84 14.89 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.494 1.518 . . . . 0.0 110.612 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -118.94 134.96 54.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.624 1.17 . . . . 0.0 112.432 -176.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.71 137.72 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.677 1.591 . . . . 0.0 112.226 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.81 -172.03 45.66 Favored Glycine 0 CA--C 1.544 1.857 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 170.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -84.93 -22.49 29.22 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.719 1.208 . . . . 0.0 112.155 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -84.22 -9.19 58.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.633 1.173 . . . . 0.0 113.382 165.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 60.56 50.74 5.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.529 1.532 . . . . 0.0 113.578 165.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.29 144.66 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.883 1.673 . . . . 0.0 112.078 -173.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.2 tp -84.98 129.46 34.79 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.621 1.568 . . . . 0.0 114.703 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.2 m -138.53 158.19 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 126.403 1.881 . . . . 0.0 112.268 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -117.75 123.3 45.69 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.939 1.295 . . . . 0.0 114.184 -169.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.188 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -174.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.224 0.535 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 9.2 ttt -154.51 114.67 3.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.258 1.823 . . . . 0.0 107.381 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -131.25 77.29 1.77 Allowed 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.292 -0.88 . . . . 0.0 111.073 -162.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -141.29 174.31 10.66 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.733 1.213 . . . . 0.0 113.455 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.449 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 96.7 m-85 -125.42 153.28 43.69 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.437 1.495 . . . . 0.0 111.668 172.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 m -68.36 159.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.358 0.599 . . . . 0.0 111.928 173.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.04 152.17 6.14 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.082 0.953 . . . . 0.0 112.487 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.14 -7.11 24.61 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 117.712 -1.605 . . . . 0.0 116.238 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.1 m -61.82 121.88 14.0 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.379 2.089 . . . . 0.0 110.474 174.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -77.2 142.54 39.55 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.69 1.196 . . . . 0.0 112.329 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -121.8 137.07 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.416 2.286 . . . . 0.0 109.494 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.66 127.13 32.37 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 p -127.15 171.1 11.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.834 1.253 . . . . 0.0 112.039 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.3 65.48 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.3 p -103.26 -24.56 13.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.2 -107.9 0.32 Allowed Glycine 0 CA--C 1.522 0.488 0 O-C-N 121.663 -0.648 . . . . 0.0 112.002 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.58 140.04 45.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.961 1.304 . . . . 0.0 111.535 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.5 t -127.19 141.51 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.205 1.402 . . . . 0.0 109.019 172.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.13 147.67 49.65 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.268 -0.895 . . . . 0.0 110.922 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.6 tt -61.03 -26.57 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.025 -1.047 . . . . 0.0 113.351 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.68 -7.09 52.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.496 1.518 . . . . 0.0 114.341 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -117.39 -12.3 10.46 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.902 1.681 . . . . 0.0 112.652 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.7 mm -65.15 132.73 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 119.147 0.885 . . . . 0.0 110.36 164.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -119.21 161.74 19.86 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.431 1.892 . . . . 0.0 111.679 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.65 138.54 58.06 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.09 -1.006 . . . . 0.0 110.63 167.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.95 4.89 89.69 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 114.536 0.574 . . . . 0.0 114.536 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -86.18 157.07 20.08 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.523 1.161 . . . . 0.0 109.84 162.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -116.8 141.24 48.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.75 1.22 . . . . 0.0 111.319 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.95 159.47 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.934 1.694 . . . . 0.0 111.465 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 mm -71.64 143.86 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 122.797 0.439 . . . . 0.0 111.96 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.28 126.25 18.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.78 1.232 . . . . 0.0 109.251 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.8 m -84.53 111.67 19.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 165.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -56.03 114.64 7.91 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.789 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.18 -8.16 22.85 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.6 2.2 . . . . 0.0 113.94 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -79.49 -39.64 31.63 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.017 -1.052 . . . . 0.0 113.616 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -138.08 -1.29 1.98 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.323 1.049 . . . . 0.0 113.278 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 58.73 40.04 23.61 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.679 1.192 . . . . 0.0 113.407 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.06 138.82 33.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.542 0.737 . . . . 0.0 109.029 165.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -109.11 121.93 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.995 1.318 . . . . 0.0 109.169 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.34 162.79 33.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.456 0.703 . . . . 0.0 112.673 -176.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -93.51 124.66 37.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.797 1.239 . . . . 0.0 109.307 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -132.67 152.67 51.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.416 1.487 . . . . 0.0 111.194 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 t -85.57 152.98 22.73 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.9 t -89.1 130.55 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.98 1.712 . . . . 0.0 110.279 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.6 mt -92.71 -40.76 10.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.811 0.845 . . . . 0.0 112.384 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -143.93 152.52 41.21 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.338 1.455 . . . . 0.0 111.247 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.5 p -124.47 124.66 42.78 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.197 2.199 . . . . 0.0 109.073 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -116.63 159.91 21.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.17 1.788 . . . . 0.0 114.412 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 114' ' ' TYR . 21.8 t -143.63 144.56 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.849 1.66 . . . . 0.0 111.426 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -142.49 178.77 7.37 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.024 2.13 . . . . 0.0 112.053 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -131.47 145.23 51.68 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.081 2.152 . . . . 0.0 112.306 173.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -154.72 152.52 30.0 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.967 0.907 . . . . 0.0 111.148 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 p -86.9 -14.55 41.6 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 163.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -101.54 105.53 16.51 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.073 0.851 . . . . 0.0 110.201 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.5 mt -123.49 162.32 23.1 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.85 1.31 . . . . 0.0 113.67 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.3 tp -126.29 131.21 51.92 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.811 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.98 134.1 45.72 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.244 1.417 . . . . 0.0 109.442 165.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 mt -126.28 126.59 44.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.874 0.869 . . . . 0.0 109.064 163.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.1 m -93.17 120.35 33.36 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 167.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.4 117.09 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.949 1.3 . . . . 0.0 108.92 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 50.54 38.18 34.75 Favored Glycine 0 CA--C 1.544 1.876 0 N-CA-C 115.186 0.835 . . . . 0.0 115.186 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.73 -0.56 89.18 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 121.297 -1.119 . . . . 0.0 115.701 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -109.06 120.97 44.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.326 1.563 . . . . 0.0 110.442 172.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.48 128.36 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.803 0.811 . . . . 0.0 111.555 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.4 mt -118.09 128.3 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.689 1.596 . . . . 0.0 108.375 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -108.03 110.99 22.82 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.507 1.523 . . . . 0.0 110.27 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 t -139.7 176.14 8.98 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.223 1.009 . . . . 0.0 112.473 -161.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.3 p -82.08 152.28 26.65 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.177 0.989 . . . . 0.0 112.349 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -65.96 -19.97 66.04 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.188 -0.945 . . . . 0.0 113.27 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.337 3.5 p-10 -110.6 17.44 20.7 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 175.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.449 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 3.2 t60 -66.11 132.72 94.59 Favored Pre-proline 0 CA--C 1.555 1.155 0 O-C-N 121.071 -1.018 . . . . 0.0 113.665 176.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.11 118.84 3.05 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.279 3.319 . . . . 0.0 115.096 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -116.89 140.51 49.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.872 2.069 . . . . 0.0 112.216 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -84.2 127.46 33.96 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.049 1.295 . . . . 0.0 114.05 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.91 134.82 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 127.989 2.516 . . . . 0.0 111.355 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -52.24 126.92 20.37 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.919 1.688 . . . . 0.0 111.717 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 57.31 19.42 5.02 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.993 1.717 . . . . 0.0 115.488 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.8 t -130.31 -58.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.893 0.877 . . . . 0.0 111.12 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.32 -159.47 15.88 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.643 0.64 . . . . 0.0 113.43 -171.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -81.06 142.49 33.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 p -141.26 152.19 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.622 1.969 . . . . 0.0 110.884 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.73 129.45 39.8 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.947 0.899 . . . . 0.0 111.868 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.63 -36.67 69.73 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.546 1.138 . . . . 0.0 113.343 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.62 -5.08 88.17 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.909 -1.119 . . . . 0.0 114.134 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -101.89 -2.19 30.42 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.871 1.335 . . . . 0.0 113.319 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.55 161.15 31.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.011 1.324 . . . . 0.0 112.631 167.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.44 164.78 18.24 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.04 2.136 . . . . 0.0 111.572 171.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.32 141.93 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.187 -0.945 . . . . 0.0 109.813 167.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.69 7.83 88.15 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.265 -0.742 . . . . 0.0 114.683 -175.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -85.65 152.2 23.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.509 1.155 . . . . 0.0 111.098 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -108.24 109.69 21.12 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.837 1.255 . . . . 0.0 112.323 -163.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.1 mt -106.3 171.38 7.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.927 1.291 . . . . 0.0 111.295 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.7 mt -122.88 159.73 27.58 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -115.63 -174.31 2.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.19 1.796 . . . . 0.0 113.874 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.4 t -58.14 -15.42 9.56 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -97.34 -12.48 22.78 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 119.816 -1.803 . . . . 0.0 113.552 170.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.36 22.1 49.1 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.925 1.25 . . . . 0.0 111.864 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.53 139.65 33.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.878 1.271 . . . . 0.0 112.025 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.92 111.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.092 0.957 . . . . 0.0 112.913 -171.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 63.4 mt -90.35 161.95 15.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.89 2.076 . . . . 0.0 111.374 161.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.72 141.41 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.677 1.191 . . . . 0.0 110.683 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.04 121.6 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.706 0.802 . . . . 0.0 109.459 172.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.27 -36.32 15.66 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.439 1.895 . . . . 0.0 112.142 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -160.49 151.7 19.18 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.648 1.579 . . . . 0.0 111.61 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -129.56 139.48 51.48 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.716 2.006 . . . . 0.0 110.352 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -143.2 139.67 30.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.368 1.467 . . . . 0.0 111.634 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.3 tp -116.87 136.4 52.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.724 2.01 . . . . 0.0 108.636 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -145.65 153.36 40.93 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 171.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.8 mm -91.91 121.41 42.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.037 0.935 . . . . 0.0 109.15 166.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.22 149.79 49.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.001 1.32 . . . . 0.0 113.664 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.65 -30.29 71.26 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.409 1.083 . . . . 0.0 112.851 175.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -148.38 152.62 39.16 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.023 2.529 . . . . 0.0 109.944 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -59.1 120.51 8.42 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.149 3.233 . . . . 0.0 111.985 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.56 137.87 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.107 1.363 . . . . 0.0 109.522 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -74.24 139.2 44.17 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.979 1.312 . . . . 0.0 110.363 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -137.93 143.78 32.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 124.643 1.177 . . . . 0.0 110.611 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.42 ' CD2' HG22 ' A' ' 46' ' ' VAL . 71.5 m-85 -121.82 149.15 43.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.901 1.28 . . . . 0.0 110.9 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -153.22 166.03 33.81 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.806 1.243 . . . . 0.0 111.481 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -150.29 167.39 27.13 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.792 -1.192 . . . . 0.0 112.561 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -116.0 142.83 46.27 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.3 t -99.83 143.52 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.929 2.092 . . . . 0.0 111.195 -173.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -60.02 -76.28 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.216 1.406 . . . . 0.0 113.636 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -118.19 -11.3 10.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -163.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -105.28 170.72 7.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.402 1.481 . . . . 0.0 109.149 163.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -114.67 13.68 17.42 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.832 2.053 . . . . 0.0 113.391 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 p -144.1 162.39 36.38 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.888 -1.133 . . . . 0.0 112.776 -163.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -156.48 172.91 17.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.919 1.688 . . . . 0.0 110.337 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -120.05 136.68 54.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.384 1.074 . . . . 0.0 112.343 -174.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.42 149.0 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.325 1.45 . . . . 0.0 113.71 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.62 175.47 18.88 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.254 1.407 . . . . 0.0 115.044 173.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.7 -28.8 69.67 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -88.63 4.44 47.08 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 60.86 46.54 8.6 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.715 1.206 . . . . 0.0 112.238 166.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -82.33 138.46 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.692 1.997 . . . . 0.0 112.122 -165.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.3 tp -80.49 124.73 29.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.357 1.463 . . . . 0.0 113.983 -173.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.14 159.88 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.969 1.708 . . . . 0.0 111.793 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -99.3 157.53 16.33 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.347 1.059 . . . . 0.0 113.832 -170.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.668 2.387 . . . . 0.0 113.226 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 46.9 ttm -147.49 135.88 21.66 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.117 0.567 . . . . 0.0 112.34 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -115.29 94.73 4.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.22 1.408 . . . . 0.0 110.537 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -157.94 165.56 34.87 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.921 0.888 . . . . 0.0 113.124 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -121.43 153.66 37.57 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.313 1.445 . . . . 0.0 111.657 170.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.3 m -70.7 158.6 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.672 0.749 . . . . 0.0 112.419 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.87 146.76 7.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.215 1.006 . . . . 0.0 112.782 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.38 -8.67 52.52 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 117.332 -1.816 . . . . 0.0 115.929 -172.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.3 m -61.56 118.13 6.65 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.124 2.462 . . . . 0.0 110.113 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 mmt -75.37 141.35 43.31 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.239 1.016 . . . . 0.0 111.972 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.8 mm -124.78 136.12 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.03 2.132 . . . . 0.0 109.754 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.46 124.32 26.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.381 1.072 . . . . 0.0 112.641 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.9 p -127.15 174.07 9.21 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.527 1.131 . . . . 0.0 111.829 -176.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.9 71.28 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.084 -1.01 . . . . 0.0 111.954 167.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.9 p -77.69 -33.69 53.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.255 1.022 . . . . 0.0 111.968 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.37 -90.01 0.12 Allowed Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.486 1.517 . . . . 0.0 111.619 172.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.1 mt -134.16 140.1 46.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.731 1.612 . . . . 0.0 111.196 170.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -134.36 145.85 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.665 1.986 . . . . 0.0 108.974 174.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.78 146.86 51.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.849 -1.157 . . . . 0.0 111.159 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 tt -60.95 -29.59 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 120.973 -1.08 . . . . 0.0 113.121 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.13 -20.03 64.87 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 173.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -101.67 -17.2 16.42 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.075 1.35 . . . . 0.0 113.022 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.06 126.91 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.595 0.758 . . . . 0.0 109.534 165.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -122.2 154.94 36.81 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.7 1.6 . . . . 0.0 111.733 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.09 126.46 26.09 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.604 -0.685 . . . . 0.0 111.541 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.59 -19.74 41.22 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.001 1.286 . . . . 0.0 114.749 -168.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -71.2 177.23 3.94 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.4 1.6 . . . . 0.0 112.981 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -120.16 154.93 34.08 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.586 1.554 . . . . 0.0 113.429 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -143.54 159.29 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.081 2.152 . . . . 0.0 109.851 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -77.09 139.18 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 O-C-N 121.205 -0.934 . . . . 0.0 110.827 166.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.87 129.25 40.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.5 m -93.38 110.39 21.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -52.67 112.36 3.39 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.633 1.573 . . . . 0.0 112.354 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -69.75 -6.69 19.2 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.156 1.904 . . . . 0.0 113.961 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -77.45 -42.65 35.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.711 -1.243 . . . . 0.0 112.737 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.8 t -138.05 2.68 2.36 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.27 1.028 . . . . 0.0 113.163 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.274 68.8 m-85 58.69 32.34 22.07 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.436 1.494 . . . . 0.0 113.944 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.77 139.87 49.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.05 0.94 . . . . 0.0 109.753 167.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.14 109.15 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.719 1.207 . . . . 0.0 109.885 -168.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.75 157.29 44.78 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.44 125.82 29.93 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.035 1.334 . . . . 0.0 110.06 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HE2' ' HB2' ' A' ' 120' ' ' ASP . 29.9 mmmt -129.23 151.21 50.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.999 1.319 . . . . 0.0 110.196 174.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.26 7.0 t -81.63 159.69 23.96 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.189 0.995 . . . . 0.0 113.45 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.1 t -94.54 125.79 47.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 126.584 1.954 . . . . 0.0 109.543 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.7 mt -82.25 -49.09 10.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.602 1.161 . . . . 0.0 111.268 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.59 151.68 39.4 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.684 1.194 . . . . 0.0 111.088 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.0 p -121.68 119.94 33.25 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.112 1.765 . . . . 0.0 110.145 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -108.76 150.44 27.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.124 1.77 . . . . 0.0 113.317 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.74 136.49 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.706 1.602 . . . . 0.0 111.646 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -134.79 175.13 9.84 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.678 1.991 . . . . 0.0 110.475 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -136.65 138.77 41.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.28 1.032 . . . . 0.0 110.411 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.2 t -153.39 147.32 25.42 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.248 -0.907 . . . . 0.0 112.246 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.1 p -86.7 -22.04 26.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.54 1.136 . . . . 0.0 112.855 168.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -100.84 86.0 3.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.134 0.969 . . . . 0.0 110.596 -166.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.23 177.91 5.7 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.756 1.223 . . . . 0.0 112.674 -172.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.1 tp -145.66 143.2 29.68 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.136 1.774 . . . . 0.0 109.649 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -109.37 136.78 48.25 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.024 -1.047 . . . . 0.0 108.43 162.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.2 mt -118.88 144.36 46.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.76 0.824 . . . . 0.0 109.252 161.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.4 m -109.04 123.18 48.74 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.16 120.41 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.378 1.471 . . . . 0.0 108.584 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.49 30.82 42.66 Favored Glycine 0 CA--C 1.543 1.82 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.05 -3.92 82.81 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 118.636 1.218 . . . . 0.0 115.684 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.66 126.88 44.4 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.189 1.395 . . . . 0.0 110.262 171.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.03 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.984 -0.447 . . . . 0.0 110.773 162.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.3 mt -122.23 106.42 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 109.636 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -78.49 117.06 19.33 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.913 2.485 . . . . 0.0 110.812 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 t -145.06 -179.68 6.78 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.552 1.141 . . . . 0.0 113.248 -164.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.2 p -85.62 155.64 21.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.501 1.12 . . . . 0.0 112.159 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -64.32 -28.14 69.5 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.927 -1.108 . . . . 0.0 112.552 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.91 5.26 52.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.06 0.944 . . . . 0.0 113.17 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -68.19 125.82 91.97 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.476 -1.39 . . . . 0.0 112.767 -169.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.22 114.24 3.3 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.501 2.8 . . . . 0.0 114.073 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -102.95 148.85 25.16 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.818 1.647 . . . . 0.0 110.997 170.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -93.83 130.89 39.69 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.196 0.907 . . . . 0.0 112.704 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.4 133.4 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.08 1.752 . . . . 0.0 111.071 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -52.81 126.98 21.86 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.528 1.531 . . . . 0.0 111.032 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.15 16.83 5.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.065 1.746 . . . . 0.0 115.266 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.28 -51.61 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.417 1.487 . . . . 0.0 111.59 -172.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.5 -160.8 13.02 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.027 0.822 . . . . 0.0 113.547 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.251 15.1 p90 -79.46 149.89 31.42 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -171.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 p -150.43 145.53 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.982 2.113 . . . . 0.0 110.999 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -70.19 138.23 51.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.667 1.587 . . . . 0.0 112.129 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.95 -39.92 66.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.812 1.245 . . . . 0.0 113.834 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.27 -10.75 79.05 Favored Glycine 0 CA--C 1.539 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 114.262 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -109.69 -0.49 18.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.456 1.903 . . . . 0.0 113.172 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 mt -67.57 160.1 28.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.507 0.723 . . . . 0.0 111.593 167.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -127.47 155.15 44.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.156 1.382 . . . . 0.0 111.711 172.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.25 137.94 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.801 0.84 . . . . 0.0 110.288 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.33 1.49 81.26 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.413 -1.215 . . . . 0.0 115.472 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -83.92 157.85 21.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.763 1.781 . . . . 0.0 112.089 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.45 98.02 8.41 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.096 1.358 . . . . 0.0 112.031 -166.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.01 179.21 6.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.037 1.335 . . . . 0.0 110.796 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 71.4 mt -131.56 155.75 46.93 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.297 1.039 . . . . 0.0 113.249 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.46 173.31 6.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.025 0.93 . . . . 0.0 112.671 168.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.2 t -51.4 -36.75 45.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -85.83 -11.7 52.7 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.777 1.231 . . . . 0.0 112.848 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.91 16.08 31.8 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 126.077 1.798 . . . . 0.0 112.633 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -72.57 143.43 48.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.636 0.774 . . . . 0.0 110.73 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.52 130.17 36.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 122.616 1.198 . . . . 0.0 111.128 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.7 mt -111.57 151.5 28.64 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.796 1.638 . . . . 0.0 111.33 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -118.89 137.03 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.549 0.74 . . . . 0.0 111.216 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.2 t -71.62 128.76 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.731 0.813 . . . . 0.0 109.593 170.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.59 -29.27 9.26 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.339 1.856 . . . . 0.0 112.485 -176.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -162.21 153.05 17.52 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.032 1.333 . . . . 0.0 112.243 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -120.55 132.41 55.15 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.329 1.852 . . . . 0.0 109.312 157.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -130.43 142.42 50.5 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.827 1.651 . . . . 0.0 110.127 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.7 tp -129.1 133.13 47.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.209 1.404 . . . . 0.0 111.162 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.37 156.31 48.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.295 1.038 . . . . 0.0 112.174 166.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.1 mm -108.79 107.85 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.227 1.411 . . . . 0.0 107.334 168.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.74 143.57 55.83 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.863 0.84 . . . . 0.0 112.804 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.65 -24.0 67.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -140.53 153.71 68.57 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.502 1.921 . . . . 0.0 111.435 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.39 120.09 7.4 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.393 2.729 . . . . 0.0 111.522 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.49 142.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.23 1.412 . . . . 0.0 109.593 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -78.51 140.94 38.52 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.564 0.697 . . . . 0.0 111.519 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.0 m -139.42 145.65 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 124.57 1.148 . . . . 0.0 111.727 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -125.2 148.14 48.76 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.343 1.457 . . . . 0.0 110.723 -166.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -151.7 168.71 24.17 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.38 1.472 . . . . 0.0 110.114 168.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -149.19 173.84 13.01 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.753 -1.217 . . . . 0.0 112.384 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -130.37 146.28 51.92 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.36 144.84 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.679 1.992 . . . . 0.0 113.004 -162.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.74 -18.24 62.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.521 2.729 . . . . 0.0 117.115 -168.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 4.5 m-20 -148.61 -63.86 0.24 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.915 1.234 . . . . 0.0 110.965 164.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -69.94 108.58 4.08 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.414 1.085 . . . . 0.0 110.74 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -70.02 36.11 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.292 1.837 . . . . 0.0 115.765 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.8 p -131.9 164.05 26.96 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.776 2.03 . . . . 0.0 111.935 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -157.94 -176.06 5.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.545 1.538 . . . . 0.0 110.037 166.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -127.66 141.4 51.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.366 1.066 . . . . 0.0 113.039 -172.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.32 138.24 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.495 1.118 . . . . 0.0 112.373 -175.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.02 179.46 53.08 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -73.7 -23.99 59.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.477 1.111 . . . . 0.0 112.148 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -80.25 1.68 27.53 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 166.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 54.87 39.3 31.43 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.268 1.427 . . . . 0.0 114.352 166.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.63 138.37 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.21 1.804 . . . . 0.0 112.02 -166.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.1 tp -81.65 126.75 32.14 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.408 1.483 . . . . 0.0 114.023 -173.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.29 157.96 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.673 1.589 . . . . 0.0 112.105 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -102.34 143.37 32.18 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.5 1.52 . . . . 0.0 112.02 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 C--O 1.252 1.21 0 C-N-CA 124.15 0.98 . . . . 0.0 112.509 176.688 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 117.382 -1.294 . . . . 0.0 113.796 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 44.1 ttm -145.94 137.03 24.64 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.84 2.109 . . . . 0.0 114.288 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -120.4 99.13 6.39 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.747 1.619 . . . . 0.0 110.469 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -155.52 172.24 18.59 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.846 0.858 . . . . 0.0 113.16 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.77 154.85 40.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.542 1.537 . . . . 0.0 111.411 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.0 m -71.66 158.62 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.336 0.654 . . . . 0.0 112.431 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.52 147.56 10.77 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.332 1.053 . . . . 0.0 111.191 172.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.37 6.61 62.07 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-O 117.949 -1.473 . . . . 0.0 115.756 -171.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.4 m -70.75 121.73 18.53 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.962 2.381 . . . . 0.0 109.639 164.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -80.08 140.14 36.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.67 1.188 . . . . 0.0 111.505 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.0 mm -125.25 136.29 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.301 2.24 . . . . 0.0 109.946 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.4 tp -78.61 123.65 27.33 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.161 0.984 . . . . 0.0 113.398 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 p -117.83 177.05 4.91 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.24 1.416 . . . . 0.0 111.334 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.09 -21.46 64.96 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.117 -0.989 . . . . 0.0 113.262 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -96.62 -14.33 22.23 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.201 1.8 . . . . 0.0 113.108 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.26 -108.29 0.61 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.789 1.662 . . . . 0.0 111.462 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.2 mt -127.95 142.07 51.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.293 1.037 . . . . 0.0 113.548 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.7 t -130.16 144.41 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.949 2.1 . . . . 0.0 108.887 174.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.93 147.52 48.65 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.114 -0.991 . . . . 0.0 110.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -61.87 -27.75 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 120.457 -1.402 . . . . 0.0 113.124 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.83 -7.15 43.29 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.891 1.276 . . . . 0.0 114.18 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -115.87 -12.14 11.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.185 1.794 . . . . 0.0 113.976 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -63.22 140.26 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 165.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -125.75 159.03 33.39 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.18 1.792 . . . . 0.0 112.401 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.38 123.98 19.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 122.897 0.479 . . . . 0.0 110.317 164.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.73 -6.69 70.44 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.955 1.265 . . . . 0.0 114.646 -172.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -75.03 177.87 6.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.65 1.225 . . . . 0.0 111.24 166.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -134.8 140.78 46.14 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.905 1.282 . . . . 0.0 113.046 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -135.14 159.26 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.124 1.769 . . . . 0.0 111.099 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.6 mm -77.98 136.91 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.972 -0.455 . . . . 0.0 111.803 171.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.6 117.89 20.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.139 1.376 . . . . 0.0 108.596 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.5 m -90.85 104.59 17.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -49.2 113.58 3.25 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.013 0.925 . . . . 0.0 112.008 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.99 -3.66 13.65 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.41 2.74 . . . . 0.0 113.871 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.07 -38.08 25.43 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.841 -1.162 . . . . 0.0 112.841 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -141.83 -2.18 1.2 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -166.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 55.19 37.28 28.65 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.919 1.688 . . . . 0.0 113.747 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.5 131.72 35.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.279 1.432 . . . . 0.0 108.896 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -106.23 125.17 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.441 1.097 . . . . 0.0 109.309 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.72 161.73 37.09 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -78.08 134.79 37.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.512 0.725 . . . . 0.0 109.298 161.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -139.75 150.95 45.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.478 1.111 . . . . 0.0 111.618 170.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 t -85.39 159.74 19.92 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -92.1 129.69 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.997 1.719 . . . . 0.0 110.868 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.5 mt -84.23 -50.01 8.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.38 0.672 . . . . 0.0 112.142 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -145.12 151.84 39.11 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.937 1.695 . . . . 0.0 111.02 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 p -125.81 109.23 12.3 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.425 1.89 . . . . 0.0 110.543 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -98.92 146.8 25.62 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.404 1.082 . . . . 0.0 113.321 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 114' ' ' TYR . 39.4 t -139.12 134.51 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.866 1.266 . . . . 0.0 111.751 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -132.03 174.28 10.35 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.222 1.809 . . . . 0.0 111.342 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.89 135.52 49.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.484 1.514 . . . . 0.0 110.151 170.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -146.03 143.06 29.19 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.897 1.279 . . . . 0.0 111.419 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -86.04 -16.0 39.55 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.214 1.006 . . . . 0.0 112.417 164.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -102.45 110.07 21.9 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 120.838 -1.163 . . . . 0.0 109.75 -173.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.6 mt -120.47 172.5 7.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.84 1.256 . . . . 0.0 112.257 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -142.12 140.16 32.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.071 1.748 . . . . 0.0 110.065 175.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -107.53 137.86 44.8 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.188 -0.945 . . . . 0.0 108.84 163.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.8 mt -121.32 142.65 49.76 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.009 0.924 . . . . 0.0 109.266 160.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -110.06 122.29 47.25 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.156 0.982 . . . . 0.0 108.981 172.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.17 121.67 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.978 1.711 . . . . 0.0 108.616 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.02 31.29 58.59 Favored Glycine 0 CA--C 1.543 1.84 0 O-C-N 121.401 -0.812 . . . . 0.0 114.866 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.09 -1.06 88.98 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.252 1.405 . . . . 0.0 115.465 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -106.35 124.13 49.12 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.983 1.713 . . . . 0.0 110.828 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.8 130.52 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.2 1.0 . . . . 0.0 111.196 172.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.0 mt -120.8 102.26 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.417 1.487 . . . . 0.0 108.709 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -79.76 116.46 19.95 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.175 1.79 . . . . 0.0 111.428 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 t -142.18 -176.13 4.7 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.305 1.442 . . . . 0.0 112.015 -163.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 67.3 p -95.04 158.72 15.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.52 1.128 . . . . 0.0 111.768 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -63.94 -26.1 68.44 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.369 -0.832 . . . . 0.0 112.751 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -97.83 4.47 49.72 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -66.58 126.66 92.59 Favored Pre-proline 0 CA--C 1.55 0.97 0 O-C-N 120.511 -1.368 . . . . 0.0 112.98 -173.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.49 116.82 2.99 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.814 2.343 . . . . 0.0 114.266 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -102.01 153.24 20.07 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.187 2.195 . . . . 0.0 111.11 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.59 133.89 42.3 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.491 1.041 . . . . 0.0 113.754 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.7 t -111.24 131.87 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 127.084 2.154 . . . . 0.0 111.528 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -51.9 129.2 26.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.846 1.658 . . . . 0.0 113.027 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 56.27 12.06 0.92 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 127.988 2.515 . . . . 0.0 115.547 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.74 -56.49 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.747 1.219 . . . . 0.0 111.774 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 124.78 -159.98 19.4 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.635 0.636 . . . . 0.0 113.25 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.252 10.6 p90 -81.68 153.88 26.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.87 143.71 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.93 2.092 . . . . 0.0 111.329 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.37 136.01 57.33 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.301 1.041 . . . . 0.0 113.357 170.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.25 -39.65 70.02 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.553 1.541 . . . . 0.0 113.16 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.1 -22.19 70.49 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.739 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.38 -10.64 45.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.9 mt -67.71 154.41 41.57 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.277 0.944 . . . . 0.0 111.576 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -123.08 152.74 40.76 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.193 0.997 . . . . 0.0 110.768 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.5 t -65.5 138.03 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.693 0.797 . . . . 0.0 110.361 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.51 -3.78 85.19 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 115.254 0.862 . . . . 0.0 115.254 -175.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.22 153.48 27.15 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.085 1.442 . . . . 0.0 111.799 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -100.39 107.96 19.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.852 1.261 . . . . 0.0 112.587 -163.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.5 mt -100.91 177.26 5.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.724 1.61 . . . . 0.0 110.343 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.88 157.57 41.18 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.4 -174.32 2.47 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.43 1.492 . . . . 0.0 114.511 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.4 p -56.0 -7.25 0.31 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -119.65 -26.55 5.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.187 1.395 . . . . 0.0 114.55 165.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.16 23.39 4.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.147 1.356 . . . . 0.0 113.404 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -77.0 146.75 37.23 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.324 1.062 . . . . 0.0 111.82 171.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.54 109.43 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.239 0.616 . . . . 0.0 112.225 -173.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.8 mt -93.44 159.31 15.3 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.858 1.663 . . . . 0.0 112.312 173.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.2 t -124.55 139.11 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.111 0.964 . . . . 0.0 111.098 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.2 t -69.2 130.82 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.403 0.681 . . . . 0.0 110.081 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -98.28 -43.33 7.01 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.534 1.933 . . . . 0.0 112.796 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -159.81 154.08 23.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.27 1.028 . . . . 0.0 111.843 -172.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -118.87 135.62 54.46 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.553 1.941 . . . . 0.0 108.865 165.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -130.57 130.09 43.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.817 1.647 . . . . 0.0 109.678 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -129.16 129.75 45.51 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.665 1.186 . . . . 0.0 111.985 -169.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -147.03 163.49 36.09 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.488 1.115 . . . . 0.0 112.879 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 mm -104.63 116.7 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 159.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.21 145.57 50.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.249 1.019 . . . . 0.0 111.672 173.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -75.09 -11.82 60.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.991 1.316 . . . . 0.0 112.464 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -139.84 152.05 67.13 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 127.204 2.202 . . . . 0.0 111.57 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.59 117.69 5.04 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.078 2.519 . . . . 0.0 110.753 172.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.31 139.43 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.033 1.733 . . . . 0.0 110.353 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -76.27 139.31 41.05 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.888 0.875 . . . . 0.0 110.297 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.47 140.8 28.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 124.007 0.923 . . . . 0.0 111.657 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.438 ' CD2' HG22 ' A' ' 46' ' ' VAL . 76.3 m-85 -119.64 153.87 34.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.812 1.645 . . . . 0.0 112.049 -169.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -157.18 170.2 23.04 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.947 1.699 . . . . 0.0 110.816 170.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -152.64 167.56 28.5 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.354 -1.466 . . . . 0.0 113.249 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -117.37 144.84 44.52 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.745 1.218 . . . . 0.0 112.954 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.17 139.54 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.562 1.545 . . . . 0.0 111.48 -168.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -60.22 -34.66 73.96 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -163.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -145.87 -47.27 0.21 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.007 -1.058 . . . . 0.0 112.671 -172.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -76.39 165.99 24.05 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.198 1.399 . . . . 0.0 109.169 163.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -116.88 1.42 12.67 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -168.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.3 p -126.28 163.94 22.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.534 1.534 . . . . 0.0 113.258 -167.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -153.39 -177.08 6.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.749 1.619 . . . . 0.0 110.631 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -130.16 141.85 50.63 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.79 1.236 . . . . 0.0 113.31 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.26 140.23 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.499 1.119 . . . . 0.0 113.688 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.23 176.95 42.45 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.784 1.659 . . . . 0.0 116.496 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -57.21 -36.95 71.5 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.076 1.351 . . . . 0.0 112.775 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -82.95 -1.04 51.32 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 175.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 56.96 51.09 11.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.843 1.657 . . . . 0.0 113.486 168.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.9 t -80.32 141.98 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.215 1.806 . . . . 0.0 112.055 -167.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 48.9 tp -78.58 125.88 29.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.98 1.712 . . . . 0.0 114.216 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.09 158.9 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.257 1.823 . . . . 0.0 111.648 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -111.58 151.97 28.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.708 1.203 . . . . 0.0 112.934 -171.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.755 -1.593 . . . . 0.0 113.926 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 9.9 ttt -154.54 121.97 5.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.239 1.381 . . . . 0.0 111.056 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -139.79 98.0 3.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.462 1.105 . . . . 0.0 109.601 -164.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -164.17 173.57 12.25 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -124.37 154.81 39.8 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.289 1.436 . . . . 0.0 111.833 173.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.97 157.8 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.452 0.644 . . . . 0.0 112.356 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.3 144.31 20.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.539 0.735 . . . . 0.0 111.898 172.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.42 -8.1 69.65 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 116.489 1.355 . . . . 0.0 116.489 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.9 m -64.12 121.27 13.8 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 120.62 2.21 . . . . 0.0 110.6 174.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mmt -78.23 142.93 37.54 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.22 1.408 . . . . 0.0 112.089 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.5 mm -127.79 134.34 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.726 2.011 . . . . 0.0 109.708 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -76.38 128.95 35.85 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 p -123.64 169.67 11.24 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.991 1.316 . . . . 0.0 111.241 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.31 -19.09 65.8 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.777 -1.202 . . . . 0.0 113.294 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 p -119.56 2.66 11.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.861 2.064 . . . . 0.0 113.792 -173.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.16 -116.36 0.81 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.221 1.391 . . . . 0.0 113.982 166.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.98 154.47 45.55 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.771 1.628 . . . . 0.0 110.5 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -143.16 148.19 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 126.439 1.896 . . . . 0.0 108.585 170.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.35 147.02 46.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.017 -1.052 . . . . 0.0 111.306 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 tt -62.11 -27.06 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 120.437 -1.414 . . . . 0.0 113.498 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.58 -14.7 62.6 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 172.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -108.5 -15.06 14.53 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.232 1.813 . . . . 0.0 113.898 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.8 mm -63.04 132.25 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 163.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -133.26 170.76 14.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.523 1.929 . . . . 0.0 109.606 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.12 130.47 15.75 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.189 0.518 . . . . 0.0 111.005 166.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.24 -1.2 88.73 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 116.105 1.202 . . . . 0.0 116.105 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -76.58 155.38 33.64 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.779 1.789 . . . . 0.0 110.666 160.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -111.5 140.36 46.17 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.958 1.303 . . . . 0.0 112.509 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.11 162.16 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.542 1.937 . . . . 0.0 110.292 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.2 mm -78.63 141.73 15.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 121.819 -0.55 . . . . 0.0 110.472 162.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.95 129.3 29.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.7 m -91.53 108.37 19.85 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 165.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -52.43 117.21 10.06 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.223 1.009 . . . . 0.0 112.583 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.43 -12.98 37.7 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.097 2.532 . . . . 0.0 113.907 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -76.4 -40.62 50.37 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.225 1.01 . . . . 0.0 112.523 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.8 t -135.08 -5.26 2.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.339 1.456 . . . . 0.0 113.685 -171.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.3 t80 56.65 43.08 26.08 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.329 1.452 . . . . 0.0 114.034 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -95.71 135.16 37.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.236 1.014 . . . . 0.0 110.151 170.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -105.95 122.54 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.98 0.912 . . . . 0.0 112.339 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.22 160.51 39.26 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.324 1.049 . . . . 0.0 113.077 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -91.12 121.12 32.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.148 1.379 . . . . 0.0 109.466 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -139.05 149.09 44.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.465 1.106 . . . . 0.0 112.931 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.7 t -80.75 161.5 24.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.875 1.27 . . . . 0.0 113.435 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.9 t -98.19 133.62 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 126.236 1.814 . . . . 0.0 111.716 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.02 -45.19 10.4 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.962 1.305 . . . . 0.0 113.298 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -146.88 156.64 43.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.276 1.83 . . . . 0.0 110.614 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.1 p -116.43 135.24 54.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.221 164.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -105.7 147.92 28.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.688 1.595 . . . . 0.0 112.056 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -143.65 128.93 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.501 1.12 . . . . 0.0 111.319 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -126.28 176.05 7.38 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.04 1.736 . . . . 0.0 111.198 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -133.34 133.73 42.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.781 1.233 . . . . 0.0 111.945 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 t -148.16 143.99 27.45 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.957 1.303 . . . . 0.0 111.63 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.7 p -84.35 -21.27 30.96 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.635 0.774 . . . . 0.0 112.689 164.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -96.39 115.81 28.04 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.008 0.923 . . . . 0.0 110.203 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.4 mt -121.05 167.79 12.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.796 1.239 . . . . 0.0 112.276 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.89 134.85 46.16 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.693 1.997 . . . . 0.0 109.689 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -113.88 128.38 56.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.617 1.167 . . . . 0.0 108.866 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.2 mt -124.08 128.77 49.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.518 1.127 . . . . 0.0 110.339 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.8 m -99.04 122.9 42.9 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 169.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.74 119.67 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.895 1.278 . . . . 0.0 109.968 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.86 21.74 17.12 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 115.926 1.131 . . . . 0.0 115.926 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.35 7.64 55.74 Favored Glycine 0 CA--C 1.542 1.768 0 N-CA-C 116.914 1.526 . . . . 0.0 116.914 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -121.76 131.02 53.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.185 1.492 . . . . 0.0 109.869 172.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -97.35 134.69 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.989 0.899 . . . . 0.0 112.983 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.8 mt -130.42 133.81 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.812 2.045 . . . . 0.0 108.794 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -119.08 112.13 19.15 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.245 1.418 . . . . 0.0 110.792 -165.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -141.2 -177.63 5.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.611 1.164 . . . . 0.0 112.426 -161.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.9 p -89.66 153.54 20.65 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.198 0.999 . . . . 0.0 111.923 169.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -58.26 -27.88 64.4 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.925 1.29 . . . . 0.0 113.272 -175.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -107.52 7.44 28.8 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.723 1.209 . . . . 0.0 112.225 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -69.69 128.86 91.77 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.99 112.86 2.37 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 124.683 3.589 . . . . 0.0 115.216 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -94.7 152.99 18.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.369 2.268 . . . . 0.0 111.507 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -97.99 132.02 43.91 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -111.59 138.51 39.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 127.28 2.232 . . . . 0.0 110.226 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.54 127.4 31.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.732 1.213 . . . . 0.0 110.441 175.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t0 56.3 31.52 18.72 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.383 1.873 . . . . 0.0 115.595 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.0 t -144.12 -50.63 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.853 1.261 . . . . 0.0 112.417 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.45 -153.21 16.74 Favored Glycine 0 N--CA 1.468 0.811 0 CA-C-N 119.392 0.997 . . . . 0.0 111.512 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -92.04 147.65 22.79 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -149.14 143.49 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.596 1.958 . . . . 0.0 112.053 -175.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.81 132.33 52.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.872 1.269 . . . . 0.0 112.68 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.84 -36.96 68.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.301 1.44 . . . . 0.0 113.645 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.99 -12.67 83.2 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.561 1.077 . . . . 0.0 114.168 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -102.2 -7.88 21.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.278 1.831 . . . . 0.0 113.544 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 mt -58.49 158.69 7.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.679 0.792 . . . . 0.0 112.405 166.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -114.51 152.82 31.09 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.388 1.475 . . . . 0.0 110.395 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 50.3 t -67.59 132.63 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.351 0.596 . . . . 0.0 109.521 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.1 0.14 68.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.677 1.132 . . . . 0.0 115.201 -171.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -84.22 156.4 22.04 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.127 1.464 . . . . 0.0 111.96 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -106.73 102.41 11.79 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.118 1.367 . . . . 0.0 111.965 -156.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.7 mt -96.3 -175.36 3.33 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.486 1.514 . . . . 0.0 111.041 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.67 149.03 52.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.084 0.954 . . . . 0.0 112.51 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.02 172.46 6.91 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.218 1.007 . . . . 0.0 113.278 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.9 p -56.67 -11.34 1.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -107.37 -30.5 8.65 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.19 1.796 . . . . 0.0 112.344 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.74 19.89 5.92 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.956 1.741 . . . . 0.0 113.79 -177.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -70.59 140.26 51.64 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.658 0.729 . . . . 0.0 110.553 167.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.4 t -77.57 107.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.906 0.883 . . . . 0.0 109.832 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.3 mt -85.96 160.53 19.34 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.274 1.43 . . . . 0.0 111.816 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.89 137.71 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.334 1.053 . . . . 0.0 110.798 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.0 119.66 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.602 0.761 . . . . 0.0 109.05 170.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -96.52 -31.64 12.68 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.392 1.477 . . . . 0.0 112.213 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.93 148.12 20.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.575 1.55 . . . . 0.0 111.324 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -125.66 127.36 46.16 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.441 2.296 . . . . 0.0 109.773 168.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -125.31 156.56 38.45 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.482 2.313 . . . . 0.0 110.748 169.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.15 135.08 26.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.841 1.656 . . . . 0.0 108.266 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -142.75 158.46 43.61 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.9 mm -110.7 101.02 11.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 125.21 1.404 . . . . 0.0 109.903 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.78 146.74 35.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.403 1.481 . . . . 0.0 113.535 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.59 -14.79 61.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.848 1.259 . . . . 0.0 113.372 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -138.3 155.15 74.18 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 127.076 2.15 . . . . 0.0 109.761 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.96 111.42 2.64 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.429 2.086 . . . . 0.0 110.402 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.1 t -81.42 140.24 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.927 1.691 . . . . 0.0 110.015 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -75.64 135.8 40.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.092 0.949 . . . . 0.0 110.39 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.28 136.76 50.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 124.59 1.156 . . . . 0.0 110.61 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -118.91 149.32 41.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.609 1.564 . . . . 0.0 111.16 -167.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -153.36 166.42 32.69 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.763 1.625 . . . . 0.0 109.885 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -152.44 164.72 36.98 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.241 -1.537 . . . . 0.0 112.318 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -121.98 143.17 49.64 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.0 t -98.72 146.51 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.289 1.836 . . . . 0.0 112.364 -168.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.88 -15.13 63.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -168.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -145.35 -47.5 0.22 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.89 0.876 . . . . 0.0 112.109 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -83.41 173.51 11.46 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.36 1.064 . . . . 0.0 112.1 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -112.48 9.22 19.57 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.824 2.05 . . . . 0.0 114.58 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 p -133.08 171.44 13.98 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.104 1.361 . . . . 0.0 113.585 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -157.52 179.91 8.79 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.831 2.053 . . . . 0.0 110.362 163.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -117.24 138.95 51.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.808 1.243 . . . . 0.0 112.604 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.6 m -126.14 142.65 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.381 1.472 . . . . 0.0 113.912 -174.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.22 174.59 28.0 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.431 1.491 . . . . 0.0 115.336 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -26.0 65.9 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.756 -1.438 . . . . 0.0 113.133 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -83.54 -3.78 57.96 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.005 0.922 . . . . 0.0 113.384 170.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 57.38 55.35 5.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.134 1.773 . . . . 0.0 113.857 167.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.88 143.41 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.557 1.543 . . . . 0.0 111.603 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.5 tp -81.34 125.47 30.42 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.726 1.21 . . . . 0.0 114.091 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.6 159.05 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.478 1.511 . . . . 0.0 112.574 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -99.62 149.96 22.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.179 1.392 . . . . 0.0 113.959 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.7 m120 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.265 1.826 . . . . 0.0 112.505 179.469 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 51.7 ttm -138.16 139.15 39.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.319 0.648 . . . . 0.0 112.401 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -115.03 98.73 6.97 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.071 1.748 . . . . 0.0 110.356 171.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -157.38 168.99 25.76 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.808 0.843 . . . . 0.0 113.094 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.437 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.8 m-85 -124.78 154.52 40.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.565 1.546 . . . . 0.0 111.121 167.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.49 154.69 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.683 -0.636 . . . . 0.0 111.262 171.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.78 154.56 8.97 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.362 0.601 . . . . 0.0 111.717 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.88 -9.66 29.89 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-O 117.676 -1.625 . . . . 0.0 116.186 -171.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.5 m -62.33 125.31 23.47 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.539 2.17 . . . . 0.0 110.11 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 mmt -85.12 140.66 30.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.693 1.197 . . . . 0.0 111.982 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.66 135.18 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.781 2.033 . . . . 0.0 110.123 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.68 130.8 40.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.902 0.881 . . . . 0.0 113.208 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 p -126.18 174.21 8.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.71 1.604 . . . . 0.0 111.353 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.7 -19.38 64.88 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.26 1.424 . . . . 0.0 113.552 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -110.56 -25.39 10.02 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.17 -113.34 0.54 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.809 0.731 . . . . 0.0 112.825 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.6 mt -130.99 145.9 52.2 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.2 t -133.29 142.73 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.305 1.842 . . . . 0.0 108.941 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.77 144.77 49.08 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.214 -0.929 . . . . 0.0 110.959 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.32 -27.52 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 120.982 -1.074 . . . . 0.0 113.605 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -70.51 -14.06 62.37 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.089 1.356 . . . . 0.0 114.125 173.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -114.28 -11.01 12.64 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.551 1.54 . . . . 0.0 113.203 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.4 mm -61.68 137.23 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.569 -0.707 . . . . 0.0 109.282 163.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -125.55 164.03 21.42 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.369 1.868 . . . . 0.0 111.545 170.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.62 132.42 35.68 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.738 -0.601 . . . . 0.0 111.532 167.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.29 1.13 90.4 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.486 1.041 . . . . 0.0 115.287 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -82.65 154.54 24.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.533 1.167 . . . . 0.0 109.869 164.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -112.13 145.64 39.44 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.693 1.197 . . . . 0.0 112.311 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.03 160.56 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.229 1.811 . . . . 0.0 111.258 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -73.79 143.95 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.475 -0.765 . . . . 0.0 111.722 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.52 128.28 20.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.36 1.064 . . . . 0.0 109.446 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.4 m -78.62 115.45 18.33 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 162.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -55.21 115.39 9.03 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.231 1.012 . . . . 0.0 112.07 170.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.84 -3.95 13.77 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.9 2.4 . . . . 0.0 114.349 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -81.8 -45.99 14.81 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.309 0.958 . . . . 0.0 112.409 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -136.86 0.95 2.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.342 1.057 . . . . 0.0 112.767 -166.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 55.8 45.99 23.21 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.468 1.127 . . . . 0.0 112.678 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -86.59 134.97 33.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.564 1.546 . . . . 0.0 109.543 165.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 t -110.44 119.64 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 118.733 0.697 . . . . 0.0 109.644 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.35 164.88 33.67 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.792 0.837 . . . . 0.0 112.529 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -88.94 128.84 35.7 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.697 1.599 . . . . 0.0 110.941 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.444 ' HE3' ' CZ ' ' A' ' 121' ' ' PHE . 66.6 mmtt -134.46 148.76 50.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.365 1.066 . . . . 0.0 111.153 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -86.05 154.15 21.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.62 0.724 . . . . 0.0 112.781 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.6 t -90.18 134.86 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.655 1.582 . . . . 0.0 110.599 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.82 -48.37 7.54 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.881 0.872 . . . . 0.0 112.381 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -143.78 160.89 39.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.264 1.826 . . . . 0.0 110.235 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.3 p -116.43 134.05 55.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.562 1.145 . . . . 0.0 110.172 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -109.32 140.78 42.56 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.835 1.654 . . . . 0.0 113.705 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.33 138.45 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.651 1.18 . . . . 0.0 111.062 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -141.19 174.04 10.91 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.474 2.31 . . . . 0.0 109.532 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -130.48 138.85 50.47 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.504 1.522 . . . . 0.0 110.38 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.2 t -147.15 150.7 35.48 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.585 0.707 . . . . 0.0 111.643 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 p -94.17 -14.03 26.06 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.67 1.588 . . . . 0.0 113.848 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -118.55 111.39 18.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.039 0.836 . . . . 0.0 110.745 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.2 mt -110.14 160.79 16.17 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 tp -127.58 130.65 49.41 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 110.852 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -117.4 103.07 9.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.696 1.598 . . . . 0.0 109.413 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.7 mt -98.35 128.1 44.6 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.757 0.823 . . . . 0.0 110.22 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -100.29 119.74 38.86 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.08 116.32 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.321 1.048 . . . . 0.0 109.179 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.12 28.75 34.44 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 123.707 0.67 . . . . 0.0 114.72 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.12 -2.11 87.63 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.915 1.722 . . . . 0.0 116.332 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.4 122.49 41.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.863 1.831 . . . . 0.0 109.507 168.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.1 p -87.32 131.78 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.486 0.66 . . . . 0.0 111.71 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.92 131.04 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.823 2.049 . . . . 0.0 108.86 -175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -113.94 110.19 19.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.608 1.163 . . . . 0.0 110.777 -164.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 t -139.88 177.78 7.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.05 0.94 . . . . 0.0 112.218 -157.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.2 p -87.15 151.31 23.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.129 0.972 . . . . 0.0 112.116 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -58.75 -29.85 67.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.408 1.083 . . . . 0.0 112.845 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -98.21 9.55 42.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.437 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.3 t60 -70.58 125.96 92.13 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 120.909 -1.119 . . . . 0.0 112.475 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.99 119.82 4.04 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.139 2.559 . . . . 0.0 113.963 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -106.92 144.13 34.0 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.71 2.004 . . . . 0.0 111.074 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -83.33 128.61 34.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.464 1.029 . . . . 0.0 113.285 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.9 t -103.84 133.0 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.402 2.281 . . . . 0.0 110.96 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -49.01 118.46 2.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.056 1.743 . . . . 0.0 112.144 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 52.57 24.94 3.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.404 2.682 . . . . 0.0 115.312 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.75 -50.26 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.21 1.404 . . . . 0.0 110.577 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.48 -161.66 13.52 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 123.541 0.591 . . . . 0.0 112.54 -175.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.282 31.1 p90 -85.02 150.01 25.18 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 118.818 1.309 . . . . 0.0 114.162 -175.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.72 144.99 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.008 1.723 . . . . 0.0 110.642 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.41 136.13 57.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.94 0.896 . . . . 0.0 112.108 176.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.25 -36.12 70.56 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.78 1.232 . . . . 0.0 113.961 -171.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.66 -3.74 89.41 Favored Glycine 0 CA--C 1.539 1.561 0 O-C-N 121.027 -1.046 . . . . 0.0 113.611 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -95.77 -4.6 43.68 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.241 1.816 . . . . 0.0 112.314 167.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.0 mt -71.59 154.11 41.66 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.547 -0.721 . . . . 0.0 112.263 166.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -119.72 166.99 12.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.16 1.384 . . . . 0.0 110.976 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.31 138.53 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.57 12.99 82.3 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 115.234 0.854 . . . . 0.0 115.234 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -86.29 150.87 24.05 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.317 -1.107 . . . . 0.0 110.841 169.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -107.44 111.81 24.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.333 1.453 . . . . 0.0 112.056 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.1 mt -104.2 -177.82 3.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.339 1.456 . . . . 0.0 111.06 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -131.46 156.19 46.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.272 1.029 . . . . 0.0 113.518 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.8 p30 -105.15 179.85 4.15 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.914 1.286 . . . . 0.0 113.289 174.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.3 t -66.06 -17.87 64.97 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.871 1.669 . . . . 0.0 114.14 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -85.48 -25.53 26.83 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.261 -1.525 . . . . 0.0 112.171 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.72 25.31 8.16 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.699 2.095 . . . . 0.0 113.224 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.81 142.82 34.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.309 1.444 . . . . 0.0 111.812 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.9 t -57.11 120.3 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.51 1.124 . . . . 0.0 112.248 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -99.71 154.37 18.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.169 1.388 . . . . 0.0 110.901 161.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.42 140.6 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.865 1.266 . . . . 0.0 110.471 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.9 119.54 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.526 0.679 . . . . 0.0 109.237 170.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.02 -35.15 14.81 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.782 2.033 . . . . 0.0 112.626 -176.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -162.91 148.86 12.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.195 1.798 . . . . 0.0 110.817 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -129.41 124.5 34.29 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.932 1.693 . . . . 0.0 110.31 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 mmtm -132.22 151.1 51.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.531 1.532 . . . . 0.0 112.102 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 tp -136.13 137.65 41.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.858 1.663 . . . . 0.0 108.996 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.39 151.13 43.23 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.4 mm -99.77 119.01 47.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.779 170.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.89 149.59 43.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 112.795 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -67.95 -19.06 64.93 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.455 1.502 . . . . 0.0 113.251 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -157.27 156.64 29.56 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.913 2.485 . . . . 0.0 108.961 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -60.59 129.14 28.2 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.452 2.101 . . . . 0.0 112.603 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.83 144.35 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.595 1.558 . . . . 0.0 109.618 173.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -79.69 140.95 36.84 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.618 -0.677 . . . . 0.0 110.643 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.6 m -136.79 137.66 47.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.606 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -111.69 154.15 25.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.721 1.608 . . . . 0.0 111.974 -172.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -155.58 174.01 15.88 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.85 2.46 . . . . 0.0 108.033 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -153.76 170.9 19.8 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.044 -1.66 . . . . 0.0 110.744 173.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -121.94 137.25 54.86 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.774 0.83 . . . . 0.0 112.834 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.6 t -100.05 144.89 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.963 1.305 . . . . 0.0 111.95 -167.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -57.59 -39.07 75.96 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -170.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -139.6 -48.83 0.48 Allowed 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.97 -1.081 . . . . 0.0 113.372 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.444 ' CZ ' ' HE3' ' A' ' 39' ' ' LYS . 5.8 m-30 -69.94 163.87 25.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 168.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -116.29 23.48 12.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.954 1.302 . . . . 0.0 112.103 -171.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 p -147.69 160.64 42.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.553 1.541 . . . . 0.0 111.84 -157.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -160.24 175.89 12.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.836 1.655 . . . . 0.0 110.391 171.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -122.27 134.2 54.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.393 1.077 . . . . 0.0 112.802 -171.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.6 m -122.05 143.42 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.271 1.428 . . . . 0.0 114.663 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.53 176.98 30.14 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 126.118 1.818 . . . . 0.0 116.19 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.15 -34.5 66.19 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 120.92 -1.341 . . . . 0.0 113.237 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -83.02 0.1 46.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 57.35 43.6 23.08 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.027 1.331 . . . . 0.0 113.334 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.25 136.81 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.127 1.371 . . . . 0.0 111.723 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.6 tp -79.22 124.92 28.82 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.829 1.252 . . . . 0.0 113.98 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.4 m -138.27 157.01 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.127 1.771 . . . . 0.0 112.062 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -107.16 129.31 54.86 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.194 1.398 . . . . 0.0 112.823 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.213 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 118.966 -0.54 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 8.6 ttt -162.74 128.65 3.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.278 1.431 . . . . 0.0 111.381 170.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -133.38 97.4 3.95 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.093 0.957 . . . . 0.0 111.696 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.85 176.04 12.83 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.44 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 98.4 m-85 -123.62 157.12 34.47 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.14 1.776 . . . . 0.0 110.699 168.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 m -68.79 157.61 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.809 -0.557 . . . . 0.0 111.808 173.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.5 153.36 4.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.364 0.666 . . . . 0.0 111.948 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.8 3.95 30.97 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-O 117.95 -1.472 . . . . 0.0 116.475 -174.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -67.77 125.34 25.95 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 120.922 2.361 . . . . 0.0 109.617 165.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.6 mmt -80.5 142.19 34.44 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.353 1.461 . . . . 0.0 111.858 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -123.29 137.11 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.787 2.035 . . . . 0.0 109.905 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.91 122.14 22.06 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 112.592 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 p -115.21 168.14 10.21 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.115 1.366 . . . . 0.0 110.562 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.28 66.57 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.402 -0.812 . . . . 0.0 112.969 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.0 p -100.05 -31.66 11.32 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.626 0.77 . . . . 0.0 112.547 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.97 -120.09 0.76 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.877 0.751 . . . . 0.0 112.715 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.57 140.83 51.87 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.611 1.164 . . . . 0.0 112.67 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.1 t -132.25 142.64 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.848 1.659 . . . . 0.0 108.747 173.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.38 150.41 48.99 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.103 -0.998 . . . . 0.0 111.725 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.9 tt -62.45 -25.85 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 120.876 -1.14 . . . . 0.0 113.558 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -75.09 -15.28 60.62 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.376 1.07 . . . . 0.0 113.765 171.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -107.97 -16.25 14.34 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.571 1.948 . . . . 0.0 112.401 -176.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.7 mm -63.29 134.66 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 160.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -134.17 160.21 38.51 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.043 1.337 . . . . 0.0 111.604 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.42 120.21 8.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.785 0.434 . . . . 0.0 110.406 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.73 -24.67 23.15 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.535 1.064 . . . . 0.0 115.716 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.86 170.83 8.9 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.394 1.597 . . . . 0.0 111.648 172.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -125.33 146.53 49.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.725 1.61 . . . . 0.0 111.167 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.18 160.55 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.131 1.372 . . . . 0.0 110.455 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -75.09 140.94 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.234 0.54 . . . . 0.0 110.514 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.49 125.78 24.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.222 1.009 . . . . 0.0 108.695 175.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.2 m -79.79 112.3 16.94 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 161.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -53.92 111.44 2.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 118.343 -0.836 . . . . 0.0 110.718 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -69.18 -12.25 33.54 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.35 2.034 . . . . 0.0 112.691 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -77.19 -38.66 51.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.076 1.351 . . . . 0.0 112.828 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.7 t -136.23 -6.1 2.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.01 1.324 . . . . 0.0 112.53 -170.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.259 15.6 m-85 54.5 52.3 12.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.221 1.408 . . . . 0.0 112.185 -175.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -100.64 135.65 41.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.108 1.763 . . . . 0.0 108.889 167.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 t -113.04 128.89 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 119.01 0.823 . . . . 0.0 111.27 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.78 172.19 18.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.91 0.884 . . . . 0.0 113.079 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -74.23 138.04 43.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.71 1.204 . . . . 0.0 111.443 165.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -139.31 152.63 47.37 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.396 1.078 . . . . 0.0 112.23 160.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -79.08 155.32 28.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.668 1.187 . . . . 0.0 114.131 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.7 t -93.12 131.73 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 126.537 1.935 . . . . 0.0 111.318 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.42 -41.05 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.363 1.465 . . . . 0.0 113.508 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -147.37 156.02 42.52 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 127.159 2.184 . . . . 0.0 109.703 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -113.26 135.92 53.31 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.475 1.51 . . . . 0.0 109.14 163.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -112.35 141.83 45.59 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.183 1.393 . . . . 0.0 113.912 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -135.02 138.29 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.056 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -140.15 176.19 8.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.209 2.203 . . . . 0.0 110.112 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.12 133.62 50.36 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.375 1.47 . . . . 0.0 110.973 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 t -142.42 145.11 33.46 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.125 -0.984 . . . . 0.0 113.12 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.8 p -88.27 -14.52 38.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.806 1.642 . . . . 0.0 113.25 167.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -107.66 108.85 20.29 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.005 -1.059 . . . . 0.0 110.9 -172.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.6 mt -116.45 167.96 10.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.251 1.021 . . . . 0.0 112.818 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.1 tp -135.28 133.21 38.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.859 2.064 . . . . 0.0 109.268 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -105.54 130.43 53.6 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.232 -0.918 . . . . 0.0 109.292 170.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.5 mt -114.14 147.53 38.7 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.371 1.069 . . . . 0.0 110.1 169.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.7 m -123.17 124.83 43.92 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.452 0.701 . . . . 0.0 109.627 166.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.1 mt -132.77 123.55 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.84 1.656 . . . . 0.0 109.425 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.08 28.79 50.28 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 115.611 1.005 . . . . 0.0 115.611 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.11 7.51 87.7 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.82 1.2 . . . . 0.0 115.567 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -109.1 137.55 46.83 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.745 1.618 . . . . 0.0 109.567 171.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.61 135.84 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.345 1.058 . . . . 0.0 111.171 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mt -129.7 104.58 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.161 1.784 . . . . 0.0 109.341 173.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -81.94 121.82 26.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.823 1.649 . . . . 0.0 111.429 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.5 t -144.64 175.36 10.21 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.165 -0.96 . . . . 0.0 112.73 -167.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.3 p -79.19 153.86 29.69 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.591 -0.693 . . . . 0.0 111.181 167.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -59.43 -28.83 67.31 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.763 0.825 . . . . 0.0 112.62 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -98.01 1.21 47.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.963 0.905 . . . . 0.0 113.164 -171.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.44 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.2 t60 -64.68 128.07 93.13 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 117.657 -1.163 . . . . 0.0 112.87 -173.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 68' ' ' HIS . 7.6 Cg_exo -84.4 127.87 3.97 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.003 1.802 . . . . 0.0 114.673 -175.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -115.93 139.58 50.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.129 2.572 . . . . 0.0 111.407 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -89.6 129.58 36.03 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.0 134.36 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.561 2.344 . . . . 0.0 112.4 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -50.05 126.36 14.27 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.982 1.713 . . . . 0.0 112.779 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 52.5 22.54 2.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.239 2.216 . . . . 0.0 115.259 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.09 -53.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.81 -1.181 . . . . 0.0 111.141 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.92 -159.68 13.57 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.095 0.855 . . . . 0.0 113.014 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -92.57 139.13 30.89 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.159 1.541 . . . . 0.0 115.159 -170.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.57 146.98 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 127.45 2.3 . . . . 0.0 111.987 -172.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.48 135.85 56.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 173.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.48 -40.14 61.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.958 1.703 . . . . 0.0 113.688 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.3 -10.58 66.29 Favored Glycine 0 CA--C 1.539 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 113.683 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -112.14 4.37 17.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.563 2.345 . . . . 0.0 113.04 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.85 159.66 19.14 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.969 -1.082 . . . . 0.0 111.295 163.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.42 156.68 32.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.441 1.096 . . . . 0.0 111.465 172.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.44 132.58 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 165.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.84 11.32 82.92 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 118.404 -1.22 . . . . 0.0 115.706 -172.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.3 165.19 7.82 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.908 1.854 . . . . 0.0 112.097 170.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -117.71 83.28 1.97 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.742 1.217 . . . . 0.0 111.735 -169.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.25 162.96 13.64 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.189 0.996 . . . . 0.0 113.533 -170.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.43 140.75 38.06 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.521 1.128 . . . . 0.0 112.552 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.12 177.14 5.17 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.501 1.12 . . . . 0.0 114.004 171.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.0 p -59.95 -12.08 7.09 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -107.85 -25.91 11.0 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.295 1.838 . . . . 0.0 111.905 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.6 25.14 6.72 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 126.402 1.954 . . . . 0.0 112.719 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -74.83 154.71 38.16 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.709 0.804 . . . . 0.0 110.437 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.8 t -92.83 112.76 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.785 0.834 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.5 mt -84.68 163.11 19.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.755 2.822 . . . . 0.0 112.324 175.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.71 134.78 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.554 1.542 . . . . 0.0 110.033 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.48 131.52 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.685 -0.635 . . . . 0.0 109.542 170.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -105.43 -35.26 7.55 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.613 1.565 . . . . 0.0 112.407 -175.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -157.87 149.24 21.47 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.194 0.998 . . . . 0.0 112.574 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -123.0 128.54 50.33 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.771 2.029 . . . . 0.0 108.743 161.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -130.27 151.61 50.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.116 1.766 . . . . 0.0 111.577 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 tt -138.62 142.99 39.1 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 111.416 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -150.52 161.92 41.61 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.933 0.893 . . . . 0.0 112.555 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mm -111.02 109.93 30.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.991 1.317 . . . . 0.0 108.329 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.47 140.37 58.59 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.318 0.647 . . . . 0.0 110.943 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.88 -21.63 60.89 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.64 -1.288 . . . . 0.0 113.283 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -127.54 151.12 74.61 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 127.221 2.208 . . . . 0.0 109.887 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.05 110.71 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.727 2.285 . . . . 0.0 112.069 -174.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.35 142.1 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.03 1.732 . . . . 0.0 110.18 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -71.2 140.28 50.42 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.081 0.943 . . . . 0.0 112.144 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.1 m -140.04 137.5 38.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.645 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -121.92 149.05 43.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.527 1.531 . . . . 0.0 111.354 -166.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -154.11 173.18 16.41 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.666 1.986 . . . . 0.0 108.413 170.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -150.27 170.71 18.35 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.218 -1.551 . . . . 0.0 111.283 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -119.46 136.52 54.27 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.82 0.848 . . . . 0.0 112.912 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.51 146.61 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.756 1.622 . . . . 0.0 111.491 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.08 -45.26 74.29 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -168.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -127.65 -32.85 2.34 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 119.732 1.151 . . . . 0.0 113.654 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -96.32 169.27 10.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.263 1.425 . . . . 0.0 108.925 167.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -120.97 19.68 11.65 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.742 1.217 . . . . 0.0 113.282 -171.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 p -142.13 164.28 30.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.524 1.53 . . . . 0.0 111.649 -162.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.69 179.31 9.22 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.387 1.475 . . . . 0.0 110.151 170.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -121.81 134.6 54.9 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.538 1.135 . . . . 0.0 111.943 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.19 144.81 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.239 1.416 . . . . 0.0 113.583 -173.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.6 175.16 26.71 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.663 1.601 . . . . 0.0 115.396 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -63.08 -29.44 70.81 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.309 -1.113 . . . . 0.0 112.112 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -86.11 1.72 49.44 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 174.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 58.33 46.24 15.77 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.271 1.428 . . . . 0.0 114.126 166.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.52 140.1 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.505 1.122 . . . . 0.0 111.443 -172.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.3 125.88 30.89 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.379 1.471 . . . . 0.0 113.922 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.05 155.57 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.847 1.659 . . . . 0.0 112.359 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -97.69 136.49 37.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.441 1.496 . . . . 0.0 111.73 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.217 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 6.0 ttt -154.41 -40.49 0.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.136 1.774 . . . . 0.0 112.523 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt 51.43 63.74 2.12 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.655 1.982 . . . . 0.0 115.657 163.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -140.61 174.17 10.78 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -123.49 154.74 38.72 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.973 1.709 . . . . 0.0 110.809 170.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.6 m -69.63 160.74 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.427 0.632 . . . . 0.0 111.772 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 157.78 2.34 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 122.166 0.984 . . . . 0.0 112.921 174.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.78 -8.54 4.34 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 116.965 -2.02 . . . . 0.0 116.258 -171.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -62.6 119.82 9.97 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.039 2.419 . . . . 0.0 110.077 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mmt -78.36 141.37 38.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.55 1.14 . . . . 0.0 111.797 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -125.24 135.68 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.406 1.883 . . . . 0.0 109.785 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 tp -76.73 123.61 26.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.895 1.278 . . . . 0.0 112.623 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -123.54 176.84 5.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.736 1.214 . . . . 0.0 112.146 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.86 68.1 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.353 -0.842 . . . . 0.0 112.804 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 p -100.01 -14.45 18.65 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.297 1.439 . . . . 0.0 113.434 -170.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.99 -107.41 0.41 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.375 1.464 . . . . 0.0 110.754 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.36 150.91 48.26 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.291 1.036 . . . . 0.0 112.455 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.7 t -140.05 146.59 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.116 2.166 . . . . 0.0 107.738 168.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.34 149.49 47.3 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.8 -1.188 . . . . 0.0 111.077 175.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -60.83 -30.81 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 120.63 -1.293 . . . . 0.0 112.887 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -65.58 -18.05 65.04 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.823 1.649 . . . . 0.0 114.179 171.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -116.62 -5.14 11.65 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.644 1.978 . . . . 0.0 112.776 -174.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -65.17 134.53 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.123 -0.986 . . . . 0.0 108.543 158.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -120.54 156.9 30.61 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.777 1.631 . . . . 0.0 111.544 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.45 136.27 58.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 167.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.68 -4.05 86.31 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.212 0.91 . . . . 0.0 113.83 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -74.79 -179.68 4.33 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.683 1.241 . . . . 0.0 111.224 167.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -126.1 141.52 51.91 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.51 1.524 . . . . 0.0 112.103 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.67 153.7 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.608 1.563 . . . . 0.0 110.101 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -71.06 134.89 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 121.676 -0.64 . . . . 0.0 111.175 171.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.94 120.02 20.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.088 1.355 . . . . 0.0 108.014 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.9 m -86.7 107.76 18.36 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -54.52 113.08 4.67 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.84 175.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.37 -8.42 22.04 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 122.604 2.203 . . . . 0.0 114.129 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -72.79 -41.67 64.73 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.181 1.393 . . . . 0.0 112.674 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.8 t -143.36 -4.13 0.9 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.254 1.422 . . . . 0.0 112.49 -165.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 58.54 32.0 21.65 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.02 1.728 . . . . 0.0 114.17 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.71 129.59 40.02 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 169.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.52 107.49 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.887 0.875 . . . . 0.0 109.579 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.19 163.39 33.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.707 1.203 . . . . 0.0 111.535 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.39 135.53 35.15 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.53 -0.731 . . . . 0.0 110.188 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HE3' ' CE1' ' A' ' 121' ' ' PHE . 72.2 mmtt -131.62 150.13 52.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.435 1.494 . . . . 0.0 110.657 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.4 t -82.58 156.51 23.9 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.73 126.97 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.733 1.613 . . . . 0.0 110.962 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.75 -47.4 11.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.834 1.254 . . . . 0.0 113.434 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -146.1 156.0 43.14 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.536 1.935 . . . . 0.0 110.376 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.3 p -125.17 118.45 26.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.354 1.862 . . . . 0.0 111.027 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -108.97 152.69 24.61 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.031 1.332 . . . . 0.0 113.57 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.2 141.31 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.582 1.953 . . . . 0.0 110.729 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -141.77 176.54 8.83 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.36 1.864 . . . . 0.0 110.704 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -127.84 139.58 52.55 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.532 1.533 . . . . 0.0 111.614 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 t -147.91 147.17 29.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.138 1.375 . . . . 0.0 111.518 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 p -88.49 -19.37 26.54 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.215 1.006 . . . . 0.0 113.002 164.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -97.48 110.84 23.32 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.477 1.111 . . . . 0.0 109.904 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.9 mt -121.92 169.23 11.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.378 1.071 . . . . 0.0 112.37 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 tp -138.24 130.32 28.6 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.465 1.506 . . . . 0.0 109.425 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -112.51 119.89 39.73 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.426 -0.796 . . . . 0.0 109.168 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.9 mt -108.69 140.18 42.45 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.699 0.799 . . . . 0.0 109.534 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.6 m -110.14 119.68 40.06 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 166.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.75 117.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.515 1.126 . . . . 0.0 109.884 -177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.06 30.3 46.06 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-O 119.5 -0.611 . . . . 0.0 114.442 -175.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.04 -7.49 80.97 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.45 1.5 . . . . 0.0 115.605 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -97.88 118.97 35.65 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.262 1.425 . . . . 0.0 111.073 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.9 133.49 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.139 0.575 . . . . 0.0 111.481 170.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mt -133.98 105.76 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 127.382 2.273 . . . . 0.0 108.656 173.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -87.99 120.72 29.61 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.874 1.669 . . . . 0.0 112.739 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -142.02 175.41 9.75 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.389 1.476 . . . . 0.0 112.581 -164.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.2 p -83.64 153.56 24.2 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.977 0.894 . . . . 0.0 111.293 167.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -62.11 -18.29 60.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.505 1.122 . . . . 0.0 113.328 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -104.01 0.93 30.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.448 1.499 . . . . 0.0 113.902 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.2 127.64 93.06 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 119.619 1.1 . . . . 0.0 112.952 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -79.86 123.82 5.37 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.02 2.48 . . . . 0.0 114.325 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -112.2 143.54 43.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.758 2.423 . . . . 0.0 111.282 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -88.07 126.46 35.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.159 0.89 . . . . 0.0 112.492 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -102.45 135.59 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.642 1.977 . . . . 0.0 110.822 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -53.51 129.15 31.51 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.9 1.28 . . . . 0.0 110.785 174.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.3 t70 61.12 13.43 4.71 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.532 1.933 . . . . 0.0 115.518 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.4 t -135.77 -45.33 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 121.026 -1.047 . . . . 0.0 113.072 -172.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.49 -159.07 17.08 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.999 0.809 . . . . 0.0 113.456 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -77.88 145.24 36.34 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -170.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.0 p -149.78 150.45 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.427 2.291 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.02 140.81 58.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 173.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.47 -40.18 65.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.024 1.73 . . . . 0.0 113.689 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.35 -8.26 87.59 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.966 -1.084 . . . . 0.0 113.966 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -97.21 -5.03 37.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.637 1.575 . . . . 0.0 112.121 171.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.53 155.21 41.01 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.095 -1.003 . . . . 0.0 111.292 164.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -123.27 170.12 10.6 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.579 1.151 . . . . 0.0 110.429 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.35 136.37 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.616 -0.677 . . . . 0.0 109.695 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 5.13 87.93 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.103 -0.832 . . . . 0.0 115.09 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -76.22 153.36 36.12 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.522 1.161 . . . . 0.0 110.599 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.47 107.76 18.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.591 1.157 . . . . 0.0 111.791 -169.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.6 mt -99.95 172.82 6.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.547 1.139 . . . . 0.0 111.047 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.2 mt -123.68 165.23 17.58 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.885 0.874 . . . . 0.0 112.705 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -117.73 -174.51 2.64 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.354 1.462 . . . . 0.0 114.745 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.9 p -58.19 -1.31 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.811 2.444 . . . . 0.0 117.235 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -115.89 -20.91 9.79 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.473 1.509 . . . . 0.0 112.66 170.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.88 13.18 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.98 1.752 . . . . 0.0 112.606 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -96.06 137.56 34.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.689 1.195 . . . . 0.0 112.377 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.4 t -67.45 119.85 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.603 1.161 . . . . 0.0 113.534 -170.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.13 159.41 15.56 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.455 2.302 . . . . 0.0 112.612 169.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 t -126.17 139.14 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.977 1.311 . . . . 0.0 111.582 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.83 125.52 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.92 0.888 . . . . 0.0 109.874 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.28 -30.94 10.78 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 127.357 2.263 . . . . 0.0 112.933 -175.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -156.65 152.96 27.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.497 1.119 . . . . 0.0 111.121 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -136.54 101.31 4.6 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.277 1.831 . . . . 0.0 109.545 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -104.77 130.58 52.84 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.314 1.846 . . . . 0.0 110.909 -171.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.9 tp -120.37 128.79 53.56 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.831 1.252 . . . . 0.0 110.81 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.17 162.1 41.42 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.125 1.37 . . . . 0.0 112.874 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.63 117.73 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.157 1.383 . . . . 0.0 108.86 171.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.88 142.62 53.23 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.583 -0.698 . . . . 0.0 112.2 167.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.6 -26.35 67.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.031 1.332 . . . . 0.0 112.987 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -146.91 150.87 40.38 Favored Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 127.051 2.14 . . . . 0.0 109.988 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -56.63 127.54 26.31 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.473 2.782 . . . . 0.0 112.869 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.3 t -99.04 141.36 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 127.072 2.149 . . . . 0.0 110.095 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -74.19 144.85 44.58 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.893 0.769 . . . . 0.0 112.079 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.78 144.26 27.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.309 1.444 . . . . 0.0 110.565 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -128.8 147.59 50.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.521 1.529 . . . . 0.0 110.41 -166.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -156.46 171.64 19.91 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.537 1.135 . . . . 0.0 111.685 169.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -149.78 163.37 38.16 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.465 -0.772 . . . . 0.0 112.117 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.68 144.24 43.27 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.666 1.186 . . . . 0.0 113.204 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.9 t -104.76 147.84 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.059 1.744 . . . . 0.0 111.676 -168.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.35 -72.4 0.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.8 -19.98 12.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -166.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.47 ' CE1' ' HE3' ' A' ' 39' ' ' LYS . 10.5 m-30 -105.92 175.34 5.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.273 1.829 . . . . 0.0 108.524 165.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -132.21 33.13 3.9 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.164 1.386 . . . . 0.0 112.729 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 p -139.75 159.01 43.16 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.061 1.744 . . . . 0.0 112.17 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -158.29 -173.32 4.26 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.82 1.648 . . . . 0.0 110.768 170.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -131.67 141.4 49.58 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.885 1.274 . . . . 0.0 113.392 -170.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.98 142.39 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.678 1.191 . . . . 0.0 112.625 -173.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.55 173.8 23.41 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.283 1.421 . . . . 0.0 115.697 175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.4 -31.2 72.29 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.982 -1.305 . . . . 0.0 113.367 -176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -84.04 2.19 40.31 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.842 1.257 . . . . 0.0 114.0 173.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.88 46.16 17.25 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.454 1.901 . . . . 0.0 114.551 166.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.84 136.53 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.569 1.148 . . . . 0.0 111.515 -170.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 54.1 tp -77.86 126.19 30.47 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.786 1.634 . . . . 0.0 112.639 -176.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.15 157.2 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.768 1.627 . . . . 0.0 111.142 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -108.28 161.38 15.06 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.531 1.132 . . . . 0.0 112.924 -172.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.663 1.585 . . . . 0.0 112.953 171.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 7.7 ttm -76.84 125.8 29.9 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.344 1.458 . . . . 0.0 111.116 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -133.07 73.12 1.5 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.909 2.084 . . . . 0.0 110.178 -168.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.8 167.27 21.48 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -171.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 85.9 m-85 -123.6 154.24 39.58 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.552 1.541 . . . . 0.0 111.276 172.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.92 161.53 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.53 0.681 . . . . 0.0 112.053 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.32 154.23 3.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.206 1.002 . . . . 0.0 112.681 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.96 -9.0 7.04 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 117.546 -1.697 . . . . 0.0 116.3 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.0 m -63.03 121.57 13.91 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 121.179 2.49 . . . . 0.0 110.373 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 mmt -78.35 142.94 37.32 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.694 1.597 . . . . 0.0 111.72 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.8 mm -127.32 132.91 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.697 1.999 . . . . 0.0 109.867 -175.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -77.92 123.07 26.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.699 1.199 . . . . 0.0 112.552 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -117.44 178.87 4.22 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.507 1.123 . . . . 0.0 113.647 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.84 52.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.45 1.1 . . . . 0.0 113.832 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 p -113.82 -28.04 7.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.924 1.29 . . . . 0.0 113.706 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.76 -107.96 0.34 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.271 0.939 . . . . 0.0 111.476 -171.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -127.29 149.2 50.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.483 1.113 . . . . 0.0 113.204 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.9 t -142.35 147.73 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 127.286 2.234 . . . . 0.0 108.389 170.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.6 147.09 41.97 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.888 -1.133 . . . . 0.0 111.27 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 tt -61.34 -29.47 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 120.614 -1.304 . . . . 0.0 112.926 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.46 -8.22 44.86 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.918 1.287 . . . . 0.0 114.434 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -119.4 -8.0 10.11 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.749 1.62 . . . . 0.0 113.489 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.19 136.53 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.117 -0.99 . . . . 0.0 110.052 165.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -117.92 166.31 12.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.907 2.083 . . . . 0.0 110.312 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.9 147.02 54.13 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.479 -0.763 . . . . 0.0 111.032 163.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.37 3.24 82.07 Favored Glycine 0 CA--C 1.54 1.637 0 O-C-N 121.77 -0.581 . . . . 0.0 114.543 -171.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -89.81 152.94 21.04 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.099 0.96 . . . . 0.0 110.292 168.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -115.85 120.9 40.74 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.799 1.239 . . . . 0.0 112.709 -168.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 m -110.32 154.06 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 126.88 2.072 . . . . 0.0 110.257 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.3 mm -75.53 135.16 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 O-C-N 121.604 -0.685 . . . . 0.0 109.773 166.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.99 121.48 28.07 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.2 m -101.46 104.1 15.02 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -55.96 114.75 8.08 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.96 -1.019 . . . . 0.0 111.83 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.96 -5.53 12.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.168 1.912 . . . . 0.0 113.443 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.07 -42.51 76.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.833 0.853 . . . . 0.0 112.538 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.2 t -150.01 5.66 0.58 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.787 0.835 . . . . 0.0 112.928 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.265 21.0 m-85 57.11 41.54 27.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.34 1.456 . . . . 0.0 112.642 -173.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -78.79 131.37 36.5 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 165.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.22 123.93 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.133 0.973 . . . . 0.0 109.912 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.38 153.22 43.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -82.27 117.39 22.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.199 1.0 . . . . 0.0 109.96 168.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -132.28 146.63 52.13 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.707 1.203 . . . . 0.0 112.351 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -83.99 155.65 22.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.367 1.067 . . . . 0.0 113.766 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.7 t -87.22 132.98 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 125.645 1.578 . . . . 0.0 111.295 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.3 mt -90.92 -41.37 11.18 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.207 1.003 . . . . 0.0 112.866 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.25 150.67 35.29 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.247 1.819 . . . . 0.0 110.376 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.3 p -121.48 121.57 37.82 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.441 1.897 . . . . 0.0 109.999 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -106.89 144.33 33.69 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.78 1.632 . . . . 0.0 114.214 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.3 t -141.24 133.0 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.861 0.864 . . . . 0.0 112.126 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.6 mmt-85 -138.16 175.13 9.85 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.512 1.925 . . . . 0.0 110.652 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -136.63 136.29 39.03 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.029 0.931 . . . . 0.0 112.941 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -151.1 150.93 31.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.495 1.118 . . . . 0.0 112.107 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.4 p -90.94 -16.86 27.36 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.177 1.391 . . . . 0.0 113.874 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.39 106.89 17.52 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.363 1.065 . . . . 0.0 109.999 -169.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.3 mt -117.69 162.24 18.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.69 1.233 . . . . 0.0 113.372 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -127.3 132.56 50.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.13 1.772 . . . . 0.0 109.029 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -111.08 125.43 53.76 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.172 0.989 . . . . 0.0 108.875 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 mt -112.44 140.82 46.86 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.594 0.758 . . . . 0.0 109.568 170.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.3 m -113.84 119.04 35.94 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 mt -127.24 117.32 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.111 0.965 . . . . 0.0 108.859 -172.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.88 21.08 28.88 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.79 -4.35 53.25 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.617 1.58 . . . . 0.0 116.306 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -107.08 127.92 53.92 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.128 1.771 . . . . 0.0 110.294 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.5 t -81.71 132.34 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.47 1.108 . . . . 0.0 111.958 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -132.48 103.26 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.897 1.679 . . . . 0.0 109.492 174.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -81.86 121.47 26.5 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.607 1.563 . . . . 0.0 111.706 176.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -143.46 176.68 8.99 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.335 1.454 . . . . 0.0 113.477 -165.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.6 p -81.67 151.63 27.48 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.736 0.815 . . . . 0.0 112.255 170.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -64.17 -18.1 64.15 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.163 -0.961 . . . . 0.0 113.186 -174.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -110.98 13.41 22.08 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.0 OUTLIER -65.42 128.73 94.05 Favored Pre-proline 0 CA--C 1.55 0.978 0 O-C-N 120.772 -1.205 . . . . 0.0 111.582 176.255 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.64 125.82 5.72 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.061 2.508 . . . . 0.0 113.714 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -118.46 142.77 47.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.973 2.109 . . . . 0.0 111.788 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -85.31 133.35 34.15 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.371 0.987 . . . . 0.0 113.614 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.88 138.72 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 127.683 2.393 . . . . 0.0 111.293 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.17 130.45 42.11 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.424 0.69 . . . . 0.0 111.12 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 61.3 7.13 1.57 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.596 2.358 . . . . 0.0 116.59 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -130.64 -35.25 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.029 1.331 . . . . 0.0 111.973 -170.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.61 -150.96 22.85 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 123.938 0.78 . . . . 0.0 111.62 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.292 12.3 p90 -77.4 145.69 37.07 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.78 150.02 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 128.523 2.729 . . . . 0.0 109.683 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -64.48 137.87 58.11 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.115 -0.99 . . . . 0.0 113.415 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.72 67.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.804 1.641 . . . . 0.0 113.304 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.35 -7.46 68.11 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.373 -0.83 . . . . 0.0 114.362 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -102.76 -6.41 22.65 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.251 1.42 . . . . 0.0 113.171 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -67.94 164.28 20.25 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.089 1.356 . . . . 0.0 112.834 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.27 162.79 27.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.611 1.564 . . . . 0.0 112.881 168.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.94 123.63 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 165.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.0 1.98 61.15 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.868 -1.518 . . . . 0.0 114.988 -170.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -76.74 152.95 35.46 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.754 2.277 . . . . 0.0 111.367 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -110.6 101.82 10.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.681 1.192 . . . . 0.0 112.413 -170.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.3 mt -91.81 170.5 9.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.929 1.692 . . . . 0.0 110.654 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.9 mt -119.32 155.73 31.32 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 170.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.3 176.87 5.56 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.908 1.283 . . . . 0.0 113.879 176.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.8 p -54.34 -22.4 12.06 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -106.79 -10.05 16.2 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.542 1.937 . . . . 0.0 112.616 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.59 13.29 28.42 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.422 1.963 . . . . 0.0 113.183 171.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -79.17 145.84 33.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.719 1.208 . . . . 0.0 111.384 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.2 t -74.69 127.9 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.565 0.746 . . . . 0.0 111.322 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.1 mt -114.26 150.79 33.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.14 2.176 . . . . 0.0 112.03 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.3 t -118.23 137.71 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 125.183 1.393 . . . . 0.0 110.474 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.4 t -73.7 119.06 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.957 0.903 . . . . 0.0 109.452 169.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -94.29 -27.88 15.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.852 2.461 . . . . 0.0 112.853 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -155.03 147.33 23.91 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.778 1.631 . . . . 0.0 110.248 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -132.85 116.18 16.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.946 1.699 . . . . 0.0 109.308 168.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -127.76 151.59 48.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.359 2.264 . . . . 0.0 110.822 -171.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.02 133.81 25.32 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.15 1.38 . . . . 0.0 109.584 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -144.68 151.21 38.6 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.1 mm -98.2 103.3 14.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.895 1.278 . . . . 0.0 108.38 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.86 150.87 31.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.09 0.956 . . . . 0.0 111.954 174.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.05 -18.81 63.3 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.14 -0.975 . . . . 0.0 112.983 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -137.68 154.68 75.06 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 126.762 2.025 . . . . 0.0 111.339 -172.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.33 110.09 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.547 2.165 . . . . 0.0 110.013 170.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.2 t -83.5 141.66 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.013 1.725 . . . . 0.0 109.631 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -77.6 139.56 39.54 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.839 0.855 . . . . 0.0 110.397 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.2 m -138.34 142.83 34.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 125.006 1.322 . . . . 0.0 111.345 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -121.79 152.46 39.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.514 1.526 . . . . 0.0 111.707 -167.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -156.5 165.91 34.92 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.38 2.272 . . . . 0.0 109.767 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -156.97 165.36 36.38 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.304 -1.497 . . . . 0.0 111.248 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -120.2 145.9 46.54 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.27 145.86 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.293 1.437 . . . . 0.0 112.867 -166.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -64.43 -47.34 79.47 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -170.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -109.49 -66.31 1.07 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 120.056 1.298 . . . . 0.0 109.957 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -72.71 175.93 5.99 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.667 1.187 . . . . 0.0 112.153 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -115.94 3.9 13.75 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.501 1.52 . . . . 0.0 113.349 -172.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.4 p -124.74 160.66 28.1 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.308 1.443 . . . . 0.0 113.981 -168.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.07 -179.62 8.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.843 2.057 . . . . 0.0 109.875 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -132.12 140.68 48.88 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.352 1.061 . . . . 0.0 113.183 -168.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.6 142.02 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -170.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.25 173.44 25.74 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.928 1.728 . . . . 0.0 115.346 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.1 -25.42 67.7 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.11 -1.229 . . . . 0.0 113.11 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -90.41 5.22 48.38 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.578 1.551 . . . . 0.0 114.667 172.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 56.11 46.5 21.44 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 164.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.53 140.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.379 1.072 . . . . 0.0 111.779 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.06 126.22 31.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.749 1.62 . . . . 0.0 113.491 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.6 m -145.82 162.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.542 1.937 . . . . 0.0 111.429 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -116.92 141.07 48.71 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.431 1.492 . . . . 0.0 113.049 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.209 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 49.1 p . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 7.8 ttt -163.45 123.8 2.24 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.122 0.569 . . . . 0.0 110.184 -174.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -127.58 79.07 1.87 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.304 -0.872 . . . . 0.0 111.017 -170.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -146.72 174.73 11.2 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.21 1.004 . . . . 0.0 112.801 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.435 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 98.6 m-85 -124.73 154.64 40.55 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.1 1.36 . . . . 0.0 111.071 172.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.51 158.0 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.203 0.525 . . . . 0.0 111.661 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.1 151.8 0.92 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.218 1.007 . . . . 0.0 112.371 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.07 -17.26 7.55 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.437 -1.757 . . . . 0.0 116.077 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.6 m -61.89 124.19 20.1 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 120.707 2.253 . . . . 0.0 110.11 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -82.12 141.62 32.95 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.879 1.272 . . . . 0.0 111.538 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.0 mm -117.33 133.32 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.619 1.968 . . . . 0.0 109.577 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.7 tp -71.28 127.18 31.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.678 0.752 . . . . 0.0 112.969 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 p -127.81 166.02 19.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.02 1.328 . . . . 0.0 110.423 174.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.04 70.12 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.503 -0.748 . . . . 0.0 112.126 168.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.8 p -80.02 -25.99 39.99 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.199 1.4 . . . . 0.0 112.677 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.72 -99.11 0.19 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.84 2.162 . . . . 0.0 111.039 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.0 mt -134.98 149.28 50.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.745 1.218 . . . . 0.0 111.855 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.63 143.69 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.633 1.573 . . . . 0.0 108.552 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.45 146.12 53.47 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.022 -1.048 . . . . 0.0 111.127 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 tt -60.8 -30.59 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 120.942 -1.099 . . . . 0.0 113.107 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.27 -16.77 63.65 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.471 1.109 . . . . 0.0 113.836 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -109.37 -12.55 14.73 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.794 1.638 . . . . 0.0 113.117 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.7 mm -63.03 135.64 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.09 0.859 . . . . 0.0 109.421 164.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -127.75 156.09 42.98 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.885 1.674 . . . . 0.0 111.442 175.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.93 135.27 56.01 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.223 -0.923 . . . . 0.0 111.457 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.11 -19.54 54.05 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.712 -1.049 . . . . 0.0 115.166 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -68.42 166.11 17.44 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.899 1.349 . . . . 0.0 111.121 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -124.21 138.67 54.38 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.077 1.351 . . . . 0.0 112.836 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.04 163.88 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.206 1.802 . . . . 0.0 111.203 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -80.09 145.88 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.227 0.536 . . . . 0.0 111.56 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.55 132.3 21.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 m -97.43 112.03 24.04 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.5 0.667 . . . . 0.0 109.864 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -52.76 114.83 6.26 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.448 1.499 . . . . 0.0 113.288 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.75 -7.07 19.52 Favored 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 122.877 2.385 . . . . 0.0 115.299 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -79.44 -38.67 34.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.257 1.423 . . . . 0.0 113.261 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.6 t -141.76 -1.8 1.24 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.784 1.234 . . . . 0.0 112.873 -168.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.26 33.8 m-85 55.13 33.78 21.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.915 2.086 . . . . 0.0 114.244 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -77.95 135.02 37.76 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.632 -0.668 . . . . 0.0 110.342 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.02 122.07 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.317 1.047 . . . . 0.0 110.927 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.13 151.7 41.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.765 0.793 . . . . 0.0 112.872 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -90.14 124.6 34.96 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.213 1.405 . . . . 0.0 109.291 174.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -134.44 150.89 50.88 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.584 1.154 . . . . 0.0 111.424 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.3 t -79.76 153.58 29.11 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -88.83 133.0 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.32 1.848 . . . . 0.0 110.624 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 mt -90.73 -44.21 9.61 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.66 0.784 . . . . 0.0 112.682 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -141.58 157.81 44.64 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.503 1.521 . . . . 0.0 110.641 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.7 p -130.98 116.34 17.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.842 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -103.48 157.94 16.69 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.989 1.315 . . . . 0.0 113.309 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.74 142.52 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.883 2.073 . . . . 0.0 110.204 175.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.1 mmt-85 -140.38 172.81 12.21 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.239 2.215 . . . . 0.0 109.933 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -141.34 135.05 30.12 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.95 -1.094 . . . . 0.0 113.064 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.3 t -151.01 152.59 33.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.875 0.87 . . . . 0.0 112.019 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.7 p -86.24 -15.48 40.66 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.988 1.315 . . . . 0.0 113.43 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -105.75 108.35 19.81 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.205 0.911 . . . . 0.0 112.262 -171.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.6 mt -116.67 160.53 20.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.358 1.075 . . . . 0.0 113.658 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -123.69 138.57 54.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.123 1.769 . . . . 0.0 109.945 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -115.93 128.13 55.53 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.656 1.582 . . . . 0.0 109.253 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.3 mt -128.92 132.76 47.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.233 1.013 . . . . 0.0 110.182 175.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -99.13 113.01 25.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 169.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 mp -107.74 113.19 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.462 1.105 . . . . 0.0 108.469 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.73 -28.67 0.14 Allowed Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.744 2.116 . . . . 0.0 116.751 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.26 -0.35 0.32 Allowed Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.723 1.63 . . . . 0.0 114.073 -165.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -112.31 124.27 52.11 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.511 1.524 . . . . 0.0 109.533 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.56 114.17 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.331 0.652 . . . . 0.0 109.674 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mt -106.31 101.34 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.412 1.085 . . . . 0.0 109.12 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.99 122.18 21.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.019 1.328 . . . . 0.0 110.65 168.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 t -146.91 175.68 10.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.306 1.043 . . . . 0.0 112.639 -168.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.4 p -78.18 146.49 34.98 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.521 -0.737 . . . . 0.0 111.137 169.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.84 -28.45 66.08 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.022 -1.049 . . . . 0.0 112.442 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -96.83 0.14 48.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.56 1.544 . . . . 0.0 113.305 -171.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.435 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.3 t60 -64.8 129.15 94.26 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.473 1.509 . . . . 0.0 113.305 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.52 113.68 2.62 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.463 2.775 . . . . 0.0 114.093 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -103.25 143.69 32.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.133 2.173 . . . . 0.0 111.408 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -89.33 126.18 35.42 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -103.95 135.75 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.489 1.515 . . . . 0.0 111.213 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -57.04 129.12 40.34 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.633 1.173 . . . . 0.0 112.936 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.8 t0 56.19 23.8 7.41 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.172 1.789 . . . . 0.0 114.45 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.5 t -140.74 -50.39 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.799 1.239 . . . . 0.0 111.92 -172.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.21 -169.17 22.53 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.727 0.68 . . . . 0.0 114.201 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -75.8 146.77 39.7 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -162.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.1 p -150.68 146.91 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.89 1.676 . . . . 0.0 111.854 -173.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -54.55 133.31 46.2 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.556 0.742 . . . . 0.0 112.664 171.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.26 -36.7 66.34 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.607 1.563 . . . . 0.0 113.137 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.4 -4.89 81.02 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.03 -1.044 . . . . 0.0 114.739 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -107.45 -4.44 18.48 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.228 1.811 . . . . 0.0 112.553 176.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.59 151.52 46.26 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.449 -0.782 . . . . 0.0 110.428 155.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -118.34 173.78 6.62 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.064 1.346 . . . . 0.0 110.375 170.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.36 139.92 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 165.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.93 9.62 86.93 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 119.099 -0.834 . . . . 0.0 114.565 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -86.38 154.91 20.84 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.28 1.54 . . . . 0.0 110.228 169.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -113.56 115.57 28.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.322 1.049 . . . . 0.0 113.606 -164.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.9 mt -104.98 -176.85 3.19 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.022 2.129 . . . . 0.0 111.441 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.9 mt -131.01 158.89 39.07 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.605 1.162 . . . . 0.0 113.193 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -109.49 172.29 6.94 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.728 1.211 . . . . 0.0 113.395 169.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 t -45.54 -36.88 4.9 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.146 1.779 . . . . 0.0 114.116 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -88.63 -16.92 31.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.054 1.742 . . . . 0.0 113.114 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.46 20.56 10.81 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.914 1.721 . . . . 0.0 112.763 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -83.26 141.02 32.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.444 0.698 . . . . 0.0 110.582 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.93 115.45 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.641 0.776 . . . . 0.0 110.08 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.9 mt -97.01 161.41 13.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.427 1.491 . . . . 0.0 111.449 170.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.84 144.85 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.07 0.948 . . . . 0.0 110.643 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.54 130.99 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.426 0.69 . . . . 0.0 109.66 170.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -108.27 -28.08 9.65 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.838 2.055 . . . . 0.0 112.079 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -157.75 149.59 22.01 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.129 1.772 . . . . 0.0 110.384 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -131.73 130.84 42.46 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.701 2.0 . . . . 0.0 109.629 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -143.2 155.06 44.44 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.023 1.729 . . . . 0.0 111.513 -175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 tp -132.8 144.14 50.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.89 1.676 . . . . 0.0 109.267 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.45 153.81 41.57 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.372 0.987 . . . . 0.0 113.183 166.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 mm -101.4 121.04 51.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.5 152.78 44.5 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.198 0.999 . . . . 0.0 112.953 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -69.63 -28.7 66.13 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.702 -1.249 . . . . 0.0 111.838 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -144.34 148.35 40.48 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.983 2.113 . . . . 0.0 110.123 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -54.69 120.0 7.37 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.489 3.459 . . . . 0.0 112.576 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.73 139.54 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.359 1.463 . . . . 0.0 109.496 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -76.89 139.19 40.15 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.936 0.874 . . . . 0.0 111.212 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.37 147.93 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.279 1.432 . . . . 0.0 110.516 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.72 148.22 50.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.849 1.26 . . . . 0.0 110.893 -165.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -157.54 168.38 27.47 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.462 1.105 . . . . 0.0 111.803 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -153.19 163.66 39.49 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.838 -1.164 . . . . 0.0 112.972 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -113.97 143.86 44.03 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.69 136.13 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 125.528 1.531 . . . . 0.0 112.974 -166.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.18 -28.41 69.11 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -141.62 -44.23 0.36 Allowed 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.978 -1.076 . . . . 0.0 112.607 173.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -71.45 171.67 10.88 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.441 1.115 . . . . 0.0 111.973 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -124.84 12.29 8.46 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.854 2.061 . . . . 0.0 112.715 -169.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.4 p -142.53 168.87 18.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.497 2.319 . . . . 0.0 111.519 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -160.64 175.13 13.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.118 2.167 . . . . 0.0 109.617 166.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -122.74 135.57 54.61 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.046 0.939 . . . . 0.0 113.141 -170.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.94 140.74 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.555 1.542 . . . . 0.0 112.429 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.73 170.15 20.27 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.671 1.605 . . . . 0.0 115.46 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.85 -22.49 66.54 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.693 -1.475 . . . . 0.0 113.023 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -81.49 2.78 27.35 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.182 1.393 . . . . 0.0 114.445 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 61.27 38.94 16.16 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.701 1.2 . . . . 0.0 113.345 164.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.63 137.36 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.668 1.587 . . . . 0.0 112.019 -164.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.2 tp -83.14 120.43 25.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.154 1.382 . . . . 0.0 113.848 -171.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.94 157.46 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.644 1.578 . . . . 0.0 112.052 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -106.87 128.94 54.72 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -167.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--O 1.25 1.098 0 C-N-CA 125.74 1.616 . . . . 0.0 111.993 172.461 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.041 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 99.1 m-85 -126.12 154.03 43.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.837 1.655 . . . . 0.0 111.415 172.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -70.64 162.14 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.495 0.664 . . . . 0.0 112.327 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.47 150.26 5.05 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.439 1.096 . . . . 0.0 112.639 173.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.18 -6.22 22.76 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 117.877 -1.513 . . . . 0.0 116.788 -173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.5 m -63.1 120.38 11.34 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.81 2.305 . . . . 0.0 110.147 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.0 mmt -76.02 146.44 39.48 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.915 1.286 . . . . 0.0 112.224 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 mm -131.64 134.1 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 127.685 2.394 . . . . 0.0 109.918 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 tp -78.91 127.01 31.46 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -120.63 173.89 6.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.667 1.587 . . . . 0.0 111.792 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.87 -24.85 67.66 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.939 -1.1 . . . . 0.0 113.429 175.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 p -107.31 -19.31 13.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.539 1.135 . . . . 0.0 113.518 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.89 -115.34 0.61 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.439 1.019 . . . . 0.0 113.363 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -122.8 153.32 39.7 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.048 1.739 . . . . 0.0 111.799 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.1 p -136.53 152.29 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.929 1.691 . . . . 0.0 110.268 168.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.26 146.09 37.1 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.773 -1.204 . . . . 0.0 110.819 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.2 tt -62.65 -29.49 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 121.044 -1.035 . . . . 0.0 112.664 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -65.39 -11.12 39.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.689 1.196 . . . . 0.0 113.729 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -120.13 -3.65 10.07 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.914 1.685 . . . . 0.0 113.371 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.1 mm -61.43 137.89 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 120.018 1.281 . . . . 0.0 108.806 166.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -124.16 159.05 30.91 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.021 1.328 . . . . 0.0 112.027 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.62 131.71 47.06 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.792 -1.193 . . . . 0.0 110.579 165.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.88 -4.44 82.68 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.601 1.095 . . . . 0.0 115.046 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.92 155.55 37.32 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.148 1.474 . . . . 0.0 111.542 163.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -109.48 150.76 27.64 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.362 1.465 . . . . 0.0 112.393 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.23 157.78 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.567 1.947 . . . . 0.0 110.072 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -73.97 137.9 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.795 -0.566 . . . . 0.0 110.712 165.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.41 118.24 16.19 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -98.05 111.88 24.03 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -54.47 114.76 7.25 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.873 1.269 . . . . 0.0 112.365 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.89 -4.52 14.96 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.711 2.274 . . . . 0.0 114.09 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -77.19 -46.87 21.87 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.682 1.193 . . . . 0.0 112.234 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 t -141.22 6.37 1.93 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.143 0.977 . . . . 0.0 112.84 -168.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 54.68 33.0 18.42 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.573 1.549 . . . . 0.0 114.037 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -71.05 125.85 27.98 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 167.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -96.66 120.13 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 124.227 1.011 . . . . 0.0 109.029 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.6 154.73 50.59 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.2 133.62 36.04 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.078 0.951 . . . . 0.0 108.998 162.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -138.92 152.54 47.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.078 0.951 . . . . 0.0 110.878 171.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 t -89.09 160.16 17.19 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.0 t -96.12 133.73 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.463 1.905 . . . . 0.0 111.575 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 mt -90.8 -43.0 10.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.932 0.893 . . . . 0.0 113.355 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -148.94 156.12 41.82 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.796 2.038 . . . . 0.0 111.138 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.4 p -132.34 103.49 6.24 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.08 1.752 . . . . 0.0 110.416 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -91.06 150.73 21.3 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.6 1.56 . . . . 0.0 112.727 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.8 t -143.02 129.57 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.342 1.057 . . . . 0.0 110.453 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -122.89 175.54 6.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.307 1.843 . . . . 0.0 110.931 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -128.2 137.44 52.04 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.679 1.192 . . . . 0.0 111.323 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.9 t -148.35 149.34 31.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.691 1.196 . . . . 0.0 111.88 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.2 p -91.21 -14.74 30.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.895 1.278 . . . . 0.0 113.863 170.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -100.32 111.34 23.6 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.384 -0.822 . . . . 0.0 111.399 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -120.5 157.83 28.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 122.939 1.352 . . . . 0.0 112.922 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.431 HD11 ' HE2' ' A' ' 102' ' ' LYS . 16.2 tp -126.39 133.31 51.33 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.535 1.934 . . . . 0.0 109.259 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -110.4 124.86 52.51 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.215 1.006 . . . . 0.0 108.773 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.8 mt -118.24 138.76 52.13 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.977 0.911 . . . . 0.0 109.779 171.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.6 m -106.54 122.34 46.11 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.99 117.97 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.075 1.35 . . . . 0.0 108.515 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.65 28.24 51.22 Favored Glycine 0 CA--C 1.544 1.888 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.7 -9.3 78.08 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.35 1.452 . . . . 0.0 115.737 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -92.79 122.93 35.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.002 1.401 . . . . 0.0 110.068 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.0 t -78.98 125.81 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.566 0.746 . . . . 0.0 110.617 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mt -121.77 103.77 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.979 1.711 . . . . 0.0 109.352 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -80.58 122.55 27.19 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.11 1.764 . . . . 0.0 111.035 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 t -146.16 178.22 8.39 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.629 1.172 . . . . 0.0 112.702 -167.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.8 p -82.23 152.75 26.25 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.048 0.927 . . . . 0.0 112.472 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -65.69 -19.38 65.88 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.44 9.38 31.71 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.976 1.311 . . . . 0.0 113.616 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.1 t60 -65.56 129.84 94.46 Favored Pre-proline 0 CA--C 1.552 1.053 0 O-C-N 120.465 -1.397 . . . . 0.0 113.042 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.7 119.92 4.97 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.98 3.12 . . . . 0.0 114.732 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -112.2 150.04 31.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.963 2.105 . . . . 0.0 111.223 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -93.86 130.8 39.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.275 0.943 . . . . 0.0 113.382 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.14 134.32 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 127.499 2.319 . . . . 0.0 111.339 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -58.06 130.26 45.75 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.733 1.213 . . . . 0.0 111.677 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 60.88 16.41 6.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.779 1.632 . . . . 0.0 114.555 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.9 t -133.8 -58.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.255 1.022 . . . . 0.0 111.231 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.93 -152.12 17.16 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.925 0.774 . . . . 0.0 113.714 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -86.75 139.16 30.99 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -170.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.12 149.01 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.249 1.82 . . . . 0.0 111.666 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.93 134.03 51.19 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.482 1.113 . . . . 0.0 112.632 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.95 -36.61 72.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.343 1.457 . . . . 0.0 112.856 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.72 -8.28 81.47 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.508 -1.162 . . . . 0.0 114.559 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -103.02 -12.88 17.12 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.025 1.412 . . . . 0.0 113.731 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.2 mt -56.97 163.08 2.13 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.27 1.428 . . . . 0.0 113.543 170.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.97 164.53 18.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.614 1.565 . . . . 0.0 110.727 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.5 t -67.92 143.73 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 122.39 1.09 . . . . 0.0 110.347 167.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.59 3.69 89.0 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.716 -1.047 . . . . 0.0 114.315 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -84.95 160.56 20.06 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.641 1.72 . . . . 0.0 111.471 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -104.84 103.71 13.36 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.399 1.08 . . . . 0.0 112.458 -160.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.8 mt -93.56 175.84 6.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.07 0.948 . . . . 0.0 110.453 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -122.19 158.85 28.5 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.76 -178.0 3.53 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.398 1.479 . . . . 0.0 113.871 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.1 p -61.25 -17.66 54.48 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -90.33 -25.57 20.41 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.243 1.383 . . . . 0.0 111.603 170.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.73 19.31 18.04 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.796 1.665 . . . . 0.0 112.369 -176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -88.4 155.61 19.59 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.007 1.723 . . . . 0.0 110.793 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -80.73 128.11 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -169.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.6 mt -107.48 162.72 13.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.094 2.158 . . . . 0.0 112.231 169.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.83 139.71 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.365 1.066 . . . . 0.0 111.195 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.5 t -73.73 124.95 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.427 0.691 . . . . 0.0 109.44 171.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -94.83 -33.63 12.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.425 1.89 . . . . 0.0 112.912 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -156.73 149.01 23.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.929 1.291 . . . . 0.0 111.292 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.431 ' HE2' HD11 ' A' ' 53' ' ' LEU . 34.8 tttm -124.73 127.43 47.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.836 2.054 . . . . 0.0 110.3 166.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -140.37 154.06 46.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.667 1.987 . . . . 0.0 111.505 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 tp -140.43 148.67 41.56 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.554 1.542 . . . . 0.0 110.083 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -155.28 164.86 38.2 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.718 0.807 . . . . 0.0 113.102 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mm -96.11 124.62 48.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 123.751 0.82 . . . . 0.0 109.188 161.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.95 150.65 45.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.744 1.218 . . . . 0.0 112.638 172.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -78.4 -13.02 60.03 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.685 1.594 . . . . 0.0 113.075 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -146.87 153.32 45.91 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.55 2.34 . . . . 0.0 110.132 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.48 114.76 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.916 2.411 . . . . 0.0 111.131 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.5 t -85.55 142.8 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.382 1.473 . . . . 0.0 109.989 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -79.71 139.39 37.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.119 0.962 . . . . 0.0 111.613 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.1 m -141.46 141.43 30.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.005 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -120.18 146.61 45.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.241 1.417 . . . . 0.0 110.77 -165.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -153.9 159.57 41.81 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.868 1.267 . . . . 0.0 111.397 173.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -150.72 163.14 39.29 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.434 -1.416 . . . . 0.0 113.568 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -120.26 138.85 53.43 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.72 149.42 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 127.557 2.343 . . . . 0.0 111.898 -168.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.89 -33.86 76.18 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 -168.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -143.81 -53.25 0.35 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.895 1.225 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -66.24 165.95 12.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.684 0.754 . . . . 0.0 110.297 167.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -133.51 27.64 4.04 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.429 1.492 . . . . 0.0 112.25 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.5 p -128.66 164.69 22.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.239 1.816 . . . . 0.0 111.881 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -159.03 -176.59 5.95 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.455 1.902 . . . . 0.0 109.922 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -127.24 138.37 53.09 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.395 1.078 . . . . 0.0 112.95 -171.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.47 143.6 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.194 0.997 . . . . 0.0 113.612 -171.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.35 168.83 20.07 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.615 1.579 . . . . 0.0 114.657 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.36 -22.8 61.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.175 1.39 . . . . 0.0 113.279 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -91.27 -0.9 57.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.762 1.625 . . . . 0.0 114.786 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 62.67 44.25 6.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.9 t -71.64 137.9 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.094 1.358 . . . . 0.0 111.406 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 57.2 tp -80.69 125.63 30.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.704 1.601 . . . . 0.0 113.247 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.49 160.07 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.894 1.678 . . . . 0.0 111.696 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -102.31 156.9 17.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.019 1.328 . . . . 0.0 113.06 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.088 1.755 . . . . 0.0 113.651 171.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.086 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 91.6 m-85 -121.26 156.02 33.39 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.332 1.453 . . . . 0.0 111.511 169.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.95 160.78 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.34 0.591 . . . . 0.0 112.054 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.59 152.5 2.71 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.905 0.86 . . . . 0.0 112.95 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.18 -9.16 20.69 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-O 117.349 -1.806 . . . . 0.0 116.696 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -62.91 123.55 18.79 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 120.878 2.339 . . . . 0.0 110.811 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -80.57 141.91 34.61 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.426 1.49 . . . . 0.0 112.294 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.81 134.85 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.87 2.068 . . . . 0.0 110.036 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.06 126.84 31.62 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.297 1.039 . . . . 0.0 113.032 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.8 p -121.9 172.75 7.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.025 1.33 . . . . 0.0 111.487 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.8 -20.32 65.69 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 120.844 -1.16 . . . . 0.0 113.268 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 p -109.41 -13.07 14.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.913 2.085 . . . . 0.0 113.759 -170.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.24 -112.75 0.64 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 126.087 1.803 . . . . 0.0 112.443 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -133.33 141.67 48.06 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.222 1.009 . . . . 0.0 112.583 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -133.06 144.29 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.446 1.899 . . . . 0.0 109.111 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.59 147.8 47.25 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.274 -0.891 . . . . 0.0 111.027 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -62.9 -27.6 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 120.315 -1.491 . . . . 0.0 113.043 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.58 -16.35 63.83 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.206 1.003 . . . . 0.0 113.457 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -110.61 -10.41 14.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.293 1.837 . . . . 0.0 113.146 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.4 mm -65.12 137.47 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 119.407 1.003 . . . . 0.0 108.921 162.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -127.65 166.06 18.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.915 2.086 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.53 133.67 46.18 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.89 -0.506 . . . . 0.0 110.511 160.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.29 6.73 89.09 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.972 1.272 . . . . 0.0 115.674 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -85.38 155.44 21.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.295 1.048 . . . . 0.0 110.333 165.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.59 135.25 52.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.311 1.044 . . . . 0.0 112.539 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.8 157.13 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.016 1.726 . . . . 0.0 110.652 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.3 mm -76.1 142.38 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.75 0.31 . . . . 0.0 111.275 168.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.63 126.73 22.66 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.904 0.881 . . . . 0.0 109.144 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.0 m -88.41 107.95 19.12 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 165.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -52.94 116.35 9.03 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.529 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.11 -11.22 28.72 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.673 2.249 . . . . 0.0 114.272 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -78.23 -49.1 14.38 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.748 1.219 . . . . 0.0 111.766 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 t -121.67 -7.88 9.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.525 1.13 . . . . 0.0 112.677 -167.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.276 12.9 m-85 53.5 43.02 31.83 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.703 1.601 . . . . 0.0 112.12 -173.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -81.44 131.37 35.28 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.927 0.891 . . . . 0.0 108.755 165.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.17 123.38 47.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 123.232 0.613 . . . . 0.0 110.621 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.2 159.22 42.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.311 1.045 . . . . 0.0 112.502 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -92.14 126.06 37.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.64 1.176 . . . . 0.0 108.87 164.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -137.84 152.83 49.48 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.189 0.996 . . . . 0.0 111.153 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -83.56 156.08 22.96 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.311 1.045 . . . . 0.0 113.058 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.8 t -87.58 134.55 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.706 1.602 . . . . 0.0 111.071 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.6 mt -84.21 -49.03 9.18 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.426 1.09 . . . . 0.0 112.508 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -151.28 159.77 44.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.694 1.998 . . . . 0.0 110.38 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.5 p -120.17 122.96 42.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.919 2.088 . . . . 0.0 109.571 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -101.46 147.02 26.85 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.89 0.876 . . . . 0.0 112.998 173.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.03 135.09 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.06 1.344 . . . . 0.0 110.077 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -126.86 170.93 11.71 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.028 2.131 . . . . 0.0 109.246 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -131.56 136.59 47.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.426 0.69 . . . . 0.0 111.714 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 t -154.57 146.93 23.91 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.598 0.759 . . . . 0.0 111.348 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.7 p -84.24 -18.32 36.89 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.716 0.806 . . . . 0.0 111.884 162.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -99.47 110.03 22.54 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 120.857 -1.152 . . . . 0.0 110.766 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.1 mt -121.5 172.53 8.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.767 1.627 . . . . 0.0 111.383 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.7 tp -141.32 130.48 23.43 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.893 1.277 . . . . 0.0 111.321 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -112.19 106.9 15.61 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.019 -1.05 . . . . 0.0 109.971 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.8 142.25 29.8 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.458 -0.776 . . . . 0.0 110.376 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.6 m -115.45 120.83 40.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.951 0.901 . . . . 0.0 109.471 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.02 117.37 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 126.32 1.848 . . . . 0.0 108.634 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.57 30.09 41.51 Favored Glycine 0 CA--C 1.543 1.789 0 N-CA-C 115.717 1.047 . . . . 0.0 115.717 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.08 6.4 84.8 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -102.37 129.38 48.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.881 1.341 . . . . 0.0 110.149 165.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -86.71 129.02 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.895 0.878 . . . . 0.0 110.287 164.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mt -121.7 101.51 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.07 1.348 . . . . 0.0 109.201 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.87 117.16 15.32 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.819 1.648 . . . . 0.0 110.732 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 t -142.72 -179.97 6.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.886 1.274 . . . . 0.0 112.464 -165.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.0 p -87.72 156.98 19.18 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 122.135 0.969 . . . . 0.0 112.353 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -59.45 -31.38 69.26 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.534 1.134 . . . . 0.0 113.082 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -101.05 8.96 42.67 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.5 t60 -64.08 128.12 92.68 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.474 1.034 . . . . 0.0 112.871 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.12 119.07 2.74 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.181 2.587 . . . . 0.0 114.947 -175.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -108.74 150.3 27.79 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.98 2.112 . . . . 0.0 111.472 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -98.19 130.04 44.94 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.517 1.053 . . . . 0.0 113.556 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.97 137.1 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.762 2.425 . . . . 0.0 111.392 -173.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -57.59 121.93 11.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.767 2.027 . . . . 0.0 112.671 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 53.03 30.04 8.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.616 1.967 . . . . 0.0 114.262 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.5 t -136.29 -50.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.469 1.508 . . . . 0.0 112.009 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.71 -153.58 17.53 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.046 0.831 . . . . 0.0 113.783 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -87.57 141.24 28.77 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.415 -1.05 . . . . 0.0 113.667 -173.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.95 145.28 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.284 1.433 . . . . 0.0 111.808 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.25 137.12 57.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.949 1.3 . . . . 0.0 112.098 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.18 -35.77 69.99 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.346 1.058 . . . . 0.0 113.64 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.04 -16.82 67.04 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 121.299 -0.876 . . . . 0.0 114.02 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -103.29 -2.04 27.8 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.467 1.907 . . . . 0.0 113.512 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.28 151.82 39.52 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.676 -0.64 . . . . 0.0 110.836 162.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.21 157.87 39.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.894 1.678 . . . . 0.0 109.623 170.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.53 136.8 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.07 4.78 88.17 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-O 118.856 -0.969 . . . . 0.0 115.441 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -83.29 150.17 26.32 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.546 1.673 . . . . 0.0 110.098 170.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -108.6 113.54 26.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.561 1.544 . . . . 0.0 112.631 -165.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.6 165.49 11.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.645 1.578 . . . . 0.0 112.627 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.71 142.42 36.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.667 1.587 . . . . 0.0 110.892 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -96.11 -178.13 4.23 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.986 0.915 . . . . 0.0 113.203 166.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.7 p -62.57 -1.77 0.91 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.628 1.971 . . . . 0.0 116.257 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.7 mtm-85 -117.8 -27.49 6.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.101 2.161 . . . . 0.0 111.565 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 104.43 17.32 15.67 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.813 2.149 . . . . 0.0 113.449 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -69.28 159.3 33.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.891 0.876 . . . . 0.0 111.14 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.3 t -75.87 131.41 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.747 0.784 . . . . 0.0 110.786 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.6 mt -117.5 158.47 24.49 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.931 2.092 . . . . 0.0 109.699 161.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.4 142.26 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.408 0.683 . . . . 0.0 111.277 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.48 129.4 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.429 1.091 . . . . 0.0 110.352 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -102.45 -33.91 9.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.351 2.26 . . . . 0.0 112.966 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -159.52 152.19 21.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.795 1.638 . . . . 0.0 111.797 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -124.92 124.06 41.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.053 2.141 . . . . 0.0 109.816 159.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -118.59 140.17 50.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.891 2.076 . . . . 0.0 109.868 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 tp -121.31 125.59 47.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.884 1.274 . . . . 0.0 110.637 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.66 159.34 39.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.582 0.706 . . . . 0.0 112.268 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.7 mm -111.36 114.07 46.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 166.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.36 150.7 42.8 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 122.103 0.954 . . . . 0.0 111.723 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.04 -22.09 60.69 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.944 1.298 . . . . 0.0 112.819 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -134.74 151.88 76.56 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 126.292 1.837 . . . . 0.0 111.131 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.91 111.28 3.0 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.683 2.256 . . . . 0.0 110.899 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.16 141.5 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 126.245 1.818 . . . . 0.0 109.674 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -75.28 134.27 41.12 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.297 1.046 . . . . 0.0 110.247 172.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.44 130.49 67.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.226 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -112.36 148.18 34.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.012 1.725 . . . . 0.0 110.959 -166.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -153.35 169.02 24.13 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.327 1.451 . . . . 0.0 109.867 171.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -148.73 171.74 15.73 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 120.398 -1.439 . . . . 0.0 111.674 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -128.52 139.55 52.26 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.817 0.847 . . . . 0.0 112.682 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.421 ' H ' ' ND2' ' A' ' 135' ' ' ASN . 89.9 t -98.47 145.43 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.982 1.713 . . . . 0.0 111.62 -169.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.13 -40.62 86.04 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -166.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -133.6 -36.9 0.95 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.035 0.934 . . . . 0.0 112.57 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.76 160.45 29.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.933 0.873 . . . . 0.0 110.533 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -114.95 11.52 16.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.202 1.401 . . . . 0.0 112.832 -171.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 p -145.5 166.51 25.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.191 1.797 . . . . 0.0 112.381 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -156.42 -179.01 7.76 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.768 1.627 . . . . 0.0 110.774 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -122.79 138.54 54.61 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.161 1.384 . . . . 0.0 112.413 -175.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -123.3 141.46 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.323 1.449 . . . . 0.0 111.962 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.96 -176.22 53.21 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 168.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.53 -34.66 72.54 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.995 1.718 . . . . 0.0 112.41 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -82.73 -4.54 58.03 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.362 1.065 . . . . 0.0 113.471 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 59.14 47.17 12.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.202 1.801 . . . . 0.0 114.093 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 t -72.96 137.15 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.916 1.286 . . . . 0.0 111.316 -170.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 52.7 tp -81.43 125.98 31.09 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.167 1.387 . . . . 0.0 113.104 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.1 m -138.33 156.72 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.956 1.702 . . . . 0.0 111.301 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -105.81 146.66 29.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.851 1.26 . . . . 0.0 112.129 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 118' ' ' VAL . 18.3 m-20 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.177 0.991 . . . . 0.0 111.835 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.025 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.431 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 96.9 m-85 -128.02 153.23 47.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.408 1.483 . . . . 0.0 112.168 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 m -69.07 154.72 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.15 139.69 28.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.816 0.847 . . . . 0.0 111.55 171.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.72 -6.09 81.7 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.113 -1.382 . . . . 0.0 116.156 -170.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.9 m -64.3 123.43 19.12 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 121.163 2.482 . . . . 0.0 110.336 172.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.5 mmt -83.16 142.12 31.44 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.337 1.055 . . . . 0.0 112.08 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.19 135.03 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.369 2.267 . . . . 0.0 109.642 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.69 133.41 42.07 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 p -137.23 165.84 25.19 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.281 1.432 . . . . 0.0 111.195 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.56 -19.33 63.57 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.44 1.096 . . . . 0.0 113.372 170.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.4 p -86.57 -32.73 20.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.955 1.302 . . . . 0.0 111.64 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.71 -98.79 0.19 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.211 1.862 . . . . 0.0 110.612 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.4 mt -130.48 149.29 52.22 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.153 0.981 . . . . 0.0 111.867 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.5 141.25 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.859 1.663 . . . . 0.0 108.884 169.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.18 148.79 49.39 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.122 -0.986 . . . . 0.0 110.75 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.1 tt -61.48 -28.17 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 120.752 -1.217 . . . . 0.0 112.847 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.98 -6.64 46.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.905 1.282 . . . . 0.0 113.96 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -117.59 -7.96 11.0 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.121 1.769 . . . . 0.0 114.322 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.1 mm -66.81 139.41 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.928 0.785 . . . . 0.0 109.545 161.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -120.42 162.73 19.02 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.614 1.966 . . . . 0.0 110.32 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.5 135.54 54.37 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.093 0.473 . . . . 0.0 110.139 155.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.04 11.6 83.52 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.728 -1.04 . . . . 0.0 115.192 -176.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -96.86 158.0 15.64 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.846 1.323 . . . . 0.0 110.947 162.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -112.55 137.95 50.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.997 1.719 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -135.07 161.25 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.199 1.799 . . . . 0.0 111.163 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -76.52 143.11 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.661 0.664 . . . . 0.0 111.425 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.84 132.06 23.3 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.49 172.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.9 m -79.69 112.98 17.5 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 162.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -52.9 123.49 32.76 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 124.585 1.154 . . . . 0.0 112.392 171.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.0 -2.46 11.78 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 123.076 2.517 . . . . 0.0 114.778 -174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -90.78 -48.86 6.78 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.687 1.195 . . . . 0.0 112.004 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 t -127.67 1.56 6.13 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -166.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 61.02 27.41 17.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.339 1.456 . . . . 0.0 114.365 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.85 120.13 15.13 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.422 1.489 . . . . 0.0 109.157 170.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.5 t -100.56 120.48 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.454 0.701 . . . . 0.0 109.163 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.24 164.94 33.37 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.833 0.853 . . . . 0.0 112.089 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.56 137.82 48.34 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.692 0.397 . . . . 0.0 110.416 159.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -135.71 153.04 51.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.687 1.195 . . . . 0.0 111.117 161.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 t -78.12 154.46 31.24 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.2 t -91.93 135.0 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 127.039 2.136 . . . . 0.0 110.393 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.1 mt -87.56 -49.48 7.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.579 1.151 . . . . 0.0 112.33 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -146.57 156.66 43.4 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.179 1.392 . . . . 0.0 111.132 -175.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.5 p -124.86 119.51 29.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.238 1.815 . . . . 0.0 109.071 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -106.72 149.45 27.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.522 1.129 . . . . 0.0 113.316 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.6 t -139.03 142.32 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.2 1.4 . . . . 0.0 111.379 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -139.96 178.22 7.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.419 2.287 . . . . 0.0 111.988 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -129.65 141.09 50.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.05 1.74 . . . . 0.0 111.992 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 t -155.2 153.1 30.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.64 1.176 . . . . 0.0 111.639 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 p -90.0 -18.41 26.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.435 1.094 . . . . 0.0 113.296 164.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -95.0 106.98 19.0 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.391 -0.818 . . . . 0.0 111.725 -177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.7 mt -118.72 168.51 10.66 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.854 1.262 . . . . 0.0 112.571 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 tp -139.04 133.95 32.35 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.715 1.606 . . . . 0.0 110.967 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -106.06 138.1 42.83 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.469 1.508 . . . . 0.0 109.889 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.2 mt -127.21 130.53 49.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.309 1.043 . . . . 0.0 109.961 167.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.9 m -96.73 124.1 40.61 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 167.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.57 117.53 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.362 1.465 . . . . 0.0 109.289 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.53 29.36 31.56 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.09 7.75 79.86 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 116.856 1.502 . . . . 0.0 116.856 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -112.04 140.33 46.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.844 1.822 . . . . 0.0 108.519 163.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -108.49 134.4 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 124.612 1.165 . . . . 0.0 111.837 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 57.9 mt -129.17 136.45 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.858 1.663 . . . . 0.0 109.278 -171.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -120.44 107.21 12.62 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.249 1.42 . . . . 0.0 109.905 -162.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -138.73 175.65 9.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.223 1.409 . . . . 0.0 113.241 -157.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 p -82.87 152.16 25.7 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.922 0.868 . . . . 0.0 111.472 166.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -56.87 -31.02 64.41 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.652 1.181 . . . . 0.0 112.702 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -95.4 1.64 54.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.022 1.329 . . . . 0.0 114.109 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.431 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.0 t60 -65.69 126.64 92.03 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 118.509 -0.758 . . . . 0.0 112.602 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.28 117.37 2.8 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.732 2.288 . . . . 0.0 114.508 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -100.98 143.21 31.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.004 2.121 . . . . 0.0 111.046 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -89.15 127.48 35.73 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.537 1.062 . . . . 0.0 112.432 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.41 136.53 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.472 1.909 . . . . 0.0 110.395 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.2 tptt -50.85 130.75 25.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.772 1.629 . . . . 0.0 110.658 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t70 58.7 10.09 1.34 Allowed 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.5 t -131.55 -47.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.406 -1.433 . . . . 0.0 111.567 -167.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.63 -162.59 14.83 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.791 0.71 . . . . 0.0 113.3 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -76.72 147.5 37.34 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -172.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.91 145.8 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.102 2.161 . . . . 0.0 111.014 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.15 136.72 58.11 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.771 0.828 . . . . 0.0 112.839 172.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.88 -39.47 62.69 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.455 1.502 . . . . 0.0 113.41 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.34 -17.42 74.26 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 121.217 -0.927 . . . . 0.0 114.199 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -104.7 5.32 33.38 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.167 2.187 . . . . 0.0 113.806 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.04 160.89 30.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.632 0.651 . . . . 0.0 110.544 165.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -125.01 150.31 46.85 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.54 1.136 . . . . 0.0 111.58 172.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.72 134.85 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.26 4.35 81.14 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.791 -1.005 . . . . 0.0 114.956 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -92.33 159.53 15.55 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.247 1.524 . . . . 0.0 112.396 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -108.88 109.01 20.0 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.915 1.286 . . . . 0.0 112.47 -157.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 mt -103.14 -177.69 3.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.702 1.601 . . . . 0.0 111.725 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.1 mt -134.53 156.75 48.08 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.445 1.098 . . . . 0.0 113.274 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.96 -175.7 2.79 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.485 1.514 . . . . 0.0 114.413 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -64.62 -6.51 7.84 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -103.44 -16.02 15.71 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.104 1.762 . . . . 0.0 112.605 167.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.04 19.54 50.33 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.442 1.496 . . . . 0.0 112.238 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -84.2 145.94 28.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.46 1.104 . . . . 0.0 110.278 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.9 t -76.0 115.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.087 0.47 . . . . 0.0 110.985 -174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.6 mt -93.37 157.64 16.13 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.973 1.709 . . . . 0.0 111.388 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 t -123.04 138.78 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.294 1.037 . . . . 0.0 110.841 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.16 126.01 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.664 0.786 . . . . 0.0 109.414 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -106.35 -25.25 12.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.759 2.024 . . . . 0.0 113.089 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -163.07 150.81 13.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.933 1.293 . . . . 0.0 111.857 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -120.59 128.37 52.98 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.739 2.016 . . . . 0.0 109.466 161.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -130.85 123.78 29.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.985 1.314 . . . . 0.0 110.964 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.3 tp -102.26 129.32 48.64 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.033 1.333 . . . . 0.0 109.795 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -126.88 149.59 49.69 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.105 0.955 . . . . 0.0 112.961 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.2 mm -111.68 105.6 19.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 171.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.65 154.55 32.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.25 1.02 . . . . 0.0 111.369 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.43 -21.31 28.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.912 0.885 . . . . 0.0 112.054 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -136.95 140.39 31.44 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.43 1.492 . . . . 0.0 110.321 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.12 117.63 4.43 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.019 3.146 . . . . 0.0 111.886 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.04 137.04 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.557 1.543 . . . . 0.0 110.001 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -74.98 135.52 41.33 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.98 0.895 . . . . 0.0 110.566 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -132.6 133.84 59.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 125.096 1.358 . . . . 0.0 110.946 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -117.2 153.94 32.0 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.713 1.605 . . . . 0.0 111.273 -166.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -152.49 155.71 38.0 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.332 2.253 . . . . 0.0 109.348 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -150.46 161.04 43.28 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.57 -1.331 . . . . 0.0 112.614 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.4 148.39 43.84 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.26 144.85 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 125.806 1.643 . . . . 0.0 112.819 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.74 -29.22 63.15 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -164.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -138.63 -41.08 0.5 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.792 -1.192 . . . . 0.0 113.144 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -75.88 165.36 25.11 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.706 -0.621 . . . . 0.0 110.134 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -124.99 32.05 5.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.376 1.471 . . . . 0.0 110.747 -170.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -156.85 164.02 38.54 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.588 1.555 . . . . 0.0 111.268 -162.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -161.97 174.3 13.26 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.189 1.796 . . . . 0.0 110.447 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -121.07 136.34 55.0 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.767 1.227 . . . . 0.0 112.975 -173.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.9 m -127.27 144.91 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.712 1.605 . . . . 0.0 113.91 -173.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.72 172.94 30.13 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 126.038 1.78 . . . . 0.0 115.063 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.63 -20.03 63.62 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.48 -1.6 . . . . 0.0 113.236 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -85.08 -2.18 57.7 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 169.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 57.33 51.52 9.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.664 1.585 . . . . 0.0 112.694 163.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.02 140.1 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.845 2.058 . . . . 0.0 111.697 -168.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 46.0 tp -79.07 127.37 31.91 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.134 1.373 . . . . 0.0 114.33 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.48 154.71 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.858 1.663 . . . . 0.0 111.377 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -103.04 141.63 35.48 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.086 0.954 . . . . 0.0 113.272 -169.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.27 0 CA-C-O 116.322 -1.799 . . . . 0.0 111.242 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.982 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.415 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.4 m-85 -122.35 154.14 38.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.088 1.355 . . . . 0.0 111.491 172.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 m -69.3 154.69 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.0 0.429 . . . . 0.0 111.998 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.21 140.58 20.91 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.034 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.53 -9.46 71.47 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.544 2.021 . . . . 0.0 114.662 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 59.0 m -67.4 126.46 29.35 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.367 1.583 . . . . 0.0 111.5 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.4 mmt -78.1 143.6 37.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.858 1.663 . . . . 0.0 112.487 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.0 mm -129.61 139.0 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.608 1.963 . . . . 0.0 110.431 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.92 129.77 34.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.262 1.425 . . . . 0.0 113.066 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.8 p -134.66 173.03 12.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.777 1.231 . . . . 0.0 113.71 -167.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.07 -13.12 32.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.55 1.54 . . . . 0.0 113.794 171.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.7 p -124.33 1.89 8.43 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.7 -117.89 2.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.396 1.951 . . . . 0.0 110.758 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.51 142.54 46.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.496 1.118 . . . . 0.0 112.634 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.97 148.91 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 127.269 2.227 . . . . 0.0 108.94 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.87 147.33 51.86 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.313 -0.867 . . . . 0.0 112.027 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.5 tt -62.48 -33.31 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 120.936 -1.103 . . . . 0.0 112.514 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.8 pm0 -68.71 -16.5 63.84 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -104.78 -14.74 15.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.039 1.336 . . . . 0.0 112.571 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.2 mm -58.66 133.96 23.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 O-C-N 121.126 -0.984 . . . . 0.0 109.432 164.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -119.81 161.67 20.4 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.386 1.874 . . . . 0.0 112.357 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.38 133.74 53.18 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.84 -0.538 . . . . 0.0 110.556 167.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.13 -6.54 81.22 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.869 1.223 . . . . 0.0 114.785 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.96 150.72 40.61 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.099 1.45 . . . . 0.0 109.628 168.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.87 120.6 42.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.87 0.868 . . . . 0.0 111.2 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.5 m -106.06 151.46 8.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 125.195 1.398 . . . . 0.0 110.083 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.6 mm -81.67 137.08 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.52 116.23 13.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 m -93.07 111.41 23.04 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -52.95 115.01 6.62 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.897 1.279 . . . . 0.0 112.24 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -74.61 -1.61 11.32 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.054 2.503 . . . . 0.0 115.285 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -85.67 -46.75 10.45 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.785 -1.197 . . . . 0.0 112.317 170.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -126.31 -7.4 6.43 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.166 0.986 . . . . 0.0 113.127 -163.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.279 95.5 m-85 58.13 30.41 19.31 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.344 2.257 . . . . 0.0 115.017 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.92 130.05 39.12 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.57 0.748 . . . . 0.0 109.238 170.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -92.37 128.34 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.766 0.826 . . . . 0.0 109.501 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.37 149.36 39.29 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -69.3 136.11 51.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.389 0.676 . . . . 0.0 110.235 156.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 149.01 44.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.886 1.274 . . . . 0.0 110.026 159.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -78.06 153.58 32.16 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.898 0.856 . . . . 0.0 113.176 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.0 t -85.88 120.62 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.7 1.6 . . . . 0.0 109.757 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.71 -52.05 23.49 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.32 0.648 . . . . 0.0 111.12 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -146.24 156.58 43.48 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.266 1.426 . . . . 0.0 111.9 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 p -117.73 118.47 32.15 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.266 1.827 . . . . 0.0 111.148 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -104.52 151.93 23.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.693 1.597 . . . . 0.0 113.316 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 114' ' ' TYR . 16.3 t -136.4 140.98 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.0 1.72 . . . . 0.0 109.016 173.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -140.76 176.54 8.71 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.081 1.752 . . . . 0.0 109.889 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -131.61 134.32 45.89 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.576 1.15 . . . . 0.0 111.271 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -144.21 152.03 40.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.211 1.004 . . . . 0.0 110.926 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.7 p -96.76 -15.03 21.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.219 1.407 . . . . 0.0 113.658 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -109.17 106.05 15.77 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.824 0.85 . . . . 0.0 110.682 -170.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.3 mt -116.78 163.94 15.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 122.369 1.081 . . . . 0.0 113.817 -172.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.4 HD11 ' HD2' ' A' ' 102' ' ' LYS . 14.8 tp -137.26 129.14 28.97 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.694 1.597 . . . . 0.0 111.853 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -110.51 103.83 12.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.616 1.566 . . . . 0.0 111.188 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.21 141.29 28.59 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.057 0.943 . . . . 0.0 110.058 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.0 m -114.18 125.26 53.73 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 167.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.06 119.46 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.953 1.301 . . . . 0.0 109.891 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.05 24.55 35.64 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.158 0.885 . . . . 0.0 115.149 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.89 -0.36 69.62 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.042 1.306 . . . . 0.0 116.285 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -108.74 125.54 52.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.592 1.696 . . . . 0.0 110.292 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -91.7 134.74 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.143 0.977 . . . . 0.0 112.64 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 mt -133.9 132.21 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.642 1.977 . . . . 0.0 108.828 -170.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -120.99 105.92 11.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.154 0.982 . . . . 0.0 109.538 -159.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 t -140.05 175.75 9.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.916 0.887 . . . . 0.0 113.328 -156.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.0 p -80.54 152.39 28.67 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.897 0.879 . . . . 0.0 112.182 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -61.18 -29.37 69.76 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.974 -1.079 . . . . 0.0 112.656 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -94.19 2.4 55.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.397 1.079 . . . . 0.0 113.456 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.415 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.1 t60 -64.52 128.73 93.72 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 120.97 -1.081 . . . . 0.0 112.826 -172.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -79.93 112.39 2.86 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.561 2.841 . . . . 0.0 114.45 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -102.64 145.59 29.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.18 1.792 . . . . 0.0 111.956 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -93.3 132.04 37.88 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -116.65 135.63 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 127.303 2.241 . . . . 0.0 111.395 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -55.39 129.38 38.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.154 0.982 . . . . 0.0 110.982 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 64.66 9.01 4.83 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.47 1.908 . . . . 0.0 115.588 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.4 t -132.06 -44.66 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 120.882 -1.136 . . . . 0.0 112.344 -172.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.23 -147.75 17.83 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.213 -0.771 . . . . 0.0 112.377 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.28 53.4 p90 -91.26 143.12 26.98 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -144.63 147.98 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.829 2.052 . . . . 0.0 111.922 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -59.37 135.04 57.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.911 0.885 . . . . 0.0 112.63 171.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.58 -37.15 72.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.738 1.215 . . . . 0.0 113.014 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.36 -18.32 71.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.997 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -97.06 -1.94 44.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.629 1.572 . . . . 0.0 113.943 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.9 mt -70.51 156.59 39.19 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.651 0.78 . . . . 0.0 112.46 171.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -118.26 156.91 28.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.789 1.636 . . . . 0.0 111.433 170.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.36 132.33 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.883 0.873 . . . . 0.0 110.065 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.76 60.87 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.98 1.276 . . . . 0.0 115.655 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -86.97 159.03 19.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.489 1.645 . . . . 0.0 113.047 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -101.89 102.92 13.56 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.448 1.499 . . . . 0.0 112.361 -159.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.7 mt -95.81 166.84 11.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.528 1.131 . . . . 0.0 111.67 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.62 153.44 22.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.92 1.288 . . . . 0.0 110.306 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -109.89 -174.35 2.47 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 172.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.9 p -57.59 -12.75 3.03 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -103.7 -26.6 12.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.171 1.389 . . . . 0.0 111.342 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.83 22.2 24.04 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.335 1.922 . . . . 0.0 111.819 -167.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -76.75 159.58 30.03 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.764 0.826 . . . . 0.0 109.898 167.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.26 130.73 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.528 0.68 . . . . 0.0 112.328 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.4 158.65 20.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.036 2.934 . . . . 0.0 111.227 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.13 139.24 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.212 1.005 . . . . 0.0 111.266 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.2 t -73.71 125.75 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.539 0.736 . . . . 0.0 110.23 172.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -100.96 -26.71 13.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.621 2.369 . . . . 0.0 113.515 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -161.77 152.4 17.63 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.203 1.401 . . . . 0.0 111.565 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.4 ' HD2' HD11 ' A' ' 53' ' ' LEU . 20.3 ttpp -127.17 132.8 50.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.737 1.615 . . . . 0.0 111.067 156.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -132.12 154.83 49.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 128.524 2.73 . . . . 0.0 110.023 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 tt -142.6 137.18 29.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.509 1.524 . . . . 0.0 110.436 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -135.1 149.89 50.13 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.1 mm -106.58 105.67 19.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.954 1.302 . . . . 0.0 108.6 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.62 148.35 49.47 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.754 1.222 . . . . 0.0 113.221 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.19 -14.61 60.15 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.748 1.219 . . . . 0.0 113.354 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -151.25 153.52 32.72 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 126.708 2.003 . . . . 0.0 110.69 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.18 122.92 11.31 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.328 2.686 . . . . 0.0 112.861 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.97 142.04 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.8 1.64 . . . . 0.0 109.837 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -79.81 140.62 36.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.797 0.839 . . . . 0.0 111.269 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.2 m -143.75 150.59 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.307 1.043 . . . . 0.0 111.162 -173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.463 ' CD2' HG22 ' A' ' 46' ' ' VAL . 64.4 m-85 -128.1 147.15 50.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.712 1.205 . . . . 0.0 111.265 -165.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -155.94 166.79 32.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.257 1.823 . . . . 0.0 109.129 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -150.54 172.33 15.66 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.329 -1.482 . . . . 0.0 111.655 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -122.02 132.7 54.65 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.47 138.23 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.948 1.699 . . . . 0.0 111.486 -172.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.38 -33.33 65.63 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -148.28 -37.08 0.19 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.025 -1.047 . . . . 0.0 113.689 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -73.71 166.65 22.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.987 0.915 . . . . 0.0 110.424 172.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -133.77 28.58 3.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.448 1.499 . . . . 0.0 112.791 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.7 p -136.34 161.24 36.34 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.075 1.75 . . . . 0.0 111.511 175.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -157.6 -179.28 8.02 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.287 1.835 . . . . 0.0 109.814 167.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -132.95 139.33 47.25 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.26 1.024 . . . . 0.0 112.841 -168.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.78 141.4 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -170.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.36 172.55 31.59 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.39 1.472 . . . . 0.0 115.709 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.33 -19.23 65.31 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.927 -1.337 . . . . 0.0 113.808 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -93.77 1.51 56.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.402 1.481 . . . . 0.0 114.154 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 57.74 46.17 17.64 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.861 1.664 . . . . 0.0 114.217 166.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.26 138.09 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.397 1.079 . . . . 0.0 111.632 -171.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.66 124.96 28.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.799 1.639 . . . . 0.0 112.498 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.97 151.82 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.311 1.444 . . . . 0.0 110.845 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -81.69 146.76 29.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.976 0.51 . . . . 0.0 110.569 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 C--O 1.251 1.18 0 C-N-CA 124.788 1.235 . . . . 0.0 113.592 178.254 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.966 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -119.45 151.22 38.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.842 1.257 . . . . 0.0 110.915 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.82 158.73 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.272 0.558 . . . . 0.0 111.918 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.21 150.6 4.45 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.089 0.947 . . . . 0.0 111.63 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.47 -18.97 15.96 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 117.272 -1.849 . . . . 0.0 116.357 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.9 m -63.6 121.41 13.83 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.202 2.501 . . . . 0.0 110.718 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -77.76 143.77 37.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.476 1.111 . . . . 0.0 112.387 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.2 mm -126.81 136.46 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 127.548 2.339 . . . . 0.0 109.828 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -78.5 129.09 34.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.518 1.127 . . . . 0.0 113.441 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -127.52 173.59 9.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.57 1.548 . . . . 0.0 111.751 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.53 -15.1 63.14 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.851 -1.156 . . . . 0.0 113.371 172.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 p -109.03 -8.74 15.14 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.898 1.679 . . . . 0.0 114.21 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.38 -113.98 0.97 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.408 1.48 . . . . 0.0 111.412 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.8 mt -120.66 153.97 36.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.625 1.17 . . . . 0.0 111.584 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -137.63 144.99 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.667 1.987 . . . . 0.0 108.029 166.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.75 148.32 46.46 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.756 -1.215 . . . . 0.0 111.316 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 tt -63.32 -27.4 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 120.42 -1.425 . . . . 0.0 113.056 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -70.46 -7.15 41.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.964 1.306 . . . . 0.0 114.351 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -118.17 -15.37 9.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.644 1.578 . . . . 0.0 113.084 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.02 135.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.918 1.235 . . . . 0.0 110.295 169.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -120.75 159.06 26.18 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.644 1.578 . . . . 0.0 112.375 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 137.89 55.5 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.421 -0.8 . . . . 0.0 110.533 167.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.61 -6.67 72.4 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.376 0.989 . . . . 0.0 115.133 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -67.95 177.65 2.08 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.812 1.306 . . . . 0.0 110.99 167.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -120.14 153.45 36.17 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.9 -1.125 . . . . 0.0 112.584 168.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 m -141.45 160.83 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.754 1.622 . . . . 0.0 110.609 175.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.2 mm -77.99 135.87 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 122.041 -0.412 . . . . 0.0 111.2 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.2 120.82 21.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.754 1.222 . . . . 0.0 107.71 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.2 m -96.65 103.18 15.07 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -47.84 118.91 6.55 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.027 1.331 . . . . 0.0 112.479 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.46 -10.37 28.47 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.27 1.98 . . . . 0.0 114.107 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -77.54 -34.96 53.71 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.791 1.636 . . . . 0.0 113.315 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.7 t -144.91 -3.91 0.76 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.142 1.377 . . . . 0.0 112.702 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 54.73 40.23 31.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.598 1.559 . . . . 0.0 113.565 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -77.87 124.22 27.73 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.505 1.122 . . . . 0.0 109.494 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -85.92 123.85 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.083 0.553 . . . . 0.0 110.779 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.35 162.83 34.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.849 0.833 . . . . 0.0 112.972 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -103.84 116.47 32.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.853 1.661 . . . . 0.0 109.416 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -133.91 154.5 51.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.876 1.27 . . . . 0.0 111.444 -170.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 t -87.87 157.1 19.07 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.6 t -88.59 128.35 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.408 1.483 . . . . 0.0 110.843 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -83.3 -55.78 4.13 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.009 0.524 . . . . 0.0 111.333 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -138.7 152.73 48.26 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.601 1.161 . . . . 0.0 111.627 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -128.01 107.98 10.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.759 1.624 . . . . 0.0 110.411 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -96.31 146.3 24.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.403 1.081 . . . . 0.0 111.706 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 t -136.79 137.04 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.996 0.918 . . . . 0.0 109.192 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -133.95 175.4 9.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.525 2.33 . . . . 0.0 109.256 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -131.6 132.22 43.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.312 1.045 . . . . 0.0 111.751 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 t -141.66 140.27 33.19 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.422 1.089 . . . . 0.0 111.101 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -85.19 -21.98 28.92 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.535 0.734 . . . . 0.0 112.287 165.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -92.87 120.63 33.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.92 0.782 . . . . 0.0 109.495 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.3 mt -126.61 161.96 26.82 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.481 1.134 . . . . 0.0 112.673 174.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 tp -127.83 128.87 45.99 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.461 1.904 . . . . 0.0 109.918 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -113.22 95.9 5.63 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.197 -0.94 . . . . 0.0 109.29 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.0 mt -83.69 145.04 28.99 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.444 -0.785 . . . . 0.0 110.291 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -117.32 120.01 36.89 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -128.12 120.99 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.997 1.319 . . . . 0.0 108.61 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.52 31.12 28.43 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.42 -5.75 83.76 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.221 1.391 . . . . 0.0 116.0 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -94.96 125.93 39.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.236 1.518 . . . . 0.0 109.581 172.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.19 132.42 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.313 0.645 . . . . 0.0 110.998 167.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -123.47 103.32 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.282 1.833 . . . . 0.0 109.072 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -77.67 106.91 9.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.48 2.312 . . . . 0.0 110.766 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 t -137.47 -179.34 5.68 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.156 1.382 . . . . 0.0 112.103 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.0 p -88.25 163.36 16.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.77 1.228 . . . . 0.0 111.91 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -68.45 -25.76 65.17 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.867 -1.146 . . . . 0.0 112.45 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -106.43 9.6 31.67 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.654 0.782 . . . . 0.0 113.006 -171.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -72.19 131.68 84.96 Favored Pre-proline 0 CA--C 1.553 1.066 0 O-C-N 121.369 -0.832 . . . . 0.0 112.717 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.3 120.05 2.83 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.201 3.268 . . . . 0.0 115.575 -175.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -106.88 145.16 32.52 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.462 1.905 . . . . 0.0 111.201 172.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -88.96 131.45 35.15 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.305 1.412 . . . . 0.0 113.506 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.31 133.7 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 127.126 2.171 . . . . 0.0 111.504 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -56.58 127.68 32.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.786 0.834 . . . . 0.0 112.855 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 59.99 15.5 5.09 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.316 1.847 . . . . 0.0 115.488 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.3 t -125.26 -59.15 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 120.833 -1.167 . . . . 0.0 111.09 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.39 -162.47 22.7 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.242 0.925 . . . . 0.0 112.653 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -83.29 146.19 28.67 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.845 1.322 . . . . 0.0 114.143 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.83 145.35 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 127.307 2.243 . . . . 0.0 111.259 -175.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -66.04 136.74 56.44 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.682 0.793 . . . . 0.0 112.485 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.74 -39.32 68.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.489 1.516 . . . . 0.0 113.799 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.35 -17.8 77.84 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.355 -0.84 . . . . 0.0 114.041 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -93.63 -9.76 36.88 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.392 1.477 . . . . 0.0 113.761 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.99 167.76 1.53 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.35 1.06 . . . . 0.0 113.103 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 162.43 27.37 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.463 1.505 . . . . 0.0 110.115 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.97 145.39 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.307 0.575 . . . . 0.0 109.505 167.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.43 4.8 89.26 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.727 -1.041 . . . . 0.0 114.807 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -84.58 158.01 21.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.153 1.476 . . . . 0.0 112.426 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -105.9 104.43 14.14 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.815 1.246 . . . . 0.0 111.591 -162.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.8 mt -101.19 169.37 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.904 1.281 . . . . 0.0 111.11 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -115.49 144.1 44.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.955 1.302 . . . . 0.0 110.634 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.96 -177.11 5.11 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.533 1.133 . . . . 0.0 112.805 168.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.1 p -59.98 -17.42 38.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -97.51 -26.34 14.85 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.837 1.653 . . . . 0.0 112.737 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 104.08 23.4 8.15 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.448 1.499 . . . . 0.0 113.15 -170.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -81.34 151.07 28.18 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.791 1.236 . . . . 0.0 110.649 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.9 t -84.85 133.12 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.124 0.97 . . . . 0.0 112.159 -168.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -118.62 148.74 42.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.575 2.35 . . . . 0.0 111.424 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.56 135.43 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.224 1.01 . . . . 0.0 110.714 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.04 127.21 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 169.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.47 -38.34 8.44 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.329 1.452 . . . . 0.0 112.565 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -161.48 154.82 21.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.29 1.436 . . . . 0.0 111.913 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -120.07 133.21 55.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.458 1.503 . . . . 0.0 110.51 163.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -124.43 153.25 42.22 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.989 2.515 . . . . 0.0 109.965 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 tp -135.11 143.16 46.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.095 1.758 . . . . 0.0 109.942 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.46 157.17 44.37 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.3 mm -108.33 105.24 18.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.656 1.182 . . . . 0.0 108.364 166.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.78 147.51 49.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.899 1.28 . . . . 0.0 113.71 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -74.16 -10.61 59.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.585 1.554 . . . . 0.0 113.972 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -139.65 157.13 70.67 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 127.034 2.134 . . . . 0.0 110.291 166.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.77 119.09 6.04 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.653 2.236 . . . . 0.0 110.492 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.7 t -90.02 136.9 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 126.011 1.725 . . . . 0.0 109.419 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -74.61 138.39 42.92 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.679 0.792 . . . . 0.0 110.226 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.95 142.53 29.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 123.926 0.89 . . . . 0.0 110.764 -174.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -122.08 145.46 48.13 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.032 1.333 . . . . 0.0 110.433 -163.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -153.1 165.54 35.3 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.968 1.307 . . . . 0.0 110.801 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -147.03 164.09 34.13 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.423 -1.423 . . . . 0.0 113.02 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -117.69 141.43 48.39 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.02 147.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.078 1.751 . . . . 0.0 111.556 -168.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.16 -67.65 0.42 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.637 1.175 . . . . 0.0 113.886 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -94.88 -54.57 3.42 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.645 -0.66 . . . . 0.0 112.28 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -83.44 177.63 8.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.856 1.263 . . . . 0.0 111.579 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -131.75 29.2 4.49 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.027 1.331 . . . . 0.0 114.187 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 p -137.04 161.61 35.6 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.992 1.717 . . . . 0.0 112.507 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -156.16 -177.48 6.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.528 1.931 . . . . 0.0 110.751 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -132.24 139.57 48.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.096 1.358 . . . . 0.0 113.176 -168.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.22 144.17 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.375 1.07 . . . . 0.0 113.351 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.13 -179.42 39.13 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.051 1.786 . . . . 0.0 116.642 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.92 -39.15 71.23 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.951 1.301 . . . . 0.0 111.973 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -86.33 2.21 48.24 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 59.78 39.53 20.63 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.24 134.5 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.269 0.627 . . . . 0.0 111.578 -169.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.7 tp -73.76 121.93 21.6 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.859 1.664 . . . . 0.0 112.445 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.13 161.92 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.647 1.579 . . . . 0.0 111.623 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -111.03 143.65 41.4 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -167.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 127.343 2.257 . . . . 0.0 113.262 172.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.07 152.73 37.13 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.495 1.518 . . . . 0.0 111.068 173.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.1 m -68.25 157.43 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.382 0.611 . . . . 0.0 111.707 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.5 150.11 2.83 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.62 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.94 -10.83 45.18 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.269 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.0 m -64.2 123.91 20.32 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 120.901 2.351 . . . . 0.0 110.641 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 mmt -80.26 140.03 36.41 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.284 1.434 . . . . 0.0 111.831 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.6 mm -123.12 135.71 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.367 1.867 . . . . 0.0 109.719 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.53 123.86 26.7 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.653 0.781 . . . . 0.0 111.608 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 p -117.36 177.36 4.77 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.764 1.226 . . . . 0.0 112.71 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.72 -15.01 50.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.092 1.357 . . . . 0.0 114.128 170.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.5 p -124.68 -12.23 7.17 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.43 -115.1 0.65 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.04 0.828 . . . . 0.0 112.726 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 78.7 mt -125.72 139.65 53.36 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.232 1.013 . . . . 0.0 112.799 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -136.38 147.69 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.83 2.052 . . . . 0.0 109.012 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.42 148.11 47.25 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.273 -0.892 . . . . 0.0 111.442 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.0 tt -61.44 -26.29 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 120.682 -1.261 . . . . 0.0 113.496 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -72.27 -9.07 57.99 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.953 1.301 . . . . 0.0 114.198 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -118.7 -10.28 10.04 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.986 1.714 . . . . 0.0 113.332 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -66.91 136.69 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.668 1.122 . . . . 0.0 109.391 162.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -130.07 166.77 19.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.048 1.739 . . . . 0.0 111.182 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.86 134.08 55.01 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.212 -0.93 . . . . 0.0 110.199 165.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.2 -7.84 81.19 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -67.95 167.73 13.17 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.825 1.312 . . . . 0.0 111.496 161.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -124.23 123.84 41.14 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.431 1.492 . . . . 0.0 111.863 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.98 152.76 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.815 1.646 . . . . 0.0 110.227 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -77.79 139.12 19.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.373 0.606 . . . . 0.0 110.543 169.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.23 126.4 28.07 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.413 1.085 . . . . 0.0 108.378 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.4 m -78.93 111.99 15.67 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 159.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -53.63 114.31 6.08 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.655 1.182 . . . . 0.0 112.15 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.75 -12.77 35.62 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.611 2.207 . . . . 0.0 114.29 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.66 -48.85 14.22 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.793 -1.192 . . . . 0.0 111.887 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -129.0 -0.41 5.26 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.036 1.335 . . . . 0.0 114.117 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.324 4.0 m-85 61.72 25.39 15.29 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.046 1.738 . . . . 0.0 115.541 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.79 136.81 53.34 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.416 -0.803 . . . . 0.0 110.251 168.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.31 117.36 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.268 1.027 . . . . 0.0 110.497 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.31 160.9 43.01 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -71.92 132.26 44.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.414 1.085 . . . . 0.0 110.453 166.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HE3' ' CE1' ' A' ' 121' ' ' PHE . 70.5 mmtt -135.62 150.13 49.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.535 1.534 . . . . 0.0 110.359 170.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -82.39 155.01 24.92 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.9 t -90.21 131.6 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.86 1.264 . . . . 0.0 111.176 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.98 -45.72 10.51 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.942 0.897 . . . . 0.0 112.476 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -148.83 153.45 38.11 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.38 1.872 . . . . 0.0 110.669 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.7 p -120.73 122.59 40.74 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.238 1.415 . . . . 0.0 111.095 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -104.7 148.05 27.0 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.604 1.562 . . . . 0.0 112.421 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.0 t -143.31 132.22 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.552 1.141 . . . . 0.0 111.251 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -134.14 177.67 7.56 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.258 2.223 . . . . 0.0 111.936 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -139.51 138.8 36.66 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.423 1.489 . . . . 0.0 111.511 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.1 t -155.23 154.29 31.96 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.984 0.914 . . . . 0.0 111.907 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.7 p -87.39 -15.48 37.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.781 1.232 . . . . 0.0 113.424 164.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -98.55 108.26 20.91 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.086 -1.009 . . . . 0.0 110.972 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.3 mt -108.86 174.38 5.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.949 0.899 . . . . 0.0 111.935 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.8 tp -147.76 137.97 22.93 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.214 1.406 . . . . 0.0 110.726 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -124.17 112.91 17.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.863 1.265 . . . . 0.0 110.18 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.9 130.54 54.56 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.801 0.84 . . . . 0.0 109.819 176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -105.52 116.51 32.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.845 1.258 . . . . 0.0 108.542 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -127.77 116.06 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.55 1.54 . . . . 0.0 109.472 -171.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.49 30.82 34.91 Favored Glycine 0 CA--C 1.542 1.774 0 O-C-N 121.628 -0.67 . . . . 0.0 113.97 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.93 -1.61 88.23 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.245 1.403 . . . . 0.0 115.73 -177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.28 120.92 38.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.857 1.829 . . . . 0.0 109.52 170.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -88.57 138.05 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.238 0.615 . . . . 0.0 111.824 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.5 mt -133.67 131.91 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.36 1.864 . . . . 0.0 109.139 -176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -114.05 109.73 18.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.73 1.612 . . . . 0.0 110.607 -165.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 t -140.63 -179.38 6.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.164 1.386 . . . . 0.0 112.668 -158.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.1 p -90.29 155.45 18.97 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.302 1.041 . . . . 0.0 112.287 169.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -59.72 -29.9 68.45 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.107 -0.996 . . . . 0.0 113.442 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -94.52 3.44 55.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -64.54 127.89 92.82 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 120.912 -1.118 . . . . 0.0 112.6 -170.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -81.1 113.2 2.68 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 123.695 2.93 . . . . 0.0 114.292 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -103.63 144.05 31.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.952 1.701 . . . . 0.0 111.64 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -84.89 134.35 34.27 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.307 0.958 . . . . 0.0 112.756 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.9 t -118.71 132.87 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.769 2.028 . . . . 0.0 111.867 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 121.92 4.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.325 1.45 . . . . 0.0 111.899 172.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 56.38 30.07 16.26 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.312 1.445 . . . . 0.0 113.977 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -141.65 -42.11 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 125.373 1.469 . . . . 0.0 112.737 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.66 -148.99 18.77 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.965 0.793 . . . . 0.0 112.848 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -88.06 135.83 33.25 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.8 p -136.84 145.08 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.132 1.773 . . . . 0.0 111.455 -176.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -63.58 131.99 49.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.092 1.357 . . . . 0.0 111.016 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.34 67.34 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.152 -0.967 . . . . 0.0 113.44 -175.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.03 -7.28 81.5 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 121.119 -0.988 . . . . 0.0 114.494 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -107.23 -2.47 20.78 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.087 1.755 . . . . 0.0 113.543 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.76 161.7 17.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.992 1.317 . . . . 0.0 112.326 166.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.7 159.32 24.71 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.812 1.245 . . . . 0.0 113.256 160.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.78 130.87 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 159.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.87 -0.89 84.82 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 117.185 -1.897 . . . . 0.0 115.558 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.01 151.42 41.76 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 121.404 2.602 . . . . 0.0 111.509 166.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -102.86 107.87 18.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.028 1.731 . . . . 0.0 112.854 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.9 mt -97.75 167.65 10.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.647 1.179 . . . . 0.0 111.871 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.14 146.8 38.61 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.052 1.341 . . . . 0.0 111.182 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.24 -178.05 3.54 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 172.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.4 p -59.89 -6.6 1.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.77 2.028 . . . . 0.0 116.466 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.51 -17.17 10.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.513 1.925 . . . . 0.0 112.621 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.48 23.88 32.64 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.045 1.783 . . . . 0.0 112.033 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -66.65 148.78 51.44 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.205 0.502 . . . . 0.0 109.768 161.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.3 t -84.16 128.15 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 122.491 0.317 . . . . 0.0 110.381 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.8 mt -108.4 161.07 15.37 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.465 2.706 . . . . 0.0 110.652 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.5 t -134.6 140.4 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.507 1.123 . . . . 0.0 110.605 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.08 129.13 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.361 0.664 . . . . 0.0 109.894 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -96.64 -41.73 8.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.428 2.291 . . . . 0.0 112.011 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -153.53 149.92 28.18 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.807 1.643 . . . . 0.0 110.681 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -132.75 122.73 24.99 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.95 2.1 . . . . 0.0 108.727 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mmtm -134.48 128.71 33.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.492 1.117 . . . . 0.0 112.992 -166.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.1 tp -102.55 134.88 45.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.033 1.733 . . . . 0.0 109.612 173.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -136.09 147.95 48.07 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.361 0.664 . . . . 0.0 111.423 158.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.0 mm -91.7 117.05 34.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 165.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.03 142.19 55.97 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.263 1.025 . . . . 0.0 111.183 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.0 -17.87 62.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.437 0.695 . . . . 0.0 112.738 -176.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -144.38 147.52 37.11 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.373 2.269 . . . . 0.0 110.178 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.11 120.06 7.38 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 124.389 3.393 . . . . 0.0 112.809 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.75 141.7 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.906 1.682 . . . . 0.0 110.441 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -75.14 141.11 43.73 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.494 0.718 . . . . 0.0 111.482 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 m -136.47 144.07 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.938 1.695 . . . . 0.0 110.397 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.47 147.3 49.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.468 1.507 . . . . 0.0 110.644 -166.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -155.38 170.46 21.85 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.721 1.608 . . . . 0.0 111.495 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -154.19 166.1 34.18 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.428 -1.42 . . . . 0.0 113.043 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -120.04 146.13 46.19 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.668 1.187 . . . . 0.0 113.857 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.71 147.09 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.954 1.701 . . . . 0.0 112.44 -162.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.37 -39.56 92.45 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -168.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -133.99 -48.16 0.8 Allowed 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.599 -1.313 . . . . 0.0 113.386 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.414 ' CE1' ' HE3' ' A' ' 39' ' ' LYS . 7.8 m-30 -77.61 168.86 19.29 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 169.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -114.93 17.87 16.7 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.2 1.4 . . . . 0.0 112.669 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 p -141.08 165.16 28.31 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.968 1.707 . . . . 0.0 112.794 -160.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -158.98 178.38 10.13 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.054 1.742 . . . . 0.0 110.662 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -120.41 139.81 52.27 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.038 1.335 . . . . 0.0 112.501 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.0 144.48 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.092 1.357 . . . . 0.0 113.61 -175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.21 173.7 29.73 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.232 1.396 . . . . 0.0 116.034 172.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.13 -27.84 69.65 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.178 -1.189 . . . . 0.0 113.648 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -88.66 -1.34 58.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.346 1.458 . . . . 0.0 113.519 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 59.25 49.8 8.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.182 1.793 . . . . 0.0 113.988 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t -74.91 138.79 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.11 1.364 . . . . 0.0 111.579 -173.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.9 tp -79.78 128.86 33.95 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.575 1.55 . . . . 0.0 113.524 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.5 m -138.06 155.06 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.724 . . . . 0.0 111.356 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -104.23 158.44 16.44 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.47 1.508 . . . . 0.0 110.778 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 C--O 1.254 1.327 0 O-C-N 120.622 -1.299 . . . . 0.0 114.097 172.334 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.101 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.87 154.38 41.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.29 1.436 . . . . 0.0 111.985 169.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.07 161.6 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.242 0.617 . . . . 0.0 112.554 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 150.55 7.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.326 1.05 . . . . 0.0 111.358 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.59 -7.03 9.47 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-O 117.795 -1.558 . . . . 0.0 116.486 -172.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.8 m -61.65 119.36 8.52 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 121.552 2.676 . . . . 0.0 109.685 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -74.62 143.29 44.41 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.851 0.861 . . . . 0.0 111.405 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.3 mm -127.51 135.51 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.796 2.038 . . . . 0.0 109.519 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -78.23 126.36 30.69 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.0 p -117.96 176.39 5.23 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.789 1.235 . . . . 0.0 111.82 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.81 -10.8 59.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 171.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 p -119.46 -16.04 8.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.27 1.828 . . . . 0.0 113.934 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.03 -122.8 1.26 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.089 1.328 . . . . 0.0 111.53 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.5 mt -124.28 142.8 50.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.163 1.385 . . . . 0.0 112.258 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.15 143.08 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.12 1.768 . . . . 0.0 108.613 171.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.57 148.03 51.09 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.999 -1.063 . . . . 0.0 111.352 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 tt -61.34 -26.88 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 O-C-N 120.592 -1.317 . . . . 0.0 113.524 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.82 -16.44 64.11 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -112.54 -12.04 13.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.151 1.78 . . . . 0.0 112.665 -174.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.54 141.12 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.04 0.836 . . . . 0.0 109.837 162.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -128.43 159.77 34.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.443 1.897 . . . . 0.0 112.263 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.72 124.8 21.7 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.485 165.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.65 -0.34 84.76 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.497 1.046 . . . . 0.0 115.392 -170.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -76.8 154.15 34.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.424 1.612 . . . . 0.0 110.539 158.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -108.92 142.89 38.89 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.218 1.407 . . . . 0.0 112.217 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -136.5 159.85 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.376 1.87 . . . . 0.0 111.026 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.9 mm -74.59 137.85 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.966 -0.459 . . . . 0.0 111.898 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.49 123.08 19.75 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.167 0.987 . . . . 0.0 108.657 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.4 m -93.33 103.85 16.05 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 170.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -52.97 113.91 5.2 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.818 1.647 . . . . 0.0 113.18 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.58 -11.24 31.46 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.159 2.573 . . . . 0.0 114.413 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -76.43 -38.9 54.83 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.381 1.072 . . . . 0.0 112.638 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 t -133.96 -6.96 2.73 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.282 1.033 . . . . 0.0 112.516 -172.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.267 2.4 t80 61.99 39.34 13.45 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.31 1.844 . . . . 0.0 113.601 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -95.2 135.75 36.39 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.452 1.501 . . . . 0.0 110.522 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.04 136.71 30.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 122.956 0.502 . . . . 0.0 111.653 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.8 167.99 25.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.379 1.472 . . . . 0.0 111.951 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -89.71 126.88 35.82 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.686 0.794 . . . . 0.0 110.196 164.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -130.23 151.75 50.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.496 1.118 . . . . 0.0 112.123 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -87.53 154.5 20.58 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.42 1.088 . . . . 0.0 113.141 -176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.4 t -89.66 132.68 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.661 1.584 . . . . 0.0 110.753 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.38 -43.19 9.9 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.903 0.881 . . . . 0.0 112.785 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -142.85 153.09 42.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.157 1.383 . . . . 0.0 110.297 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 p -122.1 118.42 28.66 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.9 1.68 . . . . 0.0 108.832 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.02 143.71 28.3 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.424 1.49 . . . . 0.0 112.258 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.41 HG22 ' CD2' ' A' ' 114' ' ' TYR . 41.5 t -141.13 126.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.751 1.221 . . . . 0.0 110.889 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -132.8 174.77 9.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.825 2.05 . . . . 0.0 109.62 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -132.33 130.2 40.46 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.871 0.868 . . . . 0.0 111.093 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.7 t -140.18 139.54 35.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.522 1.129 . . . . 0.0 110.87 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.0 p -81.12 -19.88 42.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.854 0.862 . . . . 0.0 111.926 166.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -94.2 111.63 23.37 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.383 1.073 . . . . 0.0 110.668 -173.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.0 mt -127.85 157.2 41.13 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 123.409 1.576 . . . . 0.0 113.908 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.4 tp -121.77 136.15 54.93 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.495 1.918 . . . . 0.0 109.956 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -110.39 124.09 51.07 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.712 1.205 . . . . 0.0 109.2 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.0 mt -121.52 137.91 54.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 167.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.7 m -109.25 120.75 43.48 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 167.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.14 122.87 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.463 1.105 . . . . 0.0 108.269 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.64 18.59 16.94 Favored Glycine 0 CA--C 1.547 2.083 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.58 5.08 67.22 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 119.581 1.691 . . . . 0.0 116.323 -171.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -103.52 122.57 45.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.29 1.545 . . . . 0.0 110.296 164.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -77.18 124.03 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.537 0.735 . . . . 0.0 109.407 164.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mt -119.5 100.69 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.175 1.39 . . . . 0.0 109.122 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.57 119.24 21.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.591 1.556 . . . . 0.0 110.49 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -143.05 -179.06 6.14 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.129 0.972 . . . . 0.0 111.305 -168.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.4 p -88.69 155.65 19.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.955 0.883 . . . . 0.0 111.669 167.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.97 -33.59 69.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.536 1.135 . . . . 0.0 112.146 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -85.92 -7.73 58.49 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.634 1.173 . . . . 0.0 113.315 -170.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -64.57 127.48 92.41 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-O 118.213 -0.899 . . . . 0.0 113.177 -166.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.59 108.19 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.373 2.715 . . . . 0.0 114.313 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.26 141.92 34.31 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.625 1.97 . . . . 0.0 111.865 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -85.91 127.13 34.53 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.67 135.86 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 127.601 2.36 . . . . 0.0 111.257 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -52.67 121.22 6.76 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.13 1.372 . . . . 0.0 112.638 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.29 14.06 4.38 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.064 2.146 . . . . 0.0 115.54 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.8 t -122.77 -54.56 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.537 1.135 . . . . 0.0 110.728 -173.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.44 -161.93 16.42 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.586 0.612 . . . . 0.0 113.436 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -84.63 145.12 28.17 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.577 1.188 . . . . 0.0 114.166 -174.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.48 149.62 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.474 1.91 . . . . 0.0 111.263 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -55.73 131.48 46.76 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.743 1.217 . . . . 0.0 111.861 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.05 -35.81 64.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.635 1.174 . . . . 0.0 113.075 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.67 -5.73 88.3 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.63 -1.095 . . . . 0.0 114.898 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -97.93 -4.64 36.01 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.246 1.418 . . . . 0.0 113.519 171.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.52 160.07 33.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.556 0.693 . . . . 0.0 111.278 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -117.35 167.78 10.94 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.494 1.518 . . . . 0.0 110.535 166.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.88 144.71 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.495 -0.753 . . . . 0.0 109.323 155.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.84 1.43 89.54 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.951 -0.916 . . . . 0.0 114.132 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -82.9 152.14 25.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 119.038 1.419 . . . . 0.0 111.385 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -108.45 112.02 24.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.429 1.092 . . . . 0.0 112.484 -163.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.9 mt -107.27 179.41 4.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.341 1.856 . . . . 0.0 110.588 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.89 156.63 44.72 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.026 0.931 . . . . 0.0 113.467 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -98.15 174.04 6.72 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.578 1.151 . . . . 0.0 113.117 166.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.6 t -55.58 -35.38 65.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.782 1.233 . . . . 0.0 113.787 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -75.24 -29.55 60.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.555 1.542 . . . . 0.0 112.727 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.79 24.67 6.87 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.597 1.57 . . . . 0.0 113.499 173.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -78.43 152.94 31.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.441 1.496 . . . . 0.0 110.193 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.12 125.07 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 122.579 0.352 . . . . 0.0 110.992 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.0 mt -106.34 149.75 26.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.277 1.431 . . . . 0.0 111.863 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.0 t -127.23 137.0 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.457 1.103 . . . . 0.0 111.455 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.16 123.7 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.598 1.159 . . . . 0.0 111.074 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -88.63 -32.87 17.84 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.673 2.389 . . . . 0.0 114.48 175.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -152.82 147.92 26.59 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.954 1.302 . . . . 0.0 111.482 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -133.55 132.85 41.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.034 1.733 . . . . 0.0 110.699 168.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -145.77 157.0 43.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.836 2.054 . . . . 0.0 112.388 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tt -149.2 133.64 17.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.808 1.643 . . . . 0.0 109.639 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -146.62 154.51 41.56 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.588 1.155 . . . . 0.0 112.429 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.0 mm -94.53 107.61 19.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.708 0.803 . . . . 0.0 109.121 168.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.51 147.28 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.907 1.283 . . . . 0.0 111.709 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -76.04 -18.86 59.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.76 0.824 . . . . 0.0 112.709 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -127.97 158.21 71.42 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 126.785 2.034 . . . . 0.0 108.879 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -61.92 122.27 10.71 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.212 1.941 . . . . 0.0 110.437 162.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.6 t -93.17 140.44 16.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.288 1.835 . . . . 0.0 108.952 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -73.9 139.21 44.81 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.685 -0.635 . . . . 0.0 110.645 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 m -141.54 147.21 22.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.695 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' A' ' 46' ' ' VAL . 41.9 m-85 -128.78 151.11 49.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.391 1.477 . . . . 0.0 110.879 -165.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -155.56 167.55 30.03 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.065 1.346 . . . . 0.0 110.343 168.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -150.42 159.86 44.17 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.54 -1.35 . . . . 0.0 112.973 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -113.86 138.83 49.77 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t -98.23 139.74 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.437 1.895 . . . . 0.0 111.127 -168.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -57.08 -63.99 1.03 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.725 1.21 . . . . 0.0 113.441 -173.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -112.0 -39.22 4.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -89.03 173.32 8.52 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.465 0.706 . . . . 0.0 110.52 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -116.7 7.96 13.64 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.39 1.476 . . . . 0.0 113.536 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 p -134.86 162.33 32.7 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.87 1.668 . . . . 0.0 112.593 -167.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -157.27 -176.84 6.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.072 1.749 . . . . 0.0 109.993 170.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -131.25 137.42 48.87 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.447 1.099 . . . . 0.0 112.891 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.0 145.32 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.034 1.333 . . . . 0.0 112.597 -172.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.91 169.54 31.14 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.105 1.336 . . . . 0.0 115.154 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.74 -37.71 19.66 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.002 1.321 . . . . 0.0 112.988 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -94.91 15.0 19.79 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 63.84 35.13 11.27 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 158.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.33 135.85 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.767 1.227 . . . . 0.0 111.525 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 56.1 tp -79.19 122.57 26.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.042 1.337 . . . . 0.0 113.623 -170.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.01 154.83 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.628 1.571 . . . . 0.0 111.627 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -100.38 146.72 26.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.268 1.027 . . . . 0.0 112.628 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.289 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.959 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -123.91 149.31 46.02 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.39 1.876 . . . . 0.0 111.134 171.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -65.66 158.51 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.378 -0.826 . . . . 0.0 112.172 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.83 148.43 7.56 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.883 0.873 . . . . 0.0 112.04 173.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.55 -10.6 43.7 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 116.358 1.303 . . . . 0.0 116.358 -171.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.8 m -62.07 125.86 25.34 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.863 2.332 . . . . 0.0 110.38 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -77.88 148.34 34.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.452 1.101 . . . . 0.0 112.059 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.1 mm -128.09 136.54 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 127.348 2.259 . . . . 0.0 109.662 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.0 tp -81.8 134.66 35.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.356 1.074 . . . . 0.0 113.363 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.5 p -132.28 176.96 7.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.412 1.485 . . . . 0.0 111.534 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.73 -0.33 26.5 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.675 1.59 . . . . 0.0 114.664 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.4 p -124.46 -16.28 6.38 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.75 1.22 . . . . 0.0 113.375 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.52 -129.92 2.73 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 127.468 2.461 . . . . 0.0 110.683 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.8 151.75 24.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.137 1.375 . . . . 0.0 111.869 168.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.09 146.89 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 127.425 2.29 . . . . 0.0 108.532 169.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.17 45.77 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.679 -1.263 . . . . 0.0 112.154 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 tt -62.72 -28.74 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 120.69 -1.256 . . . . 0.0 113.109 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.47 -2.28 31.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.015 1.326 . . . . 0.0 114.495 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -118.23 -13.09 9.89 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.488 1.515 . . . . 0.0 112.821 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.56 134.93 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.119 0.968 . . . . 0.0 109.664 159.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -134.6 164.94 26.37 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.279 1.832 . . . . 0.0 110.96 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.67 134.08 41.71 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.646 -0.659 . . . . 0.0 111.324 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.68 -15.24 59.44 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.587 1.089 . . . . 0.0 115.692 -175.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -66.49 166.88 11.72 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.431 1.615 . . . . 0.0 111.241 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -118.23 148.19 42.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.24 1.416 . . . . 0.0 113.359 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.19 166.6 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 127.095 2.158 . . . . 0.0 111.123 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -79.86 146.67 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.163 0.585 . . . . 0.0 111.22 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.18 132.28 23.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.354 0.662 . . . . 0.0 109.889 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.6 m -86.33 109.19 18.81 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 163.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -53.24 117.08 10.75 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.577 1.151 . . . . 0.0 112.347 174.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -65.7 -14.33 44.19 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.537 2.158 . . . . 0.0 113.906 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -79.29 -36.28 39.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.487 1.515 . . . . 0.0 113.923 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 t -140.89 0.83 1.62 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.264 1.426 . . . . 0.0 112.884 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.255 1.7 t80 63.17 27.41 15.63 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.744 1.617 . . . . 0.0 114.067 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -78.73 134.32 37.08 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.304 1.042 . . . . 0.0 110.519 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.5 t -94.53 136.63 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.264 0.626 . . . . 0.0 110.289 170.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.35 164.6 35.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.352 1.061 . . . . 0.0 112.35 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -87.6 126.85 35.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.327 1.051 . . . . 0.0 110.277 165.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -136.84 150.98 48.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.979 1.311 . . . . 0.0 112.942 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 t -82.27 157.98 23.67 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -91.98 132.61 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.137 2.175 . . . . 0.0 111.417 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 mt -87.68 -50.34 6.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.569 1.148 . . . . 0.0 112.754 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -143.81 157.22 44.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.159 2.183 . . . . 0.0 110.466 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p -119.38 118.55 31.46 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.025 1.73 . . . . 0.0 110.944 173.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -93.29 139.63 30.43 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.588 1.155 . . . . 0.0 113.084 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.469 HG22 ' CD2' ' A' ' 114' ' ' TYR . 18.4 t -137.97 130.8 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.752 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -135.3 175.81 9.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.203 2.201 . . . . 0.0 110.264 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -132.32 142.91 49.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.485 1.514 . . . . 0.0 110.746 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -152.97 155.33 36.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.832 0.853 . . . . 0.0 112.033 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.1 p -88.71 -16.23 32.8 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.733 2.013 . . . . 0.0 113.669 170.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -112.74 110.41 20.52 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.099 0.96 . . . . 0.0 110.339 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.8 mt -110.07 173.36 6.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.475 1.11 . . . . 0.0 112.527 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.1 tp -135.28 132.28 37.58 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.128 1.771 . . . . 0.0 109.141 170.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -111.56 115.32 28.98 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.189 0.996 . . . . 0.0 109.245 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.12 143.51 38.39 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.352 0.661 . . . . 0.0 109.862 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.7 m -118.18 120.86 38.99 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 167.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -125.94 116.59 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.628 1.171 . . . . 0.0 109.44 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.74 21.69 37.31 Favored Glycine 0 CA--C 1.545 1.935 0 O-C-N 121.605 -0.684 . . . . 0.0 114.723 -173.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.3 -16.09 61.41 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.576 2.036 . . . . 0.0 115.603 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -79.2 117.6 20.37 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.722 1.261 . . . . 0.0 109.174 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.1 t -75.57 130.04 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 122.974 0.51 . . . . 0.0 110.203 171.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.9 mt -129.86 102.9 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.768 1.627 . . . . 0.0 108.614 171.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -79.37 123.82 27.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.628 1.171 . . . . 0.0 110.581 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.0 t -141.31 174.76 10.24 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.083 1.353 . . . . 0.0 112.113 -167.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.1 p -81.28 145.97 30.65 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.428 -0.795 . . . . 0.0 111.203 165.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -54.74 -26.97 37.58 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.089 1.356 . . . . 0.0 113.334 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -102.9 2.48 35.29 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -62.57 133.06 94.65 Favored Pre-proline 0 CA--C 1.553 1.061 0 O-C-N 121.12 -0.988 . . . . 0.0 113.398 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.26 112.47 2.25 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.376 3.384 . . . . 0.0 114.844 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -101.18 148.46 25.07 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.679 1.992 . . . . 0.0 111.969 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -92.73 129.87 38.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.387 0.994 . . . . 0.0 113.452 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.4 t -108.25 135.57 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.918 2.487 . . . . 0.0 111.06 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.26 132.95 55.13 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.736 0.814 . . . . 0.0 111.127 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 66.62 3.51 2.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.085 1.754 . . . . 0.0 115.174 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.54 -63.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 120.967 -1.083 . . . . 0.0 110.556 -168.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.24 -150.63 18.13 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.647 0.641 . . . . 0.0 112.741 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -88.09 140.24 29.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.794 1.297 . . . . 0.0 113.968 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -145.32 145.9 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.751 1.621 . . . . 0.0 111.996 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -56.71 131.5 49.32 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.788 1.235 . . . . 0.0 112.405 171.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.92 -34.94 68.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.443 1.497 . . . . 0.0 113.672 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.39 -18.79 79.82 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 119.108 -0.829 . . . . 0.0 113.609 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -89.33 -3.52 58.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.366 1.467 . . . . 0.0 113.336 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.44 162.95 24.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.102 0.961 . . . . 0.0 112.236 166.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.35 159.8 30.9 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.044 1.738 . . . . 0.0 110.933 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.53 138.52 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.208 -0.932 . . . . 0.0 109.05 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.03 10.57 86.03 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.846 -0.974 . . . . 0.0 114.894 -171.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -78.68 155.48 29.44 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.47 1.635 . . . . 0.0 112.162 172.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.88 102.3 12.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.851 1.661 . . . . 0.0 111.163 -168.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.6 mt -97.23 179.55 4.86 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.037 0.935 . . . . 0.0 110.859 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.8 mt -131.55 159.83 37.03 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.164 -0.96 . . . . 0.0 113.49 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.0 p30 -118.59 -178.04 3.44 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -65.86 -0.88 2.48 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -102.35 -35.99 8.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.574 1.55 . . . . 0.0 110.874 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.48 17.35 11.44 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.966 1.745 . . . . 0.0 112.776 -170.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -92.37 148.88 21.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.311 1.055 . . . . 0.0 111.881 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.05 114.2 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 mt -88.05 158.4 18.61 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.0 1.32 . . . . 0.0 112.525 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.03 138.72 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.48 1.112 . . . . 0.0 111.705 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.63 121.86 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.867 0.867 . . . . 0.0 109.871 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -94.17 -29.97 14.85 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.913 2.085 . . . . 0.0 112.26 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -155.18 148.4 24.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.217 1.407 . . . . 0.0 112.2 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.1 tttm -132.85 115.85 15.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.402 1.881 . . . . 0.0 108.986 168.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.09 148.89 51.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.606 1.562 . . . . 0.0 112.169 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.2 tp -121.91 134.44 54.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.951 1.3 . . . . 0.0 110.197 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -139.57 150.78 45.45 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.723 0.809 . . . . 0.0 112.367 171.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.9 mm -108.19 111.61 36.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.754 1.222 . . . . 0.0 108.477 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.64 153.09 42.61 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 122.409 1.099 . . . . 0.0 113.531 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.66 -13.35 60.62 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.741 1.217 . . . . 0.0 113.419 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -155.27 160.13 31.14 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 128.302 2.641 . . . . 0.0 110.006 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.65 125.36 12.63 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.674 2.25 . . . . 0.0 111.433 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.43 139.92 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.983 2.113 . . . . 0.0 110.244 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -75.7 142.33 42.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.752 0.821 . . . . 0.0 112.644 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.28 139.17 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.115 1.366 . . . . 0.0 110.974 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.469 ' CD2' HG22 ' A' ' 46' ' ' VAL . 33.4 m-85 -118.52 153.03 34.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.708 2.003 . . . . 0.0 111.944 -171.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -153.65 171.31 19.01 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.868 2.067 . . . . 0.0 109.231 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -152.04 173.86 14.38 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.202 -1.561 . . . . 0.0 112.389 173.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -127.86 142.86 51.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.856 1.262 . . . . 0.0 113.239 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.2 140.64 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.767 1.627 . . . . 0.0 112.611 -164.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.23 -21.75 66.79 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -165.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.48 -63.63 0.98 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.811 0.732 . . . . 0.0 111.209 169.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -70.56 170.47 12.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.694 0.759 . . . . 0.0 111.854 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -113.55 18.89 17.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.724 1.61 . . . . 0.0 112.381 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.0 p -140.3 167.14 22.85 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.11 1.364 . . . . 0.0 112.252 -164.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -160.7 177.31 10.59 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.797 2.039 . . . . 0.0 109.496 167.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -121.39 132.47 54.77 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.226 1.01 . . . . 0.0 111.846 -173.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.9 m -118.06 146.44 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.481 1.512 . . . . 0.0 113.603 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.07 169.63 20.53 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.987 1.279 . . . . 0.0 115.196 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.02 -23.33 66.38 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.993 1.317 . . . . 0.0 112.885 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -89.77 2.1 55.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 114.232 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 63.85 36.33 10.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.375 1.47 . . . . 0.0 114.915 162.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.43 135.61 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.363 1.465 . . . . 0.0 111.886 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.3 tp -78.54 125.25 29.1 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.215 1.406 . . . . 0.0 113.214 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.92 161.04 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.082 1.753 . . . . 0.0 111.591 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -112.0 149.06 32.53 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.012 1.325 . . . . 0.0 112.924 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.9 m120 . . . . . 0 C--O 1.254 1.332 0 C-N-CA 125.939 1.695 . . . . 0.0 112.208 178.612 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.038 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.424 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.8 m-85 -122.63 153.95 38.65 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.455 1.502 . . . . 0.0 111.068 167.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.16 163.12 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.839 -0.538 . . . . 0.0 111.811 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.74 159.27 0.56 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.543 1.163 . . . . 0.0 113.298 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.07 -13.92 4.16 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 117.9 -1.5 . . . . 0.0 115.901 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.9 m -62.95 118.3 7.61 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.497 2.148 . . . . 0.0 110.955 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -79.22 142.31 36.36 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.208 1.403 . . . . 0.0 112.861 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.1 mm -130.7 137.26 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.082 2.153 . . . . 0.0 109.561 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.1 tp -83.56 137.46 33.83 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.368 1.08 . . . . 0.0 113.506 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -135.79 168.97 18.31 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.2 1.4 . . . . 0.0 111.461 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.58 -18.26 64.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 p -106.7 -28.9 9.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.078 1.351 . . . . 0.0 112.944 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.72 -130.42 2.12 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.041 -1.037 . . . . 0.0 112.904 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.58 148.96 29.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.543 1.137 . . . . 0.0 112.184 170.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.4 t -138.97 148.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.083 2.153 . . . . 0.0 108.362 172.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.38 149.9 38.52 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.983 -1.073 . . . . 0.0 111.514 172.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.5 tt -61.16 -23.81 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 O-C-N 120.826 -1.171 . . . . 0.0 113.479 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -70.46 -11.81 61.16 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.113 1.365 . . . . 0.0 114.329 172.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -122.88 -5.26 8.54 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.929 1.692 . . . . 0.0 113.909 -171.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 mm -67.0 137.17 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.014 -1.054 . . . . 0.0 109.077 161.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -134.77 161.2 35.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.719 1.208 . . . . 0.0 112.301 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.42 127.7 32.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.931 0.892 . . . . 0.0 111.718 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.54 -2.32 80.32 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.708 -1.051 . . . . 0.0 115.407 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.22 172.21 13.23 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.088 1.944 . . . . 0.0 111.168 164.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.62 150.04 40.37 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.049 1.74 . . . . 0.0 112.907 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.73 157.87 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 127.165 2.186 . . . . 0.0 109.843 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.8 mm -74.48 140.54 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 O-C-N 121.836 -0.54 . . . . 0.0 110.929 166.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.88 121.48 18.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.6 m -88.52 109.96 20.49 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -53.7 113.37 4.8 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.472 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.14 -9.7 26.0 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.991 1.794 . . . . 0.0 114.455 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -78.31 -40.07 37.82 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.998 -1.064 . . . . 0.0 112.158 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.9 t -132.7 -2.6 3.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.062 0.945 . . . . 0.0 112.756 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.293 20.6 m-85 56.9 35.6 26.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.167 1.787 . . . . 0.0 113.21 -176.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.83 126.51 31.07 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.053 1.341 . . . . 0.0 109.763 173.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.31 113.04 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.777 0.831 . . . . 0.0 110.589 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.56 163.4 29.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.533 1.133 . . . . 0.0 113.031 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -95.93 119.34 34.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.522 1.529 . . . . 0.0 110.757 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -128.39 149.92 50.33 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.748 1.219 . . . . 0.0 111.664 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.2 t -86.36 154.85 20.9 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.8 t -93.14 130.28 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 126.303 1.841 . . . . 0.0 110.444 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.2 mt -89.39 -37.71 14.64 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.288 1.035 . . . . 0.0 113.317 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -153.73 161.39 42.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.283 2.233 . . . . 0.0 109.883 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.8 p -117.34 137.72 52.26 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.902 1.281 . . . . 0.0 111.07 165.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -105.7 142.3 35.67 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.984 1.314 . . . . 0.0 112.569 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.05 138.31 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.737 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 68.4 mmt-85 -142.24 176.42 8.99 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.719 2.008 . . . . 0.0 110.391 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -127.3 137.87 52.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.688 1.195 . . . . 0.0 110.421 167.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.8 t -146.45 148.03 31.84 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.473 1.109 . . . . 0.0 111.473 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -86.11 -20.15 29.12 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.976 1.31 . . . . 0.0 113.416 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -97.17 105.05 17.12 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.338 -0.851 . . . . 0.0 110.086 -169.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.5 mt -124.09 156.86 35.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 123.622 1.677 . . . . 0.0 113.9 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.9 tp -138.44 126.37 22.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.381 -1.736 . . . . 0.0 111.412 -169.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -113.6 111.12 21.33 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.485 1.514 . . . . 0.0 108.723 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -106.6 125.18 50.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.387 1.075 . . . . 0.0 109.938 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -102.74 120.8 41.22 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.0 mt -133.01 116.41 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.928 1.291 . . . . 0.0 108.984 -171.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.94 24.44 34.44 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 115.191 0.836 . . . . 0.0 115.191 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.26 -6.36 68.6 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.576 1.56 . . . . 0.0 116.646 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -101.87 126.67 48.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.893 1.677 . . . . 0.0 109.238 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 p -97.33 133.02 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.841 0.829 . . . . 0.0 112.977 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.3 mt -126.8 133.79 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.761 2.024 . . . . 0.0 108.719 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -116.71 110.9 19.05 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.219 1.007 . . . . 0.0 110.658 -165.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.8 t -141.46 176.82 8.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.755 1.622 . . . . 0.0 113.272 -157.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.8 p -89.91 158.14 17.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.245 1.418 . . . . 0.0 113.01 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -65.82 -18.9 65.65 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.488 1.115 . . . . 0.0 113.649 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -101.11 -2.98 30.1 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.424 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.1 t60 -65.4 129.05 94.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.366 -1.302 . . . . 0.0 111.923 -172.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.67 120.89 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 122.061 1.772 . . . . 0.0 113.691 -169.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.25 141.08 36.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.381 2.272 . . . . 0.0 112.093 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -84.77 127.31 34.06 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -112.41 134.51 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.671 2.389 . . . . 0.0 111.525 -174.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -56.27 127.23 29.81 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.107 1.363 . . . . 0.0 112.499 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 57.17 22.51 7.61 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.961 2.104 . . . . 0.0 115.03 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.3 t -133.97 -58.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.963 -1.086 . . . . 0.0 111.882 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.79 -152.23 17.16 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.02 0.819 . . . . 0.0 112.916 -173.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -91.14 132.57 35.98 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.804 1.302 . . . . 0.0 114.417 -170.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -137.78 141.53 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.183 1.393 . . . . 0.0 112.669 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.03 132.92 54.35 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.809 1.244 . . . . 0.0 112.901 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.59 66.59 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.81 1.644 . . . . 0.0 113.529 -173.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.36 -12.24 84.75 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 121.504 -0.747 . . . . 0.0 113.797 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -90.71 -20.71 22.14 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.121 0.961 . . . . 0.0 112.76 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.95 154.5 2.85 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.417 1.087 . . . . 0.0 112.856 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -117.48 149.53 40.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.066 1.347 . . . . 0.0 110.969 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.83 126.65 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.394 0.678 . . . . 0.0 110.049 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.91 1.4 58.56 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-O 118.501 -1.166 . . . . 0.0 115.326 -172.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -86.95 159.5 18.99 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.833 1.817 . . . . 0.0 112.25 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -104.03 108.36 19.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.161 1.384 . . . . 0.0 111.203 -157.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.49 169.05 8.9 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.696 1.598 . . . . 0.0 111.791 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.22 142.74 43.03 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.351 1.06 . . . . 0.0 111.409 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.02 176.85 6.26 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.65 0.78 . . . . 0.0 112.995 166.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.1 p -52.17 -24.88 7.8 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -97.72 -31.59 12.18 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.888 1.275 . . . . 0.0 111.764 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.38 22.55 5.12 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.884 2.183 . . . . 0.0 113.435 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -64.21 147.26 52.76 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.319 1.059 . . . . 0.0 110.786 167.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.84 110.24 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.924 0.869 . . . . 0.0 110.741 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.5 mt -94.05 160.68 14.6 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.67 1.988 . . . . 0.0 111.289 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.22 141.84 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.64 1.176 . . . . 0.0 110.632 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.13 115.95 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.574 0.749 . . . . 0.0 109.485 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -90.12 -28.35 19.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.011 2.124 . . . . 0.0 112.732 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -160.71 151.74 18.85 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.42 1.488 . . . . 0.0 111.635 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -131.57 111.34 11.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.522 2.329 . . . . 0.0 109.127 171.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.6 mmtm -117.32 125.92 51.85 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.104 1.761 . . . . 0.0 110.94 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 tp -120.0 133.01 55.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.751 1.62 . . . . 0.0 109.941 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -149.21 161.62 41.64 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.3 mm -110.0 107.02 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.112 1.365 . . . . 0.0 108.521 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.02 150.31 42.77 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.253 1.021 . . . . 0.0 113.604 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.77 -26.81 67.89 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.144 1.778 . . . . 0.0 112.321 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -142.68 151.22 56.47 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.943 2.497 . . . . 0.0 108.287 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.27 121.76 8.08 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.415 2.077 . . . . 0.0 110.288 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.03 143.91 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.127 1.771 . . . . 0.0 110.15 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -74.54 139.4 43.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.283 0.633 . . . . 0.0 110.225 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.02 147.12 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 124.526 1.13 . . . . 0.0 111.268 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -128.46 148.0 50.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.683 1.593 . . . . 0.0 110.846 -164.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -150.48 170.96 17.86 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.507 1.523 . . . . 0.0 109.89 167.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -152.27 158.02 42.2 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.532 -1.355 . . . . 0.0 111.515 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -113.49 135.65 53.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.008 0.923 . . . . 0.0 112.969 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -98.89 147.92 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.3 1.84 . . . . 0.0 111.739 -170.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.94 -39.14 91.08 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.61 -45.33 0.36 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.993 0.917 . . . . 0.0 112.661 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -77.55 172.01 14.02 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.435 0.694 . . . . 0.0 109.207 164.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -134.53 30.72 3.47 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.684 1.193 . . . . 0.0 111.934 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.5 p -141.36 158.06 44.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.672 1.589 . . . . 0.0 112.135 -171.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.91 170.34 22.35 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.058 1.343 . . . . 0.0 111.852 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.76 140.08 29.89 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.439 1.895 . . . . 0.0 110.508 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 m -125.29 136.74 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.5 1.12 . . . . 0.0 112.99 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.3 173.3 35.99 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.029 1.3 . . . . 0.0 115.694 169.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -57.15 -37.86 72.67 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.195 -1.179 . . . . 0.0 112.023 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -85.33 9.47 15.33 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.663 1.585 . . . . 0.0 114.867 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 62.65 36.36 13.59 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 165.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.68 138.04 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 121.591 -0.693 . . . . 0.0 111.091 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.9 tp -87.78 128.54 35.32 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.897 1.279 . . . . 0.0 113.143 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.5 m -135.43 151.27 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.201 1.401 . . . . 0.0 112.213 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -93.75 116.5 28.98 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.97 1.708 . . . . 0.0 110.257 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.631 1.172 . . . . 0.0 113.864 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.83 156.3 33.54 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.285 1.434 . . . . 0.0 110.667 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.3 m -67.7 159.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.715 0.769 . . . . 0.0 111.458 171.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.38 154.63 1.7 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.572 0.749 . . . . 0.0 112.77 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.42 -2.32 22.21 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 117.768 -1.573 . . . . 0.0 116.263 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.3 m -64.58 124.61 22.3 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.305 2.052 . . . . 0.0 110.057 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.5 mmt -83.07 139.48 33.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.974 1.31 . . . . 0.0 111.951 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.6 mm -123.26 134.39 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.387 1.875 . . . . 0.0 110.174 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -75.42 121.51 22.41 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.137 0.975 . . . . 0.0 112.668 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.6 p -112.38 177.33 4.68 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.919 1.288 . . . . 0.0 112.001 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.68 -23.47 65.3 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.207 -0.933 . . . . 0.0 113.276 171.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -106.92 -18.81 13.82 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.958 1.303 . . . . 0.0 114.385 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.26 -114.45 0.61 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.987 1.279 . . . . 0.0 113.008 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -129.0 140.96 51.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.2 1.0 . . . . 0.0 113.294 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.2 t -133.45 143.74 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.333 1.853 . . . . 0.0 108.577 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.43 147.96 47.37 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.324 -0.86 . . . . 0.0 110.881 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 tt -61.72 -27.57 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 120.796 -1.19 . . . . 0.0 112.998 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.19 -13.19 61.48 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -112.17 -11.37 13.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.797 2.039 . . . . 0.0 113.153 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.9 mm -64.25 135.85 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.665 0.786 . . . . 0.0 109.261 162.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -125.05 164.85 19.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.489 1.916 . . . . 0.0 111.193 173.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.35 136.65 58.03 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.731 -0.605 . . . . 0.0 110.614 167.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.36 -9.29 75.96 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.482 1.039 . . . . 0.0 114.537 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.78 174.36 6.13 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.771 1.285 . . . . 0.0 111.288 168.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -131.39 142.35 50.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.713 1.205 . . . . 0.0 113.238 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.49 157.71 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.854 2.061 . . . . 0.0 110.757 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.6 mm -76.92 137.01 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.586 -0.696 . . . . 0.0 111.519 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.64 118.92 17.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.789 1.236 . . . . 0.0 108.157 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -89.91 107.45 19.12 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -55.91 113.99 6.72 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.895 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.56 -5.29 16.36 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.125 1.883 . . . . 0.0 114.109 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.16 -38.52 75.48 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.916 -1.115 . . . . 0.0 112.563 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -144.12 -2.11 0.92 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.949 0.9 . . . . 0.0 112.852 -171.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 55.5 44.83 26.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.62 1.168 . . . . 0.0 112.284 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -90.8 139.53 30.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.768 0.827 . . . . 0.0 109.832 167.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.33 124.26 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.749 0.82 . . . . 0.0 110.319 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.61 153.77 48.66 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.782 0.801 . . . . 0.0 112.538 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.67 115.4 23.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.424 1.49 . . . . 0.0 108.674 169.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -126.53 149.15 49.56 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.893 1.277 . . . . 0.0 110.81 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -90.62 157.84 17.27 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -174.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.3 t -89.25 128.61 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.562 1.545 . . . . 0.0 110.645 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.19 -51.43 7.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.359 0.664 . . . . 0.0 111.804 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -146.18 149.97 34.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.39 1.876 . . . . 0.0 109.462 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.4 p -118.65 126.7 52.52 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.049 1.34 . . . . 0.0 110.177 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -105.9 160.38 15.31 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.155 1.382 . . . . 0.0 113.077 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.1 t -134.36 143.91 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.304 2.242 . . . . 0.0 109.302 171.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -137.19 170.84 15.42 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.916 1.687 . . . . 0.0 109.825 166.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -117.68 143.13 46.47 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.424 1.09 . . . . 0.0 110.522 164.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.3 t -148.11 146.26 28.72 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.74 -0.6 . . . . 0.0 111.264 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.1 p -87.72 -18.13 30.16 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.374 0.67 . . . . 0.0 112.617 162.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HG2' HD12 ' A' ' 106' ' ' ILE . 56.6 mt-10 -93.86 114.19 26.37 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.863 -1.148 . . . . 0.0 111.551 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.1 mt -121.46 171.28 8.9 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.847 1.259 . . . . 0.0 111.63 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.5 tp -145.6 131.18 18.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.518 1.527 . . . . 0.0 110.146 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -106.36 137.46 44.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.274 1.03 . . . . 0.0 109.43 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 mt -129.61 135.13 48.17 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.909 1.284 . . . . 0.0 110.089 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.5 m -104.13 119.97 40.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.91 0.884 . . . . 0.0 109.476 173.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.56 116.29 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.183 1.393 . . . . 0.0 108.781 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.78 35.74 47.75 Favored Glycine 0 CA--C 1.542 1.729 0 O-C-N 121.477 -0.765 . . . . 0.0 114.863 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.38 -14.04 55.9 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.294 1.426 . . . . 0.0 115.507 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -90.91 117.94 29.9 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.805 1.302 . . . . 0.0 109.258 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.46 133.76 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.826 0.85 . . . . 0.0 111.972 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.7 mt -129.01 134.66 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.473 1.909 . . . . 0.0 108.798 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -117.34 112.82 21.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.538 1.535 . . . . 0.0 110.98 -168.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -140.47 178.45 7.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.759 1.224 . . . . 0.0 112.302 -159.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.0 p -84.54 152.4 23.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.175 0.988 . . . . 0.0 111.878 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.98 -20.47 65.31 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.734 1.213 . . . . 0.0 113.41 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -109.61 11.88 24.53 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.407 1.083 . . . . 0.0 113.529 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -67.2 130.3 93.68 Favored Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 120.89 -1.131 . . . . 0.0 112.414 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.84 127.49 5.54 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.515 2.81 . . . . 0.0 114.759 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -118.29 141.48 48.47 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.18 2.192 . . . . 0.0 110.952 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.405 ' CE2' ' HA2' ' A' ' 76' ' ' GLY . 47.9 t80 -93.36 129.93 39.3 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.735 1.152 . . . . 0.0 114.034 -176.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.7 t -109.44 133.53 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.995 2.118 . . . . 0.0 111.739 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -51.08 123.69 9.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.641 1.576 . . . . 0.0 113.917 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 54.37 23.55 4.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.388 1.875 . . . . 0.0 114.34 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.7 t -130.19 -54.91 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.951 1.3 . . . . 0.0 110.928 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 71' ' ' TYR . . . 119.94 -165.82 13.53 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.571 0.605 . . . . 0.0 114.047 -175.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -81.41 140.88 34.42 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.385 1.088 . . . . 0.0 113.864 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.19 147.95 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 127.503 2.321 . . . . 0.0 109.475 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -66.86 144.08 56.48 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.529 -0.732 . . . . 0.0 112.176 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.33 -40.22 64.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.811 1.244 . . . . 0.0 113.39 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.43 -20.46 67.7 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.307 -0.87 . . . . 0.0 114.177 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.85 0.96 30.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.096 2.158 . . . . 0.0 113.254 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.1 mt -72.97 161.84 30.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.198 0.599 . . . . 0.0 111.365 168.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.1 162.62 29.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.888 1.275 . . . . 0.0 111.545 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.61 140.48 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.384 1.073 . . . . 0.0 109.611 170.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.78 4.15 89.35 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.188 -0.784 . . . . 0.0 114.439 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -80.82 152.07 28.41 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.126 1.463 . . . . 0.0 110.824 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.2 108.43 19.81 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.762 1.625 . . . . 0.0 113.483 -165.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.4 mt -103.79 164.12 11.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.162 1.385 . . . . 0.0 112.524 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.75 144.96 34.15 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.637 1.175 . . . . 0.0 111.507 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -102.07 -177.25 3.35 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.063 0.945 . . . . 0.0 113.489 169.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.6 p -54.44 -23.48 16.14 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.793 2.037 . . . . 0.0 115.733 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -104.71 -20.76 13.52 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.588 1.555 . . . . 0.0 113.274 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.29 27.42 10.02 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.336 1.922 . . . . 0.0 112.863 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -66.38 149.54 50.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.608 0.363 . . . . 0.0 110.416 162.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.1 99.26 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.217 1.007 . . . . 0.0 110.303 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -80.31 161.31 25.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.188 2.595 . . . . 0.0 112.238 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.62 139.64 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.358 1.063 . . . . 0.0 111.719 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.18 127.73 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.29 1.036 . . . . 0.0 110.925 170.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -97.85 -32.47 11.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.891 2.076 . . . . 0.0 113.357 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -161.5 150.72 16.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.05 0.94 . . . . 0.0 113.013 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -123.13 128.22 49.77 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.438 1.895 . . . . 0.0 109.526 162.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm -127.29 124.69 39.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.374 1.469 . . . . 0.0 110.777 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 tt -121.35 135.54 55.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.756 1.222 . . . . 0.0 110.33 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -141.71 171.11 14.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.36 1.064 . . . . 0.0 111.403 168.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.428 HD12 ' HG2' ' A' ' 51' ' ' GLU . 15.7 mm -116.97 115.08 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 162.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.66 148.72 19.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.626 1.17 . . . . 0.0 112.197 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -72.62 -24.69 61.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.913 0.885 . . . . 0.0 111.827 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -143.0 152.93 59.78 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.946 2.099 . . . . 0.0 109.517 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.74 123.26 11.7 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.276 2.65 . . . . 0.0 113.188 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.4 t -92.0 143.67 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.459 1.504 . . . . 0.0 110.291 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -76.82 141.87 40.51 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.514 0.673 . . . . 0.0 111.537 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.08 148.44 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.921 1.288 . . . . 0.0 110.368 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -127.74 144.75 51.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.912 1.285 . . . . 0.0 111.856 -169.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -152.18 161.56 42.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.431 1.092 . . . . 0.0 111.252 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -148.02 159.38 43.96 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.797 -1.19 . . . . 0.0 113.508 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -108.89 138.02 45.9 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.73 1.212 . . . . 0.0 113.534 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.49 145.9 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 126.009 1.724 . . . . 0.0 112.474 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.38 -24.18 65.66 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 -167.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -148.6 -49.93 0.16 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.922 1.692 . . . . 0.0 112.067 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -73.07 167.33 21.35 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.63 0.772 . . . . 0.0 110.54 168.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -123.91 24.08 8.42 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.301 1.44 . . . . 0.0 113.937 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 p -135.97 158.07 45.3 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.971 1.708 . . . . 0.0 113.063 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -160.89 -176.01 5.27 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.88 1.672 . . . . 0.0 110.709 171.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -128.59 138.95 52.48 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.361 1.464 . . . . 0.0 113.582 -169.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.32 142.08 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.268 1.427 . . . . 0.0 113.379 -173.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.83 173.22 27.41 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.571 1.558 . . . . 0.0 116.198 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.24 -23.93 67.48 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.736 -1.45 . . . . 0.0 113.917 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -88.99 0.87 56.29 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 58.61 45.75 15.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.17 1.788 . . . . 0.0 114.648 168.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 t -72.43 137.54 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.547 1.539 . . . . 0.0 111.71 -170.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 64.6 tp -79.66 125.26 29.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.681 1.592 . . . . 0.0 113.391 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.52 157.92 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.968 1.707 . . . . 0.0 111.377 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.99 145.5 32.21 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.902 1.281 . . . . 0.0 111.437 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -124.87 157.36 36.11 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.922 1.689 . . . . 0.0 110.493 166.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.1 m -66.23 156.81 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.332 0.587 . . . . 0.0 112.076 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.29 150.49 1.25 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.165 0.986 . . . . 0.0 111.821 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.52 -3.95 22.74 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.5 m -65.51 125.05 23.95 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 120.976 2.388 . . . . 0.0 109.864 171.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -78.99 143.6 35.56 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.233 1.013 . . . . 0.0 111.954 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.31 135.09 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.411 1.884 . . . . 0.0 109.829 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.26 122.09 22.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.796 0.838 . . . . 0.0 112.12 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.0 p -117.23 171.32 8.03 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.307 1.043 . . . . 0.0 111.736 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.8 -17.55 64.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.817 0.847 . . . . 0.0 113.175 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -105.81 -20.3 13.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.992 2.117 . . . . 0.0 113.827 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.06 -105.57 0.27 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.116 1.341 . . . . 0.0 113.06 174.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.8 mt -132.94 140.76 47.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.779 1.632 . . . . 0.0 111.965 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.1 t -135.05 145.6 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.485 1.914 . . . . 0.0 108.543 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.97 147.43 52.45 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.206 -0.934 . . . . 0.0 111.388 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.1 tt -60.32 -29.91 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 120.712 -1.242 . . . . 0.0 112.827 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.29 -17.97 64.41 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -107.72 -10.38 15.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.694 1.998 . . . . 0.0 112.919 -174.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.7 136.74 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.976 161.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -126.29 162.16 26.12 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.939 2.096 . . . . 0.0 111.301 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.94 130.33 43.01 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.435 0.694 . . . . 0.0 110.432 168.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.36 16.94 65.5 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.833 -0.542 . . . . 0.0 113.902 -170.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -96.43 -179.63 4.7 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.155 0.982 . . . . 0.0 110.603 157.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -128.71 145.83 51.06 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.706 1.603 . . . . 0.0 112.341 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.89 158.67 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.037 1.735 . . . . 0.0 110.526 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -76.44 141.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.65 -0.656 . . . . 0.0 111.547 167.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.62 128.04 24.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.001 0.92 . . . . 0.0 109.163 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.0 m -79.44 112.76 17.01 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 160.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -52.66 114.83 6.2 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.235 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.14 -13.18 36.28 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.982 2.455 . . . . 0.0 113.738 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -84.67 -37.26 21.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -172.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -133.39 -6.1 2.95 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.408 1.483 . . . . 0.0 112.922 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.252 15.2 m-85 66.39 30.53 8.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.33 1.852 . . . . 0.0 115.009 -175.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -79.43 130.8 35.77 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.611 1.165 . . . . 0.0 110.155 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.8 128.65 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.889 0.768 . . . . 0.0 110.815 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.95 167.16 28.44 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.316 1.047 . . . . 0.0 112.811 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -78.87 139.7 38.27 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.515 1.126 . . . . 0.0 110.413 163.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -142.48 154.94 44.97 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.493 1.517 . . . . 0.0 110.61 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.8 t -85.35 156.77 20.75 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.79 123.95 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.453 1.901 . . . . 0.0 110.367 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.91 -44.48 16.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.379 0.672 . . . . 0.0 112.736 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -146.14 154.31 41.66 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.486 1.915 . . . . 0.0 110.572 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.7 p -122.22 128.7 51.47 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.949 1.3 . . . . 0.0 111.274 172.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -108.1 149.01 29.03 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.33 1.852 . . . . 0.0 114.38 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 114' ' ' TYR . 45.1 t -139.8 140.51 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.375 1.07 . . . . 0.0 112.428 177.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -138.52 179.83 6.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.58 2.752 . . . . 0.0 112.209 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -131.61 148.35 52.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.636 1.574 . . . . 0.0 112.431 167.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.6 t -152.74 149.24 28.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.423 1.089 . . . . 0.0 111.557 170.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 p -86.36 -17.16 35.18 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.335 1.054 . . . . 0.0 113.3 164.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HG2' HD12 ' A' ' 106' ' ' ILE . 52.7 mt-10 -105.36 116.17 31.5 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.353 1.061 . . . . 0.0 110.798 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.3 mt -117.8 170.7 8.59 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.651 1.58 . . . . 0.0 112.218 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.7 tp -141.38 134.7 29.57 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.958 1.703 . . . . 0.0 110.062 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -114.75 120.54 40.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.395 1.078 . . . . 0.0 110.067 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.94 130.37 55.45 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.189 -0.945 . . . . 0.0 109.808 173.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.8 m -104.43 118.55 36.89 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.271 1.028 . . . . 0.0 108.582 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -132.02 119.81 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.59 1.556 . . . . 0.0 109.136 -173.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.35 25.11 47.85 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 115.19 0.836 . . . . 0.0 115.19 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.7 -5.39 84.67 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.893 1.711 . . . . 0.0 116.068 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -91.93 132.02 36.81 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.206 1.503 . . . . 0.0 109.483 166.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.82 138.45 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.951 0.9 . . . . 0.0 112.28 163.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.2 mt -132.8 136.12 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 126.126 1.771 . . . . 0.0 109.345 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -117.23 110.39 18.06 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.088 1.355 . . . . 0.0 110.445 -162.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.2 t -138.05 177.13 8.11 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.708 1.203 . . . . 0.0 113.165 -156.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.2 p -86.58 156.5 20.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.74 0.816 . . . . 0.0 111.952 169.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -63.85 -24.69 67.84 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.354 -0.842 . . . . 0.0 113.249 -174.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -99.63 3.63 45.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -60.78 121.3 60.44 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 118.004 -0.998 . . . . 0.0 112.503 -174.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -78.82 115.08 3.52 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.005 1.803 . . . . 0.0 113.056 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.903 1.681 . . . . 0.0 110.797 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -91.37 129.99 37.28 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.5 132.27 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 127.93 2.492 . . . . 0.0 110.731 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -54.49 122.29 10.2 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.261 1.424 . . . . 0.0 111.722 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 t70 53.87 26.7 6.41 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.754 2.422 . . . . 0.0 115.751 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.9 t -129.12 -54.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.939 1.296 . . . . 0.0 110.356 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.02 -155.37 19.77 Favored Glycine 0 N--CA 1.467 0.749 0 CA-C-O 119.499 -0.612 . . . . 0.0 112.027 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -96.57 150.74 20.3 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.053 1.426 . . . . 0.0 114.15 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.78 141.42 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.905 1.682 . . . . 0.0 111.786 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.52 134.91 46.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.61 0.764 . . . . 0.0 112.859 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.05 -37.13 66.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.822 1.249 . . . . 0.0 113.095 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.88 -19.93 72.03 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 121.418 -0.802 . . . . 0.0 113.935 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -97.61 -1.26 44.15 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.836 1.654 . . . . 0.0 114.218 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.26 159.15 29.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.46 0.704 . . . . 0.0 112.377 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -118.97 153.2 35.01 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.556 1.542 . . . . 0.0 110.989 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.4 t -64.86 136.42 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 170.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.75 87.84 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.387 -1.23 . . . . 0.0 115.576 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -84.09 158.2 21.49 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.423 1.612 . . . . 0.0 111.78 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.75 106.79 18.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.557 1.543 . . . . 0.0 112.325 -163.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.5 mt -98.13 -176.79 3.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.683 1.593 . . . . 0.0 111.068 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.6 mt -132.9 154.11 50.72 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.33 177.47 4.85 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 122.886 1.327 . . . . 0.0 114.486 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.6 p -56.79 -6.01 0.29 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.384 2.674 . . . . 0.0 117.318 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -119.17 -18.11 8.76 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.157 1.783 . . . . 0.0 112.221 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.73 18.83 19.48 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.439 1.495 . . . . 0.0 112.885 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -72.65 143.1 48.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.967 0.907 . . . . 0.0 110.457 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.91 114.57 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.195 0.522 . . . . 0.0 110.786 171.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 mt -91.5 157.89 16.78 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.481 1.112 . . . . 0.0 111.188 167.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.0 t -130.98 139.04 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.316 1.046 . . . . 0.0 110.393 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.96 116.38 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 173.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.15 -41.38 28.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.72 1.608 . . . . 0.0 110.84 174.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -159.85 153.58 22.8 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.647 1.179 . . . . 0.0 112.186 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -113.57 134.44 54.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.404 1.482 . . . . 0.0 109.484 159.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -131.45 161.34 32.72 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 128.578 2.751 . . . . 0.0 110.476 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 tt -146.78 139.42 25.08 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.676 1.191 . . . . 0.0 109.927 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -137.51 150.45 47.54 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.043 0.838 . . . . 0.0 112.329 168.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.403 HD12 ' HG2' ' A' ' 51' ' ' GLU . 5.7 mm -103.41 116.23 46.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.48 145.16 51.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.861 1.264 . . . . 0.0 111.551 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -74.96 -20.5 59.65 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.412 -0.805 . . . . 0.0 112.249 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -140.41 155.86 69.82 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.629 1.972 . . . . 0.0 110.977 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.32 124.74 15.79 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.89 2.393 . . . . 0.0 113.079 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 t -93.95 141.62 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.226 1.811 . . . . 0.0 109.628 172.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -76.22 141.95 41.6 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.553 0.692 . . . . 0.0 111.78 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.82 146.61 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.892 1.277 . . . . 0.0 110.829 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.402 ' CD2' HG22 ' A' ' 46' ' ' VAL . 61.2 m-85 -129.05 150.42 50.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.017 1.327 . . . . 0.0 111.331 -166.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -156.81 169.36 24.92 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.08 1.752 . . . . 0.0 109.548 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -156.09 169.59 24.14 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.346 -1.471 . . . . 0.0 111.947 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -123.84 142.34 51.21 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -100.33 151.71 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.018 1.727 . . . . 0.0 112.893 -170.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.4 -27.86 69.59 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -169.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.12 -34.86 0.09 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 120.212 -1.555 . . . . 0.0 113.638 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -77.67 164.65 25.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 164.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -123.34 33.56 5.33 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.458 1.103 . . . . 0.0 111.959 -174.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.6 p -150.14 162.31 40.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.464 1.506 . . . . 0.0 111.775 -164.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -156.81 174.84 14.89 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.494 1.518 . . . . 0.0 110.612 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -118.94 134.96 54.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.624 1.17 . . . . 0.0 112.432 -176.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.71 137.72 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.677 1.591 . . . . 0.0 112.226 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.81 -172.03 45.66 Favored Glycine 0 CA--C 1.544 1.857 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 170.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -84.93 -22.49 29.22 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.719 1.208 . . . . 0.0 112.155 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -84.22 -9.19 58.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.633 1.173 . . . . 0.0 113.382 165.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 60.56 50.74 5.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.529 1.532 . . . . 0.0 113.578 165.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.29 144.66 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.883 1.673 . . . . 0.0 112.078 -173.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.2 tp -84.98 129.46 34.79 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.621 1.568 . . . . 0.0 114.703 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.2 m -138.53 158.19 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 126.403 1.881 . . . . 0.0 112.268 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -117.75 123.3 45.69 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.939 1.295 . . . . 0.0 114.184 -169.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.188 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -174.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.896 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.449 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 96.7 m-85 -125.42 153.28 43.69 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.437 1.495 . . . . 0.0 111.668 172.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 m -68.36 159.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.358 0.599 . . . . 0.0 111.928 173.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.04 152.17 6.14 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.082 0.953 . . . . 0.0 112.487 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.14 -7.11 24.61 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 117.712 -1.605 . . . . 0.0 116.238 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.1 m -61.82 121.88 14.0 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.379 2.089 . . . . 0.0 110.474 174.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -77.2 142.54 39.55 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.69 1.196 . . . . 0.0 112.329 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -121.8 137.07 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.416 2.286 . . . . 0.0 109.494 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.66 127.13 32.37 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 p -127.15 171.1 11.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.834 1.253 . . . . 0.0 112.039 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.3 65.48 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.3 p -103.26 -24.56 13.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.2 -107.9 0.32 Allowed Glycine 0 CA--C 1.522 0.488 0 O-C-N 121.663 -0.648 . . . . 0.0 112.002 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.58 140.04 45.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.961 1.304 . . . . 0.0 111.535 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.5 t -127.19 141.51 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.205 1.402 . . . . 0.0 109.019 172.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.13 147.67 49.65 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.268 -0.895 . . . . 0.0 110.922 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.6 tt -61.03 -26.57 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.025 -1.047 . . . . 0.0 113.351 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.68 -7.09 52.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.496 1.518 . . . . 0.0 114.341 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -117.39 -12.3 10.46 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.902 1.681 . . . . 0.0 112.652 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.7 mm -65.15 132.73 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 119.147 0.885 . . . . 0.0 110.36 164.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -119.21 161.74 19.86 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.431 1.892 . . . . 0.0 111.679 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.65 138.54 58.06 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.09 -1.006 . . . . 0.0 110.63 167.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.95 4.89 89.69 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 114.536 0.574 . . . . 0.0 114.536 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -86.18 157.07 20.08 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.523 1.161 . . . . 0.0 109.84 162.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -116.8 141.24 48.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.75 1.22 . . . . 0.0 111.319 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.95 159.47 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.934 1.694 . . . . 0.0 111.465 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 mm -71.64 143.86 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 122.797 0.439 . . . . 0.0 111.96 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.28 126.25 18.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.78 1.232 . . . . 0.0 109.251 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.8 m -84.53 111.67 19.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 165.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -56.03 114.64 7.91 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.789 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.18 -8.16 22.85 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.6 2.2 . . . . 0.0 113.94 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -79.49 -39.64 31.63 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.017 -1.052 . . . . 0.0 113.616 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -138.08 -1.29 1.98 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.323 1.049 . . . . 0.0 113.278 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 58.73 40.04 23.61 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.679 1.192 . . . . 0.0 113.407 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.06 138.82 33.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.542 0.737 . . . . 0.0 109.029 165.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -109.11 121.93 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.995 1.318 . . . . 0.0 109.169 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.34 162.79 33.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.456 0.703 . . . . 0.0 112.673 -176.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -93.51 124.66 37.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.797 1.239 . . . . 0.0 109.307 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -132.67 152.67 51.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.416 1.487 . . . . 0.0 111.194 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 t -85.57 152.98 22.73 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.9 t -89.1 130.55 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.98 1.712 . . . . 0.0 110.279 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.6 mt -92.71 -40.76 10.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.811 0.845 . . . . 0.0 112.384 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -143.93 152.52 41.21 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.338 1.455 . . . . 0.0 111.247 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.5 p -124.47 124.66 42.78 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.197 2.199 . . . . 0.0 109.073 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -116.63 159.91 21.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.17 1.788 . . . . 0.0 114.412 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 114' ' ' TYR . 21.8 t -143.63 144.56 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.849 1.66 . . . . 0.0 111.426 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -142.49 178.77 7.37 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.024 2.13 . . . . 0.0 112.053 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -131.47 145.23 51.68 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.081 2.152 . . . . 0.0 112.306 173.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -154.72 152.52 30.0 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.967 0.907 . . . . 0.0 111.148 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 p -86.9 -14.55 41.6 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 163.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -101.54 105.53 16.51 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.073 0.851 . . . . 0.0 110.201 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.5 mt -123.49 162.32 23.1 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.85 1.31 . . . . 0.0 113.67 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.3 tp -126.29 131.21 51.92 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.811 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -101.98 134.1 45.72 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.244 1.417 . . . . 0.0 109.442 165.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 mt -126.28 126.59 44.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.874 0.869 . . . . 0.0 109.064 163.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.1 m -93.17 120.35 33.36 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 167.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.4 117.09 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.949 1.3 . . . . 0.0 108.92 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 50.54 38.18 34.75 Favored Glycine 0 CA--C 1.544 1.876 0 N-CA-C 115.186 0.835 . . . . 0.0 115.186 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.73 -0.56 89.18 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 121.297 -1.119 . . . . 0.0 115.701 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -109.06 120.97 44.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.326 1.563 . . . . 0.0 110.442 172.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.48 128.36 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.803 0.811 . . . . 0.0 111.555 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.4 mt -118.09 128.3 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.689 1.596 . . . . 0.0 108.375 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -108.03 110.99 22.82 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.507 1.523 . . . . 0.0 110.27 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 t -139.7 176.14 8.98 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.223 1.009 . . . . 0.0 112.473 -161.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.3 p -82.08 152.28 26.65 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.177 0.989 . . . . 0.0 112.349 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -65.96 -19.97 66.04 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.188 -0.945 . . . . 0.0 113.27 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.337 3.5 p-10 -110.6 17.44 20.7 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 175.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.449 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 3.2 t60 -66.11 132.72 94.59 Favored Pre-proline 0 CA--C 1.555 1.155 0 O-C-N 121.071 -1.018 . . . . 0.0 113.665 176.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.11 118.84 3.05 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.279 3.319 . . . . 0.0 115.096 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -116.89 140.51 49.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.872 2.069 . . . . 0.0 112.216 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -84.2 127.46 33.96 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.049 1.295 . . . . 0.0 114.05 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.91 134.82 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 127.989 2.516 . . . . 0.0 111.355 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -52.24 126.92 20.37 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.919 1.688 . . . . 0.0 111.717 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 57.31 19.42 5.02 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.993 1.717 . . . . 0.0 115.488 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.8 t -130.31 -58.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.893 0.877 . . . . 0.0 111.12 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.32 -159.47 15.88 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.643 0.64 . . . . 0.0 113.43 -171.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -81.06 142.49 33.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 p -141.26 152.19 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.622 1.969 . . . . 0.0 110.884 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.73 129.45 39.8 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.947 0.899 . . . . 0.0 111.868 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.63 -36.67 69.73 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.546 1.138 . . . . 0.0 113.343 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.62 -5.08 88.17 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.909 -1.119 . . . . 0.0 114.134 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -101.89 -2.19 30.42 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.871 1.335 . . . . 0.0 113.319 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.55 161.15 31.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.011 1.324 . . . . 0.0 112.631 167.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.44 164.78 18.24 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.04 2.136 . . . . 0.0 111.572 171.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.32 141.93 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.187 -0.945 . . . . 0.0 109.813 167.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.69 7.83 88.15 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.265 -0.742 . . . . 0.0 114.683 -175.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -85.65 152.2 23.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.509 1.155 . . . . 0.0 111.098 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -108.24 109.69 21.12 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.837 1.255 . . . . 0.0 112.323 -163.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.1 mt -106.3 171.38 7.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.927 1.291 . . . . 0.0 111.295 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.7 mt -122.88 159.73 27.58 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -115.63 -174.31 2.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.19 1.796 . . . . 0.0 113.874 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.4 t -58.14 -15.42 9.56 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -97.34 -12.48 22.78 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 119.816 -1.803 . . . . 0.0 113.552 170.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.36 22.1 49.1 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.925 1.25 . . . . 0.0 111.864 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.53 139.65 33.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.878 1.271 . . . . 0.0 112.025 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.92 111.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.092 0.957 . . . . 0.0 112.913 -171.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 63.4 mt -90.35 161.95 15.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.89 2.076 . . . . 0.0 111.374 161.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.72 141.41 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.677 1.191 . . . . 0.0 110.683 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.04 121.6 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.706 0.802 . . . . 0.0 109.459 172.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.27 -36.32 15.66 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.439 1.895 . . . . 0.0 112.142 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -160.49 151.7 19.18 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.648 1.579 . . . . 0.0 111.61 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -129.56 139.48 51.48 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.716 2.006 . . . . 0.0 110.352 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -143.2 139.67 30.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.368 1.467 . . . . 0.0 111.634 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.3 tp -116.87 136.4 52.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.724 2.01 . . . . 0.0 108.636 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -145.65 153.36 40.93 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 171.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.8 mm -91.91 121.41 42.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.037 0.935 . . . . 0.0 109.15 166.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.22 149.79 49.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.001 1.32 . . . . 0.0 113.664 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.65 -30.29 71.26 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.409 1.083 . . . . 0.0 112.851 175.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -148.38 152.62 39.16 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.023 2.529 . . . . 0.0 109.944 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -59.1 120.51 8.42 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.149 3.233 . . . . 0.0 111.985 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.56 137.87 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.107 1.363 . . . . 0.0 109.522 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -74.24 139.2 44.17 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.979 1.312 . . . . 0.0 110.363 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -137.93 143.78 32.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 124.643 1.177 . . . . 0.0 110.611 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.42 ' CD2' HG22 ' A' ' 46' ' ' VAL . 71.5 m-85 -121.82 149.15 43.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.901 1.28 . . . . 0.0 110.9 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -153.22 166.03 33.81 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.806 1.243 . . . . 0.0 111.481 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -150.29 167.39 27.13 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.792 -1.192 . . . . 0.0 112.561 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -116.0 142.83 46.27 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.3 t -99.83 143.52 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.929 2.092 . . . . 0.0 111.195 -173.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -60.02 -76.28 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.216 1.406 . . . . 0.0 113.636 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -118.19 -11.3 10.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -163.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -105.28 170.72 7.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.402 1.481 . . . . 0.0 109.149 163.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -114.67 13.68 17.42 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.832 2.053 . . . . 0.0 113.391 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 p -144.1 162.39 36.38 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.888 -1.133 . . . . 0.0 112.776 -163.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -156.48 172.91 17.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.919 1.688 . . . . 0.0 110.337 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -120.05 136.68 54.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.384 1.074 . . . . 0.0 112.343 -174.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.42 149.0 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.325 1.45 . . . . 0.0 113.71 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.62 175.47 18.88 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.254 1.407 . . . . 0.0 115.044 173.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.7 -28.8 69.67 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -88.63 4.44 47.08 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 60.86 46.54 8.6 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.715 1.206 . . . . 0.0 112.238 166.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -82.33 138.46 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.692 1.997 . . . . 0.0 112.122 -165.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.3 tp -80.49 124.73 29.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.357 1.463 . . . . 0.0 113.983 -173.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.14 159.88 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.969 1.708 . . . . 0.0 111.793 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -99.3 157.53 16.33 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.347 1.059 . . . . 0.0 113.832 -170.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.668 2.387 . . . . 0.0 113.226 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.123 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -121.43 153.66 37.57 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.313 1.445 . . . . 0.0 111.657 170.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.3 m -70.7 158.6 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.672 0.749 . . . . 0.0 112.419 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.87 146.76 7.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.215 1.006 . . . . 0.0 112.782 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.38 -8.67 52.52 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 117.332 -1.816 . . . . 0.0 115.929 -172.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.3 m -61.56 118.13 6.65 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.124 2.462 . . . . 0.0 110.113 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 mmt -75.37 141.35 43.31 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.239 1.016 . . . . 0.0 111.972 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.8 mm -124.78 136.12 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.03 2.132 . . . . 0.0 109.754 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.46 124.32 26.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.381 1.072 . . . . 0.0 112.641 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.9 p -127.15 174.07 9.21 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.527 1.131 . . . . 0.0 111.829 -176.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.9 71.28 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.084 -1.01 . . . . 0.0 111.954 167.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.9 p -77.69 -33.69 53.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.255 1.022 . . . . 0.0 111.968 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.37 -90.01 0.12 Allowed Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.486 1.517 . . . . 0.0 111.619 172.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.1 mt -134.16 140.1 46.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.731 1.612 . . . . 0.0 111.196 170.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -134.36 145.85 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.665 1.986 . . . . 0.0 108.974 174.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.78 146.86 51.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.849 -1.157 . . . . 0.0 111.159 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 tt -60.95 -29.59 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 120.973 -1.08 . . . . 0.0 113.121 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.13 -20.03 64.87 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 173.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -101.67 -17.2 16.42 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.075 1.35 . . . . 0.0 113.022 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.06 126.91 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.595 0.758 . . . . 0.0 109.534 165.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -122.2 154.94 36.81 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.7 1.6 . . . . 0.0 111.733 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.09 126.46 26.09 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.604 -0.685 . . . . 0.0 111.541 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.59 -19.74 41.22 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.001 1.286 . . . . 0.0 114.749 -168.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -71.2 177.23 3.94 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.4 1.6 . . . . 0.0 112.981 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -120.16 154.93 34.08 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.586 1.554 . . . . 0.0 113.429 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -143.54 159.29 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.081 2.152 . . . . 0.0 109.851 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -77.09 139.18 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 O-C-N 121.205 -0.934 . . . . 0.0 110.827 166.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.87 129.25 40.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.5 m -93.38 110.39 21.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -52.67 112.36 3.39 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.633 1.573 . . . . 0.0 112.354 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -69.75 -6.69 19.2 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.156 1.904 . . . . 0.0 113.961 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -77.45 -42.65 35.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.711 -1.243 . . . . 0.0 112.737 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.8 t -138.05 2.68 2.36 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.27 1.028 . . . . 0.0 113.163 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.274 68.8 m-85 58.69 32.34 22.07 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.436 1.494 . . . . 0.0 113.944 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.77 139.87 49.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.05 0.94 . . . . 0.0 109.753 167.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.14 109.15 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.719 1.207 . . . . 0.0 109.885 -168.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.75 157.29 44.78 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.44 125.82 29.93 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.035 1.334 . . . . 0.0 110.06 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HE2' ' HB2' ' A' ' 120' ' ' ASP . 29.9 mmmt -129.23 151.21 50.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.999 1.319 . . . . 0.0 110.196 174.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.26 7.0 t -81.63 159.69 23.96 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.189 0.995 . . . . 0.0 113.45 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.1 t -94.54 125.79 47.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 126.584 1.954 . . . . 0.0 109.543 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.7 mt -82.25 -49.09 10.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.602 1.161 . . . . 0.0 111.268 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.59 151.68 39.4 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.684 1.194 . . . . 0.0 111.088 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.0 p -121.68 119.94 33.25 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.112 1.765 . . . . 0.0 110.145 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -108.76 150.44 27.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.124 1.77 . . . . 0.0 113.317 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.74 136.49 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.706 1.602 . . . . 0.0 111.646 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -134.79 175.13 9.84 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.678 1.991 . . . . 0.0 110.475 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -136.65 138.77 41.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.28 1.032 . . . . 0.0 110.411 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.2 t -153.39 147.32 25.42 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.248 -0.907 . . . . 0.0 112.246 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.1 p -86.7 -22.04 26.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.54 1.136 . . . . 0.0 112.855 168.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -100.84 86.0 3.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.134 0.969 . . . . 0.0 110.596 -166.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.23 177.91 5.7 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.756 1.223 . . . . 0.0 112.674 -172.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.1 tp -145.66 143.2 29.68 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.136 1.774 . . . . 0.0 109.649 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -109.37 136.78 48.25 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.024 -1.047 . . . . 0.0 108.43 162.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.2 mt -118.88 144.36 46.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.76 0.824 . . . . 0.0 109.252 161.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.4 m -109.04 123.18 48.74 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.16 120.41 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.378 1.471 . . . . 0.0 108.584 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.49 30.82 42.66 Favored Glycine 0 CA--C 1.543 1.82 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.05 -3.92 82.81 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 118.636 1.218 . . . . 0.0 115.684 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.66 126.88 44.4 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.189 1.395 . . . . 0.0 110.262 171.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.03 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.984 -0.447 . . . . 0.0 110.773 162.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.3 mt -122.23 106.42 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 109.636 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -78.49 117.06 19.33 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.913 2.485 . . . . 0.0 110.812 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 t -145.06 -179.68 6.78 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.552 1.141 . . . . 0.0 113.248 -164.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.2 p -85.62 155.64 21.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.501 1.12 . . . . 0.0 112.159 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -64.32 -28.14 69.5 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.927 -1.108 . . . . 0.0 112.552 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.91 5.26 52.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.06 0.944 . . . . 0.0 113.17 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -68.19 125.82 91.97 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.476 -1.39 . . . . 0.0 112.767 -169.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.22 114.24 3.3 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.501 2.8 . . . . 0.0 114.073 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -102.95 148.85 25.16 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.818 1.647 . . . . 0.0 110.997 170.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -93.83 130.89 39.69 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.196 0.907 . . . . 0.0 112.704 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.4 133.4 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.08 1.752 . . . . 0.0 111.071 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -52.81 126.98 21.86 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.528 1.531 . . . . 0.0 111.032 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.15 16.83 5.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.065 1.746 . . . . 0.0 115.266 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.28 -51.61 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.417 1.487 . . . . 0.0 111.59 -172.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.5 -160.8 13.02 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.027 0.822 . . . . 0.0 113.547 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.251 15.1 p90 -79.46 149.89 31.42 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -171.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 p -150.43 145.53 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.982 2.113 . . . . 0.0 110.999 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -70.19 138.23 51.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.667 1.587 . . . . 0.0 112.129 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.95 -39.92 66.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.812 1.245 . . . . 0.0 113.834 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.27 -10.75 79.05 Favored Glycine 0 CA--C 1.539 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 114.262 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -109.69 -0.49 18.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.456 1.903 . . . . 0.0 113.172 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 mt -67.57 160.1 28.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.507 0.723 . . . . 0.0 111.593 167.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -127.47 155.15 44.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.156 1.382 . . . . 0.0 111.711 172.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.25 137.94 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.801 0.84 . . . . 0.0 110.288 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.33 1.49 81.26 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.413 -1.215 . . . . 0.0 115.472 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -83.92 157.85 21.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.763 1.781 . . . . 0.0 112.089 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.45 98.02 8.41 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.096 1.358 . . . . 0.0 112.031 -166.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.01 179.21 6.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.037 1.335 . . . . 0.0 110.796 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 71.4 mt -131.56 155.75 46.93 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.297 1.039 . . . . 0.0 113.249 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.46 173.31 6.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.025 0.93 . . . . 0.0 112.671 168.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.2 t -51.4 -36.75 45.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -85.83 -11.7 52.7 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.777 1.231 . . . . 0.0 112.848 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.91 16.08 31.8 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 126.077 1.798 . . . . 0.0 112.633 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -72.57 143.43 48.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.636 0.774 . . . . 0.0 110.73 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.52 130.17 36.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 122.616 1.198 . . . . 0.0 111.128 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.7 mt -111.57 151.5 28.64 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.796 1.638 . . . . 0.0 111.33 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -118.89 137.03 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.549 0.74 . . . . 0.0 111.216 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.2 t -71.62 128.76 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.731 0.813 . . . . 0.0 109.593 170.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.59 -29.27 9.26 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.339 1.856 . . . . 0.0 112.485 -176.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -162.21 153.05 17.52 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.032 1.333 . . . . 0.0 112.243 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -120.55 132.41 55.15 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.329 1.852 . . . . 0.0 109.312 157.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -130.43 142.42 50.5 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.827 1.651 . . . . 0.0 110.127 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.7 tp -129.1 133.13 47.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.209 1.404 . . . . 0.0 111.162 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.37 156.31 48.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.295 1.038 . . . . 0.0 112.174 166.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.1 mm -108.79 107.85 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.227 1.411 . . . . 0.0 107.334 168.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.74 143.57 55.83 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.863 0.84 . . . . 0.0 112.804 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.65 -24.0 67.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -140.53 153.71 68.57 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.502 1.921 . . . . 0.0 111.435 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.39 120.09 7.4 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.393 2.729 . . . . 0.0 111.522 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.49 142.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.23 1.412 . . . . 0.0 109.593 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -78.51 140.94 38.52 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.564 0.697 . . . . 0.0 111.519 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.0 m -139.42 145.65 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 124.57 1.148 . . . . 0.0 111.727 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -125.2 148.14 48.76 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.343 1.457 . . . . 0.0 110.723 -166.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -151.7 168.71 24.17 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.38 1.472 . . . . 0.0 110.114 168.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -149.19 173.84 13.01 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.753 -1.217 . . . . 0.0 112.384 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -130.37 146.28 51.92 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.36 144.84 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.679 1.992 . . . . 0.0 113.004 -162.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.74 -18.24 62.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.521 2.729 . . . . 0.0 117.115 -168.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 4.5 m-20 -148.61 -63.86 0.24 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.915 1.234 . . . . 0.0 110.965 164.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -69.94 108.58 4.08 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.414 1.085 . . . . 0.0 110.74 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -70.02 36.11 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.292 1.837 . . . . 0.0 115.765 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.8 p -131.9 164.05 26.96 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.776 2.03 . . . . 0.0 111.935 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -157.94 -176.06 5.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.545 1.538 . . . . 0.0 110.037 166.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -127.66 141.4 51.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.366 1.066 . . . . 0.0 113.039 -172.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.32 138.24 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.495 1.118 . . . . 0.0 112.373 -175.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.02 179.46 53.08 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -73.7 -23.99 59.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.477 1.111 . . . . 0.0 112.148 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -80.25 1.68 27.53 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 166.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 54.87 39.3 31.43 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.268 1.427 . . . . 0.0 114.352 166.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.63 138.37 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.21 1.804 . . . . 0.0 112.02 -166.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.1 tp -81.65 126.75 32.14 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.408 1.483 . . . . 0.0 114.023 -173.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.29 157.96 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.673 1.589 . . . . 0.0 112.105 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -102.34 143.37 32.18 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.5 1.52 . . . . 0.0 112.02 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 C--O 1.252 1.21 0 C-N-CA 124.15 0.98 . . . . 0.0 112.509 176.688 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.77 154.85 40.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.542 1.537 . . . . 0.0 111.411 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.0 m -71.66 158.62 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.336 0.654 . . . . 0.0 112.431 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.52 147.56 10.77 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.332 1.053 . . . . 0.0 111.191 172.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.37 6.61 62.07 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-O 117.949 -1.473 . . . . 0.0 115.756 -171.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.4 m -70.75 121.73 18.53 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.962 2.381 . . . . 0.0 109.639 164.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -80.08 140.14 36.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.67 1.188 . . . . 0.0 111.505 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.0 mm -125.25 136.29 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.301 2.24 . . . . 0.0 109.946 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.4 tp -78.61 123.65 27.33 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.161 0.984 . . . . 0.0 113.398 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 p -117.83 177.05 4.91 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.24 1.416 . . . . 0.0 111.334 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.09 -21.46 64.96 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.117 -0.989 . . . . 0.0 113.262 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -96.62 -14.33 22.23 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.201 1.8 . . . . 0.0 113.108 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.26 -108.29 0.61 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.789 1.662 . . . . 0.0 111.462 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.2 mt -127.95 142.07 51.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.293 1.037 . . . . 0.0 113.548 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.7 t -130.16 144.41 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.949 2.1 . . . . 0.0 108.887 174.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.93 147.52 48.65 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.114 -0.991 . . . . 0.0 110.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -61.87 -27.75 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 120.457 -1.402 . . . . 0.0 113.124 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.83 -7.15 43.29 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.891 1.276 . . . . 0.0 114.18 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -115.87 -12.14 11.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.185 1.794 . . . . 0.0 113.976 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -63.22 140.26 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 165.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -125.75 159.03 33.39 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.18 1.792 . . . . 0.0 112.401 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.38 123.98 19.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 122.897 0.479 . . . . 0.0 110.317 164.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.73 -6.69 70.44 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.955 1.265 . . . . 0.0 114.646 -172.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -75.03 177.87 6.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.65 1.225 . . . . 0.0 111.24 166.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -134.8 140.78 46.14 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.905 1.282 . . . . 0.0 113.046 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -135.14 159.26 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.124 1.769 . . . . 0.0 111.099 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.6 mm -77.98 136.91 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.972 -0.455 . . . . 0.0 111.803 171.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.6 117.89 20.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.139 1.376 . . . . 0.0 108.596 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.5 m -90.85 104.59 17.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -49.2 113.58 3.25 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.013 0.925 . . . . 0.0 112.008 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.99 -3.66 13.65 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.41 2.74 . . . . 0.0 113.871 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.07 -38.08 25.43 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.841 -1.162 . . . . 0.0 112.841 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -141.83 -2.18 1.2 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -166.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 55.19 37.28 28.65 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.919 1.688 . . . . 0.0 113.747 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.5 131.72 35.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.279 1.432 . . . . 0.0 108.896 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -106.23 125.17 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.441 1.097 . . . . 0.0 109.309 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.72 161.73 37.09 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -78.08 134.79 37.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.512 0.725 . . . . 0.0 109.298 161.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -139.75 150.95 45.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.478 1.111 . . . . 0.0 111.618 170.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 t -85.39 159.74 19.92 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -92.1 129.69 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.997 1.719 . . . . 0.0 110.868 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.5 mt -84.23 -50.01 8.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.38 0.672 . . . . 0.0 112.142 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -145.12 151.84 39.11 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.937 1.695 . . . . 0.0 111.02 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 p -125.81 109.23 12.3 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.425 1.89 . . . . 0.0 110.543 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -98.92 146.8 25.62 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.404 1.082 . . . . 0.0 113.321 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 114' ' ' TYR . 39.4 t -139.12 134.51 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.866 1.266 . . . . 0.0 111.751 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -132.03 174.28 10.35 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.222 1.809 . . . . 0.0 111.342 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.89 135.52 49.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.484 1.514 . . . . 0.0 110.151 170.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -146.03 143.06 29.19 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.897 1.279 . . . . 0.0 111.419 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -86.04 -16.0 39.55 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.214 1.006 . . . . 0.0 112.417 164.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -102.45 110.07 21.9 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 120.838 -1.163 . . . . 0.0 109.75 -173.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.6 mt -120.47 172.5 7.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.84 1.256 . . . . 0.0 112.257 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -142.12 140.16 32.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.071 1.748 . . . . 0.0 110.065 175.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -107.53 137.86 44.8 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.188 -0.945 . . . . 0.0 108.84 163.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.8 mt -121.32 142.65 49.76 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.009 0.924 . . . . 0.0 109.266 160.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -110.06 122.29 47.25 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.156 0.982 . . . . 0.0 108.981 172.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.17 121.67 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.978 1.711 . . . . 0.0 108.616 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.02 31.29 58.59 Favored Glycine 0 CA--C 1.543 1.84 0 O-C-N 121.401 -0.812 . . . . 0.0 114.866 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.09 -1.06 88.98 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.252 1.405 . . . . 0.0 115.465 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -106.35 124.13 49.12 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.983 1.713 . . . . 0.0 110.828 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.8 130.52 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.2 1.0 . . . . 0.0 111.196 172.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.0 mt -120.8 102.26 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.417 1.487 . . . . 0.0 108.709 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -79.76 116.46 19.95 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.175 1.79 . . . . 0.0 111.428 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 t -142.18 -176.13 4.7 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.305 1.442 . . . . 0.0 112.015 -163.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 67.3 p -95.04 158.72 15.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.52 1.128 . . . . 0.0 111.768 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -63.94 -26.1 68.44 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.369 -0.832 . . . . 0.0 112.751 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -97.83 4.47 49.72 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -66.58 126.66 92.59 Favored Pre-proline 0 CA--C 1.55 0.97 0 O-C-N 120.511 -1.368 . . . . 0.0 112.98 -173.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.49 116.82 2.99 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.814 2.343 . . . . 0.0 114.266 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -102.01 153.24 20.07 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.187 2.195 . . . . 0.0 111.11 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.59 133.89 42.3 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.491 1.041 . . . . 0.0 113.754 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.7 t -111.24 131.87 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 127.084 2.154 . . . . 0.0 111.528 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -51.9 129.2 26.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.846 1.658 . . . . 0.0 113.027 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 56.27 12.06 0.92 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 127.988 2.515 . . . . 0.0 115.547 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.74 -56.49 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.747 1.219 . . . . 0.0 111.774 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 124.78 -159.98 19.4 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.635 0.636 . . . . 0.0 113.25 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.252 10.6 p90 -81.68 153.88 26.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.87 143.71 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.93 2.092 . . . . 0.0 111.329 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.37 136.01 57.33 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.301 1.041 . . . . 0.0 113.357 170.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.25 -39.65 70.02 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.553 1.541 . . . . 0.0 113.16 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.1 -22.19 70.49 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.739 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.38 -10.64 45.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.9 mt -67.71 154.41 41.57 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.277 0.944 . . . . 0.0 111.576 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -123.08 152.74 40.76 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.193 0.997 . . . . 0.0 110.768 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.5 t -65.5 138.03 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.693 0.797 . . . . 0.0 110.361 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.51 -3.78 85.19 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 115.254 0.862 . . . . 0.0 115.254 -175.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.22 153.48 27.15 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.085 1.442 . . . . 0.0 111.799 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -100.39 107.96 19.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.852 1.261 . . . . 0.0 112.587 -163.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.5 mt -100.91 177.26 5.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.724 1.61 . . . . 0.0 110.343 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.88 157.57 41.18 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.4 -174.32 2.47 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.43 1.492 . . . . 0.0 114.511 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.4 p -56.0 -7.25 0.31 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -119.65 -26.55 5.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.187 1.395 . . . . 0.0 114.55 165.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.16 23.39 4.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.147 1.356 . . . . 0.0 113.404 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -77.0 146.75 37.23 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.324 1.062 . . . . 0.0 111.82 171.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.54 109.43 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.239 0.616 . . . . 0.0 112.225 -173.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.8 mt -93.44 159.31 15.3 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.858 1.663 . . . . 0.0 112.312 173.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.2 t -124.55 139.11 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.111 0.964 . . . . 0.0 111.098 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.2 t -69.2 130.82 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.403 0.681 . . . . 0.0 110.081 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -98.28 -43.33 7.01 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.534 1.933 . . . . 0.0 112.796 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -159.81 154.08 23.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.27 1.028 . . . . 0.0 111.843 -172.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -118.87 135.62 54.46 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.553 1.941 . . . . 0.0 108.865 165.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -130.57 130.09 43.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.817 1.647 . . . . 0.0 109.678 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -129.16 129.75 45.51 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.665 1.186 . . . . 0.0 111.985 -169.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -147.03 163.49 36.09 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.488 1.115 . . . . 0.0 112.879 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 mm -104.63 116.7 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 159.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.21 145.57 50.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.249 1.019 . . . . 0.0 111.672 173.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -75.09 -11.82 60.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.991 1.316 . . . . 0.0 112.464 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -139.84 152.05 67.13 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 127.204 2.202 . . . . 0.0 111.57 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.59 117.69 5.04 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.078 2.519 . . . . 0.0 110.753 172.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.31 139.43 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.033 1.733 . . . . 0.0 110.353 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -76.27 139.31 41.05 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.888 0.875 . . . . 0.0 110.297 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.47 140.8 28.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 124.007 0.923 . . . . 0.0 111.657 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.438 ' CD2' HG22 ' A' ' 46' ' ' VAL . 76.3 m-85 -119.64 153.87 34.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.812 1.645 . . . . 0.0 112.049 -169.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -157.18 170.2 23.04 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.947 1.699 . . . . 0.0 110.816 170.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -152.64 167.56 28.5 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.354 -1.466 . . . . 0.0 113.249 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -117.37 144.84 44.52 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.745 1.218 . . . . 0.0 112.954 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.17 139.54 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.562 1.545 . . . . 0.0 111.48 -168.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -60.22 -34.66 73.96 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -163.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -145.87 -47.27 0.21 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.007 -1.058 . . . . 0.0 112.671 -172.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -76.39 165.99 24.05 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.198 1.399 . . . . 0.0 109.169 163.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -116.88 1.42 12.67 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -168.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.3 p -126.28 163.94 22.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.534 1.534 . . . . 0.0 113.258 -167.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -153.39 -177.08 6.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.749 1.619 . . . . 0.0 110.631 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -130.16 141.85 50.63 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.79 1.236 . . . . 0.0 113.31 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.26 140.23 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.499 1.119 . . . . 0.0 113.688 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.23 176.95 42.45 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.784 1.659 . . . . 0.0 116.496 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -57.21 -36.95 71.5 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.076 1.351 . . . . 0.0 112.775 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -82.95 -1.04 51.32 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 175.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 56.96 51.09 11.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.843 1.657 . . . . 0.0 113.486 168.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.9 t -80.32 141.98 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.215 1.806 . . . . 0.0 112.055 -167.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 48.9 tp -78.58 125.88 29.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.98 1.712 . . . . 0.0 114.216 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.09 158.9 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.257 1.823 . . . . 0.0 111.648 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -111.58 151.97 28.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.708 1.203 . . . . 0.0 112.934 -171.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.755 -1.593 . . . . 0.0 113.926 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.989 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -124.37 154.81 39.8 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.289 1.436 . . . . 0.0 111.833 173.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.97 157.8 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.452 0.644 . . . . 0.0 112.356 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.3 144.31 20.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.539 0.735 . . . . 0.0 111.898 172.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.42 -8.1 69.65 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 116.489 1.355 . . . . 0.0 116.489 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.9 m -64.12 121.27 13.8 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 120.62 2.21 . . . . 0.0 110.6 174.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mmt -78.23 142.93 37.54 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.22 1.408 . . . . 0.0 112.089 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.5 mm -127.79 134.34 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.726 2.011 . . . . 0.0 109.708 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -76.38 128.95 35.85 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 p -123.64 169.67 11.24 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.991 1.316 . . . . 0.0 111.241 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.31 -19.09 65.8 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.777 -1.202 . . . . 0.0 113.294 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 p -119.56 2.66 11.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.861 2.064 . . . . 0.0 113.792 -173.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.16 -116.36 0.81 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.221 1.391 . . . . 0.0 113.982 166.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.98 154.47 45.55 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.771 1.628 . . . . 0.0 110.5 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -143.16 148.19 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 126.439 1.896 . . . . 0.0 108.585 170.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.35 147.02 46.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.017 -1.052 . . . . 0.0 111.306 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 tt -62.11 -27.06 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 120.437 -1.414 . . . . 0.0 113.498 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.58 -14.7 62.6 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 172.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -108.5 -15.06 14.53 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.232 1.813 . . . . 0.0 113.898 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.8 mm -63.04 132.25 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 163.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -133.26 170.76 14.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.523 1.929 . . . . 0.0 109.606 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.12 130.47 15.75 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.189 0.518 . . . . 0.0 111.005 166.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.24 -1.2 88.73 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 116.105 1.202 . . . . 0.0 116.105 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -76.58 155.38 33.64 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.779 1.789 . . . . 0.0 110.666 160.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -111.5 140.36 46.17 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.958 1.303 . . . . 0.0 112.509 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.11 162.16 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.542 1.937 . . . . 0.0 110.292 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.2 mm -78.63 141.73 15.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 121.819 -0.55 . . . . 0.0 110.472 162.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.95 129.3 29.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.7 m -91.53 108.37 19.85 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 165.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -52.43 117.21 10.06 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.223 1.009 . . . . 0.0 112.583 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.43 -12.98 37.7 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.097 2.532 . . . . 0.0 113.907 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -76.4 -40.62 50.37 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.225 1.01 . . . . 0.0 112.523 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.8 t -135.08 -5.26 2.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.339 1.456 . . . . 0.0 113.685 -171.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.3 t80 56.65 43.08 26.08 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.329 1.452 . . . . 0.0 114.034 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -95.71 135.16 37.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.236 1.014 . . . . 0.0 110.151 170.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -105.95 122.54 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.98 0.912 . . . . 0.0 112.339 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.22 160.51 39.26 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.324 1.049 . . . . 0.0 113.077 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -91.12 121.12 32.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.148 1.379 . . . . 0.0 109.466 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -139.05 149.09 44.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.465 1.106 . . . . 0.0 112.931 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.7 t -80.75 161.5 24.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.875 1.27 . . . . 0.0 113.435 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.9 t -98.19 133.62 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 126.236 1.814 . . . . 0.0 111.716 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.02 -45.19 10.4 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.962 1.305 . . . . 0.0 113.298 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -146.88 156.64 43.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.276 1.83 . . . . 0.0 110.614 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.1 p -116.43 135.24 54.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.221 164.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -105.7 147.92 28.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.688 1.595 . . . . 0.0 112.056 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -143.65 128.93 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.501 1.12 . . . . 0.0 111.319 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -126.28 176.05 7.38 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.04 1.736 . . . . 0.0 111.198 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -133.34 133.73 42.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.781 1.233 . . . . 0.0 111.945 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 t -148.16 143.99 27.45 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.957 1.303 . . . . 0.0 111.63 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.7 p -84.35 -21.27 30.96 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.635 0.774 . . . . 0.0 112.689 164.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -96.39 115.81 28.04 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.008 0.923 . . . . 0.0 110.203 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.4 mt -121.05 167.79 12.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.796 1.239 . . . . 0.0 112.276 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.89 134.85 46.16 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.693 1.997 . . . . 0.0 109.689 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -113.88 128.38 56.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.617 1.167 . . . . 0.0 108.866 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.2 mt -124.08 128.77 49.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.518 1.127 . . . . 0.0 110.339 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.8 m -99.04 122.9 42.9 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 169.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.74 119.67 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.895 1.278 . . . . 0.0 109.968 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.86 21.74 17.12 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 115.926 1.131 . . . . 0.0 115.926 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.35 7.64 55.74 Favored Glycine 0 CA--C 1.542 1.768 0 N-CA-C 116.914 1.526 . . . . 0.0 116.914 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -121.76 131.02 53.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.185 1.492 . . . . 0.0 109.869 172.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -97.35 134.69 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.989 0.899 . . . . 0.0 112.983 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.8 mt -130.42 133.81 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.812 2.045 . . . . 0.0 108.794 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -119.08 112.13 19.15 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.245 1.418 . . . . 0.0 110.792 -165.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -141.2 -177.63 5.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.611 1.164 . . . . 0.0 112.426 -161.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.9 p -89.66 153.54 20.65 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.198 0.999 . . . . 0.0 111.923 169.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -58.26 -27.88 64.4 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.925 1.29 . . . . 0.0 113.272 -175.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -107.52 7.44 28.8 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.723 1.209 . . . . 0.0 112.225 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -69.69 128.86 91.77 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.99 112.86 2.37 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 124.683 3.589 . . . . 0.0 115.216 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -94.7 152.99 18.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.369 2.268 . . . . 0.0 111.507 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -97.99 132.02 43.91 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -111.59 138.51 39.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 127.28 2.232 . . . . 0.0 110.226 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.54 127.4 31.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.732 1.213 . . . . 0.0 110.441 175.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t0 56.3 31.52 18.72 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.383 1.873 . . . . 0.0 115.595 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.0 t -144.12 -50.63 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.853 1.261 . . . . 0.0 112.417 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.45 -153.21 16.74 Favored Glycine 0 N--CA 1.468 0.811 0 CA-C-N 119.392 0.997 . . . . 0.0 111.512 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -92.04 147.65 22.79 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -149.14 143.49 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.596 1.958 . . . . 0.0 112.053 -175.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.81 132.33 52.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.872 1.269 . . . . 0.0 112.68 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.84 -36.96 68.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.301 1.44 . . . . 0.0 113.645 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.99 -12.67 83.2 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.561 1.077 . . . . 0.0 114.168 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -102.2 -7.88 21.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.278 1.831 . . . . 0.0 113.544 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 mt -58.49 158.69 7.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.679 0.792 . . . . 0.0 112.405 166.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -114.51 152.82 31.09 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.388 1.475 . . . . 0.0 110.395 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 50.3 t -67.59 132.63 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.351 0.596 . . . . 0.0 109.521 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.1 0.14 68.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.677 1.132 . . . . 0.0 115.201 -171.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -84.22 156.4 22.04 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.127 1.464 . . . . 0.0 111.96 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -106.73 102.41 11.79 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.118 1.367 . . . . 0.0 111.965 -156.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.7 mt -96.3 -175.36 3.33 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.486 1.514 . . . . 0.0 111.041 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.67 149.03 52.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.084 0.954 . . . . 0.0 112.51 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.02 172.46 6.91 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.218 1.007 . . . . 0.0 113.278 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.9 p -56.67 -11.34 1.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -107.37 -30.5 8.65 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.19 1.796 . . . . 0.0 112.344 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.74 19.89 5.92 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.956 1.741 . . . . 0.0 113.79 -177.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -70.59 140.26 51.64 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.658 0.729 . . . . 0.0 110.553 167.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.4 t -77.57 107.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.906 0.883 . . . . 0.0 109.832 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.3 mt -85.96 160.53 19.34 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.274 1.43 . . . . 0.0 111.816 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.89 137.71 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.334 1.053 . . . . 0.0 110.798 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.0 119.66 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.602 0.761 . . . . 0.0 109.05 170.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -96.52 -31.64 12.68 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.392 1.477 . . . . 0.0 112.213 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.93 148.12 20.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.575 1.55 . . . . 0.0 111.324 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -125.66 127.36 46.16 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.441 2.296 . . . . 0.0 109.773 168.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -125.31 156.56 38.45 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.482 2.313 . . . . 0.0 110.748 169.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.15 135.08 26.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.841 1.656 . . . . 0.0 108.266 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -142.75 158.46 43.61 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.9 mm -110.7 101.02 11.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 125.21 1.404 . . . . 0.0 109.903 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.78 146.74 35.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.403 1.481 . . . . 0.0 113.535 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.59 -14.79 61.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.848 1.259 . . . . 0.0 113.372 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -138.3 155.15 74.18 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 127.076 2.15 . . . . 0.0 109.761 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.96 111.42 2.64 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.429 2.086 . . . . 0.0 110.402 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.1 t -81.42 140.24 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.927 1.691 . . . . 0.0 110.015 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -75.64 135.8 40.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.092 0.949 . . . . 0.0 110.39 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.28 136.76 50.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 124.59 1.156 . . . . 0.0 110.61 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -118.91 149.32 41.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.609 1.564 . . . . 0.0 111.16 -167.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -153.36 166.42 32.69 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.763 1.625 . . . . 0.0 109.885 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -152.44 164.72 36.98 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.241 -1.537 . . . . 0.0 112.318 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -121.98 143.17 49.64 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.0 t -98.72 146.51 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.289 1.836 . . . . 0.0 112.364 -168.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.88 -15.13 63.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -168.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -145.35 -47.5 0.22 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.89 0.876 . . . . 0.0 112.109 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -83.41 173.51 11.46 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.36 1.064 . . . . 0.0 112.1 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -112.48 9.22 19.57 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.824 2.05 . . . . 0.0 114.58 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 p -133.08 171.44 13.98 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.104 1.361 . . . . 0.0 113.585 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -157.52 179.91 8.79 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.831 2.053 . . . . 0.0 110.362 163.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -117.24 138.95 51.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.808 1.243 . . . . 0.0 112.604 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.6 m -126.14 142.65 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.381 1.472 . . . . 0.0 113.912 -174.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.22 174.59 28.0 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.431 1.491 . . . . 0.0 115.336 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -26.0 65.9 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.756 -1.438 . . . . 0.0 113.133 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -83.54 -3.78 57.96 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.005 0.922 . . . . 0.0 113.384 170.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 57.38 55.35 5.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.134 1.773 . . . . 0.0 113.857 167.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.88 143.41 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.557 1.543 . . . . 0.0 111.603 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.5 tp -81.34 125.47 30.42 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.726 1.21 . . . . 0.0 114.091 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.6 159.05 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.478 1.511 . . . . 0.0 112.574 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -99.62 149.96 22.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.179 1.392 . . . . 0.0 113.959 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.7 m120 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.265 1.826 . . . . 0.0 112.505 179.469 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.041 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.437 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.8 m-85 -124.78 154.52 40.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.565 1.546 . . . . 0.0 111.121 167.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.49 154.69 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.683 -0.636 . . . . 0.0 111.262 171.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.78 154.56 8.97 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.362 0.601 . . . . 0.0 111.717 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.88 -9.66 29.89 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-O 117.676 -1.625 . . . . 0.0 116.186 -171.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.5 m -62.33 125.31 23.47 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.539 2.17 . . . . 0.0 110.11 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 mmt -85.12 140.66 30.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.693 1.197 . . . . 0.0 111.982 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.66 135.18 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.781 2.033 . . . . 0.0 110.123 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.68 130.8 40.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.902 0.881 . . . . 0.0 113.208 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 p -126.18 174.21 8.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.71 1.604 . . . . 0.0 111.353 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.7 -19.38 64.88 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.26 1.424 . . . . 0.0 113.552 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -110.56 -25.39 10.02 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.17 -113.34 0.54 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.809 0.731 . . . . 0.0 112.825 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.6 mt -130.99 145.9 52.2 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.2 t -133.29 142.73 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.305 1.842 . . . . 0.0 108.941 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.77 144.77 49.08 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.214 -0.929 . . . . 0.0 110.959 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.32 -27.52 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 120.982 -1.074 . . . . 0.0 113.605 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -70.51 -14.06 62.37 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.089 1.356 . . . . 0.0 114.125 173.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -114.28 -11.01 12.64 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.551 1.54 . . . . 0.0 113.203 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.4 mm -61.68 137.23 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.569 -0.707 . . . . 0.0 109.282 163.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -125.55 164.03 21.42 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.369 1.868 . . . . 0.0 111.545 170.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.62 132.42 35.68 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.738 -0.601 . . . . 0.0 111.532 167.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.29 1.13 90.4 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.486 1.041 . . . . 0.0 115.287 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -82.65 154.54 24.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.533 1.167 . . . . 0.0 109.869 164.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -112.13 145.64 39.44 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.693 1.197 . . . . 0.0 112.311 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.03 160.56 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.229 1.811 . . . . 0.0 111.258 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -73.79 143.95 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.475 -0.765 . . . . 0.0 111.722 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.52 128.28 20.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.36 1.064 . . . . 0.0 109.446 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.4 m -78.62 115.45 18.33 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 162.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -55.21 115.39 9.03 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.231 1.012 . . . . 0.0 112.07 170.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.84 -3.95 13.77 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.9 2.4 . . . . 0.0 114.349 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -81.8 -45.99 14.81 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.309 0.958 . . . . 0.0 112.409 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -136.86 0.95 2.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.342 1.057 . . . . 0.0 112.767 -166.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 55.8 45.99 23.21 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.468 1.127 . . . . 0.0 112.678 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -86.59 134.97 33.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.564 1.546 . . . . 0.0 109.543 165.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 t -110.44 119.64 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 118.733 0.697 . . . . 0.0 109.644 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.35 164.88 33.67 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.792 0.837 . . . . 0.0 112.529 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -88.94 128.84 35.7 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.697 1.599 . . . . 0.0 110.941 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.444 ' HE3' ' CZ ' ' A' ' 121' ' ' PHE . 66.6 mmtt -134.46 148.76 50.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.365 1.066 . . . . 0.0 111.153 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -86.05 154.15 21.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.62 0.724 . . . . 0.0 112.781 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.6 t -90.18 134.86 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.655 1.582 . . . . 0.0 110.599 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.82 -48.37 7.54 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.881 0.872 . . . . 0.0 112.381 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -143.78 160.89 39.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.264 1.826 . . . . 0.0 110.235 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.3 p -116.43 134.05 55.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.562 1.145 . . . . 0.0 110.172 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -109.32 140.78 42.56 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.835 1.654 . . . . 0.0 113.705 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.33 138.45 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.651 1.18 . . . . 0.0 111.062 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -141.19 174.04 10.91 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.474 2.31 . . . . 0.0 109.532 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -130.48 138.85 50.47 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.504 1.522 . . . . 0.0 110.38 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.2 t -147.15 150.7 35.48 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.585 0.707 . . . . 0.0 111.643 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 p -94.17 -14.03 26.06 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.67 1.588 . . . . 0.0 113.848 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -118.55 111.39 18.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.039 0.836 . . . . 0.0 110.745 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.2 mt -110.14 160.79 16.17 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 tp -127.58 130.65 49.41 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 110.852 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -117.4 103.07 9.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.696 1.598 . . . . 0.0 109.413 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.7 mt -98.35 128.1 44.6 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.757 0.823 . . . . 0.0 110.22 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -100.29 119.74 38.86 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.08 116.32 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.321 1.048 . . . . 0.0 109.179 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.12 28.75 34.44 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 123.707 0.67 . . . . 0.0 114.72 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.12 -2.11 87.63 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.915 1.722 . . . . 0.0 116.332 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.4 122.49 41.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.863 1.831 . . . . 0.0 109.507 168.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.1 p -87.32 131.78 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.486 0.66 . . . . 0.0 111.71 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.92 131.04 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.823 2.049 . . . . 0.0 108.86 -175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -113.94 110.19 19.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.608 1.163 . . . . 0.0 110.777 -164.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 t -139.88 177.78 7.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.05 0.94 . . . . 0.0 112.218 -157.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.2 p -87.15 151.31 23.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.129 0.972 . . . . 0.0 112.116 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -58.75 -29.85 67.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.408 1.083 . . . . 0.0 112.845 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -98.21 9.55 42.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.437 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.3 t60 -70.58 125.96 92.13 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 120.909 -1.119 . . . . 0.0 112.475 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.99 119.82 4.04 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.139 2.559 . . . . 0.0 113.963 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -106.92 144.13 34.0 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.71 2.004 . . . . 0.0 111.074 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -83.33 128.61 34.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.464 1.029 . . . . 0.0 113.285 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.9 t -103.84 133.0 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.402 2.281 . . . . 0.0 110.96 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -49.01 118.46 2.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.056 1.743 . . . . 0.0 112.144 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 52.57 24.94 3.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.404 2.682 . . . . 0.0 115.312 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.75 -50.26 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.21 1.404 . . . . 0.0 110.577 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.48 -161.66 13.52 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 123.541 0.591 . . . . 0.0 112.54 -175.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.282 31.1 p90 -85.02 150.01 25.18 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 118.818 1.309 . . . . 0.0 114.162 -175.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.72 144.99 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.008 1.723 . . . . 0.0 110.642 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.41 136.13 57.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.94 0.896 . . . . 0.0 112.108 176.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.25 -36.12 70.56 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.78 1.232 . . . . 0.0 113.961 -171.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.66 -3.74 89.41 Favored Glycine 0 CA--C 1.539 1.561 0 O-C-N 121.027 -1.046 . . . . 0.0 113.611 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -95.77 -4.6 43.68 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.241 1.816 . . . . 0.0 112.314 167.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.0 mt -71.59 154.11 41.66 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.547 -0.721 . . . . 0.0 112.263 166.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -119.72 166.99 12.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.16 1.384 . . . . 0.0 110.976 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.31 138.53 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.57 12.99 82.3 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 115.234 0.854 . . . . 0.0 115.234 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -86.29 150.87 24.05 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.317 -1.107 . . . . 0.0 110.841 169.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -107.44 111.81 24.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.333 1.453 . . . . 0.0 112.056 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.1 mt -104.2 -177.82 3.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.339 1.456 . . . . 0.0 111.06 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -131.46 156.19 46.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.272 1.029 . . . . 0.0 113.518 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.8 p30 -105.15 179.85 4.15 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.914 1.286 . . . . 0.0 113.289 174.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.3 t -66.06 -17.87 64.97 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.871 1.669 . . . . 0.0 114.14 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -85.48 -25.53 26.83 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.261 -1.525 . . . . 0.0 112.171 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.72 25.31 8.16 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.699 2.095 . . . . 0.0 113.224 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.81 142.82 34.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.309 1.444 . . . . 0.0 111.812 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.9 t -57.11 120.3 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.51 1.124 . . . . 0.0 112.248 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -99.71 154.37 18.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.169 1.388 . . . . 0.0 110.901 161.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.42 140.6 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.865 1.266 . . . . 0.0 110.471 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.9 119.54 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.526 0.679 . . . . 0.0 109.237 170.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.02 -35.15 14.81 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.782 2.033 . . . . 0.0 112.626 -176.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -162.91 148.86 12.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.195 1.798 . . . . 0.0 110.817 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -129.41 124.5 34.29 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.932 1.693 . . . . 0.0 110.31 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 mmtm -132.22 151.1 51.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.531 1.532 . . . . 0.0 112.102 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 tp -136.13 137.65 41.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.858 1.663 . . . . 0.0 108.996 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.39 151.13 43.23 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.4 mm -99.77 119.01 47.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.779 170.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.89 149.59 43.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 112.795 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -67.95 -19.06 64.93 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.455 1.502 . . . . 0.0 113.251 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -157.27 156.64 29.56 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.913 2.485 . . . . 0.0 108.961 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -60.59 129.14 28.2 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.452 2.101 . . . . 0.0 112.603 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.83 144.35 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.595 1.558 . . . . 0.0 109.618 173.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -79.69 140.95 36.84 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.618 -0.677 . . . . 0.0 110.643 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.6 m -136.79 137.66 47.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.606 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -111.69 154.15 25.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.721 1.608 . . . . 0.0 111.974 -172.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -155.58 174.01 15.88 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.85 2.46 . . . . 0.0 108.033 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -153.76 170.9 19.8 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.044 -1.66 . . . . 0.0 110.744 173.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -121.94 137.25 54.86 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.774 0.83 . . . . 0.0 112.834 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.6 t -100.05 144.89 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.963 1.305 . . . . 0.0 111.95 -167.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -57.59 -39.07 75.96 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -170.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -139.6 -48.83 0.48 Allowed 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.97 -1.081 . . . . 0.0 113.372 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.444 ' CZ ' ' HE3' ' A' ' 39' ' ' LYS . 5.8 m-30 -69.94 163.87 25.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 168.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -116.29 23.48 12.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.954 1.302 . . . . 0.0 112.103 -171.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 p -147.69 160.64 42.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.553 1.541 . . . . 0.0 111.84 -157.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -160.24 175.89 12.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.836 1.655 . . . . 0.0 110.391 171.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -122.27 134.2 54.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.393 1.077 . . . . 0.0 112.802 -171.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.6 m -122.05 143.42 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.271 1.428 . . . . 0.0 114.663 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.53 176.98 30.14 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 126.118 1.818 . . . . 0.0 116.19 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.15 -34.5 66.19 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 120.92 -1.341 . . . . 0.0 113.237 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -83.02 0.1 46.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 57.35 43.6 23.08 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.027 1.331 . . . . 0.0 113.334 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.25 136.81 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.127 1.371 . . . . 0.0 111.723 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.6 tp -79.22 124.92 28.82 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.829 1.252 . . . . 0.0 113.98 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.4 m -138.27 157.01 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.127 1.771 . . . . 0.0 112.062 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -107.16 129.31 54.86 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.194 1.398 . . . . 0.0 112.823 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.213 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.924 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.44 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 98.4 m-85 -123.62 157.12 34.47 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.14 1.776 . . . . 0.0 110.699 168.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 m -68.79 157.61 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.809 -0.557 . . . . 0.0 111.808 173.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.5 153.36 4.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.364 0.666 . . . . 0.0 111.948 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.8 3.95 30.97 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-O 117.95 -1.472 . . . . 0.0 116.475 -174.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -67.77 125.34 25.95 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 120.922 2.361 . . . . 0.0 109.617 165.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.6 mmt -80.5 142.19 34.44 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.353 1.461 . . . . 0.0 111.858 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -123.29 137.11 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.787 2.035 . . . . 0.0 109.905 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.91 122.14 22.06 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 112.592 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 p -115.21 168.14 10.21 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.115 1.366 . . . . 0.0 110.562 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.28 66.57 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.402 -0.812 . . . . 0.0 112.969 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.0 p -100.05 -31.66 11.32 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.626 0.77 . . . . 0.0 112.547 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.97 -120.09 0.76 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.877 0.751 . . . . 0.0 112.715 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.57 140.83 51.87 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.611 1.164 . . . . 0.0 112.67 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.1 t -132.25 142.64 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.848 1.659 . . . . 0.0 108.747 173.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.38 150.41 48.99 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.103 -0.998 . . . . 0.0 111.725 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.9 tt -62.45 -25.85 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 120.876 -1.14 . . . . 0.0 113.558 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -75.09 -15.28 60.62 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.376 1.07 . . . . 0.0 113.765 171.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -107.97 -16.25 14.34 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.571 1.948 . . . . 0.0 112.401 -176.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.7 mm -63.29 134.66 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 160.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -134.17 160.21 38.51 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.043 1.337 . . . . 0.0 111.604 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.42 120.21 8.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.785 0.434 . . . . 0.0 110.406 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.73 -24.67 23.15 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.535 1.064 . . . . 0.0 115.716 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.86 170.83 8.9 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.394 1.597 . . . . 0.0 111.648 172.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -125.33 146.53 49.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.725 1.61 . . . . 0.0 111.167 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.18 160.55 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.131 1.372 . . . . 0.0 110.455 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -75.09 140.94 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.234 0.54 . . . . 0.0 110.514 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.49 125.78 24.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.222 1.009 . . . . 0.0 108.695 175.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.2 m -79.79 112.3 16.94 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 161.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -53.92 111.44 2.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 118.343 -0.836 . . . . 0.0 110.718 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -69.18 -12.25 33.54 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.35 2.034 . . . . 0.0 112.691 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -77.19 -38.66 51.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.076 1.351 . . . . 0.0 112.828 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.7 t -136.23 -6.1 2.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.01 1.324 . . . . 0.0 112.53 -170.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.259 15.6 m-85 54.5 52.3 12.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.221 1.408 . . . . 0.0 112.185 -175.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -100.64 135.65 41.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.108 1.763 . . . . 0.0 108.889 167.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 t -113.04 128.89 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 119.01 0.823 . . . . 0.0 111.27 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.78 172.19 18.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.91 0.884 . . . . 0.0 113.079 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -74.23 138.04 43.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.71 1.204 . . . . 0.0 111.443 165.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -139.31 152.63 47.37 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.396 1.078 . . . . 0.0 112.23 160.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -79.08 155.32 28.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.668 1.187 . . . . 0.0 114.131 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.7 t -93.12 131.73 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 126.537 1.935 . . . . 0.0 111.318 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.42 -41.05 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.363 1.465 . . . . 0.0 113.508 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -147.37 156.02 42.52 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 127.159 2.184 . . . . 0.0 109.703 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -113.26 135.92 53.31 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.475 1.51 . . . . 0.0 109.14 163.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -112.35 141.83 45.59 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.183 1.393 . . . . 0.0 113.912 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -135.02 138.29 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.056 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -140.15 176.19 8.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.209 2.203 . . . . 0.0 110.112 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.12 133.62 50.36 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.375 1.47 . . . . 0.0 110.973 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 t -142.42 145.11 33.46 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.125 -0.984 . . . . 0.0 113.12 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.8 p -88.27 -14.52 38.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.806 1.642 . . . . 0.0 113.25 167.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -107.66 108.85 20.29 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.005 -1.059 . . . . 0.0 110.9 -172.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.6 mt -116.45 167.96 10.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.251 1.021 . . . . 0.0 112.818 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.1 tp -135.28 133.21 38.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.859 2.064 . . . . 0.0 109.268 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -105.54 130.43 53.6 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.232 -0.918 . . . . 0.0 109.292 170.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.5 mt -114.14 147.53 38.7 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.371 1.069 . . . . 0.0 110.1 169.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.7 m -123.17 124.83 43.92 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.452 0.701 . . . . 0.0 109.627 166.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.1 mt -132.77 123.55 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.84 1.656 . . . . 0.0 109.425 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.08 28.79 50.28 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 115.611 1.005 . . . . 0.0 115.611 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.11 7.51 87.7 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.82 1.2 . . . . 0.0 115.567 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -109.1 137.55 46.83 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.745 1.618 . . . . 0.0 109.567 171.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.61 135.84 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.345 1.058 . . . . 0.0 111.171 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mt -129.7 104.58 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.161 1.784 . . . . 0.0 109.341 173.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -81.94 121.82 26.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.823 1.649 . . . . 0.0 111.429 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.5 t -144.64 175.36 10.21 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.165 -0.96 . . . . 0.0 112.73 -167.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.3 p -79.19 153.86 29.69 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.591 -0.693 . . . . 0.0 111.181 167.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -59.43 -28.83 67.31 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.763 0.825 . . . . 0.0 112.62 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -98.01 1.21 47.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.963 0.905 . . . . 0.0 113.164 -171.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.44 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.2 t60 -64.68 128.07 93.13 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 117.657 -1.163 . . . . 0.0 112.87 -173.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 68' ' ' HIS . 7.6 Cg_exo -84.4 127.87 3.97 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.003 1.802 . . . . 0.0 114.673 -175.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -115.93 139.58 50.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.129 2.572 . . . . 0.0 111.407 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -89.6 129.58 36.03 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.0 134.36 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.561 2.344 . . . . 0.0 112.4 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -50.05 126.36 14.27 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.982 1.713 . . . . 0.0 112.779 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 52.5 22.54 2.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.239 2.216 . . . . 0.0 115.259 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.09 -53.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.81 -1.181 . . . . 0.0 111.141 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.92 -159.68 13.57 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.095 0.855 . . . . 0.0 113.014 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -92.57 139.13 30.89 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.159 1.541 . . . . 0.0 115.159 -170.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.57 146.98 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 127.45 2.3 . . . . 0.0 111.987 -172.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.48 135.85 56.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 173.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.48 -40.14 61.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.958 1.703 . . . . 0.0 113.688 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.3 -10.58 66.29 Favored Glycine 0 CA--C 1.539 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 113.683 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -112.14 4.37 17.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.563 2.345 . . . . 0.0 113.04 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.85 159.66 19.14 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.969 -1.082 . . . . 0.0 111.295 163.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.42 156.68 32.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.441 1.096 . . . . 0.0 111.465 172.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.44 132.58 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 165.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.84 11.32 82.92 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 118.404 -1.22 . . . . 0.0 115.706 -172.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.3 165.19 7.82 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.908 1.854 . . . . 0.0 112.097 170.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -117.71 83.28 1.97 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.742 1.217 . . . . 0.0 111.735 -169.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.25 162.96 13.64 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.189 0.996 . . . . 0.0 113.533 -170.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.43 140.75 38.06 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.521 1.128 . . . . 0.0 112.552 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.12 177.14 5.17 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.501 1.12 . . . . 0.0 114.004 171.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.0 p -59.95 -12.08 7.09 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -107.85 -25.91 11.0 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.295 1.838 . . . . 0.0 111.905 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.6 25.14 6.72 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 126.402 1.954 . . . . 0.0 112.719 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -74.83 154.71 38.16 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.709 0.804 . . . . 0.0 110.437 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.8 t -92.83 112.76 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.785 0.834 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.5 mt -84.68 163.11 19.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.755 2.822 . . . . 0.0 112.324 175.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.71 134.78 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.554 1.542 . . . . 0.0 110.033 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.48 131.52 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.685 -0.635 . . . . 0.0 109.542 170.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -105.43 -35.26 7.55 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.613 1.565 . . . . 0.0 112.407 -175.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -157.87 149.24 21.47 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.194 0.998 . . . . 0.0 112.574 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -123.0 128.54 50.33 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.771 2.029 . . . . 0.0 108.743 161.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -130.27 151.61 50.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.116 1.766 . . . . 0.0 111.577 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 tt -138.62 142.99 39.1 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 111.416 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -150.52 161.92 41.61 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.933 0.893 . . . . 0.0 112.555 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mm -111.02 109.93 30.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.991 1.317 . . . . 0.0 108.329 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.47 140.37 58.59 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.318 0.647 . . . . 0.0 110.943 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.88 -21.63 60.89 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.64 -1.288 . . . . 0.0 113.283 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -127.54 151.12 74.61 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 127.221 2.208 . . . . 0.0 109.887 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.05 110.71 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.727 2.285 . . . . 0.0 112.069 -174.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.35 142.1 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.03 1.732 . . . . 0.0 110.18 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -71.2 140.28 50.42 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.081 0.943 . . . . 0.0 112.144 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.1 m -140.04 137.5 38.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.645 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -121.92 149.05 43.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.527 1.531 . . . . 0.0 111.354 -166.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -154.11 173.18 16.41 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.666 1.986 . . . . 0.0 108.413 170.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -150.27 170.71 18.35 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.218 -1.551 . . . . 0.0 111.283 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -119.46 136.52 54.27 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.82 0.848 . . . . 0.0 112.912 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.51 146.61 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.756 1.622 . . . . 0.0 111.491 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.08 -45.26 74.29 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -168.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -127.65 -32.85 2.34 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 119.732 1.151 . . . . 0.0 113.654 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -96.32 169.27 10.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.263 1.425 . . . . 0.0 108.925 167.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -120.97 19.68 11.65 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.742 1.217 . . . . 0.0 113.282 -171.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 p -142.13 164.28 30.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.524 1.53 . . . . 0.0 111.649 -162.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.69 179.31 9.22 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.387 1.475 . . . . 0.0 110.151 170.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -121.81 134.6 54.9 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.538 1.135 . . . . 0.0 111.943 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.19 144.81 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.239 1.416 . . . . 0.0 113.583 -173.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.6 175.16 26.71 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.663 1.601 . . . . 0.0 115.396 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -63.08 -29.44 70.81 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.309 -1.113 . . . . 0.0 112.112 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -86.11 1.72 49.44 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 174.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 58.33 46.24 15.77 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.271 1.428 . . . . 0.0 114.126 166.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.52 140.1 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.505 1.122 . . . . 0.0 111.443 -172.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.3 125.88 30.89 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.379 1.471 . . . . 0.0 113.922 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.05 155.57 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.847 1.659 . . . . 0.0 112.359 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -97.69 136.49 37.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.441 1.496 . . . . 0.0 111.73 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.217 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.977 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -123.49 154.74 38.72 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.973 1.709 . . . . 0.0 110.809 170.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.6 m -69.63 160.74 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.427 0.632 . . . . 0.0 111.772 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 157.78 2.34 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 122.166 0.984 . . . . 0.0 112.921 174.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.78 -8.54 4.34 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 116.965 -2.02 . . . . 0.0 116.258 -171.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -62.6 119.82 9.97 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.039 2.419 . . . . 0.0 110.077 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mmt -78.36 141.37 38.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.55 1.14 . . . . 0.0 111.797 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -125.24 135.68 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.406 1.883 . . . . 0.0 109.785 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 tp -76.73 123.61 26.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.895 1.278 . . . . 0.0 112.623 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -123.54 176.84 5.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.736 1.214 . . . . 0.0 112.146 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.86 68.1 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.353 -0.842 . . . . 0.0 112.804 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 p -100.01 -14.45 18.65 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.297 1.439 . . . . 0.0 113.434 -170.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.99 -107.41 0.41 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.375 1.464 . . . . 0.0 110.754 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.36 150.91 48.26 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.291 1.036 . . . . 0.0 112.455 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.7 t -140.05 146.59 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.116 2.166 . . . . 0.0 107.738 168.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.34 149.49 47.3 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.8 -1.188 . . . . 0.0 111.077 175.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -60.83 -30.81 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 120.63 -1.293 . . . . 0.0 112.887 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -65.58 -18.05 65.04 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.823 1.649 . . . . 0.0 114.179 171.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -116.62 -5.14 11.65 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.644 1.978 . . . . 0.0 112.776 -174.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -65.17 134.53 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.123 -0.986 . . . . 0.0 108.543 158.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -120.54 156.9 30.61 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.777 1.631 . . . . 0.0 111.544 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.45 136.27 58.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 167.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.68 -4.05 86.31 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.212 0.91 . . . . 0.0 113.83 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -74.79 -179.68 4.33 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.683 1.241 . . . . 0.0 111.224 167.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -126.1 141.52 51.91 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.51 1.524 . . . . 0.0 112.103 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.67 153.7 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.608 1.563 . . . . 0.0 110.101 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -71.06 134.89 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 121.676 -0.64 . . . . 0.0 111.175 171.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.94 120.02 20.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.088 1.355 . . . . 0.0 108.014 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.9 m -86.7 107.76 18.36 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -54.52 113.08 4.67 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.84 175.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.37 -8.42 22.04 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 122.604 2.203 . . . . 0.0 114.129 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -72.79 -41.67 64.73 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.181 1.393 . . . . 0.0 112.674 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.8 t -143.36 -4.13 0.9 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.254 1.422 . . . . 0.0 112.49 -165.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 58.54 32.0 21.65 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.02 1.728 . . . . 0.0 114.17 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.71 129.59 40.02 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 169.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.52 107.49 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.887 0.875 . . . . 0.0 109.579 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.19 163.39 33.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.707 1.203 . . . . 0.0 111.535 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.39 135.53 35.15 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.53 -0.731 . . . . 0.0 110.188 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HE3' ' CE1' ' A' ' 121' ' ' PHE . 72.2 mmtt -131.62 150.13 52.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.435 1.494 . . . . 0.0 110.657 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.4 t -82.58 156.51 23.9 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.73 126.97 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.733 1.613 . . . . 0.0 110.962 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.75 -47.4 11.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.834 1.254 . . . . 0.0 113.434 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -146.1 156.0 43.14 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.536 1.935 . . . . 0.0 110.376 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.3 p -125.17 118.45 26.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.354 1.862 . . . . 0.0 111.027 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -108.97 152.69 24.61 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.031 1.332 . . . . 0.0 113.57 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.2 141.31 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.582 1.953 . . . . 0.0 110.729 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -141.77 176.54 8.83 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.36 1.864 . . . . 0.0 110.704 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -127.84 139.58 52.55 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.532 1.533 . . . . 0.0 111.614 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 t -147.91 147.17 29.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.138 1.375 . . . . 0.0 111.518 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 p -88.49 -19.37 26.54 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.215 1.006 . . . . 0.0 113.002 164.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -97.48 110.84 23.32 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.477 1.111 . . . . 0.0 109.904 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.9 mt -121.92 169.23 11.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.378 1.071 . . . . 0.0 112.37 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 tp -138.24 130.32 28.6 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.465 1.506 . . . . 0.0 109.425 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -112.51 119.89 39.73 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.426 -0.796 . . . . 0.0 109.168 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.9 mt -108.69 140.18 42.45 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.699 0.799 . . . . 0.0 109.534 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.6 m -110.14 119.68 40.06 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 166.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.75 117.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.515 1.126 . . . . 0.0 109.884 -177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.06 30.3 46.06 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-O 119.5 -0.611 . . . . 0.0 114.442 -175.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.04 -7.49 80.97 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.45 1.5 . . . . 0.0 115.605 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -97.88 118.97 35.65 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.262 1.425 . . . . 0.0 111.073 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.9 133.49 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.139 0.575 . . . . 0.0 111.481 170.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mt -133.98 105.76 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 127.382 2.273 . . . . 0.0 108.656 173.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -87.99 120.72 29.61 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.874 1.669 . . . . 0.0 112.739 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -142.02 175.41 9.75 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.389 1.476 . . . . 0.0 112.581 -164.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.2 p -83.64 153.56 24.2 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.977 0.894 . . . . 0.0 111.293 167.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -62.11 -18.29 60.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.505 1.122 . . . . 0.0 113.328 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -104.01 0.93 30.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.448 1.499 . . . . 0.0 113.902 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.2 127.64 93.06 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 119.619 1.1 . . . . 0.0 112.952 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -79.86 123.82 5.37 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.02 2.48 . . . . 0.0 114.325 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -112.2 143.54 43.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.758 2.423 . . . . 0.0 111.282 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -88.07 126.46 35.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.159 0.89 . . . . 0.0 112.492 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -102.45 135.59 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.642 1.977 . . . . 0.0 110.822 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -53.51 129.15 31.51 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.9 1.28 . . . . 0.0 110.785 174.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.3 t70 61.12 13.43 4.71 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.532 1.933 . . . . 0.0 115.518 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.4 t -135.77 -45.33 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 121.026 -1.047 . . . . 0.0 113.072 -172.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.49 -159.07 17.08 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.999 0.809 . . . . 0.0 113.456 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -77.88 145.24 36.34 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -170.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.0 p -149.78 150.45 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.427 2.291 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.02 140.81 58.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 173.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.47 -40.18 65.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.024 1.73 . . . . 0.0 113.689 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.35 -8.26 87.59 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.966 -1.084 . . . . 0.0 113.966 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -97.21 -5.03 37.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.637 1.575 . . . . 0.0 112.121 171.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.53 155.21 41.01 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.095 -1.003 . . . . 0.0 111.292 164.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -123.27 170.12 10.6 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.579 1.151 . . . . 0.0 110.429 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.35 136.37 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.616 -0.677 . . . . 0.0 109.695 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 5.13 87.93 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.103 -0.832 . . . . 0.0 115.09 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -76.22 153.36 36.12 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.522 1.161 . . . . 0.0 110.599 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.47 107.76 18.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.591 1.157 . . . . 0.0 111.791 -169.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.6 mt -99.95 172.82 6.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.547 1.139 . . . . 0.0 111.047 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.2 mt -123.68 165.23 17.58 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.885 0.874 . . . . 0.0 112.705 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -117.73 -174.51 2.64 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.354 1.462 . . . . 0.0 114.745 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.9 p -58.19 -1.31 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.811 2.444 . . . . 0.0 117.235 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -115.89 -20.91 9.79 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.473 1.509 . . . . 0.0 112.66 170.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.88 13.18 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.98 1.752 . . . . 0.0 112.606 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -96.06 137.56 34.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.689 1.195 . . . . 0.0 112.377 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.4 t -67.45 119.85 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.603 1.161 . . . . 0.0 113.534 -170.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.13 159.41 15.56 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.455 2.302 . . . . 0.0 112.612 169.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 t -126.17 139.14 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.977 1.311 . . . . 0.0 111.582 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.83 125.52 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.92 0.888 . . . . 0.0 109.874 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.28 -30.94 10.78 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 127.357 2.263 . . . . 0.0 112.933 -175.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -156.65 152.96 27.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.497 1.119 . . . . 0.0 111.121 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -136.54 101.31 4.6 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.277 1.831 . . . . 0.0 109.545 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -104.77 130.58 52.84 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.314 1.846 . . . . 0.0 110.909 -171.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.9 tp -120.37 128.79 53.56 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.831 1.252 . . . . 0.0 110.81 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.17 162.1 41.42 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.125 1.37 . . . . 0.0 112.874 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.63 117.73 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.157 1.383 . . . . 0.0 108.86 171.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.88 142.62 53.23 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.583 -0.698 . . . . 0.0 112.2 167.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.6 -26.35 67.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.031 1.332 . . . . 0.0 112.987 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -146.91 150.87 40.38 Favored Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 127.051 2.14 . . . . 0.0 109.988 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -56.63 127.54 26.31 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.473 2.782 . . . . 0.0 112.869 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.3 t -99.04 141.36 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 127.072 2.149 . . . . 0.0 110.095 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -74.19 144.85 44.58 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.893 0.769 . . . . 0.0 112.079 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.78 144.26 27.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.309 1.444 . . . . 0.0 110.565 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -128.8 147.59 50.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.521 1.529 . . . . 0.0 110.41 -166.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -156.46 171.64 19.91 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.537 1.135 . . . . 0.0 111.685 169.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -149.78 163.37 38.16 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.465 -0.772 . . . . 0.0 112.117 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.68 144.24 43.27 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.666 1.186 . . . . 0.0 113.204 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.9 t -104.76 147.84 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.059 1.744 . . . . 0.0 111.676 -168.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.35 -72.4 0.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.8 -19.98 12.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -166.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.47 ' CE1' ' HE3' ' A' ' 39' ' ' LYS . 10.5 m-30 -105.92 175.34 5.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.273 1.829 . . . . 0.0 108.524 165.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -132.21 33.13 3.9 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.164 1.386 . . . . 0.0 112.729 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 p -139.75 159.01 43.16 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.061 1.744 . . . . 0.0 112.17 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -158.29 -173.32 4.26 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.82 1.648 . . . . 0.0 110.768 170.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -131.67 141.4 49.58 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.885 1.274 . . . . 0.0 113.392 -170.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.98 142.39 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.678 1.191 . . . . 0.0 112.625 -173.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.55 173.8 23.41 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.283 1.421 . . . . 0.0 115.697 175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.4 -31.2 72.29 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.982 -1.305 . . . . 0.0 113.367 -176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -84.04 2.19 40.31 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.842 1.257 . . . . 0.0 114.0 173.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.88 46.16 17.25 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.454 1.901 . . . . 0.0 114.551 166.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.84 136.53 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.569 1.148 . . . . 0.0 111.515 -170.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 54.1 tp -77.86 126.19 30.47 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.786 1.634 . . . . 0.0 112.639 -176.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.15 157.2 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.768 1.627 . . . . 0.0 111.142 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -108.28 161.38 15.06 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.531 1.132 . . . . 0.0 112.924 -172.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.663 1.585 . . . . 0.0 112.953 171.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 85.9 m-85 -123.6 154.24 39.58 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.552 1.541 . . . . 0.0 111.276 172.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.92 161.53 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.53 0.681 . . . . 0.0 112.053 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.32 154.23 3.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.206 1.002 . . . . 0.0 112.681 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.96 -9.0 7.04 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 117.546 -1.697 . . . . 0.0 116.3 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.0 m -63.03 121.57 13.91 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 121.179 2.49 . . . . 0.0 110.373 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 mmt -78.35 142.94 37.32 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.694 1.597 . . . . 0.0 111.72 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.8 mm -127.32 132.91 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.697 1.999 . . . . 0.0 109.867 -175.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -77.92 123.07 26.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.699 1.199 . . . . 0.0 112.552 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -117.44 178.87 4.22 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.507 1.123 . . . . 0.0 113.647 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.84 52.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.45 1.1 . . . . 0.0 113.832 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 p -113.82 -28.04 7.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.924 1.29 . . . . 0.0 113.706 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.76 -107.96 0.34 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.271 0.939 . . . . 0.0 111.476 -171.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -127.29 149.2 50.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.483 1.113 . . . . 0.0 113.204 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.9 t -142.35 147.73 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 127.286 2.234 . . . . 0.0 108.389 170.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.6 147.09 41.97 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.888 -1.133 . . . . 0.0 111.27 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 tt -61.34 -29.47 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 120.614 -1.304 . . . . 0.0 112.926 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.46 -8.22 44.86 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.918 1.287 . . . . 0.0 114.434 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -119.4 -8.0 10.11 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.749 1.62 . . . . 0.0 113.489 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.19 136.53 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.117 -0.99 . . . . 0.0 110.052 165.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -117.92 166.31 12.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.907 2.083 . . . . 0.0 110.312 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.9 147.02 54.13 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.479 -0.763 . . . . 0.0 111.032 163.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.37 3.24 82.07 Favored Glycine 0 CA--C 1.54 1.637 0 O-C-N 121.77 -0.581 . . . . 0.0 114.543 -171.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -89.81 152.94 21.04 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.099 0.96 . . . . 0.0 110.292 168.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -115.85 120.9 40.74 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.799 1.239 . . . . 0.0 112.709 -168.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 m -110.32 154.06 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 126.88 2.072 . . . . 0.0 110.257 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.3 mm -75.53 135.16 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 O-C-N 121.604 -0.685 . . . . 0.0 109.773 166.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.99 121.48 28.07 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.2 m -101.46 104.1 15.02 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -55.96 114.75 8.08 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.96 -1.019 . . . . 0.0 111.83 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.96 -5.53 12.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.168 1.912 . . . . 0.0 113.443 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.07 -42.51 76.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.833 0.853 . . . . 0.0 112.538 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.2 t -150.01 5.66 0.58 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.787 0.835 . . . . 0.0 112.928 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.265 21.0 m-85 57.11 41.54 27.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.34 1.456 . . . . 0.0 112.642 -173.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -78.79 131.37 36.5 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 165.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.22 123.93 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.133 0.973 . . . . 0.0 109.912 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.38 153.22 43.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -82.27 117.39 22.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.199 1.0 . . . . 0.0 109.96 168.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -132.28 146.63 52.13 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.707 1.203 . . . . 0.0 112.351 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -83.99 155.65 22.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.367 1.067 . . . . 0.0 113.766 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.7 t -87.22 132.98 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 125.645 1.578 . . . . 0.0 111.295 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.3 mt -90.92 -41.37 11.18 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.207 1.003 . . . . 0.0 112.866 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.25 150.67 35.29 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.247 1.819 . . . . 0.0 110.376 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.3 p -121.48 121.57 37.82 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.441 1.897 . . . . 0.0 109.999 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -106.89 144.33 33.69 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.78 1.632 . . . . 0.0 114.214 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.3 t -141.24 133.0 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.861 0.864 . . . . 0.0 112.126 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.6 mmt-85 -138.16 175.13 9.85 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.512 1.925 . . . . 0.0 110.652 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -136.63 136.29 39.03 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.029 0.931 . . . . 0.0 112.941 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -151.1 150.93 31.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.495 1.118 . . . . 0.0 112.107 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.4 p -90.94 -16.86 27.36 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.177 1.391 . . . . 0.0 113.874 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.39 106.89 17.52 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.363 1.065 . . . . 0.0 109.999 -169.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.3 mt -117.69 162.24 18.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.69 1.233 . . . . 0.0 113.372 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -127.3 132.56 50.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.13 1.772 . . . . 0.0 109.029 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -111.08 125.43 53.76 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.172 0.989 . . . . 0.0 108.875 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 mt -112.44 140.82 46.86 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.594 0.758 . . . . 0.0 109.568 170.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.3 m -113.84 119.04 35.94 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 mt -127.24 117.32 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.111 0.965 . . . . 0.0 108.859 -172.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.88 21.08 28.88 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.79 -4.35 53.25 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.617 1.58 . . . . 0.0 116.306 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -107.08 127.92 53.92 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.128 1.771 . . . . 0.0 110.294 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.5 t -81.71 132.34 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.47 1.108 . . . . 0.0 111.958 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -132.48 103.26 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.897 1.679 . . . . 0.0 109.492 174.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -81.86 121.47 26.5 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.607 1.563 . . . . 0.0 111.706 176.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -143.46 176.68 8.99 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.335 1.454 . . . . 0.0 113.477 -165.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.6 p -81.67 151.63 27.48 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.736 0.815 . . . . 0.0 112.255 170.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -64.17 -18.1 64.15 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.163 -0.961 . . . . 0.0 113.186 -174.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -110.98 13.41 22.08 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.0 OUTLIER -65.42 128.73 94.05 Favored Pre-proline 0 CA--C 1.55 0.978 0 O-C-N 120.772 -1.205 . . . . 0.0 111.582 176.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.64 125.82 5.72 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.061 2.508 . . . . 0.0 113.714 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -118.46 142.77 47.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.973 2.109 . . . . 0.0 111.788 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -85.31 133.35 34.15 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.371 0.987 . . . . 0.0 113.614 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.88 138.72 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 127.683 2.393 . . . . 0.0 111.293 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.17 130.45 42.11 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.424 0.69 . . . . 0.0 111.12 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 61.3 7.13 1.57 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.596 2.358 . . . . 0.0 116.59 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -130.64 -35.25 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.029 1.331 . . . . 0.0 111.973 -170.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.61 -150.96 22.85 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 123.938 0.78 . . . . 0.0 111.62 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.292 12.3 p90 -77.4 145.69 37.07 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.78 150.02 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 128.523 2.729 . . . . 0.0 109.683 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -64.48 137.87 58.11 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.115 -0.99 . . . . 0.0 113.415 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.72 67.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.804 1.641 . . . . 0.0 113.304 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.35 -7.46 68.11 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.373 -0.83 . . . . 0.0 114.362 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -102.76 -6.41 22.65 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.251 1.42 . . . . 0.0 113.171 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -67.94 164.28 20.25 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.089 1.356 . . . . 0.0 112.834 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.27 162.79 27.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.611 1.564 . . . . 0.0 112.881 168.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.94 123.63 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 165.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.0 1.98 61.15 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.868 -1.518 . . . . 0.0 114.988 -170.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -76.74 152.95 35.46 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.754 2.277 . . . . 0.0 111.367 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -110.6 101.82 10.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.681 1.192 . . . . 0.0 112.413 -170.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.3 mt -91.81 170.5 9.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.929 1.692 . . . . 0.0 110.654 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.9 mt -119.32 155.73 31.32 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 170.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.3 176.87 5.56 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.908 1.283 . . . . 0.0 113.879 176.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.8 p -54.34 -22.4 12.06 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -106.79 -10.05 16.2 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.542 1.937 . . . . 0.0 112.616 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.59 13.29 28.42 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.422 1.963 . . . . 0.0 113.183 171.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -79.17 145.84 33.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.719 1.208 . . . . 0.0 111.384 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.2 t -74.69 127.9 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.565 0.746 . . . . 0.0 111.322 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.1 mt -114.26 150.79 33.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.14 2.176 . . . . 0.0 112.03 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.3 t -118.23 137.71 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 125.183 1.393 . . . . 0.0 110.474 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.4 t -73.7 119.06 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.957 0.903 . . . . 0.0 109.452 169.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -94.29 -27.88 15.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.852 2.461 . . . . 0.0 112.853 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -155.03 147.33 23.91 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.778 1.631 . . . . 0.0 110.248 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -132.85 116.18 16.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.946 1.699 . . . . 0.0 109.308 168.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -127.76 151.59 48.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.359 2.264 . . . . 0.0 110.822 -171.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.02 133.81 25.32 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.15 1.38 . . . . 0.0 109.584 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -144.68 151.21 38.6 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.1 mm -98.2 103.3 14.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.895 1.278 . . . . 0.0 108.38 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.86 150.87 31.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.09 0.956 . . . . 0.0 111.954 174.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.05 -18.81 63.3 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.14 -0.975 . . . . 0.0 112.983 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -137.68 154.68 75.06 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 126.762 2.025 . . . . 0.0 111.339 -172.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.33 110.09 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.547 2.165 . . . . 0.0 110.013 170.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.2 t -83.5 141.66 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.013 1.725 . . . . 0.0 109.631 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -77.6 139.56 39.54 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.839 0.855 . . . . 0.0 110.397 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.2 m -138.34 142.83 34.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 125.006 1.322 . . . . 0.0 111.345 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -121.79 152.46 39.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.514 1.526 . . . . 0.0 111.707 -167.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -156.5 165.91 34.92 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.38 2.272 . . . . 0.0 109.767 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -156.97 165.36 36.38 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.304 -1.497 . . . . 0.0 111.248 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -120.2 145.9 46.54 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.27 145.86 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.293 1.437 . . . . 0.0 112.867 -166.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -64.43 -47.34 79.47 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -170.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -109.49 -66.31 1.07 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 120.056 1.298 . . . . 0.0 109.957 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -72.71 175.93 5.99 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.667 1.187 . . . . 0.0 112.153 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -115.94 3.9 13.75 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.501 1.52 . . . . 0.0 113.349 -172.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.4 p -124.74 160.66 28.1 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.308 1.443 . . . . 0.0 113.981 -168.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.07 -179.62 8.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.843 2.057 . . . . 0.0 109.875 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -132.12 140.68 48.88 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.352 1.061 . . . . 0.0 113.183 -168.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.6 142.02 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -170.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.25 173.44 25.74 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.928 1.728 . . . . 0.0 115.346 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.1 -25.42 67.7 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.11 -1.229 . . . . 0.0 113.11 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -90.41 5.22 48.38 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.578 1.551 . . . . 0.0 114.667 172.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 56.11 46.5 21.44 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 164.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.53 140.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.379 1.072 . . . . 0.0 111.779 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.06 126.22 31.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.749 1.62 . . . . 0.0 113.491 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.6 m -145.82 162.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.542 1.937 . . . . 0.0 111.429 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -116.92 141.07 48.71 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.431 1.492 . . . . 0.0 113.049 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.209 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.435 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 98.6 m-85 -124.73 154.64 40.55 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.1 1.36 . . . . 0.0 111.071 172.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.51 158.0 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.203 0.525 . . . . 0.0 111.661 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.1 151.8 0.92 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.218 1.007 . . . . 0.0 112.371 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.07 -17.26 7.55 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.437 -1.757 . . . . 0.0 116.077 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.6 m -61.89 124.19 20.1 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 120.707 2.253 . . . . 0.0 110.11 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -82.12 141.62 32.95 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.879 1.272 . . . . 0.0 111.538 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.0 mm -117.33 133.32 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.619 1.968 . . . . 0.0 109.577 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.7 tp -71.28 127.18 31.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.678 0.752 . . . . 0.0 112.969 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 p -127.81 166.02 19.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.02 1.328 . . . . 0.0 110.423 174.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.04 70.12 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.503 -0.748 . . . . 0.0 112.126 168.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.8 p -80.02 -25.99 39.99 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.199 1.4 . . . . 0.0 112.677 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.72 -99.11 0.19 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.84 2.162 . . . . 0.0 111.039 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.0 mt -134.98 149.28 50.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.745 1.218 . . . . 0.0 111.855 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.63 143.69 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.633 1.573 . . . . 0.0 108.552 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.45 146.12 53.47 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.022 -1.048 . . . . 0.0 111.127 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 tt -60.8 -30.59 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 120.942 -1.099 . . . . 0.0 113.107 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.27 -16.77 63.65 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.471 1.109 . . . . 0.0 113.836 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -109.37 -12.55 14.73 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.794 1.638 . . . . 0.0 113.117 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.7 mm -63.03 135.64 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.09 0.859 . . . . 0.0 109.421 164.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -127.75 156.09 42.98 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.885 1.674 . . . . 0.0 111.442 175.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.93 135.27 56.01 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.223 -0.923 . . . . 0.0 111.457 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.11 -19.54 54.05 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.712 -1.049 . . . . 0.0 115.166 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -68.42 166.11 17.44 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.899 1.349 . . . . 0.0 111.121 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -124.21 138.67 54.38 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.077 1.351 . . . . 0.0 112.836 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.04 163.88 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.206 1.802 . . . . 0.0 111.203 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -80.09 145.88 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.227 0.536 . . . . 0.0 111.56 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.55 132.3 21.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 m -97.43 112.03 24.04 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.5 0.667 . . . . 0.0 109.864 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -52.76 114.83 6.26 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.448 1.499 . . . . 0.0 113.288 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.75 -7.07 19.52 Favored 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 122.877 2.385 . . . . 0.0 115.299 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -79.44 -38.67 34.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.257 1.423 . . . . 0.0 113.261 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.6 t -141.76 -1.8 1.24 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.784 1.234 . . . . 0.0 112.873 -168.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.26 33.8 m-85 55.13 33.78 21.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.915 2.086 . . . . 0.0 114.244 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -77.95 135.02 37.76 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.632 -0.668 . . . . 0.0 110.342 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.02 122.07 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.317 1.047 . . . . 0.0 110.927 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.13 151.7 41.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.765 0.793 . . . . 0.0 112.872 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -90.14 124.6 34.96 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.213 1.405 . . . . 0.0 109.291 174.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -134.44 150.89 50.88 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.584 1.154 . . . . 0.0 111.424 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.3 t -79.76 153.58 29.11 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -88.83 133.0 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.32 1.848 . . . . 0.0 110.624 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 mt -90.73 -44.21 9.61 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.66 0.784 . . . . 0.0 112.682 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -141.58 157.81 44.64 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.503 1.521 . . . . 0.0 110.641 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.7 p -130.98 116.34 17.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.842 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -103.48 157.94 16.69 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.989 1.315 . . . . 0.0 113.309 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.74 142.52 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.883 2.073 . . . . 0.0 110.204 175.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.1 mmt-85 -140.38 172.81 12.21 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.239 2.215 . . . . 0.0 109.933 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -141.34 135.05 30.12 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.95 -1.094 . . . . 0.0 113.064 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.3 t -151.01 152.59 33.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.875 0.87 . . . . 0.0 112.019 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.7 p -86.24 -15.48 40.66 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.988 1.315 . . . . 0.0 113.43 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -105.75 108.35 19.81 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.205 0.911 . . . . 0.0 112.262 -171.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.6 mt -116.67 160.53 20.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.358 1.075 . . . . 0.0 113.658 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -123.69 138.57 54.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.123 1.769 . . . . 0.0 109.945 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.1 m170 -115.93 128.13 55.53 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.656 1.582 . . . . 0.0 109.253 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.3 mt -128.92 132.76 47.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.233 1.013 . . . . 0.0 110.182 175.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -99.13 113.01 25.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 169.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 mp -107.74 113.19 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.462 1.105 . . . . 0.0 108.469 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.73 -28.67 0.14 Allowed Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.744 2.116 . . . . 0.0 116.751 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.26 -0.35 0.32 Allowed Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.723 1.63 . . . . 0.0 114.073 -165.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -112.31 124.27 52.11 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.511 1.524 . . . . 0.0 109.533 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.56 114.17 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.331 0.652 . . . . 0.0 109.674 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mt -106.31 101.34 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.412 1.085 . . . . 0.0 109.12 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.99 122.18 21.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.019 1.328 . . . . 0.0 110.65 168.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 t -146.91 175.68 10.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.306 1.043 . . . . 0.0 112.639 -168.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.4 p -78.18 146.49 34.98 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.521 -0.737 . . . . 0.0 111.137 169.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.84 -28.45 66.08 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.022 -1.049 . . . . 0.0 112.442 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -96.83 0.14 48.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.56 1.544 . . . . 0.0 113.305 -171.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.435 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.3 t60 -64.8 129.15 94.26 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.473 1.509 . . . . 0.0 113.305 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.52 113.68 2.62 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.463 2.775 . . . . 0.0 114.093 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -103.25 143.69 32.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.133 2.173 . . . . 0.0 111.408 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -89.33 126.18 35.42 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -103.95 135.75 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.489 1.515 . . . . 0.0 111.213 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -57.04 129.12 40.34 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.633 1.173 . . . . 0.0 112.936 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.8 t0 56.19 23.8 7.41 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.172 1.789 . . . . 0.0 114.45 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.5 t -140.74 -50.39 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.799 1.239 . . . . 0.0 111.92 -172.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.21 -169.17 22.53 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.727 0.68 . . . . 0.0 114.201 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -75.8 146.77 39.7 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -162.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.1 p -150.68 146.91 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.89 1.676 . . . . 0.0 111.854 -173.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -54.55 133.31 46.2 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.556 0.742 . . . . 0.0 112.664 171.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.26 -36.7 66.34 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.607 1.563 . . . . 0.0 113.137 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.4 -4.89 81.02 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.03 -1.044 . . . . 0.0 114.739 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -107.45 -4.44 18.48 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.228 1.811 . . . . 0.0 112.553 176.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.59 151.52 46.26 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.449 -0.782 . . . . 0.0 110.428 155.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -118.34 173.78 6.62 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.064 1.346 . . . . 0.0 110.375 170.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.36 139.92 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 165.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.93 9.62 86.93 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 119.099 -0.834 . . . . 0.0 114.565 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -86.38 154.91 20.84 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.28 1.54 . . . . 0.0 110.228 169.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -113.56 115.57 28.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.322 1.049 . . . . 0.0 113.606 -164.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.9 mt -104.98 -176.85 3.19 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.022 2.129 . . . . 0.0 111.441 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.9 mt -131.01 158.89 39.07 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.605 1.162 . . . . 0.0 113.193 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -109.49 172.29 6.94 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.728 1.211 . . . . 0.0 113.395 169.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 t -45.54 -36.88 4.9 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.146 1.779 . . . . 0.0 114.116 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -88.63 -16.92 31.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.054 1.742 . . . . 0.0 113.114 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.46 20.56 10.81 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.914 1.721 . . . . 0.0 112.763 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -83.26 141.02 32.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.444 0.698 . . . . 0.0 110.582 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.93 115.45 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.641 0.776 . . . . 0.0 110.08 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.9 mt -97.01 161.41 13.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.427 1.491 . . . . 0.0 111.449 170.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.84 144.85 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.07 0.948 . . . . 0.0 110.643 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.54 130.99 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.426 0.69 . . . . 0.0 109.66 170.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -108.27 -28.08 9.65 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.838 2.055 . . . . 0.0 112.079 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -157.75 149.59 22.01 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.129 1.772 . . . . 0.0 110.384 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -131.73 130.84 42.46 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.701 2.0 . . . . 0.0 109.629 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -143.2 155.06 44.44 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.023 1.729 . . . . 0.0 111.513 -175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 tp -132.8 144.14 50.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.89 1.676 . . . . 0.0 109.267 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.45 153.81 41.57 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.372 0.987 . . . . 0.0 113.183 166.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 mm -101.4 121.04 51.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.5 152.78 44.5 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.198 0.999 . . . . 0.0 112.953 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -69.63 -28.7 66.13 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.702 -1.249 . . . . 0.0 111.838 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -144.34 148.35 40.48 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.983 2.113 . . . . 0.0 110.123 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -54.69 120.0 7.37 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.489 3.459 . . . . 0.0 112.576 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.73 139.54 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.359 1.463 . . . . 0.0 109.496 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -76.89 139.19 40.15 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.936 0.874 . . . . 0.0 111.212 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.37 147.93 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.279 1.432 . . . . 0.0 110.516 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.72 148.22 50.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.849 1.26 . . . . 0.0 110.893 -165.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -157.54 168.38 27.47 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.462 1.105 . . . . 0.0 111.803 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -153.19 163.66 39.49 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.838 -1.164 . . . . 0.0 112.972 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -113.97 143.86 44.03 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.69 136.13 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 125.528 1.531 . . . . 0.0 112.974 -166.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.18 -28.41 69.11 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -141.62 -44.23 0.36 Allowed 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.978 -1.076 . . . . 0.0 112.607 173.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -71.45 171.67 10.88 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.441 1.115 . . . . 0.0 111.973 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -124.84 12.29 8.46 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.854 2.061 . . . . 0.0 112.715 -169.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.4 p -142.53 168.87 18.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.497 2.319 . . . . 0.0 111.519 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -160.64 175.13 13.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.118 2.167 . . . . 0.0 109.617 166.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -122.74 135.57 54.61 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.046 0.939 . . . . 0.0 113.141 -170.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.94 140.74 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.555 1.542 . . . . 0.0 112.429 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.73 170.15 20.27 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.671 1.605 . . . . 0.0 115.46 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.85 -22.49 66.54 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.693 -1.475 . . . . 0.0 113.023 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -81.49 2.78 27.35 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.182 1.393 . . . . 0.0 114.445 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 61.27 38.94 16.16 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.701 1.2 . . . . 0.0 113.345 164.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.63 137.36 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.668 1.587 . . . . 0.0 112.019 -164.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.2 tp -83.14 120.43 25.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.154 1.382 . . . . 0.0 113.848 -171.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.94 157.46 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.644 1.578 . . . . 0.0 112.052 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -106.87 128.94 54.72 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -167.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--O 1.25 1.098 0 C-N-CA 125.74 1.616 . . . . 0.0 111.993 172.461 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 30.1 m . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 121.363 0.601 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 42.5 ttm -73.3 141.25 47.15 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.82 -1.175 . . . . 0.0 110.117 164.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -126.23 84.82 2.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.165 1.386 . . . . 0.0 110.713 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -148.62 170.64 17.66 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -174.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 99.1 m-85 -126.12 154.03 43.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.837 1.655 . . . . 0.0 111.415 172.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -70.64 162.14 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.495 0.664 . . . . 0.0 112.327 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.47 150.26 5.05 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.439 1.096 . . . . 0.0 112.639 173.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.18 -6.22 22.76 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 117.877 -1.513 . . . . 0.0 116.788 -173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 57.5 m -63.1 120.38 11.34 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.81 2.305 . . . . 0.0 110.147 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.0 mmt -76.02 146.44 39.48 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.915 1.286 . . . . 0.0 112.224 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.9 mm -131.64 134.1 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 127.685 2.394 . . . . 0.0 109.918 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 tp -78.91 127.01 31.46 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -120.63 173.89 6.91 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.667 1.587 . . . . 0.0 111.792 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.87 -24.85 67.66 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.939 -1.1 . . . . 0.0 113.429 175.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 p -107.31 -19.31 13.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.539 1.135 . . . . 0.0 113.518 -175.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.89 -115.34 0.61 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.439 1.019 . . . . 0.0 113.363 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -122.8 153.32 39.7 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.048 1.739 . . . . 0.0 111.799 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.1 p -136.53 152.29 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.929 1.691 . . . . 0.0 110.268 168.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.26 146.09 37.1 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.773 -1.204 . . . . 0.0 110.819 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.2 tt -62.65 -29.49 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 121.044 -1.035 . . . . 0.0 112.664 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -65.39 -11.12 39.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.689 1.196 . . . . 0.0 113.729 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -120.13 -3.65 10.07 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.914 1.685 . . . . 0.0 113.371 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.1 mm -61.43 137.89 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 120.018 1.281 . . . . 0.0 108.806 166.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -124.16 159.05 30.91 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.021 1.328 . . . . 0.0 112.027 174.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.62 131.71 47.06 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 120.792 -1.193 . . . . 0.0 110.579 165.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.88 -4.44 82.68 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.601 1.095 . . . . 0.0 115.046 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.92 155.55 37.32 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.148 1.474 . . . . 0.0 111.542 163.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -109.48 150.76 27.64 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.362 1.465 . . . . 0.0 112.393 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.23 157.78 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.567 1.947 . . . . 0.0 110.072 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -73.97 137.9 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.795 -0.566 . . . . 0.0 110.712 165.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.41 118.24 16.19 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -98.05 111.88 24.03 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -54.47 114.76 7.25 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.873 1.269 . . . . 0.0 112.365 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.89 -4.52 14.96 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.711 2.274 . . . . 0.0 114.09 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -77.19 -46.87 21.87 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.682 1.193 . . . . 0.0 112.234 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 t -141.22 6.37 1.93 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.143 0.977 . . . . 0.0 112.84 -168.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 54.68 33.0 18.42 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.573 1.549 . . . . 0.0 114.037 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -71.05 125.85 27.98 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 167.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -96.66 120.13 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 124.227 1.011 . . . . 0.0 109.029 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.6 154.73 50.59 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.2 133.62 36.04 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.078 0.951 . . . . 0.0 108.998 162.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -138.92 152.54 47.83 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.078 0.951 . . . . 0.0 110.878 171.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 t -89.09 160.16 17.19 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.0 t -96.12 133.73 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.463 1.905 . . . . 0.0 111.575 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 mt -90.8 -43.0 10.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.932 0.893 . . . . 0.0 113.355 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -148.94 156.12 41.82 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.796 2.038 . . . . 0.0 111.138 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.4 p -132.34 103.49 6.24 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.08 1.752 . . . . 0.0 110.416 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -91.06 150.73 21.3 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.6 1.56 . . . . 0.0 112.727 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.8 t -143.02 129.57 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.342 1.057 . . . . 0.0 110.453 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -122.89 175.54 6.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.307 1.843 . . . . 0.0 110.931 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -128.2 137.44 52.04 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.679 1.192 . . . . 0.0 111.323 168.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.9 t -148.35 149.34 31.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.691 1.196 . . . . 0.0 111.88 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.2 p -91.21 -14.74 30.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.895 1.278 . . . . 0.0 113.863 170.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -100.32 111.34 23.6 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.384 -0.822 . . . . 0.0 111.399 -175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -120.5 157.83 28.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 122.939 1.352 . . . . 0.0 112.922 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.431 HD11 ' HE2' ' A' ' 102' ' ' LYS . 16.2 tp -126.39 133.31 51.33 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.535 1.934 . . . . 0.0 109.259 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -110.4 124.86 52.51 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.215 1.006 . . . . 0.0 108.773 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.8 mt -118.24 138.76 52.13 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.977 0.911 . . . . 0.0 109.779 171.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.6 m -106.54 122.34 46.11 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.99 117.97 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.075 1.35 . . . . 0.0 108.515 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.65 28.24 51.22 Favored Glycine 0 CA--C 1.544 1.888 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.7 -9.3 78.08 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.35 1.452 . . . . 0.0 115.737 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -92.79 122.93 35.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.002 1.401 . . . . 0.0 110.068 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.0 t -78.98 125.81 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.566 0.746 . . . . 0.0 110.617 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mt -121.77 103.77 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.979 1.711 . . . . 0.0 109.352 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -80.58 122.55 27.19 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.11 1.764 . . . . 0.0 111.035 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 t -146.16 178.22 8.39 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.629 1.172 . . . . 0.0 112.702 -167.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.8 p -82.23 152.75 26.25 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.048 0.927 . . . . 0.0 112.472 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -65.69 -19.38 65.88 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.44 9.38 31.71 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.976 1.311 . . . . 0.0 113.616 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.1 t60 -65.56 129.84 94.46 Favored Pre-proline 0 CA--C 1.552 1.053 0 O-C-N 120.465 -1.397 . . . . 0.0 113.042 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.7 119.92 4.97 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.98 3.12 . . . . 0.0 114.732 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -112.2 150.04 31.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.963 2.105 . . . . 0.0 111.223 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -93.86 130.8 39.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.275 0.943 . . . . 0.0 113.382 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.9 t -108.14 134.32 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 127.499 2.319 . . . . 0.0 111.339 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -58.06 130.26 45.75 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.733 1.213 . . . . 0.0 111.677 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 60.88 16.41 6.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.779 1.632 . . . . 0.0 114.555 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.9 t -133.8 -58.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.255 1.022 . . . . 0.0 111.231 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.93 -152.12 17.16 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.925 0.774 . . . . 0.0 113.714 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -86.75 139.16 30.99 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -170.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.12 149.01 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.249 1.82 . . . . 0.0 111.666 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -66.93 134.03 51.19 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.482 1.113 . . . . 0.0 112.632 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.95 -36.61 72.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.343 1.457 . . . . 0.0 112.856 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.72 -8.28 81.47 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.508 -1.162 . . . . 0.0 114.559 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -103.02 -12.88 17.12 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.025 1.412 . . . . 0.0 113.731 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.2 mt -56.97 163.08 2.13 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.27 1.428 . . . . 0.0 113.543 170.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.97 164.53 18.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.614 1.565 . . . . 0.0 110.727 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.5 t -67.92 143.73 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 122.39 1.09 . . . . 0.0 110.347 167.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.59 3.69 89.0 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 118.716 -1.047 . . . . 0.0 114.315 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -84.95 160.56 20.06 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.641 1.72 . . . . 0.0 111.471 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -104.84 103.71 13.36 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.399 1.08 . . . . 0.0 112.458 -160.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.8 mt -93.56 175.84 6.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.07 0.948 . . . . 0.0 110.453 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -122.19 158.85 28.5 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.76 -178.0 3.53 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.398 1.479 . . . . 0.0 113.871 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.1 p -61.25 -17.66 54.48 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -90.33 -25.57 20.41 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.243 1.383 . . . . 0.0 111.603 170.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.73 19.31 18.04 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.796 1.665 . . . . 0.0 112.369 -176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -88.4 155.61 19.59 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.007 1.723 . . . . 0.0 110.793 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -80.73 128.11 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -169.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.6 mt -107.48 162.72 13.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.094 2.158 . . . . 0.0 112.231 169.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.83 139.71 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.365 1.066 . . . . 0.0 111.195 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.5 t -73.73 124.95 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.427 0.691 . . . . 0.0 109.44 171.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -94.83 -33.63 12.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.425 1.89 . . . . 0.0 112.912 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -156.73 149.01 23.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.929 1.291 . . . . 0.0 111.292 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.431 ' HE2' HD11 ' A' ' 53' ' ' LEU . 34.8 tttm -124.73 127.43 47.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.836 2.054 . . . . 0.0 110.3 166.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -140.37 154.06 46.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.667 1.987 . . . . 0.0 111.505 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 tp -140.43 148.67 41.56 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.554 1.542 . . . . 0.0 110.083 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -155.28 164.86 38.2 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.718 0.807 . . . . 0.0 113.102 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.7 mm -96.11 124.62 48.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 123.751 0.82 . . . . 0.0 109.188 161.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.95 150.65 45.48 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.744 1.218 . . . . 0.0 112.638 172.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -78.4 -13.02 60.03 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.685 1.594 . . . . 0.0 113.075 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -146.87 153.32 45.91 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.55 2.34 . . . . 0.0 110.132 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.48 114.76 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.916 2.411 . . . . 0.0 111.131 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 99.5 t -85.55 142.8 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.382 1.473 . . . . 0.0 109.989 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -79.71 139.39 37.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.119 0.962 . . . . 0.0 111.613 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.1 m -141.46 141.43 30.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.005 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -120.18 146.61 45.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.241 1.417 . . . . 0.0 110.77 -165.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -153.9 159.57 41.81 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.868 1.267 . . . . 0.0 111.397 173.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -150.72 163.14 39.29 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.434 -1.416 . . . . 0.0 113.568 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -120.26 138.85 53.43 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.72 149.42 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 127.557 2.343 . . . . 0.0 111.898 -168.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.89 -33.86 76.18 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 -168.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -143.81 -53.25 0.35 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.895 1.225 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -66.24 165.95 12.91 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.684 0.754 . . . . 0.0 110.297 167.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -133.51 27.64 4.04 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.429 1.492 . . . . 0.0 112.25 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.5 p -128.66 164.69 22.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.239 1.816 . . . . 0.0 111.881 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -159.03 -176.59 5.95 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.455 1.902 . . . . 0.0 109.922 168.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -127.24 138.37 53.09 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.395 1.078 . . . . 0.0 112.95 -171.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.47 143.6 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.194 0.997 . . . . 0.0 113.612 -171.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.35 168.83 20.07 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.615 1.579 . . . . 0.0 114.657 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.36 -22.8 61.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.175 1.39 . . . . 0.0 113.279 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -91.27 -0.9 57.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.762 1.625 . . . . 0.0 114.786 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 62.67 44.25 6.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.9 t -71.64 137.9 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.094 1.358 . . . . 0.0 111.406 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 57.2 tp -80.69 125.63 30.28 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.704 1.601 . . . . 0.0 113.247 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.49 160.07 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.894 1.678 . . . . 0.0 111.696 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -102.31 156.9 17.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.019 1.328 . . . . 0.0 113.06 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.088 1.755 . . . . 0.0 113.651 171.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 119.251 -0.404 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 10.5 ttt -109.94 117.94 35.13 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.327 0.651 . . . . 0.0 112.157 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -131.07 100.34 5.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.662 1.185 . . . . 0.0 110.867 -168.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -162.02 174.53 12.9 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.917 1.287 . . . . 0.0 112.863 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.414 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 91.6 m-85 -121.26 156.02 33.39 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.332 1.453 . . . . 0.0 111.511 169.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.95 160.78 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.34 0.591 . . . . 0.0 112.054 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.59 152.5 2.71 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.905 0.86 . . . . 0.0 112.95 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.18 -9.16 20.69 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-O 117.349 -1.806 . . . . 0.0 116.696 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -62.91 123.55 18.79 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 120.878 2.339 . . . . 0.0 110.811 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -80.57 141.91 34.61 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.426 1.49 . . . . 0.0 112.294 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.81 134.85 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.87 2.068 . . . . 0.0 110.036 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.06 126.84 31.62 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.297 1.039 . . . . 0.0 113.032 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.8 p -121.9 172.75 7.96 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.025 1.33 . . . . 0.0 111.487 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.8 -20.32 65.69 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 120.844 -1.16 . . . . 0.0 113.268 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 p -109.41 -13.07 14.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.913 2.085 . . . . 0.0 113.759 -170.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.24 -112.75 0.64 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 126.087 1.803 . . . . 0.0 112.443 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -133.33 141.67 48.06 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.222 1.009 . . . . 0.0 112.583 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -133.06 144.29 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.446 1.899 . . . . 0.0 109.111 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.59 147.8 47.25 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.274 -0.891 . . . . 0.0 111.027 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.2 tt -62.9 -27.6 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 120.315 -1.491 . . . . 0.0 113.043 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -68.58 -16.35 63.83 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.206 1.003 . . . . 0.0 113.457 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -110.61 -10.41 14.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.293 1.837 . . . . 0.0 113.146 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.4 mm -65.12 137.47 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 119.407 1.003 . . . . 0.0 108.921 162.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -127.65 166.06 18.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.915 2.086 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.53 133.67 46.18 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.89 -0.506 . . . . 0.0 110.511 160.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.29 6.73 89.09 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.972 1.272 . . . . 0.0 115.674 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -85.38 155.44 21.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.295 1.048 . . . . 0.0 110.333 165.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.59 135.25 52.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.311 1.044 . . . . 0.0 112.539 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.8 157.13 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.016 1.726 . . . . 0.0 110.652 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.3 mm -76.1 142.38 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.75 0.31 . . . . 0.0 111.275 168.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.63 126.73 22.66 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.904 0.881 . . . . 0.0 109.144 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.0 m -88.41 107.95 19.12 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 165.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -52.94 116.35 9.03 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.529 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.11 -11.22 28.72 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.673 2.249 . . . . 0.0 114.272 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -78.23 -49.1 14.38 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.748 1.219 . . . . 0.0 111.766 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 t -121.67 -7.88 9.05 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.525 1.13 . . . . 0.0 112.677 -167.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.276 12.9 m-85 53.5 43.02 31.83 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.703 1.601 . . . . 0.0 112.12 -173.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -81.44 131.37 35.28 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.927 0.891 . . . . 0.0 108.755 165.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.17 123.38 47.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 123.232 0.613 . . . . 0.0 110.621 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.2 159.22 42.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.311 1.045 . . . . 0.0 112.502 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -92.14 126.06 37.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.64 1.176 . . . . 0.0 108.87 164.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -137.84 152.83 49.48 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.189 0.996 . . . . 0.0 111.153 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -83.56 156.08 22.96 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.311 1.045 . . . . 0.0 113.058 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.8 t -87.58 134.55 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.706 1.602 . . . . 0.0 111.071 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.6 mt -84.21 -49.03 9.18 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.426 1.09 . . . . 0.0 112.508 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -151.28 159.77 44.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.694 1.998 . . . . 0.0 110.38 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.5 p -120.17 122.96 42.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.919 2.088 . . . . 0.0 109.571 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -101.46 147.02 26.85 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.89 0.876 . . . . 0.0 112.998 173.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.03 135.09 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.06 1.344 . . . . 0.0 110.077 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -126.86 170.93 11.71 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.028 2.131 . . . . 0.0 109.246 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -131.56 136.59 47.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.426 0.69 . . . . 0.0 111.714 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 t -154.57 146.93 23.91 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.598 0.759 . . . . 0.0 111.348 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.7 p -84.24 -18.32 36.89 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.716 0.806 . . . . 0.0 111.884 162.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -99.47 110.03 22.54 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 120.857 -1.152 . . . . 0.0 110.766 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.1 mt -121.5 172.53 8.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.767 1.627 . . . . 0.0 111.383 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.7 tp -141.32 130.48 23.43 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.893 1.277 . . . . 0.0 111.321 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -112.19 106.9 15.61 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.019 -1.05 . . . . 0.0 109.971 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.8 142.25 29.8 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.458 -0.776 . . . . 0.0 110.376 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.6 m -115.45 120.83 40.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.951 0.901 . . . . 0.0 109.471 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.02 117.37 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 126.32 1.848 . . . . 0.0 108.634 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.57 30.09 41.51 Favored Glycine 0 CA--C 1.543 1.789 0 N-CA-C 115.717 1.047 . . . . 0.0 115.717 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.08 6.4 84.8 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -102.37 129.38 48.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.881 1.341 . . . . 0.0 110.149 165.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -86.71 129.02 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.895 0.878 . . . . 0.0 110.287 164.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mt -121.7 101.51 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.07 1.348 . . . . 0.0 109.201 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.87 117.16 15.32 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.819 1.648 . . . . 0.0 110.732 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 t -142.72 -179.97 6.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.886 1.274 . . . . 0.0 112.464 -165.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.0 p -87.72 156.98 19.18 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 122.135 0.969 . . . . 0.0 112.353 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -59.45 -31.38 69.26 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.534 1.134 . . . . 0.0 113.082 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -101.05 8.96 42.67 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.5 t60 -64.08 128.12 92.68 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.474 1.034 . . . . 0.0 112.871 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -83.12 119.07 2.74 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.181 2.587 . . . . 0.0 114.947 -175.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -108.74 150.3 27.79 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.98 2.112 . . . . 0.0 111.472 173.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -98.19 130.04 44.94 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.517 1.053 . . . . 0.0 113.556 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -111.97 137.1 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.762 2.425 . . . . 0.0 111.392 -173.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -57.59 121.93 11.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.767 2.027 . . . . 0.0 112.671 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 53.03 30.04 8.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.616 1.967 . . . . 0.0 114.262 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.5 t -136.29 -50.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.469 1.508 . . . . 0.0 112.009 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 114.71 -153.58 17.53 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.046 0.831 . . . . 0.0 113.783 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -87.57 141.24 28.77 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.415 -1.05 . . . . 0.0 113.667 -173.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.95 145.28 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.284 1.433 . . . . 0.0 111.808 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.25 137.12 57.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.949 1.3 . . . . 0.0 112.098 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.18 -35.77 69.99 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.346 1.058 . . . . 0.0 113.64 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.04 -16.82 67.04 Favored Glycine 0 CA--C 1.534 1.281 0 O-C-N 121.299 -0.876 . . . . 0.0 114.02 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -103.29 -2.04 27.8 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.467 1.907 . . . . 0.0 113.512 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.28 151.82 39.52 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.676 -0.64 . . . . 0.0 110.836 162.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.21 157.87 39.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.894 1.678 . . . . 0.0 109.623 170.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.53 136.8 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.07 4.78 88.17 Favored Glycine 0 CA--C 1.538 1.49 0 CA-C-O 118.856 -0.969 . . . . 0.0 115.441 -175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -83.29 150.17 26.32 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.546 1.673 . . . . 0.0 110.098 170.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -108.6 113.54 26.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.561 1.544 . . . . 0.0 112.631 -165.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.6 165.49 11.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.645 1.578 . . . . 0.0 112.627 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.71 142.42 36.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.667 1.587 . . . . 0.0 110.892 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -96.11 -178.13 4.23 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.986 0.915 . . . . 0.0 113.203 166.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.7 p -62.57 -1.77 0.91 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.628 1.971 . . . . 0.0 116.257 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.7 mtm-85 -117.8 -27.49 6.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.101 2.161 . . . . 0.0 111.565 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 104.43 17.32 15.67 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.813 2.149 . . . . 0.0 113.449 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -69.28 159.3 33.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.891 0.876 . . . . 0.0 111.14 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.3 t -75.87 131.41 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.747 0.784 . . . . 0.0 110.786 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.6 mt -117.5 158.47 24.49 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.931 2.092 . . . . 0.0 109.699 161.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.4 142.26 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.408 0.683 . . . . 0.0 111.277 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.48 129.4 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.429 1.091 . . . . 0.0 110.352 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -102.45 -33.91 9.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.351 2.26 . . . . 0.0 112.966 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -159.52 152.19 21.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.795 1.638 . . . . 0.0 111.797 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -124.92 124.06 41.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.053 2.141 . . . . 0.0 109.816 159.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -118.59 140.17 50.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.891 2.076 . . . . 0.0 109.868 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 tp -121.31 125.59 47.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.884 1.274 . . . . 0.0 110.637 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.66 159.34 39.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.582 0.706 . . . . 0.0 112.268 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.7 mm -111.36 114.07 46.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 166.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.36 150.7 42.8 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 122.103 0.954 . . . . 0.0 111.723 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.04 -22.09 60.69 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.944 1.298 . . . . 0.0 112.819 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -134.74 151.88 76.56 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 126.292 1.837 . . . . 0.0 111.131 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.91 111.28 3.0 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.683 2.256 . . . . 0.0 110.899 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -85.16 141.5 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 126.245 1.818 . . . . 0.0 109.674 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -75.28 134.27 41.12 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.297 1.046 . . . . 0.0 110.247 172.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.44 130.49 67.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.226 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -112.36 148.18 34.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.012 1.725 . . . . 0.0 110.959 -166.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 -153.35 169.02 24.13 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.327 1.451 . . . . 0.0 109.867 171.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -148.73 171.74 15.73 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 120.398 -1.439 . . . . 0.0 111.674 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -128.52 139.55 52.26 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.817 0.847 . . . . 0.0 112.682 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.421 ' H ' ' ND2' ' A' ' 135' ' ' ASN . 89.9 t -98.47 145.43 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.982 1.713 . . . . 0.0 111.62 -169.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.13 -40.62 86.04 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -166.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -133.6 -36.9 0.95 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.035 0.934 . . . . 0.0 112.57 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.76 160.45 29.99 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.933 0.873 . . . . 0.0 110.533 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -114.95 11.52 16.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.202 1.401 . . . . 0.0 112.832 -171.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.3 p -145.5 166.51 25.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.191 1.797 . . . . 0.0 112.381 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -156.42 -179.01 7.76 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.768 1.627 . . . . 0.0 110.774 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -122.79 138.54 54.61 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.161 1.384 . . . . 0.0 112.413 -175.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -123.3 141.46 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.323 1.449 . . . . 0.0 111.962 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.96 -176.22 53.21 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 168.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.53 -34.66 72.54 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.995 1.718 . . . . 0.0 112.41 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -82.73 -4.54 58.03 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.362 1.065 . . . . 0.0 113.471 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 59.14 47.17 12.16 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.202 1.801 . . . . 0.0 114.093 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 t -72.96 137.15 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.916 1.286 . . . . 0.0 111.316 -170.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 52.7 tp -81.43 125.98 31.09 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.167 1.387 . . . . 0.0 113.104 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.1 m -138.33 156.72 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.956 1.702 . . . . 0.0 111.301 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -105.81 146.66 29.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.851 1.26 . . . . 0.0 112.129 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 118' ' ' VAL . 18.3 m-20 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 124.177 0.991 . . . . 0.0 111.835 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.494 0.188 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 3.4 ttt -151.82 -45.9 0.11 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.03 1.332 . . . . 0.0 112.639 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 63.2 mttm 43.48 62.79 1.75 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.487 1.915 . . . . 0.0 114.394 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -132.46 173.51 11.23 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -171.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.431 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 96.9 m-85 -128.02 153.23 47.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.408 1.483 . . . . 0.0 112.168 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 m -69.07 154.72 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.15 139.69 28.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.816 0.847 . . . . 0.0 111.55 171.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.72 -6.09 81.7 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.113 -1.382 . . . . 0.0 116.156 -170.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.9 m -64.3 123.43 19.12 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 121.163 2.482 . . . . 0.0 110.336 172.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.5 mmt -83.16 142.12 31.44 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.337 1.055 . . . . 0.0 112.08 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.19 135.03 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.369 2.267 . . . . 0.0 109.642 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.69 133.41 42.07 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 p -137.23 165.84 25.19 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.281 1.432 . . . . 0.0 111.195 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.56 -19.33 63.57 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.44 1.096 . . . . 0.0 113.372 170.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.4 p -86.57 -32.73 20.52 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.955 1.302 . . . . 0.0 111.64 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.71 -98.79 0.19 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.211 1.862 . . . . 0.0 110.612 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.4 mt -130.48 149.29 52.22 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.153 0.981 . . . . 0.0 111.867 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.5 141.25 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.859 1.663 . . . . 0.0 108.884 169.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.18 148.79 49.39 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.122 -0.986 . . . . 0.0 110.75 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.1 tt -61.48 -28.17 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 120.752 -1.217 . . . . 0.0 112.847 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.98 -6.64 46.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.905 1.282 . . . . 0.0 113.96 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -117.59 -7.96 11.0 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.121 1.769 . . . . 0.0 114.322 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.1 mm -66.81 139.41 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 118.928 0.785 . . . . 0.0 109.545 161.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -120.42 162.73 19.02 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.614 1.966 . . . . 0.0 110.32 172.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.5 135.54 54.37 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.093 0.473 . . . . 0.0 110.139 155.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.04 11.6 83.52 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.728 -1.04 . . . . 0.0 115.192 -176.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -96.86 158.0 15.64 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.846 1.323 . . . . 0.0 110.947 162.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -112.55 137.95 50.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.997 1.719 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -135.07 161.25 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.199 1.799 . . . . 0.0 111.163 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -76.52 143.11 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.661 0.664 . . . . 0.0 111.425 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.84 132.06 23.3 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.49 172.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.9 m -79.69 112.98 17.5 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 162.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -52.9 123.49 32.76 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 124.585 1.154 . . . . 0.0 112.392 171.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.0 -2.46 11.78 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 123.076 2.517 . . . . 0.0 114.778 -174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -90.78 -48.86 6.78 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.687 1.195 . . . . 0.0 112.004 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 t -127.67 1.56 6.13 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -166.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 61.02 27.41 17.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.339 1.456 . . . . 0.0 114.365 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.85 120.13 15.13 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.422 1.489 . . . . 0.0 109.157 170.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.5 t -100.56 120.48 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.454 0.701 . . . . 0.0 109.163 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.24 164.94 33.37 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.833 0.853 . . . . 0.0 112.089 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.56 137.82 48.34 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.692 0.397 . . . . 0.0 110.416 159.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -135.71 153.04 51.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.687 1.195 . . . . 0.0 111.117 161.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 t -78.12 154.46 31.24 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.2 t -91.93 135.0 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 127.039 2.136 . . . . 0.0 110.393 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.1 mt -87.56 -49.48 7.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.579 1.151 . . . . 0.0 112.33 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -146.57 156.66 43.4 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.179 1.392 . . . . 0.0 111.132 -175.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.5 p -124.86 119.51 29.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.238 1.815 . . . . 0.0 109.071 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -106.72 149.45 27.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.522 1.129 . . . . 0.0 113.316 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.6 t -139.03 142.32 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.2 1.4 . . . . 0.0 111.379 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -139.96 178.22 7.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 127.419 2.287 . . . . 0.0 111.988 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -129.65 141.09 50.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.05 1.74 . . . . 0.0 111.992 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 t -155.2 153.1 30.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.64 1.176 . . . . 0.0 111.639 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.1 p -90.0 -18.41 26.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.435 1.094 . . . . 0.0 113.296 164.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -95.0 106.98 19.0 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.391 -0.818 . . . . 0.0 111.725 -177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.7 mt -118.72 168.51 10.66 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.854 1.262 . . . . 0.0 112.571 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 tp -139.04 133.95 32.35 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.715 1.606 . . . . 0.0 110.967 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -106.06 138.1 42.83 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.469 1.508 . . . . 0.0 109.889 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.2 mt -127.21 130.53 49.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.309 1.043 . . . . 0.0 109.961 167.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.9 m -96.73 124.1 40.61 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 167.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.57 117.53 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.362 1.465 . . . . 0.0 109.289 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.53 29.36 31.56 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 115.341 0.896 . . . . 0.0 115.341 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.09 7.75 79.86 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 116.856 1.502 . . . . 0.0 116.856 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -112.04 140.33 46.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.844 1.822 . . . . 0.0 108.519 163.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -108.49 134.4 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 124.612 1.165 . . . . 0.0 111.837 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 57.9 mt -129.17 136.45 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.858 1.663 . . . . 0.0 109.278 -171.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -120.44 107.21 12.62 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.249 1.42 . . . . 0.0 109.905 -162.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -138.73 175.65 9.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.223 1.409 . . . . 0.0 113.241 -157.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.2 p -82.87 152.16 25.7 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.922 0.868 . . . . 0.0 111.472 166.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -56.87 -31.02 64.41 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.652 1.181 . . . . 0.0 112.702 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -95.4 1.64 54.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.022 1.329 . . . . 0.0 114.109 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.431 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.0 t60 -65.69 126.64 92.03 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 118.509 -0.758 . . . . 0.0 112.602 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -82.28 117.37 2.8 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.732 2.288 . . . . 0.0 114.508 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -100.98 143.21 31.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.004 2.121 . . . . 0.0 111.046 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -89.15 127.48 35.73 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.537 1.062 . . . . 0.0 112.432 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.41 136.53 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.472 1.909 . . . . 0.0 110.395 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.2 tptt -50.85 130.75 25.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.772 1.629 . . . . 0.0 110.658 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t70 58.7 10.09 1.34 Allowed 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.5 t -131.55 -47.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.406 -1.433 . . . . 0.0 111.567 -167.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.63 -162.59 14.83 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.791 0.71 . . . . 0.0 113.3 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -76.72 147.5 37.34 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -172.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.91 145.8 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.102 2.161 . . . . 0.0 111.014 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.15 136.72 58.11 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.771 0.828 . . . . 0.0 112.839 172.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.88 -39.47 62.69 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.455 1.502 . . . . 0.0 113.41 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.34 -17.42 74.26 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 121.217 -0.927 . . . . 0.0 114.199 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -104.7 5.32 33.38 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.167 2.187 . . . . 0.0 113.806 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.04 160.89 30.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.632 0.651 . . . . 0.0 110.544 165.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -125.01 150.31 46.85 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.54 1.136 . . . . 0.0 111.58 172.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.72 134.85 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.26 4.35 81.14 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.791 -1.005 . . . . 0.0 114.956 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -92.33 159.53 15.55 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.247 1.524 . . . . 0.0 112.396 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -108.88 109.01 20.0 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.915 1.286 . . . . 0.0 112.47 -157.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 mt -103.14 -177.69 3.44 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.702 1.601 . . . . 0.0 111.725 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.1 mt -134.53 156.75 48.08 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.445 1.098 . . . . 0.0 113.274 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.96 -175.7 2.79 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.485 1.514 . . . . 0.0 114.413 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -64.62 -6.51 7.84 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -103.44 -16.02 15.71 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.104 1.762 . . . . 0.0 112.605 167.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.04 19.54 50.33 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.442 1.496 . . . . 0.0 112.238 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -84.2 145.94 28.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.46 1.104 . . . . 0.0 110.278 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.9 t -76.0 115.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.087 0.47 . . . . 0.0 110.985 -174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.6 mt -93.37 157.64 16.13 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.973 1.709 . . . . 0.0 111.388 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.0 t -123.04 138.78 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.294 1.037 . . . . 0.0 110.841 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.16 126.01 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.664 0.786 . . . . 0.0 109.414 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -106.35 -25.25 12.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.759 2.024 . . . . 0.0 113.089 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -163.07 150.81 13.41 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.933 1.293 . . . . 0.0 111.857 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -120.59 128.37 52.98 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.739 2.016 . . . . 0.0 109.466 161.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -130.85 123.78 29.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.985 1.314 . . . . 0.0 110.964 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.3 tp -102.26 129.32 48.64 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.033 1.333 . . . . 0.0 109.795 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -126.88 149.59 49.69 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.105 0.955 . . . . 0.0 112.961 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.2 mm -111.68 105.6 19.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 171.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.65 154.55 32.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.25 1.02 . . . . 0.0 111.369 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.43 -21.31 28.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.912 0.885 . . . . 0.0 112.054 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -136.95 140.39 31.44 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.43 1.492 . . . . 0.0 110.321 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.12 117.63 4.43 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.019 3.146 . . . . 0.0 111.886 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.04 137.04 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.557 1.543 . . . . 0.0 110.001 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -74.98 135.52 41.33 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.98 0.895 . . . . 0.0 110.566 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -132.6 133.84 59.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 125.096 1.358 . . . . 0.0 110.946 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -117.2 153.94 32.0 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.713 1.605 . . . . 0.0 111.273 -166.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -152.49 155.71 38.0 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.332 2.253 . . . . 0.0 109.348 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -150.46 161.04 43.28 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.57 -1.331 . . . . 0.0 112.614 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.4 148.39 43.84 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.26 144.85 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 125.806 1.643 . . . . 0.0 112.819 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.74 -29.22 63.15 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -164.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -138.63 -41.08 0.5 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.792 -1.192 . . . . 0.0 113.144 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -75.88 165.36 25.11 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.706 -0.621 . . . . 0.0 110.134 170.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -124.99 32.05 5.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.376 1.471 . . . . 0.0 110.747 -170.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -156.85 164.02 38.54 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.588 1.555 . . . . 0.0 111.268 -162.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -161.97 174.3 13.26 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.189 1.796 . . . . 0.0 110.447 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -121.07 136.34 55.0 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.767 1.227 . . . . 0.0 112.975 -173.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.9 m -127.27 144.91 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.712 1.605 . . . . 0.0 113.91 -173.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.72 172.94 30.13 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 126.038 1.78 . . . . 0.0 115.063 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -69.63 -20.03 63.62 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.48 -1.6 . . . . 0.0 113.236 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -85.08 -2.18 57.7 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 169.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 57.33 51.52 9.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.664 1.585 . . . . 0.0 112.694 163.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.02 140.1 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.845 2.058 . . . . 0.0 111.697 -168.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 46.0 tp -79.07 127.37 31.91 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.134 1.373 . . . . 0.0 114.33 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.48 154.71 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.858 1.663 . . . . 0.0 111.377 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -103.04 141.63 35.48 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.086 0.954 . . . . 0.0 113.272 -169.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.27 0 CA-C-O 116.322 -1.799 . . . . 0.0 111.242 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 119.879 -0.105 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 35.0 ttm -56.83 143.52 36.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.563 2.345 . . . . 0.0 114.277 -168.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -125.34 76.39 1.55 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.002 1.721 . . . . 0.0 110.161 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.86 169.6 17.32 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.339 1.055 . . . . 0.0 112.759 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.415 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.4 m-85 -122.35 154.14 38.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.088 1.355 . . . . 0.0 111.491 172.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 m -69.3 154.69 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.0 0.429 . . . . 0.0 111.998 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.21 140.58 20.91 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.034 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.53 -9.46 71.47 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.544 2.021 . . . . 0.0 114.662 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 59.0 m -67.4 126.46 29.35 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.367 1.583 . . . . 0.0 111.5 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.4 mmt -78.1 143.6 37.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.858 1.663 . . . . 0.0 112.487 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.0 mm -129.61 139.0 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.608 1.963 . . . . 0.0 110.431 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.7 tp -81.92 129.77 34.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.262 1.425 . . . . 0.0 113.066 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.8 p -134.66 173.03 12.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.777 1.231 . . . . 0.0 113.71 -167.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.07 -13.12 32.22 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.55 1.54 . . . . 0.0 113.794 171.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.7 p -124.33 1.89 8.43 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.7 -117.89 2.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.396 1.951 . . . . 0.0 110.758 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.51 142.54 46.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.496 1.118 . . . . 0.0 112.634 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -139.97 148.91 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 127.269 2.227 . . . . 0.0 108.94 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.87 147.33 51.86 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.313 -0.867 . . . . 0.0 112.027 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.5 tt -62.48 -33.31 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 120.936 -1.103 . . . . 0.0 112.514 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.8 pm0 -68.71 -16.5 63.84 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -104.78 -14.74 15.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.039 1.336 . . . . 0.0 112.571 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.2 mm -58.66 133.96 23.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 O-C-N 121.126 -0.984 . . . . 0.0 109.432 164.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -119.81 161.67 20.4 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.386 1.874 . . . . 0.0 112.357 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.38 133.74 53.18 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.84 -0.538 . . . . 0.0 110.556 167.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.13 -6.54 81.22 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.869 1.223 . . . . 0.0 114.785 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.96 150.72 40.61 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.099 1.45 . . . . 0.0 109.628 168.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.87 120.6 42.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.87 0.868 . . . . 0.0 111.2 -176.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.5 m -106.06 151.46 8.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 125.195 1.398 . . . . 0.0 110.083 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.6 mm -81.67 137.08 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.52 116.23 13.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 m -93.07 111.41 23.04 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -52.95 115.01 6.62 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.897 1.279 . . . . 0.0 112.24 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -74.61 -1.61 11.32 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.054 2.503 . . . . 0.0 115.285 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -85.67 -46.75 10.45 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.785 -1.197 . . . . 0.0 112.317 170.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -126.31 -7.4 6.43 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.166 0.986 . . . . 0.0 113.127 -163.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.279 95.5 m-85 58.13 30.41 19.31 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.344 2.257 . . . . 0.0 115.017 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.92 130.05 39.12 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.57 0.748 . . . . 0.0 109.238 170.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -92.37 128.34 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.766 0.826 . . . . 0.0 109.501 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.37 149.36 39.29 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -69.3 136.11 51.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.389 0.676 . . . . 0.0 110.235 156.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.59 149.01 44.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.886 1.274 . . . . 0.0 110.026 159.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -78.06 153.58 32.16 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.898 0.856 . . . . 0.0 113.176 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.0 t -85.88 120.62 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.7 1.6 . . . . 0.0 109.757 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.71 -52.05 23.49 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.32 0.648 . . . . 0.0 111.12 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -146.24 156.58 43.48 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.266 1.426 . . . . 0.0 111.9 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 p -117.73 118.47 32.15 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.266 1.827 . . . . 0.0 111.148 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -104.52 151.93 23.0 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.693 1.597 . . . . 0.0 113.316 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 114' ' ' TYR . 16.3 t -136.4 140.98 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.0 1.72 . . . . 0.0 109.016 173.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.4 mmt-85 -140.76 176.54 8.71 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.081 1.752 . . . . 0.0 109.889 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -131.61 134.32 45.89 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.576 1.15 . . . . 0.0 111.271 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -144.21 152.03 40.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.211 1.004 . . . . 0.0 110.926 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.7 p -96.76 -15.03 21.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.219 1.407 . . . . 0.0 113.658 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -109.17 106.05 15.77 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.824 0.85 . . . . 0.0 110.682 -170.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.3 mt -116.78 163.94 15.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 122.369 1.081 . . . . 0.0 113.817 -172.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.4 HD11 ' HD2' ' A' ' 102' ' ' LYS . 14.8 tp -137.26 129.14 28.97 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.694 1.597 . . . . 0.0 111.853 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -110.51 103.83 12.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.616 1.566 . . . . 0.0 111.188 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.21 141.29 28.59 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.057 0.943 . . . . 0.0 110.058 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.0 m -114.18 125.26 53.73 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 167.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.06 119.46 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.953 1.301 . . . . 0.0 109.891 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.05 24.55 35.64 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.158 0.885 . . . . 0.0 115.149 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.89 -0.36 69.62 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.042 1.306 . . . . 0.0 116.285 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -108.74 125.54 52.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.592 1.696 . . . . 0.0 110.292 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -91.7 134.74 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.143 0.977 . . . . 0.0 112.64 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 mt -133.9 132.21 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.642 1.977 . . . . 0.0 108.828 -170.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -120.99 105.92 11.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.154 0.982 . . . . 0.0 109.538 -159.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 t -140.05 175.75 9.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.916 0.887 . . . . 0.0 113.328 -156.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.0 p -80.54 152.39 28.67 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.897 0.879 . . . . 0.0 112.182 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -61.18 -29.37 69.76 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.974 -1.079 . . . . 0.0 112.656 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -94.19 2.4 55.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.397 1.079 . . . . 0.0 113.456 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.415 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.1 t60 -64.52 128.73 93.72 Favored Pre-proline 0 CA--C 1.552 1.024 0 O-C-N 120.97 -1.081 . . . . 0.0 112.826 -172.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -79.93 112.39 2.86 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.561 2.841 . . . . 0.0 114.45 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -102.64 145.59 29.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.18 1.792 . . . . 0.0 111.956 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -93.3 132.04 37.88 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -116.65 135.63 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 127.303 2.241 . . . . 0.0 111.395 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -55.39 129.38 38.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.154 0.982 . . . . 0.0 110.982 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 64.66 9.01 4.83 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.47 1.908 . . . . 0.0 115.588 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.4 t -132.06 -44.66 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 120.882 -1.136 . . . . 0.0 112.344 -172.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.23 -147.75 17.83 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.213 -0.771 . . . . 0.0 112.377 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.28 53.4 p90 -91.26 143.12 26.98 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -170.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -144.63 147.98 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.829 2.052 . . . . 0.0 111.922 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -59.37 135.04 57.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.911 0.885 . . . . 0.0 112.63 171.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.58 -37.15 72.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.738 1.215 . . . . 0.0 113.014 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.36 -18.32 71.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.997 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -97.06 -1.94 44.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.629 1.572 . . . . 0.0 113.943 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.9 mt -70.51 156.59 39.19 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.651 0.78 . . . . 0.0 112.46 171.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -118.26 156.91 28.01 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.789 1.636 . . . . 0.0 111.433 170.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.36 132.33 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.883 0.873 . . . . 0.0 110.065 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.76 60.87 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.98 1.276 . . . . 0.0 115.655 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -86.97 159.03 19.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.489 1.645 . . . . 0.0 113.047 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -101.89 102.92 13.56 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.448 1.499 . . . . 0.0 112.361 -159.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.7 mt -95.81 166.84 11.61 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.528 1.131 . . . . 0.0 111.67 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.62 153.44 22.89 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.92 1.288 . . . . 0.0 110.306 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -109.89 -174.35 2.47 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 172.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.9 p -57.59 -12.75 3.03 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -103.7 -26.6 12.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.171 1.389 . . . . 0.0 111.342 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.83 22.2 24.04 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.335 1.922 . . . . 0.0 111.819 -167.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -76.75 159.58 30.03 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.764 0.826 . . . . 0.0 109.898 167.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.26 130.73 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.528 0.68 . . . . 0.0 112.328 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.3 mt -113.4 158.65 20.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.036 2.934 . . . . 0.0 111.227 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.13 139.24 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.212 1.005 . . . . 0.0 111.266 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.2 t -73.71 125.75 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.539 0.736 . . . . 0.0 110.23 172.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -100.96 -26.71 13.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.621 2.369 . . . . 0.0 113.515 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -161.77 152.4 17.63 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.203 1.401 . . . . 0.0 111.565 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.4 ' HD2' HD11 ' A' ' 53' ' ' LEU . 20.3 ttpp -127.17 132.8 50.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.737 1.615 . . . . 0.0 111.067 156.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -132.12 154.83 49.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 128.524 2.73 . . . . 0.0 110.023 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 tt -142.6 137.18 29.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.509 1.524 . . . . 0.0 110.436 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -135.1 149.89 50.13 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.1 mm -106.58 105.67 19.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.954 1.302 . . . . 0.0 108.6 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.62 148.35 49.47 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.754 1.222 . . . . 0.0 113.221 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -76.19 -14.61 60.15 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.748 1.219 . . . . 0.0 113.354 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -151.25 153.52 32.72 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 126.708 2.003 . . . . 0.0 110.69 175.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.18 122.92 11.31 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.328 2.686 . . . . 0.0 112.861 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.97 142.04 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.8 1.64 . . . . 0.0 109.837 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -79.81 140.62 36.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.797 0.839 . . . . 0.0 111.269 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.2 m -143.75 150.59 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.307 1.043 . . . . 0.0 111.162 -173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.463 ' CD2' HG22 ' A' ' 46' ' ' VAL . 64.4 m-85 -128.1 147.15 50.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.712 1.205 . . . . 0.0 111.265 -165.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -155.94 166.79 32.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.257 1.823 . . . . 0.0 109.129 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -150.54 172.33 15.66 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.329 -1.482 . . . . 0.0 111.655 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -122.02 132.7 54.65 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.47 138.23 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.948 1.699 . . . . 0.0 111.486 -172.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -56.38 -33.33 65.63 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -148.28 -37.08 0.19 Allowed 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.025 -1.047 . . . . 0.0 113.689 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -73.71 166.65 22.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.987 0.915 . . . . 0.0 110.424 172.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -133.77 28.58 3.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.448 1.499 . . . . 0.0 112.791 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.7 p -136.34 161.24 36.34 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.075 1.75 . . . . 0.0 111.511 175.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -157.6 -179.28 8.02 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.287 1.835 . . . . 0.0 109.814 167.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -132.95 139.33 47.25 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.26 1.024 . . . . 0.0 112.841 -168.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.78 141.4 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -170.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.36 172.55 31.59 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.39 1.472 . . . . 0.0 115.709 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -64.33 -19.23 65.31 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 120.927 -1.337 . . . . 0.0 113.808 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -93.77 1.51 56.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.402 1.481 . . . . 0.0 114.154 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 57.74 46.17 17.64 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.861 1.664 . . . . 0.0 114.217 166.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.26 138.09 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.397 1.079 . . . . 0.0 111.632 -171.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.7 tp -78.66 124.96 28.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.799 1.639 . . . . 0.0 112.498 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.97 151.82 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.311 1.444 . . . . 0.0 110.845 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -81.69 146.76 29.85 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.976 0.51 . . . . 0.0 110.569 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 C--O 1.251 1.18 0 C-N-CA 124.788 1.235 . . . . 0.0 113.592 178.254 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 44.6 ttm -148.94 145.13 27.23 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.278 -0.889 . . . . 0.0 111.764 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -122.37 50.02 1.53 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.764 1.626 . . . . 0.0 113.264 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -128.34 163.4 24.9 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -166.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -119.45 151.22 38.92 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.842 1.257 . . . . 0.0 110.915 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.82 158.73 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.272 0.558 . . . . 0.0 111.918 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.21 150.6 4.45 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.089 0.947 . . . . 0.0 111.63 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.47 -18.97 15.96 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 117.272 -1.849 . . . . 0.0 116.357 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.9 m -63.6 121.41 13.83 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.202 2.501 . . . . 0.0 110.718 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -77.76 143.77 37.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.476 1.111 . . . . 0.0 112.387 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.2 mm -126.81 136.46 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 127.548 2.339 . . . . 0.0 109.828 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -78.5 129.09 34.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.518 1.127 . . . . 0.0 113.441 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -127.52 173.59 9.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.57 1.548 . . . . 0.0 111.751 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.53 -15.1 63.14 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.851 -1.156 . . . . 0.0 113.371 172.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 p -109.03 -8.74 15.14 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.898 1.679 . . . . 0.0 114.21 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.38 -113.98 0.97 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.408 1.48 . . . . 0.0 111.412 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.8 mt -120.66 153.97 36.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.625 1.17 . . . . 0.0 111.584 174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -137.63 144.99 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.667 1.987 . . . . 0.0 108.029 166.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.75 148.32 46.46 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 120.756 -1.215 . . . . 0.0 111.316 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.9 tt -63.32 -27.4 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 120.42 -1.425 . . . . 0.0 113.056 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -70.46 -7.15 41.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.964 1.306 . . . . 0.0 114.351 171.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -118.17 -15.37 9.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.644 1.578 . . . . 0.0 113.084 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.02 135.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.918 1.235 . . . . 0.0 110.295 169.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -120.75 159.06 26.18 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.644 1.578 . . . . 0.0 112.375 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.32 137.89 55.5 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.421 -0.8 . . . . 0.0 110.533 167.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.61 -6.67 72.4 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.376 0.989 . . . . 0.0 115.133 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -67.95 177.65 2.08 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.812 1.306 . . . . 0.0 110.99 167.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -120.14 153.45 36.17 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.9 -1.125 . . . . 0.0 112.584 168.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 m -141.45 160.83 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.754 1.622 . . . . 0.0 110.609 175.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.2 mm -77.99 135.87 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 122.041 -0.412 . . . . 0.0 111.2 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.2 120.82 21.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.754 1.222 . . . . 0.0 107.71 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.2 m -96.65 103.18 15.07 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -47.84 118.91 6.55 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.027 1.331 . . . . 0.0 112.479 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.46 -10.37 28.47 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.27 1.98 . . . . 0.0 114.107 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -77.54 -34.96 53.71 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.791 1.636 . . . . 0.0 113.315 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.7 t -144.91 -3.91 0.76 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.142 1.377 . . . . 0.0 112.702 -171.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 54.73 40.23 31.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.598 1.559 . . . . 0.0 113.565 -171.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -77.87 124.22 27.73 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.505 1.122 . . . . 0.0 109.494 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 p -85.92 123.85 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.083 0.553 . . . . 0.0 110.779 174.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.35 162.83 34.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.849 0.833 . . . . 0.0 112.972 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -103.84 116.47 32.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.853 1.661 . . . . 0.0 109.416 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -133.91 154.5 51.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.876 1.27 . . . . 0.0 111.444 -170.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 t -87.87 157.1 19.07 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.6 t -88.59 128.35 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.408 1.483 . . . . 0.0 110.843 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -83.3 -55.78 4.13 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.009 0.524 . . . . 0.0 111.333 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -138.7 152.73 48.26 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.601 1.161 . . . . 0.0 111.627 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -128.01 107.98 10.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.759 1.624 . . . . 0.0 110.411 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -96.31 146.3 24.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.403 1.081 . . . . 0.0 111.706 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 t -136.79 137.04 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.996 0.918 . . . . 0.0 109.192 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -133.95 175.4 9.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.525 2.33 . . . . 0.0 109.256 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -131.6 132.22 43.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.312 1.045 . . . . 0.0 111.751 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.1 t -141.66 140.27 33.19 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.422 1.089 . . . . 0.0 111.101 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -85.19 -21.98 28.92 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.535 0.734 . . . . 0.0 112.287 165.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -92.87 120.63 33.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.92 0.782 . . . . 0.0 109.495 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.3 mt -126.61 161.96 26.82 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 122.481 1.134 . . . . 0.0 112.673 174.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 tp -127.83 128.87 45.99 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.461 1.904 . . . . 0.0 109.918 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -113.22 95.9 5.63 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.197 -0.94 . . . . 0.0 109.29 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.0 mt -83.69 145.04 28.99 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.444 -0.785 . . . . 0.0 110.291 171.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -117.32 120.01 36.89 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -128.12 120.99 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.997 1.319 . . . . 0.0 108.61 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.52 31.12 28.43 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 114.71 0.644 . . . . 0.0 114.71 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.42 -5.75 83.76 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.221 1.391 . . . . 0.0 116.0 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -94.96 125.93 39.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.236 1.518 . . . . 0.0 109.581 172.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.7 t -76.19 132.42 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.313 0.645 . . . . 0.0 110.998 167.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -123.47 103.32 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.282 1.833 . . . . 0.0 109.072 172.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -77.67 106.91 9.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.48 2.312 . . . . 0.0 110.766 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 t -137.47 -179.34 5.68 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.156 1.382 . . . . 0.0 112.103 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.0 p -88.25 163.36 16.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.77 1.228 . . . . 0.0 111.91 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -68.45 -25.76 65.17 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.867 -1.146 . . . . 0.0 112.45 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -106.43 9.6 31.67 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.654 0.782 . . . . 0.0 113.006 -171.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -72.19 131.68 84.96 Favored Pre-proline 0 CA--C 1.553 1.066 0 O-C-N 121.369 -0.832 . . . . 0.0 112.717 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -83.3 120.05 2.83 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 124.201 3.268 . . . . 0.0 115.575 -175.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -106.88 145.16 32.52 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.462 1.905 . . . . 0.0 111.201 172.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -88.96 131.45 35.15 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.305 1.412 . . . . 0.0 113.506 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.31 133.7 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 127.126 2.171 . . . . 0.0 111.504 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -56.58 127.68 32.54 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.786 0.834 . . . . 0.0 112.855 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 59.99 15.5 5.09 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.316 1.847 . . . . 0.0 115.488 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.3 t -125.26 -59.15 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 120.833 -1.167 . . . . 0.0 111.09 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.39 -162.47 22.7 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.242 0.925 . . . . 0.0 112.653 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -83.29 146.19 28.67 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.845 1.322 . . . . 0.0 114.143 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.83 145.35 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 127.307 2.243 . . . . 0.0 111.259 -175.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -66.04 136.74 56.44 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.682 0.793 . . . . 0.0 112.485 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.74 -39.32 68.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.489 1.516 . . . . 0.0 113.799 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.35 -17.8 77.84 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.355 -0.84 . . . . 0.0 114.041 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -93.63 -9.76 36.88 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.392 1.477 . . . . 0.0 113.761 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.99 167.76 1.53 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.35 1.06 . . . . 0.0 113.103 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 162.43 27.37 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.463 1.505 . . . . 0.0 110.115 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.97 145.39 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.307 0.575 . . . . 0.0 109.505 167.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.43 4.8 89.26 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.727 -1.041 . . . . 0.0 114.807 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -84.58 158.01 21.04 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.153 1.476 . . . . 0.0 112.426 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -105.9 104.43 14.14 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.815 1.246 . . . . 0.0 111.591 -162.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.8 mt -101.19 169.37 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.904 1.281 . . . . 0.0 111.11 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -115.49 144.1 44.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.955 1.302 . . . . 0.0 110.634 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.96 -177.11 5.11 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.533 1.133 . . . . 0.0 112.805 168.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.1 p -59.98 -17.42 38.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -97.51 -26.34 14.85 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.837 1.653 . . . . 0.0 112.737 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 104.08 23.4 8.15 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.448 1.499 . . . . 0.0 113.15 -170.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -81.34 151.07 28.18 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.791 1.236 . . . . 0.0 110.649 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.9 t -84.85 133.12 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.124 0.97 . . . . 0.0 112.159 -168.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.4 mt -118.62 148.74 42.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.575 2.35 . . . . 0.0 111.424 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.56 135.43 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.224 1.01 . . . . 0.0 110.714 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -73.04 127.21 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 169.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.47 -38.34 8.44 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.329 1.452 . . . . 0.0 112.565 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -161.48 154.82 21.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.29 1.436 . . . . 0.0 111.913 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -120.07 133.21 55.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.458 1.503 . . . . 0.0 110.51 163.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -124.43 153.25 42.22 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.989 2.515 . . . . 0.0 109.965 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.9 tp -135.11 143.16 46.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.095 1.758 . . . . 0.0 109.942 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.46 157.17 44.37 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.3 mm -108.33 105.24 18.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.656 1.182 . . . . 0.0 108.364 166.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.78 147.51 49.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.899 1.28 . . . . 0.0 113.71 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -74.16 -10.61 59.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.585 1.554 . . . . 0.0 113.972 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -139.65 157.13 70.67 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 127.034 2.134 . . . . 0.0 110.291 166.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.77 119.09 6.04 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.653 2.236 . . . . 0.0 110.492 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 92.7 t -90.02 136.9 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 126.011 1.725 . . . . 0.0 109.419 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -74.61 138.39 42.92 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.679 0.792 . . . . 0.0 110.226 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.95 142.53 29.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 123.926 0.89 . . . . 0.0 110.764 -174.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -122.08 145.46 48.13 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.032 1.333 . . . . 0.0 110.433 -163.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -153.1 165.54 35.3 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.968 1.307 . . . . 0.0 110.801 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -147.03 164.09 34.13 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.423 -1.423 . . . . 0.0 113.02 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.7 pttt -117.69 141.43 48.39 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.02 147.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.078 1.751 . . . . 0.0 111.556 -168.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -65.16 -67.65 0.42 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.637 1.175 . . . . 0.0 113.886 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -94.88 -54.57 3.42 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.645 -0.66 . . . . 0.0 112.28 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -83.44 177.63 8.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.856 1.263 . . . . 0.0 111.579 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -131.75 29.2 4.49 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.027 1.331 . . . . 0.0 114.187 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 p -137.04 161.61 35.6 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.992 1.717 . . . . 0.0 112.507 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -156.16 -177.48 6.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.528 1.931 . . . . 0.0 110.751 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -132.24 139.57 48.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.096 1.358 . . . . 0.0 113.176 -168.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.22 144.17 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.375 1.07 . . . . 0.0 113.351 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.13 -179.42 39.13 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.051 1.786 . . . . 0.0 116.642 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -55.92 -39.15 71.23 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.951 1.301 . . . . 0.0 111.973 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -86.33 2.21 48.24 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 59.78 39.53 20.63 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.24 134.5 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.269 0.627 . . . . 0.0 111.578 -169.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.7 tp -73.76 121.93 21.6 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.859 1.664 . . . . 0.0 112.445 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.13 161.92 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.647 1.579 . . . . 0.0 111.623 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -111.03 143.65 41.4 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -167.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 127.343 2.257 . . . . 0.0 113.262 172.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 7.5 ttt -147.24 126.69 13.18 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.37 1.441 . . . . 0.0 111.416 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -134.57 75.93 1.61 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.365 1.466 . . . . 0.0 112.125 -164.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -144.12 172.27 13.13 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.07 152.73 37.13 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.495 1.518 . . . . 0.0 111.068 173.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.1 m -68.25 157.43 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.382 0.611 . . . . 0.0 111.707 174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.5 150.11 2.83 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.62 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.94 -10.83 45.18 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.269 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.0 m -64.2 123.91 20.32 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 120.901 2.351 . . . . 0.0 110.641 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 mmt -80.26 140.03 36.41 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.284 1.434 . . . . 0.0 111.831 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.6 mm -123.12 135.71 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 126.367 1.867 . . . . 0.0 109.719 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.6 tp -76.53 123.86 26.7 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.653 0.781 . . . . 0.0 111.608 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 p -117.36 177.36 4.77 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.764 1.226 . . . . 0.0 112.71 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.72 -15.01 50.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.092 1.357 . . . . 0.0 114.128 170.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.5 p -124.68 -12.23 7.17 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.43 -115.1 0.65 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.04 0.828 . . . . 0.0 112.726 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 78.7 mt -125.72 139.65 53.36 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.232 1.013 . . . . 0.0 112.799 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -136.38 147.69 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.83 2.052 . . . . 0.0 109.012 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.42 148.11 47.25 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.273 -0.892 . . . . 0.0 111.442 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.0 tt -61.44 -26.29 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 120.682 -1.261 . . . . 0.0 113.496 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -72.27 -9.07 57.99 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.953 1.301 . . . . 0.0 114.198 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -118.7 -10.28 10.04 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.986 1.714 . . . . 0.0 113.332 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -66.91 136.69 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.668 1.122 . . . . 0.0 109.391 162.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -130.07 166.77 19.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.048 1.739 . . . . 0.0 111.182 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.86 134.08 55.01 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.212 -0.93 . . . . 0.0 110.199 165.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.2 -7.84 81.19 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -67.95 167.73 13.17 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.825 1.312 . . . . 0.0 111.496 161.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -124.23 123.84 41.14 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.431 1.492 . . . . 0.0 111.863 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.98 152.76 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.815 1.646 . . . . 0.0 110.227 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -77.79 139.12 19.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.373 0.606 . . . . 0.0 110.543 169.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -135.23 126.4 28.07 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.413 1.085 . . . . 0.0 108.378 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.4 m -78.93 111.99 15.67 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 159.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -53.63 114.31 6.08 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.655 1.182 . . . . 0.0 112.15 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.75 -12.77 35.62 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.611 2.207 . . . . 0.0 114.29 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.66 -48.85 14.22 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.793 -1.192 . . . . 0.0 111.887 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -129.0 -0.41 5.26 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.036 1.335 . . . . 0.0 114.117 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.324 4.0 m-85 61.72 25.39 15.29 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.046 1.738 . . . . 0.0 115.541 -176.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.79 136.81 53.34 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.416 -0.803 . . . . 0.0 110.251 168.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.31 117.36 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.268 1.027 . . . . 0.0 110.497 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.31 160.9 43.01 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -71.92 132.26 44.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.414 1.085 . . . . 0.0 110.453 166.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.414 ' HE3' ' CE1' ' A' ' 121' ' ' PHE . 70.5 mmtt -135.62 150.13 49.56 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.535 1.534 . . . . 0.0 110.359 170.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -82.39 155.01 24.92 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.9 t -90.21 131.6 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.86 1.264 . . . . 0.0 111.176 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.98 -45.72 10.51 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.942 0.897 . . . . 0.0 112.476 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -148.83 153.45 38.11 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.38 1.872 . . . . 0.0 110.669 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.7 p -120.73 122.59 40.74 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.238 1.415 . . . . 0.0 111.095 173.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -104.7 148.05 27.0 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.604 1.562 . . . . 0.0 112.421 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.0 t -143.31 132.22 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.552 1.141 . . . . 0.0 111.251 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -134.14 177.67 7.56 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.258 2.223 . . . . 0.0 111.936 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -139.51 138.8 36.66 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.423 1.489 . . . . 0.0 111.511 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.1 t -155.23 154.29 31.96 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.984 0.914 . . . . 0.0 111.907 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.7 p -87.39 -15.48 37.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.781 1.232 . . . . 0.0 113.424 164.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -98.55 108.26 20.91 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.086 -1.009 . . . . 0.0 110.972 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.3 mt -108.86 174.38 5.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.949 0.899 . . . . 0.0 111.935 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.8 tp -147.76 137.97 22.93 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.214 1.406 . . . . 0.0 110.726 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -124.17 112.91 17.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.863 1.265 . . . . 0.0 110.18 -173.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.9 130.54 54.56 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.801 0.84 . . . . 0.0 109.819 176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -105.52 116.51 32.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.845 1.258 . . . . 0.0 108.542 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -127.77 116.06 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.55 1.54 . . . . 0.0 109.472 -171.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.49 30.82 34.91 Favored Glycine 0 CA--C 1.542 1.774 0 O-C-N 121.628 -0.67 . . . . 0.0 113.97 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.93 -1.61 88.23 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.245 1.403 . . . . 0.0 115.73 -177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.28 120.92 38.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.857 1.829 . . . . 0.0 109.52 170.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -88.57 138.05 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.238 0.615 . . . . 0.0 111.824 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.5 mt -133.67 131.91 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 126.36 1.864 . . . . 0.0 109.139 -176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -114.05 109.73 18.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.73 1.612 . . . . 0.0 110.607 -165.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.1 t -140.63 -179.38 6.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.164 1.386 . . . . 0.0 112.668 -158.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.1 p -90.29 155.45 18.97 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.302 1.041 . . . . 0.0 112.287 169.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -59.72 -29.9 68.45 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.107 -0.996 . . . . 0.0 113.442 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -94.52 3.44 55.13 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -64.54 127.89 92.82 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 120.912 -1.118 . . . . 0.0 112.6 -170.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -81.1 113.2 2.68 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 123.695 2.93 . . . . 0.0 114.292 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -103.63 144.05 31.95 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.952 1.701 . . . . 0.0 111.64 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -84.89 134.35 34.27 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.307 0.958 . . . . 0.0 112.756 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.9 t -118.71 132.87 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.769 2.028 . . . . 0.0 111.867 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.05 121.92 4.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.325 1.45 . . . . 0.0 111.899 172.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 56.38 30.07 16.26 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.312 1.445 . . . . 0.0 113.977 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -141.65 -42.11 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 125.373 1.469 . . . . 0.0 112.737 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.66 -148.99 18.77 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.965 0.793 . . . . 0.0 112.848 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -88.06 135.83 33.25 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.8 p -136.84 145.08 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.132 1.773 . . . . 0.0 111.455 -176.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -63.58 131.99 49.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.092 1.357 . . . . 0.0 111.016 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.34 67.34 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.152 -0.967 . . . . 0.0 113.44 -175.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.03 -7.28 81.5 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 121.119 -0.988 . . . . 0.0 114.494 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -107.23 -2.47 20.78 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.087 1.755 . . . . 0.0 113.543 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.76 161.7 17.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.992 1.317 . . . . 0.0 112.326 166.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.7 159.32 24.71 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.812 1.245 . . . . 0.0 113.256 160.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.78 130.87 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 159.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.87 -0.89 84.82 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 117.185 -1.897 . . . . 0.0 115.558 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.01 151.42 41.76 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 121.404 2.602 . . . . 0.0 111.509 166.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -102.86 107.87 18.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.028 1.731 . . . . 0.0 112.854 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.9 mt -97.75 167.65 10.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.647 1.179 . . . . 0.0 111.871 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.14 146.8 38.61 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.052 1.341 . . . . 0.0 111.182 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.24 -178.05 3.54 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 172.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.4 p -59.89 -6.6 1.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.77 2.028 . . . . 0.0 116.466 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.51 -17.17 10.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.513 1.925 . . . . 0.0 112.621 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.48 23.88 32.64 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.045 1.783 . . . . 0.0 112.033 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -66.65 148.78 51.44 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.205 0.502 . . . . 0.0 109.768 161.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.3 t -84.16 128.15 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 122.491 0.317 . . . . 0.0 110.381 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.8 mt -108.4 161.07 15.37 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.465 2.706 . . . . 0.0 110.652 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.5 t -134.6 140.4 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.507 1.123 . . . . 0.0 110.605 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.08 129.13 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.361 0.664 . . . . 0.0 109.894 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -96.64 -41.73 8.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.428 2.291 . . . . 0.0 112.011 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -153.53 149.92 28.18 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.807 1.643 . . . . 0.0 110.681 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -132.75 122.73 24.99 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.95 2.1 . . . . 0.0 108.727 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mmtm -134.48 128.71 33.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.492 1.117 . . . . 0.0 112.992 -166.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.1 tp -102.55 134.88 45.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.033 1.733 . . . . 0.0 109.612 173.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -136.09 147.95 48.07 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.361 0.664 . . . . 0.0 111.423 158.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.0 mm -91.7 117.05 34.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 165.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.03 142.19 55.97 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.263 1.025 . . . . 0.0 111.183 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.0 -17.87 62.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.437 0.695 . . . . 0.0 112.738 -176.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -144.38 147.52 37.11 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.373 2.269 . . . . 0.0 110.178 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.11 120.06 7.38 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 124.389 3.393 . . . . 0.0 112.809 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.75 141.7 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.906 1.682 . . . . 0.0 110.441 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -75.14 141.11 43.73 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.494 0.718 . . . . 0.0 111.482 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 m -136.47 144.07 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.938 1.695 . . . . 0.0 110.397 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -125.47 147.3 49.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.468 1.507 . . . . 0.0 110.644 -166.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -155.38 170.46 21.85 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.721 1.608 . . . . 0.0 111.495 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -154.19 166.1 34.18 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.428 -1.42 . . . . 0.0 113.043 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -120.04 146.13 46.19 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.668 1.187 . . . . 0.0 113.857 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.71 147.09 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.954 1.701 . . . . 0.0 112.44 -162.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.37 -39.56 92.45 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -168.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -133.99 -48.16 0.8 Allowed 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.599 -1.313 . . . . 0.0 113.386 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.414 ' CE1' ' HE3' ' A' ' 39' ' ' LYS . 7.8 m-30 -77.61 168.86 19.29 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 169.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -114.93 17.87 16.7 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.2 1.4 . . . . 0.0 112.669 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 p -141.08 165.16 28.31 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.968 1.707 . . . . 0.0 112.794 -160.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -158.98 178.38 10.13 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.054 1.742 . . . . 0.0 110.662 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -120.41 139.81 52.27 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.038 1.335 . . . . 0.0 112.501 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.0 144.48 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.092 1.357 . . . . 0.0 113.61 -175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.21 173.7 29.73 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.232 1.396 . . . . 0.0 116.034 172.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.13 -27.84 69.65 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.178 -1.189 . . . . 0.0 113.648 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -88.66 -1.34 58.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.346 1.458 . . . . 0.0 113.519 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 59.25 49.8 8.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.182 1.793 . . . . 0.0 113.988 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t -74.91 138.79 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.11 1.364 . . . . 0.0 111.579 -173.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.9 tp -79.78 128.86 33.95 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.575 1.55 . . . . 0.0 113.524 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.5 m -138.06 155.06 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.009 1.724 . . . . 0.0 111.356 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -104.23 158.44 16.44 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.47 1.508 . . . . 0.0 110.778 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 C--O 1.254 1.327 0 O-C-N 120.622 -1.299 . . . . 0.0 114.097 172.334 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.679 0.276 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 43.9 ttm -146.81 136.47 23.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.445 1.098 . . . . 0.0 110.752 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -109.24 102.75 11.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.4 1.48 . . . . 0.0 109.366 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -156.32 172.26 18.8 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.514 1.126 . . . . 0.0 112.677 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.87 154.38 41.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.29 1.436 . . . . 0.0 111.985 169.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.07 161.6 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.242 0.617 . . . . 0.0 112.554 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 150.55 7.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.326 1.05 . . . . 0.0 111.358 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.59 -7.03 9.47 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-O 117.795 -1.558 . . . . 0.0 116.486 -172.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.8 m -61.65 119.36 8.52 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 121.552 2.676 . . . . 0.0 109.685 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -74.62 143.29 44.41 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.851 0.861 . . . . 0.0 111.405 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.3 mm -127.51 135.51 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.796 2.038 . . . . 0.0 109.519 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -78.23 126.36 30.69 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.0 p -117.96 176.39 5.23 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.789 1.235 . . . . 0.0 111.82 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.81 -10.8 59.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 171.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.1 p -119.46 -16.04 8.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.27 1.828 . . . . 0.0 113.934 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.03 -122.8 1.26 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.089 1.328 . . . . 0.0 111.53 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.5 mt -124.28 142.8 50.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.163 1.385 . . . . 0.0 112.258 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.15 143.08 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.12 1.768 . . . . 0.0 108.613 171.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.57 148.03 51.09 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.999 -1.063 . . . . 0.0 111.352 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 tt -61.34 -26.88 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 O-C-N 120.592 -1.317 . . . . 0.0 113.524 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.82 -16.44 64.11 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -112.54 -12.04 13.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.151 1.78 . . . . 0.0 112.665 -174.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.4 mm -64.54 141.12 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.04 0.836 . . . . 0.0 109.837 162.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -128.43 159.77 34.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.443 1.897 . . . . 0.0 112.263 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.72 124.8 21.7 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.269 -0.894 . . . . 0.0 110.485 165.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.65 -0.34 84.76 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.497 1.046 . . . . 0.0 115.392 -170.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -76.8 154.15 34.23 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.424 1.612 . . . . 0.0 110.539 158.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -108.92 142.89 38.89 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.218 1.407 . . . . 0.0 112.217 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -136.5 159.85 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.376 1.87 . . . . 0.0 111.026 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.9 mm -74.59 137.85 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.966 -0.459 . . . . 0.0 111.898 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.49 123.08 19.75 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.167 0.987 . . . . 0.0 108.657 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.4 m -93.33 103.85 16.05 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 170.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -52.97 113.91 5.2 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.818 1.647 . . . . 0.0 113.18 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.58 -11.24 31.46 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.159 2.573 . . . . 0.0 114.413 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -76.43 -38.9 54.83 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.381 1.072 . . . . 0.0 112.638 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.4 t -133.96 -6.96 2.73 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.282 1.033 . . . . 0.0 112.516 -172.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.267 2.4 t80 61.99 39.34 13.45 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.31 1.844 . . . . 0.0 113.601 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -95.2 135.75 36.39 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.452 1.501 . . . . 0.0 110.522 176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.04 136.71 30.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 122.956 0.502 . . . . 0.0 111.653 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.8 167.99 25.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.379 1.472 . . . . 0.0 111.951 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 -89.71 126.88 35.82 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.686 0.794 . . . . 0.0 110.196 164.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -130.23 151.75 50.41 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.496 1.118 . . . . 0.0 112.123 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -87.53 154.5 20.58 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.42 1.088 . . . . 0.0 113.141 -176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.4 t -89.66 132.68 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.661 1.584 . . . . 0.0 110.753 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.38 -43.19 9.9 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.903 0.881 . . . . 0.0 112.785 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -142.85 153.09 42.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.157 1.383 . . . . 0.0 110.297 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.9 p -122.1 118.42 28.66 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.9 1.68 . . . . 0.0 108.832 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.02 143.71 28.3 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.424 1.49 . . . . 0.0 112.258 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.41 HG22 ' CD2' ' A' ' 114' ' ' TYR . 41.5 t -141.13 126.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.751 1.221 . . . . 0.0 110.889 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -132.8 174.77 9.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.825 2.05 . . . . 0.0 109.62 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -132.33 130.2 40.46 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.871 0.868 . . . . 0.0 111.093 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.7 t -140.18 139.54 35.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.522 1.129 . . . . 0.0 110.87 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.0 p -81.12 -19.88 42.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.854 0.862 . . . . 0.0 111.926 166.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -94.2 111.63 23.37 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.383 1.073 . . . . 0.0 110.668 -173.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.0 mt -127.85 157.2 41.13 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 123.409 1.576 . . . . 0.0 113.908 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.4 tp -121.77 136.15 54.93 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.495 1.918 . . . . 0.0 109.956 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -110.39 124.09 51.07 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.712 1.205 . . . . 0.0 109.2 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.0 mt -121.52 137.91 54.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 167.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.7 m -109.25 120.75 43.48 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 167.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.14 122.87 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.463 1.105 . . . . 0.0 108.269 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.64 18.59 16.94 Favored Glycine 0 CA--C 1.547 2.083 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.58 5.08 67.22 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 119.581 1.691 . . . . 0.0 116.323 -171.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -103.52 122.57 45.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.29 1.545 . . . . 0.0 110.296 164.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -77.18 124.03 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.537 0.735 . . . . 0.0 109.407 164.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mt -119.5 100.69 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 125.175 1.39 . . . . 0.0 109.122 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.57 119.24 21.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.591 1.556 . . . . 0.0 110.49 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -143.05 -179.06 6.14 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.129 0.972 . . . . 0.0 111.305 -168.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.4 p -88.69 155.65 19.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.955 0.883 . . . . 0.0 111.669 167.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.97 -33.59 69.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.536 1.135 . . . . 0.0 112.146 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -85.92 -7.73 58.49 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.634 1.173 . . . . 0.0 113.315 -170.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -64.57 127.48 92.41 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-O 118.213 -0.899 . . . . 0.0 113.177 -166.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -79.59 108.19 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.373 2.715 . . . . 0.0 114.313 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -102.26 141.92 34.31 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.625 1.97 . . . . 0.0 111.865 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -85.91 127.13 34.53 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.67 135.86 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 127.601 2.36 . . . . 0.0 111.257 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -52.67 121.22 6.76 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.13 1.372 . . . . 0.0 112.638 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.29 14.06 4.38 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.064 2.146 . . . . 0.0 115.54 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.8 t -122.77 -54.56 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.537 1.135 . . . . 0.0 110.728 -173.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.44 -161.93 16.42 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.586 0.612 . . . . 0.0 113.436 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -84.63 145.12 28.17 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.577 1.188 . . . . 0.0 114.166 -174.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.48 149.62 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.474 1.91 . . . . 0.0 111.263 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -55.73 131.48 46.76 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.743 1.217 . . . . 0.0 111.861 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.05 -35.81 64.89 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.635 1.174 . . . . 0.0 113.075 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.67 -5.73 88.3 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.63 -1.095 . . . . 0.0 114.898 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -97.93 -4.64 36.01 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.246 1.418 . . . . 0.0 113.519 171.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.52 160.07 33.14 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.556 0.693 . . . . 0.0 111.278 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -117.35 167.78 10.94 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.494 1.518 . . . . 0.0 110.535 166.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -57.88 144.71 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.495 -0.753 . . . . 0.0 109.323 155.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.84 1.43 89.54 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.951 -0.916 . . . . 0.0 114.132 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -82.9 152.14 25.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 119.038 1.419 . . . . 0.0 111.385 175.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -108.45 112.02 24.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.429 1.092 . . . . 0.0 112.484 -163.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.9 mt -107.27 179.41 4.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.341 1.856 . . . . 0.0 110.588 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.89 156.63 44.72 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.026 0.931 . . . . 0.0 113.467 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -98.15 174.04 6.72 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.578 1.151 . . . . 0.0 113.117 166.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.6 t -55.58 -35.38 65.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.782 1.233 . . . . 0.0 113.787 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -75.24 -29.55 60.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.555 1.542 . . . . 0.0 112.727 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.79 24.67 6.87 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.597 1.57 . . . . 0.0 113.499 173.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -78.43 152.94 31.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.441 1.496 . . . . 0.0 110.193 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.12 125.07 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 122.579 0.352 . . . . 0.0 110.992 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.0 mt -106.34 149.75 26.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.277 1.431 . . . . 0.0 111.863 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.0 t -127.23 137.0 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.457 1.103 . . . . 0.0 111.455 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.16 123.7 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.598 1.159 . . . . 0.0 111.074 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -88.63 -32.87 17.84 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.673 2.389 . . . . 0.0 114.48 175.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -152.82 147.92 26.59 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.954 1.302 . . . . 0.0 111.482 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -133.55 132.85 41.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.034 1.733 . . . . 0.0 110.699 168.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -145.77 157.0 43.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.836 2.054 . . . . 0.0 112.388 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 tt -149.2 133.64 17.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.808 1.643 . . . . 0.0 109.639 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -146.62 154.51 41.56 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.588 1.155 . . . . 0.0 112.429 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.0 mm -94.53 107.61 19.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.708 0.803 . . . . 0.0 109.121 168.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.51 147.28 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.907 1.283 . . . . 0.0 111.709 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -76.04 -18.86 59.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.76 0.824 . . . . 0.0 112.709 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -127.97 158.21 71.42 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 126.785 2.034 . . . . 0.0 108.879 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -61.92 122.27 10.71 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.212 1.941 . . . . 0.0 110.437 162.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.6 t -93.17 140.44 16.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.288 1.835 . . . . 0.0 108.952 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -73.9 139.21 44.81 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.685 -0.635 . . . . 0.0 110.645 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 m -141.54 147.21 22.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.695 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' A' ' 46' ' ' VAL . 41.9 m-85 -128.78 151.11 49.94 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.391 1.477 . . . . 0.0 110.879 -165.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -155.56 167.55 30.03 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.065 1.346 . . . . 0.0 110.343 168.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -150.42 159.86 44.17 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.54 -1.35 . . . . 0.0 112.973 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -113.86 138.83 49.77 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t -98.23 139.74 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.437 1.895 . . . . 0.0 111.127 -168.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -57.08 -63.99 1.03 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.725 1.21 . . . . 0.0 113.441 -173.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -112.0 -39.22 4.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -89.03 173.32 8.52 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.465 0.706 . . . . 0.0 110.52 174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -116.7 7.96 13.64 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.39 1.476 . . . . 0.0 113.536 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 p -134.86 162.33 32.7 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.87 1.668 . . . . 0.0 112.593 -167.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -157.27 -176.84 6.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.072 1.749 . . . . 0.0 109.993 170.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -131.25 137.42 48.87 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.447 1.099 . . . . 0.0 112.891 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.0 145.32 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 125.034 1.333 . . . . 0.0 112.597 -172.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.91 169.54 31.14 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.105 1.336 . . . . 0.0 115.154 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.74 -37.71 19.66 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.002 1.321 . . . . 0.0 112.988 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -94.91 15.0 19.79 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 63.84 35.13 11.27 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 158.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.33 135.85 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.767 1.227 . . . . 0.0 111.525 -167.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 56.1 tp -79.19 122.57 26.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.042 1.337 . . . . 0.0 113.623 -170.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.01 154.83 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.628 1.571 . . . . 0.0 111.627 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -100.38 146.72 26.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.268 1.027 . . . . 0.0 112.628 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.289 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 111.164 0.061 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 8.8 ttt -72.25 120.79 18.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.378 0.671 . . . . 0.0 111.189 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -120.66 108.83 14.49 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.818 1.247 . . . . 0.0 109.836 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -164.97 170.06 15.67 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -123.91 149.31 46.02 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.39 1.876 . . . . 0.0 111.134 171.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -65.66 158.51 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.378 -0.826 . . . . 0.0 112.172 176.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.83 148.43 7.56 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.883 0.873 . . . . 0.0 112.04 173.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.55 -10.6 43.7 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 116.358 1.303 . . . . 0.0 116.358 -171.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.8 m -62.07 125.86 25.34 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.863 2.332 . . . . 0.0 110.38 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mmt -77.88 148.34 34.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.452 1.101 . . . . 0.0 112.059 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.1 mm -128.09 136.54 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 127.348 2.259 . . . . 0.0 109.662 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.0 tp -81.8 134.66 35.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.356 1.074 . . . . 0.0 113.363 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.5 p -132.28 176.96 7.95 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.412 1.485 . . . . 0.0 111.534 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.73 -0.33 26.5 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.675 1.59 . . . . 0.0 114.664 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.4 p -124.46 -16.28 6.38 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.75 1.22 . . . . 0.0 113.375 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.52 -129.92 2.73 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 127.468 2.461 . . . . 0.0 110.683 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.8 151.75 24.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.137 1.375 . . . . 0.0 111.869 168.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.09 146.89 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 127.425 2.29 . . . . 0.0 108.532 169.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.17 45.77 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.679 -1.263 . . . . 0.0 112.154 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 tt -62.72 -28.74 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 120.69 -1.256 . . . . 0.0 113.109 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.47 -2.28 31.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.015 1.326 . . . . 0.0 114.495 171.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -118.23 -13.09 9.89 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.488 1.515 . . . . 0.0 112.821 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.56 134.93 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.119 0.968 . . . . 0.0 109.664 159.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -134.6 164.94 26.37 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.279 1.832 . . . . 0.0 110.96 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.67 134.08 41.71 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.646 -0.659 . . . . 0.0 111.324 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.68 -15.24 59.44 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.587 1.089 . . . . 0.0 115.692 -175.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -66.49 166.88 11.72 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.431 1.615 . . . . 0.0 111.241 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -118.23 148.19 42.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.24 1.416 . . . . 0.0 113.359 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.19 166.6 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 127.095 2.158 . . . . 0.0 111.123 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -79.86 146.67 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.163 0.585 . . . . 0.0 111.22 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.18 132.28 23.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.354 0.662 . . . . 0.0 109.889 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.6 m -86.33 109.19 18.81 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 163.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -53.24 117.08 10.75 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.577 1.151 . . . . 0.0 112.347 174.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -65.7 -14.33 44.19 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.537 2.158 . . . . 0.0 113.906 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -79.29 -36.28 39.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.487 1.515 . . . . 0.0 113.923 -173.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 t -140.89 0.83 1.62 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.264 1.426 . . . . 0.0 112.884 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.255 1.7 t80 63.17 27.41 15.63 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.744 1.617 . . . . 0.0 114.067 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -78.73 134.32 37.08 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.304 1.042 . . . . 0.0 110.519 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.5 t -94.53 136.63 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.264 0.626 . . . . 0.0 110.289 170.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.35 164.6 35.41 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.352 1.061 . . . . 0.0 112.35 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -87.6 126.85 35.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.327 1.051 . . . . 0.0 110.277 165.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -136.84 150.98 48.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.979 1.311 . . . . 0.0 112.942 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 t -82.27 157.98 23.67 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -91.98 132.61 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 127.137 2.175 . . . . 0.0 111.417 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 mt -87.68 -50.34 6.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.569 1.148 . . . . 0.0 112.754 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -143.81 157.22 44.53 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.159 2.183 . . . . 0.0 110.466 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p -119.38 118.55 31.46 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.025 1.73 . . . . 0.0 110.944 173.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -93.29 139.63 30.43 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 124.588 1.155 . . . . 0.0 113.084 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.469 HG22 ' CD2' ' A' ' 114' ' ' TYR . 18.4 t -137.97 130.8 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.752 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -135.3 175.81 9.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.203 2.201 . . . . 0.0 110.264 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -132.32 142.91 49.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.485 1.514 . . . . 0.0 110.746 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.3 t -152.97 155.33 36.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.832 0.853 . . . . 0.0 112.033 170.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.1 p -88.71 -16.23 32.8 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.733 2.013 . . . . 0.0 113.669 170.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -112.74 110.41 20.52 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.099 0.96 . . . . 0.0 110.339 -173.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 54.8 mt -110.07 173.36 6.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.475 1.11 . . . . 0.0 112.527 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.1 tp -135.28 132.28 37.58 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.128 1.771 . . . . 0.0 109.141 170.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -111.56 115.32 28.98 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.189 0.996 . . . . 0.0 109.245 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.8 mt -109.12 143.51 38.39 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.352 0.661 . . . . 0.0 109.862 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.7 m -118.18 120.86 38.99 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 167.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.6 mt -125.94 116.59 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.628 1.171 . . . . 0.0 109.44 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.74 21.69 37.31 Favored Glycine 0 CA--C 1.545 1.935 0 O-C-N 121.605 -0.684 . . . . 0.0 114.723 -173.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.3 -16.09 61.41 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.576 2.036 . . . . 0.0 115.603 -173.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -79.2 117.6 20.37 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.722 1.261 . . . . 0.0 109.174 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.1 t -75.57 130.04 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 122.974 0.51 . . . . 0.0 110.203 171.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.9 mt -129.86 102.9 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.768 1.627 . . . . 0.0 108.614 171.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -79.37 123.82 27.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.628 1.171 . . . . 0.0 110.581 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.0 t -141.31 174.76 10.24 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.083 1.353 . . . . 0.0 112.113 -167.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.1 p -81.28 145.97 30.65 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.428 -0.795 . . . . 0.0 111.203 165.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -54.74 -26.97 37.58 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.089 1.356 . . . . 0.0 113.334 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -102.9 2.48 35.29 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -62.57 133.06 94.65 Favored Pre-proline 0 CA--C 1.553 1.061 0 O-C-N 121.12 -0.988 . . . . 0.0 113.398 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.26 112.47 2.25 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.376 3.384 . . . . 0.0 114.844 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -101.18 148.46 25.07 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.679 1.992 . . . . 0.0 111.969 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -92.73 129.87 38.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.387 0.994 . . . . 0.0 113.452 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.4 t -108.25 135.57 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.918 2.487 . . . . 0.0 111.06 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.26 132.95 55.13 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.736 0.814 . . . . 0.0 111.127 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 66.62 3.51 2.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.085 1.754 . . . . 0.0 115.174 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -126.54 -63.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 120.967 -1.083 . . . . 0.0 110.556 -168.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.24 -150.63 18.13 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.647 0.641 . . . . 0.0 112.741 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -88.09 140.24 29.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.794 1.297 . . . . 0.0 113.968 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -145.32 145.9 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.751 1.621 . . . . 0.0 111.996 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -56.71 131.5 49.32 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.788 1.235 . . . . 0.0 112.405 171.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.92 -34.94 68.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.443 1.497 . . . . 0.0 113.672 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.39 -18.79 79.82 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 119.108 -0.829 . . . . 0.0 113.609 177.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -89.33 -3.52 58.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.366 1.467 . . . . 0.0 113.336 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.44 162.95 24.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.102 0.961 . . . . 0.0 112.236 166.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.35 159.8 30.9 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.044 1.738 . . . . 0.0 110.933 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.53 138.52 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.208 -0.932 . . . . 0.0 109.05 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.03 10.57 86.03 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 118.846 -0.974 . . . . 0.0 114.894 -171.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -78.68 155.48 29.44 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.47 1.635 . . . . 0.0 112.162 172.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.88 102.3 12.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.851 1.661 . . . . 0.0 111.163 -168.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.6 mt -97.23 179.55 4.86 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.037 0.935 . . . . 0.0 110.859 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.8 mt -131.55 159.83 37.03 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.164 -0.96 . . . . 0.0 113.49 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.0 p30 -118.59 -178.04 3.44 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -65.86 -0.88 2.48 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -102.35 -35.99 8.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.574 1.55 . . . . 0.0 110.874 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.48 17.35 11.44 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.966 1.745 . . . . 0.0 112.776 -170.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -92.37 148.88 21.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.311 1.055 . . . . 0.0 111.881 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.05 114.2 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 mt -88.05 158.4 18.61 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.0 1.32 . . . . 0.0 112.525 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.03 138.72 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.48 1.112 . . . . 0.0 111.705 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.2 t -77.63 121.86 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.867 0.867 . . . . 0.0 109.871 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -94.17 -29.97 14.85 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.913 2.085 . . . . 0.0 112.26 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -155.18 148.4 24.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.217 1.407 . . . . 0.0 112.2 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.1 tttm -132.85 115.85 15.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.402 1.881 . . . . 0.0 108.986 168.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.09 148.89 51.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.606 1.562 . . . . 0.0 112.169 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.2 tp -121.91 134.44 54.85 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.951 1.3 . . . . 0.0 110.197 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -139.57 150.78 45.45 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.723 0.809 . . . . 0.0 112.367 171.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.9 mm -108.19 111.61 36.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.754 1.222 . . . . 0.0 108.477 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.64 153.09 42.61 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 122.409 1.099 . . . . 0.0 113.531 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.66 -13.35 60.62 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.741 1.217 . . . . 0.0 113.419 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -155.27 160.13 31.14 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 128.302 2.641 . . . . 0.0 110.006 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.65 125.36 12.63 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.674 2.25 . . . . 0.0 111.433 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.43 139.92 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.983 2.113 . . . . 0.0 110.244 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -75.7 142.33 42.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.752 0.821 . . . . 0.0 112.644 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.28 139.17 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.115 1.366 . . . . 0.0 110.974 -177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.469 ' CD2' HG22 ' A' ' 46' ' ' VAL . 33.4 m-85 -118.52 153.03 34.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.708 2.003 . . . . 0.0 111.944 -171.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -153.65 171.31 19.01 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.868 2.067 . . . . 0.0 109.231 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -152.04 173.86 14.38 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.202 -1.561 . . . . 0.0 112.389 173.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -127.86 142.86 51.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.856 1.262 . . . . 0.0 113.239 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.2 140.64 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.767 1.627 . . . . 0.0 112.611 -164.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.23 -21.75 66.79 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -165.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.48 -63.63 0.98 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.811 0.732 . . . . 0.0 111.209 169.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -70.56 170.47 12.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.694 0.759 . . . . 0.0 111.854 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -113.55 18.89 17.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.724 1.61 . . . . 0.0 112.381 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.0 p -140.3 167.14 22.85 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.11 1.364 . . . . 0.0 112.252 -164.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -160.7 177.31 10.59 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.797 2.039 . . . . 0.0 109.496 167.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -121.39 132.47 54.77 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.226 1.01 . . . . 0.0 111.846 -173.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.9 m -118.06 146.44 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.481 1.512 . . . . 0.0 113.603 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.07 169.63 20.53 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.987 1.279 . . . . 0.0 115.196 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.02 -23.33 66.38 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.993 1.317 . . . . 0.0 112.885 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -89.77 2.1 55.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 114.232 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 63.85 36.33 10.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.375 1.47 . . . . 0.0 114.915 162.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.43 135.61 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.363 1.465 . . . . 0.0 111.886 -170.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.3 tp -78.54 125.25 29.1 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.215 1.406 . . . . 0.0 113.214 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.92 161.04 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.082 1.753 . . . . 0.0 111.591 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -112.0 149.06 32.53 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.012 1.325 . . . . 0.0 112.924 -171.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.9 m120 . . . . . 0 C--O 1.254 1.332 0 C-N-CA 125.939 1.695 . . . . 0.0 112.208 178.612 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 43.7 ttm -147.13 131.72 17.79 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.925 0.89 . . . . 0.0 112.135 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -106.13 103.01 12.39 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.536 1.534 . . . . 0.0 110.313 170.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -156.05 168.54 26.94 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.424 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.8 m-85 -122.63 153.95 38.65 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.455 1.502 . . . . 0.0 111.068 167.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.16 163.12 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.839 -0.538 . . . . 0.0 111.811 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.74 159.27 0.56 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.543 1.163 . . . . 0.0 113.298 172.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.07 -13.92 4.16 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 117.9 -1.5 . . . . 0.0 115.901 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.9 m -62.95 118.3 7.61 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.497 2.148 . . . . 0.0 110.955 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -79.22 142.31 36.36 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.208 1.403 . . . . 0.0 112.861 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.1 mm -130.7 137.26 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.082 2.153 . . . . 0.0 109.561 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.1 tp -83.56 137.46 33.83 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.368 1.08 . . . . 0.0 113.506 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.4 p -135.79 168.97 18.31 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.2 1.4 . . . . 0.0 111.461 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.58 -18.26 64.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 p -106.7 -28.9 9.9 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.078 1.351 . . . . 0.0 112.944 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.72 -130.42 2.12 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.041 -1.037 . . . . 0.0 112.904 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.58 148.96 29.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.543 1.137 . . . . 0.0 112.184 170.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.4 t -138.97 148.04 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.083 2.153 . . . . 0.0 108.362 172.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.38 149.9 38.52 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.983 -1.073 . . . . 0.0 111.514 172.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.5 tt -61.16 -23.81 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 O-C-N 120.826 -1.171 . . . . 0.0 113.479 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -70.46 -11.81 61.16 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.113 1.365 . . . . 0.0 114.329 172.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -122.88 -5.26 8.54 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.929 1.692 . . . . 0.0 113.909 -171.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 mm -67.0 137.17 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.014 -1.054 . . . . 0.0 109.077 161.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -134.77 161.2 35.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.719 1.208 . . . . 0.0 112.301 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.42 127.7 32.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.931 0.892 . . . . 0.0 111.718 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.54 -2.32 80.32 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.708 -1.051 . . . . 0.0 115.407 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.22 172.21 13.23 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.088 1.944 . . . . 0.0 111.168 164.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.62 150.04 40.37 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.049 1.74 . . . . 0.0 112.907 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.73 157.87 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 127.165 2.186 . . . . 0.0 109.843 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.8 mm -74.48 140.54 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 O-C-N 121.836 -0.54 . . . . 0.0 110.929 166.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.88 121.48 18.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.6 m -88.52 109.96 20.49 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -53.7 113.37 4.8 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.472 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.14 -9.7 26.0 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 121.991 1.794 . . . . 0.0 114.455 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -78.31 -40.07 37.82 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.998 -1.064 . . . . 0.0 112.158 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.9 t -132.7 -2.6 3.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.062 0.945 . . . . 0.0 112.756 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.293 20.6 m-85 56.9 35.6 26.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.167 1.787 . . . . 0.0 113.21 -176.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.83 126.51 31.07 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.053 1.341 . . . . 0.0 109.763 173.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t -102.31 113.04 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.777 0.831 . . . . 0.0 110.589 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.56 163.4 29.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.533 1.133 . . . . 0.0 113.031 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -95.93 119.34 34.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.522 1.529 . . . . 0.0 110.757 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -128.39 149.92 50.33 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.748 1.219 . . . . 0.0 111.664 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.2 t -86.36 154.85 20.9 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.8 t -93.14 130.28 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 126.303 1.841 . . . . 0.0 110.444 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.2 mt -89.39 -37.71 14.64 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.288 1.035 . . . . 0.0 113.317 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -153.73 161.39 42.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.283 2.233 . . . . 0.0 109.883 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.8 p -117.34 137.72 52.26 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.902 1.281 . . . . 0.0 111.07 165.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -105.7 142.3 35.67 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.984 1.314 . . . . 0.0 112.569 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.05 138.31 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.737 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 68.4 mmt-85 -142.24 176.42 8.99 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.719 2.008 . . . . 0.0 110.391 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -127.3 137.87 52.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.688 1.195 . . . . 0.0 110.421 167.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.8 t -146.45 148.03 31.84 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.473 1.109 . . . . 0.0 111.473 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -86.11 -20.15 29.12 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.976 1.31 . . . . 0.0 113.416 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -97.17 105.05 17.12 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.338 -0.851 . . . . 0.0 110.086 -169.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.5 mt -124.09 156.86 35.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 123.622 1.677 . . . . 0.0 113.9 -174.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.9 tp -138.44 126.37 22.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.381 -1.736 . . . . 0.0 111.412 -169.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -113.6 111.12 21.33 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.485 1.514 . . . . 0.0 108.723 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -106.6 125.18 50.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.387 1.075 . . . . 0.0 109.938 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 m -102.74 120.8 41.22 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.0 mt -133.01 116.41 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.928 1.291 . . . . 0.0 108.984 -171.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.94 24.44 34.44 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 115.191 0.836 . . . . 0.0 115.191 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.26 -6.36 68.6 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.576 1.56 . . . . 0.0 116.646 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -101.87 126.67 48.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.893 1.677 . . . . 0.0 109.238 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.4 p -97.33 133.02 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.841 0.829 . . . . 0.0 112.977 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.3 mt -126.8 133.79 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.761 2.024 . . . . 0.0 108.719 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -116.71 110.9 19.05 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.219 1.007 . . . . 0.0 110.658 -165.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.8 t -141.46 176.82 8.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.755 1.622 . . . . 0.0 113.272 -157.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.8 p -89.91 158.14 17.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.245 1.418 . . . . 0.0 113.01 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -65.82 -18.9 65.65 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.488 1.115 . . . . 0.0 113.649 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -101.11 -2.98 30.1 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.424 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.1 t60 -65.4 129.05 94.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.366 -1.302 . . . . 0.0 111.923 -172.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.67 120.89 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 CA-C-N 122.061 1.772 . . . . 0.0 113.691 -169.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.25 141.08 36.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.381 2.272 . . . . 0.0 112.093 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -84.77 127.31 34.06 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -112.41 134.51 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 127.671 2.389 . . . . 0.0 111.525 -174.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -56.27 127.23 29.81 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.107 1.363 . . . . 0.0 112.499 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 57.17 22.51 7.61 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.961 2.104 . . . . 0.0 115.03 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.3 t -133.97 -58.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.963 -1.086 . . . . 0.0 111.882 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.79 -152.23 17.16 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.02 0.819 . . . . 0.0 112.916 -173.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -91.14 132.57 35.98 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.804 1.302 . . . . 0.0 114.417 -170.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -137.78 141.53 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.183 1.393 . . . . 0.0 112.669 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.03 132.92 54.35 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.809 1.244 . . . . 0.0 112.901 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.59 66.59 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.81 1.644 . . . . 0.0 113.529 -173.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.36 -12.24 84.75 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 121.504 -0.747 . . . . 0.0 113.797 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -90.71 -20.71 22.14 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.121 0.961 . . . . 0.0 112.76 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.95 154.5 2.85 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.417 1.087 . . . . 0.0 112.856 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -117.48 149.53 40.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.066 1.347 . . . . 0.0 110.969 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.83 126.65 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.394 0.678 . . . . 0.0 110.049 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.91 1.4 58.56 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-O 118.501 -1.166 . . . . 0.0 115.326 -172.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -86.95 159.5 18.99 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.833 1.817 . . . . 0.0 112.25 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -104.03 108.36 19.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.161 1.384 . . . . 0.0 111.203 -157.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.49 169.05 8.9 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.696 1.598 . . . . 0.0 111.791 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.22 142.74 43.03 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.351 1.06 . . . . 0.0 111.409 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.02 176.85 6.26 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.65 0.78 . . . . 0.0 112.995 166.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.1 p -52.17 -24.88 7.8 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -97.72 -31.59 12.18 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.888 1.275 . . . . 0.0 111.764 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.38 22.55 5.12 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.884 2.183 . . . . 0.0 113.435 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -64.21 147.26 52.76 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.319 1.059 . . . . 0.0 110.786 167.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.84 110.24 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.924 0.869 . . . . 0.0 110.741 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.5 mt -94.05 160.68 14.6 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.67 1.988 . . . . 0.0 111.289 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.22 141.84 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.64 1.176 . . . . 0.0 110.632 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.3 t -74.13 115.95 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.574 0.749 . . . . 0.0 109.485 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -90.12 -28.35 19.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.011 2.124 . . . . 0.0 112.732 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -160.71 151.74 18.85 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.42 1.488 . . . . 0.0 111.635 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -131.57 111.34 11.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.522 2.329 . . . . 0.0 109.127 171.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.6 mmtm -117.32 125.92 51.85 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.104 1.761 . . . . 0.0 110.94 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 tp -120.0 133.01 55.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.751 1.62 . . . . 0.0 109.941 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -149.21 161.62 41.64 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.3 mm -110.0 107.02 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.112 1.365 . . . . 0.0 108.521 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.02 150.31 42.77 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.253 1.021 . . . . 0.0 113.604 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.77 -26.81 67.89 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.144 1.778 . . . . 0.0 112.321 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -142.68 151.22 56.47 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.943 2.497 . . . . 0.0 108.287 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.27 121.76 8.08 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.415 2.077 . . . . 0.0 110.288 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.03 143.91 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.127 1.771 . . . . 0.0 110.15 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -74.54 139.4 43.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.283 0.633 . . . . 0.0 110.225 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.02 147.12 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 124.526 1.13 . . . . 0.0 111.268 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -128.46 148.0 50.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.683 1.593 . . . . 0.0 110.846 -164.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -150.48 170.96 17.86 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.507 1.523 . . . . 0.0 109.89 167.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -152.27 158.02 42.2 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.532 -1.355 . . . . 0.0 111.515 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -113.49 135.65 53.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.008 0.923 . . . . 0.0 112.969 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.4 t -98.89 147.92 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.3 1.84 . . . . 0.0 111.739 -170.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.94 -39.14 91.08 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -141.61 -45.33 0.36 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.993 0.917 . . . . 0.0 112.661 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -77.55 172.01 14.02 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.435 0.694 . . . . 0.0 109.207 164.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -134.53 30.72 3.47 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.684 1.193 . . . . 0.0 111.934 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.5 p -141.36 158.06 44.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.672 1.589 . . . . 0.0 112.135 -171.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.91 170.34 22.35 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.058 1.343 . . . . 0.0 111.852 171.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.76 140.08 29.89 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.439 1.895 . . . . 0.0 110.508 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 m -125.29 136.74 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.5 1.12 . . . . 0.0 112.99 166.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.3 173.3 35.99 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.029 1.3 . . . . 0.0 115.694 169.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -57.15 -37.86 72.67 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.195 -1.179 . . . . 0.0 112.023 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -85.33 9.47 15.33 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.663 1.585 . . . . 0.0 114.867 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 62.65 36.36 13.59 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 165.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.68 138.04 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 121.591 -0.693 . . . . 0.0 111.091 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.9 tp -87.78 128.54 35.32 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.897 1.279 . . . . 0.0 113.143 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.5 m -135.43 151.27 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.201 1.401 . . . . 0.0 112.213 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -93.75 116.5 28.98 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.97 1.708 . . . . 0.0 110.257 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.631 1.172 . . . . 0.0 113.864 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 3.2 ttt -87.25 121.54 29.83 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.374 -0.829 . . . . 0.0 109.836 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -136.51 62.7 1.6 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.778 1.631 . . . . 0.0 110.363 -164.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -133.34 170.71 15.06 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.053 0.941 . . . . 0.0 113.24 -171.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -121.83 156.3 33.54 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.285 1.434 . . . . 0.0 110.667 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.3 m -67.7 159.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.715 0.769 . . . . 0.0 111.458 171.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.38 154.63 1.7 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.572 0.749 . . . . 0.0 112.77 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.42 -2.32 22.21 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 117.768 -1.573 . . . . 0.0 116.263 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 58.3 m -64.58 124.61 22.3 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.305 2.052 . . . . 0.0 110.057 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.5 mmt -83.07 139.48 33.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.974 1.31 . . . . 0.0 111.951 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.6 mm -123.26 134.39 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.387 1.875 . . . . 0.0 110.174 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -75.42 121.51 22.41 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.137 0.975 . . . . 0.0 112.668 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.6 p -112.38 177.33 4.68 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.919 1.288 . . . . 0.0 112.001 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.68 -23.47 65.3 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.207 -0.933 . . . . 0.0 113.276 171.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -106.92 -18.81 13.82 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.958 1.303 . . . . 0.0 114.385 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 159.26 -114.45 0.61 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.987 1.279 . . . . 0.0 113.008 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -129.0 140.96 51.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.2 1.0 . . . . 0.0 113.294 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.2 t -133.45 143.74 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.333 1.853 . . . . 0.0 108.577 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.43 147.96 47.37 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.324 -0.86 . . . . 0.0 110.881 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 tt -61.72 -27.57 42.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 120.796 -1.19 . . . . 0.0 112.998 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.19 -13.19 61.48 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -112.17 -11.37 13.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.797 2.039 . . . . 0.0 113.153 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.9 mm -64.25 135.85 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.665 0.786 . . . . 0.0 109.261 162.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -125.05 164.85 19.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.489 1.916 . . . . 0.0 111.193 173.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.35 136.65 58.03 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.731 -0.605 . . . . 0.0 110.614 167.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.36 -9.29 75.96 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.482 1.039 . . . . 0.0 114.537 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.78 174.36 6.13 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.771 1.285 . . . . 0.0 111.288 168.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -131.39 142.35 50.03 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.713 1.205 . . . . 0.0 113.238 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.49 157.71 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.854 2.061 . . . . 0.0 110.757 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.6 mm -76.92 137.01 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.586 -0.696 . . . . 0.0 111.519 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -134.64 118.92 17.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.789 1.236 . . . . 0.0 108.157 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -89.91 107.45 19.12 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -55.91 113.99 6.72 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.895 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.56 -5.29 16.36 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.125 1.883 . . . . 0.0 114.109 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.16 -38.52 75.48 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.916 -1.115 . . . . 0.0 112.563 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -144.12 -2.11 0.92 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.949 0.9 . . . . 0.0 112.852 -171.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 55.5 44.83 26.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.62 1.168 . . . . 0.0 112.284 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -90.8 139.53 30.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.768 0.827 . . . . 0.0 109.832 167.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.33 124.26 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.749 0.82 . . . . 0.0 110.319 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.61 153.77 48.66 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.782 0.801 . . . . 0.0 112.538 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.67 115.4 23.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.424 1.49 . . . . 0.0 108.674 169.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -126.53 149.15 49.56 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.893 1.277 . . . . 0.0 110.81 -172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -90.62 157.84 17.27 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -174.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.3 t -89.25 128.61 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.562 1.545 . . . . 0.0 110.645 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.19 -51.43 7.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.359 0.664 . . . . 0.0 111.804 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -146.18 149.97 34.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.39 1.876 . . . . 0.0 109.462 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.4 p -118.65 126.7 52.52 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.049 1.34 . . . . 0.0 110.177 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -105.9 160.38 15.31 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.155 1.382 . . . . 0.0 113.077 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.1 t -134.36 143.91 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.304 2.242 . . . . 0.0 109.302 171.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -137.19 170.84 15.42 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.916 1.687 . . . . 0.0 109.825 166.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -117.68 143.13 46.47 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.424 1.09 . . . . 0.0 110.522 164.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.3 t -148.11 146.26 28.72 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.74 -0.6 . . . . 0.0 111.264 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.1 p -87.72 -18.13 30.16 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.374 0.67 . . . . 0.0 112.617 162.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HG2' HD12 ' A' ' 106' ' ' ILE . 56.6 mt-10 -93.86 114.19 26.37 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.863 -1.148 . . . . 0.0 111.551 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.1 mt -121.46 171.28 8.9 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.847 1.259 . . . . 0.0 111.63 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.5 tp -145.6 131.18 18.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.518 1.527 . . . . 0.0 110.146 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -106.36 137.46 44.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.274 1.03 . . . . 0.0 109.43 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 mt -129.61 135.13 48.17 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.909 1.284 . . . . 0.0 110.089 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.5 m -104.13 119.97 40.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.91 0.884 . . . . 0.0 109.476 173.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.56 116.29 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.183 1.393 . . . . 0.0 108.781 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.78 35.74 47.75 Favored Glycine 0 CA--C 1.542 1.729 0 O-C-N 121.477 -0.765 . . . . 0.0 114.863 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.38 -14.04 55.9 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.294 1.426 . . . . 0.0 115.507 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -90.91 117.94 29.9 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.805 1.302 . . . . 0.0 109.258 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.46 133.76 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.826 0.85 . . . . 0.0 111.972 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.7 mt -129.01 134.66 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.473 1.909 . . . . 0.0 108.798 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -117.34 112.82 21.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.538 1.535 . . . . 0.0 110.98 -168.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -140.47 178.45 7.3 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.759 1.224 . . . . 0.0 112.302 -159.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.0 p -84.54 152.4 23.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.175 0.988 . . . . 0.0 111.878 170.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.98 -20.47 65.31 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.734 1.213 . . . . 0.0 113.41 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -109.61 11.88 24.53 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.407 1.083 . . . . 0.0 113.529 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -67.2 130.3 93.68 Favored Pre-proline 0 CA--C 1.551 1.012 0 O-C-N 120.89 -1.131 . . . . 0.0 112.414 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.84 127.49 5.54 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.515 2.81 . . . . 0.0 114.759 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -118.29 141.48 48.47 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.18 2.192 . . . . 0.0 110.952 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.405 ' CE2' ' HA2' ' A' ' 76' ' ' GLY . 47.9 t80 -93.36 129.93 39.3 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.735 1.152 . . . . 0.0 114.034 -176.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.7 t -109.44 133.53 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.995 2.118 . . . . 0.0 111.739 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -51.08 123.69 9.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.641 1.576 . . . . 0.0 113.917 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 54.37 23.55 4.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.388 1.875 . . . . 0.0 114.34 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.7 t -130.19 -54.91 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.951 1.3 . . . . 0.0 110.928 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 71' ' ' TYR . . . 119.94 -165.82 13.53 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.571 0.605 . . . . 0.0 114.047 -175.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -81.41 140.88 34.42 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.385 1.088 . . . . 0.0 113.864 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.19 147.95 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 127.503 2.321 . . . . 0.0 109.475 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -66.86 144.08 56.48 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.529 -0.732 . . . . 0.0 112.176 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.33 -40.22 64.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.811 1.244 . . . . 0.0 113.39 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.43 -20.46 67.7 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.307 -0.87 . . . . 0.0 114.177 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -103.85 0.96 30.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.096 2.158 . . . . 0.0 113.254 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.1 mt -72.97 161.84 30.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.198 0.599 . . . . 0.0 111.365 168.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.1 162.62 29.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.888 1.275 . . . . 0.0 111.545 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -63.61 140.48 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.384 1.073 . . . . 0.0 109.611 170.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.78 4.15 89.35 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.188 -0.784 . . . . 0.0 114.439 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -80.82 152.07 28.41 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.126 1.463 . . . . 0.0 110.824 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.2 108.43 19.81 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.762 1.625 . . . . 0.0 113.483 -165.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.4 mt -103.79 164.12 11.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.162 1.385 . . . . 0.0 112.524 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.75 144.96 34.15 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.637 1.175 . . . . 0.0 111.507 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -102.07 -177.25 3.35 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.063 0.945 . . . . 0.0 113.489 169.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.6 p -54.44 -23.48 16.14 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.793 2.037 . . . . 0.0 115.733 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -104.71 -20.76 13.52 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.588 1.555 . . . . 0.0 113.274 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.29 27.42 10.02 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.336 1.922 . . . . 0.0 112.863 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -66.38 149.54 50.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.608 0.363 . . . . 0.0 110.416 162.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.1 99.26 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 124.217 1.007 . . . . 0.0 110.303 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -80.31 161.31 25.13 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.188 2.595 . . . . 0.0 112.238 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.62 139.64 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.358 1.063 . . . . 0.0 111.719 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.18 127.73 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.29 1.036 . . . . 0.0 110.925 170.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -97.85 -32.47 11.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.891 2.076 . . . . 0.0 113.357 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -161.5 150.72 16.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.05 0.94 . . . . 0.0 113.013 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -123.13 128.22 49.77 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.438 1.895 . . . . 0.0 109.526 162.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm -127.29 124.69 39.37 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.374 1.469 . . . . 0.0 110.777 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 tt -121.35 135.54 55.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.756 1.222 . . . . 0.0 110.33 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -141.71 171.11 14.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.36 1.064 . . . . 0.0 111.403 168.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.428 HD12 ' HG2' ' A' ' 51' ' ' GLU . 15.7 mm -116.97 115.08 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 162.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.66 148.72 19.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.626 1.17 . . . . 0.0 112.197 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -72.62 -24.69 61.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.913 0.885 . . . . 0.0 111.827 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -143.0 152.93 59.78 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.946 2.099 . . . . 0.0 109.517 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.74 123.26 11.7 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.276 2.65 . . . . 0.0 113.188 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.4 t -92.0 143.67 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.459 1.504 . . . . 0.0 110.291 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -76.82 141.87 40.51 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.514 0.673 . . . . 0.0 111.537 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.08 148.44 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.921 1.288 . . . . 0.0 110.368 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -127.74 144.75 51.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.912 1.285 . . . . 0.0 111.856 -169.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -152.18 161.56 42.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.431 1.092 . . . . 0.0 111.252 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -148.02 159.38 43.96 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.797 -1.19 . . . . 0.0 113.508 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -108.89 138.02 45.9 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.73 1.212 . . . . 0.0 113.534 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.49 145.9 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 126.009 1.724 . . . . 0.0 112.474 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.38 -24.18 65.66 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 -167.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -148.6 -49.93 0.16 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.922 1.692 . . . . 0.0 112.067 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -73.07 167.33 21.35 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.63 0.772 . . . . 0.0 110.54 168.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -123.91 24.08 8.42 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.301 1.44 . . . . 0.0 113.937 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 p -135.97 158.07 45.3 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.971 1.708 . . . . 0.0 113.063 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -160.89 -176.01 5.27 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.88 1.672 . . . . 0.0 110.709 171.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -128.59 138.95 52.48 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.361 1.464 . . . . 0.0 113.582 -169.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.32 142.08 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.268 1.427 . . . . 0.0 113.379 -173.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.83 173.22 27.41 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.571 1.558 . . . . 0.0 116.198 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.24 -23.93 67.48 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.736 -1.45 . . . . 0.0 113.917 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -88.99 0.87 56.29 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 58.61 45.75 15.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.17 1.788 . . . . 0.0 114.648 168.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 t -72.43 137.54 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.547 1.539 . . . . 0.0 111.71 -170.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 64.6 tp -79.66 125.26 29.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.681 1.592 . . . . 0.0 113.391 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.52 157.92 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.968 1.707 . . . . 0.0 111.377 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.99 145.5 32.21 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.902 1.281 . . . . 0.0 111.437 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 10.7 ttt -130.32 130.79 44.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.261 1.024 . . . . 0.0 111.585 -169.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -127.3 103.75 7.56 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.777 0.831 . . . . 0.0 112.969 -172.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -163.1 178.4 8.31 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -124.87 157.36 36.11 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.922 1.689 . . . . 0.0 110.493 166.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.1 m -66.23 156.81 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.332 0.587 . . . . 0.0 112.076 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.29 150.49 1.25 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.165 0.986 . . . . 0.0 111.821 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.52 -3.95 22.74 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.5 m -65.51 125.05 23.95 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 120.976 2.388 . . . . 0.0 109.864 171.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mmt -78.99 143.6 35.56 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.233 1.013 . . . . 0.0 111.954 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.31 135.09 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.411 1.884 . . . . 0.0 109.829 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.1 tp -74.26 122.09 22.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.796 0.838 . . . . 0.0 112.12 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.0 p -117.23 171.32 8.03 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.307 1.043 . . . . 0.0 111.736 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.8 -17.55 64.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.817 0.847 . . . . 0.0 113.175 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 p -105.81 -20.3 13.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.992 2.117 . . . . 0.0 113.827 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.06 -105.57 0.27 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.116 1.341 . . . . 0.0 113.06 174.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.8 mt -132.94 140.76 47.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.779 1.632 . . . . 0.0 111.965 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.1 t -135.05 145.6 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.485 1.914 . . . . 0.0 108.543 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.97 147.43 52.45 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.206 -0.934 . . . . 0.0 111.388 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.1 tt -60.32 -29.91 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 120.712 -1.242 . . . . 0.0 112.827 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.29 -17.97 64.41 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -107.72 -10.38 15.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.694 1.998 . . . . 0.0 112.919 -174.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.7 136.74 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.976 161.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -126.29 162.16 26.12 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.939 2.096 . . . . 0.0 111.301 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.94 130.33 43.01 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.435 0.694 . . . . 0.0 110.432 168.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.36 16.94 65.5 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 121.833 -0.542 . . . . 0.0 113.902 -170.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -96.43 -179.63 4.7 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.155 0.982 . . . . 0.0 110.603 157.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -128.71 145.83 51.06 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.706 1.603 . . . . 0.0 112.341 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.89 158.67 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.037 1.735 . . . . 0.0 110.526 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -76.44 141.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.65 -0.656 . . . . 0.0 111.547 167.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.62 128.04 24.53 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.001 0.92 . . . . 0.0 109.163 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.0 m -79.44 112.76 17.01 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 160.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -52.66 114.83 6.2 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 118.169 -0.92 . . . . 0.0 111.235 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.14 -13.18 36.28 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.982 2.455 . . . . 0.0 113.738 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -84.67 -37.26 21.21 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -172.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -133.39 -6.1 2.95 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.408 1.483 . . . . 0.0 112.922 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.252 15.2 m-85 66.39 30.53 8.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.33 1.852 . . . . 0.0 115.009 -175.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -79.43 130.8 35.77 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.611 1.165 . . . . 0.0 110.155 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.8 128.65 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.889 0.768 . . . . 0.0 110.815 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.95 167.16 28.44 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.316 1.047 . . . . 0.0 112.811 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -78.87 139.7 38.27 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.515 1.126 . . . . 0.0 110.413 163.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -142.48 154.94 44.97 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.493 1.517 . . . . 0.0 110.61 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.8 t -85.35 156.77 20.75 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.79 123.95 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.453 1.901 . . . . 0.0 110.367 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.91 -44.48 16.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.379 0.672 . . . . 0.0 112.736 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -146.14 154.31 41.66 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.486 1.915 . . . . 0.0 110.572 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.7 p -122.22 128.7 51.47 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.949 1.3 . . . . 0.0 111.274 172.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -108.1 149.01 29.03 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.33 1.852 . . . . 0.0 114.38 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 114' ' ' TYR . 45.1 t -139.8 140.51 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.375 1.07 . . . . 0.0 112.428 177.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -138.52 179.83 6.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.58 2.752 . . . . 0.0 112.209 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -131.61 148.35 52.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.636 1.574 . . . . 0.0 112.431 167.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.6 t -152.74 149.24 28.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.423 1.089 . . . . 0.0 111.557 170.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 p -86.36 -17.16 35.18 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.335 1.054 . . . . 0.0 113.3 164.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HG2' HD12 ' A' ' 106' ' ' ILE . 52.7 mt-10 -105.36 116.17 31.5 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.353 1.061 . . . . 0.0 110.798 -176.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.3 mt -117.8 170.7 8.59 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.651 1.58 . . . . 0.0 112.218 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.7 tp -141.38 134.7 29.57 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.958 1.703 . . . . 0.0 110.062 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -114.75 120.54 40.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.395 1.078 . . . . 0.0 110.067 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.94 130.37 55.45 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.189 -0.945 . . . . 0.0 109.808 173.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.8 m -104.43 118.55 36.89 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.271 1.028 . . . . 0.0 108.582 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mt -132.02 119.81 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.59 1.556 . . . . 0.0 109.136 -173.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.35 25.11 47.85 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 115.19 0.836 . . . . 0.0 115.19 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.7 -5.39 84.67 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.893 1.711 . . . . 0.0 116.068 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -91.93 132.02 36.81 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.206 1.503 . . . . 0.0 109.483 166.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.82 138.45 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.951 0.9 . . . . 0.0 112.28 163.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.2 mt -132.8 136.12 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 126.126 1.771 . . . . 0.0 109.345 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -117.23 110.39 18.06 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.088 1.355 . . . . 0.0 110.445 -162.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.2 t -138.05 177.13 8.11 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.708 1.203 . . . . 0.0 113.165 -156.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.2 p -86.58 156.5 20.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.74 0.816 . . . . 0.0 111.952 169.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -63.85 -24.69 67.84 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.354 -0.842 . . . . 0.0 113.249 -174.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -99.63 3.63 45.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -60.78 121.3 60.44 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 118.004 -0.998 . . . . 0.0 112.503 -174.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -78.82 115.08 3.52 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.005 1.803 . . . . 0.0 113.056 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -95.67 146.42 24.51 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.903 1.681 . . . . 0.0 110.797 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -91.37 129.99 37.28 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.5 132.27 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 127.93 2.492 . . . . 0.0 110.731 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -54.49 122.29 10.2 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.261 1.424 . . . . 0.0 111.722 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 t70 53.87 26.7 6.41 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.754 2.422 . . . . 0.0 115.751 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.9 t -129.12 -54.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.939 1.296 . . . . 0.0 110.356 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.02 -155.37 19.77 Favored Glycine 0 N--CA 1.467 0.749 0 CA-C-O 119.499 -0.612 . . . . 0.0 112.027 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -96.57 150.74 20.3 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.053 1.426 . . . . 0.0 114.15 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.78 141.42 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.905 1.682 . . . . 0.0 111.786 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.52 134.91 46.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.61 0.764 . . . . 0.0 112.859 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.05 -37.13 66.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.822 1.249 . . . . 0.0 113.095 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.88 -19.93 72.03 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 121.418 -0.802 . . . . 0.0 113.935 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -97.61 -1.26 44.15 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.836 1.654 . . . . 0.0 114.218 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.26 159.15 29.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.46 0.704 . . . . 0.0 112.377 174.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -118.97 153.2 35.01 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.556 1.542 . . . . 0.0 110.989 171.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.4 t -64.86 136.42 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 170.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.75 87.84 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.387 -1.23 . . . . 0.0 115.576 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -84.09 158.2 21.49 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.423 1.612 . . . . 0.0 111.78 174.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.75 106.79 18.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.557 1.543 . . . . 0.0 112.325 -163.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.5 mt -98.13 -176.79 3.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.683 1.593 . . . . 0.0 111.068 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.6 mt -132.9 154.11 50.72 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -106.33 177.47 4.85 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 122.886 1.327 . . . . 0.0 114.486 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.6 p -56.79 -6.01 0.29 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.384 2.674 . . . . 0.0 117.318 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -119.17 -18.11 8.76 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.157 1.783 . . . . 0.0 112.221 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.73 18.83 19.48 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.439 1.495 . . . . 0.0 112.885 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -72.65 143.1 48.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.967 0.907 . . . . 0.0 110.457 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.91 114.57 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.195 0.522 . . . . 0.0 110.786 171.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 mt -91.5 157.89 16.78 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.481 1.112 . . . . 0.0 111.188 167.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.0 t -130.98 139.04 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.316 1.046 . . . . 0.0 110.393 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.96 116.38 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 173.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -79.15 -41.38 28.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.72 1.608 . . . . 0.0 110.84 174.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -159.85 153.58 22.8 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.647 1.179 . . . . 0.0 112.186 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -113.57 134.44 54.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.404 1.482 . . . . 0.0 109.484 159.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -131.45 161.34 32.72 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 128.578 2.751 . . . . 0.0 110.476 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 tt -146.78 139.42 25.08 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.676 1.191 . . . . 0.0 109.927 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -137.51 150.45 47.54 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.043 0.838 . . . . 0.0 112.329 168.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.403 HD12 ' HG2' ' A' ' 51' ' ' GLU . 5.7 mm -103.41 116.23 46.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.48 145.16 51.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.861 1.264 . . . . 0.0 111.551 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -74.96 -20.5 59.65 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.412 -0.805 . . . . 0.0 112.249 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -140.41 155.86 69.82 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.629 1.972 . . . . 0.0 110.977 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.32 124.74 15.79 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.89 2.393 . . . . 0.0 113.079 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 t -93.95 141.62 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.226 1.811 . . . . 0.0 109.628 172.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -76.22 141.95 41.6 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.553 0.692 . . . . 0.0 111.78 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.82 146.61 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.892 1.277 . . . . 0.0 110.829 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.402 ' CD2' HG22 ' A' ' 46' ' ' VAL . 61.2 m-85 -129.05 150.42 50.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.017 1.327 . . . . 0.0 111.331 -166.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -156.81 169.36 24.92 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.08 1.752 . . . . 0.0 109.548 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -156.09 169.59 24.14 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.346 -1.471 . . . . 0.0 111.947 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -123.84 142.34 51.21 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -100.33 151.71 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.018 1.727 . . . . 0.0 112.893 -170.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.4 -27.86 69.59 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -169.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.12 -34.86 0.09 Allowed 'General case' 0 N--CA 1.484 1.229 0 O-C-N 120.212 -1.555 . . . . 0.0 113.638 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -77.67 164.65 25.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 164.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -123.34 33.56 5.33 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.458 1.103 . . . . 0.0 111.959 -174.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.6 p -150.14 162.31 40.68 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.464 1.506 . . . . 0.0 111.775 -164.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -156.81 174.84 14.89 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.494 1.518 . . . . 0.0 110.612 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -118.94 134.96 54.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.624 1.17 . . . . 0.0 112.432 -176.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.71 137.72 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.677 1.591 . . . . 0.0 112.226 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.81 -172.03 45.66 Favored Glycine 0 CA--C 1.544 1.857 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 170.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -84.93 -22.49 29.22 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.719 1.208 . . . . 0.0 112.155 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -84.22 -9.19 58.73 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.633 1.173 . . . . 0.0 113.382 165.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 60.56 50.74 5.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.529 1.532 . . . . 0.0 113.578 165.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.29 144.66 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.883 1.673 . . . . 0.0 112.078 -173.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.2 tp -84.98 129.46 34.79 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.621 1.568 . . . . 0.0 114.703 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.2 m -138.53 158.19 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 126.403 1.881 . . . . 0.0 112.268 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -117.75 123.3 45.69 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.939 1.295 . . . . 0.0 114.184 -169.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.188 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -174.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.224 0.535 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 9.2 ttt -154.51 114.67 3.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.258 1.823 . . . . 0.0 107.381 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -131.25 77.29 1.77 Allowed 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.292 -0.88 . . . . 0.0 111.073 -162.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -141.29 174.31 10.66 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.733 1.213 . . . . 0.0 113.455 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.449 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 96.7 m-85 -125.42 153.28 43.69 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.437 1.495 . . . . 0.0 111.668 172.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 m -68.36 159.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.358 0.599 . . . . 0.0 111.928 173.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.04 152.17 6.14 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.082 0.953 . . . . 0.0 112.487 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.14 -7.11 24.61 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 117.712 -1.605 . . . . 0.0 116.238 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.1 m -61.82 121.88 14.0 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.379 2.089 . . . . 0.0 110.474 174.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 mmt -77.2 142.54 39.55 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.69 1.196 . . . . 0.0 112.329 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 mm -121.8 137.07 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.416 2.286 . . . . 0.0 109.494 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.66 127.13 32.37 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 p -127.15 171.1 11.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.834 1.253 . . . . 0.0 112.039 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.48 -19.3 65.48 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.3 p -103.26 -24.56 13.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.2 -107.9 0.32 Allowed Glycine 0 CA--C 1.522 0.488 0 O-C-N 121.663 -0.648 . . . . 0.0 112.002 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.58 140.04 45.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.961 1.304 . . . . 0.0 111.535 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.5 t -127.19 141.51 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.205 1.402 . . . . 0.0 109.019 172.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.13 147.67 49.65 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.268 -0.895 . . . . 0.0 110.922 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.6 tt -61.03 -26.57 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.025 -1.047 . . . . 0.0 113.351 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -74.68 -7.09 52.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.496 1.518 . . . . 0.0 114.341 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -117.39 -12.3 10.46 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.902 1.681 . . . . 0.0 112.652 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.7 mm -65.15 132.73 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 119.147 0.885 . . . . 0.0 110.36 164.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -119.21 161.74 19.86 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.431 1.892 . . . . 0.0 111.679 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.65 138.54 58.06 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.09 -1.006 . . . . 0.0 110.63 167.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.95 4.89 89.69 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 114.536 0.574 . . . . 0.0 114.536 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -86.18 157.07 20.08 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.523 1.161 . . . . 0.0 109.84 162.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -116.8 141.24 48.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.75 1.22 . . . . 0.0 111.319 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.95 159.47 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.934 1.694 . . . . 0.0 111.465 -177.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 mm -71.64 143.86 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 122.797 0.439 . . . . 0.0 111.96 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.28 126.25 18.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.78 1.232 . . . . 0.0 109.251 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.8 m -84.53 111.67 19.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 165.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -56.03 114.64 7.91 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.789 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.18 -8.16 22.85 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.6 2.2 . . . . 0.0 113.94 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -79.49 -39.64 31.63 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.017 -1.052 . . . . 0.0 113.616 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -138.08 -1.29 1.98 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.323 1.049 . . . . 0.0 113.278 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 58.73 40.04 23.61 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.679 1.192 . . . . 0.0 113.407 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.06 138.82 33.57 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.542 0.737 . . . . 0.0 109.029 165.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -109.11 121.93 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.995 1.318 . . . . 0.0 109.169 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.34 162.79 33.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.456 0.703 . . . . 0.0 112.673 -176.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -93.51 124.66 37.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.797 1.239 . . . . 0.0 109.307 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -132.67 152.67 51.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.416 1.487 . . . . 0.0 111.194 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 t -85.57 152.98 22.73 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.9 t -89.1 130.55 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.98 1.712 . . . . 0.0 110.279 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.6 mt -92.71 -40.76 10.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.811 0.845 . . . . 0.0 112.384 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -143.93 152.52 41.21 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.338 1.455 . . . . 0.0 111.247 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.5 p -124.47 124.66 42.78 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.197 2.199 . . . . 0.0 109.073 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -116.63 159.91 21.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.17 1.788 . . . . 0.0 114.412 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 114' ' ' TYR . 21.8 t -143.63 144.56 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 125.849 1.66 . . . . 0.0 111.426 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -142.49 178.77 7.37 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.024 2.13 . . . . 0.0 112.053 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -131.47 145.23 51.68 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.081 2.152 . . . . 0.0 112.306 173.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -154.72 152.52 30.0 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.967 0.907 . . . . 0.0 111.148 169.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 p -86.9 -14.55 41.6 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 163.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -101.54 105.53 16.51 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.073 0.851 . . . . 0.0 110.201 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.5 mt -123.49 162.32 23.1 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.85 1.31 . . . . 0.0 113.67 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.3 tp -126.29 131.21 51.92 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 113.846 -1.524 . . . . 0.0 110.811 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -101.98 134.1 45.72 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.244 1.417 . . . . 0.0 109.442 165.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 mt -126.28 126.59 44.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.874 0.869 . . . . 0.0 109.064 163.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.1 m -93.17 120.35 33.36 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 167.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.4 117.09 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.949 1.3 . . . . 0.0 108.92 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 50.54 38.18 34.75 Favored Glycine 0 CA--C 1.544 1.876 0 N-CA-C 115.186 0.835 . . . . 0.0 115.186 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.73 -0.56 89.18 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 121.297 -1.119 . . . . 0.0 115.701 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -109.06 120.97 44.12 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.326 1.563 . . . . 0.0 110.442 172.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 p -88.48 128.36 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.803 0.811 . . . . 0.0 111.555 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.4 mt -118.09 128.3 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.689 1.596 . . . . 0.0 108.375 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -108.03 110.99 22.82 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.507 1.523 . . . . 0.0 110.27 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 t -139.7 176.14 8.98 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.223 1.009 . . . . 0.0 112.473 -161.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.3 p -82.08 152.28 26.65 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.177 0.989 . . . . 0.0 112.349 171.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -65.96 -19.97 66.04 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 121.188 -0.945 . . . . 0.0 113.27 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.337 3.5 p-10 -110.6 17.44 20.7 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 175.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.449 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 3.2 t60 -66.11 132.72 94.59 Favored Pre-proline 0 CA--C 1.555 1.155 0 O-C-N 121.071 -1.018 . . . . 0.0 113.665 176.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.11 118.84 3.05 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.279 3.319 . . . . 0.0 115.096 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -116.89 140.51 49.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.872 2.069 . . . . 0.0 112.216 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -84.2 127.46 33.96 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.049 1.295 . . . . 0.0 114.05 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.91 134.82 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 127.989 2.516 . . . . 0.0 111.355 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -52.24 126.92 20.37 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.919 1.688 . . . . 0.0 111.717 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 57.31 19.42 5.02 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.993 1.717 . . . . 0.0 115.488 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.8 t -130.31 -58.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.893 0.877 . . . . 0.0 111.12 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.32 -159.47 15.88 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 123.643 0.64 . . . . 0.0 113.43 -171.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -81.06 142.49 33.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 p -141.26 152.19 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 126.622 1.969 . . . . 0.0 110.884 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.73 129.45 39.8 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.947 0.899 . . . . 0.0 111.868 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.63 -36.67 69.73 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.546 1.138 . . . . 0.0 113.343 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.62 -5.08 88.17 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.909 -1.119 . . . . 0.0 114.134 177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -101.89 -2.19 30.42 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.871 1.335 . . . . 0.0 113.319 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.55 161.15 31.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.011 1.324 . . . . 0.0 112.631 167.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.44 164.78 18.24 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.04 2.136 . . . . 0.0 111.572 171.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.32 141.93 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.187 -0.945 . . . . 0.0 109.813 167.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.69 7.83 88.15 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.265 -0.742 . . . . 0.0 114.683 -175.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -85.65 152.2 23.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.509 1.155 . . . . 0.0 111.098 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -108.24 109.69 21.12 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.837 1.255 . . . . 0.0 112.323 -163.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.1 mt -106.3 171.38 7.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.927 1.291 . . . . 0.0 111.295 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.7 mt -122.88 159.73 27.58 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -115.63 -174.31 2.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.19 1.796 . . . . 0.0 113.874 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.4 t -58.14 -15.42 9.56 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -97.34 -12.48 22.78 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 119.816 -1.803 . . . . 0.0 113.552 170.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.36 22.1 49.1 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.925 1.25 . . . . 0.0 111.864 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -97.53 139.65 33.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.878 1.271 . . . . 0.0 112.025 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.92 111.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.092 0.957 . . . . 0.0 112.913 -171.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 63.4 mt -90.35 161.95 15.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.89 2.076 . . . . 0.0 111.374 161.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.6 t -132.72 141.41 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.677 1.191 . . . . 0.0 110.683 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.04 121.6 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.706 0.802 . . . . 0.0 109.459 172.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.27 -36.32 15.66 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.439 1.895 . . . . 0.0 112.142 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -160.49 151.7 19.18 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.648 1.579 . . . . 0.0 111.61 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -129.56 139.48 51.48 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.716 2.006 . . . . 0.0 110.352 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -143.2 139.67 30.39 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.368 1.467 . . . . 0.0 111.634 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.3 tp -116.87 136.4 52.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.724 2.01 . . . . 0.0 108.636 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -145.65 153.36 40.93 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 171.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.8 mm -91.91 121.41 42.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.037 0.935 . . . . 0.0 109.15 166.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.22 149.79 49.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.001 1.32 . . . . 0.0 113.664 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.65 -30.29 71.26 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.409 1.083 . . . . 0.0 112.851 175.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -148.38 152.62 39.16 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.023 2.529 . . . . 0.0 109.944 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -59.1 120.51 8.42 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.149 3.233 . . . . 0.0 111.985 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.56 137.87 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.107 1.363 . . . . 0.0 109.522 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -74.24 139.2 44.17 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.979 1.312 . . . . 0.0 110.363 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -137.93 143.78 32.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 124.643 1.177 . . . . 0.0 110.611 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.42 ' CD2' HG22 ' A' ' 46' ' ' VAL . 71.5 m-85 -121.82 149.15 43.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.901 1.28 . . . . 0.0 110.9 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -153.22 166.03 33.81 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.806 1.243 . . . . 0.0 111.481 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -150.29 167.39 27.13 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.792 -1.192 . . . . 0.0 112.561 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -116.0 142.83 46.27 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.3 t -99.83 143.52 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.929 2.092 . . . . 0.0 111.195 -173.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -60.02 -76.28 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.216 1.406 . . . . 0.0 113.636 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -118.19 -11.3 10.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -163.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -105.28 170.72 7.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.402 1.481 . . . . 0.0 109.149 163.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -114.67 13.68 17.42 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.832 2.053 . . . . 0.0 113.391 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 p -144.1 162.39 36.38 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.888 -1.133 . . . . 0.0 112.776 -163.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -156.48 172.91 17.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.919 1.688 . . . . 0.0 110.337 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -120.05 136.68 54.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.384 1.074 . . . . 0.0 112.343 -174.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.42 149.0 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.325 1.45 . . . . 0.0 113.71 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.62 175.47 18.88 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.254 1.407 . . . . 0.0 115.044 173.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.7 -28.8 69.67 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -88.63 4.44 47.08 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 60.86 46.54 8.6 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.715 1.206 . . . . 0.0 112.238 166.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -82.33 138.46 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.692 1.997 . . . . 0.0 112.122 -165.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 47.3 tp -80.49 124.73 29.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.357 1.463 . . . . 0.0 113.983 -173.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.14 159.88 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.969 1.708 . . . . 0.0 111.793 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -99.3 157.53 16.33 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.347 1.059 . . . . 0.0 113.832 -170.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.668 2.387 . . . . 0.0 113.226 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 46.9 ttm -147.49 135.88 21.66 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.117 0.567 . . . . 0.0 112.34 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -115.29 94.73 4.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.22 1.408 . . . . 0.0 110.537 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -157.94 165.56 34.87 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.921 0.888 . . . . 0.0 113.124 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -121.43 153.66 37.57 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.313 1.445 . . . . 0.0 111.657 170.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.3 m -70.7 158.6 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.672 0.749 . . . . 0.0 112.419 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.87 146.76 7.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.215 1.006 . . . . 0.0 112.782 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.38 -8.67 52.52 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 117.332 -1.816 . . . . 0.0 115.929 -172.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.3 m -61.56 118.13 6.65 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 121.124 2.462 . . . . 0.0 110.113 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 mmt -75.37 141.35 43.31 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.239 1.016 . . . . 0.0 111.972 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.8 mm -124.78 136.12 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 127.03 2.132 . . . . 0.0 109.754 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.46 124.32 26.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.381 1.072 . . . . 0.0 112.641 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.9 p -127.15 174.07 9.21 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.527 1.131 . . . . 0.0 111.829 -176.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.64 -30.9 71.28 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.084 -1.01 . . . . 0.0 111.954 167.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.9 p -77.69 -33.69 53.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.255 1.022 . . . . 0.0 111.968 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.37 -90.01 0.12 Allowed Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.486 1.517 . . . . 0.0 111.619 172.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.1 mt -134.16 140.1 46.31 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.731 1.612 . . . . 0.0 111.196 170.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -134.36 145.85 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.665 1.986 . . . . 0.0 108.974 174.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.78 146.86 51.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.849 -1.157 . . . . 0.0 111.159 175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 tt -60.95 -29.59 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 120.973 -1.08 . . . . 0.0 113.121 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.13 -20.03 64.87 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 173.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -101.67 -17.2 16.42 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.075 1.35 . . . . 0.0 113.022 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.06 126.91 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.595 0.758 . . . . 0.0 109.534 165.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -122.2 154.94 36.81 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.7 1.6 . . . . 0.0 111.733 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.09 126.46 26.09 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.604 -0.685 . . . . 0.0 111.541 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.59 -19.74 41.22 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.001 1.286 . . . . 0.0 114.749 -168.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -71.2 177.23 3.94 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.4 1.6 . . . . 0.0 112.981 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -120.16 154.93 34.08 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.586 1.554 . . . . 0.0 113.429 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -143.54 159.29 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.081 2.152 . . . . 0.0 109.851 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -77.09 139.18 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 O-C-N 121.205 -0.934 . . . . 0.0 110.827 166.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.87 129.25 40.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.5 m -93.38 110.39 21.94 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -52.67 112.36 3.39 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.633 1.573 . . . . 0.0 112.354 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -69.75 -6.69 19.2 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.156 1.904 . . . . 0.0 113.961 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -77.45 -42.65 35.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.711 -1.243 . . . . 0.0 112.737 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.8 t -138.05 2.68 2.36 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.27 1.028 . . . . 0.0 113.163 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.274 68.8 m-85 58.69 32.34 22.07 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.436 1.494 . . . . 0.0 113.944 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.77 139.87 49.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.05 0.94 . . . . 0.0 109.753 167.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.1 t -120.14 109.15 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.719 1.207 . . . . 0.0 109.885 -168.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.75 157.29 44.78 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -169.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -77.44 125.82 29.93 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.035 1.334 . . . . 0.0 110.06 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HE2' ' HB2' ' A' ' 120' ' ' ASP . 29.9 mmmt -129.23 151.21 50.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.999 1.319 . . . . 0.0 110.196 174.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.26 7.0 t -81.63 159.69 23.96 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.189 0.995 . . . . 0.0 113.45 176.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.1 t -94.54 125.79 47.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 126.584 1.954 . . . . 0.0 109.543 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.7 mt -82.25 -49.09 10.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.602 1.161 . . . . 0.0 111.268 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.59 151.68 39.4 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.684 1.194 . . . . 0.0 111.088 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.0 p -121.68 119.94 33.25 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.112 1.765 . . . . 0.0 110.145 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -108.76 150.44 27.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.124 1.77 . . . . 0.0 113.317 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.74 136.49 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.706 1.602 . . . . 0.0 111.646 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -134.79 175.13 9.84 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.678 1.991 . . . . 0.0 110.475 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -136.65 138.77 41.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.28 1.032 . . . . 0.0 110.411 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.2 t -153.39 147.32 25.42 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.248 -0.907 . . . . 0.0 112.246 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.1 p -86.7 -22.04 26.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.54 1.136 . . . . 0.0 112.855 168.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -100.84 86.0 3.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.134 0.969 . . . . 0.0 110.596 -166.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.23 177.91 5.7 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.756 1.223 . . . . 0.0 112.674 -172.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.1 tp -145.66 143.2 29.68 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.136 1.774 . . . . 0.0 109.649 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -109.37 136.78 48.25 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.024 -1.047 . . . . 0.0 108.43 162.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.2 mt -118.88 144.36 46.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.76 0.824 . . . . 0.0 109.252 161.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.4 m -109.04 123.18 48.74 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.16 120.41 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.378 1.471 . . . . 0.0 108.584 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.49 30.82 42.66 Favored Glycine 0 CA--C 1.543 1.82 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.05 -3.92 82.81 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 118.636 1.218 . . . . 0.0 115.684 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.66 126.88 44.4 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.189 1.395 . . . . 0.0 110.262 171.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.03 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.984 -0.447 . . . . 0.0 110.773 162.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.3 mt -122.23 106.42 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 109.636 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -78.49 117.06 19.33 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.913 2.485 . . . . 0.0 110.812 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 t -145.06 -179.68 6.78 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.552 1.141 . . . . 0.0 113.248 -164.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.2 p -85.62 155.64 21.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.501 1.12 . . . . 0.0 112.159 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -64.32 -28.14 69.5 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.927 -1.108 . . . . 0.0 112.552 -176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.91 5.26 52.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.06 0.944 . . . . 0.0 113.17 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -68.19 125.82 91.97 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.476 -1.39 . . . . 0.0 112.767 -169.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.22 114.24 3.3 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.501 2.8 . . . . 0.0 114.073 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -102.95 148.85 25.16 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.818 1.647 . . . . 0.0 110.997 170.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -93.83 130.89 39.69 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.196 0.907 . . . . 0.0 112.704 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.4 133.4 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.08 1.752 . . . . 0.0 111.071 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -52.81 126.98 21.86 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.528 1.531 . . . . 0.0 111.032 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.15 16.83 5.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.065 1.746 . . . . 0.0 115.266 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.28 -51.61 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.417 1.487 . . . . 0.0 111.59 -172.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.5 -160.8 13.02 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.027 0.822 . . . . 0.0 113.547 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.251 15.1 p90 -79.46 149.89 31.42 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -171.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.4 p -150.43 145.53 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.982 2.113 . . . . 0.0 110.999 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -70.19 138.23 51.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.667 1.587 . . . . 0.0 112.129 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.95 -39.92 66.33 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.812 1.245 . . . . 0.0 113.834 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.27 -10.75 79.05 Favored Glycine 0 CA--C 1.539 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 114.262 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -109.69 -0.49 18.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.456 1.903 . . . . 0.0 113.172 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 mt -67.57 160.1 28.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.507 0.723 . . . . 0.0 111.593 167.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -127.47 155.15 44.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.156 1.382 . . . . 0.0 111.711 172.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.25 137.94 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.801 0.84 . . . . 0.0 110.288 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.33 1.49 81.26 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 118.413 -1.215 . . . . 0.0 115.472 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -83.92 157.85 21.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.763 1.781 . . . . 0.0 112.089 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.45 98.02 8.41 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.096 1.358 . . . . 0.0 112.031 -166.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.01 179.21 6.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.037 1.335 . . . . 0.0 110.796 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 71.4 mt -131.56 155.75 46.93 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.297 1.039 . . . . 0.0 113.249 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.46 173.31 6.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.025 0.93 . . . . 0.0 112.671 168.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.2 t -51.4 -36.75 45.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -85.83 -11.7 52.7 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.777 1.231 . . . . 0.0 112.848 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.91 16.08 31.8 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 126.077 1.798 . . . . 0.0 112.633 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -72.57 143.43 48.27 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.636 0.774 . . . . 0.0 110.73 174.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.52 130.17 36.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 122.616 1.198 . . . . 0.0 111.128 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.7 mt -111.57 151.5 28.64 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.796 1.638 . . . . 0.0 111.33 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -118.89 137.03 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.549 0.74 . . . . 0.0 111.216 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.2 t -71.62 128.76 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.731 0.813 . . . . 0.0 109.593 170.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -107.59 -29.27 9.26 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.339 1.856 . . . . 0.0 112.485 -176.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -162.21 153.05 17.52 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.032 1.333 . . . . 0.0 112.243 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -120.55 132.41 55.15 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.329 1.852 . . . . 0.0 109.312 157.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -130.43 142.42 50.5 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.827 1.651 . . . . 0.0 110.127 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.7 tp -129.1 133.13 47.53 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.209 1.404 . . . . 0.0 111.162 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.37 156.31 48.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.295 1.038 . . . . 0.0 112.174 166.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.1 mm -108.79 107.85 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.227 1.411 . . . . 0.0 107.334 168.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.74 143.57 55.83 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.863 0.84 . . . . 0.0 112.804 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.65 -24.0 67.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -140.53 153.71 68.57 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.502 1.921 . . . . 0.0 111.435 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.39 120.09 7.4 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.393 2.729 . . . . 0.0 111.522 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.1 t -87.49 142.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.23 1.412 . . . . 0.0 109.593 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -78.51 140.94 38.52 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.564 0.697 . . . . 0.0 111.519 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.0 m -139.42 145.65 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 124.57 1.148 . . . . 0.0 111.727 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -125.2 148.14 48.76 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.343 1.457 . . . . 0.0 110.723 -166.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -151.7 168.71 24.17 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.38 1.472 . . . . 0.0 110.114 168.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -149.19 173.84 13.01 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.753 -1.217 . . . . 0.0 112.384 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -130.37 146.28 51.92 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.36 144.84 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.679 1.992 . . . . 0.0 113.004 -162.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -62.74 -18.24 62.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.521 2.729 . . . . 0.0 117.115 -168.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 4.5 m-20 -148.61 -63.86 0.24 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.915 1.234 . . . . 0.0 110.965 164.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -69.94 108.58 4.08 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.414 1.085 . . . . 0.0 110.74 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -70.02 36.11 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.292 1.837 . . . . 0.0 115.765 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.8 p -131.9 164.05 26.96 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.776 2.03 . . . . 0.0 111.935 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -157.94 -176.06 5.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.545 1.538 . . . . 0.0 110.037 166.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -127.66 141.4 51.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.366 1.066 . . . . 0.0 113.039 -172.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.32 138.24 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.495 1.118 . . . . 0.0 112.373 -175.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.02 179.46 53.08 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -73.7 -23.99 59.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.477 1.111 . . . . 0.0 112.148 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -80.25 1.68 27.53 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 166.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 54.87 39.3 31.43 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.268 1.427 . . . . 0.0 114.352 166.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.63 138.37 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.21 1.804 . . . . 0.0 112.02 -166.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.1 tp -81.65 126.75 32.14 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.408 1.483 . . . . 0.0 114.023 -173.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.29 157.96 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.673 1.589 . . . . 0.0 112.105 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -102.34 143.37 32.18 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.5 1.52 . . . . 0.0 112.02 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 C--O 1.252 1.21 0 C-N-CA 124.15 0.98 . . . . 0.0 112.509 176.688 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 117.382 -1.294 . . . . 0.0 113.796 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 44.1 ttm -145.94 137.03 24.64 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.84 2.109 . . . . 0.0 114.288 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -120.4 99.13 6.39 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.747 1.619 . . . . 0.0 110.469 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -155.52 172.24 18.59 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.846 0.858 . . . . 0.0 113.16 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.77 154.85 40.29 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.542 1.537 . . . . 0.0 111.411 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.0 m -71.66 158.62 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.336 0.654 . . . . 0.0 112.431 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.52 147.56 10.77 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.332 1.053 . . . . 0.0 111.191 172.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.37 6.61 62.07 Favored Glycine 0 CA--C 1.538 1.495 0 CA-C-O 117.949 -1.473 . . . . 0.0 115.756 -171.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.4 m -70.75 121.73 18.53 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.962 2.381 . . . . 0.0 109.639 164.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -80.08 140.14 36.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.67 1.188 . . . . 0.0 111.505 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.0 mm -125.25 136.29 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.301 2.24 . . . . 0.0 109.946 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.4 tp -78.61 123.65 27.33 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.161 0.984 . . . . 0.0 113.398 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 p -117.83 177.05 4.91 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.24 1.416 . . . . 0.0 111.334 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.09 -21.46 64.96 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.117 -0.989 . . . . 0.0 113.262 168.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -96.62 -14.33 22.23 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.201 1.8 . . . . 0.0 113.108 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.26 -108.29 0.61 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.789 1.662 . . . . 0.0 111.462 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.2 mt -127.95 142.07 51.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.293 1.037 . . . . 0.0 113.548 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.7 t -130.16 144.41 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.949 2.1 . . . . 0.0 108.887 174.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.93 147.52 48.65 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.114 -0.991 . . . . 0.0 110.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -61.87 -27.75 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 120.457 -1.402 . . . . 0.0 113.124 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.83 -7.15 43.29 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.891 1.276 . . . . 0.0 114.18 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -115.87 -12.14 11.46 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.185 1.794 . . . . 0.0 113.976 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -63.22 140.26 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 165.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -125.75 159.03 33.39 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.18 1.792 . . . . 0.0 112.401 175.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.38 123.98 19.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 122.897 0.479 . . . . 0.0 110.317 164.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.73 -6.69 70.44 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.955 1.265 . . . . 0.0 114.646 -172.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -75.03 177.87 6.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.65 1.225 . . . . 0.0 111.24 166.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -134.8 140.78 46.14 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.905 1.282 . . . . 0.0 113.046 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -135.14 159.26 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.124 1.769 . . . . 0.0 111.099 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.6 mm -77.98 136.91 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.972 -0.455 . . . . 0.0 111.803 171.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.6 117.89 20.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.139 1.376 . . . . 0.0 108.596 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 85.5 m -90.85 104.59 17.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -49.2 113.58 3.25 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.013 0.925 . . . . 0.0 112.008 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.99 -3.66 13.65 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.41 2.74 . . . . 0.0 113.871 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -82.07 -38.08 25.43 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.841 -1.162 . . . . 0.0 112.841 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 t -141.83 -2.18 1.2 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -166.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 55.19 37.28 28.65 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.919 1.688 . . . . 0.0 113.747 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.5 131.72 35.59 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.279 1.432 . . . . 0.0 108.896 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.6 t -106.23 125.17 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.441 1.097 . . . . 0.0 109.309 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.72 161.73 37.09 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -78.08 134.79 37.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.512 0.725 . . . . 0.0 109.298 161.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -139.75 150.95 45.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.478 1.111 . . . . 0.0 111.618 170.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 t -85.39 159.74 19.92 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -92.1 129.69 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.997 1.719 . . . . 0.0 110.868 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.5 mt -84.23 -50.01 8.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.38 0.672 . . . . 0.0 112.142 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -145.12 151.84 39.11 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.937 1.695 . . . . 0.0 111.02 -175.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 p -125.81 109.23 12.3 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.425 1.89 . . . . 0.0 110.543 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -98.92 146.8 25.62 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.404 1.082 . . . . 0.0 113.321 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.438 HG22 ' CD2' ' A' ' 114' ' ' TYR . 39.4 t -139.12 134.51 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.866 1.266 . . . . 0.0 111.751 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -132.03 174.28 10.35 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.222 1.809 . . . . 0.0 111.342 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.89 135.52 49.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.484 1.514 . . . . 0.0 110.151 170.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -146.03 143.06 29.19 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.897 1.279 . . . . 0.0 111.419 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -86.04 -16.0 39.55 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.214 1.006 . . . . 0.0 112.417 164.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -102.45 110.07 21.9 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 120.838 -1.163 . . . . 0.0 109.75 -173.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.6 mt -120.47 172.5 7.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.84 1.256 . . . . 0.0 112.257 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -142.12 140.16 32.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.071 1.748 . . . . 0.0 110.065 175.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -107.53 137.86 44.8 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 121.188 -0.945 . . . . 0.0 108.84 163.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.8 mt -121.32 142.65 49.76 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.009 0.924 . . . . 0.0 109.266 160.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 m -110.06 122.29 47.25 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.156 0.982 . . . . 0.0 108.981 172.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -124.17 121.67 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.978 1.711 . . . . 0.0 108.616 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.02 31.29 58.59 Favored Glycine 0 CA--C 1.543 1.84 0 O-C-N 121.401 -0.812 . . . . 0.0 114.866 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.09 -1.06 88.98 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.252 1.405 . . . . 0.0 115.465 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -106.35 124.13 49.12 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.983 1.713 . . . . 0.0 110.828 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.8 130.52 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.2 1.0 . . . . 0.0 111.196 172.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.0 mt -120.8 102.26 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.417 1.487 . . . . 0.0 108.709 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -79.76 116.46 19.95 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.175 1.79 . . . . 0.0 111.428 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.9 t -142.18 -176.13 4.7 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.305 1.442 . . . . 0.0 112.015 -163.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 67.3 p -95.04 158.72 15.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.52 1.128 . . . . 0.0 111.768 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -63.94 -26.1 68.44 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.369 -0.832 . . . . 0.0 112.751 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -97.83 4.47 49.72 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -66.58 126.66 92.59 Favored Pre-proline 0 CA--C 1.55 0.97 0 O-C-N 120.511 -1.368 . . . . 0.0 112.98 -173.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.49 116.82 2.99 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.814 2.343 . . . . 0.0 114.266 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -102.01 153.24 20.07 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.187 2.195 . . . . 0.0 111.11 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.59 133.89 42.3 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.491 1.041 . . . . 0.0 113.754 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.7 t -111.24 131.87 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 127.084 2.154 . . . . 0.0 111.528 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -51.9 129.2 26.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.846 1.658 . . . . 0.0 113.027 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 56.27 12.06 0.92 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 127.988 2.515 . . . . 0.0 115.547 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.74 -56.49 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.747 1.219 . . . . 0.0 111.774 -169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 124.78 -159.98 19.4 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.635 0.636 . . . . 0.0 113.25 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.252 10.6 p90 -81.68 153.88 26.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.87 143.71 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.93 2.092 . . . . 0.0 111.329 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.37 136.01 57.33 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.301 1.041 . . . . 0.0 113.357 170.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.25 -39.65 70.02 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.553 1.541 . . . . 0.0 113.16 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.1 -22.19 70.49 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.739 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.38 -10.64 45.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.9 mt -67.71 154.41 41.57 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.277 0.944 . . . . 0.0 111.576 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -123.08 152.74 40.76 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.193 0.997 . . . . 0.0 110.768 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.5 t -65.5 138.03 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.693 0.797 . . . . 0.0 110.361 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.51 -3.78 85.19 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 115.254 0.862 . . . . 0.0 115.254 -175.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -81.22 153.48 27.15 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.085 1.442 . . . . 0.0 111.799 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -100.39 107.96 19.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.852 1.261 . . . . 0.0 112.587 -163.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.5 mt -100.91 177.26 5.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.724 1.61 . . . . 0.0 110.343 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.88 157.57 41.18 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.4 -174.32 2.47 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.43 1.492 . . . . 0.0 114.511 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.4 p -56.0 -7.25 0.31 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -119.65 -26.55 5.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.187 1.395 . . . . 0.0 114.55 165.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.16 23.39 4.9 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.147 1.356 . . . . 0.0 113.404 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -77.0 146.75 37.23 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.324 1.062 . . . . 0.0 111.82 171.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.54 109.43 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.239 0.616 . . . . 0.0 112.225 -173.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.8 mt -93.44 159.31 15.3 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.858 1.663 . . . . 0.0 112.312 173.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.2 t -124.55 139.11 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.111 0.964 . . . . 0.0 111.098 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.2 t -69.2 130.82 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.403 0.681 . . . . 0.0 110.081 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -98.28 -43.33 7.01 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.534 1.933 . . . . 0.0 112.796 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -159.81 154.08 23.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.27 1.028 . . . . 0.0 111.843 -172.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -118.87 135.62 54.46 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.553 1.941 . . . . 0.0 108.865 165.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -130.57 130.09 43.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.817 1.647 . . . . 0.0 109.678 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -129.16 129.75 45.51 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.665 1.186 . . . . 0.0 111.985 -169.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -147.03 163.49 36.09 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.488 1.115 . . . . 0.0 112.879 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 mm -104.63 116.7 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 159.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.21 145.57 50.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.249 1.019 . . . . 0.0 111.672 173.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -75.09 -11.82 60.18 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.991 1.316 . . . . 0.0 112.464 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -139.84 152.05 67.13 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 127.204 2.202 . . . . 0.0 111.57 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.59 117.69 5.04 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.078 2.519 . . . . 0.0 110.753 172.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.31 139.43 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.033 1.733 . . . . 0.0 110.353 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -76.27 139.31 41.05 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.888 0.875 . . . . 0.0 110.297 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.47 140.8 28.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 124.007 0.923 . . . . 0.0 111.657 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.438 ' CD2' HG22 ' A' ' 46' ' ' VAL . 76.3 m-85 -119.64 153.87 34.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.812 1.645 . . . . 0.0 112.049 -169.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -157.18 170.2 23.04 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.947 1.699 . . . . 0.0 110.816 170.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -152.64 167.56 28.5 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.354 -1.466 . . . . 0.0 113.249 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -117.37 144.84 44.52 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.745 1.218 . . . . 0.0 112.954 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.17 139.54 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.562 1.545 . . . . 0.0 111.48 -168.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -60.22 -34.66 73.96 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -163.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -145.87 -47.27 0.21 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.007 -1.058 . . . . 0.0 112.671 -172.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -76.39 165.99 24.05 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.198 1.399 . . . . 0.0 109.169 163.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -116.88 1.42 12.67 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -168.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.3 p -126.28 163.94 22.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.534 1.534 . . . . 0.0 113.258 -167.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -153.39 -177.08 6.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.749 1.619 . . . . 0.0 110.631 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -130.16 141.85 50.63 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.79 1.236 . . . . 0.0 113.31 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.26 140.23 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.499 1.119 . . . . 0.0 113.688 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.23 176.95 42.45 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.784 1.659 . . . . 0.0 116.496 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -57.21 -36.95 71.5 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.076 1.351 . . . . 0.0 112.775 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -82.95 -1.04 51.32 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 175.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 56.96 51.09 11.09 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.843 1.657 . . . . 0.0 113.486 168.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.9 t -80.32 141.98 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.215 1.806 . . . . 0.0 112.055 -167.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 48.9 tp -78.58 125.88 29.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.98 1.712 . . . . 0.0 114.216 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.09 158.9 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.257 1.823 . . . . 0.0 111.648 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -111.58 151.97 28.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.708 1.203 . . . . 0.0 112.934 -171.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.755 -1.593 . . . . 0.0 113.926 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 9.9 ttt -154.54 121.97 5.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.239 1.381 . . . . 0.0 111.056 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -139.79 98.0 3.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.462 1.105 . . . . 0.0 109.601 -164.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -164.17 173.57 12.25 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -124.37 154.81 39.8 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.289 1.436 . . . . 0.0 111.833 173.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.97 157.8 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.452 0.644 . . . . 0.0 112.356 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.3 144.31 20.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.539 0.735 . . . . 0.0 111.898 172.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.42 -8.1 69.65 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 116.489 1.355 . . . . 0.0 116.489 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.9 m -64.12 121.27 13.8 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 120.62 2.21 . . . . 0.0 110.6 174.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 mmt -78.23 142.93 37.54 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.22 1.408 . . . . 0.0 112.089 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.5 mm -127.79 134.34 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.726 2.011 . . . . 0.0 109.708 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.0 tp -76.38 128.95 35.85 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 p -123.64 169.67 11.24 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.991 1.316 . . . . 0.0 111.241 177.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.31 -19.09 65.8 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.777 -1.202 . . . . 0.0 113.294 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 p -119.56 2.66 11.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.861 2.064 . . . . 0.0 113.792 -173.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.16 -116.36 0.81 Allowed Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.221 1.391 . . . . 0.0 113.982 166.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.9 mt -127.98 154.47 45.55 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.771 1.628 . . . . 0.0 110.5 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -143.16 148.19 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 126.439 1.896 . . . . 0.0 108.585 170.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.35 147.02 46.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.017 -1.052 . . . . 0.0 111.306 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 tt -62.11 -27.06 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 120.437 -1.414 . . . . 0.0 113.498 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.58 -14.7 62.6 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 172.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -108.5 -15.06 14.53 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.232 1.813 . . . . 0.0 113.898 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.8 mm -63.04 132.25 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 163.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -133.26 170.76 14.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.523 1.929 . . . . 0.0 109.606 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.12 130.47 15.75 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.189 0.518 . . . . 0.0 111.005 166.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.24 -1.2 88.73 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 116.105 1.202 . . . . 0.0 116.105 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -76.58 155.38 33.64 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.779 1.789 . . . . 0.0 110.666 160.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -111.5 140.36 46.17 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.958 1.303 . . . . 0.0 112.509 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.11 162.16 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.542 1.937 . . . . 0.0 110.292 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.2 mm -78.63 141.73 15.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 121.819 -0.55 . . . . 0.0 110.472 162.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.95 129.3 29.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 170.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.7 m -91.53 108.37 19.85 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 165.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -52.43 117.21 10.06 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.223 1.009 . . . . 0.0 112.583 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.43 -12.98 37.7 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.097 2.532 . . . . 0.0 113.907 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -76.4 -40.62 50.37 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.225 1.01 . . . . 0.0 112.523 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.8 t -135.08 -5.26 2.38 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.339 1.456 . . . . 0.0 113.685 -171.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.3 t80 56.65 43.08 26.08 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.329 1.452 . . . . 0.0 114.034 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -95.71 135.16 37.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.236 1.014 . . . . 0.0 110.151 170.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -105.95 122.54 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.98 0.912 . . . . 0.0 112.339 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.22 160.51 39.26 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.324 1.049 . . . . 0.0 113.077 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -91.12 121.12 32.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.148 1.379 . . . . 0.0 109.466 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -139.05 149.09 44.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.465 1.106 . . . . 0.0 112.931 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.7 t -80.75 161.5 24.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.875 1.27 . . . . 0.0 113.435 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.9 t -98.19 133.62 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 126.236 1.814 . . . . 0.0 111.716 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.02 -45.19 10.4 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.962 1.305 . . . . 0.0 113.298 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -146.88 156.64 43.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.276 1.83 . . . . 0.0 110.614 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.1 p -116.43 135.24 54.02 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.221 164.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -105.7 147.92 28.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.688 1.595 . . . . 0.0 112.056 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -143.65 128.93 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.501 1.12 . . . . 0.0 111.319 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 -126.28 176.05 7.38 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.04 1.736 . . . . 0.0 111.198 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -133.34 133.73 42.87 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.781 1.233 . . . . 0.0 111.945 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.9 t -148.16 143.99 27.45 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.957 1.303 . . . . 0.0 111.63 -176.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.7 p -84.35 -21.27 30.96 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.635 0.774 . . . . 0.0 112.689 164.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -96.39 115.81 28.04 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.008 0.923 . . . . 0.0 110.203 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.4 mt -121.05 167.79 12.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.796 1.239 . . . . 0.0 112.276 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.89 134.85 46.16 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.693 1.997 . . . . 0.0 109.689 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -113.88 128.38 56.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.617 1.167 . . . . 0.0 108.866 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.2 mt -124.08 128.77 49.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.518 1.127 . . . . 0.0 110.339 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.8 m -99.04 122.9 42.9 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 169.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.74 119.67 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.895 1.278 . . . . 0.0 109.968 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.86 21.74 17.12 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 115.926 1.131 . . . . 0.0 115.926 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.35 7.64 55.74 Favored Glycine 0 CA--C 1.542 1.768 0 N-CA-C 116.914 1.526 . . . . 0.0 116.914 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -121.76 131.02 53.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.185 1.492 . . . . 0.0 109.869 172.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -97.35 134.69 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.989 0.899 . . . . 0.0 112.983 176.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.8 mt -130.42 133.81 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.812 2.045 . . . . 0.0 108.794 -172.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -119.08 112.13 19.15 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.245 1.418 . . . . 0.0 110.792 -165.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -141.2 -177.63 5.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.611 1.164 . . . . 0.0 112.426 -161.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.9 p -89.66 153.54 20.65 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.198 0.999 . . . . 0.0 111.923 169.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -58.26 -27.88 64.4 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.925 1.29 . . . . 0.0 113.272 -175.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -107.52 7.44 28.8 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.723 1.209 . . . . 0.0 112.225 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -69.69 128.86 91.77 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.99 112.86 2.37 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 124.683 3.589 . . . . 0.0 115.216 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -94.7 152.99 18.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.369 2.268 . . . . 0.0 111.507 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -97.99 132.02 43.91 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -111.59 138.51 39.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 127.28 2.232 . . . . 0.0 110.226 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.54 127.4 31.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.732 1.213 . . . . 0.0 110.441 175.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t0 56.3 31.52 18.72 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.383 1.873 . . . . 0.0 115.595 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.0 t -144.12 -50.63 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.853 1.261 . . . . 0.0 112.417 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.45 -153.21 16.74 Favored Glycine 0 N--CA 1.468 0.811 0 CA-C-N 119.392 0.997 . . . . 0.0 111.512 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -92.04 147.65 22.79 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -149.14 143.49 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.596 1.958 . . . . 0.0 112.053 -175.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.81 132.33 52.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.872 1.269 . . . . 0.0 112.68 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.84 -36.96 68.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.301 1.44 . . . . 0.0 113.645 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.99 -12.67 83.2 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.561 1.077 . . . . 0.0 114.168 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -102.2 -7.88 21.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.278 1.831 . . . . 0.0 113.544 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 mt -58.49 158.69 7.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.679 0.792 . . . . 0.0 112.405 166.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -114.51 152.82 31.09 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.388 1.475 . . . . 0.0 110.395 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 50.3 t -67.59 132.63 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.351 0.596 . . . . 0.0 109.521 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.1 0.14 68.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.677 1.132 . . . . 0.0 115.201 -171.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -84.22 156.4 22.04 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.127 1.464 . . . . 0.0 111.96 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -106.73 102.41 11.79 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.118 1.367 . . . . 0.0 111.965 -156.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.7 mt -96.3 -175.36 3.33 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.486 1.514 . . . . 0.0 111.041 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.67 149.03 52.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.084 0.954 . . . . 0.0 112.51 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.02 172.46 6.91 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.218 1.007 . . . . 0.0 113.278 175.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.9 p -56.67 -11.34 1.31 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -107.37 -30.5 8.65 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.19 1.796 . . . . 0.0 112.344 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.74 19.89 5.92 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.956 1.741 . . . . 0.0 113.79 -177.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -70.59 140.26 51.64 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.658 0.729 . . . . 0.0 110.553 167.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.4 t -77.57 107.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.906 0.883 . . . . 0.0 109.832 173.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 25.3 mt -85.96 160.53 19.34 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.274 1.43 . . . . 0.0 111.816 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.89 137.71 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.334 1.053 . . . . 0.0 110.798 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.0 119.66 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.602 0.761 . . . . 0.0 109.05 170.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -96.52 -31.64 12.68 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.392 1.477 . . . . 0.0 112.213 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.93 148.12 20.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.575 1.55 . . . . 0.0 111.324 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -125.66 127.36 46.16 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.441 2.296 . . . . 0.0 109.773 168.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -125.31 156.56 38.45 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.482 2.313 . . . . 0.0 110.748 169.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.15 135.08 26.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.841 1.656 . . . . 0.0 108.266 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -142.75 158.46 43.61 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.9 mm -110.7 101.02 11.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 125.21 1.404 . . . . 0.0 109.903 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.78 146.74 35.89 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.403 1.481 . . . . 0.0 113.535 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.59 -14.79 61.25 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.848 1.259 . . . . 0.0 113.372 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -138.3 155.15 74.18 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 127.076 2.15 . . . . 0.0 109.761 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.96 111.42 2.64 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.429 2.086 . . . . 0.0 110.402 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.1 t -81.42 140.24 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.927 1.691 . . . . 0.0 110.015 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -75.64 135.8 40.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.092 0.949 . . . . 0.0 110.39 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.9 m -135.28 136.76 50.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 124.59 1.156 . . . . 0.0 110.61 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -118.91 149.32 41.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.609 1.564 . . . . 0.0 111.16 -167.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -153.36 166.42 32.69 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.763 1.625 . . . . 0.0 109.885 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -152.44 164.72 36.98 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.241 -1.537 . . . . 0.0 112.318 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -121.98 143.17 49.64 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.0 t -98.72 146.51 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.289 1.836 . . . . 0.0 112.364 -168.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -68.88 -15.13 63.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -168.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -145.35 -47.5 0.22 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.89 0.876 . . . . 0.0 112.109 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -83.41 173.51 11.46 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.36 1.064 . . . . 0.0 112.1 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -112.48 9.22 19.57 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.824 2.05 . . . . 0.0 114.58 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 p -133.08 171.44 13.98 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.104 1.361 . . . . 0.0 113.585 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -157.52 179.91 8.79 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.831 2.053 . . . . 0.0 110.362 163.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -117.24 138.95 51.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.808 1.243 . . . . 0.0 112.604 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.6 m -126.14 142.65 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.381 1.472 . . . . 0.0 113.912 -174.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.22 174.59 28.0 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.431 1.491 . . . . 0.0 115.336 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -26.0 65.9 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.756 -1.438 . . . . 0.0 113.133 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -83.54 -3.78 57.96 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.005 0.922 . . . . 0.0 113.384 170.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 57.38 55.35 5.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.134 1.773 . . . . 0.0 113.857 167.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.88 143.41 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.557 1.543 . . . . 0.0 111.603 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 44.5 tp -81.34 125.47 30.42 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.726 1.21 . . . . 0.0 114.091 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.6 159.05 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.478 1.511 . . . . 0.0 112.574 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -99.62 149.96 22.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.179 1.392 . . . . 0.0 113.959 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.7 m120 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.265 1.826 . . . . 0.0 112.505 179.469 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 51.7 ttm -138.16 139.15 39.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.319 0.648 . . . . 0.0 112.401 171.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -115.03 98.73 6.97 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.071 1.748 . . . . 0.0 110.356 171.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -157.38 168.99 25.76 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.808 0.843 . . . . 0.0 113.094 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.437 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 97.8 m-85 -124.78 154.52 40.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.565 1.546 . . . . 0.0 111.121 167.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.49 154.69 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.683 -0.636 . . . . 0.0 111.262 171.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.78 154.56 8.97 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.362 0.601 . . . . 0.0 111.717 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.88 -9.66 29.89 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-O 117.676 -1.625 . . . . 0.0 116.186 -171.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.5 m -62.33 125.31 23.47 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.539 2.17 . . . . 0.0 110.11 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 mmt -85.12 140.66 30.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.693 1.197 . . . . 0.0 111.982 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.66 135.18 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.781 2.033 . . . . 0.0 110.123 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 tp -73.68 130.8 40.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.902 0.881 . . . . 0.0 113.208 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 p -126.18 174.21 8.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.71 1.604 . . . . 0.0 111.353 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.7 -19.38 64.88 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.26 1.424 . . . . 0.0 113.552 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -110.56 -25.39 10.02 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.17 -113.34 0.54 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 118.809 0.731 . . . . 0.0 112.825 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.6 mt -130.99 145.9 52.2 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.2 t -133.29 142.73 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.305 1.842 . . . . 0.0 108.941 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.77 144.77 49.08 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.214 -0.929 . . . . 0.0 110.959 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.32 -27.52 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 120.982 -1.074 . . . . 0.0 113.605 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -70.51 -14.06 62.37 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.089 1.356 . . . . 0.0 114.125 173.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -114.28 -11.01 12.64 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.551 1.54 . . . . 0.0 113.203 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.4 mm -61.68 137.23 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.569 -0.707 . . . . 0.0 109.282 163.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -125.55 164.03 21.42 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.369 1.868 . . . . 0.0 111.545 170.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.62 132.42 35.68 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.738 -0.601 . . . . 0.0 111.532 167.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.29 1.13 90.4 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.486 1.041 . . . . 0.0 115.287 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -82.65 154.54 24.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.533 1.167 . . . . 0.0 109.869 164.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -112.13 145.64 39.44 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.693 1.197 . . . . 0.0 112.311 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.03 160.56 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.229 1.811 . . . . 0.0 111.258 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -73.79 143.95 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.475 -0.765 . . . . 0.0 111.722 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.52 128.28 20.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.36 1.064 . . . . 0.0 109.446 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.4 m -78.62 115.45 18.33 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 162.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -55.21 115.39 9.03 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.231 1.012 . . . . 0.0 112.07 170.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.84 -3.95 13.77 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.9 2.4 . . . . 0.0 114.349 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -81.8 -45.99 14.81 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.309 0.958 . . . . 0.0 112.409 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.9 t -136.86 0.95 2.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.342 1.057 . . . . 0.0 112.767 -166.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 55.8 45.99 23.21 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.468 1.127 . . . . 0.0 112.678 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -86.59 134.97 33.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.564 1.546 . . . . 0.0 109.543 165.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 t -110.44 119.64 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 118.733 0.697 . . . . 0.0 109.644 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.35 164.88 33.67 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.792 0.837 . . . . 0.0 112.529 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -88.94 128.84 35.7 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.697 1.599 . . . . 0.0 110.941 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.444 ' HE3' ' CZ ' ' A' ' 121' ' ' PHE . 66.6 mmtt -134.46 148.76 50.65 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.365 1.066 . . . . 0.0 111.153 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -86.05 154.15 21.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.62 0.724 . . . . 0.0 112.781 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.6 t -90.18 134.86 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.655 1.582 . . . . 0.0 110.599 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt -88.82 -48.37 7.54 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.881 0.872 . . . . 0.0 112.381 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -143.78 160.89 39.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.264 1.826 . . . . 0.0 110.235 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.3 p -116.43 134.05 55.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.562 1.145 . . . . 0.0 110.172 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -109.32 140.78 42.56 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.835 1.654 . . . . 0.0 113.705 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.33 138.45 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.651 1.18 . . . . 0.0 111.062 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -141.19 174.04 10.91 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.474 2.31 . . . . 0.0 109.532 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -130.48 138.85 50.47 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.504 1.522 . . . . 0.0 110.38 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.2 t -147.15 150.7 35.48 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.585 0.707 . . . . 0.0 111.643 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 p -94.17 -14.03 26.06 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.67 1.588 . . . . 0.0 113.848 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -118.55 111.39 18.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.039 0.836 . . . . 0.0 110.745 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.2 mt -110.14 160.79 16.17 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 tp -127.58 130.65 49.41 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 110.852 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -117.4 103.07 9.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.696 1.598 . . . . 0.0 109.413 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.7 mt -98.35 128.1 44.6 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.757 0.823 . . . . 0.0 110.22 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -100.29 119.74 38.86 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.08 116.32 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.321 1.048 . . . . 0.0 109.179 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.12 28.75 34.44 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 123.707 0.67 . . . . 0.0 114.72 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.12 -2.11 87.63 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.915 1.722 . . . . 0.0 116.332 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.4 122.49 41.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.863 1.831 . . . . 0.0 109.507 168.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.1 p -87.32 131.78 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.486 0.66 . . . . 0.0 111.71 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.92 131.04 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.823 2.049 . . . . 0.0 108.86 -175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -113.94 110.19 19.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.608 1.163 . . . . 0.0 110.777 -164.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.4 t -139.88 177.78 7.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.05 0.94 . . . . 0.0 112.218 -157.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.2 p -87.15 151.31 23.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.129 0.972 . . . . 0.0 112.116 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -58.75 -29.85 67.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.408 1.083 . . . . 0.0 112.845 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -98.21 9.55 42.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.437 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.3 t60 -70.58 125.96 92.13 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 120.909 -1.119 . . . . 0.0 112.475 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.99 119.82 4.04 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.139 2.559 . . . . 0.0 113.963 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -106.92 144.13 34.0 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.71 2.004 . . . . 0.0 111.074 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -83.33 128.61 34.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.464 1.029 . . . . 0.0 113.285 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.9 t -103.84 133.0 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.402 2.281 . . . . 0.0 110.96 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -49.01 118.46 2.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.056 1.743 . . . . 0.0 112.144 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 52.57 24.94 3.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.404 2.682 . . . . 0.0 115.312 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.7 t -123.75 -50.26 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.21 1.404 . . . . 0.0 110.577 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.48 -161.66 13.52 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 123.541 0.591 . . . . 0.0 112.54 -175.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.282 31.1 p90 -85.02 150.01 25.18 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 118.818 1.309 . . . . 0.0 114.162 -175.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.72 144.99 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.008 1.723 . . . . 0.0 110.642 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.41 136.13 57.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.94 0.896 . . . . 0.0 112.108 176.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.25 -36.12 70.56 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.78 1.232 . . . . 0.0 113.961 -171.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.66 -3.74 89.41 Favored Glycine 0 CA--C 1.539 1.561 0 O-C-N 121.027 -1.046 . . . . 0.0 113.611 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -95.77 -4.6 43.68 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.241 1.816 . . . . 0.0 112.314 167.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 69.0 mt -71.59 154.11 41.66 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.547 -0.721 . . . . 0.0 112.263 166.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -119.72 166.99 12.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.16 1.384 . . . . 0.0 110.976 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.31 138.53 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.57 12.99 82.3 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 115.234 0.854 . . . . 0.0 115.234 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -86.29 150.87 24.05 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.317 -1.107 . . . . 0.0 110.841 169.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -107.44 111.81 24.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.333 1.453 . . . . 0.0 112.056 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.1 mt -104.2 -177.82 3.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.339 1.456 . . . . 0.0 111.06 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -131.46 156.19 46.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.272 1.029 . . . . 0.0 113.518 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.8 p30 -105.15 179.85 4.15 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.914 1.286 . . . . 0.0 113.289 174.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.3 t -66.06 -17.87 64.97 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.871 1.669 . . . . 0.0 114.14 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -85.48 -25.53 26.83 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.261 -1.525 . . . . 0.0 112.171 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.72 25.31 8.16 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.699 2.095 . . . . 0.0 113.224 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.81 142.82 34.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.309 1.444 . . . . 0.0 111.812 -173.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.9 t -57.11 120.3 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.51 1.124 . . . . 0.0 112.248 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -99.71 154.37 18.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.169 1.388 . . . . 0.0 110.901 161.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.4 t -123.42 140.6 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.865 1.266 . . . . 0.0 110.471 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.9 119.54 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.526 0.679 . . . . 0.0 109.237 170.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.02 -35.15 14.81 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.782 2.033 . . . . 0.0 112.626 -176.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -162.91 148.86 12.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.195 1.798 . . . . 0.0 110.817 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -129.41 124.5 34.29 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.932 1.693 . . . . 0.0 110.31 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 mmtm -132.22 151.1 51.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.531 1.532 . . . . 0.0 112.102 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 tp -136.13 137.65 41.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.858 1.663 . . . . 0.0 108.996 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.39 151.13 43.23 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.4 mm -99.77 119.01 47.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.779 170.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.89 149.59 43.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 112.795 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -67.95 -19.06 64.93 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.455 1.502 . . . . 0.0 113.251 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -157.27 156.64 29.56 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.913 2.485 . . . . 0.0 108.961 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -60.59 129.14 28.2 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.452 2.101 . . . . 0.0 112.603 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.83 144.35 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.595 1.558 . . . . 0.0 109.618 173.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -79.69 140.95 36.84 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.618 -0.677 . . . . 0.0 110.643 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.6 m -136.79 137.66 47.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.606 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -111.69 154.15 25.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.721 1.608 . . . . 0.0 111.974 -172.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -155.58 174.01 15.88 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.85 2.46 . . . . 0.0 108.033 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -153.76 170.9 19.8 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.044 -1.66 . . . . 0.0 110.744 173.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -121.94 137.25 54.86 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.774 0.83 . . . . 0.0 112.834 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.6 t -100.05 144.89 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.963 1.305 . . . . 0.0 111.95 -167.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -57.59 -39.07 75.96 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -170.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -139.6 -48.83 0.48 Allowed 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.97 -1.081 . . . . 0.0 113.372 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.444 ' CZ ' ' HE3' ' A' ' 39' ' ' LYS . 5.8 m-30 -69.94 163.87 25.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 168.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -116.29 23.48 12.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.954 1.302 . . . . 0.0 112.103 -171.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 p -147.69 160.64 42.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.553 1.541 . . . . 0.0 111.84 -157.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -160.24 175.89 12.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.836 1.655 . . . . 0.0 110.391 171.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -122.27 134.2 54.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.393 1.077 . . . . 0.0 112.802 -171.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.6 m -122.05 143.42 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.271 1.428 . . . . 0.0 114.663 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.53 176.98 30.14 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 126.118 1.818 . . . . 0.0 116.19 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.15 -34.5 66.19 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 120.92 -1.341 . . . . 0.0 113.237 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -83.02 0.1 46.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 57.35 43.6 23.08 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.027 1.331 . . . . 0.0 113.334 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.25 136.81 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.127 1.371 . . . . 0.0 111.723 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.6 tp -79.22 124.92 28.82 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.829 1.252 . . . . 0.0 113.98 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.4 m -138.27 157.01 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 126.127 1.771 . . . . 0.0 112.062 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -107.16 129.31 54.86 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.194 1.398 . . . . 0.0 112.823 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.213 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 118.966 -0.54 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 8.6 ttt -162.74 128.65 3.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.278 1.431 . . . . 0.0 111.381 170.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -133.38 97.4 3.95 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.093 0.957 . . . . 0.0 111.696 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -158.85 176.04 12.83 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.44 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 98.4 m-85 -123.62 157.12 34.47 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.14 1.776 . . . . 0.0 110.699 168.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.3 m -68.79 157.61 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.809 -0.557 . . . . 0.0 111.808 173.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.5 153.36 4.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.364 0.666 . . . . 0.0 111.948 174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.8 3.95 30.97 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-O 117.95 -1.472 . . . . 0.0 116.475 -174.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -67.77 125.34 25.95 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 120.922 2.361 . . . . 0.0 109.617 165.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.6 mmt -80.5 142.19 34.44 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.353 1.461 . . . . 0.0 111.858 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -123.29 137.11 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.787 2.035 . . . . 0.0 109.905 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.7 tp -73.91 122.14 22.06 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 112.592 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 p -115.21 168.14 10.21 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.115 1.366 . . . . 0.0 110.562 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 -21.28 66.57 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.402 -0.812 . . . . 0.0 112.969 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.0 p -100.05 -31.66 11.32 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.626 0.77 . . . . 0.0 112.547 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.97 -120.09 0.76 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.877 0.751 . . . . 0.0 112.715 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.57 140.83 51.87 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.611 1.164 . . . . 0.0 112.67 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.1 t -132.25 142.64 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.848 1.659 . . . . 0.0 108.747 173.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.38 150.41 48.99 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.103 -0.998 . . . . 0.0 111.725 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.9 tt -62.45 -25.85 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 120.876 -1.14 . . . . 0.0 113.558 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -75.09 -15.28 60.62 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.376 1.07 . . . . 0.0 113.765 171.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -107.97 -16.25 14.34 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.571 1.948 . . . . 0.0 112.401 -176.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.7 mm -63.29 134.66 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 160.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -134.17 160.21 38.51 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.043 1.337 . . . . 0.0 111.604 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.42 120.21 8.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.785 0.434 . . . . 0.0 110.406 173.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.73 -24.67 23.15 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.535 1.064 . . . . 0.0 115.716 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.86 170.83 8.9 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.394 1.597 . . . . 0.0 111.648 172.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -125.33 146.53 49.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.725 1.61 . . . . 0.0 111.167 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.18 160.55 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.131 1.372 . . . . 0.0 110.455 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -75.09 140.94 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.234 0.54 . . . . 0.0 110.514 170.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.49 125.78 24.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.222 1.009 . . . . 0.0 108.695 175.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.2 m -79.79 112.3 16.94 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 161.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -53.92 111.44 2.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 118.343 -0.836 . . . . 0.0 110.718 169.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -69.18 -12.25 33.54 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.35 2.034 . . . . 0.0 112.691 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -77.19 -38.66 51.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.076 1.351 . . . . 0.0 112.828 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.7 t -136.23 -6.1 2.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.01 1.324 . . . . 0.0 112.53 -170.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.259 15.6 m-85 54.5 52.3 12.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.221 1.408 . . . . 0.0 112.185 -175.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -100.64 135.65 41.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.108 1.763 . . . . 0.0 108.889 167.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 t -113.04 128.89 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 119.01 0.823 . . . . 0.0 111.27 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.78 172.19 18.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.91 0.884 . . . . 0.0 113.079 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -74.23 138.04 43.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.71 1.204 . . . . 0.0 111.443 165.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -139.31 152.63 47.37 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.396 1.078 . . . . 0.0 112.23 160.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -79.08 155.32 28.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.668 1.187 . . . . 0.0 114.131 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.7 t -93.12 131.73 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 126.537 1.935 . . . . 0.0 111.318 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.42 -41.05 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.363 1.465 . . . . 0.0 113.508 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -147.37 156.02 42.52 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 127.159 2.184 . . . . 0.0 109.703 174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -113.26 135.92 53.31 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.475 1.51 . . . . 0.0 109.14 163.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -112.35 141.83 45.59 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.183 1.393 . . . . 0.0 113.912 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -135.02 138.29 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.056 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -140.15 176.19 8.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.209 2.203 . . . . 0.0 110.112 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.12 133.62 50.36 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.375 1.47 . . . . 0.0 110.973 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.9 t -142.42 145.11 33.46 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.125 -0.984 . . . . 0.0 113.12 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.8 p -88.27 -14.52 38.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.806 1.642 . . . . 0.0 113.25 167.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -107.66 108.85 20.29 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.005 -1.059 . . . . 0.0 110.9 -172.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.6 mt -116.45 167.96 10.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.251 1.021 . . . . 0.0 112.818 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.1 tp -135.28 133.21 38.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.859 2.064 . . . . 0.0 109.268 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -105.54 130.43 53.6 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.232 -0.918 . . . . 0.0 109.292 170.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.5 mt -114.14 147.53 38.7 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.371 1.069 . . . . 0.0 110.1 169.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.7 m -123.17 124.83 43.92 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.452 0.701 . . . . 0.0 109.627 166.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.1 mt -132.77 123.55 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.84 1.656 . . . . 0.0 109.425 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.08 28.79 50.28 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 115.611 1.005 . . . . 0.0 115.611 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.11 7.51 87.7 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.82 1.2 . . . . 0.0 115.567 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -109.1 137.55 46.83 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.745 1.618 . . . . 0.0 109.567 171.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.61 135.84 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.345 1.058 . . . . 0.0 111.171 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mt -129.7 104.58 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.161 1.784 . . . . 0.0 109.341 173.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -81.94 121.82 26.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.823 1.649 . . . . 0.0 111.429 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.5 t -144.64 175.36 10.21 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.165 -0.96 . . . . 0.0 112.73 -167.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.3 p -79.19 153.86 29.69 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.591 -0.693 . . . . 0.0 111.181 167.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -59.43 -28.83 67.31 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.763 0.825 . . . . 0.0 112.62 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -98.01 1.21 47.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.963 0.905 . . . . 0.0 113.164 -171.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.44 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.2 t60 -64.68 128.07 93.13 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 117.657 -1.163 . . . . 0.0 112.87 -173.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 68' ' ' HIS . 7.6 Cg_exo -84.4 127.87 3.97 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.003 1.802 . . . . 0.0 114.673 -175.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -115.93 139.58 50.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.129 2.572 . . . . 0.0 111.407 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -89.6 129.58 36.03 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.0 134.36 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 127.561 2.344 . . . . 0.0 112.4 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -50.05 126.36 14.27 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.982 1.713 . . . . 0.0 112.779 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 52.5 22.54 2.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.239 2.216 . . . . 0.0 115.259 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.09 -53.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.81 -1.181 . . . . 0.0 111.141 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.92 -159.68 13.57 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.095 0.855 . . . . 0.0 113.014 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -92.57 139.13 30.89 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.159 1.541 . . . . 0.0 115.159 -170.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.0 p -138.57 146.98 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 127.45 2.3 . . . . 0.0 111.987 -172.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.48 135.85 56.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 173.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.48 -40.14 61.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.958 1.703 . . . . 0.0 113.688 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.3 -10.58 66.29 Favored Glycine 0 CA--C 1.539 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 113.683 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -112.14 4.37 17.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.563 2.345 . . . . 0.0 113.04 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.85 159.66 19.14 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.969 -1.082 . . . . 0.0 111.295 163.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.42 156.68 32.18 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.441 1.096 . . . . 0.0 111.465 172.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.44 132.58 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 165.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.84 11.32 82.92 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 118.404 -1.22 . . . . 0.0 115.706 -172.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.3 165.19 7.82 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.908 1.854 . . . . 0.0 112.097 170.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -117.71 83.28 1.97 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.742 1.217 . . . . 0.0 111.735 -169.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.25 162.96 13.64 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.189 0.996 . . . . 0.0 113.533 -170.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.43 140.75 38.06 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.521 1.128 . . . . 0.0 112.552 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.12 177.14 5.17 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.501 1.12 . . . . 0.0 114.004 171.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.0 p -59.95 -12.08 7.09 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -107.85 -25.91 11.0 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.295 1.838 . . . . 0.0 111.905 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.6 25.14 6.72 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 126.402 1.954 . . . . 0.0 112.719 175.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -74.83 154.71 38.16 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.709 0.804 . . . . 0.0 110.437 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.8 t -92.83 112.76 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.785 0.834 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.5 mt -84.68 163.11 19.42 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.755 2.822 . . . . 0.0 112.324 175.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.71 134.78 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.554 1.542 . . . . 0.0 110.033 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.48 131.52 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.685 -0.635 . . . . 0.0 109.542 170.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -105.43 -35.26 7.55 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.613 1.565 . . . . 0.0 112.407 -175.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -157.87 149.24 21.47 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.194 0.998 . . . . 0.0 112.574 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -123.0 128.54 50.33 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.771 2.029 . . . . 0.0 108.743 161.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -130.27 151.61 50.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.116 1.766 . . . . 0.0 111.577 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.0 tt -138.62 142.99 39.1 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 111.416 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -150.52 161.92 41.61 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.933 0.893 . . . . 0.0 112.555 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mm -111.02 109.93 30.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 124.991 1.317 . . . . 0.0 108.329 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.47 140.37 58.59 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.318 0.647 . . . . 0.0 110.943 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.88 -21.63 60.89 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.64 -1.288 . . . . 0.0 113.283 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -127.54 151.12 74.61 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 127.221 2.208 . . . . 0.0 109.887 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.05 110.71 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.727 2.285 . . . . 0.0 112.069 -174.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.35 142.1 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.03 1.732 . . . . 0.0 110.18 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -71.2 140.28 50.42 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.081 0.943 . . . . 0.0 112.144 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.1 m -140.04 137.5 38.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.645 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -121.92 149.05 43.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.527 1.531 . . . . 0.0 111.354 -166.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -154.11 173.18 16.41 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.666 1.986 . . . . 0.0 108.413 170.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -150.27 170.71 18.35 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.218 -1.551 . . . . 0.0 111.283 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -119.46 136.52 54.27 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.82 0.848 . . . . 0.0 112.912 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -99.51 146.61 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.756 1.622 . . . . 0.0 111.491 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.08 -45.26 74.29 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -168.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -127.65 -32.85 2.34 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 119.732 1.151 . . . . 0.0 113.654 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -96.32 169.27 10.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.263 1.425 . . . . 0.0 108.925 167.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -120.97 19.68 11.65 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.742 1.217 . . . . 0.0 113.282 -171.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 p -142.13 164.28 30.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.524 1.53 . . . . 0.0 111.649 -162.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -158.69 179.31 9.22 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.387 1.475 . . . . 0.0 110.151 170.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -121.81 134.6 54.9 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.538 1.135 . . . . 0.0 111.943 -174.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.19 144.81 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.239 1.416 . . . . 0.0 113.583 -173.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.6 175.16 26.71 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.663 1.601 . . . . 0.0 115.396 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -63.08 -29.44 70.81 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.309 -1.113 . . . . 0.0 112.112 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -86.11 1.72 49.44 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 174.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 58.33 46.24 15.77 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.271 1.428 . . . . 0.0 114.126 166.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.52 140.1 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.505 1.122 . . . . 0.0 111.443 -172.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.3 125.88 30.89 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.379 1.471 . . . . 0.0 113.922 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.05 155.57 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.847 1.659 . . . . 0.0 112.359 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -97.69 136.49 37.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.441 1.496 . . . . 0.0 111.73 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.217 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 6.0 ttt -154.41 -40.49 0.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.136 1.774 . . . . 0.0 112.523 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt 51.43 63.74 2.12 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.655 1.982 . . . . 0.0 115.657 163.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -140.61 174.17 10.78 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -123.49 154.74 38.72 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.973 1.709 . . . . 0.0 110.809 170.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.6 m -69.63 160.74 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 121.427 0.632 . . . . 0.0 111.772 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 157.78 2.34 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 122.166 0.984 . . . . 0.0 112.921 174.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.78 -8.54 4.34 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 116.965 -2.02 . . . . 0.0 116.258 -171.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -62.6 119.82 9.97 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.039 2.419 . . . . 0.0 110.077 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.2 mmt -78.36 141.37 38.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.55 1.14 . . . . 0.0 111.797 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.1 mm -125.24 135.68 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.406 1.883 . . . . 0.0 109.785 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 tp -76.73 123.61 26.43 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.895 1.278 . . . . 0.0 112.623 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -123.54 176.84 5.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.736 1.214 . . . . 0.0 112.146 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.86 68.1 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.353 -0.842 . . . . 0.0 112.804 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 p -100.01 -14.45 18.65 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.297 1.439 . . . . 0.0 113.434 -170.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.99 -107.41 0.41 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.375 1.464 . . . . 0.0 110.754 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.36 150.91 48.26 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.291 1.036 . . . . 0.0 112.455 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.7 t -140.05 146.59 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.116 2.166 . . . . 0.0 107.738 168.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.34 149.49 47.3 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.8 -1.188 . . . . 0.0 111.077 175.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.0 tt -60.83 -30.81 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 120.63 -1.293 . . . . 0.0 112.887 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -65.58 -18.05 65.04 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.823 1.649 . . . . 0.0 114.179 171.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -116.62 -5.14 11.65 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.644 1.978 . . . . 0.0 112.776 -174.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.4 mm -65.17 134.53 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.123 -0.986 . . . . 0.0 108.543 158.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -120.54 156.9 30.61 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.777 1.631 . . . . 0.0 111.544 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.45 136.27 58.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 167.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.68 -4.05 86.31 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.212 0.91 . . . . 0.0 113.83 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -74.79 -179.68 4.33 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.683 1.241 . . . . 0.0 111.224 167.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -126.1 141.52 51.91 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.51 1.524 . . . . 0.0 112.103 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.67 153.7 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.608 1.563 . . . . 0.0 110.101 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.6 mm -71.06 134.89 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 121.676 -0.64 . . . . 0.0 111.175 171.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.94 120.02 20.89 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.088 1.355 . . . . 0.0 108.014 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.9 m -86.7 107.76 18.36 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -54.52 113.08 4.67 Favored Pre-proline 0 CA--C 1.551 1.015 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.84 175.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.37 -8.42 22.04 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 122.604 2.203 . . . . 0.0 114.129 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -72.79 -41.67 64.73 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.181 1.393 . . . . 0.0 112.674 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.8 t -143.36 -4.13 0.9 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.254 1.422 . . . . 0.0 112.49 -165.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 58.54 32.0 21.65 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.02 1.728 . . . . 0.0 114.17 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.71 129.59 40.02 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 169.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.52 107.49 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.887 0.875 . . . . 0.0 109.579 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.19 163.39 33.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.707 1.203 . . . . 0.0 111.535 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.39 135.53 35.15 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 121.53 -0.731 . . . . 0.0 110.188 171.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HE3' ' CE1' ' A' ' 121' ' ' PHE . 72.2 mmtt -131.62 150.13 52.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.435 1.494 . . . . 0.0 110.657 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.4 t -82.58 156.51 23.9 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.73 126.97 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.733 1.613 . . . . 0.0 110.962 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.75 -47.4 11.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.834 1.254 . . . . 0.0 113.434 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -146.1 156.0 43.14 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.536 1.935 . . . . 0.0 110.376 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.3 p -125.17 118.45 26.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.354 1.862 . . . . 0.0 111.027 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -108.97 152.69 24.61 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.031 1.332 . . . . 0.0 113.57 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.2 141.31 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.582 1.953 . . . . 0.0 110.729 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -141.77 176.54 8.83 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.36 1.864 . . . . 0.0 110.704 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -127.84 139.58 52.55 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.532 1.533 . . . . 0.0 111.614 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 t -147.91 147.17 29.43 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.138 1.375 . . . . 0.0 111.518 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 p -88.49 -19.37 26.54 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.215 1.006 . . . . 0.0 113.002 164.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -97.48 110.84 23.32 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.477 1.111 . . . . 0.0 109.904 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.9 mt -121.92 169.23 11.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.378 1.071 . . . . 0.0 112.37 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 tp -138.24 130.32 28.6 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.465 1.506 . . . . 0.0 109.425 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -112.51 119.89 39.73 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.426 -0.796 . . . . 0.0 109.168 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.9 mt -108.69 140.18 42.45 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.699 0.799 . . . . 0.0 109.534 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.6 m -110.14 119.68 40.06 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 166.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.75 117.43 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.515 1.126 . . . . 0.0 109.884 -177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.06 30.3 46.06 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-O 119.5 -0.611 . . . . 0.0 114.442 -175.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.04 -7.49 80.97 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.45 1.5 . . . . 0.0 115.605 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -97.88 118.97 35.65 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.262 1.425 . . . . 0.0 111.073 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.9 133.49 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.139 0.575 . . . . 0.0 111.481 170.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.7 mt -133.98 105.76 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 127.382 2.273 . . . . 0.0 108.656 173.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -87.99 120.72 29.61 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.874 1.669 . . . . 0.0 112.739 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 t -142.02 175.41 9.75 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.389 1.476 . . . . 0.0 112.581 -164.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.2 p -83.64 153.56 24.2 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.977 0.894 . . . . 0.0 111.293 167.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -62.11 -18.29 60.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.505 1.122 . . . . 0.0 113.328 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -104.01 0.93 30.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.448 1.499 . . . . 0.0 113.902 -178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -65.2 127.64 93.06 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 119.619 1.1 . . . . 0.0 112.952 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -79.86 123.82 5.37 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.02 2.48 . . . . 0.0 114.325 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -112.2 143.54 43.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.758 2.423 . . . . 0.0 111.282 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -88.07 126.46 35.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.159 0.89 . . . . 0.0 112.492 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -102.45 135.59 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.642 1.977 . . . . 0.0 110.822 -178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -53.51 129.15 31.51 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.9 1.28 . . . . 0.0 110.785 174.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.3 t70 61.12 13.43 4.71 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.532 1.933 . . . . 0.0 115.518 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.4 t -135.77 -45.33 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 121.026 -1.047 . . . . 0.0 113.072 -172.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.49 -159.07 17.08 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.999 0.809 . . . . 0.0 113.456 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -77.88 145.24 36.34 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -170.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.0 p -149.78 150.45 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 127.427 2.291 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.02 140.81 58.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 173.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.47 -40.18 65.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.024 1.73 . . . . 0.0 113.689 -177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.35 -8.26 87.59 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.966 -1.084 . . . . 0.0 113.966 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -97.21 -5.03 37.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.637 1.575 . . . . 0.0 112.121 171.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.53 155.21 41.01 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.095 -1.003 . . . . 0.0 111.292 164.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -123.27 170.12 10.6 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.579 1.151 . . . . 0.0 110.429 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.35 136.37 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.616 -0.677 . . . . 0.0 109.695 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 5.13 87.93 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.103 -0.832 . . . . 0.0 115.09 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -76.22 153.36 36.12 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.522 1.161 . . . . 0.0 110.599 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.47 107.76 18.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.591 1.157 . . . . 0.0 111.791 -169.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.6 mt -99.95 172.82 6.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.547 1.139 . . . . 0.0 111.047 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.2 mt -123.68 165.23 17.58 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.885 0.874 . . . . 0.0 112.705 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -117.73 -174.51 2.64 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.354 1.462 . . . . 0.0 114.745 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.9 p -58.19 -1.31 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.811 2.444 . . . . 0.0 117.235 175.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -115.89 -20.91 9.79 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.473 1.509 . . . . 0.0 112.66 170.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.88 13.18 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.98 1.752 . . . . 0.0 112.606 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -96.06 137.56 34.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.689 1.195 . . . . 0.0 112.377 -173.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.4 t -67.45 119.85 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.603 1.161 . . . . 0.0 113.534 -170.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.13 159.41 15.56 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.455 2.302 . . . . 0.0 112.612 169.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 t -126.17 139.14 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.977 1.311 . . . . 0.0 111.582 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.83 125.52 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.92 0.888 . . . . 0.0 109.874 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.28 -30.94 10.78 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 127.357 2.263 . . . . 0.0 112.933 -175.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -156.65 152.96 27.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.497 1.119 . . . . 0.0 111.121 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -136.54 101.31 4.6 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.277 1.831 . . . . 0.0 109.545 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -104.77 130.58 52.84 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.314 1.846 . . . . 0.0 110.909 -171.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.9 tp -120.37 128.79 53.56 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.831 1.252 . . . . 0.0 110.81 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.17 162.1 41.42 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.125 1.37 . . . . 0.0 112.874 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.63 117.73 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.157 1.383 . . . . 0.0 108.86 171.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.88 142.62 53.23 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.583 -0.698 . . . . 0.0 112.2 167.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.6 -26.35 67.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.031 1.332 . . . . 0.0 112.987 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -146.91 150.87 40.38 Favored Pre-proline 0 N--CA 1.47 0.531 0 C-N-CA 127.051 2.14 . . . . 0.0 109.988 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -56.63 127.54 26.31 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.473 2.782 . . . . 0.0 112.869 -176.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.3 t -99.04 141.36 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 127.072 2.149 . . . . 0.0 110.095 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -74.19 144.85 44.58 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.893 0.769 . . . . 0.0 112.079 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.78 144.26 27.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.309 1.444 . . . . 0.0 110.565 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -128.8 147.59 50.81 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.521 1.529 . . . . 0.0 110.41 -166.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -156.46 171.64 19.91 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.537 1.135 . . . . 0.0 111.685 169.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -149.78 163.37 38.16 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.465 -0.772 . . . . 0.0 112.117 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.68 144.24 43.27 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.666 1.186 . . . . 0.0 113.204 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.9 t -104.76 147.84 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.059 1.744 . . . . 0.0 111.676 -168.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.35 -72.4 0.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.8 -19.98 12.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -166.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.47 ' CE1' ' HE3' ' A' ' 39' ' ' LYS . 10.5 m-30 -105.92 175.34 5.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.273 1.829 . . . . 0.0 108.524 165.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -132.21 33.13 3.9 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.164 1.386 . . . . 0.0 112.729 178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.1 p -139.75 159.01 43.16 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.061 1.744 . . . . 0.0 112.17 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -158.29 -173.32 4.26 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.82 1.648 . . . . 0.0 110.768 170.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -131.67 141.4 49.58 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.885 1.274 . . . . 0.0 113.392 -170.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.98 142.39 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.678 1.191 . . . . 0.0 112.625 -173.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.55 173.8 23.41 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.283 1.421 . . . . 0.0 115.697 175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.4 -31.2 72.29 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.982 -1.305 . . . . 0.0 113.367 -176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -84.04 2.19 40.31 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.842 1.257 . . . . 0.0 114.0 173.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 57.88 46.16 17.25 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.454 1.901 . . . . 0.0 114.551 166.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.84 136.53 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.569 1.148 . . . . 0.0 111.515 -170.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 54.1 tp -77.86 126.19 30.47 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.786 1.634 . . . . 0.0 112.639 -176.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.3 m -137.15 157.2 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.768 1.627 . . . . 0.0 111.142 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -108.28 161.38 15.06 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.531 1.132 . . . . 0.0 112.924 -172.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.663 1.585 . . . . 0.0 112.953 171.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 7.7 ttm -76.84 125.8 29.9 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.344 1.458 . . . . 0.0 111.116 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -133.07 73.12 1.5 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.909 2.084 . . . . 0.0 110.178 -168.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -135.8 167.27 21.48 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -171.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.429 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 85.9 m-85 -123.6 154.24 39.58 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.552 1.541 . . . . 0.0 111.276 172.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.92 161.53 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 121.53 0.681 . . . . 0.0 112.053 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.32 154.23 3.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.206 1.002 . . . . 0.0 112.681 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.96 -9.0 7.04 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 117.546 -1.697 . . . . 0.0 116.3 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.0 m -63.03 121.57 13.91 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 121.179 2.49 . . . . 0.0 110.373 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 mmt -78.35 142.94 37.32 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.694 1.597 . . . . 0.0 111.72 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.8 mm -127.32 132.91 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.697 1.999 . . . . 0.0 109.867 -175.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -77.92 123.07 26.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.699 1.199 . . . . 0.0 112.552 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -117.44 178.87 4.22 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.507 1.123 . . . . 0.0 113.647 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.84 52.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.45 1.1 . . . . 0.0 113.832 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 p -113.82 -28.04 7.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.924 1.29 . . . . 0.0 113.706 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.76 -107.96 0.34 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.271 0.939 . . . . 0.0 111.476 -171.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -127.29 149.2 50.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.483 1.113 . . . . 0.0 113.204 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.9 t -142.35 147.73 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 127.286 2.234 . . . . 0.0 108.389 170.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.6 147.09 41.97 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.888 -1.133 . . . . 0.0 111.27 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.4 tt -61.34 -29.47 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 120.614 -1.304 . . . . 0.0 112.926 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.46 -8.22 44.86 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.918 1.287 . . . . 0.0 114.434 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -119.4 -8.0 10.11 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.749 1.62 . . . . 0.0 113.489 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.19 136.53 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.117 -0.99 . . . . 0.0 110.052 165.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -117.92 166.31 12.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.907 2.083 . . . . 0.0 110.312 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.9 147.02 54.13 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.479 -0.763 . . . . 0.0 111.032 163.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.37 3.24 82.07 Favored Glycine 0 CA--C 1.54 1.637 0 O-C-N 121.77 -0.581 . . . . 0.0 114.543 -171.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -89.81 152.94 21.04 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.099 0.96 . . . . 0.0 110.292 168.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -115.85 120.9 40.74 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.799 1.239 . . . . 0.0 112.709 -168.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 m -110.32 154.06 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 126.88 2.072 . . . . 0.0 110.257 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.3 mm -75.53 135.16 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 O-C-N 121.604 -0.685 . . . . 0.0 109.773 166.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.99 121.48 28.07 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.2 m -101.46 104.1 15.02 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -55.96 114.75 8.08 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.96 -1.019 . . . . 0.0 111.83 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -65.96 -5.53 12.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.168 1.912 . . . . 0.0 113.443 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -69.07 -42.51 76.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.833 0.853 . . . . 0.0 112.538 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.2 t -150.01 5.66 0.58 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.787 0.835 . . . . 0.0 112.928 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.265 21.0 m-85 57.11 41.54 27.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.34 1.456 . . . . 0.0 112.642 -173.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -78.79 131.37 36.5 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 165.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.22 123.93 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.133 0.973 . . . . 0.0 109.912 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.38 153.22 43.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -82.27 117.39 22.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.199 1.0 . . . . 0.0 109.96 168.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -132.28 146.63 52.13 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.707 1.203 . . . . 0.0 112.351 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 t -83.99 155.65 22.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.367 1.067 . . . . 0.0 113.766 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.7 t -87.22 132.98 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 125.645 1.578 . . . . 0.0 111.295 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.3 mt -90.92 -41.37 11.18 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.207 1.003 . . . . 0.0 112.866 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.25 150.67 35.29 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.247 1.819 . . . . 0.0 110.376 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.3 p -121.48 121.57 37.82 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.441 1.897 . . . . 0.0 109.999 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -106.89 144.33 33.69 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.78 1.632 . . . . 0.0 114.214 -174.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.3 t -141.24 133.0 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.861 0.864 . . . . 0.0 112.126 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 64.6 mmt-85 -138.16 175.13 9.85 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.512 1.925 . . . . 0.0 110.652 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -136.63 136.29 39.03 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.029 0.931 . . . . 0.0 112.941 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -151.1 150.93 31.27 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.495 1.118 . . . . 0.0 112.107 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.4 p -90.94 -16.86 27.36 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.177 1.391 . . . . 0.0 113.874 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.39 106.89 17.52 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.363 1.065 . . . . 0.0 109.999 -169.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.3 mt -117.69 162.24 18.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.69 1.233 . . . . 0.0 113.372 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -127.3 132.56 50.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.13 1.772 . . . . 0.0 109.029 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -111.08 125.43 53.76 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.172 0.989 . . . . 0.0 108.875 174.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 mt -112.44 140.82 46.86 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.594 0.758 . . . . 0.0 109.568 170.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.3 m -113.84 119.04 35.94 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.7 mt -127.24 117.32 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.111 0.965 . . . . 0.0 108.859 -172.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.88 21.08 28.88 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.79 -4.35 53.25 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.617 1.58 . . . . 0.0 116.306 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -107.08 127.92 53.92 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.128 1.771 . . . . 0.0 110.294 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 53.5 t -81.71 132.34 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.47 1.108 . . . . 0.0 111.958 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.8 mt -132.48 103.26 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.897 1.679 . . . . 0.0 109.492 174.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -81.86 121.47 26.5 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.607 1.563 . . . . 0.0 111.706 176.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -143.46 176.68 8.99 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.335 1.454 . . . . 0.0 113.477 -165.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 76.6 p -81.67 151.63 27.48 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.736 0.815 . . . . 0.0 112.255 170.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -64.17 -18.1 64.15 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.163 -0.961 . . . . 0.0 113.186 -174.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -110.98 13.41 22.08 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.429 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 1.0 OUTLIER -65.42 128.73 94.05 Favored Pre-proline 0 CA--C 1.55 0.978 0 O-C-N 120.772 -1.205 . . . . 0.0 111.582 176.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.64 125.82 5.72 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.061 2.508 . . . . 0.0 113.714 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -118.46 142.77 47.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.973 2.109 . . . . 0.0 111.788 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -85.31 133.35 34.15 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.371 0.987 . . . . 0.0 113.614 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 82.7 t -115.88 138.72 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 127.683 2.393 . . . . 0.0 111.293 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.17 130.45 42.11 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.424 0.69 . . . . 0.0 111.12 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 61.3 7.13 1.57 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.596 2.358 . . . . 0.0 116.59 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.2 t -130.64 -35.25 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.029 1.331 . . . . 0.0 111.973 -170.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.61 -150.96 22.85 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 123.938 0.78 . . . . 0.0 111.62 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . 0.292 12.3 p90 -77.4 145.69 37.07 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -174.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.78 150.02 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 128.523 2.729 . . . . 0.0 109.683 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -64.48 137.87 58.11 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.115 -0.99 . . . . 0.0 113.415 169.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.72 67.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.804 1.641 . . . . 0.0 113.304 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.35 -7.46 68.11 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.373 -0.83 . . . . 0.0 114.362 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -102.76 -6.41 22.65 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.251 1.42 . . . . 0.0 113.171 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -67.94 164.28 20.25 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.089 1.356 . . . . 0.0 112.834 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.27 162.79 27.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.611 1.564 . . . . 0.0 112.881 168.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.94 123.63 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 165.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.0 1.98 61.15 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.868 -1.518 . . . . 0.0 114.988 -170.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -76.74 152.95 35.46 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.754 2.277 . . . . 0.0 111.367 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -110.6 101.82 10.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.681 1.192 . . . . 0.0 112.413 -170.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.3 mt -91.81 170.5 9.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.929 1.692 . . . . 0.0 110.654 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.9 mt -119.32 155.73 31.32 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 170.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.3 176.87 5.56 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.908 1.283 . . . . 0.0 113.879 176.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.8 p -54.34 -22.4 12.06 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -106.79 -10.05 16.2 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.542 1.937 . . . . 0.0 112.616 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.59 13.29 28.42 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.422 1.963 . . . . 0.0 113.183 171.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -79.17 145.84 33.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.719 1.208 . . . . 0.0 111.384 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.2 t -74.69 127.9 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.565 0.746 . . . . 0.0 111.322 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.1 mt -114.26 150.79 33.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.14 2.176 . . . . 0.0 112.03 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.3 t -118.23 137.71 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 125.183 1.393 . . . . 0.0 110.474 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.4 t -73.7 119.06 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.957 0.903 . . . . 0.0 109.452 169.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -94.29 -27.88 15.89 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.852 2.461 . . . . 0.0 112.853 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -155.03 147.33 23.91 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.778 1.631 . . . . 0.0 110.248 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -132.85 116.18 16.19 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.946 1.699 . . . . 0.0 109.308 168.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -127.76 151.59 48.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.359 2.264 . . . . 0.0 110.822 -171.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.02 133.81 25.32 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.15 1.38 . . . . 0.0 109.584 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -144.68 151.21 38.6 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.1 mm -98.2 103.3 14.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.895 1.278 . . . . 0.0 108.38 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.86 150.87 31.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.09 0.956 . . . . 0.0 111.954 174.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.05 -18.81 63.3 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.14 -0.975 . . . . 0.0 112.983 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -137.68 154.68 75.06 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 126.762 2.025 . . . . 0.0 111.339 -172.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.33 110.09 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.547 2.165 . . . . 0.0 110.013 170.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.2 t -83.5 141.66 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.013 1.725 . . . . 0.0 109.631 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -77.6 139.56 39.54 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.839 0.855 . . . . 0.0 110.397 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.2 m -138.34 142.83 34.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 125.006 1.322 . . . . 0.0 111.345 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -121.79 152.46 39.47 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.514 1.526 . . . . 0.0 111.707 -167.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -156.5 165.91 34.92 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.38 2.272 . . . . 0.0 109.767 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -156.97 165.36 36.38 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.304 -1.497 . . . . 0.0 111.248 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -120.2 145.9 46.54 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.27 145.86 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.293 1.437 . . . . 0.0 112.867 -166.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -64.43 -47.34 79.47 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -170.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -109.49 -66.31 1.07 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 120.056 1.298 . . . . 0.0 109.957 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -72.71 175.93 5.99 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.667 1.187 . . . . 0.0 112.153 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -115.94 3.9 13.75 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.501 1.52 . . . . 0.0 113.349 -172.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.4 p -124.74 160.66 28.1 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.308 1.443 . . . . 0.0 113.981 -168.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -154.07 -179.62 8.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.843 2.057 . . . . 0.0 109.875 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -132.12 140.68 48.88 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.352 1.061 . . . . 0.0 113.183 -168.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.6 142.02 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -170.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.25 173.44 25.74 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.928 1.728 . . . . 0.0 115.346 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.1 -25.42 67.7 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.11 -1.229 . . . . 0.0 113.11 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -90.41 5.22 48.38 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.578 1.551 . . . . 0.0 114.667 172.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 56.11 46.5 21.44 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 164.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.53 140.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.379 1.072 . . . . 0.0 111.779 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.06 126.22 31.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.749 1.62 . . . . 0.0 113.491 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.6 m -145.82 162.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.542 1.937 . . . . 0.0 111.429 -173.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -116.92 141.07 48.71 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.431 1.492 . . . . 0.0 113.049 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.209 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 49.1 p . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' MET . . . . . . . . . . . . . 7.8 ttt -163.45 123.8 2.24 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.122 0.569 . . . . 0.0 110.184 -174.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -127.58 79.07 1.87 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.304 -0.872 . . . . 0.0 111.017 -170.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -146.72 174.73 11.2 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.21 1.004 . . . . 0.0 112.801 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.435 ' CE2' ' CE1' ' A' ' 68' ' ' HIS . 98.6 m-85 -124.73 154.64 40.55 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.1 1.36 . . . . 0.0 111.071 172.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.51 158.0 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.203 0.525 . . . . 0.0 111.661 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.1 151.8 0.92 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.218 1.007 . . . . 0.0 112.371 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.07 -17.26 7.55 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.437 -1.757 . . . . 0.0 116.077 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.6 m -61.89 124.19 20.1 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 120.707 2.253 . . . . 0.0 110.11 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -82.12 141.62 32.95 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.879 1.272 . . . . 0.0 111.538 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.0 mm -117.33 133.32 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.619 1.968 . . . . 0.0 109.577 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.7 tp -71.28 127.18 31.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.678 0.752 . . . . 0.0 112.969 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 p -127.81 166.02 19.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.02 1.328 . . . . 0.0 110.423 174.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.51 -31.04 70.12 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.503 -0.748 . . . . 0.0 112.126 168.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.8 p -80.02 -25.99 39.99 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.199 1.4 . . . . 0.0 112.677 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.72 -99.11 0.19 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.84 2.162 . . . . 0.0 111.039 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.0 mt -134.98 149.28 50.18 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.745 1.218 . . . . 0.0 111.855 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.63 143.69 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.633 1.573 . . . . 0.0 108.552 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.45 146.12 53.47 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.022 -1.048 . . . . 0.0 111.127 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.7 tt -60.8 -30.59 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 120.942 -1.099 . . . . 0.0 113.107 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.27 -16.77 63.65 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.471 1.109 . . . . 0.0 113.836 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -109.37 -12.55 14.73 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.794 1.638 . . . . 0.0 113.117 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.7 mm -63.03 135.64 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.09 0.859 . . . . 0.0 109.421 164.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -127.75 156.09 42.98 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.885 1.674 . . . . 0.0 111.442 175.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.93 135.27 56.01 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.223 -0.923 . . . . 0.0 111.457 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.11 -19.54 54.05 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.712 -1.049 . . . . 0.0 115.166 -170.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -68.42 166.11 17.44 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.899 1.349 . . . . 0.0 111.121 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -124.21 138.67 54.38 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.077 1.351 . . . . 0.0 112.836 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.04 163.88 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.206 1.802 . . . . 0.0 111.203 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 mm -80.09 145.88 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.227 0.536 . . . . 0.0 111.56 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.55 132.3 21.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 m -97.43 112.03 24.04 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.5 0.667 . . . . 0.0 109.864 172.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -52.76 114.83 6.26 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.448 1.499 . . . . 0.0 113.288 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.75 -7.07 19.52 Favored 'Trans proline' 0 CA--C 1.549 1.269 0 C-N-CA 122.877 2.385 . . . . 0.0 115.299 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -79.44 -38.67 34.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.257 1.423 . . . . 0.0 113.261 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.6 t -141.76 -1.8 1.24 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.784 1.234 . . . . 0.0 112.873 -168.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . 0.26 33.8 m-85 55.13 33.78 21.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.915 2.086 . . . . 0.0 114.244 -175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -77.95 135.02 37.76 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.632 -0.668 . . . . 0.0 110.342 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.02 122.07 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.317 1.047 . . . . 0.0 110.927 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.13 151.7 41.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.765 0.793 . . . . 0.0 112.872 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -90.14 124.6 34.96 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.213 1.405 . . . . 0.0 109.291 174.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -134.44 150.89 50.88 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.584 1.154 . . . . 0.0 111.424 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.3 t -79.76 153.58 29.11 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -88.83 133.0 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.32 1.848 . . . . 0.0 110.624 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 mt -90.73 -44.21 9.61 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.66 0.784 . . . . 0.0 112.682 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -141.58 157.81 44.64 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.503 1.521 . . . . 0.0 110.641 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.7 p -130.98 116.34 17.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.842 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -103.48 157.94 16.69 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.989 1.315 . . . . 0.0 113.309 -175.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.74 142.52 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.883 2.073 . . . . 0.0 110.204 175.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 58.1 mmt-85 -140.38 172.81 12.21 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.239 2.215 . . . . 0.0 109.933 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -141.34 135.05 30.12 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.95 -1.094 . . . . 0.0 113.064 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.3 t -151.01 152.59 33.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.875 0.87 . . . . 0.0 112.019 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.7 p -86.24 -15.48 40.66 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.988 1.315 . . . . 0.0 113.43 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -105.75 108.35 19.81 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.205 0.911 . . . . 0.0 112.262 -171.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.6 mt -116.67 160.53 20.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.358 1.075 . . . . 0.0 113.658 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -123.69 138.57 54.5 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.123 1.769 . . . . 0.0 109.945 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.1 m170 -115.93 128.13 55.53 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.656 1.582 . . . . 0.0 109.253 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.3 mt -128.92 132.76 47.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.233 1.013 . . . . 0.0 110.182 175.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -99.13 113.01 25.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 169.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 mp -107.74 113.19 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.462 1.105 . . . . 0.0 108.469 175.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.73 -28.67 0.14 Allowed Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.744 2.116 . . . . 0.0 116.751 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.26 -0.35 0.32 Allowed Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.723 1.63 . . . . 0.0 114.073 -165.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -112.31 124.27 52.11 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.511 1.524 . . . . 0.0 109.533 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.56 114.17 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.331 0.652 . . . . 0.0 109.674 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.7 mt -106.31 101.34 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.412 1.085 . . . . 0.0 109.12 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.99 122.18 21.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.019 1.328 . . . . 0.0 110.65 168.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 t -146.91 175.68 10.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.306 1.043 . . . . 0.0 112.639 -168.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.4 p -78.18 146.49 34.98 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.521 -0.737 . . . . 0.0 111.137 169.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.84 -28.45 66.08 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.022 -1.049 . . . . 0.0 112.442 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -96.83 0.14 48.82 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.56 1.544 . . . . 0.0 113.305 -171.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.435 ' CE1' ' CE2' ' A' ' 2' ' ' PHE . 2.3 t60 -64.8 129.15 94.26 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.473 1.509 . . . . 0.0 113.305 -177.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.52 113.68 2.62 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.463 2.775 . . . . 0.0 114.093 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -103.25 143.69 32.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.133 2.173 . . . . 0.0 111.408 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -89.33 126.18 35.42 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -103.95 135.75 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.489 1.515 . . . . 0.0 111.213 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -57.04 129.12 40.34 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.633 1.173 . . . . 0.0 112.936 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.8 t0 56.19 23.8 7.41 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.172 1.789 . . . . 0.0 114.45 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.5 t -140.74 -50.39 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.799 1.239 . . . . 0.0 111.92 -172.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.21 -169.17 22.53 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.727 0.68 . . . . 0.0 114.201 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -75.8 146.77 39.7 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -162.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.1 p -150.68 146.91 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.89 1.676 . . . . 0.0 111.854 -173.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -54.55 133.31 46.2 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.556 0.742 . . . . 0.0 112.664 171.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.26 -36.7 66.34 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.607 1.563 . . . . 0.0 113.137 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.4 -4.89 81.02 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.03 -1.044 . . . . 0.0 114.739 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -107.45 -4.44 18.48 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.228 1.811 . . . . 0.0 112.553 176.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.59 151.52 46.26 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.449 -0.782 . . . . 0.0 110.428 155.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -118.34 173.78 6.62 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.064 1.346 . . . . 0.0 110.375 170.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.1 t -66.36 139.92 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 165.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.93 9.62 86.93 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 119.099 -0.834 . . . . 0.0 114.565 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -86.38 154.91 20.84 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.28 1.54 . . . . 0.0 110.228 169.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -113.56 115.57 28.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.322 1.049 . . . . 0.0 113.606 -164.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.9 mt -104.98 -176.85 3.19 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.022 2.129 . . . . 0.0 111.441 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.9 mt -131.01 158.89 39.07 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.605 1.162 . . . . 0.0 113.193 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 p30 -109.49 172.29 6.94 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.728 1.211 . . . . 0.0 113.395 169.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 t -45.54 -36.88 4.9 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.146 1.779 . . . . 0.0 114.116 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -88.63 -16.92 31.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.054 1.742 . . . . 0.0 113.114 -176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.46 20.56 10.81 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.914 1.721 . . . . 0.0 112.763 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -83.26 141.02 32.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.444 0.698 . . . . 0.0 110.582 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.93 115.45 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.641 0.776 . . . . 0.0 110.08 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.9 mt -97.01 161.41 13.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.427 1.491 . . . . 0.0 111.449 170.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.84 144.85 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.07 0.948 . . . . 0.0 110.643 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.54 130.99 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.426 0.69 . . . . 0.0 109.66 170.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -108.27 -28.08 9.65 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.838 2.055 . . . . 0.0 112.079 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -157.75 149.59 22.01 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.129 1.772 . . . . 0.0 110.384 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -131.73 130.84 42.46 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.701 2.0 . . . . 0.0 109.629 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -143.2 155.06 44.44 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.023 1.729 . . . . 0.0 111.513 -175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 tp -132.8 144.14 50.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.89 1.676 . . . . 0.0 109.267 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.45 153.81 41.57 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.372 0.987 . . . . 0.0 113.183 166.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 mm -101.4 121.04 51.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 169.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.5 152.78 44.5 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.198 0.999 . . . . 0.0 112.953 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -69.63 -28.7 66.13 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.702 -1.249 . . . . 0.0 111.838 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -144.34 148.35 40.48 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.983 2.113 . . . . 0.0 110.123 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -54.69 120.0 7.37 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.489 3.459 . . . . 0.0 112.576 -176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.73 139.54 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.359 1.463 . . . . 0.0 109.496 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -76.89 139.19 40.15 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.936 0.874 . . . . 0.0 111.212 176.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.37 147.93 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.279 1.432 . . . . 0.0 110.516 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.72 148.22 50.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.849 1.26 . . . . 0.0 110.893 -165.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -157.54 168.38 27.47 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.462 1.105 . . . . 0.0 111.803 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -153.19 163.66 39.49 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.838 -1.164 . . . . 0.0 112.972 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -113.97 143.86 44.03 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.69 136.13 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 125.528 1.531 . . . . 0.0 112.974 -166.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.18 -28.41 69.11 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -141.62 -44.23 0.36 Allowed 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.978 -1.076 . . . . 0.0 112.607 173.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -71.45 171.67 10.88 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.441 1.115 . . . . 0.0 111.973 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -124.84 12.29 8.46 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.854 2.061 . . . . 0.0 112.715 -169.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.4 p -142.53 168.87 18.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.497 2.319 . . . . 0.0 111.519 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -160.64 175.13 13.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.118 2.167 . . . . 0.0 109.617 166.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -122.74 135.57 54.61 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.046 0.939 . . . . 0.0 113.141 -170.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.94 140.74 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.555 1.542 . . . . 0.0 112.429 -172.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.73 170.15 20.27 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.671 1.605 . . . . 0.0 115.46 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.85 -22.49 66.54 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.693 -1.475 . . . . 0.0 113.023 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -81.49 2.78 27.35 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.182 1.393 . . . . 0.0 114.445 171.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 61.27 38.94 16.16 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.701 1.2 . . . . 0.0 113.345 164.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.63 137.36 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.668 1.587 . . . . 0.0 112.019 -164.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 34.2 tp -83.14 120.43 25.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.154 1.382 . . . . 0.0 113.848 -171.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.94 157.46 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.644 1.578 . . . . 0.0 112.052 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -106.87 128.94 54.72 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -167.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--O 1.25 1.098 0 C-N-CA 125.74 1.616 . . . . 0.0 111.993 172.461 . . . . . . . . 0 0 . 1 stop_ save_